PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Cincotta, RP; Wisnewski, J; Engelman, R				Cincotta, RP; Wisnewski, J; Engelman, R			Human population in the biodiversity hotspots	NATURE			English	Article								Biologists have identified 25 areas, called biodiversity hotspots, that are especially rich in endemic species and particularly threatened by human activities. The human population dynamics of these areas, however, are not well quantified. Here we report estimates of key demographic variables for each hotspot, and for three extensive tropical forest areas(1) that are less immediately threatened. We estimate that in 1995 more than 1.1 billion people, nearly 20% of world population, were living within the hotspots, an area covering about 12% of Earth's terrestrial surface. We estimate that the population growth rate in the hotspots (1995-2000) is 1.8% yr(-1), substantially higher than the population growth rate of the world as a whole (1.3% yr(-1)) and above that of the developing countries (1.6% yr(-1)). These results suggest that substantial human-induced environmental changes are likely to continue in the hotspots and that demographic change remains an important factor in global biodiversity conservation. The results also underline the potential conservation significance of the continuing worldwide declines in human fertility and of policies and programs that influence human migration.	Populat Act Int, Res Dept, Washington, DC 20036 USA		Cincotta, RP (corresponding author), Populat Act Int, Res Dept, 1300 19th St NW,2nd Floor, Washington, DC 20036 USA.	cincotta@popact.org						Mittermeier R.A., 1988, P145; Mittermeier R. A., 1999, CHELONIAN CONSERV BI; Mittermeier RA, 1998, CONSERV BIOL, V12, P516, DOI 10.1046/j.1523-1739.1998.012003516.x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Myers N, 1990, Environmentalist, V10, P243, DOI 10.1007/BF02239720; MYERS N, 1994, POPULATION COMPLEX R, P117; NEWMAN JL, 1984, POPULATION PATTERNS; Repetto R, 1994, 2 INDIA REVISITED PO; STEDMANEDWARDS P, 1997, ROOT CAUSES BIODIVER; TOBLER W, 1995, 956 U CAL NAT CTR GE; *UN POP DIV, 1998, WORLD POP PROSP 1998	12	639	690	10	286	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 27	2000	404	6781					990	992		10.1038/35010105	http://dx.doi.org/10.1038/35010105			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801126				2022-12-24	WOS:000086762000054
J	Omer, AD; Lowe, TM; Russell, AG; Ebhardt, H; Eddy, SR; Dennis, PP				Omer, AD; Lowe, TM; Russell, AG; Ebhardt, H; Eddy, SR; Dennis, PP			Homologs of small nucleolar RNAs in archaea	SCIENCE			English	Article							ARCHAEBACTERIUM SULFOLOBUS-ACIDOCALDARIUS; EUKARYOTIC RIBOSOMAL-RNA; PRERIBOSOMAL RNA; GUIDE SNORNAS; METHYLATION; SOLFATARICUS; SEQUENCES; PROTEIN; 16S; IDENTIFICATION	In eukaryotes, dozens of posttranscriptional modifications are directed to specific nucleotides in ribosomal RNAs (rRNAs) by small nucleolar RNAs (snoRNAs). We identified homologs of snoRNA genes in both branches of the Archaea. Eighteen small sno-like RNAs (sRNAs) were cloned from the archaeon Sulfolobus acidocaldarius by coimmunoprecipitation with archaeal fibrillarin and NOP56, the homologs of eukaryotic snoRNA-associated proteins. We trained a probabilistic model on these sRNAs to search for more sRNAs in archaeal genomic sequences. Over 200 additional sRNAs were identified in seven archaeal genomes representing both the Crenarchaeota and the Euryarchaeota, snoRNA-based rRNA processing was therefore probably present in, the Last common ancestor of Archaea and Eukarya, predating the evolution of a morphologically distinct nucleolus.	Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of British Columbia; Washington University (WUSTL)	Dennis, PP (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2146 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.		Omer, Arina/AAS-7960-2021; Lowe, Todd Michael/ABJ-5261-2022	Eddy, Sean/0000-0001-6676-4706	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001363] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01363] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMIRI KA, 1994, J BACTERIOL, V176, P2124, DOI 10.1128/jb.176.7.2124-2127.1994; Armbruster DW, 1997, J BIOL CHEM, V272, P19758, DOI 10.1074/jbc.272.32.19758; Balakin AG, 1996, CELL, V86, P823, DOI 10.1016/S0092-8674(00)80156-7; BousquetAntonelli C, 1997, EMBO J, V16, P4770, DOI 10.1093/emboj/16.15.4770; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Chamberlain JR, 1998, GENE DEV, V12, P1678, DOI 10.1101/gad.12.11.1678; DAMS E, 1983, NUCLEIC ACIDS RES, V11, P4667, DOI 10.1093/nar/11.14.4667; DANIELS CJ, COMMUNICATION; DUROVIC P, 1994, MOL MICROBIOL, V13, P229, DOI 10.1111/j.1365-2958.1994.tb00418.x; DUROVIC P, 1994, J BACTERIOL, V176, P514, DOI 10.1128/JB.176.2.514-517.1994; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; GUPTA R, 1984, J BIOL CHEM, V259, P9461; Kiss-Laszlo Z, 1998, EMBO J, V17, P797, DOI 10.1093/emboj/17.3.797; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Lafontaine DLJ, 1998, TRENDS BIOCHEM SCI, V23, P383, DOI 10.1016/S0968-0004(98)01260-2; Lowe TM, 1999, SCIENCE, V283, P1168, DOI 10.1126/science.283.5405.1168; MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4; MAXWELL ES, 1995, ANNU REV BIOCHEM, V64, P897, DOI 10.1146/annurev.bi.64.070195.004341; Michot B, 1999, NUCLEIC ACIDS RES, V27, P2271, DOI 10.1093/nar/27.11.2271; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Noon KR, 1998, J BACTERIOL, V180, P2883, DOI 10.1128/JB.180.11.2883-2888.1998; OLSEN GJ, 1985, J MOL EVOL, V22, P301, DOI 10.1007/BF02115685; Pederson T, 1998, NUCLEIC ACIDS RES, V26, P3871, DOI 10.1093/nar/26.17.3871; STAHL DA, 1981, NUCLEIC ACIDS RES, V9, P6129, DOI 10.1093/nar/9.22.6129; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOLLERVEY D, 1991, EMBO J, V10, P573, DOI 10.1002/j.1460-2075.1991.tb07984.x; Tycowski KT, 1996, P NATL ACAD SCI USA, V93, P14480, DOI 10.1073/pnas.93.25.14480; Tycowski KT, 1998, MOL CELL, V2, P629, DOI 10.1016/S1097-2765(00)80161-6; Weinstein LB, 1999, CURR OPIN CELL BIOL, V11, P378, DOI 10.1016/S0955-0674(99)80053-2; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P4576, DOI 10.1073/pnas.87.12.4576; Wu P, 1998, J BIOL CHEM, V273, P16453, DOI 10.1074/jbc.273.26.16453	34	264	277	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2000	288	5465					517	522		10.1126/science.288.5465.517	http://dx.doi.org/10.1126/science.288.5465.517			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775111				2022-12-24	WOS:000086626000046
J	Young, RK				Young, RK			The old man's friend	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2000	283	14					1793	1794		10.1001/jama.283.14.1793	http://dx.doi.org/10.1001/jama.283.14.1793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300HY	10770128				2022-12-24	WOS:000086248600001
J	Agalarov, SC; Prasad, GS; Funke, PM; Stout, CD; Williamson, JR				Agalarov, SC; Prasad, GS; Funke, PM; Stout, CD; Williamson, JR			Structure of the S15,S18-rRNA complex: Assembly of the 30S ribosome central domain	SCIENCE			English	Article							ESCHERICHIA-COLI; PROTEIN S15; THERMUS-THERMOPHILUS; RIBONUCLEOPROTEIN PARTICLE; BINDING-SITE; RNA; 16S; SUBUNIT; S6	The crystal structure of a 70-kilodalton ribonucleoprotein complex from the central domain of the Thermus thermophilus 30S ribosomal subunit was solved at 2.6 angstrom resolution. The complex consists of a 104-nucleotide RNA fragment composed of two three-helix junctions that Lie at the end of a central helix, and the ribosomal proteins S15, S6, and S18. S15 binds the ribosomal RNA early in the assembly of the 30S ribosomal subunit, stabilizing a conformational reorganization of the two three-helix junctions that creates the RNA fold necessary for subsequent binding of S6 and S18. The structure of the complex demonstrates the central role of S15-induced reorganization of central domain RNA for the subsequent steps of ribosome assembly.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; Russian Acad Sci, Inst Prot Res, Pushchino 142292, Russia; MIT, Dept Chem, Cambridge, MA 02139 USA	Scripps Research Institute; Scripps Research Institute; Russian Academy of Sciences; Massachusetts Institute of Technology (MIT)	Stout, CD (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.		Williamson, James R/B-2891-2009; Williamson, James/AAL-2104-2021; Agalarov, Sultan/L-1969-2015	Williamson, James R/0000-0002-8772-468X; Williamson, James/0000-0002-8772-468X; Agalarov, Sultan/0000-0002-2567-447X	NIGMS NIH HHS [GM53757] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053757, R37GM053757] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGALAROV AS, UNPUB; Agalarov SC, 2000, RNA, V6, P402, DOI 10.1017/S1355838200991945; Agalarov SC, 1998, P NATL ACAD SCI USA, V95, P999, DOI 10.1073/pnas.95.3.999; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; Batey RT, 1996, J MOL BIOL, V261, P550, DOI 10.1006/jmbi.1996.0482; Batey RT, 1998, RNA, V4, P984, DOI 10.1017/S1355838298980426; Batey RT, 1996, J MOL BIOL, V261, P536, DOI 10.1006/jmbi.1996.0481; Berglund H, 1997, NAT STRUCT BIOL, V4, P20, DOI 10.1038/nsb0197-20; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAPEL MS, 1988, J MOL BIOL, V200, P65, DOI 10.1016/0022-2836(88)90334-8; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1998, STRUCT FOLD DES, V6, P429, DOI 10.1016/S0969-2126(98)00045-8; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; GREGORY RJ, 1984, J MOL BIOL, V178, P287, DOI 10.1016/0022-2836(84)90145-1; GUTELL RR, 1994, NUCLEIC ACIDS RES, V22, P3502, DOI 10.1093/nar/22.17.3502; HELD WA, 1974, J BIOL CHEM, V249, P3103; LESLIE AGW, 1994, ACTA CRYSTALLOGR D, V50, P760; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MOAZED D, 1990, J MOL BIOL, V211, P135, DOI 10.1016/0022-2836(90)90016-F; Orr JW, 1998, J MOL BIOL, V275, P453, DOI 10.1006/jmbi.1997.1489; OTWINOWSKI Z, 1994, ACTA CRYSTALLOGR D, V50, P760; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; POWERS T, 1995, RNA, V1, P194; SAMAHA RR, 1994, P NATL ACAD SCI USA, V91, P7884, DOI 10.1073/pnas.91.17.7884; Serganov AA, 1996, RNA, V2, P1124; SVENSSON P, 1988, J MOL BIOL, V200, P301, DOI 10.1016/0022-2836(88)90242-2; Tocilj A, 1999, P NATL ACAD SCI USA, V96, P14252, DOI 10.1073/pnas.96.25.14252; WEITZMANN CJ, 1993, FASEB J, V7, P177, DOI 10.1096/fasebj.7.1.7916699; ZWIEB C, 1992, NUCLEIC ACIDS RES, V20, P4397, DOI 10.1093/nar/20.17.4397	33	176	197	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					107	112		10.1126/science.288.5463.107	http://dx.doi.org/10.1126/science.288.5463.107			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753109				2022-12-24	WOS:000086387700043
J	Friedman, JM				Friedman, JM			Obesity in the new millennium	NATURE			English	Editorial Material							EARLY-ONSET OBESITY; BODY-WEIGHT; FRAMESHIFT MUTATION; LEPTIN LEVELS; OB/OB MICE; HUMANS; GENE; OVERWEIGHT; MC4R	Obesity has increased at ale alarming rate in recent years and is now a worldwide public health problem. In addition to suffering poor health and an increased risk of illnesses such as hypertension and heart disease, obese people are often stigmatized socially. But major advances have now been made in identifying the components of the homeostatic system that regulates body weight, including several of the genes responsible for animal and human obesity. A key element of the physiological system is the hormone leptin, which acts on nerve cells in the brain (and elsewhere) to regulate food intake and body weight. The identification of additional molecules that comprise this homeostatic system will provide further insights into the molecular basis of obesity end possibilities for new treatments.	Rockefeller Univ, New York, NY 10021 USA	Rockefeller University	Friedman, JM (corresponding author), Rockefeller Univ, Box 305,1230 York Ave, New York, NY 10021 USA.		Friedman, Jeffrey M/E-5784-2011					Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Erickson JC, 1996, SCIENCE, V274, P1704, DOI 10.1126/science.274.5293.1704; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; James WPT, 1996, CIBA F SYMP, V201, P1; KENNEDY GC, 1953, PROC R SOC SER B-BIO, V140, P578, DOI 10.1098/rspb.1953.0009; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; RAVUSSIN E, 1995, METABOLISM S3, V9, P12; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Troiano RP, 1998, PEDIATRICS, V101, P497; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; WADDEN TA, 1993, ANN INTERN MED, V119, P688, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00012; WEIGLE DS, 1994, FASEB J, V8, P302, DOI 10.1096/fasebj.8.3.8143936; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	25	536	583	0	32	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					632	634		10.1038/35007504	http://dx.doi.org/10.1038/35007504			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766249	Bronze			2022-12-24	WOS:000086400100062
J	Richards, MA; Stockton, D; Babb, P; Coleman, MP				Richards, MA; Stockton, D; Babb, P; Coleman, MP			How many deaths have been avoided through improvements in cancer survival?	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER	Objective To estimate holy many deaths from cancer have been avoided in England and Wales because of recent improvements in survival. Design Analysis of national statistics. Setting England and Wales. Subjects 1.5 million adults with diagnosis of one of 47 different cancers during 1981-5 or 1986-90. Main outcome measures Reduction in number of cancer deaths within five years of diagnosis among patients with cancer diagnosed during 1986-90 compared with patients with cancer diagnosed during 1981-5, Results 17 041 deaths were avoided within five years of diagnosis among patients with cancer diagnosed during 1986-90. This represents 3.3% of the cancer deaths that would have been expected if survival had been the same as for patients with cancer diagnosed during 1981-5, Two thirds of the avoided deaths arose from improvements in survival for just five cancers: female br east cancer (4822), cancers of the colon (2560), rectum (1090), and bladder (1157), and melanoma of the skin (1098). The largest proportionate reductions in excess deaths were for melanoma of the skin (23%) and cancers of the testis (17%) and bone (17%). About 12 000 (70%) of the avoided deaths arose among adults aged under 75 at death. Improvements in survival from cancers of lung, prostate, stomach, ovary, and brain were small: the) accounted for 33% of all cancers but only 11% of avoided deaths. Conclusions Small gains in survival from common cancers save more lives than larger gains for uncommon cancers. If recent rates of improvement in cancer survival continue, about 24 000 deaths within five years of diagnosis would be avoided in patents aged under 75 by the year 2010, representing about a quarter of the government's overall target of 100 000 fewer cancer deaths.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; St Thomas Hosp, Dept Palliat Med, London SE17 7EH, England; Informat & Stat Div, Scottish Canc Intelligence Unit, Canc Surveillance Grp, Edinburgh EH5 3SQ, Midlothian, Scotland; Off Natl Stat, Demog & Hlth Div, London SW1V 2QQ, England	University of London; London School of Hygiene & Tropical Medicine; Guy's & St Thomas' NHS Foundation Trust	Coleman, MP (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Keppel St, London WC1E 7HT, England.		Coleman, Michel/AAA-9543-2020	Coleman, Michel/0000-0001-8940-3807				Abe O, 1998, LANCET, V352, P930; BERAL V, 1995, LANCET, V345, P1642, DOI 10.1016/S0140-6736(95)90151-5; Carstairs V., 1991, DEPRIVATION HLTH SCO; COLEMAN MP, 1999, SERIES SMPS, V61; *DEP HLTH, 1999, SAV LIV OUR HLTH NAT; ESTEVE J, 1990, STAT MED, V9, P529, DOI 10.1002/sim.4780090506; Expert Advisory Group on Cancer, 1995, POL FRAM COMM CANC S; *OFF NAT STAT, 1999, CANC 1971 1997 CD RO; Stockton D, 1997, BRIT MED J, V314, P472, DOI 10.1136/bmj.314.7079.472	9	63	63	0	6	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 1	2000	320	7239					895	898		10.1136/bmj.320.7239.895	http://dx.doi.org/10.1136/bmj.320.7239.895			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	301YA	10741993	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000086337100020
J	Schoonjans, K; Auwerx, J				Schoonjans, K; Auwerx, J			Thiazolidinediones: an update	LANCET			English	Article							ACTIVATED RECEPTOR-GAMMA; II DIABETES-MELLITUS; PPAR-GAMMA; INSULIN SENSITIZER; TROGLITAZONE; MICE; ADIPOGENESIS; BINDING; OBESITY; TISSUE	Thiazolidinediones, which are being developed for the treatment of insulin resistance and type 2 diabetes mellitus bind and activate peroxisome proliferator-activated receptor gamma, a nuclear receptor that regulates the expression of several genes involved in metabolism. This receptor controls adipocyte differentation, lipid storage, and insulin sensitisation. Besides metabolic activities, thiazolidinediones have effects as diverse as the control of host defence :ell proliferation, and tumorigenesis.	Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Auwerx, J (corresponding author), Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries,Parc Innovat, F-67404 Illkirch Graffenstaden, France.	auwerx@igbmc.u-strasbg.fr	Auwerx, Johan/ABE-9307-2021	Schoonjans, Kristina/0000-0003-1247-4265; Auwerx, Johan/0000-0002-5065-5393				Al-Salman J, 2000, ANN INTERN MED, V132, P121, DOI 10.7326/0003-4819-132-2-200001180-00006; Auwerx J, 1999, DIABETOLOGIA, V42, P1033, DOI 10.1007/s001250051268; Balfour JAB, 1999, DRUGS, V57, P921; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Berger J, 1996, ENDOCRINOLOGY, V137, P4189, DOI 10.1210/en.137.10.4189; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Deeb SS, 1998, NAT GENET, V20, P284, DOI 10.1038/3099; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Fajas L, 1998, CURR OPIN CELL BIOL, V10, P165, DOI 10.1016/S0955-0674(98)80138-5; Freid J, 2000, ANN INTERN MED, V132, P164, DOI 10.7326/0003-4819-132-2-200001180-00015; Inzucchi SE, 1998, NEW ENGL J MED, V338, P867, DOI 10.1056/NEJM199803263381303; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Lefebvre AM, 1998, NAT MED, V4, P1053, DOI 10.1038/2036; Martin G, 1997, J BIOL CHEM, V272, P28210, DOI 10.1074/jbc.272.45.28210; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Murakami K, 1998, DIABETES, V47, P1841, DOI 10.2337/diabetes.47.12.1841; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Oakes ND, 1997, METABOLISM, V46, P935, DOI 10.1016/S0026-0495(97)90083-4; Pill J, 1999, METABOLISM, V48, P34, DOI 10.1016/S0026-0495(99)90007-0; Plosker GL, 1999, DRUGS, V57, P409, DOI 10.2165/00003495-199957030-00014; Ristow M, 1998, NEW ENGL J MED, V339, P953, DOI 10.1056/NEJM199810013391403; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Saez E, 1998, NAT MED, V4, P1058, DOI 10.1038/2042; Schwartz S, 1998, NEW ENGL J MED, V338, P861, DOI 10.1056/NEJM199803263381302; Shibata T, 1999, EUR J PHARMACOL, V364, P211, DOI 10.1016/S0014-2999(98)00832-2; Shibuya A, 1998, DIABETES CARE, V21, P2140, DOI 10.2337/diacare.21.12.2140; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; SUTER SL, 1992, DIABETES CARE, V15, P193, DOI 10.2337/diacare.15.2.193; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Watkins PB, 1998, NEW ENGL J MED, V338, P916, DOI 10.1056/NEJM199803263381314; Willson TM, 1996, J MED CHEM, V39, P665, DOI 10.1021/jm950395a	34	166	173	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2000	355	9208					1008	1010		10.1016/S0140-6736(00)90002-3	http://dx.doi.org/10.1016/S0140-6736(00)90002-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YH	10768450				2022-12-24	WOS:000086054000041
J	Waller, AE; Daniels, JL; Weaver, NL; Robinson, P				Waller, AE; Daniels, JL; Weaver, NL; Robinson, P			Jockey injuries in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context: In the sport of horse racing, the position of the jockey and speed of the horse predispose the jockey to risk of injury. Objective To estimate rates of medically treated injuries among professional jockeys and identify patterns of injury events. Design Cross-sectional survey from data compiled by an insurance broker. Information on the cause of injury, location on the track, and body part injured was evaluated. Setting Official races at US professional racing facilities (n = 114) from January 1, 1993, through December 31, 1996. Participants A licensed jockey population of approximately 2700 persons. Main Outcome Measures Annual injury incidence rates per 1000 jockey-years, as well as injury type, cause, and location on the track. Results A total of 6545 injury events occurred during official races between 1993 and 1996 (606 per 1000 jockey-years). Nearly 1 in 5 injuries (18.8%) was to the jockey's head or neck. Other frequent sites included the leg (15.5%), foot/ankle (10.7%), back (10.7%), arm/hand (11.0%), and shoulder (9.6%). The most frequent location where injuries occurred was entering, within, or leaving the starting gate (35.1%), including 29.5% of head injuries, 39.8% of arm/hand injuries, and 52.0% of injuries to the leg/foot. Most head injuries resulted from being thrown from the horse (41.8%) or struck by the horse's head (23.2%), Being thrown from the horse was the cause of 55.1% of back and 49.6% of chest injuries. Conclusions Our data suggest that jockeys have a high injury rate. Efforts are needed to reduce the number of potential injury events on the track and to improve protective equipment so events do not lead to injury.	Univ N Carolina, Sch Med, Dept Emergency Med, Chapel Hill, NC 27599 USA; Univ N Carolina, Injury Prevent Res Ctr, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Publ Hlth, Dept Epidemiol, Chapel Hill, NC 27599 USA; Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Waller, AE (corresponding author), Univ N Carolina, Sch Med, Dept Emergency Med, CB 7594, Chapel Hill, NC 27599 USA.				PHS HHS [R49/CCR402444] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		BARONE GW, 1989, J TRAUMA, V29, P245, DOI 10.1097/00005373-198902000-00019; BILES DB, 1996, BLOOD HORSE     0210, P730; BIXBYHAMMETT DM, 1987, AM FAM PHYSICIAN, V36, P206; Firth John L.., 1985, SPORTS INJURIES MECH, P431; INGEMARSON H, 1989, J TRAUMA, V29, P25, DOI 10.1097/00005373-198901000-00005; POUNDER DJ, 1984, MED J AUSTRALIA, V141, P632, DOI 10.5694/j.1326-5377.1984.tb113173.x; PRESS JM, 1995, CLIN J SPORT MED, V5, P236, DOI 10.1097/00042752-199510000-00005; Whitlock M R, 1987, Br J Sports Med, V21, P25	8	57	60	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2000	283	10					1326	1328		10.1001/jama.283.10.1326	http://dx.doi.org/10.1001/jama.283.10.1326			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289ND	10714733	Bronze			2022-12-24	WOS:000085628100030
J	MacNeilage, PF; Davis, BL				MacNeilage, PF; Davis, BL			On the origin of internal structure of word forms	SCIENCE			English	Article							SPEECH	This study shows that a corpus of proto-word forms shares four sequential sound patterns with words of modern languages and the first words of infants. Three of the patterns involve intrasyllabic consonant-vowel (CV) co-occurrence: labial (Lip) consonants with central vowels, coronal (tongue front) consonants with front vowels, and dorsal (tongue back) consonants with back vowels. The fourth pattern is an intersyllabic preference for initiating words with a labial consonant-vowel-coronal consonant sequence (LC). The CV effects may be primarily biomechanically motivated. The LC effect may be self-organizational, with multivariate causality. The findings support the hypothesis that these four patterns were basic to the origin of words.	Univ Texas, Dept Psychol, Austin, TX 78712 USA; Univ Texas, Dept Commun Sci & Disorders, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	MacNeilage, PF (corresponding author), Univ Texas, Dept Psychol, Austin, TX 78712 USA.	macneilage@psy.utexas.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027733] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD 27733-07] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bengtson J. D., 1994, ORIGIN LANGUAGES STU, P277; Boe L.-J., 1999, P 14 INT C PHON SCI, P2501; Boysson-Bardies B.de., 1992, PHONOLOGICAL DEV MOD, P369; CHOMSKY N, 1968, LANGUAGE PROBLEMS KN; Clark A, 1998, BEING THERE PUTTING; DAVIS BD, UNPUB; DAVIS BL, 1995, J SPEECH HEAR RES, V38, P1199, DOI 10.1044/jshr.3806.1199; DAVIS BL, 1999, 20 ANN CHILD PHON C; DEBOYSSONBARDIES B, 1993, NATO ADV SCI INST SE, V69, P353; Dixon R. M. W., 1980, LANGUAGES AUSTR; GILDERSLEEVE C, THESIS U TEXAS; GODDARD I, 1987, CURR ANTHROPOL, V28, P657; Greenberg J. H, 1987, LANGUAGE AM; GREENBERG JH, 1963, LANGUAGES AFRICA; Hockett C.F., 1960, ANIMAL SOUNDS COMMUN, P392; Ingram D., 1974, J CHILD LANG, V1, P49; Janson T., 1986, PHONOLOGY YB, V3, P179, DOI DOI 10.1017/S0952675700000634; KORNHUBER HH, 1987, ENCY NEUROSCIENCE, P1302; Langsdale, 1996, FIRST LANG, V16, P159, DOI 10.1177/014272379601604702; LIEBERMAN PH, 1969, SCIENCE, V164, P1185, DOI 10.1126/science.164.3884.1185; LOCKE JL, 1990, J CHILD LANG, V17, P1, DOI 10.1017/S0305000900013076; LOCKE JL, 1993, PHONOLOGICAL ACQUISI; LOEB GE, 1987, ENCY NEUROSCIENCE, P690; MACKEN M, 1987, LINGUA, V44, P219; MacNeilage PF, 1997, SPEECH COMMUN, V22, P269, DOI 10.1016/S0167-6393(97)00022-8; MacNeilage PF, 1998, BEHAV BRAIN SCI, V21, P499, DOI 10.1017/S0140525X98001265; MacNeilage PF, 1999, PSYCHOL SCI, V10, P459, DOI 10.1111/1467-9280.00187; MacNeilage PF, 2000, CHILD DEV, V71, P153, DOI 10.1111/1467-8624.00129; MACNEILAGE PF, 1993, DEV NEUROCOGNITION S, P123; MACNEILAGE PF, IN PRESS EVOLUTIONAR; Maddieson Ian, 1992, PHONOLOGY, V9.1, P45; MENSTOWICZ M, 1994, PHONOLOGY GEN GRAMMA; Oller DK, 1993, 1 2 LANGUAGE PHONOLO, P45; Ruhlen Merritt, 1994, ORIGIN LANGUAGES STU; TEIXERA E, UNPUB; Vihman M. M, 1992, PHONOLOGICAL DEV MOD, P393	36	194	196	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2000	288	5465					527	531		10.1126/science.288.5465.527	http://dx.doi.org/10.1126/science.288.5465.527			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	306YJ	10775113				2022-12-24	WOS:000086626000048
J	Laurance, WF; Delamonica, P; Laurance, SG; Vasconcelos, HL; Lovejoy, TE				Laurance, WF; Delamonica, P; Laurance, SG; Vasconcelos, HL; Lovejoy, TE			Conservation - Rainforest fragmentation kills big trees	NATURE			English	Article							FOREST		INPA, Biol Dynam Forest Fragments Project, BR-69011970 Manaus, Amazonas, Brazil; Smithsonian Inst, Washington, DC 20560 USA	Institute Nacional de Pesquisas da Amazonia; Smithsonian Institution	Laurance, WF (corresponding author), INPA, Biol Dynam Forest Fragments Project, CP 478, BR-69011970 Manaus, Amazonas, Brazil.	wfl@inpag.gov.br	Laurance, Susan/G-6021-2011; Laurance, William F/B-2709-2012; Vasconcelos, Heraldo L/C-3353-2013	Laurance, Susan/0000-0002-2831-2933; Laurance, William F/0000-0003-4430-9408; Vasconcelos, Heraldo L/0000-0001-6969-7131				Chambers JQ, 1998, NATURE, V391, P135, DOI 10.1038/34325; Clark DB, 1996, FOREST ECOL MANAG, V80, P235, DOI 10.1016/0378-1127(95)03607-5; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; KAPOS V, 1989, J TROP ECOL, V5, P173, DOI 10.1017/S0266467400003448; Laurance W, 1998, SCIENCE, V282, p1611a; Laurance WF, 1998, ECOLOGY, V79, P2032, DOI 10.1890/0012-9658(1998)079[2032:RFFATD]2.0.CO;2; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Leighton M., 1986, AAAS (American Association for the Advancement of Science) Selected Symposium, V101, P75; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; Nepstad DC, 1999, NATURE, V398, P505, DOI 10.1038/19066; PUTZ FE, 1984, ECOLOGY, V65, P1713, DOI 10.2307/1937767; RICHARDS P. W., 1998, TROPICAL RAIN FOREST	12	443	462	3	93	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 20	2000	404	6780					836	836		10.1038/35009032	http://dx.doi.org/10.1038/35009032			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786782	Bronze			2022-12-24	WOS:000086625000034
J	McKeganey, N; Norrie, J				McKeganey, N; Norrie, J			Association between illegal drugs and weapon carrying in young people in Scotland: schools' survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SCOTTISH SCHOOLCHILDREN; VIOLENT BEHAVIOR; SAMPLE; ADOLESCENTS; STUDENTS	Objectives To identify the type and extent of weapons being carried among young people in Scotland, and to determine the relation between use of illegal drugs and weapon carrying. Design Questionnaire school survey. Setting Independent schools in central Scotland and schools in Lanarkshire and Perth and Kinross. Participants 3121 students aged 11 to 16 in 20 schools. Main outcome measures Self completion questionnaire reporting history of drug use and weapon carrying. Results Overall, 34.1% of males and 8.6% of females reported having carried a weapon (P < 0.0001), ranging From 29.2% of boys aged 11-13 (classes S1 to S2) to 39.3% of boys aged 13-15 (S3 to S4). These values are higher than those in a recent survey of young people in England. Weapon carrying in Lanarkshire was 70% higher for males than in the rural area of Perth and Kinross. Both males and females who had taken drugs were more likely to carry weapons (63.5% of male drug users versus 20.5%, of non-users and 22.8% of female drug users versus 3.7% of non-users; both P < 0.0001). The proportions of males carrying weapons who used none, one, two, three or four, or five or more illegal drugs were 21%, 52%, 68% 74%, and 92% respectively. A similar trend was found among females. Conclusions Better information is needed on the nature and extent of weapon carrying by young people in the United Kingdom, and better educational campaigns are needed warning of the dangers of carrying weapons.	Univ Glasgow, Ctr Drug Misuse Res, Glasgow G12 8SQ, Lanark, Scotland; Univ Glasgow, Robertson Ctr Biostat, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow; University of Glasgow	McKeganey, N (corresponding author), Univ Glasgow, Ctr Drug Misuse Res, Glasgow G12 8SQ, Lanark, Scotland.	gkua27@udcf.gla.ac.uk						BALDING J, 1996, CASH CARRY YOUNG PEO; Barnard M, 1996, DRUG-EDUC PREV POLIC, V3, P81, DOI 10.3109/09687639609019313; Barnard M, 1998, ADDICT RES, V6, P421, DOI 10.3109/16066359809026060; DuRant RH, 1997, ARCH PEDIAT ADOL MED, V151, P360, DOI 10.1001/archpedi.1997.02170410034004; Forsyth A, 1998, DRUG-EDUC PREV POLIC, V5, P157, DOI 10.3109/09687639809006681; Friedman AS, 1998, AGGRESS VIOLENT BEH, V3, P339, DOI 10.1016/S1359-1789(97)00012-8; Komro KA, 1998, J CHILD ADOLES SUBST, V8, P77; Lowry R, 1998, AM J PREV MED, V14, P122, DOI 10.1016/S0749-3797(97)00020-2; McKeganey N, 1996, BRIT MED J, V313, P401; McKeganey N, 1999, ADDICT RES, V7, P493, DOI 10.3109/16066359909004402; Presley CA, 1997, J AM COLL HEALTH, V46, P3, DOI 10.1080/07448489709595580; VALOIS RF, 1995, J ADOLESCENT HEALTH, V16, P26, DOI 10.1016/1054-139X(95)94070-O; Wagner EF, 1996, AGGRESS VIOLENT BEH, V1, P375, DOI 10.1016/S1359-1789(96)00008-0	13	30	30	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 8	2000	320	7240					982	984		10.1136/bmj.320.7240.982	http://dx.doi.org/10.1136/bmj.320.7240.982			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303XP	10753152	Green Accepted, Green Published, Bronze, Green Submitted			2022-12-24	WOS:000086453100024
J	Matsunami, H; Montmayeur, JP; Buck, LB				Matsunami, H; Montmayeur, JP; Buck, LB			A family of candidate taste receptors in human and mouse	NATURE			English	Article							PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; MAMMALS; TRANSDUCTION; GENETICS; MICE	The gustatory system of mammals can sense four basic taste qualities, bitter, sweet, salty and sour, as well as umami, the taste of glutamate(1-6). Previous studies suggested that the detection of bitter and sweet tastants by taste receptor cells in the mouth is likely to involve G-protein-coupled receptors(2,7,8). Although two putative G-protein-coupled bitter/sweet taste receptors have been identified(9), the chemical diversity of bitter and sweet compounds leads one to expect that there is a larger number of different receptors(8,10,11). Here we report the identification of a family of candidate taste receptors (the TRBs) that are members of the G-protein-coupled receptor superfamily and that are specifically expressed by taste receptor cells. A cluster of genes encoding human TRBs is located adjacent to a Prp gene locus(12), which in mouse is tightly linked to the SOA genetic locus that is involved in detecting the bitter compound sucrose octaacetate(13-15). Another TRB gene is found on a human contig assigned to chromosome 5p15, the location of a genetic locus (PROP) that controls the detection of the bitter compound 6-n-propyl-2-thiouracil in humans(16,17).	Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Buck, LB (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02215 USA.	lbuck@hms.harvard.edu	Montmayeur, Jean-Pierre R/A-5723-2009	Montmayeur, Jean-Pierre/0000-0002-0942-1114				AZEN E, 1984, P NATL ACAD SCI-BIOL, V81, P5561, DOI 10.1073/pnas.81.17.5561; BARTOSHUK LM, 1994, PHYSIOL BEHAV, V56, P1165, DOI 10.1016/0031-9384(94)90361-1; BARTOSHUK LM, 1994, ANNU REV PSYCHOL, V45, P419, DOI 10.1146/annurev.ps.45.020194.002223; Berghard A, 1996, J NEUROSCI, V16, P909; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; CAPELESS CG, 1992, BEHAV GENET, V22, P655, DOI 10.1007/BF01066636; Chaudhari N, 1998, ANN NY ACAD SCI, V855, P398, DOI 10.1111/j.1749-6632.1998.tb10598.x; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Chaudhari N, 1996, J NEUROSCI, V16, P3817; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Herness MS, 1999, ANNU REV PHYSIOL, V61, P873, DOI 10.1146/annurev.physiol.61.1.873; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Kinnamon SC, 1996, CURR OPIN NEUROBIOL, V6, P506, DOI 10.1016/S0959-4388(96)80057-2; Lindemann B, 1999, NAT MED, V5, P381, DOI 10.1038/7377; Lindemann B, 2000, NAT NEUROSCI, V3, P99, DOI 10.1038/72153; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LUSH IE, 1995, GENET RES, V66, P167, DOI 10.1017/S0016672300034510; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; ROPER SD, 1989, ANNU REV NEUROSCI, V12, P329, DOI 10.1146/annurev.ne.12.030189.001553; ROUX KH, 1995, PCR PRIMER LAB MANUA; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Smith DV, 1999, CURR BIOL, V9, pR453, DOI 10.1016/S0960-9822(99)80280-2; SPIELMAN AI, 1992, SOC GEN PHY, V47, P307; WHITNEY G, 1994, PHYSIOL BEHAV, V56, P1141, DOI 10.1016/0031-9384(94)90358-1; Wong GT, 1999, J NEUROSCI, V19, P5802, DOI 10.1523/JNEUROSCI.19-14-05802.1999	29	539	582	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					601	+		10.1038/35007072	http://dx.doi.org/10.1038/35007072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766242				2022-12-24	WOS:000086400100053
J	Halliday, DM; Conway, BA; Farmer, SF; Shahani, U; Russell, AJC; Rosenberg, JR				Halliday, DM; Conway, BA; Farmer, SF; Shahani, U; Russell, AJC; Rosenberg, JR			Coherence between low-frequency activation of the motor cortex and tremor in patients with essential tremor	LANCET			English	Article							ELECTROMYOGRAMS; OSCILLATIONS; CEREBELLAR; DISORDERS; TASK	Background In healthy people, rhythmic activation of the motor cortex in the 15-30 Hz frequency range accompanies and contributes to voluntarily-generate postural contractions of contralateral muscle. In patients with Parkinson's disease, an abnormal low-frequency activation of the motor areas of the cortex occurs and has been directly linked to the characteristic 3-6 Hz rest tremor of this disease. We therefore investigated whether the motor cortex is involved in the transmission of the rhythmic motor drive responsible for generating essential tremor. Methods Non-invasive recordings of activity from the hand area of the motor cortex were made from six patients with essential tremor by magnetoencephalography. The recordings were made simultaneously with the electromyogram recorded from contralateral finger muscles during periods of postural tremor. A statistical spectral analysis was done to determine at which frequencies the two signals were correlated. Findings Spectral analysis of the electromyogram signals showed a significant low-frequency component at the frequency of the tremor bursts. However, there was no coherence between magnetoencephalogram and electromyogram recordings at the tremor frequency, indicating that no correlation existed between the tremor signal and low-frequency activity recorded from the primary motor cortex in individuals with essential tremor. Coherence at frequencies higher than the tremor frequency was similar to that in healthy individuals performing voluntary postural contractions. Interpretation The absence of significant coherence between the magnetoencephalogram and electromyogram at tremor frequencies suggests that in essential tremor the tremor is imposed on the active muscle through descending pathways other than those originating in the primary motor cortex. These findings challenge the model widely used to explain the efficacy of neurosurgical treatment of essential tremor, are in contrast to those of previous studies of parkinsonian rest tremor, and highlight an important difference in the pathophysiology of essential and parkinsonian tremor.	Univ Strathclyde, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland; St Marys Hosp, Dept Neurol, London, England; UCL Natl Hosp Neurol & Neurosurg, Dept Neurol, London WC1N 3BG, England; So Gen Hosp NHS Trust, Dept Neurophysiol, Wellcome Biomagnetism Unit, Glasgow, Lanark, Scotland; Univ Glasgow, Inst Biomed & Life Sci, Div Neurosci, Glasgow, Lanark, Scotland	University of Strathclyde; Imperial College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Glasgow	Conway, BA (corresponding author), Univ Strathclyde, Bioengn Unit, Glasgow G4 0NW, Lanark, Scotland.	b.a.conway@strath.ac.uk	Shahani, Uma/V-9096-2019; Conway, Bernard/A-9625-2016; Farmer, Simon F/D-1969-2012; Halliday, David M/A-3848-2009	Shahani, Uma/0000-0003-2597-9334; Conway, Bernard/0000-0002-0069-0131; Farmer, Simon F/0000-0001-5193-8195; Halliday, David M/0000-0001-9957-0983				Baker SN, 1997, J PHYSIOL-LONDON, V501, P225, DOI 10.1111/j.1469-7793.1997.225bo.x; Benabid AL, 1996, J NEUROSURG, V84, P203, DOI 10.3171/jns.1996.84.2.0203; Bucher SF, 1997, ANN NEUROL, V41, P32, DOI 10.1002/ana.410410108; COLEBATCH JG, 1990, LANCET, V336, P1028, DOI 10.1016/0140-6736(90)92489-5; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; DUBINSKY R, 1987, ANN NEUROL, V22, P118; DUPUIS MJM, 1989, MOVEMENT DISORD, V4, P183, DOI 10.1002/mds.870040210; Elble RJ, 1990, TREMOR; FARMER SF, 1993, J PHYSIOL-LONDON, V470, P127, DOI 10.1113/jphysiol.1993.sp019851; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Halliday DM, 1997, J PHYSIOL-LONDON, V501P, pP38; Halliday DM, 1998, NEUROSCI LETT, V241, P5, DOI 10.1016/S0304-3940(97)00964-6; Hari R, 1999, NEUROREPORT, V10, pR1; Hua SE, 1998, J NEUROL NEUROSUR PS, V64, P273, DOI 10.1136/jnnp.64.2.273; Koller W, 1996, EUR J NEUROL, V3, P507, DOI 10.1111/j.1468-1331.1996.tb00265.x; LAMARRE Y, 1984, MOVEMENT DISORDERS T, P183; LEE RG, 1987, MOVEMENT DISORD, V2, P423; LLINAS R, 1984, MOVEMENT DISORDERS T, P165, DOI DOI 10.1007/978-1-349-06757-2_10; Strick PL, 1998, NOVART FDN SYMP, V218, P64; STRICK PL, 1998, NOVART FDN SYMP, V218, P104; Volkmann J, 1996, NEUROLOGY, V46, P1359, DOI 10.1212/WNL.46.5.1359; WILLS AJ, 1994, ANN NEUROL, V36, P636, DOI 10.1002/ana.410360413	22	70	72	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2000	355	9210					1149	1153		10.1016/S0140-6736(00)02064-X	http://dx.doi.org/10.1016/S0140-6736(00)02064-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TC	10791378				2022-12-24	WOS:000086380900013
J	Yamamoto, A; Lucas, JJ; Hen, R				Yamamoto, A; Lucas, JJ; Hen, R			Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease	CELL			English	Article							INTRANUCLEAR NEURONAL INCLUSIONS; EXPANDED CAG REPEAT; TRANSGENIC MICE; GENE-EXPRESSION; EMBRYONIC LETHALITY; TETRACYCLINE; BRAIN; INACTIVATION; PATHOGENESIS; AGGREGATION	Neurodegenerative disorders like Huntington's disease (HD) are characterized by progressive and putative irreversible clinical and neuropathological symptoms, including neuronal protein aggregates. Conditional transgenic models of neurodegenerative diseases therefore could be a powerful means to explore the relationship between mutant protein expression and progression of the disease. We have created a conditional model of HD by using the tet-regulatable system. Mice expressing a mutated huntingtin fragment demonstrate neuronal inclusions, characteristic neuropathology, and progressive motor dysfunction. Blockade of expression in symptomatic mice leads to a disappearance of inclusions and an amelioration of the behavioral phenotype. We thus demonstrate that a continuous influx of the mutant protein is required to maintain inclusions and symptoms, raising the possibility that HD may be reversible.	Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA	Columbia University	Hen, R (corresponding author), Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10032 USA.		Yamamoto, Ai/D-1100-2011; Lucas, Jose J./U-6543-2019	Lucas, Jose J./0000-0003-1597-3916				Alves-Rodrigues A, 1998, TRENDS NEUROSCI, V21, P516, DOI 10.1016/S0166-2236(98)01276-4; AMBROSE CM, 1994, SOMAT CELL MOLEC GEN, V20, P27, DOI 10.1007/BF02257483; Augood SJ, 1997, ANN NEUROL, V42, P215, DOI 10.1002/ana.410420213; AYLWARD EH, 1994, NEUROLOGY, V44, P823, DOI 10.1212/WNL.44.5.823; Backman L, 1997, BRAIN, V120, P2207, DOI 10.1093/brain/120.12.2207; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Becher MW, 1998, NEUROBIOL DIS, V4, P387, DOI 10.1006/nbdi.1998.0168; Carter RJ, 1999, J NEUROSCI, V19, P3248; Cha JHJ, 1999, PHILOS T R SOC B, V354, P981, DOI 10.1098/rstb.1999.0449; Cha JHJ, 1998, P NATL ACAD SCI USA, V95, P6480, DOI 10.1073/pnas.95.11.6480; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; DAVIES SW, 1999, PHILOS T R SOC LON B, V354, P81; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Freundlieb S, 1997, METHOD ENZYMOL, V283, P159; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Ghavami A, 1999, J CELL SCI, V112, P967; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gusella JF, 1996, ANNU REV MED, V47, P201; Halliday GM, 1998, EXP NEUROL, V154, P663, DOI 10.1006/exnr.1998.6919; Hansson O, 1999, P NATL ACAD SCI USA, V96, P8727, DOI 10.1073/pnas.96.15.8727; HEDREEN JC, 1995, J NEUROPATH EXP NEUR, V54, P105, DOI 10.1097/00005072-199501000-00013; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Koshy BT, 1997, BRAIN PATHOL, V7, P927, DOI 10.1111/j.1750-3639.1997.tb00894.x; Lansbury PT, 1997, NEURON, V19, P1151, DOI 10.1016/S0896-6273(00)80406-7; Levine MS, 1999, J NEUROSCI RES, V58, P515, DOI 10.1002/(SICI)1097-4547(19991115)58:4<515::AID-JNR5>3.0.CO;2-F; Li H, 1999, HUM MOL GENET, V8, P1227, DOI 10.1093/hmg/8.7.1227; Lucas JJ, 1998, J NEUROSCI, V18, P5537, DOI 10.1523/JNEUROSCI.18-14-05537.1998; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; NASIR J, 1995, CELL, V81, P811, DOI 10.1016/0092-8674(95)90542-1; PERSICHETTI F, 1995, MOL MED, V1, P374, DOI 10.1007/BF03401575; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; RUBINSZTEIN DC, 1994, NAT GENET, V7, P525, DOI 10.1038/ng0894-525; Saudou F, 1998, CELL, V95, P55, DOI 10.1016/S0092-8674(00)81782-1; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 1999, HUM MOL GENET, V8, P397, DOI 10.1093/hmg/8.3.397; TURJANSKI N, 1995, BRAIN, V118, P689, DOI 10.1093/brain/118.3.689; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; WEXLER NS, 1987, NATURE, V326, P194, DOI 10.1038/326194a0; Wheeler VC, 1999, HUM MOL GENET, V8, P115, DOI 10.1093/hmg/8.1.115; White JK, 1997, NAT GENET, V17, P404, DOI 10.1038/ng1297-404; ZEITLIN S, 1995, NAT GENET, V11, P155, DOI 10.1038/ng1095-155	53	842	881	1	45	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 31	2000	101	1					57	66		10.1016/S0092-8674(00)80623-6	http://dx.doi.org/10.1016/S0092-8674(00)80623-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	300JM	10778856	Bronze			2022-12-24	WOS:000086249900008
J	Mitchell, SJ; Silver, RA				Mitchell, SJ; Silver, RA			Glutamate spillover suppresses inhibition by activating presynaptic mGluRs	NATURE			English	Article							PURKINJE-CELL SYNAPSES; RAT CEREBELLUM; SYNAPTIC INHIBITION; GABA(A) RECEPTORS; GRANULE CELLS; MODULATION; TRANSMISSION; PROBABILITY; DEPRESSION; CURRENTS	Metabotropic glutamate receptors (mGluRs) found on synaptic terminals throughout the brain are thought to be important in modulating neurotransmission(1,2). Activation of mGluRs by synaptically released glutamate depresses glutamate release from excitatory terminals(3-5) but the physiological role of mGluRs on inhibitory terminals is unclear. We have investigated activation of mGluRs on inhibitory terminals within the cerebellar glomerulus, a structure in which GABA (gamma-aminobutyric acid)-releasing inhibitory terminals and glutamatergic excitatory terminals are in close apposition and make axo-dendritic synapses onto granule cells(6). Here we show that 'spillover' of glutamate, which is released from excitatory mossy fibres, inhibits GABA release from Golgi cell terminals by activating presynaptic mGluRs under physiological conditions. The magnitude of the depression of the inhibitory postsynaptic current is dependent on the frequency of mossy fibre stimulation, reaching 50% at 100 Hz. Furthermore, the duration of inhibitory postsynaptic current depression mirrors the time course of mossy fibre activity. Our results establish that mGluRs on inhibitory interneuron axons(7) sense the activity of neighbouring excitatory synapses. This heterosynaptic mechanism is likely to boost the efficacy of active excitatory fibres by locally reducing the level of inhibition.	UCL, Dept Physiol, London WC1E 6BT, England	University of London; University College London	Silver, RA (corresponding author), UCL, Dept Physiol, Gower St, London WC1E 6BT, England.	a.silver@ucl.ac.uk		Silver, Robin/0000-0002-5480-6638				Barbour B, 1997, TRENDS NEUROSCI, V20, P377; BAUDE A, 1993, NEURON, V11, P771, DOI 10.1016/0896-6273(93)90086-7; Brickley SG, 1996, J PHYSIOL-LONDON, V497, P753, DOI 10.1113/jphysiol.1996.sp021806; Clements JD, 2000, TRENDS NEUROSCI, V23, P105, DOI 10.1016/S0166-2236(99)01520-9; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Eccles JC, 1967, CEREBELLUM NEURONAL; Glitsch M, 1996, J PHYSIOL-LONDON, V497, P531, DOI 10.1113/jphysiol.1996.sp021786; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; HAYASHI Y, 1993, NATURE, V366, P687, DOI 10.1038/366687a0; Ito M, 1984, CEREBELLUM NEURAL CO; Jaarsma D, 1998, J NEUROCYTOL, V27, P303, DOI 10.1023/A:1006982023657; JAKAB RL, 1988, ANAT EMBRYOL, V179, P81, DOI 10.1007/BF00305102; Knoflach F, 1998, J PHYSIOL-LONDON, V509, P347, DOI 10.1111/j.1469-7793.1998.347bn.x; LLANO I, 1995, J PHYSIOL-LONDON, V486, P163, DOI 10.1113/jphysiol.1995.sp020800; MARR D, 1969, J PHYSIOL-LONDON, V202, P437, DOI 10.1113/jphysiol.1969.sp008820; Morishita W, 1998, J NEUROSCI, V18, P4870; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Neki A, 1996, NEUROSCIENCE, V75, P815, DOI 10.1016/0306-4522(96)00316-8; OHISHI H, 1994, NEURON, V13, P55, DOI 10.1016/0896-6273(94)90459-6; PONCER JC, 1995, J PHYSIOL-LONDON, V485, P121, DOI 10.1113/jphysiol.1995.sp020717; Rossi DJ, 1998, NEURON, V20, P783, DOI 10.1016/S0896-6273(00)81016-8; Scanziani M, 1997, NATURE, V385, P630, DOI 10.1038/385630a0; Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x; Silver RA, 1996, J PHYSIOL-LONDON, V494, P231, DOI 10.1113/jphysiol.1996.sp021487; Tia S, 1996, J NEUROSCI, V16, P3630; VANKAN PLE, 1993, J NEUROPHYSIOL, V69, P74, DOI 10.1152/jn.1993.69.1.74; Vetter P, 1999, NEUROPHARMACOLOGY, V38, P805, DOI 10.1016/S0028-3908(99)00003-9; Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118; vonGersdorff H, 1997, J NEUROSCI, V17, P8137; Wall MJ, 1997, EUR J NEUROSCI, V9, P533, DOI 10.1111/j.1460-9568.1997.tb01630.x	30	195	198	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					498	502		10.1038/35006649	http://dx.doi.org/10.1038/35006649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761918				2022-12-24	WOS:000086257700049
J	Reilly, JG; Ayis, SA; Ferrier, IN; Jones, SJ; Thomas, SHL				Reilly, JG; Ayis, SA; Ferrier, IN; Jones, SJ; Thomas, SHL			QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients	LANCET			English	Article							TORSADE-DE-POINTES; SUDDEN-DEATH; DISPERSION; THIORIDAZINE; NEUROLEPTICS; GUIDELINES; MEDICATION; DOSAGE; RISK	Background Sudden unexplained death in psychiatric patients may be due to drug-induced arrhythmia, of which lengthening of the rate-corrected QT interval (QTc) on the electrocardiogram is a predictive marker. We estimated the point prevalence of QTc lengthening in psychiatric patients and the effects of various psychotropic drugs. Methods Electrocardiograms were obtained from 101 healthy reference individuals and 495 psychiatric patients in various inpatient and community settings and were analysed with a previously validated digitiser technique. Patients with and without QTc lengthening, QTc dispersion, and T-wave abnormality were compared by logistic regression to calculate odds ratios for predictive variables. Findings Abnormal QTc was defined from the healthy reference group as more than 456 ms and was present in 8% (40 of 495) of patients. Age over 65 years (odds ratio 3.0 [95% CI 1.1-8.3]), use of tricyclic antidepressants (4.4 [1.6-12.1]), thioridazine (5.4 [2.0-13.7]), and droperidol (6.7 [1.8-24.8]) were robust predictors of QTc lengthening, as was antipsychotic dose (high dose 5.3 [1.2-24.4]; very high dose 8.2 [1.5-43.6]). Abnormal QT dispersion or T-wave abnormalities were not significantly associated with antipsychotic treatment, but were associated with lithium therapy. Interpretation Antipsychotic drugs cause QTc lengthening in a dose-related manner. Risks are substantially higher for thioridazine and droperidol. These drugs may therefore confer an increased risk of drug-induced arrhythmia.	Univ Newcastle Upon Tyne, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Newcastle Upon Tyne, Acad Dept Psychiat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Parkside Community Mental Hlth Ctr, Tees & NE Yorkshire NHS Trust, Middlesbrough, Cleveland, England	Newcastle University - UK; Newcastle University - UK	Thomas, SHL (corresponding author), Univ Newcastle Upon Tyne, Wolfson Unit Clin Pharmacol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.		Ayis, Salma/AAD-5336-2019	Ayis, Salma/0000-0002-0449-869X				ALGRA A, 1991, CIRCULATION, V83, P1888, DOI 10.1161/01.CIR.83.6.1888; Atkins M., 1997, PSYCHIATR BULL, V21, P224, DOI DOI 10.1192/PB.21.4.224; Barnett AA, 1996, LANCET, V348, P256, DOI 10.1016/S0140-6736(05)65549-3; BARR CS, 1994, LANCET, V343, P327, DOI 10.1016/S0140-6736(94)91164-9; DAY CP, 1990, BRIT HEART J, V63, P342; DONATINI B, 1992, CARDIOLOGY, V81, P340, DOI 10.1159/000175827; Drolet B, 1999, J PHARMACOL EXP THER, V288, P1261; FABER TS, 1994, DRUG SAFETY, V11, P463, DOI 10.2165/00002018-199411060-00007; GIARDINA EGV, 1979, CIRCULATION, V60, P1045, DOI 10.1161/01.CIR.60.5.1045; Hartigan-Go K., 1995, British Journal of Clinical Pharmacology, V39, p104P; HartiganGo K, 1996, CLIN PHARMACOL THER, V60, P543, DOI 10.1016/S0009-9236(96)90150-2; HENDERSON RA, 1991, HUM EXP TOXICOL, V10, P59, DOI 10.1177/096032719101000110; HII JTY, 1992, CIRCULATION, V86, P1376, DOI 10.1161/01.CIR.86.5.1376; Huston J R, 1966, JAMA, V198, P134, DOI 10.1001/jama.198.1.134; KAUTZNER J, 1994, PACE, V17, P928, DOI 10.1111/j.1540-8159.1994.tb01435.x; KIRCHNER V, 1998, COCHRANE LIB; Lawrence KR, 1997, PHARMACOTHERAPY, V17, P531; LIBERATORE MA, 1984, J CLIN PSYCHOPHARM, V4, P143; MITCHELL JE, 1982, J CLIN PSYCHIAT, V43, P47; NEWMAN SC, 1991, CAN J PSYCHIAT, V36, P239, DOI 10.1177/070674379103600401; REY MJ, 1989, INT CLIN PSYCHOPHARM, V4, P95, DOI 10.1097/00004850-198904000-00001; Royal College of psychiatrists, 1997, CR57 ROYAL COLL PSYC; SCHULZ P, 1989, INT CLIN PSYCHOPHARM, V4, P105, DOI 10.1097/00004850-198904000-00002; THOMAS SHL, 1994, ADVERSE DRUG REACT T, V13, P77; THOMPSON C, 1994, BRIT J PSYCHIAT, V164, P448, DOI 10.1192/bjp.164.4.448; Warner JP, 1996, ACTA PSYCHIAT SCAND, V93, P311, DOI 10.1111/j.1600-0447.1996.tb10653.x	26	445	464	0	9	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1048	1052		10.1016/S0140-6736(00)02035-3	http://dx.doi.org/10.1016/S0140-6736(00)02035-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	302TB	10744090				2022-12-24	WOS:000086380800011
J	Kornberg, TB; Krasnow, MA				Kornberg, TB; Krasnow, MA			The Drosophila genome sequence: Implications for biology and medicine	SCIENCE			English	Editorial Material								The 120-megabase euchromatic portion of the Drosophila melanogaster genome has been sequenced. Because the genome is compact and many genetic tools are available, and because fly cell biology and development have much in common with mammals, this sequence may be the Rosetta stone for deciphering the human genome.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; Stanford University; Stanford University	Kornberg, TB (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA.							Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; BELLEN HJ, 1989, GENE DEV, V3, P1288, DOI 10.1101/gad.3.9.1288; BODMER R, 1999, HEART DEV, P65; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; KERKUT GA, 1985, COMP INSECT PHYSIOL; McMahon AP, 2000, CELL, V100, P185, DOI 10.1016/S0092-8674(00)81555-X; Min KT, 1999, SCIENCE, V284, P1985, DOI 10.1126/science.284.5422.1985; Moore MS, 1998, CELL, V93, P997, DOI 10.1016/S0092-8674(00)81205-2; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Riddle RD, 1999, SCI AM, V280, P74, DOI 10.1038/scientificamerican0299-74; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Spradling AC, 1999, GENETICS, V153, P135; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Wigglesworth, 1939, PRINCIPLES INSECT PH; XU T, 1993, DEVELOPMENT, V117, P1223	25	55	63	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2218	2220		10.1126/science.287.5461.2218	http://dx.doi.org/10.1126/science.287.5461.2218			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731136				2022-12-24	WOS:000086049100037
J	Matsuoka, T; Hirata, M; Tanaka, H; Takahashi, Y; Murata, T; Kabashima, K; Sugimoto, Y; Kobayashi, T; Ushikubi, F; Aze, Y; Eguchi, N; Urade, Y; Yoshida, N; Kimura, K; Mizoguchi, A; Honda, Y; Nagai, H; Narumiya, S				Matsuoka, T; Hirata, M; Tanaka, H; Takahashi, Y; Murata, T; Kabashima, K; Sugimoto, Y; Kobayashi, T; Ushikubi, F; Aze, Y; Eguchi, N; Urade, Y; Yoshida, N; Kimura, K; Mizoguchi, A; Honda, Y; Nagai, H; Narumiya, S			Prostaglandin D-2 as a mediator of allergic asthma	SCIENCE			English	Article							CELL-DEFICIENT; D RECEPTOR; AIRWAYS; HYPERREACTIVITY; ACCUMULATION; INFLAMMATION; EXPRESSION; CHALLENGE; RELEASE; POTENT	Allergic asthma is caused by the aberrant expansion in the lung of T helper cells that produce type 2 (T(H)2) cytokines and is characterized by infiltration of eosinophils and bronchial hyperreactivity. This disease is often triggered by mast cells activated by immunoglobulin E (IgE)-mediated allergic challenge. Activated mast cells release Various chemical mediators, including prostaglandin D-2 (PCD2), whose role in allergic asthma has now been investigated by the generation of mice deficient in the PCD receptor (DP). Sensitization and aerosol challenge of the homozygous mutant (DP-/-) mice with ovalbumin (OVA) induced increases in the serum concentration of IgE similar to those in wild-type mice subjected to this model of asthma. However, the concentrations of T(H)2 cytokines and the extent of lymphocyte accumulation in the lung of OVA-challenged DP-/- mice were greatly reduced compared with those in wild-type animals. Moreover, DP-/- mice showed only marginal infiltration of eosinophils and failed to develop airway hyperreactivity. Thus, PGD(2) functions as a mast cell-derived mediator to trigger asthmatic responses.	Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Dept Ophthalmol, Sakyo Ku, Kyoto 6068501, Japan; Kyoto Univ, Fac Med, Dept Anat, Sakyo Ku, Kyoto 6068501, Japan; Gifu Pharmaceut Univ, Dept Pharmacol, Gifu 5020003, Japan; Kyoto Univ, Fac Pharmaceut Sci, Dept Physiol Chem, Kyoto 6068501, Japan; Ono Pharmaceut Co, Fukui Safety Res Labs, Fukui 9138538, Japan; Osaka Biosci Inst, Osaka 5650874, Japan; Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan	Kyoto University; Kyoto University; Kyoto University; Gifu Pharmaceutical University; Kyoto University; Ono Pharmaceutical Co Ltd; University of Tokyo	Narumiya, S (corresponding author), Kyoto Univ, Fac Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan.	snaru@mfour.med.kyoto-u.ac.jp	Kimura, Kazushi/ABB-4007-2020; Sugimoto, Yukihiko/AAV-6470-2021; Kabashima, Kenji/G-2521-2014	Sugimoto, Yukihiko/0000-0001-6973-932X; Kabashima, Kenji/0000-0002-0773-0554; Murata, Takahiko/0000-0003-0132-5424				AIKAWA T, 1992, CHEST, V101, P916, DOI 10.1378/chest.101.4.916; BARR RM, 1988, BRIT J PHARMACOL, V94, P773, DOI 10.1111/j.1476-5381.1988.tb11588.x; BOUSQUET J, 1990, NEW ENGL J MED, V323, P1033, DOI 10.1056/NEJM199010113231505; Corry DB, 1998, MOL MED, V4, P344, DOI 10.1007/BF03401741; EMERY DL, 1989, J APPL PHYSIOL, V67, P959, DOI 10.1152/jappl.1989.67.3.959; Foster PS, 1996, J EXP MED, V183, P195, DOI 10.1084/jem.183.1.195; FUJITANI Y, UNPUB; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HIRATA M, 1994, P NATL ACAD SCI USA, V91, P11192, DOI 10.1073/pnas.91.23.11192; Holgate ST, 1998, CLIN EXP ALLERGY, V28, P97; Howarth PH, 1997, ALLERGY, V52, P12, DOI 10.1111/j.1398-9995.1997.tb04878.x; IKAI K, 1985, J INVEST DERMATOL, V85, P82, DOI 10.1111/1523-1747.ep12275365; Konzett H, 1940, N-S ARCH EX PATH PH, V195, P71, DOI 10.1007/BF01861842; LEWIS RA, 1981, NATURE, V293, P103, DOI 10.1038/293103a0; LIU MC, 1990, AM REV RESPIR DIS, V142, P126, DOI 10.1164/ajrccm/142.1.126; MATSUOKA T, UNPUB; MIZOGUCHI A, IN PRESS P NATL ACAD; MURRAY JJ, 1986, NEW ENGL J MED, V315, P800, DOI 10.1056/NEJM198609253151304; O'Sullivan S, 1999, ACTA PHYSIOL SCAND, V166, P1; Oida H, 1997, FEBS LETT, V417, P53, DOI 10.1016/S0014-5793(97)01253-2; ROBERTS LJ, 1980, NEW ENGL J MED, V303, P1400, DOI 10.1056/NEJM198012113032405; Tanaka H, 1998, LIFE SCI, V62, pPL169, DOI 10.1016/S0024-3205(98)00047-2; Tsuri T, 1997, J MED CHEM, V40, P3504, DOI 10.1021/jm970343g; URADE Y, 1989, J IMMUNOL, V143, P2982; WALLS AF, 1991, LUNG, V169, P227, DOI 10.1007/BF02714157; WENZEL SE, 1991, J ALLERGY CLIN IMMUN, V87, P540, DOI 10.1016/0091-6749(91)90013-E; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258	28	602	641	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 17	2000	287	5460					2013	2017		10.1126/science.287.5460.2013	http://dx.doi.org/10.1126/science.287.5460.2013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720327	Green Submitted			2022-12-24	WOS:000085902800061
J	Reich, MR				Reich, MR			The global drug cap	SCIENCE			English	Article							COMMUNITY; HEALTH	Global inequities in access to pharmaceutical products exist between rich and poor countries because of market and government failures as well as huge income differences. Multiple policies are required to address this global drug gap for three categories of pharmaceutical products: essential drugs, new drugs, and yet-to-be-developed drugs. Policies should combine "push" approaches of financial subsidies to support targeted drug development, "pull" approaches of financial incentives such as market guarantees, and "process" approaches aimed at improved institutional-capacity. Constructive solutions are needed that can both protect the incentives for research and development and reduce the inequities of access.	Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Reich, MR (corresponding author), Harvard Univ, Sch Publ Hlth, 667 Huntington Ave, Boston, MA 02115 USA.							[Anonymous], 1993, WORLD DEV REP 1993 I; Bond P, 1999, INT J HEALTH SERV, V29, P765, DOI 10.2190/4MA6-53E3-LE1X-C1YY; Fauci AS, 1999, NEW ENGL J MED, V341, P1046, DOI 10.1056/NEJM199909303411406; FUJISAKI T, 1997, ASSESSMENT TDRS CONT; *IMS, 1999, IMS HLTH; Kremer M, 1998, Q J ECON, V113, P1137, DOI 10.1162/003355398555865; KREMER M, 1999, PURCHASE PRECOMMITME; Lanjouw J.O., 1999, 6366 NAT BUR EC RES; Management Sciences for Health, 1997, MAN DRUG SUPPL; MCPAKE B, 1993, SOC SCI MED, V36, P1383, DOI 10.1016/0277-9536(93)90381-D; Milstien JB, 1998, DRUG INF J, V32, P175, DOI 10.1177/009286159803200125; Olliaro P, 1996, JAMA-J AM MED ASSOC, V275, P230, DOI 10.1001/jama.275.3.230; Parry E, 1997, THORAX, V52, P589, DOI 10.1136/thx.52.7.589; Pecoul B, 1999, JAMA-J AM MED ASSOC, V281, P361, DOI 10.1001/jama.281.4.361; Reich M.R., 1998, DAP RES SERIES; REICH MR, 1987, HEALTH POLICY, V8, P39, DOI 10.1016/0168-8510(87)90129-1; Reich MR, 1999, B WORLD HEALTH ORGAN, V77, P675; Trouiller P, 1999, TROP MED INT HEALTH, V4, P412, DOI 10.1046/j.1365-3156.1999.00420.x; *UNDP WORLD BANK W, 1995, TROP DIS RES PROGR 1; Wehrwein P, 1999, HARV PUBLIC HLTH SUM, P32; *WHO EXP COMM, 1998, WHO TECHN REP SER, V882; 1999, GUIDELINES DRUG DONA; 1999, SUPPLY DIVISION ANN; 1998, AIDS EPIDEMIC UPDATE	24	50	51	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1979	1981		10.1126/science.287.5460.1979	http://dx.doi.org/10.1126/science.287.5460.1979			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10755953				2022-12-24	WOS:000085902800051
J	Hulka, BS; Kerkvliet, NL; Tugwell, P				Hulka, BS; Kerkvliet, NL; Tugwell, P			Experience of a scientific panel formed to advise the federal judiciary on silicone breast implants.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27599 USA; Oregon State Univ, Corvallis, OR 97331 USA; Ottawa Gen Hosp, Ottawa, ON K1H 8L6, Canada	University of North Carolina; University of North Carolina Chapel Hill; Oregon State University; University of Ottawa; Ottawa Hospital Research Institute	Hulka, BS (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.		Tugwell, Peter/AFD-8076-2022	Tugwell, Peter/0000-0001-5062-0556				Angell M, 1996, NEW ENGL J MED, V334, P1513, DOI 10.1056/NEJM199606063342306; Bondurant S, 1999, SAFETY SILICONE BREA; Janowsky EC, 2000, NEW ENGL J MED, V342, P781, DOI 10.1056/NEJM200003163421105; Kaiser J, 1999, SCIENCE, V284, P1600; 1975, FED REG, P706	5	22	22	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2000	342	11					812	815		10.1056/NEJM200003163421111	http://dx.doi.org/10.1056/NEJM200003163421111			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293HW	10717019				2022-12-24	WOS:000085846900011
J	Savaglio, S; Carbone, V				Savaglio, S; Carbone, V			Human performance - Scaling in athletic world records	NATURE			English	Article									Space Telescope Sci Inst, Baltimore, MD 21218 USA; Univ Calabria, Dipartimento Fis, I-87036 Arcavacata Di Rende, CS, Italy; Univ Calabria, Ist Nazl Fis Mat, Unita Cosenza, I-87036 Arcavacata Di Rende, CS, Italy	Space Telescope Science Institute; University of Calabria; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Calabria	Savaglio, S (corresponding author), Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA.	savaglio@stsci.edu	Carbone, Vincenzo/AAD-8557-2020	Carbone, Vincenzo/0000-0002-3182-6679; Savaglio, Sandra/0000-0003-2354-3238				di Prampero P E, 1981, Rev Physiol Biochem Pharmacol, V89, P143; Henry FM, 1955, RES QUART, V26, P147, DOI 10.1080/10671188.1955.10612815; Katz JS, 1999, J SPORT SCI, V17, P467; Kennelly AE, 1906, P AM ACAD ARTS SCI, V42, P273; MOGNONI P, 1982, EUR J APPL PHYSIOL O, V49, P287, DOI 10.1007/BF00441290	5	26	26	1	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					244	244		10.1038/35005165	http://dx.doi.org/10.1038/35005165			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749198	Bronze, Green Submitted			2022-12-24	WOS:000086022200036
J	Zuber, MT; Solomon, SC; Phillips, RJ; Smith, DE; Tyler, GL; Aharonson, O; Balmino, G; Banerdt, WB; Head, JW; Johnson, CL; Lemoine, FG; McGovern, PJ; Neumann, GA; Rowlands, DD; Zhong, SJ				Zuber, MT; Solomon, SC; Phillips, RJ; Smith, DE; Tyler, GL; Aharonson, O; Balmino, G; Banerdt, WB; Head, JW; Johnson, CL; Lemoine, FG; McGovern, PJ; Neumann, GA; Rowlands, DD; Zhong, SJ			Internal structure and early thermal evolution of Mars from Mars Global Surveyor topography and gravity	SCIENCE			English	Article							HEMISPHERIC DICHOTOMY; GIANT IMPACT; FLOW; CONSTRAINTS; THICKNESS; DYNAMICS; MISSION; CHANNEL; BASINS; MANTLE	Topography and gravity measured by the Mars Global Surveyor have enabled determination of the global crust and upper mantle structure of Mars. The planet displays two distinct crustal zones that do not correlate globally with the geologic dichotomy: a region of crust that thins progressively from south to north and encompasses much of the southern highlands and Tharsis province and a region of approximately uniform crustal thickness that includes the northern lowlands and Arabia Terra. The strength of the lithosphere beneath the ancient southern highlands suggests that the northern hemisphere was a locus of high heat flow early in martian history. The thickness of the elastic lithosphere increases with time of loading in the northern plains and Tharsis. The northern lowlands contain structures interpreted as large buried channels that are consistent with northward transport of water and sediment to the lowlands before the end of northern hemisphere resurfacing.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; NASA, Goddard Space Flight Ctr, Earth Sci Directorate, Greenbelt, MD 20771 USA; Stanford Univ, Ctr Radio Astron, Moffett Field, CA 94035 USA; Grp Rech Geodesie Spatiale, Toulouse, France; CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	Massachusetts Institute of Technology (MIT); Carnegie Institution for Science; Washington University (WUSTL); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Stanford University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Brown University	Zuber, MT (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.		Lemoine, Frank/D-1215-2013; Banerdt, William/Q-7324-2019; Rowlands, David/D-2751-2012; Zhong, Shijie/A-5290-2010; Neumann, Gregory A/I-5591-2013	Banerdt, William/0000-0003-3125-1542; Neumann, Gregory A/0000-0003-0644-9944; Aharonson, Oded/0000-0001-9930-2495				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Albee AL, 1998, SCIENCE, V279, P1671, DOI 10.1126/science.279.5357.1671; BANERDT WB, 1992, MARS, P249; BILLS BG, 1978, J GEOPHYS RES, V83, P3497, DOI 10.1029/JB083iB07p03497; BRACE WF, 1980, J GEOPHYS RES, V85, P6248, DOI 10.1029/JB085iB11p06248; BRATT SR, 1985, J GEOPHYS RES-SOLID, V90, P3049, DOI 10.1029/JB090iB04p03049; CARISTAN Y, 1982, J GEOPHYS RES, V87, P6781, DOI 10.1029/JB087iB08p06781; Carr M., 1981, SURFACE MARS; CHOBLET G, 1998, LUNAR PLANET SCI, V30, P1556; Connerney JEP, 1999, SCIENCE, V284, P794, DOI 10.1126/science.284.5415.794; Dunlop D, 1997, ROCK MAGNETISM; FORSYTH DW, 1985, J GEOPHYS RES-SOLID, V90, P2623, DOI 10.1029/JB090iB14p12623; FORSYTH DW, 1993, J GEOPHYS RES-SOL EA, V98, P16073, DOI 10.1029/93JB01722; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey H, 1998, GEOPHYS RES LETT, V25, P4409, DOI 10.1029/1998GL900095; Frey HV, 1996, GEOPHYS RES LETT, V23, P721, DOI 10.1029/96GL00744; GOETZE C, 1978, PHILOS T R SOC A, V288, P99, DOI 10.1098/rsta.1978.0008; Grasset O, 1998, J GEOPHYS RES-SOL EA, V103, P18171, DOI 10.1029/98JB01492; Head JW, 1999, SCIENCE, V286, P2134, DOI 10.1126/science.286.5447.2134; Kaula W.M., 1966, THEORY SATELLITE GEO; Kiefer WS, 1996, J GEOPHYS RES-PLANET, V101, P9239, DOI 10.1029/95JE03699; Klaucke I, 1997, SEDIMENTOLOGY, V44, P1093, DOI 10.1111/j.1365-3091.1997.tb02180.x; Klaucke I, 1998, GEOL SOC AM BULL, V110, P22, DOI 10.1130/0016-7606(1998)110<0022:MASOAD>2.3.CO;2; LEMOINE FG, 1999, EOS S, V80, pF618; LEMOINE FG, UNPUB; MCGILL GE, 1989, J GEOPHYS RES-SOLID, V94, P2753, DOI 10.1029/JB094iB03p02753; MCNUTT MK, 1984, J GEOPHYS RES, V89, P1180, DOI 10.1029/JB089iB13p11180; MCSWEEN HY, 1985, REV GEOPHYS, V23, P391, DOI 10.1029/RG023i004p00391; Morgan J, 1999, GEOLOGY, V27, P407, DOI 10.1130/0091-7613(1999)027<0407:CTTDOA>2.3.CO;2; NIMMO F, IN PRESS J GEOPHYS R; PARKER TJ, 1993, J GEOPHYS RES-PLANET, V98, P11061, DOI 10.1029/93JE00618; PHILLIPS RJ, 1973, J GEOPHYS RES, V78, P4815, DOI 10.1029/JB078i023p04815; PHILLIPS RJ, 2000, LUNEAR PLANET SCI, V31; SCHUBERT G, 1990, J GEOPHYS RES-SOLID, V95, P14095, DOI 10.1029/JB095iB09p14095; SIMONS FJ, IN PRESS J GEOPHYS R; Simons M, 1997, GEOPHYS J INT, V131, P24, DOI 10.1111/j.1365-246X.1997.tb00593.x; SJOGREN WL, 1999, EOS S, V80, pF618; SLEEP NH, 1994, J GEOPHYS RES-PLANET, V99, P5639, DOI 10.1029/94JE00216; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Smith DE, 1998, SCIENCE, V279, P1686, DOI 10.1126/science.279.5357.1686; Smith DE, 1996, SCIENCE, V271, P184, DOI 10.1126/science.271.5246.184; Smith DE, 1999, SCIENCE, V286, P94, DOI 10.1126/science.286.5437.94; Sohl F, 1997, J GEOPHYS RES-PLANET, V102, P1613, DOI 10.1029/96JE03419; SOLOMON SC, 1990, J GEOPHYS RES-SOLID, V95, P11073, DOI 10.1029/JB095iB07p11073; SOLOMON SC, 1982, J GEOPHYS RES, V87, P9755, DOI 10.1029/JB087iB12p09755; SPOHN T, 1999, EOS S, V80, pF619; Tanaka K. L., 1992, MARS, P345; TURCOTTE DL, 1981, J GEOPHYS RES, V86, P3951, DOI 10.1029/JB086iB05p03951; TYLER GL, 1992, J GEOPHYS RES-PLANET, V97, P7759, DOI 10.1029/92JE00513; WATTS AB, 1980, J GEOPHYS RES, V85, P5369; Wieczorek MA, 1998, J GEOPHYS RES-PLANET, V103, P1715, DOI 10.1029/97JE03136; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; ZHONG S, IN PRESS J GEOPHYS R; ZUBER MT, 1994, SCIENCE, V266, P1839, DOI 10.1126/science.266.5192.1839; ZUBER MT, 1992, J GEOPHYS RES-PLANET, V97, P7781, DOI 10.1029/92JE00341	55	436	444	4	84	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1788	1793		10.1126/science.287.5459.1788	http://dx.doi.org/10.1126/science.287.5459.1788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710301				2022-12-24	WOS:000085775300033
J	Brown, BE; Dunne, RP; Goodson, MS; Douglas, AE				Brown, BE; Dunne, RP; Goodson, MS; Douglas, AE			Marine ecology - Bleaching patterns in reef corals	NATURE			English	Article							EVENT		Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England	Newcastle University - UK; University of York - UK	Brown, BE (corresponding author), Univ Newcastle Upon Tyne, Dept Marine Sci & Coastal Management, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.		Brown, Barbara E/N-2104-2015; Brown, Barbara/AAT-7991-2021	Goodson, Michael/0000-0002-5004-551X				ADACHI M, 1994, J PHYCOL, V30, P857, DOI 10.1111/j.0022-3646.1994.00857.x; Brown BE, 1996, CORAL REEFS, V15, P151, DOI 10.1007/BF01145885; BROWN BE, 1994, MAR ECOL PROG SER, V105, P219, DOI 10.3354/meps105219; BROWN BE, IN PRESS MAR ECOL PR; Brown BE, 1997, CORAL REEFS, V16, P129; FITT WK, 1993, CORAL REEFS, V12, P57, DOI 10.1007/BF00302102; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; HILLIS DM, 1991, Q REV BIOL, V66, P411, DOI 10.1086/417338; HUGHES TP, 1985, ECOL MONOGR, V55, P141, DOI 10.2307/1942555; Jones RJ, 1997, MAR ECOL PROG SER, V158, P51, DOI 10.3354/meps158051; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843	11	142	148	5	61	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					142	143		10.1038/35004657	http://dx.doi.org/10.1038/35004657			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724156				2022-12-24	WOS:000085870900036
J	Schlossmann, J; Ammendola, A; Ashman, K; Zong, XG; Huber, A; Neubauer, G; Wang, GX; Allescher, HD; Korth, M; Wilm, M; Hofmann, F; Ruth, P				Schlossmann, J; Ammendola, A; Ashman, K; Zong, XG; Huber, A; Neubauer, G; Wang, GX; Allescher, HD; Korth, M; Wilm, M; Hofmann, F; Ruth, P			Regulation of intracellular calcium by a signalling complex of IRAG, IP3 receptor and cGMP kinase I beta	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; VASCULAR SMOOTH-MUSCLE; MEMBRANE-PROTEIN; CA2+ RELEASE; ION; PHOSPHORYLATION; PURIFICATION; SUBSTRATE	Calcium release from the endoplasmic reticulum controls a number of cellular processes, including proliferation and contraction of smooth muscle and other cells(1,2). Calcium release from inositol 1,4,5-trisphosphate (IP3)-sensitive stores is negatively regulated by binding of calmodulin to the IP3 receptor (IP3R)(3,4) and the NO/cGMP/cGMP kinase I (cGKI) signalling pathways(5,6). Activation of cGKI decreases IP3-stimulated elevations in intracellular calcium(7), induces smooth muscle relaxation(8) and contributes to the antiproliferative(9) and pro-apoptotic effects of NO/cGMP(10). Here we show that, in microsomal smooth muscle membranes, cGKI beta phosphorylated the IP3R and cGKI beta, and a protein of relative molecular mass 125,000 which we now identify as the IP3R-associated cGMP kinase substrate (IRAG). These proteins were co-immunoprecipitated by antibodies directed against cGKI, IP3R or IRAG. IRAG was found in many tissues including aorta, trachea and uterus, and was localized perinuclearly after heterologous expression in COS-7 cells. Bradykinin-stimulated calcium release was not affected by the expression of either IRAG or cGKI beta, which we tested in the absence and presence of cGMP. However, calcium release was inhibited after co-expression of IRAG and cGKI beta in the presence of cGMP. These results identify IRAG as an essential NO/cGKI-dependent regulator of IP3-induced calcium release.	Tech Univ Munich, Inst Pharmakol & Toxikol, D-80802 Munich, Germany; European Mol Biol Lab, Prot & Peptide Grp, D-69117 Heidelberg, Germany; Univ Hamburg, Hosp Eppendorf, Abt Pharmakol Pharmazeuten, D-20246 Hamburg, Germany	Technical University of Munich; European Molecular Biology Laboratory (EMBL); University of Hamburg	Hofmann, F (corresponding author), Tech Univ Munich, Inst Pharmakol & Toxikol, Biedersteiner Str 29, D-80802 Munich, Germany.		Ashman, Keith/G-2328-2011; Schlossmann, Jens/I-7743-2016	Schlossmann, Jens/0000-0002-2550-6839; Wilm, Matthias/0000-0002-5461-6834				BALTENSPERGER K, 1988, EUR J BIOCHEM, V172, P7, DOI 10.1111/j.1432-1033.1988.tb13848.x; BEHRENS TW, 1994, J IMMUNOL, V153, P682; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Brenman JE, 1997, DEV NEUROSCI-BASEL, V19, P224, DOI 10.1159/000111211; Broad LM, 1999, J BIOL CHEM, V274, P32881, DOI 10.1074/jbc.274.46.32881; CASNELLI.JE, 1974, P NATL ACAD SCI USA, V71, P1891, DOI 10.1073/pnas.71.5.1891; Chiche JD, 1998, J BIOL CHEM, V273, P34263, DOI 10.1074/jbc.273.51.34263; Eigenthaler M, 1999, Rev Physiol Biochem Pharmacol, V135, P173, DOI 10.1007/BFb0033673; Fujita S, 1999, J VASC RES, V36, P299, DOI 10.1159/000025658; Haug LS, 1999, J BIOL CHEM, V274, P7467, DOI 10.1074/jbc.274.11.7467; KEILBACH A, 1992, EUR J BIOCHEM, V208, P467, DOI 10.1111/j.1432-1033.1992.tb17209.x; KOGA T, 1994, J BIOL CHEM, V269, P11640; KOMALAVILAS P, 1994, J BIOL CHEM, V269, P8701; Lipp P, 1997, EMBO J, V16, P7166, DOI 10.1093/emboj/16.23.7166; Michikawa T, 1999, NEURON, V23, P799, DOI 10.1016/S0896-6273(01)80037-4; Missiaen L, 1999, J BIOL CHEM, V274, P13748, DOI 10.1074/jbc.274.20.13748; NEWTON CL, 1994, J BIOL CHEM, V269, P28613; Nguyen T, 1998, NATURE, V395, P908, DOI 10.1038/27686; OROURKE F, 1994, BIOCHEM J, V300, P673, DOI 10.1042/bj3000673; Pfeifer A, 1999, Rev Physiol Biochem Pharmacol, V135, P105, DOI 10.1007/BFb0033671; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; Rooney TA, 1996, J BIOL CHEM, V271, P19817, DOI 10.1074/jbc.271.33.19817; RUTH P, 1993, P NATL ACAD SCI USA, V90, P2623, DOI 10.1073/pnas.90.7.2623; Shaughnessy JD, 1999, ONCOGENE, V18, P2069; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; Surks HK, 1999, SCIENCE, V286, P1583, DOI 10.1126/science.286.5444.1583; Tertyshnikova X, 1998, J PHYSIOL-LONDON, V512, P89, DOI 10.1111/j.1469-7793.1998.089bf.x; VONDERLEYEN H, 1994, P NATL ACAD SCI USA, V92, P1137; Wilm M, 1996, ANAL CHEM, V68, P527, DOI 10.1021/ac950875+	29	352	372	0	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					197	201		10.1038/35004606	http://dx.doi.org/10.1038/35004606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724174				2022-12-24	WOS:000085870900055
J	Shearman, LP; Sriram, S; Weaver, DR; Maywood, ES; Chaves, I; Zheng, BH; Kume, K; Lee, CC; van der Horst, GTJ; Hastings, MH; Reppert, SM				Shearman, LP; Sriram, S; Weaver, DR; Maywood, ES; Chaves, I; Zheng, BH; Kume, K; Lee, CC; van der Horst, GTJ; Hastings, MH; Reppert, SM			Interacting molecular loops in the mammalian circadian clock	SCIENCE			English	Article							RAT SUPRACHIASMATIC NUCLEUS; PERIOD HOMOLOGS; GENE CLOCK; TIMELESS; EXPRESSION; PROTEIN; RHYTHMS; TRANSCRIPTION; OSCILLATION; NEURONS	We show that, in the mouse, the core mechanism for the master circadian clock consists of interacting positive and negative transcription and translation feedback Loops. Analysis of Clock/Clock mutant mice, homozygous period2(Brdm1) mutants, and Cryptochrome-deficient mice reveals substantially altered Small rhythms, consistent with a dominant role of PERIOD2 in the positive regulation of the Bmal1 Loop. In vitro analysis of CRYPTOCHROME inhibition of CLOCK: BMAL1-mediated transcription shows that the inhibition is through direct protein:protein interactions, independent of the PERIOD and TIMELESS proteins. PERIOD2 is a positive regulator of the Bmal1 Loop, and CRYPTOCHROMES are the negative regulators of the Period and Cryptochrome cycles.	Massachusetts Gen Hosp, Massachusetts Gen Hosp Children, Lab Dev Chronobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA; Univ Cambridge, Dept Anat, Cambridge CB2 3DY, England; Erasmus Univ, Dept Cell Biol & Genet, Ctr Med Genet, NL-3000 DR Rotterdam, Netherlands; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of Cambridge; Erasmus University Rotterdam; Baylor College of Medicine	Reppert, SM (corresponding author), Massachusetts Gen Hosp, Massachusetts Gen Hosp Children, Lab Dev Chronobiol, Boston, MA 02114 USA.	reppert@helix.mgh.harvard.edu	van der Horst, Gijsbertus TJ/E-3661-2015; Chaves, Ines/L-3074-2015; Jansen, Heiko T./A-5770-2008	van der Horst, Gijsbertus TJ/0000-0002-7773-6396; Jansen, Heiko T./0000-0003-0178-396X; Hastings, Michael Harvey/0000-0001-8576-6651; Weaver, David/0000-0001-7941-6719; Kume, Kazuhiko/0000-0003-4232-1657	NHLBI NIH HHS [HL07901] Funding Source: Medline; NICHD NIH HHS [R37 HD14427] Funding Source: Medline; NINDS NIH HHS [R01 NS39303] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD014427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039303] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GEKAKIS N, 1995, SCIENCE, V270, P811, DOI 10.1126/science.270.5237.811; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Gotter A. L., UNPUB; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hastings M H, 1999, J Neurosci, V19, pRC11; Herzog ED, 1998, NAT NEUROSCI, V1, P708, DOI 10.1038/3708; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Honma S, 1998, NEUROSCI LETT, V250, P157, DOI 10.1016/S0304-3940(98)00464-9; Honma S, 1998, BIOCHEM BIOPH RES CO, V250, P83, DOI 10.1006/bbrc.1998.9275; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Keesler GA, 2000, NEUROREPORT, V11, P951, DOI 10.1097/00001756-200004070-00011; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; KLEIN DC, 1991, SUPRACHLASMATIC NUCL; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; OLSHI K, 1998, BIOCHEM BIOPH RES CO, V253, P199; OLSHI K, 2000, BIOCHEM BIOPH RES CO, V268, P164; Ripperger JA, 2000, GENE DEV, V14, P679; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; SHEARMAN LP, UNPUB; Silver R, 1999, NEUROREPORT, V10, P3165, DOI 10.1097/00001756-199910190-00008; Takahata S, 1998, BIOCHEM BIOPH RES CO, V248, P789, DOI 10.1006/bbrc.1998.9012; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VIELHABER E, IN PRESS MOL CELL BI; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Weaver DR, 1998, J BIOL RHYTHM, V13, P100, DOI 10.1177/074873098128999952; WELSH DK, 1995, NEURON, V14, P697, DOI 10.1016/0896-6273(95)90214-7; Yu WJ, 1999, BIOCHEM BIOPH RES CO, V260, P760, DOI 10.1006/bbrc.1999.0970; ZHENG B, UNPUB; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	44	1053	1097	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 12	2000	288	5468					1013	1019		10.1126/science.288.5468.1013	http://dx.doi.org/10.1126/science.288.5468.1013			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10807566				2022-12-24	WOS:000086988400028
J	Wight, D; Henderson, M; Raab, G; Abraham, C; Buston, K; Scott, S; Hart, G				Wight, D; Henderson, M; Raab, G; Abraham, C; Buston, K; Scott, S; Hart, G			Extent of regretted sexual intercourse among young teenagers in Scotland: a cross sectional survey	BRITISH MEDICAL JOURNAL			English	Article									MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland; Napier Univ, Sch Math & Phys Sci, Edinburgh EH10 5DT, Midlothian, Scotland; Univ Sussex, Sch Social Sci, Brighton BN1 9QN, England; Univ Durham, Dept Sociol & Social Policy, Durham, England	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; Edinburgh Napier University; University of Sussex; Durham University	Wight, D (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow G12 8RZ, Lanark, Scotland.		Hart, Graham J/C-1591-2008; Henderson, Marion Mackay/AAS-2759-2021; Abraham, Charles/C-7130-2012; Henderson, Marion/M-2136-2019; Henderson, Marion/G-3310-2019	Henderson, Marion/0000-0001-7582-9516; Henderson, Marion/0000-0001-7582-9516; Abraham, Charles/0000-0002-0901-1975; Hart, Graham/0000-0001-9676-6577; Buston, Katie/0000-0003-4162-8868				Dickson N, 1998, BRIT MED J, V316, P29, DOI 10.1136/bmj.316.7124.29; JOHNSON AM, 1994, SEXUAL ATTITUDES LIF; RICHARD R, 1996, J BEHAV DECIS MAKING, V3, P263; *SAS I, 1996, SAS LOG PROC SAS STA; WIGHT D, 1997, HLTH ED, V2, P52	5	62	62	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 6	2000	320	7244					1243	1244		10.1136/bmj.320.7244.1243	http://dx.doi.org/10.1136/bmj.320.7244.1243			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	313CF	10797033	Green Accepted, Bronze, Green Submitted, Green Published			2022-12-24	WOS:000086981400018
J	Nickeleit, V; Klimkait, T; Binet, IF; Dalquen, P; Del Zenero, V; Thiel, G; Mihatsch, MJ; Hirsch, HH				Nickeleit, V; Klimkait, T; Binet, IF; Dalquen, P; Del Zenero, V; Thiel, G; Mihatsch, MJ; Hirsch, HH			Testing for polyomavirus type BK DNA in plasma to identify renal-allograft recipients with viral nephropathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW TRANSPLANT; JC-VIRUS INFECTIONS; HEMORRHAGIC CYSTITIS; PREVALENCE	Background: Reactivation of polyomavirus type BK (BK virus) is increasingly recognized as a cause of severe renal-allograft dysfunction. Currently, patients at risk for nephropathy due to infection with the BK virus are identified by the presence of cells containing viral inclusion bodies ("decoy cells'') in the urine or by biopsy of allograft tissue. Methods: In a retrospective analysis, we performed polymerase-chain-reaction assays for BK virus DNA in plasma samples from 9 renal-allograft recipients with BK virus nephropathy; 41 renal-allograft recipients who did not have signs of nephropathy, 16 of whom had decoy cells in the urine; and as immunocompromised controls, 17 patients who had human immunodeficiency virus type 1 (HIV-1) infection (stage C3 according to the classification of the Centers for Disease Control and Prevention) and who had not undergone transplantation. Results: In all nine patients with BK virus nephropathy, BK virus DNA was detected in the plasma at the time of the initial histologic diagnosis (a mean [+/-SD] of 46+/-28 weeks after transplantation) and during the course of histologically diagnosed, persistent BK virus disease. In three of the six patients with nephropathy who were studied serially after transplantation, BK virus DNA was initially undetectable but was detected 16 to 33 weeks before nephropathy became clinically evident and was confirmed by biopsy. Tests for BK virus DNA in plasma became negative and the nephropathy resolved after the doses of immunosuppressive drugs were decreased in two patients and after removal of the renal allograft in three patients. BK virus DNA was found in the plasma of only 2 of the 41 renal-allograft recipients who had no signs of nephropathy and in none of the patients with HIV-1 infection. Conclusions: Testing for BK virus DNA in plasma from renal-allograft recipients with use of the polymerase chain reaction is a sensitive and specific method for identifying viral nephropathy. (N Engl J Med 2000;342:1309-15.) (C) 2000, Massachusetts Medical Society.	Univ Basel, Inst Pathol, Basel, Switzerland; Univ Basel, Inst Med Microbiol, Basel, Switzerland; Univ Basel, Dept Internal Med, Div Nephrol, Basel, Switzerland	University of Basel; University of Basel; University of Basel	Hirsch, HH (corresponding author), Univ Basel Hosp, Dept Internal Med, Petersgraben 4, CH-4031 Basel, Switzerland.		Klimkait, Thomas/A-1057-2008	Klimkait, Thomas/0000-0003-4945-6511; Hirsch, Hans H./0000-0003-0883-0423				ANDREWS CA, 1988, J INFECT DIS, V158, P176, DOI 10.1093/infdis/158.1.176; ARTHUR RR, 1988, J INFECT DIS, V158, P563, DOI 10.1093/infdis/158.3.563; Binet I, 1999, TRANSPLANTATION, V67, P918, DOI 10.1097/00007890-199903270-00022; Bogdanovic G, 1996, BONE MARROW TRANSPL, V17, P573; Boubenider S, 1999, J NEPHROL, V12, P24; CHESTERS PM, 1983, J INFECT DIS, V147, P676, DOI 10.1093/infdis/147.4.676; COLEMAN DV, 1980, J INFECT DIS, V142, P1, DOI 10.1093/infdis/142.1.1; COTTLERFOX M, 1989, BONE MARROW TRANSPL, V4, P279; DORRIES K, 1994, VIROLOGY, V198, P59, DOI 10.1006/viro.1994.1008; GARDNER SD, 1984, J CLIN PATHOL, V37, P578, DOI 10.1136/jcp.37.5.578; Hirsch Hans H., 1998, Clin Microbiol Infect, V4, P577, DOI 10.1111/j.1469-0691.1998.tb00040.x; Hogan T F, 1983, Prog Clin Biol Res, V105, P311; HOGAN TF, 1980, ANN INTERN MED, V92, P373, DOI 10.7326/0003-4819-92-3-373; Holman RC, 1998, NEUROEPIDEMIOLOGY, V17, P303, DOI 10.1159/000026184; Mackenzie E F, 1978, Proc Eur Dial Transplant Assoc, V15, P352; MARKOWITZ RB, 1993, J INFECT DIS, V167, P13, DOI 10.1093/infdis/167.1.13; Mathur VS, 1997, AM J KIDNEY DIS, V29, P754; Nickeleit V, 1999, J AM SOC NEPHROL, V10, P1080; PADGETT BL, 1971, LANCET, V1, P1257; Randhawa PS, 1999, TRANSPLANTATION, V67, P103, DOI 10.1097/00007890-199901150-00018; SHAH KV, 1973, J INFECT DIS, V128, P784, DOI 10.1093/infdis/128.6.784; Shah KV, 1996, FIELDS VIROLOGY, P2027; STILMANT MM, 1987, ACTA CYTOL, V31, P625; SUNDSFJORD A, 1994, J INFECT DIS, V169, P485, DOI 10.1093/infdis/169.3.485	24	393	415	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2000	342	18					1309	1315		10.1056/NEJM200005043421802	http://dx.doi.org/10.1056/NEJM200005043421802			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	309RE	10793163				2022-12-24	WOS:000086782400002
J	Han, SSW; Fischer, I				Han, SSW; Fischer, I			Neural stem cells and gene therapy: Prospects for repairing the injured spinal card	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PRECURSORS		Hahnemann Univ, Sch Med, Philadelphia, PA 19102 USA	Drexel University	Han, SSW (corresponding author), Hahnemann Univ, Sch Med, Philadelphia, PA 19102 USA.		Fischer, Itzhak/D-1080-2012	Fischer, Itzhak/0000-0003-3187-8740				Kalyani AJ, 1998, J NEUROSCI, V18, P7856; Liu Y, 1999, J NEUROSCI, V19, P4370; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; MURRAY M, 2000, IN PRESS NERVE REGEN; Rao MS, 1999, ANAT RECORD, V257, P137; Studer L, 1998, NAT NEUROSCI, V1, P290, DOI 10.1038/1105; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Svendsen CN, 1999, BRAIN PATHOL, V9, P499, DOI 10.1111/j.1750-3639.1999.tb00538.x; Yandava BD, 1999, P NATL ACAD SCI USA, V96, P7029, DOI 10.1073/pnas.96.12.7029	9	15	19	1	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2000	283	17					2300	2301		10.1001/jama.283.17.2300	http://dx.doi.org/10.1001/jama.283.17.2300			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307UB	10807395	hybrid			2022-12-24	WOS:000086671600043
J	Wies, I; Brunner, S; Henninger, J; Herkel, J; Kanzler, S; zum Buchenfelde, KHM; Lohse, AW				Wies, I; Brunner, S; Henninger, J; Herkel, J; Kanzler, S; zum Buchenfelde, KHM; Lohse, AW			Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis	LANCET			English	Article							GLUTATHIONE-S-TRANSFERASE; CHRONIC ACTIVE HEPATITIS; SOLUBLE LIVER ANTIGEN; T-CELL VACCINATION; AUTOANTIGEN; DISEASES; SUBGROUP	Background Autoantibodies are a hallmark of autoimmune hepatitis, but most are not disease specific. Autoantibodies to soluble liver antigen (SLA) and to liver and pancreas antigen (LP) have been described as disease specific, occurring in about 30% of all patients with autoimmune hepatitis, but no standardised assays are available. Methods We tested 2000 serum samples from patients with various liver diseases and controls for SLA autoantibodies by inhibition ELISA. Serum samples positive for SLA antibodies were used for immunoscreening of cDNA expression libraries. Identified clones were tested against a panel of serum samples positive for SLA and LP autoantibodies and control serum samples, and the epitope mapped by deletion mutants and exonuclease digestion. Findings SLA and LP autoantibodies were identical. Of 2000 serum samples screened, 35 were positive for SLA autoantibodies. These positive samples came from patients with autoimmune hepatitis; three from patients with an overlap syndrome (primary biliary cirrhosis and secondary autoimmune hepatitis). Expression cloning and absorption experiments identified a 422 aminoacid protein present in two splice variants as the sole target antigen. Aminoacids 371-409 were critical for immune recognition. Interpretation The identified cDNA encodes the primary target antigen of SLA/LP autoantibodies. The SLA/LP antigen has a previously unknown aminoacid sequence, and presumably codes for an unindentified enzyme, suggested to be UGA-suppressor tRNA-associated protein. SLA/LP autoantibodies are disease specific and recognise a dominant epitope, suggesting a specific antigen-driven immune response. Identification of the SLA/LP target antigen will allow establishment of a reliable, widely available diagnostic assay. Furthermore, its role in the pathogenesis of autoimmune hepatitis can now be studied.	Johannes Gutenberg Univ Mainz, Dept Med, D-55101 Mainz, Germany	Johannes Gutenberg University of Mainz	Lohse, AW (corresponding author), Johannes Gutenberg Univ Mainz, Dept Med, D-55101 Mainz, Germany.	lohse@mail.uni-mainz.de		Herkel, Johannes/0000-0001-9055-9999				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez E, 1999, J HEPATOL, V31, P929, DOI 10.1016/S0168-8278(99)80297-9; Berg PA, 1981, VERH DTSCH GES INN M, V87, P921; CAMPANELLI D, 1990, J EXP MED, V172, P1709, DOI 10.1084/jem.172.6.1709; COHEN IR, 1983, IMMUNOL TODAY, V4, P227, DOI 10.1016/0167-5699(83)90032-4; CZAJA AJ, 1998, AUTOIMMUNE LIVER DIS, P499; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Herkel J, 1997, J AUTOIMMUN, V10, P137, DOI 10.1006/jaut.1997.0125; JANKNECHT R, 1991, P NATL ACAD SCI USA, V88, P8972, DOI 10.1073/pnas.88.20.8972; Kanzler S, 1999, J HEPATOL, V31, P635, DOI 10.1016/S0168-8278(99)80342-0; Klein R, 1999, GASTROENTEROLOGY, V116, P1015, DOI 10.1016/S0016-5085(99)70095-8; Krawitt EL, 1996, NEW ENGL J MED, V334, P897, DOI 10.1056/NEJM199604043341406; Lohse A.W., 1994, AUTOIMMUNE DIS MODEL, P191; Lohse AW, 1998, HEPATOLOGY, V27, P1536, DOI 10.1002/hep.510270611; Lohse AW, 1999, HEPATOLOGY, V29, P1078, DOI 10.1002/hep.510290409; LOHSE AW, 1995, Z GASTROENTEROL, V33, P527; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; MANNS M, 1989, J HEPATOL, V9, P272, DOI 10.1016/0168-8278(89)90063-9; MANNS M, 1987, LANCET, V1, P292; STECHEMESSER E, 1987, LANCET, V1, P683; STECHEMESSER E, 1993, HEPATOLOGY, V18, P1; TEUFEL M, 1983, EUR J PEDIATR, V140, P30, DOI 10.1007/BF00661901; VANDEWATER J, 1988, J EXP MED, V167, P1791, DOI 10.1084/jem.167.6.1791; WAECHTER B, 1997, J HEPATOL, V11, P232; WEINER HL, 1993, SCIENCE, V259, P1321, DOI 10.1126/science.7680493; Wesierska-Gadek J, 1998, GASTROENTEROLOGY, V114, P329, DOI 10.1016/S0016-5085(98)70485-8; ZUMBUSCHENFELDE KHM, 1995, NEW ENGL J MED, V333, P1004, DOI 10.1056/NEJM199510123331512	27	214	238	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2000	355	9214					1510	1515		10.1016/S0140-6736(00)02166-8	http://dx.doi.org/10.1016/S0140-6736(00)02166-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LR	10801173				2022-12-24	WOS:000086830100013
J	Yamazaki, S; Numano, R; Abe, M; Hida, A; Takahashi, R; Ueda, M; Block, GD; Sakaki, Y; Menaker, M; Tei, H				Yamazaki, S; Numano, R; Abe, M; Hida, A; Takahashi, R; Ueda, M; Block, GD; Sakaki, Y; Menaker, M; Tei, H			Resetting central and peripheral circadian oscillators in transgenic rats	SCIENCE			English	Article							GENE-EXPRESSION; RHYTHMS; PERIOD; CLOCK; DROSOPHILA	In multicellular organisms, circadian oscillators are organized into multitissue systems which function as biological clocks that regulate the activities of the organism in relation to environmental cycles and provide an internal temporal framework. To investigate the organization of a mammalian circadian system, we constructed a transgenic rat Line in which luciferase is rhythmically expressed under the control of the mouse Per1 promoter. Light emission from cultured suprachiasmatic nuclei (SCN) of these rats was invariably and robustly rhythmic and persisted for up to 32 days in vitro. Liver, Lung, and skeletal muscle also expressed circadian rhythms, which damped after two to seven cycles in vitro. In response to advances and delays of the environmental Light cycle, the circadian rhythm of light emission from the SCN shifted more rapidly than did the rhythm of locomotor behavior or the rhythms in peripheral tissues. We hypothesize that a self-sustained circadian pacemaker in the SCN entrains circadian oscillators in the periphery to maintain adaptive phase control, which is temporarily Lost following Large, abrupt shifts in the environmental Light cycle.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo 1088639, Japan; YS New Technol Inst, Ishibashi, Tochigi 3290500, Japan; Univ Virginia, NSF Ctr Biol Timing, Charlottesville, VA 22903 USA; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA	University of Tokyo; National Science Foundation (NSF); University of Virginia; University of Virginia	Menaker, M (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Jansen, Heiko T./A-5770-2008	Jansen, Heiko T./0000-0003-0178-396X	NIMH NIH HHS [MH56647, R01 MH056647] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH056647] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andrews R V, 1971, Gegenbaurs Morphol Jahrb, V117, P89; Aschoff J., 1981, BIOL RHYTHMS, P311; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Best JD, 1999, J NEUROSCI, V19, P828; Geusz ME, 1997, CURR BIOL, V7, P758, DOI 10.1016/S0960-9822(06)00334-4; HALBERG F, 1960, COLD SPRING HARB SYM, V25, P289, DOI 10.1101/SQB.1960.025.01.031; HOCHI S-I, 1990, Animal Biotechnology, V1, P175, DOI 10.1080/10495399009525739; HONMA K, 1989, BIOL RHYTHMS; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Klein D.C., 1991, SUPRACHIASMATIC NUCL; MENAKER M, 1996, CIRCADIAN ORG OSCILL, P39; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; TAKAMURE M, 1991, PHYSIOL BEHAV, V50, P443, DOI 10.1016/0031-9384(91)90092-3; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Ueyama T, 1999, NAT NEUROSCI, V2, P1051, DOI 10.1038/15973; US Congress. Office of Technology Assessment, 1991, OTABA463 US C; YAMAZAKI S, UNPUB; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	20	1371	1414	4	153	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2000	288	5466					682	685		10.1126/science.288.5466.682	http://dx.doi.org/10.1126/science.288.5466.682			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308RR	10784453				2022-12-24	WOS:000086727100047
J	Finette, BA; Homans, AC; Albertini, RJ				Finette, BA; Homans, AC; Albertini, RJ			Emergence of genetic instability in children treated for leukemia	SCIENCE			English	Article							T-LYMPHOCYTES; HPRT LOCUS; MUTATIONS; CANCER; POPULATION; EXPOSURE; DELETION; MUTATORS; P53	T cells from patients who had received chemotherapy for B-lineage acute lymphocytic Leukemia were studied to determine whether genetic instability, a principal characteristic of cancer cells, can also occur in nonmalignant cells. Consistent with expectations for a genetic instability phenotype, multiple mutations were detected in the hypoxanthine-guanine phosphoribosyltransferase (HPRT) reporter gene in independently isolated mutant T cells expressing identical rearranged T cell receptor beta (TCR beta) gene hypervariable regions. These results indicate that cancer treatment can lead to genetic instability in nonmalignant cells in some individuals. They also suggest a mechanistic paradigm for the induction of second malignancies and drug resistance.	Univ Vermont, Dept Pediat, Burlington, VT 05405 USA; Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA; Univ Vermont, Vermont Canc Ctr, Burlington, VT 05405 USA; Univ Vermont, Dept Med, Burlington, VT 05405 USA	University of Vermont; University of Vermont; University of Vermont; University of Vermont	Finette, BA (corresponding author), Univ Vermont, Dept Pediat, Med Alumni Bldg, Burlington, VT 05405 USA.	finette@salus.med.uvm.edu			NCI NIH HHS [1K01CA77737, P30CA22435] Funding Source: Medline; NICHD NIH HHS [1R29HD35309] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R29HD035309] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA022435, K01CA077737] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertini RJ, 1998, MUTAT RES-FUND MOL M, V400, P381, DOI 10.1016/S0027-5107(98)00063-3; BRANDA RF, 1991, CANCER RES, V51, P6603; Cariello NF, 1998, NUCLEIC ACIDS RES, V26, P198, DOI 10.1093/nar/26.1.198; Finette BA, 1998, NAT MED, V4, P1144, DOI 10.1038/2640; FINETTE BA, 1994, MUTAT RES, V308, P223, DOI 10.1016/0027-5107(94)90157-0; FUSCOE JC, 1991, CANCER RES, V51, P6001; GIBBS RA, 1990, GENOMICS, V7, P235, DOI 10.1016/0888-7543(90)90545-6; HIROTA H, 1994, MUTAT RES-DNA REPAIR, V315, P95, DOI 10.1016/0921-8777(94)90010-8; Hunt CR, 1998, CANCER RES, V58, P3986; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; KOSHI S, 1998, MUTAT RES, V422, P213; Kunkel TA, 1997, CELL, V88, P155, DOI 10.1016/S0092-8674(00)81832-2; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Loeb LA, 1998, ADV CANCER RES, V72, P25, DOI 10.1016/S0065-230X(08)60699-5; Mao EF, 1997, J BACTERIOL, V179, P417, DOI 10.1128/jb.179.2.417-422.1997; Miller JH, 1996, ANNU REV MICROBIOL, V50, P625, DOI 10.1146/annurev.micro.50.1.625; Orr-Weaver TL, 1998, NATURE, V392, P223, DOI 10.1038/32520; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Strauss BS, 1997, CARCINOGENESIS, V18, P1445, DOI 10.1093/carcin/18.8.1445; Strauss BS, 1998, SEMIN CANCER BIOL, V8, P431, DOI 10.1006/scbi.1998.0092; Tomlinson I, 1999, NAT MED, V5, P11, DOI 10.1038/4687; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Wickremasinghe RG, 1999, BLOOD, V93, P3587, DOI 10.1182/blood.V93.11.3587.411k46_3587_3600	23	45	46	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2000	288	5465					514	517		10.1126/science.288.5465.514	http://dx.doi.org/10.1126/science.288.5465.514			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775110				2022-12-24	WOS:000086626000045
J	Reysenbach, AL; Banta, AB; Boone, DR; Cary, SC; Luther, GW				Reysenbach, AL; Banta, AB; Boone, DR; Cary, SC; Luther, GW			Biogeochemistry - Microbial essentials at hydrothermal vents	NATURE			English	Article							DIVERSITY		Portland State Univ, Dept Environm Biol, Portland, OR 97201 USA; Univ Delaware, Coll Marine Studies, Lewes, DE 19958 USA	Portland State University; University of Delaware	Reysenbach, AL (corresponding author), Portland State Univ, Dept Environm Biol, Portland, OR 97201 USA.		Luther, George/A-6384-2008	Luther, George/0000-0002-0780-885X; Banta, Amy/0000-0002-1843-5059; Cary, Stephen/0000-0002-2876-2387				ARAGNO M, 1990, PROKARYOTES, P3917; Blochl E, 1997, EXTREMOPHILES, V1, P14; DEVEREUX R, 1990, J BACTERIOL, V172, P3609, DOI 10.1128/jb.172.7.3609-3619.1990; Doolittle RF, 1998, NATURE, V392, P339, DOI 10.1038/32789; Hugenholtz P, 1998, J BACTERIOL, V180, P366, DOI 10.1128/JB.180.2.366-376.1998; Maidak BL, 1999, NUCLEIC ACIDS RES, V27, P171, DOI 10.1093/nar/27.1.171; Reysenbach AL, 1999, BIOL BULL, V196, P367, DOI 10.2307/1542972; REYSENBACH AL, 1994, APPL ENVIRON MICROB, V60, P2133; Strous M, 1999, NATURE, V400, P446, DOI 10.1038/22749; WARD DM, 1992, ADV MICROB ECOL, V12, P219; Yamamoto H, 1998, APPL ENVIRON MICROB, V64, P1680	11	81	85	0	31	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					835	835		10.1038/35009029	http://dx.doi.org/10.1038/35009029			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786781				2022-12-24	WOS:000086625000033
J	Sharma, J; Angelucci, A; Sur, M				Sharma, J; Angelucci, A; Sur, M			Induction of visual orientation modules in auditory cortex	NATURE			English	Article							CORRELATED NEURONAL-ACTIVITY; HORIZONTAL CONNECTIONS; RETINAL PROJECTIONS; PREFERENCE MAPS; SIMPLE CELLS; CAT; FERRET; THALAMUS; DEPRIVATION; SELECTIVITY	Modules of neurons sharing a common property are a basic organizational feature of mammalian sensory cortex. Primary visual cortex (V1) is characterized by orientation modules-groups of cells that share a preferred stimulus orientation-which are organized into a highly ordered orientation map. Here we show that in ferrets in which retinal projections are routed into the auditory pathway, visually responsive neurons in 'rewired' primary auditory cortex are also organized into orientation modules. The orientation tuning of neurons within these modules is comparable to the tuning of cells in V1 but the orientation map is less orderly. Horizontal connections in rewired cortex are more patchy and periodic than connections in normal auditory cortex, but less so than connections in V1. These data show that afferent activity has a profound influence on diverse components of cortical circuitry, including thalamocortical and local intracortical connections, which are involved in the generation of orientation tuning, and long-range horizontal connections, which are important in creating an orientation map.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sur, M (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.							ANDERSEN RA, 1980, J COMP NEUROL, V194, P663, DOI 10.1002/cne.901940312; Angelucci A, 1998, J COMP NEUROL, V400, P417, DOI 10.1002/(SICI)1096-9861(19981026)400:3<417::AID-CNE10>3.0.CO;2-O; Angelucci A, 1996, J NEUROSCI METH, V65, P101, DOI 10.1016/0165-0270(95)00155-7; Angelucci A, 1997, J NEUROSCI, V17, P2040; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Bonhoeffer T., 1996, BRAIN MAPPING METHOD; CALLAWAY EM, 1991, P NATL ACAD SCI USA, V88, P745, DOI 10.1073/pnas.88.3.745; CHAPMAN B, 1993, J NEUROSCI, V13, P5251, DOI 10.1523/JNEUROSCI.13-12-05251.1993; Chapman B, 1996, J NEUROSCI, V16, P6443; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CROWLEY, 1999, NATURE NEUROSCI, V2, P1125; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; FROSTIG RD, 1990, P NATL ACAD SCI USA, V87, P6082, DOI 10.1073/pnas.87.16.6082; Gao WJ, 1999, J NEUROSCI, V19, P7940; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; Goodhill GJ, 1997, TRENDS NEUROSCI, V20, P375; HOPKINS B, 1954, ANN BOT-LONDON, V18, P213, DOI 10.1093/oxfordjournals.aob.a083391; IMIG TJ, 1980, J COMP NEUROL, V192, P293, DOI 10.1002/cne.901920208; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; KIM DS, 1994, NATURE, V370, P370, DOI 10.1038/370370a0; KOWALSKI N, 1995, J NEUROPHYSIOL, V73, P1513, DOI 10.1152/jn.1995.73.4.1513; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; MATSUBARA JA, 1988, J COMP NEUROL, V268, P38, DOI 10.1002/cne.902680105; Oppenheim A.V., 1975, DIGIT SIGNAL PROCESS; PALLAS SL, 1993, J COMP NEUROL, V337, P317, DOI 10.1002/cne.903370212; Rao SC, 1997, J COMP NEUROL, V387, P358; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; ROE AW, 1993, J COMP NEUROL, V334, P263, DOI 10.1002/cne.903340208; ROE AW, 1992, J NEUROSCI, V12, P3651; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; Schmidt KE, 1997, J NEUROSCI, V17, P5480; Sengpiel F, 1999, NAT NEUROSCI, V2, P727, DOI 10.1038/11192; Sharma J., 1995, Society for Neuroscience Abstracts, V21, P392; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Sur M, 1999, J NEUROBIOL, V41, P33, DOI 10.1002/(SICI)1097-4695(199910)41:1<33::AID-NEU6>3.0.CO;2-1; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; TOLHURST DJ, 1981, PROC R SOC SER B-BIO, V213, P183, DOI 10.1098/rspb.1981.0061; von Melchner L, 2000, NATURE, V404, P871, DOI 10.1038/35009102; WALLACE MN, 1991, EXP BRAIN RES, V86, P527; Weliky M, 1997, NATURE, V386, P680, DOI 10.1038/386680a0; WORGOTTER F, 1987, BIOL CYBERN, V57, P349, DOI 10.1007/BF00354980; Yuste R, 1999, J NEUROBIOL, V41, P1, DOI 10.1002/(SICI)1097-4695(199910)41:1<1::AID-NEU1>3.0.CO;2-2	44	237	243	0	27	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					841	847		10.1038/35009043	http://dx.doi.org/10.1038/35009043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786784				2022-12-24	WOS:000086625000036
J	Maiorano, D; Moreau, J; Mechali, M				Maiorano, D; Moreau, J; Mechali, M			XCDT1 is required for the assembly of pre-replicative complexes in Xenopus laevis	NATURE			English	Article							ORIGIN RECOGNITION COMPLEX; DNA-REPLICATION; CELL-CYCLE; LICENSING SYSTEM; MCM PROTEINS; CDC6 PROTEIN; S-PHASE; CHROMATIN; INITIATION; EXTRACTS	In eukaryotic cells, chromosomal DNA replication begins with the formation of pre-replication complexes at replication origins. Formation and maintenance of pre-replication complexes is dependent upon CDC6 (ref. 1), a protein which allows assembly of MCM2-7 proteins(2-4), which are putative replicative helicases(5). The functional assembly of MCM proteins into chromatin corresponds to replication licensing. Removal of these proteins from chromatin in S phase is crucial in origins firing regulation(6). We have identified a protein that is required for the assembly of prereplication complexes, in a screen for maternally expressed genes in Xenopus. This factor (XCDT1) is a relative of fission yeast cdt1, a protein proposed to function in DNA replication(7), and is the first to be identified in vertebrates. Here we show, using Xenopus in vitro systems, that XCDT1 is required for chromosomal DNA replication. XCDT1 associates with pre-replicative chromatin in a manner dependent on ORC protein and is removed from chromatin at the time of initiation of DNA synthesis. Immunodepletion and reconstitution experiments show that XCDT1 is required to load MCM2-7 proteins onto pre-replicative chromatin. These findings indicate that XCDT1 is an essential component of the system that regulates origins firing during S phase.	CNRS, Inst Human Genet, F-34396 Montpellier 5, France; Univ Paris 07, Inst Jacques Monod, Paris 05, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; UDICE-French Research Universities; Universite Paris Cite	Mechali, M (corresponding author), CNRS, Inst Human Genet, 141 Rue Cardonille, F-34396 Montpellier 5, France.	mechali@igh.cnrs.fr	Maiorano, Domenico/N-5755-2017	Maiorano, Domenico/0000-0003-4229-5903				ALMOUZNI G, 1988, EMBO J, V7, P665, DOI 10.1002/j.1460-2075.1988.tb02861.x; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BLOW JJ, 1993, J CELL BIOL, V122, P993, DOI 10.1083/jcb.122.5.993; Carpenter PB, 1996, NATURE, V379, P357, DOI 10.1038/379357a0; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Cocker JH, 1996, NATURE, V379, P180, DOI 10.1038/379180a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Coue M, 1998, EXP CELL RES, V245, P282, DOI 10.1006/excr.1998.4271; Coue M, 1996, EMBO J, V15, P1085, DOI 10.1002/j.1460-2075.1996.tb00446.x; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; MAIORANO D, IN PRESS J BIOL CHEM; MECHALI M, 1982, CELL, V30, P93, DOI 10.1016/0092-8674(82)90015-0; Menut S, 1999, ADV MOLEC BIOL, P196; MOREAU J, 1995, MOL REPROD DEV, V41, P1, DOI 10.1002/mrd.1080410102; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Romanowski P, 1996, CURR BIOL, V6, P1416, DOI 10.1016/S0960-9822(96)00746-4; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; Rowles A, 1999, J CELL SCI, V112, P2011; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Vuillard L, 1998, EUR J BIOCHEM, V256, P128, DOI 10.1046/j.1432-1327.1998.2560128.x	25	290	292	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					622	625		10.1038/35007104	http://dx.doi.org/10.1038/35007104			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766247				2022-12-24	WOS:000086400100058
J	Annane, D; Sanquer, S; Sebille, V; Faye, A; Djuranovic, D; Raphael, JC; Gajdos, P; Bellissant, E				Annane, D; Sanquer, S; Sebille, V; Faye, A; Djuranovic, D; Raphael, JC; Gajdos, P; Bellissant, E			Compartmentalised inducible nitric-oxide synthase activity in septic shock	LANCET			English	Article							MURINE MACROPHAGES; LIPOTEICHOIC ACID; HUMAN NEUTROPHILS; EXPRESSION; ENDOTOXIN; INDUCTION; FAILURE; SEPSIS; PHYSIOLOGY; INHIBITOR	Background Previous experimental studies support a role for inducible nitric-oxide synthase (iNOS) in the pathogenesis of severe sepsis. The aim of the study was to characterise iNOS activity in different tissues in patients with septic shock. Methods 13 consecutive patients with septic shock caused by cellulitis were enrolled. Skin, muscle, fat, and artery samples were obtained from normal, inflamed, and putrescent areas to measure iNOS activity, and concentrations of tumour necrosis factor alpha (TNF alpha) and interleukin 1 beta (IL-1 beta), In two patients, iNOS activity was also assessed in peripheral blood mononuclear cells (PRMC) incubated with microorganisms causing the sepsis, or in macrophages isolated from suppurating peritoneal fluid incubated with IL-1 beta. Findings: Compared with normal and inflamed areas, iNOS activity was increased in putrescent areas for muscle (71-fold [95% CI 20-259] vs normal areas, 69-fold [19-246] vs inflamed areas; p<0.01 for each) and for fat (68-fold [23-199] and 49-fold [18-137], respectively; p<0.01), but not for shin. Compared with normal areas, putrescent areas of arteries showed increased iNOS expression (1280-fold [598-3153]; p<0.01). Compared with normal areas, TNF alpha and IL-1 beta were increased in putrescent areas of arteries (223-fold and 41-fold, respectively; p<0.01 for each). PBMCs and tissue macrophages expressed iNOS. Plasma nitrite/nitrate concentrations inversely correlated with mean arterial pressure and systemic vascular resistance. Interpretation: In human septic shock we found that iNOS activity is compartmentalised at the very site of infection and parallels expression of TNF alpha and IL-1 beta. PBMCs and tissue macrophages can be a cellular source for iNOS.	Assistance Publ Hop Paris, Hop Raymond Poincare, Fac Med Paris Ouest, Serv Reanimat Med, Garches, France; AP HP, Hop Henri Mondor, Fac Med Creteil, Toxicol Lab, Creteil, France; Fac Med St Peres, INSERM 490, Paris, France; Univ Rennes 1, Fac Med, Lab Pharmacol Expt & Clin, Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Rennes	Annane, D (corresponding author), Assistance Publ Hop Paris, Hop Raymond Poincare, Fac Med Paris Ouest, Serv Reanimat Med, 104 Blvd Raymond Poincare, Garches, France.	djillali.annane@rpc.ap-hop-paris.fr	Annane, Djillali/R-7947-2019; Sebille, Veronique/I-3309-2015	Sebille, Veronique/0000-0002-0780-7742				BONE RC, 1991, ANN INTERN MED, V114, P332, DOI 10.7326/0003-4819-114-4-332; BRADY AJB, 1992, AM J PHYSIOL, V263, pH1963, DOI 10.1152/ajpheart.1992.263.6.H1963; COBB JP, 1992, J EXP MED, V176, P1175, DOI 10.1084/jem.176.4.1175; CUNHA FQ, 1994, IMMUNOLOGY, V81, P211; DEGROOTE MA, 1995, CLIN INFECT DIS, V21, pS162, DOI 10.1093/clinids/21.Supplement_2.S162; DEKIMPE SJ, 1995, BRIT J PHARMACOL, V114, P1317; English BK, 1996, J INFECT DIS, V174, P1348, DOI 10.1093/infdis/174.6.1348; Evans TJ, 1996, P NATL ACAD SCI USA, V93, P9553, DOI 10.1073/pnas.93.18.9553; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; GELLER DA, 1993, P NATL ACAD SCI USA, V90, P3491, DOI 10.1073/pnas.90.8.3491; IADECOLA C, 1995, J CEREBR BLOOD F MET, V15, P52, DOI 10.1038/jcbfm.1995.6; JULOUSCHAEFFER G, 1990, AM J PHYSIOL, V259, pH1038, DOI 10.1152/ajpheart.1990.259.4.H1038; KNAUS WA, 1985, ANN SURG, V202, P685, DOI 10.1097/00000658-198512000-00004; Kobayashi A, 1998, CHEST, V113, P1632, DOI 10.1378/chest.113.6.1632; LASZLO F, 1995, EUR J PHARMACOL, V283, P47, DOI 10.1016/0014-2999(95)00281-O; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; MACNAUL KL, 1993, BIOCHEM BIOPH RES CO, V196, P1330, DOI 10.1006/bbrc.1993.2398; MONCADA S, 1991, PHARMACOL REV, V43, P109; MOSHAGE H, 1995, CLIN CHEM, V41, P892; NATHAN C, 1994, J BIOL CHEM, V269, P13725; NAVA E, 1991, LANCET, V338, P1555, DOI 10.1016/0140-6736(91)92375-C; OCHOA JB, 1991, ANN SURG, V214, P621, DOI 10.1097/00000658-199111000-00013; Orman KL, 1998, J INFECT DIS, V178, P1649, DOI 10.1086/314526; PARRILLO JE, 1990, ANN INTERN MED, V113, P227, DOI 10.7326/0003-4819-113-3-227; SALTER M, 1991, FEBS LETT, V291, P145, DOI 10.1016/0014-5793(91)81123-P; SCHNEIDER F, 1994, AM J PHYSIOL, V266, pH191, DOI 10.1152/ajpheart.1994.266.1.H191; SCHOEDON G, 1995, CLIN INFECT DIS, V21, pS152, DOI 10.1093/clinids/21.Supplement_2.S152; SZABO C, 1994, P NATL ACAD SCI USA, V91, P12472, DOI 10.1073/pnas.91.26.12472; Wheeler MA, 1997, J CLIN INVEST, V99, P110, DOI 10.1172/JCI119121; WRIGHT CE, 1992, CARDIOVASC RES, V26, P48, DOI 10.1093/cvr/26.1.48	30	125	127	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2000	355	9210					1143	1148		10.1016/S0140-6736(00)02063-8	http://dx.doi.org/10.1016/S0140-6736(00)02063-8			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TC	10791377				2022-12-24	WOS:000086380900012
J	Quinn, TC; Wawer, MJ; Sewankambo, N; Serwadda, D; Li, CJ; Wabwire-Mangen, F; Meehan, MO; Lutalo, T; Gray, RH				Quinn, TC; Wawer, MJ; Sewankambo, N; Serwadda, D; Li, CJ; Wabwire-Mangen, F; Meehan, MO; Lutalo, T; Gray, RH		Rakai Project Study Grp	Viral load and heterosexual transmission of human immunodeficiency virus type 1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; HIV-1 RNA LEVELS; TRANSFUSION RECIPIENTS; SEXUAL TRANSMISSION; SEMEN; MEN; REDUCTION; BLOOD; RISK	Background and Methods: We examined the influence of viral load in relation to other risk factors for the heterosexual transmission of human immunodeficiency virus type 1 (HIV-1). In a community-based study of 15,127 persons in a rural district of Uganda, we identified 415 couples in which one partner was HIV-1-positive and one was initially HIV-1-negative and followed them prospectively for up to 30 months. The incidence of HIV-1 infection per 100 person-years among the initially seronegative partners was examined in relation to behavioral and biologic variables. Results: The male partner was HIV-1-positive in 228 couples, and the female partner was HIV-1-positive in 187 couples. Ninety of the 415 initially HIV-1-negative partners seroconverted (incidence, 11.8 per 100 person-years). The rate of male-to-female transmission was not significantly different from the rate of female-to-male transmission (12.0 per 100 person-years vs. 11.6 per 100 person-years). The incidence of seroconversion was highest among the partners who were 15 to 19 years of age (15.3 per 100 person-years). The incidence was 16.7 per 100 person-years among 137 uncircumcised male partners, whereas there were no seroconversions among the 50 circumcised male partners (P<0.001). The mean serum HIV-1 RNA level was significantly higher among HIV-1-positive subjects whose partners seroconverted than among those whose partners did not seroconvert (90,254 copies per milliliter vs. 38,029 copies per milliliter, P=0.01). There were no instances of transmission among the 51 subjects with serum HIV-1 RNA levels of less than 1500 copies per milliliter; there was a significant dose-response relation of increased transmission with increasing viral load. In multivariate analyses of log-transformed HIV-1 RNA levels, each log increment in the viral load was associated with a rate ratio of 2.45 for seroconversion (95 percent confidence interval, 1.85 to 3.26). Conclusions: The viral load is the chief predictor of the risk of heterosexual transmission of HIV-1, and transmission is rare among persons with levels of less than 1500 copies of HIV-1 RNA per milliliter. (N Engl J Med 2000;342:921-9.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Div Infect Dis, Baltimore, MD 21205 USA; NIAID, Bethesda, MD 20892 USA; Columbia Univ, New York, NY USA; Makerere Univ, Fac Med, Kampala, Uganda	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; Makerere University	Quinn, TC (corresponding author), Johns Hopkins Univ, Div Infect Dis, 720 Rutland Ave,Ross 1159, Baltimore, MD 21205 USA.		Quinn, Thomas/A-2494-2010	Sewankambo, Nelson/0000-0001-9362-053X	NIAID NIH HHS [R01 AI34826S, R01 AI34826B] Funding Source: Medline; NICHD NIH HHS [5P30HD06826] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000361, Z01AI000358, ZIAAI000361, ZIAAI000358, R01AI034826] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*AIDS CONTR PROGR, 1992, HIV TEST POL, P1; ARMITAGE P, 1977, STAT METHODS MED RES; BRESLOW NE, 1987, IARC SCI PUBLICATION, V82; CAMERON DW, 1989, LANCET, V2, P403; *CDCP, 1998, HIV AIDS SURV REP, V10; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Cohen MS, 1997, LANCET, V349, P1868, DOI 10.1016/S0140-6736(97)02190-9; Coombs RW, 1998, J INFECT DIS, V177, P320, DOI 10.1086/514213; DEVINCENZI I, 1994, NEW ENGL J MED, V331, P341, DOI 10.1056/NEJM199408113310601; Downs AM, 1996, J ACQ IMMUN DEF SYND, V11, P388, DOI 10.1097/00042560-199604010-00010; Farzadegan H, 1998, LANCET, V352, P1510, DOI 10.1016/S0140-6736(98)02372-1; Fiscus SA, 1998, AIDS RES HUM RETROV, V14, pS27; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997; Haase AT, 1998, NEW ENGL J MED, V339, P1846, DOI 10.1056/NEJM199812173392510; Halperin DT, 1999, LANCET, V354, P1813, DOI 10.1016/S0140-6736(99)03421-2; Hart CE, 1999, J INFECT DIS, V179, P871, DOI 10.1086/314656; Hoffman TL, 1997, J INFECT DIS, V176, P1093, DOI 10.1086/516519; Iversen AKN, 1998, J INFECT DIS, V177, P1214, DOI 10.1086/515266; Lavreys L, 1999, J INFECT DIS, V180, P330, DOI 10.1086/314884; Lee TH, 1996, J ACQ IMMUN DEF SYND, V12, P427, DOI 10.1097/00042560-199608010-00015; Mayaux MJ, 1997, J INFECT DIS, V175, P172, DOI 10.1093/infdis/175.1.172; Michael NL, 1999, J CLIN MICROBIOL, V37, P2557, DOI 10.1128/JCM.37.8.2557-2563.1999; Mock PA, 1999, AIDS, V13, P407, DOI 10.1097/00002030-199902250-00014; Mofenson LM, 1999, NEW ENGL J MED, V341, P385, DOI 10.1056/NEJM199908053410601; Moore JP, 1997, SCIENCE, V276, P51, DOI 10.1126/science.276.5309.51; Moses S, 1998, SEX TRANSM INFECT, V74, P368, DOI 10.1136/sti.74.5.368; MUSICCO M, 1994, ARCH INTERN MED, V154, P1971, DOI 10.1001/archinte.154.17.1971; Nelson KE, 1999, J INFECT DIS, V180, P337, DOI 10.1086/314882; Nelson KE, 1999, J INFECT DIS, V180, P1756; Operskalski EA, 1997, AM J EPIDEMIOL, V146, P655, DOI 10.1093/oxfordjournals.aje.a009331; Padian NS, 1997, AM J EPIDEMIOL, V146, P350, DOI 10.1093/oxfordjournals.aje.a009276; Pedraza MA, 1999, J ACQ IMMUN DEF SYND, V21, P120; Quinn, 1996, LANCET, V348, P276; Quinn TC, 1996, LANCET, V348, P99, DOI 10.1016/S0140-6736(96)01029-X; Ragni MV, 1998, J ACQ IMMUN DEF SYND, V17, P42, DOI 10.1097/00042560-199801010-00006; Royce RA, 1997, NEW ENGL J MED, V336, P1072, DOI 10.1056/NEJM199704103361507; Royce RA, 1997, NEW ENGL J MED, V337, P799; Shaffer N, 1999, LANCET, V353, P773, DOI 10.1016/S0140-6736(98)10411-7; SHIBOSKI SC, 1999, J ACQ IMMUN DEF SYND, V19, P527; Sperling RS, 1996, NEW ENGL J MED, V335, P1621, DOI 10.1056/NEJM199611283352201; *STAT DEP, 1996, UG DEM HLTH SURV 199, P48; Sterling TR, 1999, J INFECT DIS, V180, P666, DOI 10.1086/314967; *UNAIDS JOINT UN P, 1999, AIDS EP UPD; Vernazza PL, 1997, AIDS, V11, P987, DOI 10.1097/00002030-199708000-00006; Vittinghoff E, 1999, AM J EPIDEMIOL, V150, P306, DOI 10.1093/oxfordjournals.aje.a010003; Wawer MJ, 1999, LANCET, V353, P525, DOI 10.1016/S0140-6736(98)06439-3; *WHO, 1985, WEEKL EP REC, V60, P342; Zhang H, 1998, NEW ENGL J MED, V339, P1803, DOI 10.1056/NEJM199812173392502	50	2267	2312	1	104	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2000	342	13					921	929		10.1056/NEJM200003303421303	http://dx.doi.org/10.1056/NEJM200003303421303			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DC	10738050				2022-12-24	WOS:000086179700003
J	Korinek, WS; Copeland, MJ; Chaudhuri, A; Chant, J				Korinek, WS; Copeland, MJ; Chaudhuri, A; Chant, J			Molecular linkage underlying microtubule orientation toward cortical sites in yeast	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; NUCLEAR MIGRATION; MITOTIC SPINDLE; PROTEIN; IDENTIFICATION; TUBULIN; BINDING; KINESIN; GENE	Selective microtubule orientation-toward spatially defined cortical sites is critical to polarized cellular processes as diverse as axon outgrowth and T cell cytotoxicity. In yeast, oriented cytoplasmic microtubules align the mitotic spindle between mother and bud. The cortical marker protein Kar9 Localizes to the bud tip and is required for the orientation of microtubules toward this region. Here, we show that Kar9 directs microtubule orientation by acting through Bim1, a conserved microtubule-binding protein. Bim1 homolog EB1 was originally identified through its interaction with adenomatous polyposis coil (APC) tumor suppressor, raising the possibility that an APC-EB1 linkage orients microtubules in higher cells.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Chant, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	chant@fas.harvard.edu		Korinek, William/0000-0002-6293-1623	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049782] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM07620-19, GM49782, GM07620-20] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BERLIN V, 1990, J CELL BIOL, V111, P2573, DOI 10.1083/jcb.111.6.2573; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; GOODE BL, 1994, J CELL BIOL, V124, P769, DOI 10.1083/jcb.124.5.769; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; James P, 1996, GENETICS, V144, P1425; Kaiser C., 1994, METHODS YEAST GENETI; KILMARTIN JV, 1984, J CELL BIOL, V98, P922, DOI 10.1083/jcb.98.3.922; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; KORINEK WS, UNPUB; KURIHARA LJ, 1994, J CELL BIOL, V126, P911, DOI 10.1083/jcb.126.4.911; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U; Miller JH, 1972, EXPT MOL GENETICS; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; Sambrook JFE, 1989, MOL CLONING LAB MANU; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985; Sia RAL, 1998, EMBO J, V17, P6678, DOI 10.1093/emboj/17.22.6678; SNYDER M, 1991, J CELL BIOL, V114, P515, DOI 10.1083/jcb.114.3.515; Stearns T, 1997, J CELL BIOL, V138, P957, DOI 10.1083/jcb.138.5.957; SU LK, 1995, CANCER RES, V55, P2972; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993	26	179	180	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2257	2259		10.1126/science.287.5461.2257	http://dx.doi.org/10.1126/science.287.5461.2257			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731146				2022-12-24	WOS:000086049100049
J	Misura, KMS; Scheller, RH; Weis, WI				Misura, KMS; Scheller, RH; Weis, WI			Three-dimensional structure of the neuronal-Sec1-syntaxin 1a complex	NATURE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SYNAPTIC VESICLE DOCKING; N-TERMINAL DOMAIN; SNARE COMPLEX; NEUROTRANSMITTER RELEASE; SEC1 HOMOLOG; SYNTAXIN; FUSION; ROP; SPECIFICITY	Syntaxin 1a and neuronal Sec1 (nSec1) form an evolutionarily conserved heterodimer that is essential for vesicle trafficking and membrane fusion. The crystal structure of the nSec1-syntaxin la complex, determined at 2.6 Angstrom resolution, reveals that major conformational rearrangements occur in syntaxin relative to both the core SNARE complex and isolated syntaxin. We identify regions of the two proteins that seem to determine the binding specificity of particular Sec1 proteins for syntaxin isoforms, which is likely to be important for the fidelity of membrane trafficking. The structure also indicates mechanisms that might couple the action of upstream effector proteins to conformational changes in syntaxin la and nSec1 that lead to core complex formation and membrane fusion.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Weis, WI (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Fairchild Bldg,299 Campus Dr W, Stanford, CA 94305 USA.	bill.weis@stanford.edu	Weis, William I/G-1437-2011	Weis, William I/0000-0002-5583-6150				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CALAKOS N, 1994, SCIENCE, V263, P1146, DOI 10.1126/science.8108733; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Chen YA, 1999, CELL, V97, P165, DOI 10.1016/S0092-8674(00)80727-8; DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872; Davanger S, 1997, MOL BIOL CELL, V8, P1261, DOI 10.1091/mbc.8.7.1261; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P4582, DOI 10.1074/jbc.272.7.4582; Fernandez I, 1998, CELL, V94, P841, DOI 10.1016/S0092-8674(00)81742-0; Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117; Fletcher AI, 1999, J BIOL CHEM, V274, P4027, DOI 10.1074/jbc.274.7.4027; Fujita Y, 1996, J BIOL CHEM, V271, P7265, DOI 10.1074/jbc.271.13.7265; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KEE Y, 1995, NEURON, V14, P991, DOI 10.1016/0896-6273(95)90337-2; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEAHY DJ, 1994, PROTEINS, V19, P48, DOI 10.1002/prot.340190107; Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; Nicholls A., 1992, GRASP GRAPHICAL REPR; Nicholson KL, 1998, NAT STRUCT BIOL, V5, P793, DOI 10.1038/1834; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PALADE G, 1975, SCIENCE, V189, P347, DOI 10.1126/science.1096303; PEVSNER J, 1994, P NATL ACAD SCI USA, V91, P1445, DOI 10.1073/pnas.91.4.1445; PEVSNER J, 1994, NEURON, V13, P353, DOI 10.1016/0896-6273(94)90352-2; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Poirier MA, 1998, NAT STRUCT BIOL, V5, P765, DOI 10.1038/1799; Rowe J, 1999, J CELL SCI, V112, P1865; Sassa T, 1999, J NEUROSCI, V19, P4772; SCHEKMAN R, 1992, Current Opinion in Cell Biology, V4, P587, DOI 10.1016/0955-0674(92)90076-O; SCHULZE KL, 1994, NEURON, V13, P1099, DOI 10.1016/0896-6273(94)90048-5; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Tall GG, 1999, MOL BIOL CELL, V10, P1873, DOI 10.1091/mbc.10.6.1873; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; TERWILLIGER TC, 1997, SOLVE AUTOMATED CRYS; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Webb GC, 1997, GENETICS, V147, P467; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Yang B, 2000, J CELL BIOL, V148, P247, DOI 10.1083/jcb.148.2.247	49	587	606	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					355	362		10.1038/35006120	http://dx.doi.org/10.1038/35006120			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746715				2022-12-24	WOS:000086119000040
J	Ferner, RE; Aronson, JK				Ferner, RE; Aronson, JK			Medication errors, worse than a crime	LANCET			English	Editorial Material									City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England; Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX1 2JD, England	University of Birmingham; Radcliffe Infirmary; University of Oxford	Ferner, RE (corresponding author), City Hosp, W Midlands Ctr Adverse Drug React Reporting, Birmingham B18 7QH, W Midlands, England.			Ferner, Robin/0000-0003-3769-1346				Ashraf H, 2000, LANCET, V355, P471, DOI 10.1016/S0140-6736(00)82021-8; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; Ferner RE, 1999, BRIT J CLIN PHARMACO, V47, P581; FERNER RE, 1999, SIDE EFFECTS DRUGS A, P22; Firth-Cozens J, 1993, MED ACCIDENTS, P131; Kohn LT., 2000, ERR IS HUMAN BUILDIN; NORMAN DA, 1981, PSYCHOL REV, V88, P1, DOI 10.1037/0033-295X.88.1.1; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P506, DOI 10.1177/0310057X9302100506; TEAHON K, 1993, BRIT MED J, V307, P605, DOI 10.1136/bmj.307.6904.605; Walley T, 1997, BRIT J CLIN PHARMACO, V44, P171, DOI 10.1046/j.1365-2125.1997.00668.x	11	46	48	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2000	355	9208					947	948		10.1016/S0140-6736(00)99025-1	http://dx.doi.org/10.1016/S0140-6736(00)99025-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296YH	10768430				2022-12-24	WOS:000086054000006
J	Sander, C				Sander, C			Genomic medicine and the future of health care	SCIENCE			English	Article								Genomic technologies and computational advances are Leading to an information revolution in biology and medicine. Simulations of molecular processes in cells and predictions of drug effects in humans will advance pharmaceutical research and speed up clinical trials. Computational prognostics and diagnostics that combine clinical data with genotyping and molecular profiling may soon cause fundamental changes in the practice of health care.	Millennium Pharmaceut & Millennium Predict Med, Cambridge, MA 02139 USA; MIT, Ctr Genome Res, Cambridge, MA 02139 USA	Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Massachusetts Institute of Technology (MIT)	Sander, C (corresponding author), Millennium Pharmaceut & Millennium Predict Med, 640 Mem Dr, Cambridge, MA 02139 USA.							Abbott A, 1999, NATURE, V402, P219, DOI 10.1038/46111; Arkin A, 1998, GENETICS, V149, P1633; BRAZMA A, COMMUNICATION; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Clark DE, 2000, DRUG DISCOV TODAY, V5, P49, DOI 10.1016/S1359-6446(99)01451-8; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Mendelsohn AR, 1999, SCIENCE, V284, P1948, DOI 10.1126/science.284.5422.1948; MUIR CS, COMMUNICATION; Schaff J, 1999, Pac Symp Biocomput, P228; Schena M, 1998, TRENDS BIOTECHNOL, V16, P301, DOI 10.1016/S0167-7799(98)01219-0; Service RF, 1999, SCIENCE, V284, P80; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Tomita M, 1999, BIOINFORMATICS, V15, P72, DOI 10.1093/bioinformatics/15.1.72; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; WEINSTEIN JN, 1999, NAT GENET, V23, P81; Yates JR, 2000, TRENDS GENET, V16, P5, DOI 10.1016/S0168-9525(99)01879-X	17	119	156	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1977	1978		10.1126/science.287.5460.1977	http://dx.doi.org/10.1126/science.287.5460.1977			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10755952				2022-12-24	WOS:000085902800050
J	Pagola, S; Stephens, PW; Bohle, DS; Kosar, AD; Madsen, SK				Pagola, S; Stephens, PW; Bohle, DS; Kosar, AD; Madsen, SK			The structure of malaria pigment beta-haematin	NATURE			English	Article							FALCIPARUM HEMOGLOBIN DEGRADATION; PLASMODIUM-FALCIPARUM; HEME POLYMERIZATION; POWDER DIFFRACTION; IRON ENVIRONMENT; HEMATIN; CHLOROQUINE; MECHANISM; TROPHOZOITES; INHIBITION	Despite the worldwide public health impact of malaria, neither the mechanism by which the Plasmodium parasite detoxifies and sequesters haem, nor the action of current antimalarial drugs is well understood. The haem groups released from the digestion of the haemoglobin of infected red blood cells are aggregated into an insoluble material called haemozoin or malaria pigment. Synthetic beta-haematin (Fe-III-protoporphyrin-IX)(2) is chemically(1,2). spectroscopically(2,3) and crystallographically(4) identical to haemozoin and is believed to consist of strands of Fe-III-porphyrin units, linked into a polymer by propionate oxygen-iron bonds. Here we report the crystal structure of beta-haematin determined using simulated annealing techniques to analyse powder diffraction data obtained with synchrotron radiation. The molecules are linked into dimers through reciprocal iron-carboxylate bonds to one of the propionic side chains of each porphyrin, and the dimers form chains linked by hydrogen bonds in the crystal. This result has implications for understanding the action of current antimalarial drugs and possibly for the design of new therapeutic agents.	SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA; Univ Wyoming, Dept Chem, Laramie, WY 82071 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Wyoming	Stephens, PW (corresponding author), SUNY Stony Brook, Dept Phys & Astron, Stony Brook, NY 11794 USA.			PAGOLA, SILVINA/0000-0003-2083-7599				Adams PA, 1996, J INORG BIOCHEM, V63, P69, DOI 10.1016/0162-0134(95)00212-X; Andreev YG, 1998, J CHEM SOC DALTON, P4071, DOI 10.1039/a805437a; BENDRAT K, 1995, NATURE, V378, P138, DOI 10.1038/378138a0; Bohle DS, 1997, J BIOL CHEM, V272, P713, DOI 10.1074/jbc.272.2.713; BOHLE DS, 1993, BIOCHEM BIOPH RES CO, V193, P504, DOI 10.1006/bbrc.1993.1652; Bohle DS, 1998, J AM CHEM SOC, V120, P8255, DOI 10.1021/ja980962u; BOHLE DS, 1994, ACS SYM SER, V572, P497; BOMINAAR EL, 1992, INORG CHEM, V31, P1845, DOI 10.1021/ic00036a023; David WIF, 1998, CHEM COMMUN, P931, DOI 10.1039/a800855h; DORN A, 1995, NATURE, V374, P269, DOI 10.1038/374269a0; Dorn A, 1998, BIOCHEM PHARMACOL, V55, P727, DOI 10.1016/S0006-2952(97)00510-8; Egan TJ, 1999, J INORG BIOCHEM, V73, P101, DOI 10.1016/S0162-0134(98)10095-8; FITCH CD, 1987, J BIOL CHEM, V262, P15552; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Francis SE, 1996, MOL BIOCHEM PARASIT, V83, P189, DOI 10.1016/S0166-6851(96)02772-7; GLUZMAN IY, 1994, J CLIN INVEST, V93, P1602, DOI 10.1172/JCI117140; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; KOENIG DF, 1965, ACTA CRYSTALLOGR, V18, P663, DOI 10.1107/S0365110X65001536; LARSON AC, 1987, LAUR86748 LOS AL LAB; LE BAIL A, 1988, MATER RES BULL, V23, P447, DOI 10.1016/0025-5408(88)90019-0; LEMBERG R, 1949, HAEMATIN COMPOUNDS B; OLLIARO PL, 1995, PARASITOL TODAY, V11, P294, DOI 10.1016/0169-4758(95)80042-5; RIDLEY RG, 1995, NATURE, V378, P138, DOI 10.1038/378138b0; Scheidt W.R., 1987, METAL COMPLEXES TETR, V64, P1, DOI DOI 10.1007/BFB0036789; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; SLATER AFG, 1992, NATURE, V355, P167, DOI 10.1038/355167a0; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; YAYON A, 1985, P NATL ACAD SCI USA, V82, P2784, DOI 10.1073/pnas.82.9.2784	30	707	732	0	100	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2000	404	6775					307	310		10.1038/35005132	http://dx.doi.org/10.1038/35005132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749217				2022-12-24	WOS:000086022200055
J	Wallis, EJ; Ramsay, LE; Haq, IU; Ghahramani, P; Jackson, PR; Rowland-Yeo, K; Yeo, WW				Wallis, EJ; Ramsay, LE; Haq, IU; Ghahramani, P; Jackson, PR; Rowland-Yeo, K; Yeo, WW			Coronary and cardiovascular risk estimation for primary prevention: validation of a new Sheffield table in the 1995 Scottish health survey population	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE; THERAPY; EVENTS	Objective To examine the accuracy of a new version of the Sheffield table designed to aid decisions on lipids screening and detect thresholds for risk of coronary heart disease needed to implement current guidelines for primary prevention of cardiovascular disease. Design Comparison of decisions made on the basis of the table with absolute risk of coronary heart disease or cardiovascular disease calculated by the Framingham risk function. The decisions related to statin treatment when corollary risk is greater than or equal to 30% over 10 years; aspirin treatment when the risk is greater than or equal to 15% over 10 years; and die treatment of mild hypertension when the cardiovascular risk is greater than or equal to 20% over 10 years. Setting The table is designed for use in general practice Subjects Random sample of 1000 people aged 35-64 years from the 1995 Scottish health survey Main outcome measures Sensitivity, specificity, and positive and negative predictive values of the table. Results 13% of people had a coronary risk of greater than or equal to 15%, and 2.2% a risk of greater than or equal to 30%, over 10 years. 22% had mild hypertension (systolic blood pressure 140-159 mm Hg). The table indicated lipids screening for everyone with a coronary risk of greater than or equal to 15% over 10 years, for 95% of people with a ratio of total cholesterol to high density lipoprotein cholesterol of greater than or equal to 8.0, but for < 50% with a coronary risk of < 5% over 10 years. Sensitivity and specificity were 97% and 95% respectively for a coronary risk of greater than or equal to 15% over 10 years; 82% and 99% for a coronary risk of greater than or equal to 30% over 10 years; and 88% and 90% for a cardiovascular risk of greater than or equal to 20% over 10 years in mild hypertension. Conclusion The table identifies all high risk people for lipids screening, reduces screening of low risk people by more than half, and ensures that treatments are prescribed appropriately to those at high risk, while avoiding inappropriate treatment of people at low risk	Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Ramsay, LE (corresponding author), Royal Hallamshire Hosp, Glossop Rd, Sheffield S10 2JF, S Yorkshire, England.	d.colley@sheffield.ac.uk		Yeo, Wilfred/0000-0001-9554-5203				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Boissel JP, 1998, JAMA-J AM MED ASSOC, V280, P1949, DOI 10.1001/jama.280.22.1949; Chalmers J, 1999, J HYPERTENS, V17, P151; COLLINS R, 1992, TXB HYPERTENSION, P1156; *COR SERV COMM, 1995, MIN HLTH GUID MAN MI; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; HAQ IU, 1995, LANCET, V346, P1467, DOI 10.1016/S0140-6736(95)92477-9; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Haq IU, 1996, CLIN SCI, V91, P773; Haq IU, 1999, QJM-INT J MED, V92, P379, DOI 10.1093/qjmed/92.7.379; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; *JOINT HLTH SURV U, 1995, SCOTT HLTH SURV; *JOINT NAT COMM PR, 1998, ARCH INTERN MED, V157, P2413; *NAT CHOL ED PROGR, 1994, CIRCULATION, V89, P1333; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Ramsay LE, 1998, AM J HYPERTENS, V11, p79S, DOI 10.1016/S0895-7061(98)00063-6; *STANDM ED ADV COM, 1997, US STAT; SYTKOWSKI PA, 1997, CIRCULATION S1, V96, P437; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Wood D, 1998, HEART, V80, pS1; Wood D, 1998, EUR HEART J, V19, P1434	24	128	134	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					671	676		10.1136/bmj.320.7236.671	http://dx.doi.org/10.1136/bmj.320.7236.671			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710573	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000085895300017
J	Lee, JS; Collins, KM; Brown, AL; Lee, CH; Chung, JH				Lee, JS; Collins, KM; Brown, AL; Lee, CH; Chung, JH			hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response	NATURE			English	Article							CELL-CYCLE; OVARIAN-CANCER; S-PHASE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; GENE; TRANSCRIPTION; BREAST; YEAST; ATM	Mutations in the BRCA1 (ref. 1) tumour suppressor gene are found in almost all of the families with inherited breast and ovarian cancers and about half of the families with only breast cancer(2,3). Although the biochemical function of BRCA1 is not well understood, it is important for DNA damage repair(4-7) and cell-cycle checkpoints(8-10). BRCA1 exists in nuclear foci but is hyperphosphorylated and disperses after DNA damage(11,12). It is not known whether BRCA1 phosphorylation and dispersion and its function in DNA damage response are related. In yeast the DNA damage response and the replication-block checkpoint are mediated partly through the Cds1 kinase family(13-20). Here we report that the human Cds1 kinase (hCds1/Chk2)(21-23) regulates BRCA1 function after DNA damage by phosphorylating serine 988 of BRCA1. We show that hCds1 and BRCA1 interact and colocalize within discrete nuclear foci but separate after gamma irradiation. Phosphorylation of BRCA1 at serine 988 is required for the release of BRCA1 from hCds1. This phosphorylation is also important for the ability of BRCA1 to restore survival after DNA damage in the BRCA1-mutated cell line HCC1937.	NHLBI, Lab Mol Hematol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chung, JH (corresponding author), NHLBI, Lab Mol Hematol, NIH, Bldg 10, Bethesda, MD 20892 USA.							Abbott DW, 1999, J BIOL CHEM, V274, P18808, DOI 10.1074/jbc.274.26.18808; ALLEN JB, 1994, GENE DEV, V8, P2401, DOI 10.1101/gad.8.20.2401; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; BODDY MN, 1998, NATURE, V395, P507; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; EASTON DF, 1993, AM J HUM GENET, V52, P678; Feunteun J, 1996, BBA-REV CANCER, V1242, P177, DOI 10.1016/0304-419X(95)00016-9; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Larson JS, 1997, CANCER RES, V57, P3351; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Ruffner H, 1999, MOL CELL BIOL, V19, P4843; Sanchez Y, 1996, SCIENCE, V271, P357, DOI 10.1126/science.271.5247.357; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shen SX, 1998, ONCOGENE, V17, P3115, DOI 10.1038/sj.onc.1202243; Sidorova JM, 1997, GENE DEV, V11, P3032, DOI 10.1101/gad.11.22.3032; Somasundaram K, 1997, NATURE, V389, P187, DOI 10.1038/38291; Thomas JE, 1997, CELL GROWTH DIFFER, V8, P801; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766; ZHENG P, 1993, MOL CELL BIOL, V13, P5829, DOI 10.1128/MCB.13.9.5829; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	29	439	457	0	20	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					201	204		10.1038/35004614	http://dx.doi.org/10.1038/35004614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724175				2022-12-24	WOS:000085870900056
J	Abe, Y; Shodai, T; Muto, T; Mihara, K; Torii, H; Nishikawa, S; Endo, T; Kohda, D				Abe, Y; Shodai, T; Muto, T; Mihara, K; Torii, H; Nishikawa, S; Endo, T; Kohda, D			Structural basis of presequence recognition by the mitochondrial protein import receptor Tom20	CELL			English	Article							NUCLEAR MAGNETIC-RESONANCE; OUTER-MEMBRANE; YEAST MITOCHONDRIA; PRECURSOR PROTEINS; C-13/N-15-ENRICHED PROTEINS; PREPROTEIN TRANSLOCASE; C-13 MAGNETIZATION; BINDING DOMAIN; ACID CHAIN; NMR	Most mitochondrial proteins are synthesized in the cytosol as precursor proteins with a cleavable N-terminal presequence and are imported into mitochondria. We report here the NMR structure of a general import receptor, rat Tom20, in a complex with a presenquence peptide derived from rat aldehyde dehydrogenase, The cytosolic domain of Tom20 forms an all alpha-helical structure with a groove to accommodate the presequence peptide. The bound presequence forms an amphiphilic helical structure with hydrophobic leucines aligned on one side to interact with a hydrophobic patch in the Tom20 groove. Although the positive charges of the presequence are essential for import ability, presequence binding to Tom20 is mediated mainly by hydrophobic rather than ionic interactions.	Nagoya Univ, Fac Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; Biomol Engn Res Inst, Dept Biol Struct, Osaka 5650874, Japan; Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 8128512, Japan	Nagoya University; Kyushu University	Kohda, D (corresponding author), Nagoya Univ, Fac Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.		Abe, Yoshito/AAH-6141-2021; Kohda, Daisuke/I-4990-2019; Abe, Yoshito/D-8370-2012	Abe, Yoshito/0000-0002-0016-8490; Kohda, Daisuke/0000-0001-8234-3776; Abe, Yoshito/0000-0002-0016-8490				BAKER A, 1987, P NATL ACAD SCI USA, V84, P3117, DOI 10.1073/pnas.84.10.3117; BAX A, 1990, J MAGN RESON, V88, P425, DOI 10.1016/0022-2364(90)90202-K; Brix J, 1997, J BIOL CHEM, V272, P20730, DOI 10.1074/jbc.272.33.20730; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Dekker PJT, 1998, MOL CELL BIOL, V18, P6515, DOI 10.1128/MCB.18.11.6515; ENDO T, 1989, J BIOCHEM, V106, P396, DOI 10.1093/oxfordjournals.jbchem.a122864; GOEBL M, 1991, TRENDS BIOCHEM SCI, V16, P173, DOI 10.1016/0968-0004(91)90070-C; GOPING IS, 1995, FEBS LETT, V373, P45; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; GRZESIEK S, 1993, J BIOMOL NMR, V3, P185; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; HACHIYA N, 1995, NATURE, V376, P705, DOI 10.1038/376705a0; HAUCKE V, 1995, J BIOL CHEM, V270, P5565, DOI 10.1074/jbc.270.10.5565; Hill K, 1998, NATURE, V395, P516, DOI 10.1038/26780; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; IKURA M, 1991, Journal of Biomolecular NMR, V1, P299, DOI 10.1007/BF01875522; Iwahashi J, 1997, J BIOL CHEM, V272, P18467, DOI 10.1074/jbc.272.29.18467; Kanamori T, 1997, P NATL ACAD SCI USA, V94, P485, DOI 10.1073/pnas.94.2.485; KARSLAKE C, 1990, BIOCHEMISTRY-US, V29, P9872, DOI 10.1021/bi00494a017; Komiya T, 1998, EMBO J, V17, P3886, DOI 10.1093/emboj/17.14.3886; Komiya T, 1997, EMBO J, V16, P4267, DOI 10.1093/emboj/16.14.4267; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Kunkele KP, 1998, CELL, V93, P1009, DOI 10.1016/S0092-8674(00)81206-4; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lill R, 1996, TRENDS CELL BIOL, V6, P56, DOI 10.1016/0962-8924(96)81015-4; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; LITHGOW T, 1995, TRENDS BIOCHEM SCI, V20, P98, DOI 10.1016/S0968-0004(00)88972-0; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; NAKAI T, 1993, J BIOMOL NMR, V3, P19; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Ogura K, 1996, J BIOMOL NMR, V8, P492, DOI 10.1007/BF00228150; Pfanner N, 1997, ANNU REV CELL DEV BI, V13, P25, DOI 10.1146/annurev.cellbio.13.1.25; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; ROISE D, 1988, J BIOL CHEM, V263, P4509; ROISE D, 1988, EMBO J, V7, P649, DOI 10.1002/j.1460-2075.1988.tb02859.x; RYAN KR, 1995, CELL, V83, P517, DOI 10.1016/0092-8674(95)90089-6; Schatz G, 1997, NATURE, V388, P121, DOI 10.1038/40510; Schleiff E, 1998, BIOCHEMISTRY-US, V37, P13052, DOI 10.1021/bi980746y; Schleiff E, 1997, J BIOL CHEM, V272, P17784, DOI 10.1074/jbc.272.28.17784; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Yano M, 1998, J BIOL CHEM, V273, P26844, DOI 10.1074/jbc.273.41.26844; [No title captured]	52	414	423	2	34	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 3	2000	100	5					551	560		10.1016/S0092-8674(00)80691-1	http://dx.doi.org/10.1016/S0092-8674(00)80691-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721992	Bronze			2022-12-24	WOS:000085700000008
J	Whitmore, D; Foulkes, NS; Sassone-Corsi, P				Whitmore, D; Foulkes, NS; Sassone-Corsi, P			Light acts directly on organs and cells in culture to set the vertebrate circadian clock	NATURE			English	Article							DROSOPHILA; ZEBRAFISH; GENE; ENTRAINMENT; EXPRESSION	The expression of dock genes in vertebrates is widespread and not restricted to classical dock structures(1,2). The expression of the Clock gene in zebrafish shows a strong circadian oscillation in many tissues in vivo and in culture, showing that endogenous oscillators exist in peripheral organs(3). A defining feature of circadian clocks is that they can be set or entrained to local time, usually by the environmental light-dark cycle(4,5). An important question is whether peripheral oscillators are entrained to local time by signals from central pacemakers such as the eyes or are themselves directly light-responsive. Here we show that the peripheral organ docks of zebrafish are set by light-dark cycles in culture. We also show that a zebrafish-derived cell line contains a circadian oscillator, which is also directly light entrained.	Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, CU Strasbour, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sassone-Corsi, P (corresponding author), Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, 1 Rue Laurent Fries, F-67404 Illkirch Graffenstaden, CU Strasbourg, France.	paolosc@titus.u-strasbg.fr	Foulkes, Nicholas S/K-7003-2013; Sassone-Corsi, Paolo/H-6182-2011	Foulkes, Nicholas S/0000-0002-1794-9891; Whitmore, David/0000-0003-2420-8220				Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; ASCHOFF J, 1986, Journal of Biological Rhythms, V1, P91, DOI 10.1177/074873048600100201; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; BARRETT RK, 1995, J NEUROSCI, V15, P5681; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; CERMAKIAN N, IN PRESS P NATL ACAD, V97; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Earnest DJ, 1999, J NEUROBIOL, V39, P1, DOI 10.1002/(SICI)1097-4695(199904)39:1<1::AID-NEU1>3.0.CO;2-F; Gothilf Y, 1999, ENDOCRINOLOGY, V140, P4895, DOI 10.1210/en.140.10.4895; Ishikawa T, 1999, GENES CELLS, V4, P57, DOI 10.1046/j.1365-2443.1999.00237.x; Kazimi N, 1999, DEV BRAIN RES, V117, P47, DOI 10.1016/S0165-3806(99)00096-6; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; MCARTHUR AJ, 1991, BRAIN RES, V565, P158, DOI 10.1016/0006-8993(91)91748-P; PEPPELENBOSCH MP, 1995, EXP CELL RES, V218, P183, DOI 10.1006/excr.1995.1146; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Plautz JD, 1997, SCIENCE, V278, P1632, DOI 10.1126/science.278.5343.1632; Reppert SM, 1998, NEURON, V21, P1, DOI 10.1016/S0896-6273(00)80234-2; Roenneberg T, 1997, PHOTOCHEM PHOTOBIOL, V66, P549, DOI 10.1111/j.1751-1097.1997.tb03188.x; Shearman LP, 1999, NEUROSCIENCE, V89, P387, DOI 10.1016/S0306-4522(98)00325-X; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; Whitmore D, 1998, NAT NEUROSCI, V1, P701, DOI 10.1038/3703; Whitmore D, 1998, CURR OPIN NEUROBIOL, V8, P635, DOI 10.1016/S0959-4388(98)80092-5; Zeng HK, 1996, NATURE, V380, P129, DOI 10.1038/380129a0; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5	29	345	350	3	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					87	91		10.1038/35003589	http://dx.doi.org/10.1038/35003589			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716448				2022-12-24	WOS:000085775100051
J	Zeidler, M; Sellar, RJ; Collie, DA; Knight, R; Stewart, G; Macleod, MA; Ironside, JW; Cousens, S; Colchester, AFC; Hadley, DM; Will, RG				Zeidler, M; Sellar, RJ; Collie, DA; Knight, R; Stewart, G; Macleod, MA; Ironside, JW; Cousens, S; Colchester, AFC; Hadley, DM; Will, RG			The pulvinar sign on magnetic resonance imaging in variant Creutzfetdt-Jakob disease	LANCET			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; FATAL FAMILIAL INSOMNIA; CEREBROSPINAL-FLUID; MRI; FEATURES; PROTEIN; BRAIN	Background There is a need for an accurate non-invasive diagnostic test for variant Creutzfeldt-Jakob disease (vCJD), We investigated the sensitivity and specificity of bilateral pulvinar high signal on magnetic resonance imaging (MRI) for the diagnosis of vCJD. Methods MRI from patients with vCJD and controls (patients with suspected CJD) were analysed. Scans were reviewed on two separate occasions by two neuroradiologists and scored for the distribution of changes, and likely final diagnosis. Scans from vCJD cases were reassessed to reach a consensus on all abnormalities. Findings We analysed 36 patients and 57 controls. vCJD patients were correctly identified based on bilateral pulvinar high signal in 29 of 36 and 32 of 36 cases on the first assessment by the two radiologists, and 32 of 36 and 31 of 36 on their second assessment. Bilateral increased pulvinar signal was identified in one of 57 and one of 57 controls on the first assessment and two of 57 and three of 57 controls on the second assessment. These reported changes in controls were graded as minimal/equivocal in six of seven patients and moderate in one (<0.5% of all control assessments). 80% of the assessments in vCJD cases were graded as moderate or substantial. On consensus review, 28 of 36 cases and none of 57 controls had prominent bilateral pulvinar signal-sensitivity 78% (95% CI 60-90%) and specificity 100% (95% CI 94-100%), Other common MRI features of vCJD were medial thalamic and periaqueductal grey matter high signal, and the notable absence of cerebral atrophy. Pulvinar high signal correlated with histological gliosis. Interpretation In the appropriate clinical context the MRI identification of bilaterally increased pulvinar signal is a useful non-invasive test for the diagnosis of vCJD.	Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Edinburgh EX4 2XU, Midlothian, Scotland; Western Gen Hosp, Dept Neuroradiol, Edinburgh EX4 2XU, Midlothian, Scotland; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; So Gen Hosp, Inst Neurol Sci, Dept Neuroradiol, Glasgow G51 4TF, Lanark, Scotland; Univ Kent, Elect Engn Lab, Kent Inst Med & Hlth Sci, Canterbury, Kent, England	University of Edinburgh; University of Edinburgh; University of London; London School of Hygiene & Tropical Medicine; University of Glasgow; University of Kent	Zeidler, M (corresponding author), Western Gen Hosp, Natl Creutzfeldt Jakob Dis Surveillance Unit, Crewe Rd, Edinburgh EX4 2XU, Midlothian, Scotland.			Ironside, James/0000-0001-5869-2108				Canciani B, 1999, J NEUROPATH EXP NEUR, V58, P560, DOI 10.1097/00005072-199905000-00214; Chazot G, 1996, LANCET, V347, P1181, DOI 10.1016/S0140-6736(96)90638-8; Coulthard A, 1999, BRIT J RADIOL, V72, P742, DOI 10.1259/bjr.72.860.10624339; Cousens SN, 1997, BRIT MED J, V315, P389, DOI 10.1136/bmj.315.7105.389; CUSMAI R, 1994, NEUROPEDIATRICS, V25, P44, DOI 10.1055/s-2008-1071582; de Silva R, 1998, BRIT MED J, V316, P593, DOI 10.1136/bmj.316.7131.593; deVillemeur TB, 1996, TRANSMISSIBLE SUBACUTE SPONGIFORM ENCEPHALOPATHIES: PRION DISEASES, P451; Finkenstaedt M, 1996, RADIOLOGY, V199, P793, DOI 10.1148/radiology.199.3.8638007; GAMBETTI P, 1995, BRAIN PATHOL, V5, P43, DOI 10.1111/j.1750-3639.1995.tb00576.x; GOODBRAND IA, 1995, NEUROSCI LETT, V183, P127, DOI 10.1016/0304-3940(94)11131-2; HAHN JS, 1994, PEDIATR NEUROL, V10, P255, DOI 10.1016/0887-8994(94)90035-3; HARDING BN, 1995, J NEUROL NEUROSUR PS, V58, P320, DOI 10.1136/jnnp.58.3.320; Hsich G, 1996, NEW ENGL J MED, V335, P924, DOI 10.1056/NEJM199609263351303; Ironside JW, 1996, COLD SPRING HARB SYM, V61, P523; Johnson RT, 1998, NEW ENGL J MED, V339, P1994, DOI 10.1056/NEJM199812313392707; Salonen O, 1997, NEURORADIOLOGY, V39, P537, DOI 10.1007/s002340050463; Santos JMG, 1996, NEURORADIOLOGY, V38, P226, DOI 10.1007/s002340050235; SELLAR RJ, 1997, NEURORADIOLOGY, V39, pS53; Seno H, 1992, No To Shinkei, V44, P177; Steinhoff BJ, 1996, ARCH NEUROL-CHICAGO, V53, P162, DOI 10.1001/archneur.1996.00550020074017; Tabrizi SJ, 1996, LANCET, V347, P945, DOI 10.1016/S0140-6736(96)91419-1; Urbach H, 1998, NEURORADIOLOGY, V40, P65, DOI 10.1007/s002340050542; WILL RG, 1999, PSYCHIAT B, V23, P264; World Health Organization, 1998, REP WHO CONS GLOB SU; Yoshimura N, 1992, Rinsho Shinkeigaku, V32, P327; Zeidler M, 1997, LANCET, V350, P908, DOI 10.1016/S0140-6736(97)03148-6; Zeidler M, 1996, BRIT MED J, V312, P844; Zerr I, 1998, ANN NEUROL, V43, P32, DOI 10.1002/ana.410430109; Zerr I, 1998, NEUROLOGY, V51, P1398, DOI 10.1212/WNL.51.5.1398	29	231	235	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 22	2000	355	9213					1412	1418		10.1016/S0140-6736(00)02140-1	http://dx.doi.org/10.1016/S0140-6736(00)02140-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LN	10791525				2022-12-24	WOS:000086829800012
J	Schiller, LR				Schiller, LR			Pathophysiology and treatment ed microscopic-colitis syndrome	LANCET			English	Editorial Material							COLLAGENOUS-COLITIS; CHRONIC DIARRHEA		Baylor Univ, Med Ctr, Dept Gastroenterol, Dallas, TX 75246 USA	Baylor University; Baylor University Medical Center	Schiller, LR (corresponding author), Baylor Univ, Med Ctr, Dept Gastroenterol, Dallas, TX 75246 USA.							Bohr J, 1996, GUT, V39, P846, DOI 10.1136/gut.39.6.846; Fine K, 1999, GASTROENTEROLOGY, V116, pA880; Fine KD, 1999, GASTROENTEROLOGY, V116, pA879; Fine KD, 1998, GASTROENTEROLOGY, V114, P29, DOI 10.1016/S0016-5085(98)70629-8; Fine KD, 2000, GASTROINTEST ENDOSC, V51, P318, DOI 10.1016/S0016-5107(00)70362-2; LAZENBY AJ, 1989, HUM PATHOL, V20, P18, DOI 10.1016/0046-8177(89)90198-6; LEE E, 1988, GASTROENTEROLOGY, V94, P409, DOI 10.1016/0016-5085(88)90430-1; LEE E, 1992, GASTROENTEROLOGY, V103, P1790, DOI 10.1016/0016-5085(92)91436-8; LINDSTROM CG, 1976, PATHOL EUR, V11, P87; NELSON RW, 1988, J VET INTERN MED, V2, P133, DOI 10.1111/j.1939-1676.1988.tb02809.x; Rath HC, 1996, J CLIN INVEST, V98, P945, DOI 10.1172/JCI118878; READ NW, 1980, GASTROENTEROLOGY, V78, P264; Schiller L R, 1999, Semin Gastrointest Dis, V10, P145; SCHILLER LR, 1990, GASTROENTEROLOGY, V98, P1036, DOI 10.1016/0016-5085(90)90031-U; Ung KA, 2000, GUT, V46, P170, DOI 10.1136/gut.46.2.170	15	19	19	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1198	1199		10.1016/S0140-6736(00)02079-1	http://dx.doi.org/10.1016/S0140-6736(00)02079-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770295				2022-12-24	WOS:000086448000002
J	Sims, DW; Andrews, PLR; Young, JZ				Sims, DW; Andrews, PLR; Young, JZ			Fish behaviour - Stomach rinsing in rays	NATURE			English	Article									Univ Aberdeen, Dept Zool, Aberdeen AB24 2TZ, Scotland; St George Hosp, Sch Med, Dept Physiol, London SW17 0RE, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Aberdeen; St Georges University London; University of Oxford	Sims, DW (corresponding author), Univ Aberdeen, Dept Zool, Tillydrone Ave, Aberdeen AB24 2TZ, Scotland.			Sims, David/0000-0002-0916-7363				Andrews PLR, 1998, J MAR BIOL ASSOC UK, V78, P1269, DOI 10.1017/S0025315400044489; ANDREWS PLR, IN PRESS J EXP BIOL; BEINTEMA AJ, 1991, NATURE, V352, P480, DOI 10.1038/352480b0; BORISON HL, 1952, J PHARMACOL EXP THER, V105, P317; Budker P., 1971, LIFE SHARKS; CROW G L, 1990, Copeia, P226; NAITOH T, 1991, COMP BIOCHEM PHYS C, V100, P353; Naitoh T, 1996, NATURE, V380, P30, DOI 10.1038/380030b0; NAITOH T, 1989, PHYSIOL ZOOL, V62, P819, DOI 10.1086/physzool.62.3.30157929; Wake M. H, 1979, HYMANS COMP VERTEBRA, VThird	10	25	27	1	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					566	566		10.1038/35007149	http://dx.doi.org/10.1038/35007149			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766231	Bronze			2022-12-24	WOS:000086400100042
J	Hayashi, Y; Shi, SH; Esteban, JA; Piccini, A; Poncer, JC; Malinow, R				Hayashi, Y; Shi, SH; Esteban, JA; Piccini, A; Poncer, JC; Malinow, R			Driving AMPA receptors into synapses by LTP and CaMKII: Requirement for GluR1 and PDZ domain interaction	SCIENCE			English	Article							LONG-TERM POTENTIATION; DEPENDENT PROTEIN-KINASE; SYNAPTIC TRANSMISSION; GLUTAMATE RECEPTORS; IN-VIVO; CALMODULIN; NEURONS; PHOSPHORYLATION; MECHANISMS; COMPONENT	To elucidate mechanisms that control and execute activity-dependent synaptic plasticity, alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptors (AMPA-Rs) with an electrophysiological tag were expressed in rat hippocampal neurons. Long-term potentiation (LTP) or increased activity of the calcium/calmodulin-dependent protein kinase II (CaMKII) induced delivery of tagged AMPA-Rs into synapses. This effect was not diminished by mutating the CaMKII phosphorylation site on the GLuR1 AMPA-R subunit, but was blocked by mutating a predicted PDZ domain interaction site. These results show that LTP and CaMKII activity drive AMPA-Rs to synapses by a mechanism that requires the association between GluR1 and a PDZ domain protein.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Malinow, R (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	malinow@cshl.org	Hayashi, Yasunori/AAF-1408-2019; Hayashi, Yasunori/C-2249-2008; Esteban, Jose/L-4944-2014; Poncer, Jean Christophe/R-6362-2016	Hayashi, Yasunori/0000-0002-7560-3004; Hayashi, Yasunori/0000-0002-7560-3004; Esteban, Jose/0000-0002-3759-3300; Poncer, Jean Christophe/0000-0001-5729-3009				Barria A, 1997, J BIOL CHEM, V272, P32727, DOI 10.1074/jbc.272.52.32727; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; BARRIA A, 1998, THESIS VOLLUM I PORT; Benke TA, 1998, NATURE, V393, P793, DOI 10.1038/31709; BLACKSTONE C, 1994, J NEUROSCI, V14, P7585; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Dong HL, 1997, NATURE, V386, P279, DOI 10.1038/386279a0; HAYASHI Y, UNPUB; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; JACKSON RJ, 1990, TRENDS BIOCHEM SCI, V15, P477, DOI 10.1016/0968-0004(90)90302-R; KELLY PT, 1984, P NATL ACAD SCI-BIOL, V81, P945, DOI 10.1073/pnas.81.3.945; Kim JH, 1999, CURR OPIN CELL BIOL, V11, P248, DOI 10.1016/S0955-0674(99)80033-7; Leonard AS, 1998, J BIOL CHEM, V273, P19518, DOI 10.1074/jbc.273.31.19518; Li P, 1999, NAT NEUROSCI, V2, P972, DOI 10.1038/14771; Lisman J, 1997, SCIENCE, V276, P2001, DOI 10.1126/science.276.5321.2001; LLEDO PM, 1995, P NATL ACAD SCI USA, V92, P11175, DOI 10.1073/pnas.92.24.11175; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MALINOW R, 1999, IMAGING LIVING CELLS; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; MILLER SG, 1985, J BIOL CHEM, V260, P9039; Nagano T, 1998, J BIOCHEM-TOKYO, V124, P869, DOI 10.1093/oxfordjournals.jbchem.a022200; Neve RL, 1997, NEUROSCIENCE, V79, P435, DOI 10.1016/S0306-4522(96)00645-8; Nishimune A, 1998, NEURON, V21, P87, DOI 10.1016/S0896-6273(00)80517-6; Noel J, 1999, NEURON, V23, P365, DOI 10.1016/S0896-6273(00)80786-2; Osten P, 1998, NEURON, V21, P99, DOI 10.1016/S0896-6273(00)80518-8; PETTIT DL, 1994, SCIENCE, V266, P1881, DOI 10.1126/science.7997883; Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1; Saras J, 1997, J BIOL CHEM, V272, P20979, DOI 10.1074/jbc.272.34.20979; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shirke AM, 1997, J NEUROPHYSIOL, V78, P2682, DOI 10.1152/jn.1997.78.5.2682; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; Song I, 1998, NEURON, V21, P393, DOI 10.1016/S0896-6273(00)80548-6; Songyang Z, 1997, SCIENCE, V275, P73, DOI 10.1126/science.275.5296.73; VERDOORN TA, 1991, SCIENCE, V252, P1715, DOI 10.1126/science.1710829; Wenthold RJ, 1996, J NEUROSCI, V16, P1982; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Wyszynski M, 1999, Methods Enzymol, V294, P371	40	1168	1206	1	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2262	2267		10.1126/science.287.5461.2262	http://dx.doi.org/10.1126/science.287.5461.2262			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731148				2022-12-24	WOS:000086049100051
J	Filatov, DA; Moneger, F; Negrutiu, I; Charlesworth, D				Filatov, DA; Moneger, F; Negrutiu, I; Charlesworth, D			Low variability in a Y-linked plant gene and its implications for Y-chromosome evolution	NATURE			English	Article							SEX-DETERMINING LOCUS; DIOECIOUS PLANT; MELANDRIUM-ALBUM; DNA-SEQUENCES; POLYMORPHISM; HITCHHIKING; HYPOTHESIS; MICE; SRY	Sex chromosomes have evolved independently in several different groups of organisms, but they share common features, including genetic degeneration of the Y chromosome(1,2). Suppression of recombination between ancestral proto-X and proto-Y chromosomes is thought to have led to their gradual divergence, and to degeneration of the Y chromosome(2), but the evolutionary forces responsible are unknown. In non-recombining Y chromosomes, deleterious mutations may be carried to fixation by linked advantageous mutations ("selective sweeps")(3). Occurrence of deleterious mutations may drive "Muller's ratchet" (stochastic loss of chromosomes with the fewest mutations)(2,4). Selective elimination of deleterious mutations, causing "background selection"(5,6) may accelerate stochastic fixation of mildly detrimental mutations(2). All these processes lower effective population sizes, and therefore reduce variability of genes in evolving Y chromosomes. We have studied DNA diversity and divergence in a recently described X- and Y-linked gene pair(7) (SLX-1 and SLY-1) of the plant Silene latifolia to obtain evidence about the early stages of Y degeneration. Here we show that DNA polymorphism in SLY-1 is 20-fold lower than in SLX-1, but the pattern of polymorphism does not suggest a selective sweep.	Univ Edinburgh, Inst Cell Anim & Populat Biol, Edinburgh EH9 3JT, Midlothian, Scotland; Ecole Normale Super Lyon, ENS Lyon 1, INRA, CNRS,UMR 5667, F-69364 Lyon, France	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Normale Superieure de Lyon (ENS de LYON)	Charlesworth, D (corresponding author), Univ Edinburgh, Inst Cell Anim & Populat Biol, W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	Deborah.Charlesworth@ed.ac.uk	Charlesworth, Deborah/F-3071-2011	Filatov, Dmitry/0000-0001-8077-5452; Moneger, Francoise/0000-0003-2107-5696				Anagnostopoulos T, 1999, AM J HUM GENET, V64, P508, DOI 10.1086/302250; BRAVERMAN JM, 1995, GENETICS, V140, P783, DOI 10.1093/genetics/140.2.783; BULL JJ, 1993, EVOLUTION SEX DETERM; Burrows W, 1997, NATURE, V385, P125, DOI 10.1038/385125a0; Buzek J, 1997, CHROMOSOME RES, V5, P57, DOI 10.1023/A:1011693603279; Charlesworth B, 1996, CURR BIOL, V6, P149, DOI 10.1016/S0960-9822(02)00448-7; CHARLESWORTH D, 1995, GENETICS, V141, P1619; Delichere C, 1999, EMBO J, V18, P4169, DOI 10.1093/emboj/18.15.4169; Desfeux C, 1996, P ROY SOC B-BIOL SCI, V263, P409, DOI 10.1098/rspb.1996.0062; Filatov DA, 1999, GENETICS, V153, P1423; FU YX, 1993, GENETICS, V133, P693; Gaut BS, 1998, EVOL BIOL, V30, P93; GRANT S, 1994, DEV GENET, V15, P214, DOI 10.1002/dvg.1020150304; Guttman DS, 1998, NATURE, V393, P263, DOI 10.1038/30492; Hudson R.R., 1990, Oxford Surveys in Evolutionary Biology, V7, P1; HUDSON RR, 1987, GENET RES, V50, P245, DOI 10.1017/S0016672300023776; HUDSON RR, 1985, GENETICS, V111, P147; KUMAR S, 1993, MEGA MOL EVOLUTION G; LUNDRIGAN BL, 1994, MOL BIOL EVOL, V11, P483; MANNING JT, 1984, ACTA BIOTHEOR, V33, P219, DOI 10.1007/BF00048429; McAllister BF, 1999, GENETICS, V153, P221; NACHMAN MW, 1994, MOL BIOL EVOL, V11, P539; Nei M, 1987, MOL EVOLUTIONARY GEN; Orr HA, 1998, GENETICS, V150, P1693; RICE WR, 1987, GENETICS, V116, P161; TAJIMA F, 1989, GENETICS, V123, P585; VAGERA J, 1994, ANN BOT-LONDON, V73, P455, DOI 10.1006/anbo.1994.1056; WESTERGAARD M, 1958, ADV GENET, V9, P217, DOI 10.1016/S0065-2660(08)60163-7; YE D, 1990, SEX PLANT REPROD, V3, P179, DOI 10.1007/BF00205227; Zurovcova M, 1999, GENETICS, V153, P1709	30	147	151	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					388	390		10.1038/35006057	http://dx.doi.org/10.1038/35006057			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746725				2022-12-24	WOS:000086119000050
J	Lewis, KA; Gray, PC; Blount, AL; MacConnell, LA; Wiater, E; Bilezikjian, LM; Vale, W				Lewis, KA; Gray, PC; Blount, AL; MacConnell, LA; Wiater, E; Bilezikjian, LM; Vale, W			Betaglycan binds inhibin and can mediate functional antagonism of activin signalling	NATURE			English	Article							RECEPTOR COMPLEX; CLONING; KINASE; GROWTH	Activins and inhibins(1), structurally related members of the TGF-beta superfamily of growth and differentiation factors(2), are mutually antagonistic regulators of reproductive and other functions(1,3). Activins bind specific type II receptor serine kinases (ActRII or IIB)(4-6) to promote the recruitment and phosphorylation of the type I receptor serine kinase, ALK4 (refs 7-9), which then regulates gene expression by activating Smad proteins(2). Inhibins also bind type II activin receptors but do not recruit ALK4, providing a competitive model for the antagonism of activin by inhibing(9-11). Inhibins fail to antagonize activin in some tissues and cells, however, suggesting that additional components are required for inhibin action(9,12,13). Here we show that the type III TGF-beta receptor, betaglycan(14,15), can function as an inhibin coreceptor with ActRII. Betaglycan binds inhibin with high affinity and enhances binding in cells co-expressing ActRII and betaglycan. Inhibin also forms crosslinked complexes with both recombinant and endogenously expressed betaglycan and ActRII. Finally, betaglycan confers inhibin sensitivity to cell lines that otherwise respond poorly to this hormone. The ability of betaglycan to facilitate inhibin antagonism of activin provides a variation on the emerging roles of proteoglycans as co-receptors modulating ligand-receptor sensitivity, selectivity and function(16-19).	Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA	Salk Institute	Vale, W (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	vale@salk.edu			PHS HHS [13527] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Attisano L, 1996, MOL CELL BIOL, V16, P1066; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Draper LB, 1998, J BIOL CHEM, V273, P398, DOI 10.1074/jbc.273.1.398; Lebrun JJ, 1997, MOL CELL BIOL, V17, P1682, DOI 10.1128/MCB.17.3.1682; Martens JWM, 1997, ENDOCRINOLOGY, V138, P2928, DOI 10.1210/en.138.7.2928; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; Matzuk MM, 1996, RECENT PROG HORM RES, V51, P123; MATZUK MM, 1996, RECENT PROG HORM RES, V51, P155; VALE W, 1988, RECENT PROG HORM RES, V44, P1; XU JM, 1995, J BIOL CHEM, V270, P6308, DOI 10.1074/jbc.270.11.6308	13	464	486	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					411	414		10.1038/35006129	http://dx.doi.org/10.1038/35006129			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746731				2022-12-24	WOS:000086119000056
J	Rademann, J; Jung, G				Rademann, J; Jung, G			Drug discovery - Integrating combinatorial synthesis and bioassays	SCIENCE			English	Article							LIBRARY; SPECIFICITY; CRUZIPAIN; ASSAY		Univ Tubingen, Inst Organ Chem, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Rademann, J (corresponding author), Univ Tubingen, Inst Organ Chem, Morgenstelle 18, D-72076 Tubingen, Germany.		Rademann, Jörg/F-4893-2017	Rademann, Jörg/0000-0001-6678-3165				Bianco A, 1998, J PEPT SCI, V4, P471, DOI 10.1002/(SICI)1099-1387(199812)4:8<471::AID-PSC166>3.0.CO;2-8; BUCHARDT J, 1999, 16 AM PEPT S MINN MN; DelNery E, 1997, BIOCHEM J, V323, P427, DOI 10.1042/bj3230427; Fleckenstein B, 1999, SEMIN IMMUNOL, V11, P405, DOI 10.1006/smim.1999.0198; FLECKENSTEIN B, 1999, COMBINATORIAL CHEM S, P355; FRANK R, 1996, PEPTIDE NONPEPTIDE L; Hemmer B, 1999, NAT MED, V5, P1375; Hemmer B, 1997, J EXP MED, V185, P1651, DOI 10.1084/jem.185.9.1651; Jung G., 1999, COMBINATORIAL CHEM S; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Lebl M, 1999, J COMB CHEM, V1, P3, DOI 10.1021/cc9800327; Leipert D, 1999, ANAL CHIM ACTA, V392, P213, DOI 10.1016/S0003-2670(99)00178-6; Leipert D, 1998, ANGEW CHEM INT EDIT, V37, P3308, DOI 10.1002/(SICI)1521-3773(19981217)37:23<3308::AID-ANIE3308>3.0.CO;2-#; MacBeath G, 1999, J AM CHEM SOC, V121, P7967, DOI 10.1021/ja991083q; Meldal M, 1998, J PEPT SCI, V4, P83, DOI 10.1002/(SICI)1099-1387(199804)4:2<83::AID-PSC124>3.0.CO;2-Z; MELDAL M, 1994, P NATL ACAD SCI USA, V91, P3314, DOI 10.1073/pnas.91.8.3314; MELDAL M, 1992, TETRAHEDRON LETT, V33, P3077, DOI 10.1016/S0040-4039(00)79604-3; Piehler J, 1996, ANAL CHEM, V68, P139, DOI 10.1021/ac9504878; Rademann J, 1999, J AM CHEM SOC, V121, P5459, DOI 10.1021/ja984355i; Rothmund M, 1997, FRESEN J ANAL CHEM, V359, P15, DOI 10.1007/s002160050529; Stockwell BR, 1999, CHEM BIOL, V6, P71, DOI 10.1016/S1074-5521(99)80004-0; Walk TB, 1999, ANGEW CHEM INT EDIT, V38, P1763, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1763::AID-ANIE1763>3.0.CO;2-#	22	37	38	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1947	1948		10.1126/science.287.5460.1947	http://dx.doi.org/10.1126/science.287.5460.1947			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10755947				2022-12-24	WOS:000085902800036
J	Poulin, EC; Schlachta, CM; Mamazza, J				Poulin, EC; Schlachta, CM; Mamazza, J			Early laparoscopy to help diagnose acute non-specific abdominal pain	LANCET			English	Editorial Material							ACUTE ABDOMEN		Univ Toronto, St Michaels Hosp, Ctr Minimally Invas Surg, Toronto, ON M46 1J3, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Poulin, EC (corresponding author), Univ Toronto, St Michaels Hosp, Ctr Minimally Invas Surg, Toronto, ON M46 1J3, Canada.							ADAMS ID, 1986, BRIT MED J, V293, P800, DOI 10.1136/bmj.293.6550.800; Allemann F, 1999, EUR J SURG, V165, P966; Decadt B, 1999, BRIT J SURG, V86, P1383, DOI 10.1046/j.1365-2168.1999.01239.x; Gupta H, 1997, SURG CLIN N AM, V77, P1245, DOI 10.1016/S0039-6109(05)70616-2; Hawthorn I E, 1992, J R Coll Surg Edinb, V37, P389; IRVIN TT, 1989, BRIT J SURG, V76, P1121, DOI 10.1002/bjs.1800761105; RAHEJA SK, 1990, J ROY SOC MED, V88, P10; Rao PM, 1998, NEW ENGL J MED, V338, P141, DOI 10.1056/NEJM199801153380301; Salky BA, 1998, SURG ENDOSC-ULTRAS, V12, P911, DOI 10.1007/s004649900744; VIPOND MN, 1990, BRIT J SURG, V77, P86, DOI 10.1002/bjs.1800770130	10	22	24	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					861	863		10.1016/S0140-6736(99)00432-8	http://dx.doi.org/10.1016/S0140-6736(99)00432-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752698				2022-12-24	WOS:000085896000004
J	Martin, MW; Grazhdankin, DV; Bowring, SA; Evans, DAD; Fedonkin, MA; Kirschvink, JL				Martin, MW; Grazhdankin, DV; Bowring, SA; Evans, DAD; Fedonkin, MA; Kirschvink, JL			Age of Neoproterozoic bilatarian body and trace fossils, White Sea, Russia: Implications for metazoan evolution	SCIENCE			English	Article							EARLY ANIMAL EVOLUTION; NORTHWESTERN CANADA; CHEMOSTRATIGRAPHY; BIOSTRATIGRAPHY; STRATIGRAPHY; STRATA; EARTH	A uranium-lead zircon age for a volcanic ash interstratified with fossil-bearing, shallow marine siliciclastic rocks in the Zimnie Gory section of the White Sea region indicates that a diverse assemblage of body and trace fossils occurred before 555.3 +/- 0.3 million years ago. This age is a minimum for the oldest well-documented triploblastic bilaterian Kimberella. It also makes co-occurring trace fossils the oldest that are reliably dated. This determination of age implies that there is no simple relation between Ediacaran diversity and the carbon isotopic composition of Neoproterozoic seawater.	MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; Inst Paleontol, Moscow 117868, Russia; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA	Massachusetts Institute of Technology (MIT); California Institute of Technology	Martin, MW (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA.	mwm@mit.edu	Grazhdankin, Dima/J-4378-2019; Grazhdankin, Dmitriy/A-4060-2008	Grazhdankin, Dima/0000-0003-0797-1347; Grazhdankin, Dmitriy/0000-0003-0797-1347; Evans, David/0000-0001-8952-5273				Bartley JK, 1998, GEOL MAG, V135, P473, DOI 10.1017/S0016756898008772; Benus AP., 1988, GEOLOGICAL SURVEY B, P8; COMPSTON W, 1995, J GEOL SOC LONDON, V152, P599, DOI 10.1144/gsjgs.152.4.0599; Crimes TP, 1999, GEOL MAG, V136, P633, DOI 10.1017/S0016756899003179; Dalziel IWD, 1997, GEOL SOC AM BULL, V109, P16, DOI 10.1130/0016-7606(1997)109<0016:ONPGAT>2.3.CO;2; Erwin DH, 1999, AM ZOOL, V39, P617; Fedonkin M.A., 1981, BELOMORSKAYA BIOTA V; Fedonkin MA, 1997, NATURE, V388, P868, DOI 10.1038/42242; GEHLING JG, 1996, THESIS U CALIF, P222; GRAZHDANKIN D, UNPUB; GROTZINGER JP, 1995, SCIENCE, V270, P598, DOI 10.1126/science.270.5236.598; HAGADORN JW, 2000, J PALEONTOL, V74, P554; Hoffman PF, 1998, SCIENCE, V281, P1342, DOI 10.1126/science.281.5381.1342; HOFFMAN PF, 1991, SCIENCE, V252, P1409, DOI 10.1126/science.252.5011.1409; HOFMANN HJ, 1990, GEOLOGY, V18, P1199, DOI 10.1130/0091-7613(1990)018<1199:ERFIBI>2.3.CO;2; JENKINS RJF, 1995, PRECAMBRIAN RES, V73, P51, DOI 10.1016/0301-9268(94)00071-X; Jensen S, 1998, NATURE, V393, P567, DOI 10.1038/31215; KAUFMAN AJ, 1995, PRECAMBRIAN RES, V73, P27, DOI 10.1016/0301-9268(94)00070-8; Kirschvink J. L., 1992, PROTEROZOIC BIOSPHER, P51; KNOLL AH, 1992, NATURE, V356, P673, DOI 10.1038/356673a0; KNOLL AH, 1999, SCIENCE, V284, P2129, DOI DOI 10.1126/SCIENCE.284.5423.2129; Macnaughton RB, 1999, PALAIOS, V14, P97, DOI 10.2307/3515367; NARBONNE GM, 1994, GEOL SOC AM BULL, V106, P1281, DOI 10.1130/0016-7606(1994)106<1281:ICABOT>2.3.CO;2; NARBONNE GM, 1987, CAN J EARTH SCI, V24, P1277, DOI 10.1139/e87-124; Nedin C, 1998, ALCHERINGA, V22, P315, DOI 10.1080/03115519808619329; Pelechaty SM, 1996, GEOL SOC AM BULL, V108, P992, DOI 10.1130/0016-7606(1996)108<0992:EOCCFI>2.3.CO;2; Pell S. D., 1993, Transactions Royal Society of South Australia, V117, P153; Runnegar B.N., 1992, P999; Saylor BZ, 1998, J SEDIMENT RES, V68, P1223, DOI 10.2110/jsr.68.1223; Seilacher A, 1999, PALAIOS, V14, P86, DOI 10.2307/3515363; Sprigg R. C., 1947, Transactions of the Royal Society of South Australia, V71, P212; Waggoner B, 1999, PALEOBIOLOGY, V25, P440, DOI 10.1017/S0094837300020315; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318	33	292	317	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2000	288	5467					841	845		10.1126/science.288.5467.841	http://dx.doi.org/10.1126/science.288.5467.841			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797002				2022-12-24	WOS:000086869600032
J	Tzfati, Y; Fulton, TB; Roy, J; Blackburn, EH				Tzfati, Y; Fulton, TB; Roy, J; Blackburn, EH			Template boundary in a yeast telomerase specified by RNA structure	SCIENCE			English	Article							NORMAL HUMAN-CELLS; REVERSE-TRANSCRIPTASE; SECONDARY STRUCTURE; LIFE-SPAN; IN-VITRO; IDENTIFICATION; ELONGATION; RECONSTITUTION; MUTATIONS; DOMAIN	The telomerase ribonucleoprotein has a phylogenetically divergent RNA subunit, which contains a short template for telomeric DNA synthesis. To understand how telomerase RNA participates in mechanistic aspects of telomere synthesis, we studied a conserved secondary structure adjacent to the template. Disruption of this structure caused DNA synthesis to proceed beyond the normal template boundary, resulting in altered telomere sequences, telomere shortening, and cellular growth defects. Compensatory mutations restored normal telomerase function. Thus, the RNA structure, rather than its sequence, specifies the template boundary. This study reveals a specific function for an RNA structure in the enzymatic action of telomerase.	Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Blackburn, EH (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	telomer@itsa.ucsf.edu		Tzfati, Yehuda/0000-0001-7720-435X	NATIONAL CANCER INSTITUTE [T32CA009270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026259, R37GM026259] Funding Source: NIH RePORTER; NCI NIH HHS [T32CA09270] Funding Source: Medline; NIGMS NIH HHS [GM26259] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AnsariLari MA, 1996, BIOTECHNIQUES, V21, P34; AUTEXIER C, 1995, GENE DEV, V9, P2227, DOI 10.1101/gad.9.18.2227; Autexier C, 1996, EMBO J, V15, P5928, DOI 10.1002/j.1460-2075.1996.tb00979.x; Blackburn E. H., 1999, RNA WORLD, P609; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bryan TM, 1999, CURR OPIN CELL BIOL, V11, P318, DOI 10.1016/S0955-0674(99)80043-X; Fulton TB, 1998, MOL CELL BIOL, V18, P4961, DOI 10.1128/MCB.18.9.4961; Greene EC, 1998, MOL CELL BIOL, V18, P1544, DOI 10.1128/MCB.18.3.1544; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Harrison GP, 1998, NUCLEIC ACIDS RES, V26, P3433, DOI 10.1093/nar/26.14.3433; HENDERSON E, 1995, TELOMERES, P11; Klasens BIF, 1999, BBA-GENE STRUCT EXPR, V1444, P355, DOI 10.1016/S0167-4781(99)00011-1; LINGNER J, 1994, GENE DEV, V8, P1984, DOI 10.1101/gad.8.16.1984; MCEACHERN MJ, 1995, NATURE, V376, P403, DOI 10.1038/376403a0; McEachern MJ, 1996, GENE DEV, V10, P1822, DOI 10.1101/gad.10.14.1822; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Nakamura TM, 1998, CELL, V92, P587, DOI 10.1016/S0092-8674(00)81123-X; Prescott J, 1997, GENE DEV, V11, P528, DOI 10.1101/gad.11.4.528; ROMERO DP, 1991, CELL, V67, P343, DOI 10.1016/0092-8674(91)90186-3; Roy J, 1998, GENE DEV, V12, P3286, DOI 10.1101/gad.12.20.3286; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Tesmer VM, 1999, MOL CELL BIOL, V19, P6207; TZFATI Y, UNPUB; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Weilbaecher RG, 1999, CURR OPIN CHEM BIOL, V3, P573, DOI 10.1016/S1367-5931(99)00011-3; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181	26	115	116	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 5	2000	288	5467					863	867		10.1126/science.288.5467.863	http://dx.doi.org/10.1126/science.288.5467.863			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797010				2022-12-24	WOS:000086869600040
J	Cramer, P; Bushnell, DA; Fu, JH; Gnatt, AL; Maier-Davis, B; Thompson, NE; Burgess, RR; Edwards, AM; David, PR; Kornberg, RD				Cramer, P; Bushnell, DA; Fu, JH; Gnatt, AL; Maier-Davis, B; Thompson, NE; Burgess, RR; Edwards, AM; David, PR; Kornberg, RD			Architecture of RNA polymerase II and implications for the transcription mechanism	SCIENCE			English	Article							ELONGATION-FACTOR TFIIS; START SITE SELECTION; VIRUS X-PROTEIN; CRYSTAL-STRUCTURE; ZINC RIBBON; ESCHERICHIA-COLI; DNA-POLYMERASE; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; TERNARY COMPLEX	A backbone model of a 10-subunit yeast RNA polymerase II has been derived from x-ray diffraction data extending to 3 angstroms resolution. All 10 subunits exhibit a high degree of identity with the corresponding human proteins, and 9 of the 10 subunits are conserved among the three eukaryotic RNA polymerases I, II, and III. Notable features of the model include a pair of jaws, formed by subunits Rpb1, Rpb5, and Rpb9, that appear to grip DNA downstream of the active center. A clamp on the DNA nearer the active center, formed by Rpb1, Rpb2, and Rpb6, may be Locked in the closed position by RNA, accounting for the great stability of transcribing complexes. A pore in the protein complex beneath the active center may allow entry of substrates for polymerization and exit of the transcript during proofreading and passage through pause sites in the DNA.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Univ Wisconsin, Mcardle Lab Canc Res, Madison, WI 53706 USA; Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada	Stanford University; University of Wisconsin System; University of Wisconsin Madison; University of Toronto	Kornberg, RD (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	kornberg@stanford.edu		Burgess, Richard/0000-0001-9545-3165; Edwards, Aled/0000-0002-4782-6016	NIGMS NIH HHS [GM49985] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AGARWAL K, 1991, BIOCHEMISTRY-US, V30, P7842, DOI 10.1021/bi00245a026; Asturias FJ, 1997, J MOL BIOL, V272, P536, DOI 10.1006/jmbi.1997.1273; Awrey DE, 1998, J BIOL CHEM, V273, P22595, DOI 10.1074/jbc.273.35.22595; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x; BUSHNELL DB, UNPUB; Carson M, 1997, METHOD ENZYMOL, V277, P493, DOI 10.1016/S0076-6879(97)77027-7; CHEONG JH, 1995, EMBO J, V14, P143, DOI 10.1002/j.1460-2075.1995.tb06984.x; Conaway RC, 1997, PROG NUCLEIC ACID RE, V56, P327, DOI 10.1016/S0079-6603(08)61009-0; Corden JL, 1997, TRENDS BIOCHEM SCI, V22, P413, DOI 10.1016/S0968-0004(97)01125-0; Cramer P, 1997, EMBO J, V16, P7078, DOI 10.1093/emboj/16.23.7078; DARST SA, 1991, CELL, V66, P121, DOI 10.1016/0092-8674(91)90144-N; DARST SA, 1991, J MOL BIOL, V221, P347, DOI 10.1016/0022-2836(91)80223-H; del Rio-Portilla F, 1999, NAT STRUCT BIOL, V6, P1039; DERBYSHIRE V, 1988, SCIENCE, V240, P199, DOI 10.1126/science.2832946; Dorjsuren D, 1998, MOL CELL BIOL, V18, P7546, DOI 10.1128/MCB.18.12.7546; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; EDWARDS AH, UNPUB; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; EDWARDS AM, 1994, NAT STRUCT BIOL, V1, P195, DOI 10.1038/nsb0394-195; EDWARDS AM, 1990, P NATL ACAD SCI USA, V87, P2122, DOI 10.1073/pnas.87.6.2122; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; FURTERGRAVES EM, 1994, NUCLEIC ACIDS RES, V22, P4932, DOI 10.1093/nar/22.23.4932; FURTERGRAVES EM, 1991, MOL CELL BIOL, V11, P4121, DOI 10.1128/MCB.11.8.4121; Gnatt A, 1997, J BIOL CHEM, V272, P30799, DOI 10.1074/jbc.272.49.30799; GNATT AL, UNPUB; Huang Y, 1997, BIOCHEMISTRY-US, V36, P8231, DOI 10.1021/bi962674l; HULL MW, 1995, GENE DEV, V9, P481, DOI 10.1101/gad.9.4.481; Ishihama A, 1981, Adv Biophys, V14, P1; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; Jensen GJ, 1998, EMBO J, V17, P2353, DOI 10.1017/S1431927600024983; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; JOHNSON TL, 1994, CELL, V77, P217, DOI 10.1016/0092-8674(94)90314-X; JOKERST RS, 1989, MOL GEN GENET, V215, P266, DOI 10.1007/BF00339727; Kayukawa K, 1999, GENE, V234, P139, DOI 10.1016/S0378-1119(99)00164-X; KIM JL, 1993, NATURE, V365, P520, DOI 10.1038/365520a0; Kim TK, 1997, P NATL ACAD SCI USA, V94, P12268, DOI 10.1073/pnas.94.23.12268; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; KIM YC, 1993, NATURE, V365, P512, DOI 10.1038/365512a0; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kimura M, 1997, J BIOL CHEM, V272, P25851, DOI 10.1074/jbc.272.41.25851; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Kosa PF, 1997, P NATL ACAD SCI USA, V94, P6042, DOI 10.1073/pnas.94.12.6042; Krapp S, 1998, NAT STRUCT BIOL, V5, P110, DOI 10.1038/nsb0298-110; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LAFORTELLE E, 1997, METHOD ENZYMOL, V276, P472; LALO D, 1993, P NATL ACAD SCI USA, V90, P5524, DOI 10.1073/pnas.90.12.5524; Leuther KK, 1996, CELL, V85, P773, DOI 10.1016/S0092-8674(00)81242-8; LUE NF, 1987, P NATL ACAD SCI USA, V84, P8839, DOI 10.1073/pnas.84.24.8839; Miyao T, 1998, P NATL ACAD SCI USA, V95, P15281, DOI 10.1073/pnas.95.26.15281; Miyao T, 1998, MOL GEN GENET, V259, P123, DOI 10.1007/s004380050796; Morin PE, 1996, P NATL ACAD SCI USA, V93, P10604, DOI 10.1073/pnas.93.20.10604; MULLER CW, 1995, NATURE, V373, P311, DOI 10.1038/373311a0; Myers LC, 1997, METHODS, V12, P212, DOI 10.1006/meth.1997.0473; NIKOLOV DB, 1995, NATURE, V377, P119, DOI 10.1038/377119a0; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; Nudler E, 1999, J MOL BIOL, V288, P1, DOI 10.1006/jmbi.1999.2641; Nudler E, 1996, SCIENCE, V273, P211, DOI 10.1126/science.273.5272.211; Olmsted VK, 1998, J BIOL CHEM, V273, P22589, DOI 10.1074/jbc.273.35.22589; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Poglitsch CL, 1999, CELL, V98, P791, DOI 10.1016/S0092-8674(00)81513-5; Powell W, 1996, J BIOL CHEM, V271, P22301, DOI 10.1074/jbc.271.37.22301; QIAN XQ, 1993, BIOCHEMISTRY-US, V32, P9944, DOI 10.1021/bi00089a010; RICE GA, 1991, P NATL ACAD SCI USA, V88, P4245, DOI 10.1073/pnas.88.10.4245; RICE GA, 1993, NUCLEIC ACIDS RES, V21, P113, DOI 10.1093/nar/21.1.113; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rubbi L, 1999, J BIOL CHEM, V274, P31485, DOI 10.1074/jbc.274.44.31485; SENTENAC A, 1992, MONOGR COLD SPRING H, V22; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; SWEETSER D, 1987, P NATL ACAD SCI USA, V84, P1192, DOI 10.1073/pnas.84.5.1192; TODONE F, UNPUB; UZGIRIS EE, 1983, NATURE, V301, P125, DOI 10.1038/301125a0; Wang B, 1998, STRUCTURE, V6, P555, DOI 10.1016/S0969-2126(98)00058-6; Woychik NA, 1998, COLD SPRING HARB SYM, V63, P311, DOI 10.1101/sqb.1998.63.311; Yoon H, 1998, BIOCHEMISTRY-US, V37, P12104, DOI 10.1021/bi980924n; Zaychikov E, 1996, SCIENCE, V273, P107, DOI 10.1126/science.273.5271.107; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhang GY, 1998, SCIENCE, V281, P262, DOI 10.1126/science.281.5374.262; Zhu WL, 1996, NAT STRUCT BIOL, V3, P122, DOI 10.1038/nsb0296-122	81	447	466	2	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2000	288	5466					640	649		10.1126/science.288.5466.640	http://dx.doi.org/10.1126/science.288.5466.640			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308RR	10784442	Green Published			2022-12-24	WOS:000086727100036
J	Aureli, P; Fiorucci, GC; Caroli, D; Marchiaro, G; Novara, O; Leone, L; Salmaso, S				Aureli, P; Fiorucci, GC; Caroli, D; Marchiaro, G; Novara, O; Leone, L; Salmaso, S			An outbreak of febrile gastroenteritis associated with corn contaminated by Listeria monocytogenes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIOFILMS; EPIDEMIC	Background: On May 21, 1997, numerous cases of febrile gastrointestinal illness were reported among the students and staff of two primary schools in northern Italy, all of whom had eaten at cafeterias served by the same caterer. Methods: We interviewed people who ate at the cafeterias about symptoms and foods consumed on May 20. There were no samples of foods left at the cafeterias, but we tested routine samples taken on May 20 by the caterer and environmental specimens at the catering plant. The hospitalized patients were tested for common enteropathogens and toxins. Results: Of the 2189 persons interviewed (82 percent of those exposed), 1566 (72 percent) reported symptoms; of these, 292 (19 percent) were hospitalized. Among samples obtained from hospitalized patients, all but two of the stool specimens and all blood specimens were negative for common enteropathogens. Listeria monocytogenes was isolated from one blood specimen and from 123 of the 141 stool specimens. Consumption of a cold salad of corn and tuna was associated with the development of symptoms (relative risk, 6.19; 95 percent confidence interval, 4.81 to 7.98; P<0.001). L. monocytogenes was isolated from the caterer's sample of the salad and from environmental specimens collected from the catering plant. All listeria isolates were serotype 4b and were found to be identical on DNA analysis. Experimental contamination of sterile samples of the implicated foods showed that L. monocytogenes grew on corn when kept for at least 10 hours at 25 degrees C. Conclusions: Food-borne infection with L. monocytogenes can cause febrile illness with gastroenteritis in immunocompetent persons. (N Engl J Med 2000;342:1236-41.) (C) 2000, Massachusetts Medical Society.	Ist Super Sanita, Lab Alimenti, Reparto Microbiol Alimenti, I-00161 Rome, Italy; Ist Super Sanita, Epidemiol & Biostat Lab, Reparto Malattie Infett, I-00161 Rome, Italy; Osped Regina Margherita Santa Anna, Azienda Osped Maternoinfantile, Dipartimento Patol Clin, Turin, Italy; Azienda Reg Protez Ambientale, Dipartimento Subprov Torino, Turin, Italy; Osped San Giovanni Battista, Microbiol Lab, Turin, Italy; Osped San Croce, Lab Patol Clin, Moncalieri, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); A.O.U. Citta della Salute e della Scienza di Torino; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	Aureli, P (corresponding author), Ist Super Sanita, Lab Alimenti, Reparto Microbiol Alimenti, Viale Regina Elena 299, I-00161 Rome, Italy.							Arizcun C, 1998, J FOOD PROTECT, V61, P731, DOI 10.4315/0362-028X-61.6.731; BUCHANAN RL, 1990, J FOOD PROTECT, V53, P370, DOI 10.4315/0362-028X-53.5.370; BUCHANAN RL, 1992, FOOD MICROBIOL, V9, P279, DOI 10.1016/0740-0020(92)80037-5; BULA CJ, 1995, CLIN INFECT DIS, V20, P66, DOI 10.1093/clinids/20.1.66; Dalton CB, 1997, NEW ENGL J MED, V336, P100, DOI 10.1056/NEJM199701093360204; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; FARBER JM, 1991, MICROBIOL REV, V55, P752; *FDA, 1984, BACT AN MAN S; Franciosa G, 1998, EUR J EPIDEMIOL, V14, P205, DOI 10.1023/A:1007448210169; GOLDEN DA, 1990, INT J FOOD MICROBIOL, V10, P143, DOI 10.1016/0168-1605(90)90062-A; Goulet V, 1998, J INFECT DIS, V177, P155, DOI 10.1086/513814; Heitmann M, 1997, PEDIATR INFECT DIS J, V16, P827, DOI 10.1097/00006454-199708000-00025; HO JL, 1986, ARCH INTERN MED, V146, P520, DOI 10.1001/archinte.146.3.520; KACZMARSKI EB, 1989, LANCET, V1, P549; Matushek MG, 1997, J CLIN MICROBIOL, V35, P536; MCLAUCHLIN J, 1991, BRIT MED J, V303, P773, DOI 10.1136/bmj.303.6805.773; MCLAUCHLIN J, 1990, INT J FOOD MICROBIOL, V10, P255, DOI 10.1016/0168-1605(90)90073-E; MCLAUCHLIN J, 1995, P 12 INT S PROBL LIS, P365; Miettinen MK, 1999, J CLIN MICROBIOL, V37, P2358, DOI 10.1128/JCM.37.7.2358-2360.1999; *MIN SAN, 1997, B EP, V15; PINNER RW, 1992, JAMA-J AM MED ASSOC, V267, P2046, DOI 10.1001/jama.267.15.2046; RIEDO FX, 1994, J INFECT DIS, V170, P693, DOI 10.1093/infdis/170.3.693; Salamina G, 1996, EPIDEMIOL INFECT, V117, P429, DOI 10.1017/S0950268800059082; SCHWARTZ B, 1989, J INFECT DIS, V159, P680, DOI 10.1093/infdis/159.4.680; STELMA GN, 1987, J CLIN MICROBIOL, V25, P2085, DOI 10.1128/JCM.25.11.2085-2089.1987; TAPPERO JW, 1995, JAMA-J AM MED ASSOC, V273, P1118, DOI 10.1001/jama.273.14.1118; *WHO ICMSF, 1982, WHOICMSF M HAZ AN CR; ZOTTOLA EA, 1994, INT J FOOD MICROBIOL, V23, P125, DOI 10.1016/0168-1605(94)90047-7	28	279	296	0	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 27	2000	342	17					1236	1241		10.1056/NEJM200004273421702	http://dx.doi.org/10.1056/NEJM200004273421702			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307NZ	10781619				2022-12-24	WOS:000086660600002
J	Silvestrini, M; Vernieri, F; Pasqualetti, P; Matteis, M; Passarelli, F; Troisi, E; Caltagirone, C				Silvestrini, M; Vernieri, F; Pasqualetti, P; Matteis, M; Passarelli, F; Troisi, E; Caltagirone, C			Impaired cerebral vasoreactivity and risk of stroke in patients with asymptomatic carotid artery stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CEREBROVASCULAR REACTIVITY; TRANSCRANIAL DOPPLER; BLOOD-FLOW; ENDARTERECTOMY; OCCLUSIONS; HEMODYNAMICS	Context Standards for treating patients with asymptomatic carotid artery stenosis have been difficult to establish because of the lack of evidence for factors influencing these patients' prognoses. However, preliminary evidence suggests that an alteration in. cerebral hemodynamic function may play a relevant role in the occurrence of stroke in patients with carotid artery disease. Objective To investigate the relationship between cerebrovascular reactivity to hypercapnia and cerebrovascular events in patients with severe unilateral asymptomatic carotid artery stenosis. Design and Setting Prospective, blinded longitudinal study conducted in an outpatient neurovascular department in Italy between June 1996 and April 1998, with a median follow-up of 28.5 months. Patients Ninety-four patients with asymptomatic carotid artery stenosis of at least 70% (74 men; mean age, 71 years). Main Outcome measures Subsequent occurrence of cerebral ischemic events (transient ischemic attack or stroke) or death, analyzed by cerebrovascular reactivity to hypercapnia (measured by transcranial Doppler ultrasonography and calculated by the breath-holding index values in the middle cerebral arteries). Results The overall annual rate for all ischemic events was 7.9%. Seventeen patients (18%) had ischemic events, all but 1 of which were ipsilateral to the carotid artery stenosis. Among factors considered, only lower breath-holding index values in the middle cerebral artery ipsilateral to carotid artery stenosis were significantly associated with the risk of an event (hazard ratio, 0.09; 95% confidence interval, 0.02-0.38; P=.001, by multivariate analysis). Based on data from previously studied healthy subjects, the cutoff of the breath-holding index for distinguishing between impaired and normal cerebrovascular reactivity was determined to be 0.69. Using this cutoff, the annual ipsilateral ischemic event risk was 4.1% in patients with normal and 13.9% in those with impaired breath-holding index values. Conclusions These results suggest a link between impaired cerebrovascular reactivity and the risk of ischemic events ipsilateral to severe asymptomatic carotid stenosis.	Univ Roma Tor Vergata, Osped S Eugenio, Neurol Clin, I-00144 Rome, Italy; IRCCS S Lucia, Rome, Italy; Osped Fatebenefratelli, Dipartimento Neurosci, AFaR CRCCS, Isola Tiberina, Italy	Sant'Eugenio Hospital; University of Rome Tor Vergata; IRCCS Santa Lucia	Silvestrini, M (corresponding author), Univ Roma Tor Vergata, Osped S Eugenio, Neurol Clin, P Umanesimo 10, I-00144 Rome, Italy.		Pasqualetti, Patrizio/D-4496-2013; Caltagirone, Carlo/B-4930-2013; Silvestrini, Mauro/AAB-3838-2019	Pasqualetti, Patrizio/0000-0001-5560-1979; troisi, elio/0000-0002-5171-0243				AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Barnett HJM, 1996, NEUROLOGY, V46, P603, DOI 10.1212/WNL.46.3.603; BARTELS E, 1996, NEUROSONOLOGY, P83; Biller J, 1998, STROKE, V29, P554, DOI 10.1161/01.STR.29.2.554; Chaturvedi S, 1998, NEUROLOGY, V50, P610, DOI 10.1212/WNL.50.3.610; DAHL A, 1992, STROKE, V23, P15, DOI 10.1161/01.STR.23.1.15; DEBRAY JM, 1995, CEREBROVASC DIS, V5, P414, DOI 10.1159/000107895; Derdeyn CP, 1999, NEUROLOGY, V53, P251, DOI 10.1212/WNL.53.2.251; GIFFORD RW, 1993, ARCH INTERN MED, V153, P154; GITELMAN DR, 1991, J CEREBR BLOOD F MET, V11, P1036, DOI 10.1038/jcbfm.1991.172; GORTLER M, 1994, J NEUROL, V241, P301, DOI 10.1007/BF00868437; Grubb RL, 1998, JAMA-J AM MED ASSOC, V280, P1055, DOI 10.1001/jama.280.12.1055; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Gur AY, 1996, STROKE, V27, P2188, DOI 10.1161/01.STR.27.12.2188; HEDERA P, 1995, EUR NEUROL, V35, P212, DOI 10.1159/000117130; HOBSON RW, 1993, NEW ENGL J MED, V328, P221, DOI 10.1056/NEJM199301283280401; KLEISER B, 1992, STROKE, V23, P171, DOI 10.1161/01.STR.23.2.171; KUWABARA Y, 1995, STROKE, V26, P1825, DOI 10.1161/01.STR.26.10.1825; Lanska DJ, 1997, NEUROLOGY, V48, P1481, DOI 10.1212/WNL.48.6.1481; MARKUS HS, 1992, STROKE, V23, P668, DOI 10.1161/01.STR.23.5.668; NORRIS JW, 1991, STROKE, V22, P1485, DOI 10.1161/01.STR.22.12.1485; POWERS WJ, 1991, ANN NEUROL, V29, P231, DOI 10.1002/ana.410290302; ROTHWELL PM, 1995, LANCET, V345, P209; Silvestrini M, 1999, ACTA NEUROL SCAND, V99, P187, DOI 10.1111/j.1600-0404.1999.tb07342.x; Silvestrini M, 1996, J CEREBR BLOOD F MET, V16, P746, DOI 10.1097/00004647-199607000-00027; Silvestrini M, 1996, STROKE, V27, P1970, DOI 10.1161/01.STR.27.11.1970; TOOLE JF, 1995, JAMA-J AM MED ASSOC, V274, P1505; Totaro R, 1999, CEREBROVASC DIS, V9, P142, DOI 10.1159/000015943; Vernieri F, 1999, STROKE, V30, P593, DOI 10.1161/01.STR.30.3.593; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; Warlow C, 1996, CEREBROVASC DIS, V6, P7, DOI 10.1159/000108066; WIDDER B, 1994, STROKE, V25, P1963, DOI 10.1161/01.STR.25.10.1963; World Health Organization, 1985, DIAB MELL REP WHO ST; Yamauchi H, 1996, J NEUROL NEUROSUR PS, V61, P18, DOI 10.1136/jnnp.61.1.18; YONAS H, 1993, J NEUROSURG, V79, P483, DOI 10.3171/jns.1993.79.4.0483	35	397	409	1	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2000	283	16					2122	2127		10.1001/jama.283.16.2122	http://dx.doi.org/10.1001/jama.283.16.2122			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	305MA	10791504				2022-12-24	WOS:000086542800028
J	Willinger, M; Ko, CW; Hoffman, HJ; Kessler, RC; Corwin, MJ				Willinger, M; Ko, CW; Hoffman, HJ; Kessler, RC; Corwin, MJ			Factors associated with caregivers' choice of infant sleep position, 1994-1998 - The National Infant Sleep Position Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DEATH-SYNDROME; RECEPTOR-BINDING; ARCUATE NUCLEUS; RISK; PREVALENCE; ENVIRONMENT; DECLINE	Context The success and simplicity of the 1994 national "Back to Sleep" campaign to reduce sudden infant death syndrome provides an opportunity to study which elements determine whether a behavior will change in the desired direction in response to a public health intervention. Objective To examine sociodemographic characteristics, motivation, and message exposure to ascertain which factors influenced a caregiver's choice of infant sleep position after implementation of the campaign. Design Annual nationally representative telephone surveys conducted between 1994 and 1998. Setting The 48 contiguous United States. Participants Nighttime caregivers of infants born within the 7 months prior to interview between 1994 and 1998. Approximately 1000 interviews were conducted each year. Main Outcome Measures The position the infant was usually placed in for sleep, sleep position recommendations received from specific sources, and reasons reported for position choice. Results Between 1994 and 1998, prone placement declined from 44% to 17% among white infants and from 53% to 32% among black infants. Supine placement increased from 27% to 58% among white infants and from 17% to 31% among black infants. During this period, reports of supine recommendations from at least 1 source doubled from 38% to 79%. From 1995 to 1998, 86% of caregivers who placed the infant prone reported receiving only nonprone recommendations. Infant comfort was given as a reason for prone placement by 82% of these caregivers. In multivariate analysis, physician recommendation of "supine not prone" had the strongest influence and was associated with decreased prone placement (odds ratio [OR], 0.25 [95% confidence interval {CI}, 0.16-0.39]) and increased supine placement (OR, 3.37 [95% CI, 2.38-4.76]). Recommendations from all 4 sources (the physician, neonatal nurse, reading materials, and radio/television) further increased the probability of supine placement (OR, 6.01 [95% CI, 4.57-7.90]). Other factors independently associated with increased prone and decreased supine placement included maternal black race, parity of more than 1, and living in a southern or mid-Atlantic state. Conclusions According to our study, as of 1998, approximately one fifth of infants were still placed prone, and only half were placed supine. Recommendations of supine placement during infancy by physicians at well-baby checks and by neonatal nursery staff and print and broadcast media have increased the proportion of infants placed supine. Caregiver beliefs regarding perceived advantages of prone sleeping should be addressed to attain further reduction in prone placement.	NICHHD, Ctr Res Mothers & Children, Pregnancy & Perinatol Branch, Bethesda, MD 20892 USA; Natl Inst Deafness & Other Commun Disorders, Epidemiol Stat & Data Syst Branch, Bethesda, MD USA; Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; Boston Univ, Sch Med, Boston Med Ctr, Dept Pediat, Boston, MA 02118 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Harvard University; Harvard Medical School; Boston Medical Center; Boston University	Willinger, M (corresponding author), NICHHD, Ctr Res Mothers & Children, Pregnancy & Perinatol Branch, Execut Bldg,Room 4B03,6100 Execut Blvd,MSC 7510, Bethesda, MD 20892 USA.	mw75q@nih.gov		Corwin, Michael/0000-0002-6591-209X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD029067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [Z01DC000051] Funding Source: NIH RePORTER; NICHD NIH HHS [HD-2-9067] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Brenner RA, 1998, JAMA-J AM MED ASSOC, V280, P341, DOI 10.1001/jama.280.4.341; CHIODINI BA, 1993, J PEDIATR-US, V123, P686, DOI 10.1016/S0022-3476(05)80841-8; DWYER T, 1995, JAMA-J AM MED ASSOC, V273, P783, DOI 10.1001/jama.273.10.783; ELDERS JM, 1994, JAMA-J AM MED ASSOC, V272, P1646, DOI 10.1001/jama.272.21.1646; Fleming PJ, 1996, BMJ-BRIT MED J, V313, P191, DOI 10.1136/bmj.313.7051.191; Franco P, 1998, J PEDIATR-US, V132, P240, DOI 10.1016/S0022-3476(98)70438-X; Hiley CMH, 1996, BRIT MED J, V312, P1397, DOI 10.1136/bmj.312.7043.1397a; Hosmer D.W., 2004, APPL LOGISTIC REGRES, VSecond; HOYERT DL, 1999, NATL VITAL STAT REP, V47, P88; Hunt L, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.1.e11; KATTWINKEL J, 1994, PEDIATRICS, V93, P820; KATTWINKEL J, 1992, PEDIATRICS, V89, P1120; Kattwinkel J, 1996, PEDIATRICS, V98, P1216; KEMP JS, 1993, J PEDIATR-US, V122, P874, DOI 10.1016/S0022-3476(09)90010-5; KINNEY HC, 1995, SCIENCE, V269, P1446, DOI 10.1126/science.7660131; Lesko SM, 1998, JAMA-J AM MED ASSOC, V280, P336, DOI 10.1001/jama.280.4.336; MITCHELL EA, 1994, ARCH DIS CHILD, V70, P291, DOI 10.1136/adc.70.4.291; Panigrahy A, 1997, J NEUROPATH EXP NEUR, V56, P1253, DOI 10.1097/00005072-199711000-00010; Platt MJ, 1996, ARCH DIS CHILD, V75, P527, DOI 10.1136/adc.75.6.527; PONSONBY AL, 1994, PREV MED, V23, P402, DOI 10.1006/pmed.1994.1055; PONSONBY AL, 1992, BRIT MED J, V304, P277, DOI 10.1136/bmj.304.6822.277; Ponsonby AL, 1997, PEDIATRICS, V99, pE31, DOI 10.1542/peds.99.1.e3; PONSONBY AL, 1995, ARCH DIS CHILD, V72, P204, DOI 10.1136/adc.72.3.204; SAS Institute Inc, 1990, SAS STAT US GUID VER, V4; SCHECHTMAN VL, 1992, PEDIATR RES, V31, P606, DOI 10.1203/00006450-199206000-00014; SCHECHTMAN VL, 1992, PEDIATRICS, V89, P865; Schechtman VL, 1996, PEDIATR RES, V40, P571, DOI 10.1203/00006450-199610000-00010; Skadberg BT, 1997, ARCH DIS CHILD, V76, P320, DOI 10.1136/adc.76.4.320; Ventura S J, 1998, Mon Vital Stat Rep, V46, P1; Wennergren G, 1997, ACTA PAEDIATR, V86, P963, DOI 10.1111/j.1651-2227.1997.tb15180.x; Williams SM, 1996, INT J EPIDEMIOL, V25, P366, DOI 10.1093/ije/25.2.366; Willinger M, 1998, JAMA-J AM MED ASSOC, V280, P329, DOI 10.1001/jama.280.4.329	32	143	144	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2000	283	16					2135	2142		10.1001/jama.283.16.2135	http://dx.doi.org/10.1001/jama.283.16.2135			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	305MA	10791506	Bronze			2022-12-24	WOS:000086542800030
J	Ober, CK				Ober, CK			Polymer science - Shape persistence of synthetic polymers	SCIENCE			English	Editorial Material							POLYELECTROLYTE		Cornell Univ, Dept Mat Sci, Ithaca, NY 14853 USA	Cornell University	Ober, CK (corresponding author), Cornell Univ, Dept Mat Sci, 327 Bard Hall, Ithaca, NY 14853 USA.		Ober, Christopher/AAI-1568-2019	Ober, Christopher/0000-0002-3805-3314				Brodowski G, 1996, MACROMOLECULES, V29, P6962, DOI 10.1021/ma960256i; Chen JT, 1996, SCIENCE, V273, P343, DOI 10.1126/science.273.5273.343; Gerle M, 1999, MACROMOLECULES, V32, P2629, DOI 10.1021/ma9816463; HERMANN W, 1997, MACROMOLECULES, V30, P4966; *MAX PLANCK I POL, 2000, SHAP PERS MACR CHEM; Philippova OE, 1998, MACROMOLECULES, V31, P1168, DOI 10.1021/ma970597b; Schluter AD, 2000, ANGEW CHEM INT EDIT, V39, P864, DOI 10.1002/(SICI)1521-3773(20000303)39:5<864::AID-ANIE864>3.0.CO;2-E; Smolenyak P, 1999, J AM CHEM SOC, V121, P8628, DOI 10.1021/ja991498b; WEGNER G, 1969, Z NATURFORSCH PT B, VB 24, P824; Wegner G, 2000, ACTA MATER, V48, P253, DOI 10.1016/S1359-6454(99)00298-0	10	38	38	3	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2000	288	5465					448	449		10.1126/science.288.5465.448	http://dx.doi.org/10.1126/science.288.5465.448			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10798980				2022-12-24	WOS:000086626000024
J	Turley, SJ; Inaba, K; Garrett, WS; Ebersold, M; Unternaehrer, J; Steinman, RM; Mellman, I				Turley, SJ; Inaba, K; Garrett, WS; Ebersold, M; Unternaehrer, J; Steinman, RM; Mellman, I			Transport of peptide-MHC class II complexes in developing dendritic cells	SCIENCE			English	Article							BONE-MARROW CULTURES; DEVELOPMENTAL REGULATION; B-LYMPHOCYTES; LARGE NUMBERS; T-CELLS; MOLECULES; ACCUMULATION; COMPARTMENT; GENERATION; LYSOSOMES	Major histocompatibility complex class II (MHC II) molecules capture peptides within the endocytic pathway to generate T cell receptor (TCR) ligands. Immature dendritic cells (DCs) sequester intact antigens in Lysosomes, processing and converting antigens into peptide-MHC II complexes upon induction of DC maturation. The complexes then accumulate in distinctive, nonlysosomal MHC II+ vesicles that appear to migrate to the cell surface. Although the vesicles exclude soluble lysosomal contents and antigen-processing machinery, many contain MHC I and B7 costimulatory molecules. After arrival at the cell surface, the MHC and costimulatory molecules remain clustered. Thus, transport of peptide-MHC II complexes by DCs not only accomplishes transfer from late endocytic compartments to the plasma membrane, but does so in a manner that selectively concentrates TCR ligands and costimulatory molecules for T cell contact.	Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, New Haven, CT 06520 USA; Yale Univ, Sch Med, Ludwig Inst Canc Res, Immunobiol Sect, New Haven, CT 06520 USA; Kyoto Univ, Grad Sch Biostudies, Immunobiol Lab, Kyoto 6068502, Japan; Rockefeller Univ, Cellular Physiol & Immunol Lab, Lab Cellular Immunol & Physiol, New York, NY 10021 USA	Ludwig Institute for Cancer Research; Yale University; Ludwig Institute for Cancer Research; Yale University; Kyoto University; Rockefeller University	Mellman, I (corresponding author), Yale Univ, Sch Med, Ludwig Inst Canc Res, Dept Cell Biol, 333 Cedar St,POB 208002, New Haven, CT 06520 USA.		Steinman, Ralph/F-7729-2012; Mellman, Ira/ABG-5896-2020	Garrett, Wendy/0000-0002-5092-0150; Unternaehrer-Hamm, Julia/0000-0001-5864-4704	NIAID NIH HHS [AI-34098, AI-39672, AI-13013] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039672, R37AI013013, R01AI013013, R01AI034098, R37AI034098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; CRESSWELL P, 1994, ANNU REV IMMUNOL, V12, P259, DOI 10.1146/annurev.immunol.12.1.259; GARRETT WR, UNPUB; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HARDING CV, 1992, J CELL BIOL, V119, P531, DOI 10.1083/jcb.119.3.531; Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; KLEIJMEER MJ, 1994, J INVEST DERMATOL, V103, P516, DOI 10.1111/1523-1747.ep12395666; Kleijmeer MJ, 1997, J CELL BIOL, V139, P639, DOI 10.1083/jcb.139.3.639; KORNFELD S, 1989, ANNU REV CELL BIOL, V5, P483, DOI 10.1146/annurev.cb.05.110189.002411; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Pierre P, 1997, NATURE, V388, P787, DOI 10.1038/42039; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rescigno M, 1998, P NATL ACAD SCI USA, V95, P5229, DOI 10.1073/pnas.95.9.5229; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SLOT JW, 1985, EUR J CELL BIOL, V38, P87; Stinchcombe JC, 1999, J CELL BIOL, V147, P1, DOI 10.1083/jcb.147.1.1; Talmor M, 1998, EUR J IMMUNOL, V28, P811, DOI 10.1002/(SICI)1521-4141(199803)28:03<811::AID-IMMU811>3.3.CO;2-J; UNTERMAEHRER J, UNPUB; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; Zhong GM, 1997, P NATL ACAD SCI USA, V94, P13856, DOI 10.1073/pnas.94.25.13856	28	384	395	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2000	288	5465					522	527		10.1126/science.288.5465.522	http://dx.doi.org/10.1126/science.288.5465.522			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775112				2022-12-24	WOS:000086626000047
J	Strick, TR; Croquette, V; Bensimon, D				Strick, TR; Croquette, V; Bensimon, D			Single-molecule analysis of DNA uncoiling by a type II topoisomerase	NATURE			English	Article							STEADY-STATE ANALYSIS; SUPERCOILED DNA; ATP HYDROLYSIS; DROSOPHILA-MELANOGASTER; DOUBLE HELIX; MECHANISM; ELASTICITY; TRANSPORT; TOPOLOGY	Type II DNA topoisomerases are ubiquitous ATP-dependent enzymes capable of transporting a DNA through a transient double-strand break in a second DNA segment(1). This enables them to untangle DNA(2-6) and relax the interwound supercoils (plectonemes) that arise in twisted DNA(7). In vivo, they are responsible for untangling replicated chromosomes and their absence at mitosis or meiosis ultimately causes cell death(8,9). Here we describe a micromanipulation experiment in which we follow in real time a single Drosophila melanogaster topoisomerase II acting on a linear DNA molecule which is mechanically stretched and supercoiled(10-13). By monitoring the DNA's extension in the presence of ATP, we directly observe the relaxation of two supercoils during a single catalytic turnover. By controlling the force pulling on the molecule, we determine the variation of the reaction rate with the applied stress. Finally, in the absence of ATP, we observe the clamping of a DNA crossover by a single topoisomerase on at least two different timescales (configurations). These results show that single molecule experiments are a powerful new tool for the study of topoisomerases.	Univ Paris 06, Ecole Normale Super, Lab Phys Stat, CNRS,UMR 8550, F-75231 Paris 05, France; Univ Paris 07, F-75231 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Strick, TR (corresponding author), Univ Paris 06, Ecole Normale Super, Lab Phys Stat, CNRS,UMR 8550, 24 Rue Lhomond, F-75231 Paris 05, France.		Strick, Terence R/J-1886-2012; Bensimon, David/E-7768-2015	Bensimon, David/0000-0003-1971-9907; Strick, Terence/0000-0003-1744-3679; Croquette, Vincent/0000-0003-1400-0039				Allemand JF, 1998, P NATL ACAD SCI USA, V95, P14152, DOI 10.1073/pnas.95.24.14152; Bouchiat C, 1998, PHYS REV LETT, V80, P1556, DOI 10.1103/PhysRevLett.80.1556; BROWN PO, 1979, SCIENCE, V206, P1081, DOI 10.1126/science.227059; FROELICHAMMON SJ, 1995, J BIOL CHEM, V270, P21429, DOI 10.1074/jbc.270.37.21429; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7299, DOI 10.1021/bi9729108; Harkins TT, 1998, BIOCHEMISTRY-US, V37, P7292, DOI 10.1021/bi9729099; HSIEH T, 1983, J BIOL CHEM, V258, P8413; Hua W, 1997, NATURE, V388, P390, DOI 10.1038/41118; ISHIDA R, 1994, J CELL BIOL, V126, P1341, DOI 10.1083/jcb.126.6.1341; Landau L., 1967, THEORY ELASTICITY; LIU LF, 1980, CELL, V19, P697, DOI 10.1016/S0092-8674(80)80046-8; Moroz JD, 1997, P NATL ACAD SCI USA, V94, P14418, DOI 10.1073/pnas.94.26.14418; OSHEROFF N, 1983, J BIOL CHEM, V258, P9536; ROCA J, 1993, J BIOL CHEM, V268, P14250; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Rybenkov VV, 1997, SCIENCE, V277, P690, DOI 10.1126/science.277.5326.690; Strick TR, 1998, P NATL ACAD SCI USA, V95, P10579, DOI 10.1073/pnas.95.18.10579; Strick TR, 1998, BIOPHYS J, V74, P2016, DOI 10.1016/S0006-3495(98)77908-1; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; UEMURA T, 1986, EMBO J, V5, P1003, DOI 10.1002/j.1460-2075.1986.tb04315.x; Visscher K, 1999, NATURE, V400, P184, DOI 10.1038/22146; Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; ZECHIEDRICH EL, 1990, EMBO J, V9, P4555, DOI 10.1002/j.1460-2075.1990.tb07908.x	25	275	283	1	56	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					901	904		10.1038/35009144	http://dx.doi.org/10.1038/35009144			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786800				2022-12-24	WOS:000086625000052
J	Ong, KKL; Ahmed, ML; Emmett, PM; Preece, MA; Dunger, DB				Ong, KKL; Ahmed, ML; Emmett, PM; Preece, MA; Dunger, DB		Avon Longitudinal Study Pregnancy	Association between postnatal catch-up growth and obesity in childhood: prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							PREGNANT-WOMEN; WEIGHT-GAIN; SOUTH-WEST; POPULATION; CHILDREN; INFANTS; ENGLAND; BIRTH; DIET	Objective To identify predictors of postnatal catch-up growth from birth to two years and its relation to size and obesity at five years. Design Regional prospective cohort study. Setting Avon longitudinal study of pregnancy and childhood, United Kingdom. Subjects 848 full term singletons from a 10% random sample of the Avon longitudinal study of pregnancy and childhood. Main outcome measures Maternal birth weight, prepregnancy weight pregnancy weight gain, height, smoking, and parity, and paternal height, Weight and length of infants at birth, two years, and five years expressed as standard deviation (SD) scores fr om the UK reference scores for 1990, Percentage fat mass and total fat mass (estimated from skinfolds) and waist circumference at five years. Results Size at birth was representative of die national reference. Overall, 30.7% (260 of 848) of infants showed a gain in SD score for weight greater than 0.67 SD scores between zero and two years, indicating clinically significant catch-up growth. These children had lower weight, length, and ponderal index at birth than other children, and were more often from primiparous pregnancies. They also had taller fathers than other children, and their mothers had lower birth weights and were more likely to smoke during pregnancy. Children who showed catch-up growth between zero and two years were heavier, taller, and fatter (body mass index, percentage body fat, and waist circumference) at five years than other children. Conclusions Tn this contemporary well nourished cohort, catch-up growth was predicted by factors relating to intrauterine restraint of fetal growth. Children who showed catch-up growth between zero and two years were fatter and had more central fat distribution at five years than other children. Mechanisms that signal and regulate early catch-up growth in the postnatal period may influence associations between small size at birth and risks for disease in adulthood.	Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; Univ Bristol, Unit Paediat & Perinatal Epidemiol, Bristol BS8 1TQ, Avon, England; Inst Child Hlth, Biochem Endocrinol & Metab Unit, London WC1N 1AH, England	University of Oxford; University of Bristol; University of London; University College London	Dunger, DB (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England.		Emmett, Pauline/AAL-6815-2021	Golding, Jean/0000-0003-2826-3307; Emmett, Pauline/0000-0003-1076-4779; Dunger, Professor David/0000-0002-2566-9304	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BROOK CGD, 1971, ARCH DIS CHILD, V46, P182, DOI 10.1136/adc.46.246.182; Casteels K, 1999, LANCET, V353, P1499, DOI 10.1016/S0140-6736(98)05817-6; Crowther NJ, 1998, DIABETOLOGIA, V41, P1163, DOI 10.1007/s001250051046; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Freedman DS, 1999, AM J CLIN NUTR, V69, P308; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Haig D, 1996, AM J REPROD IMMUNOL, V35, P226; Jennings BJ, 1999, FEBS LETT, V448, P4, DOI 10.1016/S0014-5793(99)00336-1; KARLBERG J, 1995, PEDIATR RES, V38, P733, DOI 10.1203/00006450-199511000-00017; Lucas A, 1999, BRIT MED J, V319, P245, DOI 10.1136/bmj.319.7204.245; OBRIEN PM, 1999, P 36 ROYAL COLL OBST; Ong KKL, 1999, J CLIN ENDOCR METAB, V84, P1145, DOI 10.1210/jc.84.3.1145; OUNSTED M, 1986, ANN HUM BIOL, V13, P143, DOI 10.1080/03014468600008281; OUNSTED M, 1975, LANCET, V1, P1393, DOI 10.1016/S0140-6736(75)92605-7; Reilly JJ, 1999, BRIT MED J, V319, P1039, DOI 10.1136/bmj.319.7216.1039; Rogers I, 1998, EUR J CLIN NUTR, V52, P251, DOI 10.1038/sj.ejcn.1600544; Rogers I, 1998, EUR J CLIN NUTR, V52, P246, DOI 10.1038/sj.ejcn.1600543; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Siri W E, 1993, Nutrition, V9, P480; Tanner J. M., 1994, Acta Medica Auxologica (Milan), V26, P7; Tanner J. M., 1986, HUMAN GROWTH, P167; TANNER JM, 1956, ARCH DIS CHILD, V31, P372, DOI 10.1136/adc.31.159.372; Vanhala M, 1998, BRIT MED J, V317, P319, DOI 10.1136/bmj.317.7154.319; Walton A, 1938, PROC R SOC SER B-BIO, V125, P311, DOI 10.1098/rspb.1938.0029; 1999, AVON LONGITUDINAL ST	25	1181	1244	0	68	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 8	2000	320	7240					967	971		10.1136/bmj.320.7240.967	http://dx.doi.org/10.1136/bmj.320.7240.967			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303XP	10753147	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000086453100020
J	Scott, JAG; Hall, AJ; Muyodi, C; Lowe, B; Ross, M; Chohan, B; Mandaliya, K; Getambu, E; Gleeson, F; Drobniewski, F; Marsh, K				Scott, JAG; Hall, AJ; Muyodi, C; Lowe, B; Ross, M; Chohan, B; Mandaliya, K; Getambu, E; Gleeson, F; Drobniewski, F; Marsh, K			Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya	LANCET			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; HUMAN-IMMUNODEFICIENCY-VIRUS; PULMONARY COMPLICATIONS; BACTERIAL PNEUMONIA; ETIOLOGY; ADMISSIONS; INFECTION; GUINEA	Background Despite a substantial disease burden, there is little descriptive epidemiology of acute pneumonia in sub-Saharan Africa. We did this study to define the aetiology of acute pneumonia, to estimate mortality at convalescence, and to analyse mortality risk-factors. Methods We studied 281 Kenyan adults who presented to two public hospitals (one urban and one rural) with acute radiologically confirmed pneumonia during 1994-96. We did blood and lung-aspirate cultures, mycobacterial cultures, serotype-specific pneumococcal antigen detection, and serology for viral and atypical agents. Findings Aetiology was defined in 182 (65%) patients. Streptococcus pneumoniae was the most common causative agent, being found in 129 (46%) cases; Mycobacterium tuberculosis was found in 26 (9%). Of 255 patients followed up for at least 3 weeks, 25 (10%) died at a median age of 33 years. In multivariate analyses, risk or protective factors for mortality were age (odds ratio 1.51 per decade [95% CI 1.04-2.19]), unemployment (4.42 [1.21-16.1]), visiting a traditional healer (5.26 [1.67-16.5]), visiting a pharmacy (0.30 [0.10-0.91]), heart rate (1.64 per 10 beats [1.24-2.16]), and herpes labialis (1.54 [2.22-107]). HIV-1 seropositivity, found in 52%, was not associated with mortality. Death or failure to recover after 3 weeks was more common in patients with pneumococci of intermediate resistance to benzylpenicillin, which comprised 28% of pneumococcal isolates, than in those infected with susceptible pneumococci (5.60 [1.33-23.6]). Interpretation We suggest that tuberculosis is a sufficiently common cause of acute pneumonia in Kenyan adults to justify routine sputum culture, and that treatment with benzylpenicillin remains appropriate for clinical failure due to M tuberculosis, intermediate-resistant pneumococci, and other bacterial pathogens. However, interventions restricted to hospital management will fail to decrease mortality associated with socioeconomic, educational, and behavioural factors.	London Sch Hyg & Trop Med, Infect Dis Epidemiol Unit, London WC1, England; Coast Prov Gen Hosp, Mombasa, Kenya; Royal Berkshire Hosp, Publ Hlth Lab, Reading RG1 5AN, Berks, England; Churchill Hosp, Dept Radiol, Oxford OX3 7LJ, England; Publ Hlth Lab Serv, Mycobacterium Reference Unit, London, England; Publ Hlth Lab Serv, Reg Ctr Mycobacteriol, London, England; Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England	University of London; London School of Hygiene & Tropical Medicine; Royal Berkshire Hospital; University of Oxford; Public Health England; Public Health England; University of Oxford	Scott, JAG (corresponding author), Wellcome Trust Res Labs, Kenya Med Res Inst, Ctr Geog Med Res Coast, POB 230, Kilifi, Kenya.	ascott@kilifi.mimcom.net			Wellcome Trust [061089, 081835] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ABOUYA YL, 1992, AM REV RESPIR DIS, V145, P617, DOI 10.1164/ajrccm/145.3.617; ADERAYE G, 1994, ETHIOPIAN MED J, V32, P115; ALLEN SC, 1984, THORAX, V39, P612, DOI 10.1136/thx.39.8.612; ANDREWS BE, 1987, Q J MED, V62, P195; AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; BATUNGWANAYO J, 1994, AM J RESP CRIT CARE, V149, P1591, DOI 10.1164/ajrccm.149.6.8004318; Daley CL, 1996, AM J RESP CRIT CARE, V154, P105, DOI 10.1164/ajrccm.154.1.8680664; DAVIDSON M, 1976, JAMA-J AM MED ASSOC, V235, P158, DOI 10.1001/jama.235.2.158; Drobniewski FA, 1998, METH MOL B, V101, P323, DOI 10.1385/0-89603-471-2:323; FANG GD, 1990, MEDICINE, V69, P307, DOI 10.1097/00005792-199009000-00004; FINE MJ, 1990, AM J MED, V88, pN1; HARRIES AD, 1990, TROP GEOGR MED, V42, P274; HIRSCHTICK RE, 1995, NEW ENGL J MED, V333, P845, DOI 10.1056/NEJM199509283331305; KAMANFU G, 1993, AM REV RESPIR DIS, V147, P658, DOI 10.1164/ajrccm/147.3.658; Klugman KP, 1996, J ANTIMICROB CHEMOTH, V38, P133, DOI 10.1093/jac/38.suppl_A.133; KoullaShiro S, 1996, TUBERCLE LUNG DIS, V77, P47, DOI 10.1016/S0962-8479(96)90075-1; LIND K, 1988, EPIDEMIOL INFECT, V101, P377, DOI 10.1017/S0950268800054327; MACFARLANE JT, 1979, THORAX, V34, P713, DOI 10.1136/thx.34.6.713; MACFARLANE JT, 1982, LANCET, V2, P255; Marston BJ, 1997, ARCH INTERN MED, V157, P1709, DOI 10.1001/archinte.157.15.1709; MUNDY LM, 1995, AM J RESP CRIT CARE, V152, P1309, DOI 10.1164/ajrccm.152.4.7551387; PALLARES R, 1995, NEW ENGL J MED, V333, P474, DOI 10.1056/NEJM199508243330802; Scott JAG, 1999, CHEST, V116, P1716, DOI 10.1378/chest.116.6.1716; Scott JAG, 1998, CLIN INFECT DIS, V27, P1442, DOI 10.1086/515013; Scott JAG, 1999, CLIN INFECT DIS, V28, P764, DOI 10.1086/515198; SHANN F, 1984, LANCET, V2, P537; Sofowora E O, 1973, Niger Med J, V3, P144; Sow O, 1996, THORAX, V51, P385, DOI 10.1136/thx.51.4.385; WALLACE RJ, 1978, AM J MED, V64, P87, DOI 10.1016/0002-9343(78)90182-1; WILLIAMS EH, 1986, J TROP MED HYG, V89, P193	30	138	140	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2000	355	9211					1225	1230		10.1016/S0140-6736(00)02089-4	http://dx.doi.org/10.1016/S0140-6736(00)02089-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770305				2022-12-24	WOS:000086448000012
J	Bianchi, E; Denti, S; Granata, A; Bossi, G; Geginat, J; Villa, A; Rogge, L; Pardi, R				Bianchi, E; Denti, S; Granata, A; Bossi, G; Geginat, J; Villa, A; Rogge, L; Pardi, R			Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity	NATURE			English	Article							COMPLEX; KINASE; CYTOSKELETAL; REQUIRES; SUBUNIT; SIGNALS	Integrin adhesion receptors transduce signals that control complex cell functions which require the regulation of gene expression, such as proliferation, differentiation and survival(1). Their intracellular domain has no catalytic function, indicating that interaction with other transducing molecules is crucial for integrin-mediated signalling. Here we have identified a protein that interacts with the cytoplasmic domain of the beta 2 subunit of the alpha L/beta 2 integrin LFA-1. This protein is JAB1 (Jun activation domain-binding protein 1), a coactivator of the c-Jun transcription factor(2). We found that JAB1 is present both in the nucleus and in the cytoplasm of cells and that a fraction of JAB1 colocalizes with LFA-1 at the cell membrane. LFA-1 engagement is followed by an increase of the nuclear pool of JAB1, paralleled by enhanced binding of c-Jun-containing AP-1 complexes to their DNA consensus site and increased transactivation of an AP-1-dependent promoter. We suggest that signalling through the LFA-1 integrin may affect c-Jun-driven transcription by regulating JAB1 nuclear localization. This represents a new pathway for integrin-dependent modulation of gene expression.	San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; Univ Milan Bicocca, Fac Med, MIA, I-20052 Monza, Italy; Roche Milano Ric, I-20132 Milan, Italy; Univ Vita Salute San Raffaele, I-20132 Milan, Italy	University of Oxford; University of Milano-Bicocca; Roche Holding; Vita-Salute San Raffaele University	Bianchi, E (corresponding author), San Raffaele Sci Inst, DIBIT, I-20132 Milan, Italy.		Villa, Antonello/B-4781-2012; Rogge, Lars/GYJ-6142-2022; Geginat, Jens/AAA-5818-2019	Geginat, Jens/0000-0003-4813-0384; Rogge, Lars/0000-0003-1262-9204; Villa, Antonello/0000-0002-3820-8072	Telethon [E.0492] Funding Source: Medline	Telethon(Fondazione Telethon)		Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Fabbri M, 1999, EMBO J, V18, P4915, DOI 10.1093/emboj/18.18.4915; Geginat J, 1999, J IMMUNOL, V162, P5085; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Leonard WJ, 1998, ANNU REV IMMUNOL, V16, P293, DOI 10.1146/annurev.immunol.16.1.293; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; MIYAMOTO S, 1995, J CELL BIOL, V131, P791, DOI 10.1083/jcb.131.3.791; PARDI R, 1995, J IMMUNOL, V155, P1252; RINCON M, 1994, EMBO J, V13, P4370, DOI 10.1002/j.1460-2075.1994.tb06757.x; Seeger M, 1998, FASEB J, V12, P469, DOI 10.1096/fasebj.12.6.469; SMEAL T, 1991, NATURE, V354, P494, DOI 10.1038/354494a0; TASSAN JP, 1994, J CELL BIOL, V127, P467, DOI 10.1083/jcb.127.2.467; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; TREMBLE P, 1995, J CELL BIOL, V129, P1707, DOI 10.1083/jcb.129.6.1707; Wei N, 1998, CURR BIOL, V8, P919, DOI 10.1016/S0960-9822(07)00372-7	21	180	188	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					617	+		10.1038/35007098	http://dx.doi.org/10.1038/35007098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766246				2022-12-24	WOS:000086400100057
J	LeVier, K; Phillips, RW; Grippe, VK; Roop, RM; Walker, GC				LeVier, K; Phillips, RW; Grippe, VK; Roop, RM; Walker, GC			Similar requirements of a plant symbiont and a mammalian pathogen for prolonged intracellular survival	SCIENCE			English	Article							BRUCELLA-ABORTUS; SYSTEM; MUTAGENESIS; VIRULENCE; SBMA; GENE	Brucella abortus, a mammalian pathogen, and Rhizobium meliloti, a phylogenetically related plant symbiont, establish chronic infections in their respective hosts. Here a highly conserved B, abortus homolog of the R, meliloti bacA gene, which encodes a putative cytoplasmic membrane transport protein required for symbiosis, was identified. An isogenic B, abortus bacA mutant exhibited decreased survival in macrophages and greatly accelerated clearance from experimentally infected mice compared to the virulent parental strain. Thus, the bacA gene product is critical for the maintenance of two very diverse host-bacterial relationships.	MIT, Dept Biol, Cambridge, MA 02139 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, Shreveport, LA 71130 USA	Massachusetts Institute of Technology (MIT); Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Walker, GC (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	gwalker@mit.edu		/0000-0001-7243-8261	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031030] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM31030] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baldwin C.L., 2002, INFEC AGENT, P255; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; DELEY J, 1987, INT J SYST BACTERIOL, V37, P35, DOI 10.1099/00207713-37-1-35; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Elzer PH, 1996, INFECT IMMUN, V64, P4838, DOI 10.1128/IAI.64.11.4838-4841.1996; *GENB, X73522 GENB; GLAZEBROOK J, 1993, GENE DEV, V7, P1485, DOI 10.1101/gad.7.8.1485; GRIPPE VK, UNPUB; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ichige A, 1997, J BACTERIOL, V179, P209, DOI 10.1128/jb.179.1.209-216.1997; LONG S, 1988, J BACTERIOL, V170, P4257, DOI 10.1128/jb.170.9.4257-4265.1988; Medzhitov R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI 10.1016/S0952-7915(98)80024-1; MELLOR RB, 1989, J EXP BOT, V40, P831, DOI 10.1093/jxb/40.8.831; MONTARAZ JA, 1986, INFECT IMMUN, V53, P245, DOI 10.1128/IAI.53.2.245-251.1986; Niner BM, 1998, SYMBIOSIS, V24, P51; PHILLIPS RA, UNPUB; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; SCHWEIZER HP, 1995, GENE, V158, P15, DOI 10.1016/0378-1119(95)00055-B; Sola-Landa A, 1998, MOL MICROBIOL, V29, P125, DOI 10.1046/j.1365-2958.1998.00913.x	20	139	147	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2000	287	5462					2492	2493		10.1126/science.287.5462.2492	http://dx.doi.org/10.1126/science.287.5462.2492			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741969				2022-12-24	WOS:000086202200046
J	Fuentes-Prior, P; Iwanaga, Y; Huber, R; Pagila, R; Rumennik, G; Seto, M; Morser, J; Light, DR; Bode, W				Fuentes-Prior, P; Iwanaga, Y; Huber, R; Pagila, R; Rumennik, G; Seto, M; Morser, J; Light, DR; Bode, W			Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex	NATURE			English	Article							RAY CRYSTAL-STRUCTURE; FACTOR-LIKE DOMAINS; EGF-LIKE DOMAIN; PROTEIN-C; MOLECULAR MECHANISMS; COFACTOR ACTIVITY; BINDING-SITE; COAGULATION; ACTIVATION; SURFACE	The serine proteinase alpha-thrombin causes blood clotting through proteolytic cleavage of fibrinogen and protease-activated receptors and amplifies its own generation by activating the essential clotting factors V and VIII1, Thrombomodulin(2), a transmembrane thrombin receptor with six contiguous epidermal growth factor-like domains (TME1-6), profoundly alters the substrate specificity of thrombin from pro- to anticoagulant by activating protein C (see, for example, reference 2). Activated protein C then deactivates the coagulation cascade by degrading activated factors V and VIII2. The thrombin-thrombomodulin complex inhibits fibrinolysis by activating the procarboxypeptidase thrombin-activatable fibrinolysis inhibitor(3). Here we present the 2.3 Angstrom crystal structure of human alpha-thrombin bound to the smallest thrombomodulin fragment required for full protein-C co-factor activity, TME456. The Y-shaped thrombomodulin fragment binds to thrombin's anion-binding exosite-I, preventing binding of procoagulant substrates. Thrombomodulin binding does not seem to induce marked allosteric structural rearrangements at the thrombin active site. Rather, docking of a protein C model to thrombin-TME456 indicates that TME45 may bind substrates in such a manner that their zymogen-activation cleavage sites are presented optimally to the unaltered thrombin active site.	Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany; Berlex Biosci, Richmond, CA 94804 USA	Max Planck Society	Fuentes-Prior, P (corresponding author), Max Planck Inst Biochem, Abt Strukturforsch, Klopferspitz 18A, D-82152 Martinsried, Germany.	fuentes@biochem.mpg.de; bode@biochem.mpg.de		Fuentes-Prior, Pablo/0000-0002-6618-3204				ADLER M, 1995, J BIOL CHEM, V270, P23366, DOI 10.1074/jbc.270.40.23366; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bajzar L, 1996, J BIOL CHEM, V271, P16603, DOI 10.1074/jbc.271.28.16603; Benitez BAS, 1997, J MOL BIOL, V273, P913, DOI 10.1006/jmbi.1997.1356; BODE W, 1992, PROTEIN SCI, V1, P426; BRUNGER GJ, 1993, XPLOR VERSION 3 1 SY; CAMPBELL ID, 1993, CURR OPIN STRUC BIOL, V3, P385, DOI 10.1016/S0959-440X(05)80111-3; CLARKE JH, 1993, J BIOL CHEM, V268, P6309; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DiCera E, 1997, CELL MOL LIFE SCI, V53, P701, DOI 10.1007/s000180050091; Downing AK, 1996, CELL, V85, P597, DOI 10.1016/S0092-8674(00)81259-3; ESMON CT, 1995, FASEB J, V9, P946, DOI 10.1096/fasebj.9.10.7615164; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; Gerlitz B, 1996, J BIOL CHEM, V271, P22285, DOI 10.1074/jbc.271.37.22285; GIBBS CS, 1995, NATURE, V378, P413, DOI 10.1038/378413a0; GLASER CB, 1992, J CLIN INVEST, V90, P2565, DOI 10.1172/JCI116151; GRINNELL BW, 1994, BIOCHEM J, V303, P929, DOI 10.1042/bj3030929; Hall SW, 1999, J BIOL CHEM, V274, P25510, DOI 10.1074/jbc.274.36.25510; HOGG PJ, 1992, J BIOL CHEM, V267, P703; Knobe KE, 1999, PROTEINS, V35, P218, DOI 10.1002/(SICI)1097-0134(19990501)35:2<218::AID-PROT8>3.0.CO;2-2; KUROSAWA S, 1988, J BIOL CHEM, V263, P5993; LESLIE AGW, 1991, CRYSTALLOGRAPHIC COM, V5, P27; Light DR, 1999, EUR J BIOCHEM, V262, P522, DOI 10.1046/j.1432-1327.1999.00398.x; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; Mather T, 1996, EMBO J, V15, P6822, DOI 10.1002/j.1460-2075.1996.tb01073.x; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P13547, DOI 10.1021/bi00250a006; MEININGER DP, 1995, PROTEIN SCI, V4, P1683, DOI 10.1002/pro.5560040904; MUSCI G, 1988, BIOCHEMISTRY-US, V27, P769, DOI 10.1021/bi00402a042; NAGASHIMA M, 1993, J BIOL CHEM, V268, P2888; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Parry MAA, 1998, NAT STRUCT BIOL, V5, P917, DOI 10.1038/2359; VINCENOT A, 1995, FEBS LETT, V367, P153, DOI 10.1016/0014-5793(95)00552-K; Vindigni A, 1997, BIOCHEMISTRY-US, V36, P6674, DOI 10.1021/bi962766a; Weisel JW, 1996, J BIOL CHEM, V271, P31485, DOI 10.1074/jbc.271.49.31485; YE J, 1991, J BIOL CHEM, V266, P23016; ZUSHI M, 1991, J BIOL CHEM, V266, P19886	37	259	288	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2000	404	6777					518	525		10.1038/35006683	http://dx.doi.org/10.1038/35006683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761923				2022-12-24	WOS:000086257700054
J	Harms, KE; Wright, SJ; Calderon, O; Hernandez, A; Herre, EA				Harms, KE; Wright, SJ; Calderon, O; Hernandez, A; Herre, EA			Pervasive density-dependent recruitment enhances seedling diversity in a tropical forest	NATURE			English	Article							JANZEN-CONNELL MODEL; NEOTROPICAL FOREST; TREE; SPECIFICITY; HERBIVORY; SURVIVAL; DISTANCE	Negative density-dependent recruitment of seedlings, that is, seeds of a given species are less likely to become established seedlings if the density of that species is high, has been proposed to be an important mechanism contributing to the extraordinary diversity of tropical tree communities(1-3) because it can potentially prevent any particular species from usurping all available space, either in close proximity to seed sources or at relatively larger spatial scales(1-18). However, density-dependent recruitment does not necessarily enhance community diversity(14). Furthermore, although density-dependent effects have been found at some life stages in some species(3-13), no study has shown that density-dependent recruitment affects community diversity(14,15). Here we report the results of observations in a lowland, moist forest in the Republic of Panama in which the species identities of 386,027 seeds that arrived at 200 seed traps were compared with the species identities of 13,068 seedlings that recruited into adjacent plots over a 4-year period. Across the 200 sites, recruit seedling diversity was significantly higher than seed diversity. Part of this difference was explained by interspecies differences in average recruitment success. Even after accounting for these differences, however, negative density-dependent recruitment contributes significantly to the increase in diversity from Seeds to seedling recruits.	Smithsonian Trop Res Inst, Balboa, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute	Wright, SJ (corresponding author), Smithsonian Trop Res Inst, Apartado 2072, Balboa, Panama.	wrightj@tivoli.si.edu	Wright, Stuart Joseph/M-3311-2013	Wright, Stuart Joseph/0000-0003-4260-5676				AUGSPURGER CK, 1984, ECOLOGY, V65, P1705, DOI 10.2307/1937766; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; Coley P.D., 1991, PLANT ANIMAL INTERAC, P25; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 1996, J TROP ECOL, V12, P231, DOI 10.1017/S0266467400009433; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; CONNELL J H, 1971, P298; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; HAMMERSTEIN B, 1995, CD-ROM PROF, V8, P76; Hammond D. S., 1998, Dynamics of tropical communities : the 37th symposium of the British Ecological Society, Cambridge University, 1996., P51; HOWE HF, 1990, J TROP ECOL, V6, P259, DOI 10.1017/S0266467400004508; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; HUBBELL SP, 1990, PHILOS T R SOC B, V330, P269, DOI 10.1098/rstb.1990.0198; HUBBELL SP, 1980, OIKOS, V35, P214, DOI 10.2307/3544429; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; JANZEN DH, 1980, J ECOL, V68, P929, DOI 10.2307/2259466; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Leigh E. G., 1999, TROPICAL FOREST ECOL; Ridley H., 1930, J ECOL, DOI DOI 10.2307/2255951; SCHUPP EW, 1992, AM NAT, V140, P526, DOI 10.1086/285426; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; Wills C, 1999, P ROY SOC B-BIOL SCI, V266, P1445, DOI 10.1098/rspb.1999.0799; Wright SJ, 1999, HANDBOOK OF FUNCTIONAL PLANT ECOLOGY, P449; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.1890/0012-9658(1999)080[1632:TENOSO]2.0.CO;2	27	720	808	8	280	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 30	2000	404	6777					493	495		10.1038/35006630	http://dx.doi.org/10.1038/35006630			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761916				2022-12-24	WOS:000086257700047
J	Brenner, S				Brenner, S			Genomics - The end of the beginning	SCIENCE			English	Editorial Material									Inst Mol Sci, Berkeley, CA 94704 USA	The Molecular Sciences Institute	Brenner, S (corresponding author), Inst Mol Sci, Berkeley, CA 94704 USA.	brenner@molsci.org						Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204	3	34	34	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2173	2174		10.1126/science.287.5461.2173	http://dx.doi.org/10.1126/science.287.5461.2173			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10744539				2022-12-24	WOS:000086049100028
J	Chen, P; Luo, C; Deng, YL; Ryan, K; Register, J; Margosiak, S; Tempczyk-Russell, A; Nguyen, B; Myers, P; Lundgren, K; Kan, CC; O'Connor, PM				Chen, P; Luo, C; Deng, YL; Ryan, K; Register, J; Margosiak, S; Tempczyk-Russell, A; Nguyen, B; Myers, P; Lundgren, K; Kan, CC; O'Connor, PM			The 1.7 angstrom crystal structure of human cell cycle checkpoint kinase Chk1: Implications for Chk1 regulation	CELL			English	Article							DNA-DAMAGE CHECKPOINT; DEPENDENT PROTEIN-KINASE; REPLICATION CHECKPOINT; TYROSINE KINASE; FISSION YEAST; PEPTIDE SUBSTRATE; CATALYTIC SUBUNIT; PHOSPHORYLATION; ACTIVATION; CDC2	The checkpoint kinase Chk1 is an important mediator of cell cycle arrest following DNA damage. The 1.7 Angstrom resolution crystal structures of the human Chk1 kinase domain and its binary complex with an ATP analog has revealed an identical open kinase conformation. The secondary structure and side chain interactions stabilize the activation loop of Chk1 and enable kinase activity without phosphorylation of the catalytic domain. Molecular modeling of the interaction of a Cdc25C peptide with Chk1 has uncovered several conserved residues that are important for substrate selectivity. In addition, we found that the less conserved C-terminal region negatively impacts Chk1 kinase activity.	Agouron Pharmaceut Inc, San Diego, CA 92121 USA	Pfizer	Chen, P (corresponding author), Agouron Pharmaceut Inc, 3565 Gen Atom Court, San Diego, CA 92121 USA.							Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1992, XPLOR V3 1 SYSTEM XR; Chen P, 1999, ONCOGENE, V18, P249, DOI 10.1038/sj.onc.1202257; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Esashi F, 1999, MOL CELL, V4, P167, DOI 10.1016/S1097-2765(00)80364-0; FAN SJ, 1995, CANCER RES, V55, P1649; Francesconi S, 1997, EMBO J, V16, P1332, DOI 10.1093/emboj/16.6.1332; FUREY W, 1990, AM CRYSTALLOGR ASS 2, V18, P73; GRAVES PR, 2000, IN PRESS J BIOL CHEM; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; HOFFMANN I, 1993, EMBO J, V12, P53, DOI 10.1002/j.1460-2075.1993.tb05631.x; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; JONES TA, 1978, J APPL CRYSTALLOGR, V11, P268, DOI 10.1107/S0021889878013308; Kaneko Y, 1999, ONCOGENE, V18, P3673, DOI 10.1038/sj.onc.1202706; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KREK W, 1991, EMBO J, V10, P3331, DOI 10.1002/j.1460-2075.1991.tb04897.x; Kumagai A, 1998, J CELL BIOL, V142, P1559, DOI 10.1083/jcb.142.6.1559; LEE YY, 1992, APPL BIOCHEM BIOTECH, V34-5, P3, DOI 10.1007/BF02920529; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Lowe ED, 1997, EMBO J, V16, P6646, DOI 10.1093/emboj/16.22.6646; Martinho RG, 1998, EMBO J, V17, P7239, DOI 10.1093/emboj/17.24.7239; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Mayans O, 1998, NATURE, V395, P863, DOI 10.1038/27603; McRee DE, 1992, J MOL GRAPHICS, V10, P44, DOI DOI 10.1016/0263-7855(92)80022-6; MILLAR JBA, 1991, P NATL ACAD SCI USA, V88, P10500, DOI 10.1073/pnas.88.23.10500; MURRAY AW, 1992, NATURE, V359, P599, DOI 10.1038/359599a0; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; O'Connor P M, 1996, Prog Cell Cycle Res, V2, P165; OConnell MJ, 1997, EMBO J, V16, P545, DOI 10.1093/emboj/16.3.545; OConnor PM, 1997, CANCER SURV, V29, P151; Otwinowski Z., 1993, P CCP4 STUD WEEK DAT, P56; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Poon RYC, 1996, J BIOL CHEM, V271, P13283, DOI 10.1074/jbc.271.22.13283; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rhind N, 1997, GENE DEV, V11, P504, DOI 10.1101/gad.11.4.504; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sanchez Y, 1999, SCIENCE, V286, P1166, DOI 10.1126/science.286.5442.1166; Sarkaria JN, 1999, CANCER RES, V59, P4375; Suganuma M, 1999, CANCER RES, V59, P5887; TAYLOR SS, 1995, FASEB J, V9, P1255, DOI 10.1096/fasebj.9.13.7557015; WALWORTH N, 1993, NATURE, V363, P368, DOI 10.1038/363368a0; Walworth NC, 1996, SCIENCE, V271, P353, DOI 10.1126/science.271.5247.353; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Zeng Y, 1998, NATURE, V395, P507, DOI 10.1038/26766	59	176	186	0	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 17	2000	100	6					681	692		10.1016/S0092-8674(00)80704-7	http://dx.doi.org/10.1016/S0092-8674(00)80704-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761933	Bronze			2022-12-24	WOS:000085983800010
J	Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH				Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH			Using the Framingham model to predict heart disease in the United Kingdom: retrospective study	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-DISEASE		N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England; N Staffordshire Hosp, Dept Epidemiol, Stoke On Trent ST4 7PA, Staffs, England; Univ Newcastle Upon Tyne, Dept Stat, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Royal Free Hosp, Dept Endocrinol, London NW3 2QG, England	Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust; Newcastle University - UK; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Neary, RH (corresponding author), N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England.							ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; CHAMBLESS LE, 1990, STAT MED, V9, P385, DOI 10.1002/sim.4780090410; KANNEL WB, 1993, CARDIOLOGY, V82, P137, DOI 10.1159/000175864; Ramsay LE, 1996, LANCET, V348, P387, DOI 10.1016/S0140-6736(96)05516-X; Vanderpump MPJ, 1996, THYROID, V6, P155	5	73	78	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					676	677		10.1136/bmj.320.7236.676	http://dx.doi.org/10.1136/bmj.320.7236.676			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710574	Bronze, Green Published, Green Submitted			2022-12-24	WOS:000085895300018
J	Thomas, SL; Ellertson, C				Thomas, SL; Ellertson, C			Nuisance or natural and healthy: should monthly menstruation be optional for women?	LANCET			English	Article									Populat Council, Latin Amer & Caribbean Reg Off, Mexico City 04000, DF, Mexico		Ellertson, C (corresponding author), Populat Council, Latin Amer & Caribbean Reg Off, Escondrida 110,Col Villa Coyoacan, Mexico City 04000, DF, Mexico.							Beral V, 1999, BRIT MED J, V318, P96, DOI 10.1136/bmj.318.7176.96; COUTINHO EM, 1999, REPROD MED MILLENNIU; COUTINHO EM, 1996, IS MENSTRUATION OBSO; EATON SB, 1994, Q REV BIOL, V69, P353, DOI 10.1086/418650; Kjerulff KH, 1996, AM J PUBLIC HEALTH, V86, P195, DOI 10.2105/AJPH.86.2.195; LOUDON NB, 1977, BRIT MED J, V2, P487, DOI 10.1136/bmj.2.6085.487; Sulak PJ, 1997, OBSTET GYNECOL, V89, P179, DOI 10.1016/S0029-7844(96)00488-7; World Health Organization, 1996, IMPR ACC QUAL CAR FA	8	114	125	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					922	924		10.1016/S0140-6736(99)11159-0	http://dx.doi.org/10.1016/S0140-6736(99)11159-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752720				2022-12-24	WOS:000085896000043
J	Cheng, T; Rodrigues, N; Shen, HM; Yang, YG; Dombkowski, D; Sykes, M; Scadden, DT				Cheng, T; Rodrigues, N; Shen, HM; Yang, YG; Dombkowski, D; Sykes, M; Scadden, DT			Hematopoietic stem cell quiescence maintained by p21(cip1/waf1)	SCIENCE			English	Article							IN-VITRO; CDK INHIBITORS; MICE; TRANSPLANTATION; CYCLE; MOUSE; DIFFERENTIATION; CAPACITY; 5-FLUOROURACIL; CHEMOTHERAPY	Relative quiescence is a defining characteristic of hematopoietic stem cells, while their progeny have dramatic proliferative ability and inexorably move toward terminal differentiation. The quiescence of stem cells has been conjectured to be of critical biologic importance in protecting the stem cell compartment, which we directly assessed using mice engineered to be deficient in the G(1) checkpoint regulator, cyclin-dependent kinase inhibitor, p21(cip1/waf1) (p21). In the absence of p21, hematopoietic stem cell proliferation and absolute number were increased under normal homeostatic conditions. Exposing the animals to cell cycle-specific myelotoxic injury resulted in premature death due to hematopoietic cell depletion. Further, self-renewal of primitive cells was impaired in serially transplanted bone marrow from p21(-/-) mice, leading to hematopoietic failure. Therefore, p21 is the molecular switch governing the entry of stem cells into the cell cycle, and in its absence, increased cell cycling leads to stem cell exhaustion. Under conditions of stress, restricted cell cycling is crucial to prevent premature stem cell depletion and hematopoietic death.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, Boston, MA 02129 USA; Massachusetts Gen Hosp, Ctr Canc, AIDS Res Ctr, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Scadden, DT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Transplantat Biol Res Ctr, 149 13th St,Room 5212, Boston, MA 02129 USA.	scadden.david@mgh.harvard.edu		Cheng, Tao/0000-0002-5925-2769; Rodrigues, Neil/0000-0002-1925-7733; Yang, Yong-Guang/0000-0003-4985-1247	NHLBI NIH HHS [HL44851] Funding Source: Medline; NIAID NIH HHS [AI07387] Funding Source: Medline; NIDDK NIH HHS [DK50234] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK050234] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BERARDI AC, 1995, SCIENCE, V267, P104, DOI 10.1126/science.7528940; Braun SE, 1998, BLOOD CELL MOL DIS, V24, P138, DOI 10.1006/bcmd.1998.0181; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Dao MA, 1998, EXP HEMATOL, V26, P687; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Drize NJ, 1996, BLOOD, V88, P2927, DOI 10.1182/blood.V88.8.2927.bloodjournal8882927; Gardner RV, 1997, EXP HEMATOL, V25, P495; Gothot A, 1997, BLOOD, V90, P4384, DOI 10.1182/blood.V90.11.4384.4384_4384_4393; Gothot A, 1998, EXP HEMATOL, V26, P562; GRZEGORZEWSKI K, 1994, J EXP MED, V180, P1047, DOI 10.1084/jem.180.3.1047; HARRISON DE, 1980, BLOOD, V55, P77; HARRISON DE, 1990, J EXP MED, V172, P431, DOI 10.1084/jem.172.2.431; HARRISON DE, 1978, J EXP MED, V147, P1526, DOI 10.1084/jem.147.5.1526; HARRISON DE, 1982, J EXP MED, V156, P1767, DOI 10.1084/jem.156.6.1767; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; LaBaer J, 1997, GENE DEV, V11, P847, DOI 10.1101/gad.11.7.847; LERNER C, 1990, EXP HEMATOL, V18, P114; Mantel C, 1996, BLOOD, V88, P3710, DOI 10.1182/blood.V88.10.3710.bloodjournal88103710; MAUCH P, 1989, BONE MARROW TRANSPL, V4, P601; MAUCH P, 1995, INT J RADIAT ONCOL, V31, P1319, DOI 10.1016/0360-3016(94)00430-S; MULLER AM, 1993, DEVELOPMENT, V118, P1343; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; NAKANISHI M, 1995, P NATL ACAD SCI USA, V92, P4352, DOI 10.1073/pnas.92.10.4352; OGAWA M, 1993, BLOOD, V81, P2844; PLOEMACHER RE, 1989, BLOOD, V74, P2755; PLOEMACHER RE, 1991, BLOOD, V78, P2527; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Taniguchi T, 1999, BLOOD, V93, P4167, DOI 10.1182/blood.V93.12.4167.412k05_4167_4178; UCHIDA N, 1994, BLOOD, V83, P3758; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; WOLF NS, 1993, EXP HEMATOL, V21, P614; Yaroslavskiy B, 1999, BLOOD, V93, P2907; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	35	981	1041	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1804	1808		10.1126/science.287.5459.1804	http://dx.doi.org/10.1126/science.287.5459.1804			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710306				2022-12-24	WOS:000085775300038
J	Weinrich, M; Stuart, M				Weinrich, M; Stuart, M			Provision of methadone treatment in primary care medical practices - Review of the Scottish experience and implications for US policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							GENERAL-PRACTITIONERS; MAINTENANCE TREATMENT; OUTCOMES	Context Under new proposed regulations, US physicians outside of traditional methadone clinics could prescribe methadone to patients with opioid dependence. No large-scale evaluations of US programs in which methadone maintenance is provided by primary care physicians are available, but primary care physicians in Scotland have participated in such programs on a large scale. Objective To review the history, operation, and outcome data on the efficacy and safety of 2 Scottish primary care-based opioid agonist treatment programs to derive lessons for the US context. Design and Setting Naturalistic study of programs in Edinburgh and Glasgow, Scotland, with data obtained through site visits and interviews conducted in 1996 and 1998, as well as from published reports and retrospective analysis of electronic databases. Main Outcome Measures Proportions of injection drug users who were enrolled in the methadone maintenance programs, average methadone doses in the pro grams, and methadone-related deaths. Results A total of 60% to 80% of injection drug users in Edinburgh and 41% to 73% of those in Glasgow were enrolled in methadone maintenance in 1998-1999, Dose levels are consistent with US recommendations (for Edinburgh in 1998, 61 mg; for Glasgow in 1994-1996, 54 mg). The Glasgow program required supervised consumption of methadone in community pharmacies for the first year and experienced significantly fewer methadone-related deaths than Edinburgh in 1997 (17 vs 30 deaths; P<.0001). Programs in both Edinburgh and Glasgow provided support to primary care physicians and achieved levels of general practitioner participation of 59% (1998) and 30% (1999), respectively. Conclusions The Scottish experience indicates that prescription of methadone in office-based settings can expand access to an important treatment modality. Primary care physicians safely prescribed methadone for maintenance treatment when provided with adequate support. Diversion of methadone was minimized by requiring supervised consumption in community pharmacies.	Univ Maryland, Dept Neurol, Baltimore, MD 21201 USA; Univ Maryland Baltimore Cty, Dept Sociol & Anthropol, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore County	Weinrich, M (corresponding author), NICHHD, Natl Ctr Med Rehabil Res, NIH, 6100 Execut Blvd,Room 2A03,MSC 7510, Bethesda, MD 20892 USA.	mw287k@nih.gov						[Anonymous], 1995, FEDERAL REGULATION M; Bach PB, 1999, AM J PUBLIC HEALTH, V89, P662, DOI 10.2105/AJPH.89.5.662; Blendon RJ, 1998, JAMA-J AM MED ASSOC, V279, P827, DOI 10.1001/jama.279.11.827; BURY J, 1998, SUPPORTING PRACTICES; BURY J, 1995, INT J DRUG POLICY, V6, P267; Christian J, 1999, DRUG ALCOHOL DEPEN, V55, P265, DOI 10.1016/S0376-8716(99)00021-6; COLE SK, 1998, DRUG RELATED DEATHS; *COMM DRUG PROBL S, 1998, AUD DAT APR 1997 MAR; Conrad DA, 1998, JAMA-J AM MED ASSOC, V279, P853, DOI 10.1001/jama.279.11.853; Cooper GAA, 1999, MED SCI LAW, V39, P233, DOI 10.1177/002580249903900308; DAUNNO T, 1992, JAMA-J AM MED ASSOC, V267, P253, DOI 10.1001/jama.267.2.253; Deehan A, 1997, BRIT J GEN PRACT, V47, P705; DEMARIA PA, 1995, POSTGRAD MED, V97, P83, DOI 10.1080/00325481.1995.11945971; *DEP HLTH, 1995, TACKL DRUGS STRAT EN; *DEP HLTH, 1998, TACKL DRUGS BUILD BR; *DEP HLTH SCOTT OF, 1999, DRUG MIS DEP GUID CL; DESMOND DP, 1997, EFFECTIVE MED TREATM; DuPont RL, 1996, SUBST USE MISUSE, V31, P1929, DOI 10.3109/10826089609066439; EGERTSON JA, 1997, TREATING DRUG USERS; ETHERIDGE RM, 1997, EFFECTIVE MED TREATM; Gerada C, 1999, BRIT J GEN PRACT, V49, P125; GLANZ A, 1986, BRIT MED J, V293, P486, DOI 10.1136/bmj.293.6545.486; *GREAT GLASG DRUG, 1998, GETT GRIPS DRUGS GRE; *GREAT GLASG HLTH, 1999, GUID GREAT GLASG GP; GREENWOOD J, 1992, BRIT J ADDICT, V87, P567; GREENWOOD J, 1990, BRIT MED J, V300, P587, DOI 10.1136/bmj.300.6724.587; GREENWOOD J, 1996, PSYCHIAT B, V20, P8; GREENWOOD J, 1994, LOTHIAN COMMUNITY DR; Gruer L, 1997, BMJ-BRIT MED J, V314, P1730, DOI 10.1136/bmj.314.7096.1730; JAFFE JH, 1997, EFFECTIVE MED TREATM; Lewis DC, 1996, J ADDICT DIS, V15, P1, DOI 10.1300/J069v15n01_01; LEWIS DC, 1997, EFFECTIVE MED TREATM; MacGowan RJ, 1996, J PSYCHOACTIVE DRUGS, V28, P259, DOI 10.1080/02791072.1996.10472487; Martin E, 1998, BRIT J GEN PRACT, V48, P1679; Massing M., 1998, THE FIX; McCarty D, 1999, MILBANK Q, V77, P341, DOI 10.1111/1468-0009.00139; MCCLELLAN AT, 1997, TREATING DRUG USERS, P7; McLellan AT, 1996, MILBANK Q, V74, P51, DOI 10.2307/3350433; NELSON H, 1996, TREATING DRUG USERS; NOVICK DM, 1994, J GEN INTERN MED, V9, P127, DOI 10.1007/BF02600025; OCONNOR PG, 1995, J GEN INTERN MED, V10, P255, DOI 10.1007/BF02599882; *OFF NAT DRUG AB P, 1999, ROAD AHEA CONS DOC O; PAYTE JY, 1997, EFFECTIVE MED TREATM; PETERS A, 1994, AUDIT EVALUATION COM; *PRIM CAR FACT TEA, 1996, MAN DRUG US GEN PRAC; Reinhardt UE, 1999, JAMA-J AM MED ASSOC, V281, P462, DOI 10.1001/jama.281.5.462; ROSENBAUM M, 1995, J PSYCHOACTIVE DRUGS, V27, P145, DOI 10.1080/02791072.1995.10471683; SIMON D, 1997, CORNER; Stuart ME, 1998, MILBANK Q, V76, P251, DOI 10.1111/1468-0009.00088; UMBRICHTSCHNEITER A, 1994, AM J PUBLIC HEALTH, V84, P207, DOI 10.2105/AJPH.84.2.207; *US DHHS, 1999, DRUG ABU WARN NETW; *US DHHS, 1999, FED REG         0722, V64, P39810; WILSON P, 1994, BRIT MED J, V309, P641, DOI 10.1136/bmj.309.6955.641; 1998, JAMA, V280, P1936, DOI DOI 10.1001/JAMA.280.22.1936	54	52	53	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2000	283	10					1343	1348		10.1001/jama.283.10.1343	http://dx.doi.org/10.1001/jama.283.10.1343			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	289ND	10714738				2022-12-24	WOS:000085628100035
J	Farr, GW; Furtak, K; Rowland, MB; Ranson, NA; Saibil, HR; Kirchhausen, T; Horwich, AL				Farr, GW; Furtak, K; Rowland, MB; Ranson, NA; Saibil, HR; Kirchhausen, T; Horwich, AL			Multivalent binding of nonnative substrate proteins by the chaperonin GroEL	CELL			English	Article							CRYSTAL-STRUCTURE; FOLDING REACTION; MECHANISM; POLYPEPTIDE; RELEASE; ATP	The chaperonin GroEL binds nonnative substrate protein in the central cavity of an open ring through exposed hydrophobic residues at the inside aspect of the apical domains and then mediates productive folding upon binding ATP and the cochaperonin GroES. Whether nonnative proteins bind to more than one of the seven apical domains of a GroEL ring is unknown. We have addressed this using rings with various combinations of wild-type and binding-defective mutant apical domains, enabled by their production as single polypeptides. A wild-type extent of binary complex formation with two stringent substrate proteins, malate dehydrogenase or Rubisco, required a minimum of three consecutive binding-proficient apical domains. Rhodanese, a less-stringent substrate, required only two wild-type domains and was insensitive to their arrangement. As a physical correlate, multivalent binding of Rubisco was directly observed in an oxidative cross-linking experiment.	Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Univ London Birkbeck Coll, Dept Crystallog, London WC1E 7HX, England; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA	Howard Hughes Medical Institute; Yale University; Yale University; University of London; Birkbeck University London; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Horwich, AL (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.			Ranson, Neil/0000-0002-3640-5275				BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BURNETT BP, 1994, J BACTERIOL, V176, P6980, DOI 10.1128/JB.176.22.6980-6985.1994; CAREAGA CL, 1992, J MOL BIOL, V226, P1219, DOI 10.1016/0022-2836(92)91063-U; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Fenton WA, 1997, PROTEIN SCI, V6, P743; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HLODAN R, 1995, NAT STRUCT BIOL, V2, P587, DOI 10.1038/nsb0795-587; Horovitz A, 1998, CURR OPIN STRUC BIOL, V8, P93, DOI 10.1016/S0959-440X(98)80015-8; HORWICH AL, 1993, CELL, V74, P909, DOI 10.1016/0092-8674(93)90470-B; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Ranson NA, 1997, J MOL BIOL, V266, P656, DOI 10.1006/jmbi.1996.0815; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; SCHMIDT M, 1994, J BIOL CHEM, V269, P10304; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; Sigler PB, 1998, ANNU REV BIOCHEM, V67, P581, DOI 10.1146/annurev.biochem.67.1.581; Sparrer H, 1997, J BIOL CHEM, V272, P14080, DOI 10.1074/jbc.272.22.14080; Todd MJ, 1996, P NATL ACAD SCI USA, V93, P4030, DOI 10.1073/pnas.93.9.4030; Walter S, 1996, P NATL ACAD SCI USA, V93, P9425, DOI 10.1073/pnas.93.18.9425; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zahn R, 1996, SCIENCE, V271, P642, DOI 10.1126/science.271.5249.642	28	153	158	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 3	2000	100	5					561	573		10.1016/S0092-8674(00)80692-3	http://dx.doi.org/10.1016/S0092-8674(00)80692-3			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721993	Bronze			2022-12-24	WOS:000085700000009
J	Yang, A; Walker, N; Bronson, R; Kaghad, M; Oosterwegel, M; Bonnin, J; Vagner, C; Bonnet, H; Dikkes, P; Sharpe, A; McKeon, F; Caput, D				Yang, A; Walker, N; Bronson, R; Kaghad, M; Oosterwegel, M; Bonnin, J; Vagner, C; Bonnet, H; Dikkes, P; Sharpe, A; McKeon, F; Caput, D			p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours	NATURE			English	Article							DENTATE GYRUS; P53; REELER; RECEPTORS; MAMMALS; MOUSE; ORGANIZATION; FAMILY; CELLS; DEATH	p73 (ref. 1) has high homology with the tumour suppressor p53 (refs 2-4), as well as with p63, a gene implicated in the maintenance of epithelial stem cells(5-7). Despite the localization of the p73 gene to chromosome 1p36.3, a region of frequent aberration in a wide range of human cancers(1), and the ability of p73 to transactivate p53 target genes(1), it is unclear whether p73 functions as a tumour suppressor. Here we show that mice functionally deficient for all p73 isoforms exhibit profound defects, including hippocampal dysgenesis, hydrocephalus, chronic infections and inflammation, as well as abnormalities in pheromone sensory pathways. In contrast to p53-deficient mice, however, those lacking p73 show no increased susceptibility to spontaneous tumorigenesis. We report the mechanistic basis of the hippocampal dysgenesis and the loss of pheromone responses, and show that new,potentially dominant-negative, p73 variants are the predominant expression products of this gene hi developing and adult tissues. Our data suggest that there is a marked divergence in the physiological functions of the p53 family members, and reveal unique roles for p73 in neurogenesis, sensory pathways and homeostatic control.	Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; Sanofi Rech, F-31676 Labege, France; Tufts Univ, USDA, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; Tufts Univ, Sch Vet Med, Dept Pathol, Boston, MA 02111 USA; Brigham & Womens Hosp, Dept Pathol, Div Immunol Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Childrens Hosp, Dept Neurol, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Sanofi-Aventis; Sanofi France; Tufts University; United States Department of Agriculture (USDA); Tufts University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	McKeon, F (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	fmckeon@hms.harvard.edu; daniel.caput@wanadoo.fr						Alcantara S, 1998, J NEUROSCI, V18, P7779; Bargmann CI, 1997, CELL, V90, P585, DOI 10.1016/S0092-8674(00)80518-8; CAPECCHI MR, 1989, SCIENCE, V244, P1288, DOI 10.1126/science.2660260; Cressman VL, 1998, AM J RESP CELL MOL, V19, P853, DOI 10.1165/ajrcmb.19.6.3194; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; De Laurenzi V, 1998, J EXP MED, V188, P1763, DOI 10.1084/jem.188.9.1763; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Go K G, 1997, Adv Tech Stand Neurosurg, V23, P47; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kim KC, 1997, EUR RESPIR J, V10, P2644, DOI 10.1183/09031936.97.10112644; Kinzler KW, 1996, NATURE, V379, P19, DOI 10.1038/379019a0; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lindeman GJ, 1998, GENE DEV, V12, P1092, DOI 10.1101/gad.12.8.1092; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; McEwen BS, 1999, ANNU REV NEUROSCI, V22, P105, DOI 10.1146/annurev.neuro.22.1.105; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1; RAKIC P, 1995, NEURON, V14, P1101, DOI 10.1016/0896-6273(95)90258-9; STANFIELD BB, 1979, J COMP NEUROL, V185, P393, DOI 10.1002/cne.901850302; Tirindelli R, 1998, TRENDS NEUROSCI, V21, P482, DOI 10.1016/S0166-2236(98)01274-0; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	30	832	863	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					99	103		10.1038/35003607	http://dx.doi.org/10.1038/35003607			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716451				2022-12-24	WOS:000085775100054
J	Gao, YJ; Ferguson, DO; Xie, W; Manis, JP; Sekiguchi, J; Frank, KM; Chaudhuri, J; Horner, J; DePinho, RA; Alt, FW				Gao, YJ; Ferguson, DO; Xie, W; Manis, JP; Sekiguchi, J; Frank, KM; Chaudhuri, J; Horner, J; DePinho, RA; Alt, FW			Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development	NATURE			English	Article							STRAND BREAK REPAIR; V(D)J RECOMBINATION; TRANSLOCATIONS; TRANSPOSITION; CELLS; RAG1; MICE	XRCC4 is a non-homologous end-joining protein employed in DNA double strand break repair and in V(D)J recombination(1,2). In mice, XRCC4-deficiency causes a pleiotropic phenotype, which includes embryonic lethality and massive neuronal apoptosis 2. When DNA damage is not repaired, activation of the cell cycle checkpoint protein p53 can lead to apoptosis(3). Here we show that p53-deficiency rescues several aspects of the XRCC4-deficient phenotype, including embryonic lethality, neuronal apoptosis, and impaired cellular proliferation. However, there was no significant rescue of impaired V(D)J recombination or lymphocyte development. Although p53-deficiency allowed postnatal survival of XRCC4-deficient mice, they routinely succumbed to pro-B-cell lymphomas which had chromosomal translocations linking amplified c-myc oncogene and IgH locus sequences. Moreover, even XRCC4-deficient embryonic fibroblasts exhibited marked genomic instability including chromosomal translocations. Our findings support a crucial role for the non-homologous end-joining pathway as a caretaker of the mammalian genome, a role required both for normal development and for suppression of tumours.	Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Ctr Blood Res, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med & Genet, Boston, MA 02115 USA; Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Alt, FW (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@rascal.med.harvard.edu		Sekiguchi, JoAnn/0000-0002-7178-4258; DePinho, Ronald/0000-0002-5625-577X				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Bieche I, 1998, INT J CANCER, V78, P661, DOI 10.1002/(SICI)1097-0215(19981123)78:5<661::AID-IJC22>3.3.CO;2-9; Bogue MA, 1996, GENE DEV, V10, P553, DOI 10.1101/gad.10.5.553; Di JA, 1996, J EXP MED, V183, P1923, DOI 10.1084/jem.183.4.1923; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Gellert M, 1997, ADV IMMUNOL, V64, P39, DOI 10.1016/S0065-2776(08)60886-X; Gu YS, 2000, P NATL ACAD SCI USA, V97, P2668, DOI 10.1073/pnas.97.6.2668; Guidos CJ, 1996, GENE DEV, V10, P2038, DOI 10.1101/gad.10.16.2038; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jeggo PA, 1998, RADIAT RES, V150, pS80, DOI 10.2307/3579810; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Liao MJ, 1998, MOL CELL BIOL, V18, P3495, DOI 10.1128/MCB.18.6.3495; Lieber MR, 1999, GENES CELLS, V4, P77, DOI 10.1046/j.1365-2443.1999.00245.x; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; MALYNN BA, 1988, CELL, V54, P453, DOI 10.1016/0092-8674(88)90066-9; Nacht M, 1996, GENE DEV, V10, P2055, DOI 10.1101/gad.10.16.2055; Paulson TG, 1998, MOL CELL BIOL, V18, P3089, DOI 10.1128/MCB.18.5.3089; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658	25	479	488	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2000	404	6780					897	900		10.1038/35009138	http://dx.doi.org/10.1038/35009138			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786799				2022-12-24	WOS:000086625000051
J	Pouyanne, P; Haramburu, F; Imbs, JL; Begaud, B				Pouyanne, P; Haramburu, F; Imbs, JL; Begaud, B		French Pharmacovigliance Centres	Admissions to hospital caused by adverse drug reactions: cross sectional incidence study	BRITISH MEDICAL JOURNAL			English	Article									Univ Victor Segalen, CHU, Ctr Pharmacovigilance, Dept Pharmacol, F-33076 Bordeaux, France; Hop Univ, Serv Pharmacol Clin, Ctr Reg Pharmacovigilance Alsace, F-67091 Strasbourg, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; CHU Strasbourg	Haramburu, F (corresponding author), Univ Victor Segalen, CHU, Ctr Pharmacovigilance, Dept Pharmacol, F-33076 Bordeaux, France.							EINARSON TR, 1993, ANN PHARMACOTHER, V27, P832, DOI 10.1177/106002809302700702; Imbs JL, 1999, THERAPIE, V54, P21; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Roughead EE, 1998, MED J AUSTRALIA, V168, P405, DOI 10.5694/j.1326-5377.1998.tb138996.x; *WHO, 1996, WHO TECHN REP SER, V425	5	281	296	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 15	2000	320	7241					1036	1036		10.1136/bmj.320.7241.1036	http://dx.doi.org/10.1136/bmj.320.7241.1036			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307VW	10764362	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000086675700021
J	von Helden, G; Tielens, ACGM; van Heijnsbergen, D; Duncan, MA; Hony, S; Waters, LBFM; Meijer, G				von Helden, G; Tielens, ACGM; van Heijnsbergen, D; Duncan, MA; Hony, S; Waters, LBFM; Meijer, G			Titanium carbide nanocrystals in circumstellar environments	SCIENCE			English	Article							RICH PROTOPLANETARY NEBULAE; MASS-LOSS; EMISSION; STARS; EVOLUTION; GRAPHITE; SHELLS; SIS2; DUST	Meteorites contain micrometer-sized graphite grains with embedded titanium carbide grains. Although isotopic analysis identifies asymptotic giant branch stars as the birth sites of these grains, there is no direct observational identification of these grains in astronomical sources. We report that infrared wavelength spectra of gas-phase titanium carbide nanocrystals derived in the laboratory show a prominent feature at a wavelength of 20.1 micrometers, which compares well to a similar feature in observed spectra of postasymptotic giant branch stars. It is concluded that titanium carbide forms during a short (approximately 100 years) phase of catastrophic mass Loss (>0.001 solar masses per year) in dying, Low-mass stars.	EURATOM, FOM, Inst Plasma Phys Rijnhuizen, NL-3430 BE Nieuwegein, Netherlands; Catholic Univ Nijmegen, Dept Mol & Laser Phys, NL-6525 ED Nijmegen, Netherlands; Univ Groningen, SRON Kapteyn Inst, NL-9700 AV Groningen, Netherlands; Univ Georgia, Dept Chem, Athens, GA 30602 USA; Univ Amsterdam, Astron Inst, NL-1098 SJ Amsterdam, Netherlands; Katholieke Univ Leuven, Sterrekundig Inst, B-3001 Heverlee, Belgium	Euratom; Radboud University Nijmegen; University of Groningen; University System of Georgia; University of Georgia; University of Amsterdam; KU Leuven	von Helden, G (corresponding author), EURATOM, FOM, Inst Plasma Phys Rijnhuizen, Edisonbaan 14, NL-3430 BE Nieuwegein, Netherlands.	gertvh@rijnh.nl	von Helden, Gert/H-9357-2012; Meijer, Gerard/D-2141-2009	von Helden, Gert/0000-0001-7611-8740; Meijer, Gerard/0000-0001-9669-8340				ANDERS E, 1993, METEORITICS, V28, P490, DOI 10.1111/j.1945-5100.1993.tb00274.x; Begemann B, 1996, ASTROPHYS J, V464, pL195, DOI 10.1086/310110; Bernatowicz TJ, 1996, ASTROPHYS J, V472, P760, DOI 10.1086/178105; BUSS RH, 1993, ASTROPHYS J, V415, P250, DOI 10.1086/173160; Cherchneff I, 1999, IAU SYMP, P251; Crovisier J., 1999, UNIVERSE SEEN ISO ES, V427, P161; DANCE I, COMMUNICATION; Dayal A, 1998, ASTROPHYS J, V492, P603, DOI 10.1086/305051; deGraauw T, 1996, ASTRON ASTROPHYS, V315, pL49; DEMUIZON MJ, 1992, LES HOUCHES, P489; GOEBEL JH, 1993, ASTRON ASTROPHYS, V278, P226; GUO BC, 1992, SCIENCE, V255, P1411, DOI 10.1126/science.255.5050.1411; Hill HGM, 1998, ASTRON ASTROPHYS, V336, pL41; Hofner S, 1998, ASTRON ASTROPHYS, V340, P497; HRIVNAK BJ, 1995, ASTROPHYS J, V438, P341, DOI 10.1086/175078; JURA M, 1997, AIP C P, V402, P379; JUSTTANONT K, 1992, ASTROPHYS J, V389, P400, DOI 10.1086/171215; JUSTTANONT K, 1996, ASTROPHYS J, V476, P319; KWOK S, 1989, ASTROPHYS J, V345, pL51, DOI 10.1086/185550; Meixner M, 1997, ASTROPHYS J, V482, P897, DOI 10.1086/304174; Molster FJ, 1996, ASTRON ASTROPHYS, V315, pL373; OEPTS D, 1995, INFRARED PHYS TECHN, V36, P297, DOI 10.1016/1350-4495(94)00074-U; OSHLMA C, 1987, PHYS REV B, V36, P7510; PILGRIM JS, 1993, J AM CHEM SOC, V115, P9724, DOI 10.1021/ja00074a044; Renzini A., 1981, PHYS PROCESSES RED G, P431; SOURISSEAU C, 1992, ASTRON ASTROPHYS, V254, pL1; Tielens AGGM, 1999, NATO ADV SCI I C-MAT, V523, P331; van Heijnsbergen D, 1999, PHYS REV LETT, V83, P4983, DOI 10.1103/PhysRevLett.83.4983; Van Winckel H, 1999, IAU SYMP, P465; van Winckel H, 2000, ASTRON ASTROPHYS, V354, P135; VASSILIADIS E, 1993, ASTROPHYS J, V413, P641, DOI 10.1086/173033; Volk K, 1999, ASTROPHYS J, V516, pL99, DOI 10.1086/312007	32	132	133	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2000	288	5464					313	316						6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764639				2022-12-24	WOS:000086454300030
J	Snyder, L; Caplan, AL				Snyder, L; Caplan, AL			Assisted suicide: Finding common ground	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania	Snyder, L (corresponding author), Univ Penn, Ctr Bioeth, 3401 Market St,Suite 320, Philadelphia, PA 19104 USA.	lsnyder@mail.acponline.org						Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Doerflinger RM, 1999, HASTINGS CENT REP, V29, P52	2	4	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					468	469		10.7326/0003-4819-132-6-200003210-00007	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293CV	10733446				2022-12-24	WOS:000085834700006
J	Chandrashekar, J; Mueller, KL; Hoon, MA; Adler, E; Feng, LX; Guo, W; Zuker, CS; Ryba, NJP				Chandrashekar, J; Mueller, KL; Hoon, MA; Adler, E; Feng, LX; Guo, W; Zuker, CS; Ryba, NJP			T2Rs function as bitter taste receptors	CELL			English	Article							G-PROTEIN; SUCROSE OCTAACETATE; EXPRESSION; GUSTDUCIN; NERVE; MICE; RAT; TRANSDUCTION; COUPLE; SWEET	Bitter taste perception provides animals with critical protection against ingestion of poisonous compounds. In the accompanying paper, we report the characterization of a large family of putative mammalian taste receptors (T2Rs). Here we use a heterologous expression system to show that specific T2Rs function as bitter taste receptors. A mouse T2R (mT2R-5) responds to the bitter tastant cycloheximide, and a human and a mouse receptor (hT2R-4 and mT2R-8) responded to denatonium and 6-n-propyl-2-thiouracil. Mice strains deficient in their ability to detect cycloheximide have amino acid substitutions in the mT2R-5 gene; these changes render the receptor significantly less responsive to cycloheximide. We also expressed mT2R-5 in insect cells and demonstrate specific tastant-dependent activation of gustducin, a G protein implicated in bitter signaling. Since a single taste receptor cell expresses a large repertoire of T2Rs, these findings provide a plausible explanation for the uniform bitter taste that is evoked by many structurally unrelated toxic compounds.	NIH, Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, Dept Neurosci, La Jolla, CA 92093 USA; Aurora Biosci, San Diego, CA 92121 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), NIH, Natl Inst Dent & Craniofacial Res, Bldg 10, Bethesda, MD 20892 USA.			Chandrashekar, jayaram/0000-0001-6412-0114	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		ABE K, 1993, J BIOL CHEM, V268, P12033; Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; BAKER EK, 1994, EMBO J, V13, P4886, DOI 10.1002/j.1460-2075.1994.tb06816.x; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263; CAPELESS CG, 1992, BEHAV GENET, V22, P655, DOI 10.1007/BF01066636; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; CONNEALLY PM, 1976, HUM HERED, V26, P267, DOI 10.1159/000152813; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; FRANK ME, 1991, J NEUROPHYSIOL, V65, P1452, DOI 10.1152/jn.1991.65.6.1452; FRANK ME, 1983, J NEUROPHYSIOL, V50, P941, DOI 10.1152/jn.1983.50.4.941; Garcia J., 1975, OLFACTION TASTE, P39, DOI DOI 10.1016/B978-0-12-209750-8.50014-7; GLENDINNING JI, 1994, PHYSIOL BEHAV, V56, P1217, DOI 10.1016/0031-9384(94)90369-7; Glendinning JI, 1999, BEHAV NEUROSCI, V113, P840, DOI 10.1037/0735-7044.113.4.840; HARGRAVE PA, 1986, EXP EYE RES, V42, P363, DOI 10.1016/0014-4835(86)90030-8; HOON MA, 1995, BIOCHEM J, V309, P629, DOI 10.1042/bj3090629; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; KINNAMON SC, 1992, ANNU REV PHYSIOL, V54, P715, DOI 10.1146/annurev.physiol.54.1.715; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; KUSANO T, 1971, Applied Entomology and Zoology, V6, P40; LEFKOWITZ RJ, 1992, COLD SPRING HARB SYM, V57, P127, DOI 10.1101/SQB.1992.057.01.016; Lindemann B, 1996, CURR BIOL, V6, P1234, DOI 10.1016/S0960-9822(96)00704-X; LINDEMANN B, 1996, GENET RES, V44, P151; LUSH IE, 1986, GENET RES, V47, P117, DOI 10.1017/S0016672300022941; MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0; MATSUOKA I, 1993, BIOCHEM BIOPH RES CO, V194, P504, DOI 10.1006/bbrc.1993.1848; MCBURNEY DH, 1979, PSYCHOL BULL, V86, P151, DOI 10.1037/0033-2909.86.1.151; Mehta RK, 1999, BIOTECHNIQUES, V26, P1082, DOI 10.2144/99266bm17; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; NEJAD MS, 1986, CHEM SENSES, V11, P283, DOI 10.1093/chemse/11.3.283; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175, DOI 10.1074/jbc.270.25.15175; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; REISINE T, 1995, NEUROPHARMACOLOGY, V34, P463, DOI 10.1016/0028-3908(95)00025-2; RYBA NJP, 1995, J BIOL CHEM, V270, P6757, DOI 10.1074/jbc.270.12.6757; SAROLI A, 1984, NATURWISSENSCHAFTEN, V71, P428, DOI 10.1007/BF00365895; Stewart RE, 1997, AM J PHYSIOL-CELL PH, V272, pC1, DOI 10.1152/ajpcell.1997.272.1.C1; TSIEN RY, 1985, CELL CALCIUM, V6, P145, DOI 10.1016/0143-4160(85)90041-7; Tsunoda S, 1998, CURR OPIN GENET DEV, V8, P419, DOI 10.1016/S0959-437X(98)80112-3; WARREN RP, 1970, NATURE, V227, P77, DOI 10.1038/227077a0; WHITNEY G, 1986, BEHAV GENET, V16, P559, DOI 10.1007/BF01066342; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	41	1017	1125	7	282	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 17	2000	100	6					703	711		10.1016/S0092-8674(00)80706-0	http://dx.doi.org/10.1016/S0092-8674(00)80706-0			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761935	Bronze			2022-12-24	WOS:000085983800012
J	Hirotsu, T; Saeki, S; Yamamoto, M; Ilno, Y				Hirotsu, T; Saeki, S; Yamamoto, M; Ilno, Y			The Ras-MAPK pathway is important for olfaction in Caenorhabditis elegans	NATURE			English	Article							NUCLEOTIDE-GATED CHANNEL; KSR-1 GENE ENCODES; C-ELEGANS; SENSORY NEURONS; CHEMOTAXIS; PROTEIN; TRANSDUCTION; MAINTENANCE; ACTIVATION; MECHANISMS	The Ras-MAPK (mitogen-activated protein kinase) signal transduction pathway is well known to control cellular proliferation and differentiation in response to extracellular signals, but its other functions are less understood. In Caenorhabditis elegans this pathway regulates several developmental events, such as vulval induction and progression of meiosis(1), but its function in the nervous system is unknown. Here we report that the Ras-MAPK pathway is involved in olfaction in this organism. Mutational inactivation and hyperactivation of this pathway impairs efficiency of chemotaxis to a set of odorants. Experiments in which let-60 ras was expressed using a heat-shock promoter and a cell-specific promoter show that a normal activity of LET-60 Ras is required in mature olfactory neurons. Application of the odorant isoamylalcohol to wild-type animals leads to the activation of MAP kinase in olfactory neurons within 10 seconds. This induction is dependent on the function of the nucleotide-gated channel TAX-2/TAX-4 and the voltage-activated calcium channel subunit UNC-2. These results suggest a dynamic regulatory role for the Ras-MAPK pathway in perception and transmission of sensory signals in olfactory neurons.	Univ Tokyo, Mol Genet Res Lab, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Ilno, Y (corresponding author), Univ Tokyo, Mol Genet Res Lab, Tokyo 1130033, Japan.	iino@ims.u-tokyo.ac.jp	Hirotsu, Takaaki/G-9358-2013; IINO, YUICHI/G-4962-2014	Hirotsu, Takaaki/0000-0003-3936-8382; 				ALBERTSON DG, 1976, PHILOS T ROY SOC B, V275, P299, DOI 10.1098/rstb.1976.0085; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BEITEL GJ, 1990, NATURE, V348, P503, DOI 10.1038/348503a0; Brambilla R, 1997, NATURE, V390, P281, DOI 10.1038/36849; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; CLARK SG, 1992, NATURE, V356, P340, DOI 10.1038/356340a0; Coburn CM, 1998, DEVELOPMENT, V125, P249; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; DUSENBERY DB, 1975, GENETICS, V80, P297; FARNSWORTH CL, 1995, NATURE, V376, P524, DOI 10.1038/376524a0; Finkbeiner S, 1996, NEURON, V16, P233, DOI 10.1016/S0896-6273(00)80040-9; Goodman MB, 1998, NEURON, V20, P763, DOI 10.1016/S0896-6273(00)81014-4; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; KORNFELD K, 1995, CELL, V83, P903, DOI 10.1016/0092-8674(95)90206-6; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Nonet ML, 1997, J NEUROSCI, V17, P8061; Peckol EL, 1999, DEVELOPMENT, V126, P1891; Prasad BC, 1999, TRENDS GENET, V15, P150, DOI 10.1016/S0168-9525(99)01695-9; Roayaie K, 1998, NEURON, V20, P55, DOI 10.1016/S0896-6273(00)80434-1; SCHAFER WR, 1995, NATURE, V375, P73, DOI 10.1038/375073a0; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Sternberg PW, 1998, TRENDS GENET, V14, P466, DOI 10.1016/S0168-9525(98)01592-3; SUNDARAM M, 1995, CELL, V83, P889, DOI 10.1016/0092-8674(95)90205-8; Tan PB, 1998, CELL, V93, P569, DOI 10.1016/S0092-8674(00)81186-1; Troemel ER, 1997, CELL, V91, P161, DOI 10.1016/S0092-8674(00)80399-2; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384; Yung Y, 1997, FEBS LETT, V408, P292, DOI 10.1016/S0014-5793(97)00442-0	29	59	76	0	7	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					289	293		10.1038/35005101	http://dx.doi.org/10.1038/35005101			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749212				2022-12-24	WOS:000086022200050
J	Brown, BH; Tidy, JA; Boston, K; Blackett, AD; Smallwood, RH; Sharp, F				Brown, BH; Tidy, JA; Boston, K; Blackett, AD; Smallwood, RH; Sharp, F			Relation between tissue structure and imposed electrical current flow in cervical neoplasia	LANCET			English	Article							UTERINE CERVIX; CANCER	Background When an electrical potential is applied to human tissue, the pattern of the resulting current flow is determined by the shapes, arrangements, and internal structure of the tissue cells. By measurement of the electrical current patterns over a range of frequencies, and use of an inverse modelling procedure, electrical variables describing the tissue structure can be calculated, We used this method to develop a screening technique for the detection of cervical precancers. Methods We used a pencil probe (diameter 5 mm) to measure electrical impedance spectra from eight points on the cervix in 124 women with abnormal cervical smears. Variables that should be sensitive to the expected tissue changes were calculated. These were compared with the colposcopic results. Findings The measured electrical impedance changes were those predicted on the basis of the expected tissue structures. Measurements made on normal squamous tissues were well separated from those made on precancerous tissues. We constructed receiver-operating-characteristic curves, comparing measurements made on normal tissue and that showing cervical intraepithelial neoplasia grade 2/3; the area under the curve was 0.951. These groups of women could be separated with a sensitivity of 0.92 and a specificity of 0.92. Interpretation Characteristics of the electrical impedance spectra of tissues can be explained by changes in cell arrangements (layering) and in the size of the nuclei. This relation opens the way to deriving tissue structure from electrical impedance spectral measurements. We show that this approach can be used to give good separation of normal and precancerous cervical tissues.	Univ Sheffield, Royal Hallamshire Hosp, Dept Med Phys, Sheffield S10 2JF, S Yorkshire, England; Univ Sheffield, No Gen Hosp Trust, Ctr Clin Sci, Dept Obstet & Gynaecol, Sheffield, S Yorkshire, England	University of Sheffield; Northern General Hospital; University of Sheffield	Brown, BH (corresponding author), Univ Sheffield, Royal Hallamshire Hosp, Dept Med Phys, Sheffield S10 2JF, S Yorkshire, England.		Smallwood, Rod/C-5583-2011	Smallwood, Rod/0000-0003-0134-0632				ANDERSON MC, 1992, TEXT ATLAS INTEGRATE; BOON ME, 1985, HISTOPATHOLOGY, V9, P751, DOI 10.1111/j.1365-2559.1985.tb02861.x; BROWN BH, 1995, PHYSIOL MEAS, V16, P57; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; COPPLESON M, 1994, INT J GYNECOL CANCER, V4, P79, DOI 10.1046/j.1525-1438.1994.04020079.x; DUCK FA, 1990, PHYSICAL PROPERTIES; FOSTER KR, 1989, CRIT REV BIOMED ENG, V17, P25; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Mitchell MF, 1999, OBSTET GYNECOL, V93, P462, DOI 10.1016/S0029-7844(98)00385-8; PRITCHARD DA, 1996, NHS CERVICAL SCREENI, V3; SASIENI P, 1995, LANCET, V346, P1566, DOI 10.1016/S0140-6736(95)92099-4; SCHWAN H P, 1957, Adv Biol Med Phys, V5, P147; SORENSEN FB, 1991, VIRCHOWS ARCH A, V418, P225, DOI 10.1007/BF01606060	13	136	156	1	8	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					892	895		10.1016/S0140-6736(99)09095-9	http://dx.doi.org/10.1016/S0140-6736(99)09095-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752706				2022-12-24	WOS:000085896000012
J	Kazemi-Esfarjani, P; Benzer, S				Kazemi-Esfarjani, P; Benzer, S			Genetic suppression of polyglutamine toxicity in Drosophila	SCIENCE			English	Article							DNA-BINDING PROTEIN; CELL FATES; J-DOMAIN; LOCALIZATION; DEGENERATION; EXPRESSION; PHENOTYPES; INCLUSIONS; HSP70; EYE	A Drosophila model for Huntington's and other polyglutamine diseases was used to screen for genetic factors modifying the degeneration caused by expression of polyglutamine in the eye. Among 7000 P-element insertions, several suppressor strains were isolated, two of which Led to the discovery of the suppressor genes described here. The predicted product of one, dHDJ1, is homologous to human heat shock protein 40/HDJ1. That of the second, dTPR2, is homologous to the human tetratricopeptide repeat protein 2. Each of these molecules contains a chaperone-related J domain. Their suppression of polyglutamine toxicity was verified in transgenic flies.	CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Kazemi-Esfarjani, P (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.							Bergmann A, 1998, CELL, V95, P331, DOI 10.1016/S0092-8674(00)81765-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; CYR DM, 1994, TRENDS BIOCHEM SCI, V19, P176, DOI 10.1016/0968-0004(94)90281-X; DOE CQ, 1991, CELL, V65, P451, DOI 10.1016/0092-8674(91)90463-9; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9; Hata M, 1996, GENOMICS, V38, P446, DOI 10.1006/geno.1996.0653; Jackson GR, 1998, NEURON, V21, P633, DOI 10.1016/S0896-6273(00)80573-5; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kim TW, 1998, NEURON, V21, P657, DOI 10.1016/S0896-6273(00)80581-4; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; LANGER T, 1992, NATURE, V356, P683, DOI 10.1038/356683a0; Misselwitz B, 1998, MOL CELL, V2, P593, DOI 10.1016/S1097-2765(00)80158-6; MOSES K, 1991, GENE DEV, V5, P583, DOI 10.1101/gad.5.4.583; Murthy AE, 1996, DNA CELL BIOL, V15, P727, DOI 10.1089/dna.1996.15.727; PIRROTTA V, 1986, CLONING DROSOPHILA G, P83; RAABE T, 1991, NUCLEIC ACIDS RES, V19, P6645, DOI 10.1093/nar/19.23.6645; ROBERTSON HM, 1988, GENETICS, V118, P461; Rorth P, 1996, P NATL ACAD SCI USA, V93, P12418, DOI 10.1073/pnas.93.22.12418; SEROUDE L, UNPUB; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Stubdal H, 1997, MOL CELL BIOL, V17, P4979, DOI 10.1128/MCB.17.9.4979; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Warrick JM, 1999, NAT GENET, V23, P425, DOI 10.1038/70532; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3; Weiss B, 1999, AM J MED GENET, V89, P14, DOI 10.1002/(SICI)1096-8628(19990326)89:1<14::AID-AJMG5>3.3.CO;2-W	30	453	478	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1837	1840		10.1126/science.287.5459.1837	http://dx.doi.org/10.1126/science.287.5459.1837			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710314				2022-12-24	WOS:000085775300046
J	Yankner, BA				Yankner, BA			A century of cognitive decline	NATURE			English	Editorial Material									Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Div Neurosci, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Yankner, BA (corresponding author), Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA.								0	20	22	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					125	125		10.1038/35004673	http://dx.doi.org/10.1038/35004673			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724145	Bronze			2022-12-24	WOS:000085870900023
J	Holt, IJ; Lorimer, HE; Jacobs, HT				Holt, IJ; Lorimer, HE; Jacobs, HT			Coupled leading- and lagging-strand synthesis of mammalian mitochondrial DNA	CELL			English	Article							REPLICATION ORIGINS; ETHIDIUM-BROMIDE; GEL-ELECTROPHORESIS; 2-DIMENSIONAL GELS; YEAST; SEQUENCE; ORGANIZATION	Analysis of mammalian mtDNA by two-dimensional agarose gel electrophoresis revealed two classes of replication intermediate. One was resistant to single-strand nuclease digestion and displayed the mobility properties of coupled leading- and lagging- strand replication products, Intermediates of coupled, unidirectional mtDNA replication were found in mouse liver and human placenta and were the predominant species in cultured cells recovering from transient mtDNA replication. Replication intermediates sensitive to single-strand nuclease were most abundant in untreated cultured cells, These are presumed to derive from the orthodox, strand-asynchronous mode of mtDNA replication. These findings indicate that two modes of mtDNA replication operate in mammalian cells and that changes in mtDNA copy number involve an alteration in the mode of mtDNA replication.	Univ Dundee, Ninewells Med Sch, Dept Mol Pathol, Dundee DD1 9SY, Scotland; Youngstown State Univ, Dept Biol Sci, Youngstown, OH 44555 USA; Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland; Univ Tampere, Tampere Univ Hosp, FIN-33101 Tampere, Finland; Univ Glasgow, Inst Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Dundee; University System of Ohio; Youngstown State University; Tampere University; Tampere University; Tampere University Hospital; University of Glasgow	Holt, IJ (corresponding author), Dunn Human Nutr Unit, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 2XY, England.		Jacobs, Howard T/G-2434-2011	Jacobs, Howard/0000-0003-1895-6003; holt, ian/0000-0001-5468-0193	Medical Research Council [MC_U105663140] Funding Source: Medline; MRC [MC_U105663140] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; BREWER BJ, 1991, BIOESSAYS, V13, P317, DOI 10.1002/bies.950130702; BREWER BJ, 1988, CELL, V55, P637, DOI 10.1016/0092-8674(88)90222-X; BRUN C, 1995, CHROMOSOMA, V104, P92; Carrodeguas JA, 1999, MOL CELL BIOL, V19, P4039; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; CREWS S, 1979, NATURE, V277, P192, DOI 10.1038/277192a0; DESJARDINS P, 1985, MOL CELL BIOL, V5, P1163, DOI 10.1128/MCB.5.5.1163; Friedman KL, 1995, METHOD ENZYMOL, V262, P613; GHIVIZZANI SC, 1994, MOL CELL BIOL, V14, P7717, DOI 10.1128/MCB.14.12.7717; GOLDRING ES, 1970, J MOL BIOL, V52, P323, DOI 10.1016/0022-2836(70)90033-1; HAN ZY, 1994, CHROMOSOMA, V103, P162, DOI 10.1007/BF00368008; IKEDA S, 1994, CELL MOL BIOL, V40, P489; Kalejta RF, 1996, MOL CELL BIOL, V16, P4915; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; KOIKE K, 1974, J CELL BIOL, V61, P14, DOI 10.1083/jcb.61.1.14; LAUDET V, 1993, NUCLEIC ACIDS RES, V21, P2493, DOI 10.1093/nar/21.10.2493; LOCKSHON D, 1995, CELL, V81, P947, DOI 10.1016/0092-8674(95)90014-4; MAYHOOK AG, 1992, P ROY SOC B-BIOL SCI, V248, P85, DOI 10.1098/rspb.1992.0046; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAWOTKA KA, 1988, MOL CELL BIOL, V8, P1408, DOI 10.1128/MCB.8.4.1408; Preiser PR, 1996, EMBO J, V15, P684, DOI 10.1002/j.1460-2075.1996.tb00401.x; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd; SIMPSON MV, 1989, BIOCHEM PHARMACOL, V38, P1033, DOI 10.1016/0006-2952(89)90245-1; WISEMAN A, 1978, MOL GEN GENET, V167, P51, DOI 10.1007/BF00270321; Wolstenholme D R, 1974, Cold Spring Harb Symp Quant Biol, V38, P267	28	283	291	0	19	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 3	2000	100	5					515	524		10.1016/S0092-8674(00)80688-1	http://dx.doi.org/10.1016/S0092-8674(00)80688-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721989	Bronze			2022-12-24	WOS:000085700000005
J	Zhou, ZH; Dougherty, M; Jakana, J; He, J; Rixon, FJ; Chiu, W				Zhou, ZH; Dougherty, M; Jakana, J; He, J; Rixon, FJ; Chiu, W			Seeing the herpesvirus capsid at 8.5 angstrom	SCIENCE			English	Article							SIMPLEX-VIRUS TYPE-1; ELECTRON CRYOMICROSCOPY; PROTEIN; PARTICLES; TRIPLEX; DNA; RECONSTRUCTION; VISUALIZATION; MATURATION; SCAFFOLD	Human herpesviruses are large and structurally complex viruses that cause a variety of diseases. The three-dimensional structure of the herpesvirus capsid has been determined at 8.5 angstrom resolution by electron cryomicroscopy. More than 30 putative alpha helices were identified in the four proteins that make up the 0.2 billion-dalton shell. Some of these helices are located at domains that undergo conformational changes during capsid assembly and DNA packaging. The unique spatial arrangement of the heterotrimer at the local threefold positions accounts for the asymmetric interactions with adjacent capsid components and the unusual co-dependent folding of its subunits.	Baylor Coll Med, Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA; Univ Texas, Sch Med, Dept Pathol & Lab Med, Houston, TX 77030 USA; Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; Inst Virol, MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland	Baylor College of Medicine; University of Texas System; Baylor College of Medicine; University of Glasgow	Chiu, W (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Natl Ctr Macromol Imaging, Houston, TX 77030 USA.		Zhou, Z Hong/HDN-0747-2022					ARVIN AM, 1996, FIELDS VIROLOGY, V2, P2547; BATTERSON W, 1983, J VIROL, V45, P397, DOI 10.1128/JVI.45.1.397-407.1983; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BRITT WJ, 1996, FIELDS VIROLOGY, V2, P2493; Conway JF, 1997, NATURE, V386, P91, DOI 10.1038/386091a0; CROWTHER RA, 1971, PHILOS T R SOC B, V261, P221, DOI 10.1098/rstb.1971.0054; Desai P, 1999, VIROLOGY, V261, P357, DOI 10.1006/viro.1999.9877; FIELDS BN, 1996, FIELDS VIROLOGY, V2; FULLER SD, 1987, CELL, V48, P923, DOI 10.1016/0092-8674(87)90701-X; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; HARRISON SC, 1996, VIROLOGY, V1, P59; Kirkitadze MD, 1998, J VIROL, V72, P10066, DOI 10.1128/JVI.72.12.10066-10072.1998; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; NEWCOMB WW, 1994, J VIROL, V68, P433, DOI 10.1128/JVI.68.1.433-440.1994; NEWCOMB WW, 1993, J MOL BIOL, V232, P499, DOI 10.1006/jmbi.1993.1406; RICKINSON A, 1996, FIELDS VIROLOGY, V2, P2397; RIXON FJ, UNPUB; ROIZMAN B, 1996, FIELDS VIROLOGY, V2, P2231; ROSSMANN MG, 1989, ANNU REV BIOCHEM, V58, P533, DOI 10.1146/annurev.bi.58.070189.002533; Saad A, 1999, J VIROL, V73, P6821, DOI 10.1128/JVI.73.8.6821-6830.1999; SCHULZ TF, 1998, HUMAN TUMOR VIRUSES, P87; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; STEVEN AC, 1997, STRUCTURAL BIOL VIRU, P312; Thuman-Commike PA, 1999, BIOPHYS J, V76, P2249, DOI 10.1016/S0006-3495(99)77381-9; Trus BL, 1996, J MOL BIOL, V263, P447, DOI 10.1016/S0022-2836(96)80018-0; TRUS BL, 1997, NAT STRUCT BIOL, V4, P411; WHITLEY RJ, 1996, FIELDS VIROLOGY, V2, P2297; Wingfield PT, 1997, J VIROL, V71, P8955, DOI 10.1128/JVI.71.12.8955-8961.1997; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zhou ZH, 1999, J VIROL, V73, P3210, DOI 10.1128/JVI.73.4.3210-3218.1999; Zhou ZH, 1998, BIOPHYS J, V74, P576, DOI 10.1016/S0006-3495(98)77816-6; Zhou ZH, 1996, J STRUCT BIOL, V116, P216, DOI 10.1006/jsbi.1996.0033; Zhou ZH, 1998, P NATL ACAD SCI USA, V95, P2778, DOI 10.1073/pnas.95.6.2778; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026; ZHOU ZH, 1994, J MOL BIOL, V242, P456, DOI 10.1006/jmbi.1994.1594	35	254	266	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2000	288	5467					877	880		10.1126/science.288.5467.877	http://dx.doi.org/10.1126/science.288.5467.877			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797014				2022-12-24	WOS:000086869600044
J	Matsuda, T; Bebenek, K; Masutani, C; Hanaoka, F; Kunkel, TA				Matsuda, T; Bebenek, K; Masutani, C; Hanaoka, F; Kunkel, TA			Low fidelity DNA synthesis by human DNA polymerase-eta	NATURE			English	Article							PIGMENTOSUM VARIANT CELLS; ESCHERICHIA-COLI; HYPERMUTABILITY; PHOTOPRODUCTS; MUTAGENESIS; REPLICATION; MUTATION	A superfamily of DNA polymerases that bypass lesions in DNA has been described(1-4). Some family members are described as error-prone because mutations that inactivate the polymerase reduce damage-induced mutagenesis. In contrast, mutations in the skin cancer susceptibility gene XPV5,6, which encodes DNA polymerase (pol)-eta, lead to increased ultraviolet-induced mutagenesis(7-11). This, and the fact that pol-eta primarily inserts adenines during efficient bypass of thymine-thymine dimers in vitro(8,12,13), has led to the description of pol-eta as error-free. However, here we show that human pol-eta copies undamaged DNA with much lower fidelity than any other template-dependent DNA polymerase studied. Pol-eta lacks an intrinsic proofreading exonuclease activity and, depending on the mismatch, makes one base substitution error for every 18 to 380 nucleotides synthesized. This very low fidelity indicates a relaxed requirement for correct base pairing geometry and indicates that the function of pol-eta may be tightly controlled to prevent potentially mutagenic DNA synthesis.	NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA; NIEHS, Struct Biol Lab, Res Triangle Pk, NC 27709 USA; Osaka Univ, Inst Mol & Cellular Biol, Suita, Osaka 5650871, Japan; Japan Sci & Technol Corp, CREST, Suita, Osaka 5650871, Japan; RIKEN, Wako, Saitama 3510198, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Osaka University; Japan Science & Technology Agency (JST); RIKEN	Kunkel, TA (corresponding author), NIEHS, Mol Genet Lab, Res Triangle Pk, NC 27709 USA.		Masutani, Chikahide/I-6160-2014; Kunkel, Thomas/D-5088-2019	Masutani, Chikahide/0000-0002-8600-8227; Kunkel, Thomas/0000-0002-9900-1788				Bebenek K, 1995, METHOD ENZYMOL, V262, P217; BEBENEK K, 1990, J BIOL CHEM, V265, P13878; Clairmont CA, 1999, P NATL ACAD SCI USA, V96, P9580, DOI 10.1073/pnas.96.17.9580; Friedberg EC, 1999, CELL, V98, P413, DOI 10.1016/S0092-8674(00)81970-4; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; KANG XL, 1992, GENETICS, V130, P285; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; KUNKEL TA, IN PRESS ANN REV BIO, V69; Lewis DA, 1999, J BIOL CHEM, V274, P32924, DOI 10.1074/jbc.274.46.32924; MAHER VM, 1976, NATURE, V261, P593, DOI 10.1038/261593a0; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Masutani C, 1999, EMBO J, V18, P3491, DOI 10.1093/emboj/18.12.3491; McDonald JP, 1997, GENETICS, V147, P1557; MYHR BC, 1979, MUTAT RES, V62, P341, DOI 10.1016/0027-5107(79)90089-7; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Ogi T, 1999, GENES CELLS, V4, P607, DOI 10.1046/j.1365-2443.1999.00289.x; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; PERRINO FW, 1989, J BIOL CHEM, V264, P2898; Roberts J.D., 1996, DNA REPLICATION EUKA, P217; ROBERTS JD, 1988, SCIENCE, V242, P1171, DOI 10.1126/science.2460925; Wang HX, 1999, J BIOL CHEM, V274, P16894, DOI 10.1074/jbc.274.24.16894; WANG YC, 1991, P NATL ACAD SCI USA, V88, P7810, DOI 10.1073/pnas.88.17.7810; WANG YC, 1993, MOL CELL BIOL, V13, P4276, DOI 10.1128/MCB.13.7.4276; Washington MT, 1999, J BIOL CHEM, V274, P36835, DOI 10.1074/jbc.274.52.36835; WATERS HL, 1993, J INVEST DERMATOL, V101, P744, DOI 10.1111/1523-1747.ep12371686; Woodgate R, 1999, GENE DEV, V13, P2191, DOI 10.1101/gad.13.17.2191	28	312	334	0	11	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2000	404	6781					1011	1013		10.1038/35010014	http://dx.doi.org/10.1038/35010014			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801132				2022-12-24	WOS:000086762000060
J	Oesterhelt, F; Oesterhelt, D; Pfeiffer, M; Engel, A; Gaub, HE; Muller, DJ				Oesterhelt, F; Oesterhelt, D; Pfeiffer, M; Engel, A; Gaub, HE; Muller, DJ			Unfolding pathways of individual bacteriorhodopsins	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPE; PROTEIN-COUPLED RECEPTORS; SCANNING PROBE MICROSCOPY; PROTON PUMPS; RESOLUTION; MEMBRANES; MECHANISM; MOLECULES; MODEL; DNA	Atomic force microscopy and single-molecule force spectroscopy were combined to image and manipulate purple membrane patches from Halobacterium salinarum. Individual bacteriorhodopsin molecules were first localized and then extracted from the membrane; the remaining vacancies were imaged again. Anchoring forces between 100 and 200 piconewtons for the different helices were found. Upon extraction, the helices were found to unfold. The force spectra revealed the individuality of the unfolding pathways. Helices G and F as well as helices E and D always unfolded pairwise, whereas helices B and C occasionally unfolded one after the other. Experiments with cleaved Loops revealed the origin of the individuality: stabilization of helix B by neighboring helices.	Univ Munich, CeNS, D-80799 Munich, Germany; Univ Munich, Lehrstuhl Angew Phys, D-80799 Munich, Germany; Max Planck Inst Biochem, D-82152 Martinsried, Germany; Univ Basel, Bioctr, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland; Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	University of Munich; University of Munich; Max Planck Society; University of Basel; Max Planck Society	Gaub, HE (corresponding author), Univ Munich, CeNS, Arnalienstr 54, D-80799 Munich, Germany.		Müller, Daniel J./A-5967-2010	Müller, Daniel J./0000-0003-3075-0665				BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; DAMMER U, 1995, SCIENCE, V267, P1173, DOI 10.1126/science.7855599; Dammer U, 1996, BIOPHYS J, V70, P2437, DOI 10.1016/S0006-3495(96)79814-4; DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794; Engel A, 1999, CURR BIOL, V9, pR133, DOI 10.1016/S0960-9822(99)80081-5; Engel A, 1997, CURR OPIN STRUC BIOL, V7, P279, DOI 10.1016/S0959-440X(97)80037-1; ENGELMAN DM, 1981, CELL, V23, P411, DOI 10.1016/0092-8674(81)90136-7; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; EVANS E, 1999, J PHYS-CONDENS MAT, V11, P1; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328; Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997; HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W; Hargrave PA, 1991, CURR OPIN STRUC BIOL, V1, P575, DOI 10.1016/S0959-440X(05)80080-6; Haupts U, 1999, ANNU REV BIOPH BIOM, V28, P367, DOI 10.1146/annurev.biophys.28.1.367; Helmreich EJM, 1996, BBA-REV BIOMEMBRANES, V1286, P285, DOI 10.1016/S0304-4157(96)00013-5; HENDERSON R, 1990, PHILOS T ROY SOC B, V326, P379, DOI 10.1098/rstb.1990.0019; HEYMANN JB, IN PRESS STRUCTURE; Hinterdorfer P, 1996, P NATL ACAD SCI USA, V93, P3477, DOI 10.1073/pnas.93.8.3477; Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323; LANYI JK, 1995, NATURE, V375, P461, DOI 10.1038/375461a0; LANYI JK, 1993, BIOCHIM BIOPHYS ACTA, V1183, P241, DOI 10.1016/0005-2728(93)90226-6; Lanyi JK, 1997, J BIOL CHEM, V272, P31209, DOI 10.1074/jbc.272.50.31209; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Luecke H, 1999, SCIENCE, V286, P255, DOI 10.1126/science.286.5438.255; Luecke H, 1998, SCIENCE, V280, P1934, DOI 10.1126/science.280.5371.1934; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; Merkel R, 1999, NATURE, V397, P50, DOI 10.1038/16219; Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170; Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9; Muller DJ, 1999, J MOL BIOL, V285, P1903, DOI 10.1006/jmbi.1998.2441; Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Oesterhelt D, 1998, CURR OPIN STRUC BIOL, V8, P489, DOI 10.1016/S0959-440X(98)80128-0; Oesterhelt D, 1974, Methods Enzymol, V31, P667; PebayPeyroula E, 1997, SCIENCE, V277, P1676, DOI 10.1126/science.277.5332.1676; Pfeiffer M, 1999, J MOL BIOL, V287, P163, DOI 10.1006/jmbi.1998.2593; PFEIFFER M, 2000, THESIS L MAXIMILIANS; RADMACHER M, 1992, SCIENCE, V257, P1900, DOI 10.1126/science.1411505; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295; Rief M, 1998, PHYS REV LETT, V81, P4764, DOI 10.1103/PhysRevLett.81.4764; SHAO ZF, 1995, Q REV BIOPHYS, V28, P195, DOI 10.1017/S0033583500003061; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Zhang YY, 1996, BIOPHYS J, V71, P2168, DOI 10.1016/S0006-3495(96)79418-3	48	578	600	8	137	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					143	146		10.1126/science.288.5463.143	http://dx.doi.org/10.1126/science.288.5463.143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753119				2022-12-24	WOS:000086387700053
J	Smoger, SH; Felice, TL; Kloecker, GH				Smoger, SH; Felice, TL; Kloecker, GH			Urinary incontinence among male veterans receiving care in primary care clinics	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; PREVALENCE; COMMUNITY; HEALTH; SEEKING; ADULTS; WOMEN	Background: Male urinary incontinence is not a well-investigated subject. Objective: To determine the prevalence and consequences of incontinence in men. Design: Cross-sectional survey. Setting: 3 primary care clinics in a Kentucky Veterans Affairs facility. Patients: 840 men with a mean age of 59.8 years (range, 25 to 93 years). Measurements: Written survey on patient demographic information and continence, including the Incontinence Impact Questionnaire. Results: Among all study patients, 32.3% reported incontinence within the past 12 months and 13.8% (43% of those who were incontinent) reported at least weekly episodes. Age did not correlate with frequency or amount of urine loss. Frequency correlated with emotional health, social relationships, physical activity, and travel. Greater amounts of lost urine had a stronger effect on emotional health, social relationships, and travel. Among men with incontinence, only 32% had discussed incontinence with their medical provider but 75% desired evaluation and treatment. Conclusions: Urinary incontinence is common among male veterans and affects all age groups. Although incontinence often has unfavorable consequences on quality of life and although men with incontinence desired treatment, they seldom discussed the problem with medical providers. Systematic screening of men for urinary incontinence may be necessary.	Univ Louisville, Div Gen Internal Med, Louisville, KY 40292 USA; Vet Affairs Med Ctr, Louisville, KY USA	University of Louisville; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Smoger, SH (corresponding author), Univ Louisville, Div Gen Internal Med, 530 S Jackson St, Louisville, KY 40292 USA.	shsmog01@med.louisville.edu						*AG HLTH CAR POL R, 1996, AHCPR PUBL; ARMSTRONG EP, 1998, VET HLTH SYST J  OCT, P37; BURGIO KL, 1994, J AM GERIATR SOC, V42, P208, DOI 10.1111/j.1532-5415.1994.tb04954.x; DIOKNO AC, 1986, J UROLOGY, V136, P1022; DuBeau CE, 1998, J AM GERIATR SOC, V46, P683, DOI 10.1111/j.1532-5415.1998.tb03801.x; HERR HW, 1994, J UROLOGY, V151, P652, DOI 10.1016/S0022-5347(17)35038-3; HERZOG AR, 1990, J AM GERIATR SOC, V38, P273, DOI 10.1111/j.1532-5415.1990.tb03504.x; Hunskaar Steinar, 1993, Scandinavian Journal of Primary Health Care, V11, P193, DOI 10.3109/02813439308994829; Johnson TM, 1998, J AM GERIATR SOC, V46, P693, DOI 10.1111/j.1532-5415.1998.tb03802.x; LAGACE EA, 1993, J FAM PRACTICE, V36, P610; NIH, 1990, J AM GERIATR SOC, V38, P265; Nygaard IE, 1996, J AM GERIATR SOC, V44, P1049, DOI 10.1111/j.1532-5415.1996.tb02936.x; OUSLANDER JG, 1990, GERONTOLOGIST, V30, P369, DOI 10.1093/geront/30.3.369; OUSLANDER JG, 1982, JAMA-J AM MED ASSOC, V248, P1194, DOI 10.1001/jama.248.10.1194; Payne CK, 1998, UROLOGY, V51, P3, DOI 10.1016/S0090-4295(98)90001-2; Roberts RO, 1998, J AM GERIATR SOC, V46, P467, DOI 10.1111/j.1532-5415.1998.tb02468.x; SHUMAKER SA, 1994, QUAL LIFE RES, V3, P291, DOI 10.1007/BF00451721; Thom D, 1998, J AM GERIATR SOC, V46, P473, DOI 10.1111/j.1532-5415.1998.tb02469.x; THOMAS TM, 1980, BRIT MED J, V281, P1243, DOI 10.1136/bmj.281.6250.1243; WETLE T, 1995, J AM GERIATR SOC, V43, P349, DOI 10.1111/j.1532-5415.1995.tb05806.x	20	17	18	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2000	132	7					547	551		10.7326/0003-4819-132-7-200004040-00006	http://dx.doi.org/10.7326/0003-4819-132-7-200004040-00006			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298FU	10744591				2022-12-24	WOS:000086129300005
J	Stansby, G				Stansby, G			Women, pregnancy, and varicose veins	LANCET			English	Editorial Material							PREVALENCE; POPULATION		Freeman Rd Hosp, No Vasc Ctr, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England	Newcastle Freeman Hospital; Newcastle University - UK	Stansby, G (corresponding author), Freeman Rd Hosp, No Vasc Ctr, High Heaton, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England.			Stansby, Gerard/0000-0001-5539-3049				CALLAM MJ, 1994, BRIT J SURG, V81, P167, DOI 10.1002/bjs.1800810204; Canonico S, 1998, ANGIOLOGY, V49, P129, DOI 10.1177/000331979804900205; Cordts PR, 1996, J VASC SURG, V24, P763, DOI 10.1016/S0741-5214(96)70010-1; DINDELLI M, 1993, ANGIOLOGY, V44, P361, DOI 10.1177/000331979304400504; Evans CJ, 1998, J VASC SURG, V28, P767, DOI 10.1016/S0741-5214(98)70051-5; Mashiah A, 1999, CARDIOVASC SURG, V7, P327, DOI 10.1016/S0967-2109(98)00132-X; Smith JJ, 1999, J VASC SURG, V30, P710, DOI 10.1016/S0741-5214(99)70110-2; Sparey C, 1999, EUR J VASC ENDOVASC, V18, P294, DOI 10.1053/ejvs.1999.0870; Sparey C, 1999, BRIT J OBSTET GYNAEC, V106, P557, DOI 10.1111/j.1471-0528.1999.tb08324.x	9	30	31	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 1	2000	355	9210					1117	1118		10.1016/S0140-6736(00)02057-2	http://dx.doi.org/10.1016/S0140-6736(00)02057-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TC	10791371				2022-12-24	WOS:000086380900006
J	Wimmer, EA; Carleton, A; Harjes, P; Turner, T; Desplan, C				Wimmer, EA; Carleton, A; Harjes, P; Turner, T; Desplan, C			bicoid-independent formation of thoracic segments in Drosophila	SCIENCE			English	Article							GENE HUNCHBACK; BODY PATTERN; DIFFERENTIAL REGULATION; RNA-BINDING; EMBRYO; EXPRESSION; GRADIENT; PROTEIN; ANTERIOR; MORPHOGEN	The maternal determinant Bicoid (Bcd) represents the paradigm of a morphogen that provides positional information for pattern formation. However, as bicoid seems to be a recently acquired gene in flies, the question was raised as to how embryonic patterning is achieved in organisms with more ancestral modes of development. Because the phylogenetically conserved Hunchback (Hb) protein had previously been shown to act as a morphogen in abdominal patterning, we asked which functions of Bcd could be performed by Hb. By reestablishing a proposed ancient regulatory circuitry in which maternal Hb controls zygotic hunchback expression, we show that Hb is able to form thoracic segments in the absence of Bcd.	NYU, Dept Biol, New York, NY 10003 USA; Univ Bayreuth, Lehrstuhl Genet, D-95447 Bayreuth, Germany	New York University; University of Bayreuth	Desplan, C (corresponding author), NYU, Dept Biol, 100 Washington Sq E, New York, NY 10003 USA.		Carleton, Alan/C-9721-2010	Carleton, Alan/0000-0001-5633-9159; Desplan, Claude/0000-0002-6914-1413; Wimmer, Ernst A./0000-0002-2480-2804				BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chan SK, 1997, NATURE, V388, P634, DOI 10.1038/41692; CURTIS D, 1995, DEVELOPMENT, V121, P1899; DRAPER B, 1996, CELL, V82, P205; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Dubnau J, 1996, NATURE, V379, P694, DOI 10.1038/379694a0; Gao Q, 1998, DEVELOPMENT, V125, P4185; Gray S, 1996, CURR OPIN CELL BIOL, V8, P358; HULSKAMP M, 1994, GENETICS, V138, P125; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; HULSKAMP M, 1989, NATURE, V338, P629, DOI 10.1038/338629a0; IRISH V, 1989, NATURE, V338, P646, DOI 10.1038/338646a0; Isaacs HV, 1999, EVOL DEV, V1, P143, DOI 10.1046/j.1525-142x.1999.99020.x; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Janody F, 2000, DEVELOPMENT, V127, P1573; Kosman D, 1997, DEVELOPMENT, V124, P1343; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; LUKOWITZ W, 1994, MECH DEVELOP, V45, P105, DOI 10.1016/0925-4773(94)90024-8; MACDONALD PM, 1986, NATURE, V324, P537, DOI 10.1038/324537a0; MARGOLIS JS, 1995, DEVELOPMENT, V121, P3067; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; Niessing D, 2000, MOL CELL, V5, P395, DOI 10.1016/S1097-2765(00)80434-7; PATEL NH, COMMUNICATION; Raff R.A., 1996, SHAPE LIFE; RiveraPomar R, 1996, TRENDS GENET, V12, P478, DOI 10.1016/0168-9525(96)10044-5; RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0; ROTHE M, 1992, NATURE, V359, P156, DOI 10.1038/359156a0; SANDER K, 1994, DEVELOPMENT S, V120, P187; SCHRODER C, 1988, EMBO J, V7, P2881, DOI 10.1002/j.1460-2075.1988.tb03145.x; SCHRODER R, 1993, ROUX ARCH DEV BIOL, V203, P34, DOI 10.1007/BF00539888; SCHULZ C, 1994, DEVELOPMENT, V120, P3043; SIMPSONBROSE M, 1994, CELL, V78, P855, DOI 10.1016/S0092-8674(94)90622-X; SOMMER R, 1991, DEVELOPMENT, V113, P419; SOMMER RJ, 1992, P NATL ACAD SCI USA, V89, P10782, DOI 10.1073/pnas.89.22.10782; Stauber M, 1999, P NATL ACAD SCI USA, V96, P3786, DOI 10.1073/pnas.96.7.3786; STJOHNSTON D, 1992, CELL, V68, P201; STRUHL G, 1989, NATURE, V338, P741, DOI 10.1038/338741a0; STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; WIMMER E, UNPUB; Wimmer EA, 1997, DEVELOPMENT, V124, P1509; Wolff C, 1995, DEVELOPMENT, V121, P4227; Wolff C, 1998, DEVELOPMENT, V125, P3645; XU X, 1994, DEVELOPMENT, V120, P277	49	67	67	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2476	2479		10.1126/science.287.5462.2476	http://dx.doi.org/10.1126/science.287.5462.2476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741965				2022-12-24	WOS:000086202200042
J	Parkhill, J; Achtman, M; James, KD; Bentley, SD; Churcher, C; Klee, SR; Morelli, G; Basham, D; Brown, D; Chillingworth, T; Davies, RM; Davis, P; Devlin, K; Feltwell, T; Hamlin, N; Holroyd, S; Jagels, K; Leather, S; Moule, S; Mungall, K; Quail, MA; Rajandream, MA; Rutherford, KM; Simmonds, M; Skelton, J; Whitehead, S; Spratt, BG; Barrell, BG				Parkhill, J; Achtman, M; James, KD; Bentley, SD; Churcher, C; Klee, SR; Morelli, G; Basham, D; Brown, D; Chillingworth, T; Davies, RM; Davis, P; Devlin, K; Feltwell, T; Hamlin, N; Holroyd, S; Jagels, K; Leather, S; Moule, S; Mungall, K; Quail, MA; Rajandream, MA; Rutherford, KM; Simmonds, M; Skelton, J; Whitehead, S; Spratt, BG; Barrell, BG			Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491	NATURE			English	Article							PILIN ANTIGENIC VARIATION; OUTER-MEMBRANE PROTEIN; MOLECULAR CHARACTERIZATION; VARIABLE EXPRESSION; GONORRHOEAE; GENE; RECOMBINATION; IDENTIFICATION; TRANSFORMATION; BIOSYNTHESIS	Neisseria meningitidis causes bacterial meningitis and is therefore responsible for considerable morbidity and mortality in both the developed and the developing world. Meningococci are opportunistic pathogens that colonize the nasopharynges and oropharynges of asymptomatic carriers. For reasons that are still mostly unknown, they occasionally gain access to the blood, and subsequently to the cerebrospinal fluid, to cause septicaemia and meningitis. N. meningitidis strains are divided into a number of serogroups on the basis of the immunochemistry of their capsular polysaccharides; serogroup A strains are responsible for major epidemics and pandemics of meningococcal disease, and therefore most of the morbidity and mortality associated with this disease. Here we have determined the complete genome sequence of a serogroup A strain of Neisseria meningitidis, Z2491 (ref. 1). The sequence is 2,184,406 base pairs in length, with an overall G+C content of 51.8%, and contains 2,121 predicted coding sequences. The most notable feature of the genome is the presence of many hundreds of repetitive elements, ranging from short repeats, positioned either singly or in large multiple arrays, to insertion sequences and gene duplications of one kilobase or more. Many of these repeats appear to be involved in genome fluidity and antigenic variation in this important human pathogen.	Sanger Ctr, Cambridge CB10 1SA, England; Max Planck Inst Mol Genet, D-14195 Berlin, Germany; Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3FY, England	Wellcome Trust Sanger Institute; Max Planck Society; University of Oxford	Parkhill, J (corresponding author), Sanger Ctr, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.		Spratt, Brian G/A-1676-2009; Parkhill, Julian/G-4703-2011; Rutherford, Kim/Y-7995-2018; Quail, michael/ABE-6131-2020	Parkhill, Julian/0000-0002-7069-5958; Rutherford, Kim/0000-0001-6277-726X; Davies, Robert/0000-0002-9983-1378; Davis, Paul/0000-0001-5545-0824; Achtman, Mark/0000-0001-6815-0070				Adhikari P, 1996, J BACTERIOL, V178, P2145, DOI 10.1128/jb.178.7.2145-2149.1996; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersson SGE, 1998, NATURE, V396, P133, DOI 10.1038/24094; Bateman A, 1999, NUCLEIC ACIDS RES, V27, P260, DOI 10.1093/nar/27.1.260; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; CORREIA FF, 1988, J BIOL CHEM, V263, P12194; Curnow AW, 1998, P NATL ACAD SCI USA, V95, P12838, DOI 10.1073/pnas.95.22.12838; DEMPSEY JAF, 1995, J BACTERIOL, V177, P6390, DOI 10.1128/jb.177.22.6390-6400.1995; DOMENIGHINI M, 1990, MOL MICROBIOL, V4, P787, DOI 10.1111/j.1365-2958.1990.tb00649.x; Frishman D, 1998, NUCLEIC ACIDS RES, V26, P2941, DOI 10.1093/nar/26.12.2941; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x; HIGGINS DG, 1992, COMPUT APPL BIOSCI, V8, P189; HowellAdams B, 1996, MOL MICROBIOL, V22, P509, DOI 10.1046/j.1365-2958.1996.00128.x; KLEE SR, IN PRESS INFECT IMMU; Lewis LA, 1997, MOL MICROBIOL, V23, P737, DOI 10.1046/j.1365-2958.1997.2501619.x; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mehr IJ, 1998, MOL MICROBIOL, V30, P697, DOI 10.1046/j.1365-2958.1998.01089.x; Pettersson A, 1998, MOL MICROBIOL, V27, P599, DOI 10.1046/j.1365-2958.1998.00707.x; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; SARKARI J, 1994, MOL MICROBIOL, V13, P207, DOI 10.1111/j.1365-2958.1994.tb00416.x; Smith NH, 1999, MOL BIOL EVOL, V16, P773, DOI 10.1093/oxfordjournals.molbev.a026162; STOJILJKOVIC I, 1995, MOL MICROBIOL, V15, P531, DOI 10.1111/j.1365-2958.1995.tb02266.x; Swartley JS, 1998, J BACTERIOL, V180, P1533, DOI 10.1128/JB.180.6.1533-1539.1998; VANDERENDE A, 1995, J BACTERIOL, V177, P2475, DOI 10.1128/jb.177.9.2475-2480.1995; VONDERHAAR RA, 1994, J BACTERIOL, V176, P6207, DOI 10.1128/jb.176.20.6207-6213.1994; WAINWRIGHT LA, 1994, MOL MICROBIOL, V13, P75, DOI 10.1111/j.1365-2958.1994.tb00403.x; ZHOU JJ, 1992, MOL MICROBIOL, V6, P2135, DOI 10.1111/j.1365-2958.1992.tb01387.x	30	573	1193	0	17	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					502	506		10.1038/35006655	http://dx.doi.org/10.1038/35006655			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761919				2022-12-24	WOS:000086257700050
J	Tharun, S; He, WH; Mayes, AE; Lennertz, P; Beggs, JD; Parker, R				Tharun, S; He, WH; Mayes, AE; Lennertz, P; Beggs, JD; Parker, R			Yeast Sm-like proteins function in mRNA decapping and decay	NATURE			English	Article							MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; IDENTIFICATION; DEADENYLATION; DEGRADATION; TURNOVER; U6	One of the main mechanisms of messenger RNA degradation in eukaryotes occurs by deadenylation-dependent decapping which leads to 5'-to-3' decay(1,2). A family of Sm-like (Lsm) proteins has been identified, members of which contain the 'Sm' sequence motif, form a complex with U6 small nuclear RNA and are required for pre-mRNA splicing(3-9). Here we show that mutations in seven yeast Lsm proteins (Lsm1-Lsm7) also lead to inhibition of mRNA decapping. In addition, the Lsm1-Lsm7 proteins coimmunoprecipitate with the mRNA decapping enzyme (Dcp1), a decapping activator (Pat1/Mrt1) and with mRNA. This indicates that the Lsm proteins may promote decapping by interactions with the mRNA and the decapping machinery. In addition, the Lsm complex that functions in mRNA decay appears to be distinct from the U6-associated Lsm complex, indicating that Lsm proteins form specific complexes that affect different aspects of mRNA metabolism.	Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; Univ Arizona, Howard Hughes Med Inst, Tucson, AZ 85721 USA; Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh EH9 3JR, Midlothian, Scotland; Unilever Res Colworth, Sharnbrook MK44 1LQ, Beds, England	University of Arizona; Howard Hughes Medical Institute; University of Arizona; University of Edinburgh; Unilever	Parker, R (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.	rrparker@u.arizona.edu	, jbeggs/N-9551-2019; Beggs, Jean/H-4861-2011	Beggs, Jean/0000-0002-8179-6519				Achsel T, 1999, EMBO J, V18, P5789, DOI 10.1093/emboj/18.20.5789; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Boeck R, 1998, MOL CELL BIOL, V18, P5062, DOI 10.1128/MCB.18.9.5062; COOPER M, 1995, EMBO J, V14, P2066, DOI 10.1002/j.1460-2075.1995.tb07198.x; DECKER CJ, 1993, GENE DEV, V7, P1632, DOI 10.1101/gad.7.8.1632; Dix I, 1999, RNA, V5, P360, DOI 10.1017/S1355838299981396; Dunckley T, 1999, EMBO J, V18, P5411, DOI 10.1093/emboj/18.19.5411; FROMONTRACINE M, UNPUB P NATL ACAD SC; Hatfield L, 1996, MOL CELL BIOL, V16, P5830; He WH, 1999, METHODS, V17, P3, DOI 10.1006/meth.1998.0701; HERMANN H, 1995, EMBO J, V14, P2076, DOI 10.1002/j.1460-2075.1995.tb07199.x; Jacobson A, 1996, ANNU REV BIOCHEM, V65, P693, DOI 10.1146/annurev.bi.65.070196.003401; Kambach C, 1999, CELL, V96, P375, DOI 10.1016/S0092-8674(00)80550-4; Mayes AE, 1999, EMBO J, V18, P4321, DOI 10.1093/emboj/18.15.4321; MUHLRAD D, 1994, GENE DEV, V8, P855, DOI 10.1101/gad.8.7.855; Pannone BK, 1998, EMBO J, V17, P7442, DOI 10.1093/emboj/17.24.7442; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; SERAPHIN B, 1995, EMBO J, V14, P2089, DOI 10.1002/j.1460-2075.1995.tb07200.x; Stevens SW, 1999, P NATL ACAD SCI USA, V96, P7226, DOI 10.1073/pnas.96.13.7226; Tharun S, 1999, GENETICS, V151, P1273; Wang XQ, 1996, NUCLEIC ACIDS RES, V24, P4791, DOI 10.1093/nar/24.23.4791	23	329	345	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					515	518		10.1038/35006676	http://dx.doi.org/10.1038/35006676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761922	Green Published			2022-12-24	WOS:000086257700053
J	Berlyne, G; Barnes, N				Berlyne, G; Barnes, N			No role for NO in asthma?	LANCET			English	Editorial Material							EXHALED NITRIC-OXIDE; INHIBITION; AIR		London Chest Hosp, Dept Resp Med, London E2 9JX, England	University of London; Queen Mary University London	Berlyne, G (corresponding author), London Chest Hosp, Dept Resp Med, London E2 9JX, England.							de Gouw HWFM, 1999, THORAX, V54, P1033, DOI 10.1136/thx.54.11.1033; Hamad AM, 1999, EUR RESPIR J, V14, P702, DOI 10.1034/j.1399-3003.1999.14c34.x; KHARITONOV SA, 1995, EUR RESPIR J, V8, P295, DOI 10.1183/09031936.95.08020295; Kharitonov SA, 1996, AM J RESP CRIT CARE, V153, P454, DOI 10.1164/ajrccm.153.1.8542158; Kharitonov SA, 1996, EUR RESPIR J, V9, P196, DOI 10.1183/09031936.96.09020196; Lim S, 1999, AM J RESP CRIT CARE, V159, P22, DOI 10.1164/ajrccm.159.1.9706006; Saleh D, 1998, FASEB J, V12, P929, DOI 10.1096/fasebj.12.11.929; Silkoff PE, 1999, AM J RESP CRIT CARE, V159, P940, DOI 10.1164/ajrccm.159.3.9805044; Silkoff PE, 1997, AM J RESP CRIT CARE, V155, P260, DOI 10.1164/ajrccm.155.1.9001322; Taylor DA, 1998, AM J RESP CRIT CARE, V158, P99, DOI 10.1164/ajrccm.158.1.9709091; Taylor DA, 1998, THORAX, V53, P483, DOI 10.1136/thx.53.6.483; van Rensen ELJ, 1999, THORAX, V54, P403, DOI 10.1136/thx.54.5.403; Yates DH, 1996, EUR RESPIR J, V9, P1130, DOI 10.1183/09031936.96.09061130	13	16	19	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1029	1030		10.1016/S0140-6736(00)02027-4	http://dx.doi.org/10.1016/S0140-6736(00)02027-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744082				2022-12-24	WOS:000086380800003
J	Hakala, M; Niemela, RK				Hakala, M; Niemela, RK			Does autonomic nervous impairment have a role in pathophysiology of Sjogren's syndrome	LANCET			English	Editorial Material							AUTOANTIBODIES; PROGRESSION		Univ Oulu, Dept Internal Med, Div Rheumatol, FIN-90220 Oulu, Finland	University of Oulu	Hakala, M (corresponding author), Univ Oulu, Dept Internal Med, Div Rheumatol, FIN-90220 Oulu, Finland.							Andonopoulos AP, 1998, J RHEUMATOL, V25, P2385; Bacman S, 1998, INVEST OPHTH VIS SCI, V39, P151; Barendregt PJ, 1999, ANN RHEUM DIS, V58, P746, DOI 10.1136/ard.58.12.746; Fox R I, 1999, Curr Opin Rheumatol, V11, P364, DOI 10.1097/00002281-199909000-00007; JONSSON R, 1993, BRIT J RHEUMATOL, V32, P578; KAUTZNER J, 1995, HEART RATE VARIABILI, P165; Kovacs L, 2000, ANN RHEUM DIS, V59, P48, DOI 10.1136/ard.59.1.48; Mandl T, 1997, SCAND J RHEUMATOL, V26, P253, DOI 10.3109/03009749709105312; Robinson CP, 1998, P NATL ACAD SCI USA, V95, P7538, DOI 10.1073/pnas.95.13.7538; Tenovuo J, 1994, TXB CLIN CARIOLOGY, P17; Tornwall J, 1997, LANCET, V349, P1814, DOI 10.1016/S0140-6736(05)61694-7; Zoukhri D, 1998, CLIN IMMUNOL IMMUNOP, V89, P126, DOI 10.1006/clin.1998.4597	12	13	14	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1032	1033		10.1016/S0140-6736(00)02030-4	http://dx.doi.org/10.1016/S0140-6736(00)02030-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744085				2022-12-24	WOS:000086380800006
J	Yanovski, JA; Yanovski, SZ; Sovik, KN; Nguyen, TT; O'Neil, PM; Sebring, NG				Yanovski, JA; Yanovski, SZ; Sovik, KN; Nguyen, TT; O'Neil, PM; Sebring, NG			A prospective study of holiday weight gain	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; SEASONAL AFFECTIVE-DISORDER; UNITED-STATES; SMOKING CESSATION; US ADULTS; WOMEN; OVERWEIGHT; PREVALENCE; AGE; OBESITY	Background: It is commonly asserted that the average American gains 5 lb (2.3 kg) or more over the holiday period between Thanksgiving and New Year's Day, yet few data support this statement. Methods: To estimate actual holiday-related weight variation, we measured body weight in a convenience sample of 195 adults. The subjects were weighed four times at intervals of six to eight weeks, so that weight change was determined for three periods: preholiday (from late September or early October to mid-November), holiday (from mid-November to early or mid-January), and postholiday (from early or mid-January to late February or early March). A final measurement of body weight was obtained in 165 subjects the following September or October. Data on other vital signs and self-reported health measures were obtained from the patients in order to mask the main outcome of interest. Results: The mean (+/-SD) weight increased significantly during the holiday period (gain, 0.37+/-1.52 kg; P<0.001), but not during the preholiday period (gain, 0.18+/-1.49 kg; P=0.09) or the postholiday period (loss, 0.07+/-1.14 kg; P=0.36). As compared with their weight in late September or early October, the study subjects had an average net weight gain of 0.48+/-2.22 kg in late February or March (P=0.003). Between February or March and the next September or early October, there was no significant additional change in weight (gain, 0.21 kg+/-2.3 kg; P=0.13) for the 165 participants who returned for follow-up. Conclusions: The average holiday weight gain is less than commonly asserted. Since this gain is not reversed during the spring or summer months, the net 0.48-kg weight gain in the fall and winter probably contributes to the increase in body weight that frequently occurs during adulthood. (N Engl J Med 2000;342:861-7.) (C)2000, Massachusetts Medical Society.	NICHHD, Unit Growth & Obes, Dev Endocrinol Branch, NIH, Bethesda, MD 20892 USA; NIDDKD, Div Digest Dis & Nutr, NIH, Bethesda, MD 20892 USA; NIDDKD, Div Nutr Res Coordinat, NIH, Bethesda, MD 20892 USA; NIH, Warren G Magnuson Clin Ctr, Dept Nutr, Bethesda, MD 20892 USA; Med Univ S Carolina, Charleston, SC 29425 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; Medical University of South Carolina	Yanovski, JA (corresponding author), NICHHD, Unit Growth & Obes, Dev Endocrinol Branch, NIH, Bldg 10,Rm 10N262,10 Ctr Dr,MSC 1862, Bethesda, MD 20892 USA.			O'Neil, Patrick/0000-0002-0388-4046; Yanovski, Jack/0000-0001-8542-1637	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000641] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HD000641, ZIA HD000641-14] Funding Source: Medline; NICHD NIH HHS [Z01 HD-00641] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDERSSON I, 1992, INT J OBESITY, V16, P1013; Baker RC, 1998, HEALTH PSYCHOL, V17, P367, DOI 10.1037/0278-6133.17.4.367; BALLARDBARBASH R, 1990, CANCER RES, V50, P2152; Boutelle KN, 1999, HEALTH PSYCHOL, V18, P364, DOI 10.1037/0278-6133.18.4.364; CARLEY T, 1997, EXERCISE TIPS REDUCE; *CNN INT, 1995, AV AM GAINS 7 10 POU; COLDITZ GA, 1990, AM J CLIN NUTR, V51, P1100, DOI 10.1093/ajcn/51.6.1100; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; FLEGAL KM, 1995, NEW ENGL J MED, V333, P1165, DOI 10.1056/NEJM199511023331801; GOLDBOURT U, 1991, ISRAEL J MED SCI, V27, P264; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Jeffery RW, 1997, INT J OBESITY, V21, P457, DOI 10.1038/sj.ijo.0800431; Kuczmarski RJ, 1997, OBES RES, V5, P542, DOI 10.1002/j.1550-8528.1997.tb00575.x; MANSON JAE, 1990, NEW ENGL J MED, V322, P882, DOI 10.1056/NEJM199003293221303; MOE K, 1996, KEEPING HOLIDAY POUN; NAJJAR M, 1987, VITAL HLTH STAT, V11; NASH W, 1997, RICH HOLIDAY FOOD LE, P3; Nurse G T, 1968, Cent Afr J Med, V14, P122; *OH U, 1997, PART HEART RIGHT APP; PANTERBRICK C, 1995, J BIOSOC SCI, V27, P215, DOI 10.1017/S0021932000022719; PAWSON IG, 1982, SOC SCI MED, V16, P183, DOI 10.1016/0277-9536(82)90021-1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; ROOKUS MA, 1987, HUM BIOL, V59, P599; ROSENTHAL NE, 1987, ANN NY ACAD SCI, V499, P216, DOI 10.1111/j.1749-6632.1987.tb36213.x; Sahyoun NR, 1999, AM J PUBLIC HEALTH, V89, P391, DOI 10.2105/AJPH.89.3.391; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; SHAH M, 1991, INT J OBESITY, V15, P499; Shimamoto H, 1998, JPN J PHYS FIT SPORT, V47, P509, DOI 10.7600/jspfsm1949.47.509; SILVERSTEIN LJ, 1996, J AM DIET ASSOC, V96, pA30; SMITH N, 1999, HOLIDAY WEIGHT GAIN; SOBAL J, 1992, SOC SCI MED, V35, P915, DOI 10.1016/0277-9536(92)90106-Z; *TEX MED ASS, 1998, HOL EAT; THOMPSON C, 1988, J AFFECT DISORDERS, V14, P257, DOI 10.1016/0165-0327(88)90043-2; VANLIERE MJ, 1994, BRIT J NUTR, V72, P479, DOI 10.1079/BJN19940049; VANSTAVEREN WA, 1986, INT J OBESITY, V10, P133; WESCOTT WL, 1998, SURVIVAL STRATEGIES; WILLIAMSON DF, 1991, NEW ENGL J MED, V324, P739, DOI 10.1056/NEJM199103143241106; WILLIAMSON DF, 1990, ARCH INTERN MED, V150, P665, DOI 10.1001/archinte.150.3.665; WILLIAMSON DF, 1994, INT J OBESITY, V18, P561; WILLIAMSON DF, 1993, ANN INTERN MED, V119, P646, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00004; WING RR, 1991, ARCH INTERN MED, V151, P97, DOI 10.1001/archinte.151.1.97; Wolfe WS, 1997, INT J OBESITY, V21, P802, DOI 10.1038/sj.ijo.0800478; ZAHORSKAMARKIEWICZ B, 1980, INT J OBESITY, V4, P139; 1998, OBES RES, V6, P464	45	227	231	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2000	342	12					861	867		10.1056/NEJM200003233421206	http://dx.doi.org/10.1056/NEJM200003233421206			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296FU	10727591	Green Accepted			2022-12-24	WOS:000086014100006
J	Jackson, R				Jackson, R			Updated New Zealand cardiovascular disease risk-benefit prediction guide	BMJ-BRITISH MEDICAL JOURNAL			English	Article									Univ Auckland, Dept Community Hlth, Auckland, New Zealand	University of Auckland	Jackson, R (corresponding author), Univ Auckland, Dept Community Hlth, Auckland, New Zealand.	rt.jackson@auckland.ac.nz		Jackson, Rod/0000-0001-5914-6934				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; MACMAHON S, 1993, J VASC MED BIOL, V4, P265; Mann JI, 1996, NEW ZEAL MED J, V109, P224; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; National Health Committee, 1995, GUID MAN MILDL RAIS; Shepherd J, 1996, LANCET, V348, P1339	7	177	180	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					709	710		10.1136/bmj.320.7236.709	http://dx.doi.org/10.1136/bmj.320.7236.709			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710588	Green Published			2022-12-24	WOS:000085895300029
J	Tanaka, H; Arakawa, H; Yamaguchi, T; Shiraishi, K; Fukuda, S; Matsui, K; Takei, Y; Nakamura, Y				Tanaka, H; Arakawa, H; Yamaguchi, T; Shiraishi, K; Fukuda, S; Matsui, K; Takei, Y; Nakamura, Y			A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage	NATURE			English	Article							WILD-TYPE P53; SMALL-SUBUNIT; SACCHAROMYCES-CEREVISIAE; MAMMALIAN-CELLS; UV IRRADIATION; PROTEIN; EXPRESSION; REPAIR; SENSITIVITY; AGENTS	The p53 gene is frequently inactivated in human cancers. Here we have isolated a p53-inducible gene, p53R2,by using differential display to examine messenger RNAs in a cancer-derived human cell line carrying a highly regulated wild-type p53 expression system. p53R2 contains a p53-binding sequence in intron 1 and encodes a 351-amino-acid peptide with striking similarity to the ribonucleotide reductase small subunit(R2), which is important in DNA synthesis during cell division. Expression of p53R2, but not R2, was induced by ultraviolet and gamma-irradiation and adriamycin treatment in a wild-type p53-dependent manner. Induction of p53R2 in p53-deficient cells caused G2/M arrest and prevented cells from death in response to adriamycin, Inhibition of endogenous p53R2 expression in cells that have an intact p53-dependent DNA damage checkpoint reduced ribonucleotide reductase activity, DNA repair and cell survival after exposure to various genotoxins. Our results indicate that p53R2 encodes a ribonucleotide reductase that is directly involved in the p53 checkpoint for repair of damaged DNA, The discovery of p53R2 clarifies a relationship between a ribonucleotide reductase activity involved in repair of damaged DNA and tumour suppression by p53.	Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Nakamura, Y (corresponding author), Univ Tokyo, Inst Med Sci, Mol Med Lab, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Arakawa, Hirofumi/L-3459-2013	Arakawa, Hirofumi/0000-0001-6077-0638				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Ceraline J, 1998, INT J CANCER, V75, P432, DOI 10.1002/(SICI)1097-0215(19980130)75:3<432::AID-IJC17>3.3.CO;2-J; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; ELLEDGE SJ, 1990, GENE DEV, V4, P740, DOI 10.1101/gad.4.5.740; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; Eller MS, 1997, P NATL ACAD SCI USA, V94, P12627, DOI 10.1073/pnas.94.23.12627; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; ENGSTROM Y, 1988, EMBO J, V7, P1615, DOI 10.1002/j.1460-2075.1988.tb02987.x; ENGSTROM Y, 1984, EMBO J, V3, P863, DOI 10.1002/j.1460-2075.1984.tb01897.x; ERIKSSON S, 1984, J BIOL CHEM, V259, P1695; ERIKSSON S, 1981, J BIOL CHEM, V256, P9436; Ford JM, 1997, J BIOL CHEM, V272, P28073, DOI 10.1074/jbc.272.44.28073; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Furuhata T, 1996, ONCOGENE, V13, P1965; GREENBLATT MS, 1994, CANCER RES, V54, P4855; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; HARPER JW, 1993, CELL, V75, P805; Hawkins DS, 1996, CANCER RES, V56, P892; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; KASTAN MB, 1991, CANCER RES, V51, P6304; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Ng CC, 1999, GENE CHROMOSOME CANC, V26, P329, DOI 10.1002/(SICI)1098-2264(199912)26:4<329::AID-GCC7>3.0.CO;2-C; Nishimori H, 1997, ONCOGENE, V15, P2145, DOI 10.1038/sj.onc.1201542; REDDY GPV, 1982, J BIOL CHEM, V257, P2526; REICHARD P, 1993, SCIENCE, V260, P1773, DOI 10.1126/science.8511586; Smith ML, 1997, P NATL ACAD SCI USA, V94, P12255, DOI 10.1073/pnas.94.23.12255; Takei Y, 1998, GENE CHROMOSOME CANC, V23, P1; TOKINO T, 1994, HUM MOL GENET, V3, P1537, DOI 10.1093/hmg/3.9.1537; Urano T, 1997, CANCER RES, V57, P3281; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WRIGHT JA, 1990, BIOCHEM CELL BIOL, V68, P1364, DOI 10.1139/o90-199; ZHOU Z, 1993, CELL, V75, P1119, DOI 10.1016/0092-8674(93)90321-G	41	725	746	2	57	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					42	49		10.1038/35003506	http://dx.doi.org/10.1038/35003506			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716435				2022-12-24	WOS:000085775100038
J	Garcia-Castro, MI; Vielmetter, E; Bronner-Fraser, M				Garcia-Castro, MI; Vielmetter, E; Bronner-Fraser, M			N-cadherin, a cell adhesion molecule involved in establishment of embryonic left-right asymmetry	SCIENCE			English	Article							CHICK EMBRYOGENESIS; VERTEBRATE HEART; PRIMITIVE-STREAK; PATHWAY; PITX2; EXPRESSION; PROTEIN; SIGNALS; MOUSE; FGF8	Within the bilaterally symmetric vertebrate body plan, many organs develop asymmetrically, Here, it is demonstrated that a cell adhesion molecule, N-cadherin, is one of the earliest proteins to be asymmetrically expressed in the chicken embryo and that its activity is required during gastrulation for proper establishment of the Left-right axis. Blocking N-cadherin function randomizes heart Looping and alters the expression of Snail and Pitx2, Later components of the molecular cascade thar regulate left-right asymmetry. However, the expression of other components of this cascade (Nodal and Lefty) was unchanged after blocking N-cadherin function, suggesting the existence of parallel pathways in the establishment of Left-right morphogenesis. Here, the results suggest that N-cadherin-mediated cell adhesion events are required for establishment of left-right asymmetry.	CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA	California Institute of Technology	Garcia-Castro, MI (corresponding author), CALTECH, Div Biol 139 74, Pasadena, CA 91125 USA.			Bronner, Marianne/0000-0003-4274-1862; Garcia-Castro, Martin I./0000-0001-5128-0004	NICHD NIH HHS [HD 15527] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD015527] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; COOKE J, 1995, NATURE, V374, P681, DOI 10.1038/374681a0; DEHAAN RL, 1963, EXP CELL RES, V29, P544, DOI 10.1016/S0014-4827(63)80016-6; DEHAAN RL, 1966, CONTRIB EMBRYOL, V263, P111; DEHAAN RL, 1965, ORGANOGENESIS, P377; Esteban CR, 1999, NATURE, V401, P243, DOI 10.1038/45738; Fishman MC, 1997, DEVELOPMENT, V124, P2099; GARCIAMARTINEZ V, 1993, DEV BIOL, V159, P706, DOI 10.1006/dbio.1993.1276; GARCIAMARTINEZ V, 1993, J EXP ZOOL, V267, P431, DOI 10.1002/jez.1402670409; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HARA K, 1978, MILESTONE HALF CENTU, pCH7; Harvey RP, 1998, CELL, V94, P273, DOI 10.1016/S0092-8674(00)81468-3; HATTA K, 1986, NATURE, V320, P447, DOI 10.1038/320447a0; HATTA K, 1985, P NATL ACAD SCI USA, V82, P2789, DOI 10.1073/pnas.82.9.2789; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hensen V., 1876, Z ANAT ENTW GESCH, V1, P353; Isaac A, 1997, SCIENCE, V275, P1301, DOI 10.1126/science.275.5304.1301; King T, 1999, CURR BIOL, V9, pR18, DOI 10.1016/S0960-9822(99)80036-0; KNECHT AK, 1995, DEVELOPMENT, V121, P1927; LEPORI N G, 1969, Monitore Zoologico Italiano, V3, P33; Levin M, 1999, DEVELOPMENT, V126, P4703; Levin M, 1998, DEV BIOL, V203, P90, DOI 10.1006/dbio.1998.9024; LEVIN M, 1995, CELL, V82, P803, DOI 10.1016/0092-8674(95)90477-8; Linask KK, 1997, DEV BIOL, V185, P148, DOI 10.1006/dbio.1997.8570; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Nakagawa S, 1997, DEV GROWTH DIFFER, V39, P451; NEW DAT, 1955, J EMBRYOL EXP MORPH, V3, P320; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Pagan-Westphal SM, 1998, CELL, V93, P25, DOI 10.1016/S0092-8674(00)81143-5; Ramsdell AF, 1998, TRENDS GENET, V14, P459, DOI 10.1016/S0168-9525(98)01599-6; ROSENQUIST GC, 1970, DEV BIOL, V22, P461, DOI 10.1016/0012-1606(70)90163-6; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Sefton M, 1998, DEVELOPMENT, V125, P3111; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Wetzel R., 1929, Archiv fuer Entwicklungsmechanik Berlin, V119, P188; YOKOUCHIY, 1999, CELL, V98, P573; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7; Yost HJ, 1999, CURR OPIN GENET DEV, V9, P422	41	117	121	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2000	288	5468					1047	1051		10.1126/science.288.5468.1047	http://dx.doi.org/10.1126/science.288.5468.1047			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10807574				2022-12-24	WOS:000086988400036
J	Mills, JL				Mills, JL			Fortification of foods with folic acid - How much is enough?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							NEURAL-TUBE DEFECTS; COBALAMIN DEFICIENCY; PERNICIOUS-ANEMIA; FOLATE; PREVENTION; SUPPLEMENTATION		NICHHD, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Mills, JL (corresponding author), NICHHD, Bethesda, MD 20892 USA.			Mills, James/0000-0003-4496-332X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002502] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD002502] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 1999, Pediatrics, V104, P325, DOI 10.1542/peds.104.2.325; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; *BUR CENS, 1998, US POP EST AG SEX RA; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P325; Christen WG, 2000, ARCH INTERN MED, V160, P422, DOI 10.1001/archinte.160.4.422; CZEIZEL AE, 1992, NEW ENGL J MED, V327, P1832, DOI 10.1056/NEJM199212243272602; DALY LE, 1995, JAMA-J AM MED ASSOC, V274, P1698, DOI 10.1001/jama.274.21.1698; Daly S, 1997, LANCET, V350, P1666, DOI 10.1016/S0140-6736(97)07247-4; *FOOD DRUG ADM, 1996, FED REGISTER, V61, P8786; *FOOD NUTR BOARD I, 1998, DIET REF TAK THIAM R; HALE RW, 1998, COMMUNICATION   0428; Jacques PF, 1999, NEW ENGL J MED, V340, P1449, DOI 10.1056/NEJM199905133401901; Lawrence JM, 1999, LANCET, V354, P915, DOI 10.1016/S0140-6736(99)03227-4; LINDENBAUM J, 1994, AM J CLIN NUTR, V60, P2, DOI 10.1093/ajcn/60.1.2; *MRC VIT STUD RES, 1997, LANCET, V338, P131; Oakley GP, 1999, NEW ENGL J MED, V341, P1546, DOI 10.1056/NEJM199911113412012; Parry T E, 1987, Baillieres Clin Haematol, V1, P315, DOI 10.1016/S0950-3536(87)80005-7; Rader JI, 1999, FOOD TESTING ANAL, V5, P14; SAVAGE D, 1983, AM J MED, V74, P765, DOI 10.1016/0002-9343(83)91064-1; Savage D.G., 1995, FOLATE HLTH DIS, V1st, P237; SAVAGE DG, 1995, BAILLIERE CLIN HAEM, V8, P657, DOI 10.1016/S0950-3536(05)80225-2; SHOJANIA AM, 1980, CAN MED ASSOC J, V123, P1127; SINOW RM, 1987, ARCH INTERN MED, V147, P1828, DOI 10.1001/archinte.147.10.1828; U. S. Food and Drug Administration, 1993, FED REGISTER, V58, P53305; *US FDA, 1996, FED REGISTER, V61, P8781; Watkins ML, 1999, NEW ENGL J MED, V341, P923; 1947, N ENGL J MED, V237, P713; 1980, FED REG, V45, P69043	28	75	77	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2000	342	19					1442	1445		10.1056/NEJM200005113421911	http://dx.doi.org/10.1056/NEJM200005113421911			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312JR	10805832				2022-12-24	WOS:000086940600011
J	Unger, MA; Chou, HP; Thorsen, T; Scherer, A; Quake, SR				Unger, MA; Chou, HP; Thorsen, T; Scherer, A; Quake, SR			Monolithic microfabricated valves and pumps by multilayer soft lithography	SCIENCE			English	Article							CAPILLARY ELECTROPHORESIS; ELECTROOSMOTIC FLOW; SYSTEMS; CHIP; DIELECTROPHORESIS	Soft Lithography is an alternative to silicon-based micromachining that uses replica molding of nontraditional elastomeric materials to fabricate stamps and microfluidic channels. We describe here an extension to the soft Lithography. paradigm. multilayer soft lithography, with which devices consisting of multiple Layers may be fabricated from soft materials. We used this technique to build active microfluidic systems containing on-off valves, switching valves, and pumps entirely out of elastomer. The softness of these materials allows the device areas to be reduced by more than two orders of magnitude compared with silicon-based devices. The other advantages of soft Lithography, such as rapid prototyping, ease of fabrication, and biocompatibility, are retained.	CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology	Quake, SR (corresponding author), CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA.				NIDA NIH HHS [DA-9121] Funding Source: Medline; NINDS NIH HHS [NS-11756] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS011756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA009121] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		BRECHTEL R, 1995, J CHROMATOGR A, V716, P97, DOI 10.1016/0021-9673(95)00717-2; Buchaillot L, 1997, JPN J APPL PHYS 2, V36, pL794, DOI 10.1143/JJAP.36.L794; Delamarche E, 1997, SCIENCE, V276, P779, DOI 10.1126/science.276.5313.779; Duffy DC, 1999, J MICROMECH MICROENG, V9, P211, DOI 10.1088/0960-1317/9/3/301; Duffy DC, 1998, ANAL CHEM, V70, P4974, DOI 10.1021/ac980656z; Effenhauser CS, 1997, ELECTROPHORESIS, V18, P2203, DOI 10.1002/elps.1150181211; Effenhauser CS, 1997, ANAL CHEM, V69, P3451, DOI 10.1021/ac9703919; FAHRENBERG J, 1995, J MICROMECH MICROENG, V5, P77; Fu AY, 1999, NAT BIOTECHNOL, V17, P1109, DOI 10.1038/15095; Goll C, 1996, J MICROMECH MICROENG, V6, P77, DOI 10.1088/0960-1317/6/1/017; Gravesen P., 1993, Journal of Micromechanics and Microengineering, V3, P168, DOI 10.1088/0960-1317/3/4/002; HARRISON DJ, 1993, SCIENCE, V261, P895, DOI 10.1126/science.261.5123.895; Hosokawa K, 1999, ANAL CHEM, V71, P4781, DOI 10.1021/ac990571d; Ikuta K., 1994, Proceedings IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robotic Systems (Cat. No.94CH3404-1), P1, DOI 10.1109/MEMSYS.1994.555588; Jacobson SC, 1999, ANAL CHEM, V71, P4455, DOI 10.1021/ac990576a; JACOBSON SC, 1994, ANAL CHEM, V66, P1114, DOI 10.1021/ac00079a029; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; KUHN L, 1978, IEEE T ELECTRON DEV, V25, P1257, DOI 10.1109/T-ED.1978.19261; Lin LY, 1999, IEEE J SEL TOP QUANT, V5, P4, DOI 10.1109/2944.748098; Lotters JC, 1997, J MICROMECH MICROENG, V7, P145, DOI 10.1088/0960-1317/7/3/017; Lucy CA, 1996, ANAL CHEM, V68, P300, DOI 10.1021/ac950632h; Muller RS, 1998, P IEEE, V86, P1705, DOI 10.1109/5.704276; Pethig R, 1997, TRENDS BIOTECHNOL, V15, P426, DOI 10.1016/S0167-7799(97)01096-2; PJA, 1999, SCIENCE, V285, P83; ROYLANCE LM, 1979, IEEE T ELECTRON DEV, V26, P1911, DOI 10.1109/T-ED.1979.19795; Schasfoort RBM, 1999, SCIENCE, V286, P942, DOI 10.1126/science.286.5441.942; Shoji S, 1998, TOP CURR CHEM, V194, P163; TUFTE ON, 1962, J APPL PHYS, V33, P3322, DOI 10.1063/1.1931164; WASHIZU M, 1994, IEEE T IND APPL, V30, P835, DOI 10.1109/28.297897; Xia YN, 1996, SCIENCE, V273, P347, DOI 10.1126/science.273.5273.347; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yang X, 1998, SENSOR ACTUAT A-PHYS, V64, P101, DOI 10.1016/S0924-4247(97)01660-9; Yazdi N, 1998, P IEEE, V86, P1640, DOI 10.1109/5.704269; Young A. M., 1999, Transactions of the ASME. Journal of Biomechanical Engineering, V121, P2, DOI 10.1115/1.2798039; [No title captured]	35	3091	3542	36	1273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					113	116		10.1126/science.288.5463.113	http://dx.doi.org/10.1126/science.288.5463.113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753110				2022-12-24	WOS:000086387700044
J	Nakanishi-Matsui, M; Zheng, YW; Sulciner, DJ; Weiss, EJ; Ludeman, MJ; Coughlin, SR				Nakanishi-Matsui, M; Zheng, YW; Sulciner, DJ; Weiss, EJ; Ludeman, MJ; Coughlin, SR			PAR3 is a cofactor for PAR4 activation by thrombin	NATURE			English	Article							RECEPTOR ACTIVATION; SPECIFICITY; CLEAVAGE; CLONING	Identification of the mechanisms by which the coagulation protease thrombin activates platelets is critical for understanding haemostasis and thrombosis. Thrombin activates cells at least in part by cleaving protease-activated G-protein-coupled receptors (PARs)(1). PAR3 and PAR4 are thrombin receptors expressed in mouse platelets(2,3). Inhibition of thrombin binding to mPAR3 (ref. 4) and knockout of the mPAR3 gene 3 inhibited mouse platelet activation at low but not high concentrations of thrombin. Thus PAR3 is important for thrombin signalling in mouse platelets. Expression of human PAR3 in heterologous expression systems reliably resulted in responsiveness to thrombin(2). Curiously, despite its importance for the activation of mouse platelets by thrombin 3,4, mouse PAR3 (mPAR3) did not lead to thrombin signalling even when overexpressed. We now report that mPAR3 and mPAR4 interact in a novel way: mPAR3 does not itself mediate transmembrane signalling but instead functions as a cofactor for the cleavage and activation of mPAR4 by thrombin. This establishes a paradigm for cofactor-assisted PAR activation and for a G-protein-coupled receptor's acting as an accessory molecule to present ligand to another receptor.	Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Daiichi Res Ctr, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Coughlin, SR (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, 505 Parnassus Ave, San Francisco, CA 94143 USA.			Nakanishi-Matsui, Mayumi/0000-0001-9219-7442				CHEN J, 1994, J BIOL CHEM, V269, P16041; Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; COLMAN RW, 1994, HEMOSTASIS THROMBOSI, P3; Coughlin SR, 1999, P NATL ACAD SCI USA, V96, P11023, DOI 10.1073/pnas.96.20.11023; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Ishihara H, 1998, BLOOD, V91, P4152, DOI 10.1182/blood.V91.11.4152.411k22_4152_4157; Ishihara H, 1997, NATURE, V386, P502, DOI 10.1038/386502a0; ISHII K, 1995, J BIOL CHEM, V270, P16435, DOI 10.1074/jbc.270.27.16435; ISHII K, 1993, J BIOL CHEM, V268, P9780; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; Kahn ML, 1999, J CLIN INVEST, V103, P879, DOI 10.1172/JCI6042; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Klagsbrun M, 1992, Semin Cancer Biol, V3, P81; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; LIU LW, 1991, J BIOL CHEM, V266, P16977; MATHEWS II, 1994, BIOCHEMISTRY-US, V33, P3266, DOI 10.1021/bi00177a018; OKAMURA T, 1978, J BIOL CHEM, V253, P3435; Sage S.O., 1996, PRACT APPROACH SER, P67; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; VIVIEN D, 1995, J BIOL CHEM, V270, P7134, DOI 10.1074/jbc.270.13.7134; VU TKH, 1991, CELL, V64, P1057, DOI 10.1016/0092-8674(91)90261-V; VU TKH, 1991, NATURE, V353, P674, DOI 10.1038/353674a0; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	25	437	453	0	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					609	+		10.1038/35007085	http://dx.doi.org/10.1038/35007085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766244				2022-12-24	WOS:000086400100055
J	Diamond, J				Diamond, J			Archaeology - Blitzkrieg against the moas	SCIENCE			English	Editorial Material									Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Diamond, J (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	jdiamond@mednet.ucla.edu						ANDERSON A, 1991, ANTIQUITY, V65, P767, DOI 10.1017/S0003598X00080510; ANDERSON A, 1996, SHAG RIVER MOUTH; [Anonymous], 1989, PRODIGIOUS BIRDS; Holdaway RN, 2000, SCIENCE, V287, P2250, DOI 10.1126/science.287.5461.2250; Martin PS, 1984, QUATERNARY EXTINCTIO; MOSIMANN JE, 1975, AM SCI, V63, P304	6	10	10	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2170	2171		10.1126/science.287.5461.2170	http://dx.doi.org/10.1126/science.287.5461.2170			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10744538				2022-12-24	WOS:000086049100025
J	Hoskins, RA; Nelson, CR; Berman, BP; Laverty, TR; George, RA; Ciesiolka, L; Naeemuddin, M; Arenson, AD; Durbin, J; David, RG; Tabor, PE; Bailey, MR; DeShazo, DR; Catanese, J; Mammoser, A; Osoegawa, K; de Jong, PJ; Celniker, SE; Gibbs, RA; Rubin, GM; Scherer, SE				Hoskins, RA; Nelson, CR; Berman, BP; Laverty, TR; George, RA; Ciesiolka, L; Naeemuddin, M; Arenson, AD; Durbin, J; David, RG; Tabor, PE; Bailey, MR; DeShazo, DR; Catanese, J; Mammoser, A; Osoegawa, K; de Jong, PJ; Celniker, SE; Gibbs, RA; Rubin, GM; Scherer, SE			A BAC-based physical map of the major autosomes of Drosophila melanogaster	SCIENCE			English	Article							YEAST ARTIFICIAL CHROMOSOMES; GENOME; CLONES; CONTIGS	We constructed a bacterial artificial chromosome (BAC)-based physical map of chromosomes 2 and 3 of Drosophila melanogaster, which constitute 81% of the genome. Sequence tagged site (STS) content, restriction fingerprinting, and polytene chromosome in situ hybridization approaches were integrated to produce a map spanning the euchromatin. Three of five remaining gaps are in repeat-rich regions near the centromeres. A tiling path of clones spanning this map and STS maps of chromosomes X and 4 was sequenced to low coverage; the maps and tiling path sequence were used to support and verify the whole-genome sequence assembly, and tiling path BACs were used as templates in sequence finishing.	Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Baylor College of Medicine; Roswell Park Cancer Institute	Hoskins, RA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA.	hoskins@bdgp.lbl.gov	Berman, Benjamin P/D-5942-2014; BERMAN, BENJAMIN/AAT-3720-2021	Berman, Benjamin P/0000-0002-2099-9005; BERMAN, BENJAMIN/0000-0002-2099-9005; Rubin, Gerald/0000-0001-8762-8703	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000750] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG00750] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; AJIOKA JW, 1991, CHROMOSOMA, V100, P495, DOI 10.1007/BF00352200; Ashburner M, 1999, GENETICS, V153, P179; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; BRIZUELA BJ, 1994, GENETICS, V137, P803; CAI HN, 1994, GENETICS, V136, P1385; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; GARZA D, 1989, SCIENCE, V246, P641, DOI 10.1126/science.2510296; Green E D, 1991, PCR Methods Appl, V1, P77; Kimmerly W, 1996, GENOME RES, V6, P414, DOI 10.1101/gr.6.5.414; LOCKE J, IN PRESS GENETICS; MADUENO E, 1995, GENETICS, V139, P1631; Mara M, 1999, NAT GENET, V22, P265, DOI 10.1038/10327; Marra MA, 1997, GENOME RES, V7, P1072, DOI 10.1101/gr.7.11.1072; Mozo T, 1999, NAT GENET, V22, P271, DOI 10.1038/10334; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Osoegawa K, 1998, GENOMICS, V52, P1, DOI 10.1006/geno.1998.5423; PETERS AHF, UNPUB; RIETHMAN H, 1997, GENOME ANAL LAB MANU, V1, P106; Ross M.T., 1999, CURRENT PROTOCOLS HU; SIDENKIAMOS I, 1990, NUCLEIC ACIDS RES, V18, P6261, DOI 10.1093/nar/18.21.6261; Soderlund C, 1997, COMPUT APPL BIOSCI, V13, P523; SULSTON J, 1988, COMPUT APPL BIOSCI, V4, P125; [No title captured]	24	106	112	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2271	2274		10.1126/science.287.5461.2271	http://dx.doi.org/10.1126/science.287.5461.2271			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731150				2022-12-24	WOS:000086049100053
J	Pertea, M; Salzberg, SL; Gardner, MJ				Pertea, M; Salzberg, SL; Gardner, MJ			Bioinformatics - Finding genes in Plasmodium falciparum	NATURE			English	Article									Inst Genom Res, Rockville, MD 20850 USA	J. Craig Venter Institute	Pertea, M (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Salzberg, Steven/Q-6514-2019; Salzberg, Steven L/F-6162-2011; Pertea, Mihaela/AAT-2705-2021	Salzberg, Steven/0000-0002-8859-7432; Salzberg, Steven L/0000-0002-8859-7432; Pertea, Mihaela/0000-0003-0762-8637				Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; Salzberg SL, 1999, GENOMICS, V59, P24, DOI 10.1006/geno.1999.5854	3	18	18	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					34	34		10.1038/35003643	http://dx.doi.org/10.1038/35003643			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716431	Bronze			2022-12-24	WOS:000085775100032
J	EHRHARDT, DW; ATKINSON, EM; LONG, SR				EHRHARDT, DW; ATKINSON, EM; LONG, SR			DEPOLARIZATION OF ALFALFA ROOT HAIR MEMBRANE-POTENTIAL BY RHIZOBIUM-MELILOTI NOD FACTORS	SCIENCE			English	Article							ELONGATION; SIGNAL; CELLS; AUXIN	Although much is known about the bacterial genetics of early nodulation, little is known about the plant cell response. Alfalfa root hair cells were impaled with intracellular micro-electrodes to measure a membrane potential depolarizing activity in Rhizobium meliloti cell-free filtrates, a plant response dependent on the bacterial nodulation genes. The depolarization was desensitized by repeated exposure to factors and was not observed in a representative nonlegume. A purified extracellular Nod factor, NodRm-IV(S), caused membrane potential depolarization at nanomolar concentrations. This rapid single-cell assay provides a tool for dissecting the mechanisms of host cell response in early nodulation.	STANFORD UNIV, DEPT BIOL SCI, STANFORD, CA 94305 USA	Stanford University								BATES GW, 1982, J MEMBRANE BIOL, V66, P15, DOI 10.1007/BF01868478; BISSELING T, COMMUNICATION; CLARKSON DT, 1988, J CELL SCI, V91, P71; CLELAND RE, 1977, PLANT PHYSIOL, V60, P709, DOI 10.1104/pp.60.5.709; DJORDJEVIC MA, 1987, ANNU REV PHYTOPATHOL, V25, P145, DOI 10.1146/annurev.py.25.090187.001045; DUDLEY ME, 1987, PLANTA, V171, P289, DOI 10.1007/BF00398674; DUDLEY ME, 1989, PLANT CELL, V1, P65, DOI 10.1105/tpc.1.1.65; EHRHARDT DW, UNPUB; FAUCHER C, 1988, J BACTERIOL, V170, P5489, DOI 10.1128/jb.170.12.5489-5499.1988; HAGER A, 1971, PLANTA, V100, P47, DOI 10.1007/BF00386886; HOPE AB, 1978, PHYSL GIANT ALGAL CE; LEROUGE P, 1990, NITROGEN FIXATION : ACHIEVEMENTS AND OBJECTIVES, P177; LEROUGE P, 1990, NATURE, V344, P781, DOI 10.1038/344781a0; LICHTNER FT, 1981, PLANT PHYSIOL, V67, P869, DOI 10.1104/pp.67.4.869; Long S. R., 1984, Plant-microbe interactions. Molecular and genetic perspectives. Volume I., P265; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; MAYER MG, 1988, PHYSIOL MOL PLANT P, V33, P397, DOI 10.1016/0885-5765(88)90006-9; PAVLOVKIN J, 1986, PHYSIOL MOL PLANT P, V28, P125, DOI 10.1016/S0048-4059(86)80014-5; RAYLE D, 1970, PLANT PHYSIOL, V46, P250, DOI 10.1104/pp.46.2.250; RYAN CA, 1987, ANNU REV CELL BIOL, V3, P295, DOI 10.1146/annurev.cellbio.3.1.295; SCHROEDER JI, 1989, TRENDS BIOCH SCI, V14; SCHWEDOCK J, 1990, NATURE, V348, P644, DOI 10.1038/348644a0; SPAINK H, COMMUNICATION; SPAINK HP, 1991, NATURE, V354, P125, DOI 10.1038/354125a0; TRUCHET G, 1991, NATURE, V351, P670, DOI 10.1038/351670a0	25	317	326	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAY 15	1992	256	5059					998	1000		10.1126/science.10744524	http://dx.doi.org/10.1126/science.10744524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HU224	10744524				2022-12-24	WOS:A1992HU22400030
J	Liaw, LCT; Nayar, DM; Pedler, SJ; Coulthard, MG				Liaw, LCT; Nayar, DM; Pedler, SJ; Coulthard, MG			Home collection of urine for culture from infants by three methods: survey of parents' preferences and bacterial contamination rates	BRITISH MEDICAL JOURNAL			English	Article							TRACT INFECTION; EARLY-CHILDHOOD		Royal Victoria Infirm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK	Coulthard, MG (corresponding author), Royal Victoria Infirm, Queen Victoria Rd, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.							HARDY JD, 1976, BRIT J UROL, V48, P279, DOI 10.1111/j.1464-410X.1976.tb03021.x; JADRESIC L, 1993, BRIT MED J, V307, P761, DOI 10.1136/bmj.307.6907.761; KASS EH, 1956, T ASSOC AM PHYSICIAN, V69, P56; Macfarlane PI, 1999, LANCET, V354, P571, DOI 10.1016/S0140-6736(99)02270-9; Vernon S, 1997, BRIT J GEN PRACT, V47, P297	5	54	55	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 13	2000	320	7245					1312	1313		10.1136/bmj.320.7245.1312	http://dx.doi.org/10.1136/bmj.320.7245.1312			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	314VC	10807624	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000087077400024
J	Wee, CC; McCarthy, EP; David, RB; Phillips, RS				Wee, CC; McCarthy, EP; David, RB; Phillips, RS			Screening for cervical and breast cancer: Is obesity an unrecognized barrier to preventive care?	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	22nd Annual Meeting of the Society-of-General-Internal-Medicine	APR 29-MAY 01, 1999	SAN FRANCISCO, CA	Soc Gen Internal Med		cervix neoplasms; breast neoplasms; obesity; mammography; vaginal smears	BODY-WEIGHT; WHITE WOMEN; ATTITUDES; DISEASE; OVERWEIGHT; PHYSICIAN; PROFESSIONALS; CONSEQUENCES; MAMMOGRAPHY; STAGE	Background: Compared with thinner women, obese women have higher mortality rates for breast and cervical cancer. In addition, obesity leads to adverse social and psychological consequences. Whether obesity limits access to screening for breast and cervical cancer is unclear. Objective: To examine the relation between obesity and screening with Papanicolaou (Pap) smears and mammography. Design: Population-based survey. Setting: United States. Participants: 11 435 women who responded to the "Year 2000 Supplement" of the 1994 National Health Interview Survey. Measurements: Screening with Pap smears and mammography was assessed by questionnaire. Results: In women 18 to 75 years of age who had not previously undergone hysterectomy (n = 8394), fewer overweight women (78%) and obese women (78%) than normal-weight women (84%) had had Pap smears in the previous 3 years (P < 0.001). After adjustment for sociodemographic information, insurance and access to care, illness burden, and provider specialty, rate differences for screening with Pap smears were still seen among overweight (-3.5% [95% CI, -5.9% to -1.1%]) and obese women (-5.3% [CI, -8.0% to -2.6%]). In women 50 to 75 years of age (n = 3502), fewer overweight women (64%) and obese women (62%) than normal-weight women (68%) had had mammography in the previous Z years (P < 0.002). After adjustment, rate differences were -2.8% (CI, -6.7% to 0.9%) for overweight women and -5.4% (CI, -10.8% to -0.1 %) for obese women. Conclusions: Overweight and obese women were less likely to be screened for cervical and breast cancer with Pap smears and mammography, even after adjustment for other known barriers to care. Because overweight and obese women have higher mortality rates for cervical and breast cancer, they should be targeted for increased screening.	Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Harvard Med Sch, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wee, CC (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Harvard Med Sch, 330 Brookline Ave,Libby 330, Boston, MA 02215 USA.	cweekuo@caregroup.harvard.edu			AHRQ HHS [1 F32 HS00137-01] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS000137] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ADAMS CH, 1993, WOMEN HEALTH, V20, P45, DOI 10.1300/J013v20n02_04; ALLAN JD, 1993, RES NURS HEALTH, V16, P323, DOI 10.1002/nur.4770160503; ALLISON DB, 1999, JAMA-J AM MED ASSOC, V282, P1583; CADE J, 1991, BRIT J GEN PRACT, V41, P147; Caldwell MB, 1997, INT J EAT DISORDER, V22, P127, DOI 10.1002/(SICI)1098-108X(199709)22:2&lt;127::AID-EAT2&gt;3.0.CO;2-H; DAWSON DA, 1988, AM J PUBLIC HEALTH, V78, P1326, DOI 10.2105/AJPH.78.10.1326; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; FLANDERS WD, 1987, J CHRON DIS, V40, P697, DOI 10.1016/0021-9681(87)90106-8; Fontaine KR, 1998, ARCH FAM MED, V7, P381, DOI 10.1001/archfami.7.4.381; FRANK A, 1993, JAMA-J AM MED ASSOC, V269, P2132, DOI 10.1001/jama.269.16.2132; GARFINKEL L, 1985, ANN INTERN MED, V103, P1034, DOI 10.7326/0003-4819-103-6-1034; GORTMAKER SL, 1993, NEW ENGL J MED, V329, P1008, DOI 10.1056/NEJM199309303291406; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; HUNTER CP, 1993, J NATL CANCER I, V85, P1129, DOI 10.1093/jnci/85.14.1129; INGRAM D, 1989, CANCER, V64, P1049, DOI 10.1002/1097-0142(19890901)64:5&lt;1049::AID-CNCR2820640515&gt;3.0.CO;2-M; KERLIKOWSKE K, 1995, JAMA-J AM MED ASSOC, V273, P149, DOI 10.1001/jama.273.2.149; Kiefe CI, 1998, J GEN INTERN MED, V13, P357, DOI 10.1046/j.1525-1497.1998.00115.x; KOCH GG, 1975, INT STAT REV, V43, P59, DOI 10.2307/1402660; LUBITZ RM, 1995, AM J MED, V98, P491, DOI 10.1016/S0002-9343(99)80350-7; LURIE N, 1993, NEW ENGL J MED, V329, P478, DOI 10.1056/NEJM199308123290707; MILLER TM, 1980, J AM DIET ASSOC, V77, P561; *NAT CTR HLTH STAT, 1994, CD ROM SER, V10; National Center for Health Statistics, 1996, HLTH PEOPL 2000 REV; PISUNYER FX, 1993, ANN INTERN MED, V119, P655, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00006; PRICE JH, 1987, AM J PREV MED, V3, P339; Reeves MJ, 1996, CANCER, V77, P301, DOI 10.1002/(SICI)1097-0142(19960115)77:2<301::AID-CNCR12>3.0.CO;2-5; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; SHAH BV, 1992, SUDAAN USERS MANUAL; STEVENS J, 1994, AM J PUBLIC HEALTH, V84, P1322, DOI 10.2105/AJPH.84.8.1322; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; VERREAULT R, 1989, AM J EPIDEMIOL, V129, P260, DOI 10.1093/oxfordjournals.aje.a115131; WADDEN TA, 1985, ANN INTERN MED, V103, P1062, DOI 10.7326/0003-4819-103-6-1062; WOOLHANDLER S, 1988, JAMA-J AM MED ASSOC, V259, P2872; YOUNG LM, 1985, J HEALTH SOC BEHAV, V26, P233, DOI 10.2307/2136755	35	217	217	0	29	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2000	132	9					697	+		10.7326/0003-4819-132-9-200005020-00003	http://dx.doi.org/10.7326/0003-4819-132-9-200005020-00003			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	308VT	10787362				2022-12-24	WOS:000086734100002
J	Canfield, DE; Habicht, KS; Thamdrup, B				Canfield, DE; Habicht, KS; Thamdrup, B			The Archean sulfur cycle and the early history of atmospheric oxygen	SCIENCE			English	Article							BACTERIAL SULFATE REDUCTION; COASTAL MARINE BASIN; ISOTOPE FRACTIONATION; IRON-FORMATIONS; SEDIMENTS; CARBON; OCEANS; MODELS; RISE	The isotope record of sedimentary sulfides can help resolve the history of oxygen accumulation into the atmosphere. We measured sulfur isotopic fractionation during microbial sulfate reduction up to 88 degrees C and show how sulfate reduction rate influences the preservation of biological fractionations in sediments. The sedimentary sulfur isotope record suggests Low concentrations of seawater sulfate and atmospheric oxygen in the early Archean (3.4 to 2.8 billion years ago). The accumulation of oxygen and sulfate began later, in the early Proterozoic (2.5 to 0.54 billion years ago).	Odense Univ, SDU, Danish Ctr Earth Syst Sci, DK-5230 Odense M, Denmark; Odense Univ, SDU, Inst Biol, DK-5230 Odense, Denmark	University of Southern Denmark; University of Southern Denmark	Canfield, DE (corresponding author), Odense Univ, SDU, Danish Ctr Earth Syst Sci, Campusvej 55, DK-5230 Odense M, Denmark.		Thamdrup, Bo/F-3889-2016; Canfield, Don/C-1735-2012	Thamdrup, Bo/0000-0002-1221-7077; Canfield, Don/0000-0001-7602-8366				BERKNER LV, 1965, J ATMOS SCI, V22, P225, DOI 10.1175/1520-0469(1965)022<0225:OTOARO>2.0.CO;2; BIRKLUND PW, 1974, PEDOLOGY WEATHERING; Bottcher ME, 1999, ARCH MICROBIOL, V172, P125, DOI 10.1007/s002030050749; BOUDREAU BP, 1984, GEOCHIM COSMOCHIM AC, V48, P2503, DOI 10.1016/0016-7037(84)90301-6; Brocks JJ, 1999, SCIENCE, V285, P1033, DOI 10.1126/science.285.5430.1033; CAMERON EM, 1982, NATURE, V296, P145, DOI 10.1038/296145a0; CAMERON EM, 1987, CHEM GEOL, V65, P341, DOI 10.1016/0168-9622(87)90013-3; Canfield DE, 1999, AM J SCI, V299, P697, DOI 10.2475/ajs.299.7-9.697; Canfield DE, 1996, NATURE, V382, P127, DOI 10.1038/382127a0; CHAMBERS LA, 1975, CAN J MICROBIOL, V21, P1602, DOI 10.1139/m75-234; CHANTON JP, 1987, GEOCHIM COSMOCHIM AC, V51, P1201, DOI 10.1016/0016-7037(87)90212-2; CORLISS JB, 1979, SCIENCE, V203, P1073, DOI 10.1126/science.203.4385.1073; DeRonde CEJ, 1997, GEOCHIM COSMOCHIM AC, V61, P4025, DOI 10.1016/S0016-7037(97)00205-6; GARRELS RM, 1974, SEA, P303; GOODWIN AM, 1976, ECON GEOL, V71, P870, DOI 10.2113/gsecongeo.71.5.870; Habicht KS, 1997, GEOCHIM COSMOCHIM AC, V61, P5351, DOI 10.1016/S0016-7037(97)00311-6; Habicht KS, 1996, NATURE, V382, P342, DOI 10.1038/382342a0; HARRISON AG, 1958, T FARADAY SOC, V54, P84, DOI 10.1039/tf9585400084; Hayes JM., 1983, EARTHS EARLIEST BIOS, P291; HOLLAND HD, 1995, EARLY LIFE EARTH, P237; Holland HD., 1999, GEOCHEM NEWS, V100, P20; Kakegawa T, 1998, GEOCHIM COSMOCHIM AC, V62, P3205, DOI 10.1016/S0016-7037(98)00229-4; KAPLAN IR, 1964, J GEN MICROBIOL, V34, P195, DOI 10.1099/00221287-34-2-195; KLUMP JV, 1987, GEOCHIM COSMOCHIM AC, V51, P1161, DOI 10.1016/0016-7037(87)90209-2; Knoblauch C, 1999, APPL ENVIRON MICROB, V65, P4230; Knoll A. H, 1992, ORIGIN EARLY EVOLUTI, P53; KNOLL AH, 1998, ISOTOPE PALEOBIOLOGY, P212; Middelburg JJ, 1997, DEEP-SEA RES PT I, V44, P327, DOI 10.1016/S0967-0637(96)00101-X; OHMOTO H, 1993, SCIENCE, V262, P555, DOI 10.1126/science.11539502; OHMOTO H, 1987, NATURE, V328, P244, DOI 10.1038/328244a0; OHMOTO H, 1997, GEOCHEM NEWS, V93, P12; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; PETER JM, 1992, GEOCHIM COSMOCHIM AC, V56, P1025; Rabouille C, 1998, LIMNOL OCEANOGR, V43, P420, DOI 10.4319/lo.1998.43.3.0420; Rasmussen B, 1999, GEOLOGY, V27, P115, DOI 10.1130/0091-7613(1999)027<0115:RSOTAA>2.3.CO;2; Roychoudhury AN, 1998, APPL GEOCHEM, V13, P269, DOI 10.1016/S0883-2927(97)00064-4; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; STACKEBRANDT DA, 1995, SULFATE REDUCING BAC, P49; THODE HG, 1983, PRECAMBRIAN RES, V20, P337, DOI 10.1016/0301-9268(83)90080-3; WESTRICH JT, 1988, GEOMICROBIOL J, V6, P99, DOI 10.1080/01490458809377828; WILLIAMSON MA, 1994, GEOCHIM COSMOCHIM AC, V58, P5443, DOI 10.1016/0016-7037(94)90241-0	41	313	344	1	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2000	288	5466					658	661		10.1126/science.288.5466.658	http://dx.doi.org/10.1126/science.288.5466.658			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308RR	10784446				2022-12-24	WOS:000086727100040
J	Iwasaki, H; Williams, SB; Kitayama, Y; Ishiura, M; Golden, SS; Kondo, T				Iwasaki, H; Williams, SB; Kitayama, Y; Ishiura, M; Golden, SS; Kondo, T			A KaiC-interacting sensory histidine kinase, SasA, necessary to sustain robust circadian oscillation in cyanobacteria	CELL			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; CLONING; RHYTHMS; BIOLUMINESCENCE; LUCIFERASE; PHOSPHATE; PROTEINS; FRAGMENT; BACTERIA	Both regulated expression of the clock genes kaiA, kaiB, and kaiC and interactions among the Kai proteins are proposed to be important for circadian function in the cyanobacterium Synechococcus sp, strain PCC 7942. We have identified the histidine kinase SasA as a KaiC-interacting protein. SasA contains a KaiB-like sensory domain, which appears sufficient for interaction with KaiC. Disruption of the sasA gene lowered kaiBC expression and dramatically reduced amplitude of the kai expression rhythms while shortening the period. Accordingly, sasA disruption attenuated circadian expression patterns of all tested genes, some of which became arrhythmic. Continuous sasA overexpression eliminated circadian rhythms, whereas temporal overexpression changed the phase of kaiBC expression rhythm. Thus, SasA is a close associate of the cyanobacterial clock that is necessary to sustain robust circadian rhythms.	Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan; Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA	Nagoya University; Texas A&M University System; Texas A&M University College Station	Kondo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Div Biol Sci, Nagoya, Aichi 4648602, Japan.	kondo@bio.nagoya-u.ac.jp		Iwasaki, Hideo/0000-0002-3754-4955	NIGMS NIH HHS [F32 GM19644] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM019644] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIBA H, 1989, J BIOL CHEM, V264, P8563; AIBA H, 1993, MOL MICROBIOL, V8, P81, DOI 10.1111/j.1365-2958.1993.tb01205.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSSON CR, 2000, IN PRESS METHODS ENZ; AOKI S, 1995, J BACTERIOL, V177, P5606, DOI 10.1128/jb.177.19.5606-5611.1995; BALDWIN TO, 1984, BIOCHEMISTRY-US, V23, P3663, DOI 10.1021/bi00311a014; BUSTOS SA, 1991, J BACTERIOL, V173, P7525, DOI 10.1128/jb.173.23.7525-7533.1991; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; GOLDEN SS, 1986, EMBO J, V5, P2789, DOI 10.1002/j.1460-2075.1986.tb04569.x; HIRSCH PR, 1986, GENE, V48, P203, DOI 10.1016/0378-1119(86)90078-8; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Iwasaki H, 1999, EMBO J, V18, P1137, DOI 10.1093/emboj/18.5.1137; Katayama M, 1999, J BACTERIOL, V181, P3516, DOI 10.1128/JB.181.11.3516-3524.1999; Kim SK, 1996, MOL MICROBIOL, V22, P135, DOI 10.1111/j.1365-2958.1996.tb02663.x; KONDO T, 1994, J BACTERIOL, V176, P1881, DOI 10.1128/jb.176.7.1881-1885.1994; KONDO T, 1993, P NATL ACAD SCI USA, V90, P5672, DOI 10.1073/pnas.90.12.5672; KONDO T, 1994, SCIENCE, V266, P1233, DOI 10.1126/science.7973706; Kutsuna S, 1998, J BACTERIOL, V180, P2167, DOI 10.1128/JB.180.8.2167-2174.1998; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Mizuno T, 1996, DNA Res, V3, P407, DOI 10.1093/dnares/3.6.407; NAGAYA M, 1993, GENE, V131, P119; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; PARKINSON JS, 1993, CELL, V73, P857, DOI 10.1016/0092-8674(93)90267-T; Pratt L., 1995, 2 COMPONENT SIGNAL T, P105; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; SCANLAN DJ, 1992, PLANT MOL BIOL, V19, P877, DOI 10.1007/BF00027085; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; Tsinoremas NF, 1996, EMBO J, V15, P2488, DOI 10.1002/j.1460-2075.1996.tb00606.x; VOJTEK AB, 1993, CELL, V74, P205, DOI 10.1016/0092-8674(93)90307-C; WurglerMurphy SM, 1997, TRENDS BIOCHEM SCI, V22, P172, DOI 10.1016/S0968-0004(97)01036-0; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	35	194	214	3	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 14	2000	101	2					223	233		10.1016/S0092-8674(00)80832-6	http://dx.doi.org/10.1016/S0092-8674(00)80832-6			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	305DP	10786837	Bronze			2022-12-24	WOS:000086524400008
J	Schubert, U; Anton, LC; Gibbs, J; Norbury, CC; Yewdell, JW; Bennink, JR				Schubert, U; Anton, LC; Gibbs, J; Norbury, CC; Yewdell, JW; Bennink, JR			Rapid degradation of a large fraction of newly synthesized proteins by proteasomes	NATURE			English	Article							MHC CLASS-I; CHYMOTRYPSIN-LIKE ACTIVITY; MOLECULES; PEPTIDES; INHIBITION; CHAINS; CELLS	MHC class I molecules function to present peptides eight to ten residues long to the immune system. These peptides originate primarily from a cytosolic pool of proteins through the actions of proteasomes(1), and are transported into the endoplasmic reticulum, where they assemble with nascent class I molecules(2). Most peptides are generated from proteins that are apparently metabolically stable. To explain this, we previously proposed that peptides arise from proteasomal degradation of defective ribosomal products (DRiPs). DRiPs are polypeptides that never attain native structure owing to errors in translation or post-translational processes necessary for proper protein folding(3). Here we show, first, that DRiPs constitute upwards of 30% of newly synthesized proteins as determined in a variety of cell types; second, that at least some DRiPs represent ubiquitinated proteins; and last, that ubiquitinated DRiPs are formed from human immunodeficiency virus Gag polyprotein, a long-lived viral protein that serves as a source of antigenic peptides.	NIAID, Viral Dis Lab, Bethesda, MD 20892 USA; Univ Hamburg, Heinrich Pette Inst, Hamburg, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Heinrich Pette Institute; University of Hamburg	Yewdell, JW (corresponding author), NIAID, Viral Dis Lab, Bethesda, MD 20892 USA.		yewdell, jyewdell@nih.gov jonathan/A-1702-2012; Antón, Luis C/C-4740-2013	Antón, Luis C/0000-0001-9665-011X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000653, ZIAAI000658, Z01AI000658, Z01AI000653] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Alberts B., 1994, MOL BIOL CELL; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; DEGEN E, 1991, J CELL BIOL, V112, P1099, DOI 10.1083/jcb.112.6.1099; ENGELHARD VH, 1994, ANNU REV IMMUNOL, V12, P181, DOI 10.1146/annurev.iy.12.040194.001145; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; FUJIMURO M, 1994, FEBS LETT, V349, P173, DOI 10.1016/0014-5793(94)00647-4; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; RAMMENSEE HG, 1997, MHC LIGANDS PEPTIDE; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739; STEINMAN RM, 1998, FUNDAMENTAL IMMUNOLO, P547; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; VINITSKY A, 1992, BIOCHEMISTRY-US, V31, P9421, DOI 10.1021/bi00154a014; Wojcik C, 1996, EUR J CELL BIOL, V71, P311; Yewdell JW, 1996, J IMMUNOL, V157, P1823	18	1161	1200	1	59	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					770	774		10.1038/35008096	http://dx.doi.org/10.1038/35008096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783891				2022-12-24	WOS:000086523600054
J	Ong, EK; Glantz, SA				Ong, EK; Glantz, SA			Tobacco industry efforts subverting international Agency for Research on Cancer's second-hand smoke study	LANCET			English	Article							RESPIRABLE SUSPENDED PARTICLES; PASSIVE SMOKING; LUNG-CANCER; NONSMOKING WOMEN; AIR-QUALITY; EXPOSURE; MISCLASSIFICATION; MULTICENTER; HEALTH; RISK	Scientific reports on second-hand smoke have stimulated legislation on clean indoor air in the USA, but less so in Europe. Recently, the largest European study, by the International Agency for Research on Cancer (IARC), demonstrated a 16% increase in the point estimate of risk in lung cancer for nonsmokers, a result consistent with earlier studies. However, the study was described by newspapers and the tobacco industry as demonstrating no increase in risk. To understand the tobacco industry's strategy on the IARC study we analysed industry documents released in US litigation and interviewed IARC investigators, The Philip Morris tobacco company feared that the study (and a possible IARC monograph on second-hand smoke) would lead to increased restrictions in Europe so they spearheaded an inter-industry, three-prong strategy to subvert IARC's work. The scientific strategy attempted to undercut IARC's research and to develop industry-directed research to counter the anticipated findings. The communications strategy planned to shape opinion by manipulating the media and the public. The government strategy sought to prevent increased smoking restrictions. The IARC study cost $2 million over ten years; Philip Morris planned to spend $2 million in one year alone and up to $4 million on research. The documents and Interviews suggest that the tobacco industry continues to conduct a sophisticated campaign against conclusions that secondhand smoke causes lung cancer and other diseases, subverting normal scientific processes.	Univ Calif San Francisco, Inst Hlth Policy Studies, Cardiovasc Res Inst, Dept Med,Div Cardiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Glantz, SA (corresponding author), Univ Calif San Francisco, Inst Hlth Policy Studies, Cardiovasc Res Inst, Dept Med,Div Cardiol, Box 0130, San Francisco, CA 94143 USA.	glantz@medicine.ucsf.edu			NCI NIH HHS [CA-61021] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA061021] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BARNES D, 1995, JAMA-J AM MED ASSOC, P248; Barnes D E, 1997, Tob Control, V6, P19; Barnes DE, 1996, J HEALTH POLIT POLIC, V21, P515, DOI 10.1215/03616878-21-3-515; Barnes DE, 1998, JAMA-J AM MED ASSOC, V279, P1566, DOI 10.1001/jama.279.19.1566; Benowitz NL, 1996, EPIDEMIOL REV, V18, P188, DOI 10.1093/oxfordjournals.epirev.a017925; BERO LA, 1994, JAMA-J AM MED ASSOC, V271, P612, DOI 10.1001/jama.271.8.612; BERO LA, 1993, TOB CONTROL, V2, P103; Blot WJ, 1998, J NATL CANCER I, V90, P1416, DOI 10.1093/jnci/90.19.1416; Boffetta P, 1998, J NATL CANCER I, V90, P1440, DOI 10.1093/jnci/90.19.1440; Chapman S, 1998, BRIT MED J, V316, P727; DYER C, 1998, GUARDIAN        0707; FONTHAM ETH, 1994, JAMA-J AM MED ASSOC, V271, P1752, DOI 10.1001/jama.271.22.1752; GARFINKEL L, 1981, JNCI-J NATL CANCER I, V66, P1061, DOI 10.1093/jnci/66.6.1061; GARFINKEL L, 1984, NY TIMES        0605; Gelbspan R., 1997, HEAT IS HIGH STAKES; GLANTZ S, 1983, P 12 WORLD C TOB HLT, P287; Glantz S A, 1997, Tob Control, V6, P164; Glantz S.A., 1996, CIGARETTE PAPERS; *IMP TOB, 1999, IMP TOB POS SMOK REL; *INT AG RES CANC, 1998, PASS SMOK LUNG CANC; Jenkins RA, 1996, LUNG CANCER-J IASLC, V14, pS195; Jenkins RA, 1996, J EXPO ANAL ENV EPID, V6, P473; Korea Ministry of Health and Welfare, 2016, DEV NAT BIOM PROGR E; Lash TL, 1999, AM J EPIDEMIOL, V149, P5; LEGRAND C, 1998, AUSTRALIAN      0310; MACDONALD V, 1998, SUNDAY TELEGRAP 0308; Manley M W, 1997, Tob Control, V6 Suppl 2, pS12, DOI 10.1136/tc.6.suppl_2.S12; MATANOSKI G, 1995, AM J EPIDEMIOL, V142, P149, DOI 10.1093/oxfordjournals.aje.a117613; MATTHEWS R, 1998, SUNDAY TELEGRAP 0816; MOONEY L, 1998, WALL STREET J   0319, pA18; *NAT HLTH MRC, 1986, EFF PASS SMOK HLTH; *NAT HLTH MRC, 1997, HLTH EFF PASS SMOK; National Research Council Committee on Passive Smoking, 1986, ENV TOB SMOK MEAS EX; *NZ DEP HLTH, 1998, CREAT SMOK ENV; [Office of Research and Development Office of Health Environmental Assessment United States Environmental Protection Agency], 1992, RESP HLTH EFF PASS S; Phillips K, 1997, ENVIRON INT, V23, P173, DOI 10.1016/S0160-4120(97)00004-4; PHILLIPS K, 1994, ENVIRON INT, V20, P693, DOI 10.1016/0160-4120(94)90303-4; Phillips K, 1997, ENVIRON INT, V23, P851, DOI 10.1016/S0160-4120(97)00097-4; Phillips K, 1999, ATMOS ENVIRON, V33, P1889, DOI 10.1016/S1352-2310(98)00205-2; Phillips K, 1996, SCAND J WORK ENV HEA, V22, P1; Phillips K, 1998, ENVIRON INT, V24, P405, DOI 10.1016/S0160-4120(98)00020-8; Phillips K, 1998, INT ARCH OCC ENV HEA, V71, P379, DOI 10.1007/s004200050296; Phillips K, 1998, ENVIRON INT, V24, P301, DOI 10.1016/S0160-4120(98)00009-9; Phillips K, 1998, INT ARCH OCC ENV HEA, V71, P201, DOI 10.1007/s004200050271; Proctor CJ, 1998, BRIT MED J, V317, P349; REPACE J, 1998, NAT TOX PROGR BOARD; REPACE JL, 1985, ENVIRON INT, V11, P3, DOI 10.1016/0160-4120(85)90098-4; RIBOLI E, 1990, CANCER CAUSE CONTROL, V1, P243, DOI 10.1007/BF00117476; RIBOLI E, 1995, EUR RESPIR J, V8, P285, DOI 10.1183/09031936.95.08020285; *ROP ORG, 1978, STUD PUBL ATT CIG SM, V1; SCHLESINGER J, 1998, WALL STREET J   0720; Simpson D, 1998, TOB CONTROL, V7, P117; SIMPSON D, 1998, TOB CONTROL, V7, P228; Smith GD, 1996, BRIT MED J, V313, P929; Stead LF, 2006, REP SCI COMM TOB HLT, DOI 10.1002/14651858.CD002850.pub2; SWEET M, 1998, SYDNEY MORNING  0203; TEINKEN J, 1990, SMOKESCREEN CRITIQUE; THOMAS H, 1999, S CHINA MORNING 0118; *TOB I SO AFR, 1998, TISA SUBM IND PORTF; *TRONDH EUR WORK P, 1996, ENV TOB SMOK LUNG CA; *US DEP HHS, 1986, DHHS PUB; Wells AJ, 1998, AM J PUBLIC HEALTH, V88, P1503, DOI 10.2105/AJPH.88.10.1503; *WHO, 1998, PASS SMOK DOES CAUS; *WHO, 1998, ZIMBABWE INDEPE 1023; 1997, PR NEWSWIRE     1203; 1999, EUR SCI ENV FOR APR	66	144	144	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2000	355	9211					1253	1259		10.1016/S0140-6736(00)02098-5	http://dx.doi.org/10.1016/S0140-6736(00)02098-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770318				2022-12-24	WOS:000086448000039
J	Goldberg, J				Goldberg, J			Decoding of sorting signals by coatomer through a GTPase switch in the COPI coat complex	CELL			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; ADP-RIBOSYLATION FACTOR; EARLY SECRETORY PATHWAY; HUMAN KDEL RECEPTOR; ENDOPLASMIC-RETICULUM; TRANSPORT VESICLES; GOLGI TRANSPORT; BINDING-PROTEIN; ACTIVATING PROTEIN; ARF GTPASE	Sorting signals on cargo proteins are recognized by coatomer for selective uptake into COPI (coatomer)-coated vesicles. This study shows that coatomer couples sorting signal recognition to the GTP hydrolysis reaction on ARF1. Coatomer responds differently to different signals. The cytoplasmic signal sequence of hp24a inhibits coatomer-dependent GTP hydrolysis. By contrast, the dilysine retrieval signal, which competes for the same binding site on coatomer, has no effect on GTPase activity. It is inferred that, in vivo, sorting signal selection is under kinetic control, with coatomer governing a GTPase discard pathway that excludes dilysine-tagged proteins from one class of COPI-coated vesicles. The concept of competing sets of sorting signals that act positively and negatively during vesicle budding through a GTPase switch in the COPI coat complex suggests mechanisms for cargo segregation in which specificity is conferred by GTP hydrolysis.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	jonathan@ximpact4.ski.mskcc.org						Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Aoe T, 1998, P NATL ACAD SCI USA, V95, P1624, DOI 10.1073/pnas.95.4.1624; Belden WJ, 1996, J BIOL CHEM, V271, P26939, DOI 10.1074/jbc.271.43.26939; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; BURGESS SM, 1993, TRENDS BIOCHEM SCI, V18, P381, DOI 10.1016/0968-0004(93)90094-4; BURGESS SM, 1993, CELL, V73, P1377, DOI 10.1016/0092-8674(93)90363-U; COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751; DONALDSON JG, 1992, P NATL ACAD SCI USA, V89, P6408, DOI 10.1073/pnas.89.14.6408; DUDEN R, 1994, J BIOL CHEM, V269, P24486; ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043, DOI 10.1091/mbc.7.7.1043; Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396; Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649; Haucke V, 1999, SCIENCE, V285, P1268, DOI 10.1126/science.285.5431.1268; HELMS JB, 1993, J CELL BIOL, V121, P751, DOI 10.1083/jcb.121.4.751; HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KAHN RA, 1986, J BIOL CHEM, V261, P7906; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; LETOURNEUR F, 1994, CELL, V79, P1199, DOI 10.1016/0092-8674(94)90011-6; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1; Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mossessova E, 1998, CELL, V92, P415, DOI 10.1016/S0092-8674(00)80933-2; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Orci L, 1997, CELL, V90, P335, DOI 10.1016/S0092-8674(00)80341-4; OSTERMANN J, 1993, CELL, V75, P1015, DOI 10.1016/0092-8674(93)90545-2; Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; Scheffzek K, 1998, TRENDS BIOCHEM SCI, V23, P257, DOI 10.1016/S0968-0004(98)01224-9; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x; Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239; Sonnichsen B, 1996, J CELL BIOL, V134, P1411, DOI 10.1083/jcb.134.6.1411; Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698; Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9; STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Tisdale EJ, 1997, J CELL BIOL, V137, P581, DOI 10.1083/jcb.137.3.581; TOWNSLEY FM, 1993, EMBO J, V12, P2821, DOI 10.1002/j.1460-2075.1993.tb05943.x; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Wen CH, 1999, J CELL BIOL, V145, P1165, DOI 10.1083/jcb.145.6.1165; YARUS M, 1992, TRENDS BIOCHEM SCI, V17, P171, DOI 10.1016/0968-0004(92)90257-A; YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644; Zhao LY, 1999, J BIOL CHEM, V274, P14198, DOI 10.1074/jbc.274.20.14198; Zhu YX, 1998, MOL BIOL CELL, V9, P1323, DOI 10.1091/mbc.9.6.1323	58	106	110	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					671	679		10.1016/S0092-8674(00)80703-5	http://dx.doi.org/10.1016/S0092-8674(00)80703-5			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761932	Bronze			2022-12-24	WOS:000085983800009
J	Robson, J; Boomla, K; Hart, B; Feder, G				Robson, J; Boomla, K; Hart, B; Feder, G			Estimating cardiovascular risk for primary prevention: outstanding questions for primary care	BRITISH MEDICAL JOURNAL			English	Article							CORONARY HEART-DISEASE; GUIDELINES; FRAMINGHAM; PROFILE; TRIAL		Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, London E1 4NS, England; Chrisp St Hlth Ctr, London E14 6PG, England	University of London; Queen Mary University London	Robson, J (corresponding author), Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, Dept Gen Practice & Primary Care, Mile End Rd, London E1 4NS, England.		Robson, John/H-3904-2014	Robson, John/0000-0001-6889-0415; Feder, Gene/0000-0002-7890-3926				ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; FIELD K, 1995, BRIT MED J, V310, P1109, DOI 10.1136/bmj.310.6987.1109; Gotto AM, 1997, JAMA-J AM MED ASSOC, V277, P595, DOI 10.1001/jama.277.7.595; Gregory J., 1990, DIETARY NUTR SURVEY; GROVER SA, 1995, JAMA-J AM MED ASSOC, V274, P801, DOI 10.1001/jama.274.10.801; Grundy SM, 1999, CIRCULATION, V100, P1481, DOI 10.1161/01.CIR.100.13.1481; GUEFFIYER F, 1997, ANN INTERN MED, V126, P761; Haffner SM, 1998, NEW ENGL J MED, V339, P229, DOI 10.1056/NEJM199807233390404; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; HAQ IU, 1997, HEART, V77, P36; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; JACKSON R, 1998, 5 YEAR CARDIOVASCULA; Messerli FH, 1998, LANCET, V352, P1006, DOI 10.1016/S0140-6736(05)60073-6; *MRS GEN PRACT RES, 1998, LANCET, V315, P233; ODELL PM, 1994, J CLIN EPIDEMIOL, V47, P583, DOI 10.1016/0895-4356(94)90206-2; Pickin DM, 1999, HEART, V82, P325, DOI 10.1136/hrt.82.3.325; Ramsay LE, 1999, J HUM HYPERTENS, V13, P569, DOI 10.1038/sj.jhh.1000917; ROBSON J, 1997, FRAMINGHAM RISK SCOR; Unwin N, 1998, BMJ-BRIT MED J, V317, P1125; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312; Wood D, 1998, HEART, V80, pS1	24	25	28	1	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					702	704		10.1136/bmj.320.7236.702	http://dx.doi.org/10.1136/bmj.320.7236.702			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710585	Green Published			2022-12-24	WOS:000085895300027
J	Tettelin, H; Saunders, NJ; Heidelberg, J; Jeffries, AC; Nelson, KE; Eisen, JA; Ketchum, KA; Hood, DW; Peden, JF; Dodson, RJ; Nelson, WC; Gwinn, ML; DeBoy, R; Peterson, JD; Hickey, EK; Haft, DH; Salzberg, SL; White, O; Fleischmann, RD; Dougherty, BA; Mason, T; Ciecko, A; Parksey, DS; Blair, E; Cittone, H; Clark, EB; Cotton, MD; Utterback, TR; Khouri, H; Qin, HY; Vamathevan, J; Gill, J; Scarlato, V; Masignani, V; Pizza, M; Grandi, G; Sun, L; Smith, HO; Fraser, CM; Moxon, ER; Rappuoli, R; Venter, JC				Tettelin, H; Saunders, NJ; Heidelberg, J; Jeffries, AC; Nelson, KE; Eisen, JA; Ketchum, KA; Hood, DW; Peden, JF; Dodson, RJ; Nelson, WC; Gwinn, ML; DeBoy, R; Peterson, JD; Hickey, EK; Haft, DH; Salzberg, SL; White, O; Fleischmann, RD; Dougherty, BA; Mason, T; Ciecko, A; Parksey, DS; Blair, E; Cittone, H; Clark, EB; Cotton, MD; Utterback, TR; Khouri, H; Qin, HY; Vamathevan, J; Gill, J; Scarlato, V; Masignani, V; Pizza, M; Grandi, G; Sun, L; Smith, HO; Fraser, CM; Moxon, ER; Rappuoli, R; Venter, JC			Complete genome sequence of Neisseria meningitidis serogroup B strain MC58	SCIENCE			English	Article							ESCHERICHIA-COLI; HELICOBACTER-PYLORI; PATHOGENIC BACTERIA; INSERTION-SEQUENCE; ENDOTHELIAL-CELLS; DNA-SEQUENCE; GENE; EXPRESSION; IDENTIFICATION; GONORRHOEAE	The 2,272,351-base pair genome of Neisseria meningitidis strain MC58 (serogroup B), a causative agent of meningitis and septicemia, contains 2158 predicted coding regions, 1158 (53.7%) of which were assigned a biological role. Three major islands of horizontal DNA transfer were identified; two of these contain genes encoding proteins involved in pathogenicity, and the third island contains coding sequences only for hypothetical proteins. Insights into the commensal and virulence behavior of N, meningitidis can be gleaned from the genome, in which sequences for structural proteins of the pilus are clustered and several coding regions unique to serogroup B capsular polysaccharide synthesis can be identified. Finally, N. meningitidis contains more genes that undergo phase variation than any pathogen studied to date, a mechanism that controls their expression and contributes to the evasion of the host immune system.	Inst Genom Res, Rockville, MD 20850 USA; Univ Oxford, Inst Mol Med, Oxford OX3 9DS, England; Chiron SpA, Immunol Res Inst Siena, I-53100 Siena, Italy	J. Craig Venter Institute; University of Oxford; Novartis	Tettelin, H (corresponding author), Inst Genom Res, 9712 Med Ctr Dr, Rockville, MD 20850 USA.		Salzberg, Steven L/F-6162-2011; Salzberg, Steven/Q-6514-2019; Scarlato, Vincenzo/B-8558-2019; Nelson, William C/E-9263-2016; Eisen, Jonathan A./H-2706-2019; Saunders, Nigel J/W-6745-2019	Salzberg, Steven L/0000-0002-8859-7432; Salzberg, Steven/0000-0002-8859-7432; Scarlato, Vincenzo/0000-0003-4227-677X; Nelson, William C/0000-0002-1873-3929; Eisen, Jonathan A./0000-0002-0159-2197; Vamathevan, Jessica/0000-0003-2016-9754; Grandi, Guido/0000-0001-9724-2185; Heidelberg, John/0000-0003-0673-3224				Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANDERSON RP, 1978, COLD SPRING HARB SYM, V43, P1083; Bucci C, 1999, MOL CELL, V3, P435, DOI 10.1016/S1097-2765(00)80471-2; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Cao P, 1997, J BACTERIOL, V179, P2852, DOI 10.1128/jb.179.9.2852-2856.1997; Carrick CS, 1998, GENE, V220, P21, DOI 10.1016/S0378-1119(98)00424-7; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; CORNELISSEN CN, 1994, MOL MICROBIOL, V14, P843, DOI 10.1111/j.1365-2958.1994.tb01320.x; CORREIA FF, 1986, J BACTERIOL, V167, P1009, DOI 10.1128/jb.167.3.1009-1015.1986; DIAZ JL, 1984, FEMS MICROBIOL LETT, V21, P181; DOBSON SRM, 1992, INFECT IMMUN, V60, P618, DOI 10.1128/IAI.60.2.618-622.1992; DURBIN R, 1991, C ELEGANS DATABASE; Ehrmann MA, 1998, FEMS MICROBIOL LETT, V169, P81, DOI 10.1016/S0378-1097(98)00467-4; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Fraser CM, 1998, SCIENCE, V281, P375, DOI 10.1126/science.281.5375.375; FROSCH M, 1989, P NATL ACAD SCI USA, V86, P1669, DOI 10.1073/pnas.86.5.1669; FROSCH M, 1991, MOL MICROBIOL, V5, P1251, DOI 10.1111/j.1365-2958.1991.tb01899.x; Gardner MJ, 1998, SCIENCE, V282, P1126, DOI 10.1126/science.282.5391.1126; *GENB, D90911; GOODMAN SD, 1988, P NATL ACAD SCI USA, V85, P6982, DOI 10.1073/pnas.85.18.6982; GOTSCHLICH EC, 1969, J EXP MED, V129, P349; GOTSCHLICH EC, 1969, J EXP MED, V129, P1369; HAAS R, 1986, CELL, V44, P107, DOI 10.1016/0092-8674(86)90489-7; Hacker J, 1997, MOL MICROBIOL, V23, P1089, DOI 10.1046/j.1365-2958.1997.3101672.x; HILL CW, 1988, GENETICS, V119, P771; HOLTEN E, 1976, ACTA PATH MICRO IM B, V84, P9; JENNINGS HJ, 1987, J EXP MED, V165, P1207, DOI 10.1084/jem.165.4.1207; Jennings MP, 1995, MOL MICROBIOL, V18, P729, DOI 10.1111/j.1365-2958.1995.mmi_18040729.x; JONES D, 1995, MENINGOCOCCAL DIS, P147; Karlin S, 1998, ANNU REV GENET, V32, P185, DOI 10.1146/annurev.genet.32.1.185; Klein NJ, 1996, J INFECT DIS, V173, P172, DOI 10.1093/infdis/173.1.172; KNIGHT AI, 1992, MOL MICROBIOL, V6, P1565, DOI 10.1111/j.1365-2958.1992.tb00878.x; KROLL JS, 1991, MOL MICROBIOL, V5, P1549, DOI 10.1111/j.1365-2958.1991.tb00802.x; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Liu SL, 1996, P NATL ACAD SCI USA, V93, P10303, DOI 10.1073/pnas.93.19.10303; Lobry JR, 1996, MOL BIOL EVOL, V13, P660, DOI 10.1093/oxfordjournals.molbev.a025626; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; MARRS CF, 1990, J BACTERIOL, V172, P4370, DOI 10.1128/jb.172.8.4370-4377.1990; MCGUINNESS BT, 1991, LANCET, V337, P514, DOI 10.1016/0140-6736(91)91297-8; MORSE SA, 1978, INFECT IMMUN, V21, P87, DOI 10.1128/IAI.21.1.87-95.1978; MOXON ER, 1994, CURR BIOL, V4, P24, DOI 10.1016/S0960-9822(00)00005-1; NASSIF X, 1994, P NATL ACAD SCI USA, V91, P3769, DOI 10.1073/pnas.91.9.3769; Nelson KE, 1999, NATURE, V399, P323, DOI 10.1038/20601; NEUBAUER H, 1994, J BACTERIOL, V176, P3007, DOI 10.1128/JB.176.10.3007-3012.1994; PINNER RW, 1991, INFECT IMMUN, V59, P3169, DOI 10.1128/IAI.59.9.3169-3175.1991; Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816; RASMUSSEN JL, 1987, J BACTERIOL, V169, P3573, DOI 10.1128/jb.169.8.3573-3580.1987; RAYNER CFJ, 1995, J INFECT DIS, V171, P113, DOI 10.1093/infdis/171.1.113; RILEY M, 1993, MICROBIOL REV, V57, P862, DOI 10.1128/MMBR.57.4.862-952.1993; Salzberg SL, 1998, NUCLEIC ACIDS RES, V26, P544, DOI 10.1093/nar/26.2.544; Salzberg SL, 1998, GENE, V217, P57, DOI 10.1016/S0378-1119(98)00374-6; SAUNDERS N, UNPUB; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; SCHWARTZ B, 1989, CLIN MICROBIOL REV, V2, pS118, DOI 10.1128/CMR.2.Suppl.S118-S124.1989; SHIMIZU R, AB015669 GENB; Sutton G. G., 1995, GENOME SCI TECHNOL, V1, P9, DOI [10.1089/gst.1995.1.9, DOI 10.1089/GST.1995.1.9]; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Wainwright LA, 1997, NUCLEIC ACIDS RES, V25, P1362, DOI 10.1093/nar/25.7.1362; WAINWRIGHT LA, 1994, MOL MICROBIOL, V13, P75, DOI 10.1111/j.1365-2958.1994.tb00403.x; White O, 1999, SCIENCE, V286, P1571, DOI 10.1126/science.286.5444.1571; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W; YOON H, 1989, J GEN MICROBIOL, V135, P245; Zhu PX, 1999, MOL MICROBIOL, V33, P635, DOI 10.1046/j.1365-2958.1999.01514.x	68	902	1601	0	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1809	1815		10.1126/science.287.5459.1809	http://dx.doi.org/10.1126/science.287.5459.1809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710307				2022-12-24	WOS:000085775300039
J	Kirchner, JW; Weil, A				Kirchner, JW; Weil, A			Delayed biological recovery from extinctions throughout the fossil record	NATURE			English	Article							TIME-SERIES ANALYSIS; UNEVENLY SPACED DATA; SPECTRAL-ANALYSIS; END	How quickly does biodiversity rebound after extinctions? Palaeobiologists have examined the temporal, taxonomic and geographic patterns of recovery following individual mass extinctions in detail(1-5), but have not analysed recoveries from extinctions throughout the fossil record as a whole. Here, we measure how fast biodiversity rebounds after extinctions in general, rather than after individual mass extinctions, by calculating the cross-correlation between extinction and origination rates across the entire Phanerozoic marine fossil record. Our results show that extinction rates are not significantly correlated with contemporaneous origination rates, but instead are correlated with origination rates roughly 10 million years later. This lagged correlation persists when we remove the 'Big Five' major mass extinctions, indicating that recovery times following mass extinctions and background extinctions are similar. Our results suggest that there are intrinsic limits to how quickly global biodiversity can recover after extinction events, regardless of their magnitude. They also imply that today's anthropogenic extinctions will diminish biodiversity for millions of years to come.	Univ Calif Berkeley, Dept Geol & Geophys, Berkeley, CA 94720 USA; Duke Univ, Dept Biol Anthropol & Anat, Durham, NC 27708 USA	University of California System; University of California Berkeley; Duke University	Kirchner, JW (corresponding author), Univ Calif Berkeley, Dept Geol & Geophys, Berkeley, CA 94720 USA.		Kirchner, James W/B-6126-2009; Kirchner, James/AAC-4707-2019	Kirchner, James W/0000-0001-6577-3619; Kirchner, James/0000-0001-6577-3619				Agterberg F P, 1970, GEOSTATISTICS, P113; Bracewell R., 1999, FOURIER TRANSFORM IT, P46; CLEVELAND WS, 1984, J AM STAT ASSOC, V79, P807, DOI 10.2307/2288711; Erwin DH, 1998, TRENDS ECOL EVOL, V13, P344, DOI 10.1016/S0169-5347(98)01436-0; GILINSKY NL, 1991, ANAL PALEOBIOLOGY, P157; Hallam A., 1991, Historical Biology, V5, P257; Jablonski D, 1998, SCIENCE, V279, P1327, DOI 10.1126/science.279.5355.1327; Jablonski David, 1995, P25; Kirchner JW, 1998, NATURE, V395, P337, DOI 10.1038/26384; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Press W. H., 1988, Computers in Physics, V2, p77, 80; SCARGLE JD, 1982, ASTROPHYS J, V263, P835, DOI 10.1086/160554; SCARGLE JD, 1989, ASTROPHYS J, V343, P874, DOI 10.1086/167757; Schulz M, 1997, COMPUT GEOSCI, V23, P929, DOI 10.1016/S0098-3004(97)00087-3; Sepkoski J.J., 1996, GLOBAL EVENT STRATIG, P35, DOI [10.1007/978-3-642-79634-0_4, DOI 10.1007/978-3-642-79634-0_4]; SEPKOSKI JJ, 1993, PALEOBIOLOGY, V19, P43, DOI 10.1017/S0094837300012306; Sepkoski JJ, 1998, PHILOS T R SOC B, V353, P315, DOI 10.1098/rstb.1998.0212; Signor P.W., 1982, GEOL SOC AM SPEC PAP, V190, P291, DOI DOI 10.1130/SPE190-P291; Walliser O.H., 1996, GLOBAL EVENTS EVENT, P7, DOI DOI 10.1007/978-3-642-79634-0_2	19	120	125	0	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					177	180		10.1038/35004564	http://dx.doi.org/10.1038/35004564			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724168				2022-12-24	WOS:000085870900049
J	Geijtenbeek, TBH; Torensma, R; van Vliet, SJ; van Duijnhoven, GCF; Adema, GJ; van Kooyk, Y; Figdor, CG				Geijtenbeek, TBH; Torensma, R; van Vliet, SJ; van Duijnhoven, GCF; Adema, GJ; van Kooyk, Y; Figdor, CG			Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses	CELL			English	Article							INTERCELLULAR-ADHESION MOLECULE-3; PERIPHERAL LYMPHOID ORGANS; CLASS-II COMPARTMENT; C-TYPE LECTIN; MANNOSE RECEPTOR; LYMPHOCYTES-T; HUMAN BLOOD; ANTIGEN; ACTIVATION; LFA-1	Contact between dendritic cells (DC) and resting T cells is essential to initiate a primary immune response. Here, we demonstrate that ICAM-3 expressed by resting T cells is important in this first contact with DC. We discovered that instead of the common ICAM-3 receptors LFA-1 and alpha D beta 2, a novel DC-specific C-type lectin, DC-SIGN, binds ICAM-3 with high affinity. DC-SIGN, which is abundantly expressed by DC both in vitro and in vivo, mediates transient adhesion with T cells. Since antibodies against DC-SIGN inhibit DC-induced proliferation of resting T cells, our findings predict that DC-SIGN enables T cell receptor engagement by stabilization of the DC-T cell contact zone.	Radboud Univ Nijmegen Med Ctr, Dept Tumor Immunol, NL-6525 EX Nijmegen, Netherlands	Radboud University Nijmegen	van Kooyk, Y (corresponding author), Radboud Univ Nijmegen Med Ctr, Dept Tumor Immunol, Philips van Leydenlaan 25, NL-6525 EX Nijmegen, Netherlands.	y.vankooyk@dent.kun.nl	Torensma, Ruurd/C-2853-2009; Figdor, Carl G/A-4232-2010; Adema, G.J./H-8007-2014; Geijtenbeek, Teunis/C-2229-2009	Torensma, Ruurd/0000-0002-0555-7903; Figdor, Carl G/0000-0002-2366-9212; van Vliet, Sandra/0000-0003-1811-2687; Van Kooyk, Yvette/0000-0001-5997-3665				Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; ALBEROLAILA J, 1991, J IMMUNOL, V146, P1085; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Binnerts ME, 1999, IMMUNOL TODAY, V20, P240, DOI 10.1016/S0167-5699(99)01467-X; BINNERTS ME, 1994, EUR J IMMUNOL, V24, P2155, DOI 10.1002/eji.1830240933; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; David LR, 1996, J CRANIOFAC SURG, V7, P177, DOI 10.1097/00001665-199605000-00003; de Saint-Vis B, 1998, IMMUNITY, V9, P325, DOI 10.1016/S1074-7613(00)80615-9; DEFOUGEROLLES AR, 1992, J EXP MED, V175, P185, DOI 10.1084/jem.175.1.185; DELPOZO MA, 1994, CELL ADHES COMMUN, V2, P211, DOI 10.3109/15419069409004439; DRICKAMER K, 1995, CURR OPIN STRUC BIOL, V5, P612, DOI 10.1016/0959-440X(95)80052-2; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Dustin ML, 1998, CELL, V94, P667, DOI 10.1016/S0092-8674(00)81608-6; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HAUSS P, 1995, EUR J IMMUNOL, V25, P2285, DOI 10.1002/eji.1830250826; HERNANDEZCASELLES T, 1993, EUR J IMMUNOL, V23, P2799, DOI 10.1002/eji.1830231112; HOCK BD, 1994, IMMUNOLOGY, V83, P573; INABA K, 1984, J EXP MED, V160, P858, DOI 10.1084/jem.160.3.858; JIANG WP, 1995, NATURE, V375, P151, DOI 10.1038/375151a0; JUAN M, 1994, J EXP MED, V179, P1747, DOI 10.1084/jem.179.6.1747; Lub M, 1997, MOL BIOL CELL, V8, P719, DOI 10.1091/mbc.8.4.719; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mullin NP, 1997, J BIOL CHEM, V272, P5668, DOI 10.1074/jbc.272.9.5668; PARRA E, 1993, SCAND J IMMUNOL, V38, P508, DOI 10.1111/j.1365-3083.1993.tb03233.x; RIELE HT, 1990, NATURE, V348, P649, DOI 10.1038/348649a0; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Shaw AS, 1997, IMMUNITY, V6, P361, DOI 10.1016/S1074-7613(00)80279-4; SHAW S, 1986, NATURE, V323, P262, DOI 10.1038/323262a0; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STARLING GC, 1995, EUR J IMMUNOL, V25, P2528, DOI 10.1002/eji.1830250918; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1991, ANNU REV IMMUNOL, V9, P271, DOI 10.1146/annurev.iy.09.040191.001415; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; Tan MCAA, 1997, EUR J IMMUNOL, V27, P2426, DOI 10.1002/eji.1830270942; van Kooyk Y, 1999, J BIOL CHEM, V274, P26869, DOI 10.1074/jbc.274.38.26869; VanderVieren M, 1995, IMMUNITY, V3, P683, DOI 10.1016/1074-7613(95)90058-6; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; VILELLA R, 1990, TISSUE ANTIGENS, V36, P203, DOI 10.1111/j.1399-0039.1990.tb01830.x; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; Wild MK, 1999, J EXP MED, V190, P31, DOI 10.1084/jem.190.1.31; Yauch RL, 1997, J EXP MED, V186, P1347, DOI 10.1084/jem.186.8.1347; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	47	1361	1497	4	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 3	2000	100	5					575	585		10.1016/S0092-8674(00)80693-5	http://dx.doi.org/10.1016/S0092-8674(00)80693-5			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721994	Bronze			2022-12-24	WOS:000085700000010
J	Baker, D; Pryce, G; Croxford, JL; Brown, P; Pertwee, RG; Huffman, JW; Layward, L				Baker, D; Pryce, G; Croxford, JL; Brown, P; Pertwee, RG; Huffman, JW; Layward, L			Cannabinoids control spasticity and tremor in a multiple sclerosis model	NATURE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CB1	Chronic relapsing experimental allergic encephalomyelitis (CREAE) is an autoimmune model of multiple sclerosis(1). Although both these diseases are typified by relapsing-remitting paralytic episodes, after CREAE induction by sensitization to myelin antigens(1) Biozzi ABH mice also develop spasticity and tremor. These symptoms also occur during multiple sclerosis and are difficult to control. This has prompted some patients to find alternative medicines, and to perceive benefit from cannabis use(2), Although this benefit has been backed up by small clinical studies, mainly With non-quantifiable outcomes(3-7) the value of cannabis use in multiple sclerosis remains anecdotal. Here we show that cannabinoid (CB) receptor agonism using R(+)-WIN 55,212, Delta(9)-tetrahydrocannabinol, methanandamide and JWH-133 (ref. 8) quantitatively ameliorated both tremor and spasticity in diseased mice. The exacerbation Of these signs after antagonism of the CB(1) and CB(2) receptors, notably the CB(1) receptor, using SR141716A and SR144528 (ref. 8) indicative that the endogenous cannabinoid system may be tonically active in the control of tremor and spasticity. This provides a rationale for patients' indications of the therapeutic potential of cannabis in the control of the symptoms of multiple sclerosis(2), and provides a means of evaluating more selective cannabinoids in the future.	UCL, Inst Neurol, Dept Neurochem, Neuroinflammat Grp, London WC1N 1PJ, England; UCL, Inst Ophthalmol, London EC1V 9EL, England; Natl Hosp Neurol & Neurosurg, MRC, Human Movement & Balance Unit, London WC1N 3BG, England; Univ Aberdeen, Inst Med Sci, Dept Biomed Sci, Aberdeen AB25 2ZD, Scotland; Clemson Univ, Dept Chem, Clemson, SC 29634 USA; Multiple Sclerosis Soc Great Britain & No Ireland, London SW6 1EE, England	University of London; King's College London; University College London; University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of Aberdeen; Clemson University	Baker, D (corresponding author), UCL, Inst Neurol, Dept Neurochem, Neuroinflammat Grp, 1 Wakefield St, London WC1N 1PJ, England.	D.Baker@ion.ucl.ac.uk	Pertwee, Roger Guy/E-1312-2011; Brown, Peter/J-4307-2016	Brown, Peter/0000-0002-5201-3044; Pertwee, Roger/0000-0003-3227-2783	Multiple Sclerosis Society [541] Funding Source: Medline	Multiple Sclerosis Society(National Multiple Sclerosis Society)		BAKER D, 1990, J NEUROIMMUNOL, V28, P261, DOI 10.1016/0165-5728(90)90019-J; Breivogel CS, 1998, NEUROBIOL DIS, V5, P417, DOI 10.1006/nbdi.1998.0229; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; CHAI CK, 1961, J HERED, V52, P241, DOI 10.1093/oxfordjournals.jhered.a107083; CLIFFORD DB, 1983, ANN NEUROL, V13, P669, DOI 10.1002/ana.410130616; Consroe P, 1998, NEUROBIOL DIS, V5, P534, DOI 10.1006/nbdi.1998.0220; Consroe P, 1997, EUR NEUROL, V38, P44, DOI 10.1159/000112901; Giuffrida A, 1999, NAT NEUROSCI, V2, P358, DOI 10.1038/7268; HELLER AH, 1982, BRAIN RES, V234, P299, DOI 10.1016/0006-8993(82)90870-8; Huffman JW, 1999, BIOORGAN MED CHEM, V7, P2905, DOI 10.1016/S0968-0896(99)00219-9; Landsman RS, 1997, EUR J PHARMACOL, V334, pR1, DOI 10.1016/S0014-2999(97)01160-6; LYMAN WD, 1989, J NEUROIMMUNOL, V23, P73, DOI 10.1016/0165-5728(89)90075-1; MARTYN CN, 1995, LANCET, V345, P579, DOI 10.1016/S0140-6736(95)90485-9; NOTH J, 1991, J NEUROL, V238, P131, DOI 10.1007/BF00319679; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Pertwee RG, 1999, CURR MED CHEM, V6, P635; Petro D. J., 1981, J CLIN PHARMACOL, P413; Portier M, 1999, J PHARMACOL EXP THER, V288, P582; UNDERLEIDER JT, 1987, ADV ALCOHOL SUBSTANC, V7, P39; WIRGUIN I, 1994, IMMUNOPHARMACOLOGY, V28, P209, DOI 10.1016/0162-3109(94)90056-6	20	410	477	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					84	87		10.1038/35003583	http://dx.doi.org/10.1038/35003583			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716447				2022-12-24	WOS:000085775100050
J	Fernandes, PG; Brierley, AS; Simmonds, EJ; Millard, NW; McPhail, SD; Armstrong, F; Stevenson, P; Squiress, M				Fernandes, PG; Brierley, AS; Simmonds, EJ; Millard, NW; McPhail, SD; Armstrong, F; Stevenson, P; Squiress, M			Oceanography - Fish do not avoid survey vessels	NATURE			English	Article									FRS Marine Lab Aberdeen, Aberdeen AB11 9DB, Scotland; British Antarctic Survey, Cambridge CB3 0ET, England; Southampton Oceanog Ctr, Southampton SO14 3ZH, Hants, England	UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey; NERC National Oceanography Centre; University of Southampton	Fernandes, PG (corresponding author), FRS Marine Lab Aberdeen, POB 101,Victoria Rd, Aberdeen AB11 9DB, Scotland.		Brierley, Andrew S/G-8019-2011; Fernandes, Paul/H-2972-2013	Brierley, Andrew S/0000-0002-6438-6892; Fernandes, Paul/0000-0003-4135-115X				Brierley AS, 1998, DEEP-SEA RES PT II, V45, P1155, DOI 10.1016/S0967-0645(98)00025-3; Ferng W. R., 1991, Numerical Algorithms, V1, P1, DOI 10.1007/BF02145580; FOOTE KG, 1983, J ACOUST SOC AM, V73, P1932, DOI 10.1121/1.389583; FREON P, 1992, FISH RES, V15, P45, DOI 10.1016/0165-7836(92)90004-D; HOLLIDAY DV, 1995, ICES J MAR SCI, V52, P279, DOI 10.1016/1054-3139(95)80044-1; MacLennan D.N., 1992, SPRINGER SCI BUS MED; MAGURRAN AE, 1999, DYNAMICS PELAGIC FIS, pR9; Millard NW, 1998, UNDERWATER TECHNOL, V23, P7, DOI 10.3723/175605498783259894; MILLARD NW, 1999, P INT C REM TECHN HA, P19; Mitson R.B., 1995, ICES Cooperative Research Report, V209, P1; Rose GA, 1999, CAN J FISH AQUAT SCI, V56, P118, DOI 10.1139/cjfas-56-S1-118; Simmonds EJ, 1996, ICES J MAR SCI, V53, P189; WALTERS CJ, 1996, W FISHERIES      JAN, P41	13	90	92	1	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					35	36		10.1038/35003648	http://dx.doi.org/10.1038/35003648			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716432				2022-12-24	WOS:000085775100034
J	Scott, EC				Scott, EC			Not (just) in Kansas anymore	SCIENCE			English	Article									Natl Ctr Sci Educ, El Cerrito, CA 94530 USA		Scott, EC (corresponding author), Natl Ctr Sci Educ, 925 Kearny St, El Cerrito, CA 94530 USA.			Scott, Eugenie Carol/0000-0003-3795-8207					0	10	10	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2000	288	5467					813	+		10.1126/science.288.5467.813	http://dx.doi.org/10.1126/science.288.5467.813			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10809650				2022-12-24	WOS:000086869600020
J	Messenger, S				Messenger, S			Identification of molecular-cloud material in interplanetary dust particles	NATURE			English	Article							ISOTOPIC COMPOSITION; CARBON; METEORITES; ORIGIN; WATER	Interplanetary dust particles (IDPs) collected in the Earth's stratosphere and meteorites are fragments of comets and asteroids. These are 'primitive' meteorites in part because they have preserved materials which predate the formation of the Solar System. The most primitive (least altered) meteorites contain a few parts per million of micrometre-sized dust which formed in the atmospheres of giant stars(1). Some meteorites(2) have elevated D/H and N-15/N-14 ratios that are attributed to surviving interstellar organic molecules which have probably been strongly diluted and altered by parent-body processes(2). Most IDPs are chemically, mineralogically, and texturally primitive in comparison to meteorites(3,4). Here I show that H and N isotopic anomalies among fragile 'cluster' IDPs are far larger, more common, and less equilibrated than those previously observed in other IDPs or meteorites. In some cases, the D/H ratios that we measure reach the values of interstellar molecules, suggesting that molecular-cloud material has survived intact. These observations indicate that cluster IDPs are the most primitive class of Solar System materials currently available for laboratory analysis.	Washington Univ, Dept Phys, McDonnell Ctr Space Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Messenger, S (corresponding author), Washington Univ, Dept Phys, McDonnell Ctr Space Sci, St Louis, MO 63130 USA.	dbunny@howdy.wustl.edu						ADAMS NG, 1981, ASTROPHYS J, V247, pL123, DOI 10.1086/183604; Alexander CMO, 1998, METEORIT PLANET SCI, V33, P603, DOI 10.1111/j.1945-5100.1998.tb01667.x; Bockelee-Morvan D, 1998, ICARUS, V133, P147, DOI 10.1006/icar.1998.5916; BRADLEY JP, 1987, METEORITES EARLY SOL, P861; Brownlee D.E., 1995, LUNAR PLANET SCI, P183; EBERHARDT P, 1995, ASTRON ASTROPHYS, V302, P301; FLYNN GJ, 1993, METEORITICS, V28, P349; FRAUNDORF P, 1982, J GEOPHYS RES, V87, pA403, DOI 10.1029/JB087iS01p0A403; GUAN Y, 1997, LUNAR PLANET SCI, V28, P489; GUAN Y, 1998, LUNAR PLANET SCI, V29; KELLER LP, 1997, LUNAR PLANET SCI, V28; LANGER WD, 1984, ASTROPHYS J, V277, P581, DOI 10.1086/161730; MCKEEGAN KD, 1985, GEOCHIM COSMOCHIM AC, V49, P1971, DOI 10.1016/0016-7037(85)90091-2; MCKEEGAN KD, 1987, THESIS WASHINGTON U; MCKEEGAN KD, 1987, LUNAR PLANET SCI, V18, P627; Meier R, 1998, SCIENCE, V279, P1707, DOI 10.1126/science.279.5357.1707; MESSENGER S, 1998, LUNAR PLANET SCI, V29; MESSENGER S, 1997, AIP C P, V402, P545; Millar TJ, 1998, FARADAY DISCUSS, V109, P15, DOI 10.1039/a800127h; Sandford S. A., 1987, Fundamentals of Cosmic Physics, V12, P1; STADERMANN FJ, 1991, THESIS U HEIDELBERG; THOMAS KL, 1993, GEOCHIM COSMOCHIM AC, V57, P1551, DOI 10.1016/0016-7037(93)90012-L; TIELENS AGG, 1998, AIP C P, V402, P523; Zinner E, 1998, ANNU REV EARTH PL SC, V26, P147, DOI 10.1146/annurev.earth.26.1.147; ZINNER E, 1989, GEOCHIM COSMOCHIM AC, V53, P3273, DOI 10.1016/0016-7037(89)90107-5	25	282	282	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2000	404	6781					968	971		10.1038/35010053	http://dx.doi.org/10.1038/35010053			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801119				2022-12-24	WOS:000086762000047
J	Reinisch, KM; Nibert, M; Harrison, SC				Reinisch, KM; Nibert, M; Harrison, SC			Structure of the reovirus core at 3.6 angstrom resolution	NATURE			English	Article							DOUBLE-STRANDED-RNA; PARTICLES; DNA; CRYSTALLOGRAPHY; CONFORMATION; ORGANIZATION; PROTEINS; PACKING; TYPE-3; GENOME	The reovirus core is an assembly with a relative molecular mass of 52 million that synthesizes, modifies and exports viral messenger RNA. Analysis of its structure by X-ray crystallography shows that there are alternative, specific and completely nonequivalent contacts made by several surfaces of two of its proteins; that the RNA capping and export apparatus is a hollow cylinder, which probably sequesters its substrate to ensure completion of the capping reactions; that the genomic double-stranded RNA is coiled into concentric layers within the particle; and that there is a protein shell that appears to be common to all groups of double-stranded RNA viruses.	Harvard Univ, Fairchild Bldg,7 Divin Ave, Cambridge, MA 02138 USA; Howard Hughes Med Inst, Cambridge, MA 02138 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA	Harvard University; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Harrison, SC (corresponding author), Harvard Univ, Fairchild Bldg,7 Divin Ave, Cambridge, MA 02138 USA.	harrison@crystal.harvard.edu						BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BOOY FP, 1991, CELL, V64, P1007, DOI 10.1016/0092-8674(91)90324-R; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Butcher SJ, 1997, EMBO J, V16, P4477, DOI 10.1093/emboj/16.14.4477; CARSON M, 1996, MACROMOLECULAR ENZYM, P493; Cerritelli ME, 1997, CELL, V91, P271, DOI 10.1016/S0092-8674(00)80409-2; CHENG RH, 1994, J MOL BIOL, V244, P255, DOI 10.1006/jmbi.1994.1726; COOMBS KM, 1990, J MOL BIOL, V215, P1, DOI 10.1016/S0022-2836(05)80089-0; Dryden KA, 1998, VIROLOGY, V245, P33, DOI 10.1006/viro.1998.9146; DRYDEN KA, 1993, J CELL BIOL, V122, P1023, DOI 10.1083/jcb.122.5.1023; EARNSHAW WC, 1978, CELL, V14, P559, DOI 10.1016/0092-8674(78)90242-8; EARNSHAW WC, 1977, NATURE, V268, P598, DOI 10.1038/268598a0; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Fields B.N., 1996, FIELDS VIROLOGY, P1553; FURUICHI Y, 1976, J BIOL CHEM, V251, P5043; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; HARRISON SC, 1983, J MOL BIOL, V171, P577, DOI 10.1016/0022-2836(83)90045-1; Harrison SJ, 1999, VIROLOGY, V258, P54, DOI 10.1006/viro.1999.9707; HARVEY JD, 1981, VIROLOGY, V112, P240, DOI 10.1016/0042-6822(81)90629-2; Hill CL, 1999, NAT STRUCT BIOL, V6, P565, DOI 10.1038/9347; Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0; Hu GH, 1999, P NATL ACAD SCI USA, V96, P7149, DOI 10.1073/pnas.96.13.7149; Jacobson DH, 1996, ACTA CRYSTALLOGR D, V52, P693, DOI 10.1107/S0907444996001060; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; JONES TA, 1992, MOL REPLACEMENT, P91; Kleywegt GJ, 1994, 1 MAP FINAL MODEL, P59; KOHLSTAEDT LA, 1992, SCIENCE, V256, P1783, DOI 10.1126/science.1377403; LABBE M, 1991, J VIROL, V65, P2946; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIDDINGTON RC, 1991, NATURE, V354, P278, DOI 10.1038/354278a0; Luongo CL, 2000, J BIOL CHEM, V275, P2804, DOI 10.1074/jbc.275.4.2804; MAO ZX, 1991, VIROLOGY, V185, P377, DOI 10.1016/0042-6822(91)90785-A; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MOSS SR, 1994, VIRUS RES, V32, P401, DOI 10.1016/0168-1702(94)90088-4; NIBERT ML, 1996, FIELDS VIROLOGY, P1557; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; SCHLUCKEBIER G, 1995, J MOL BIOL, V247, P16, DOI 10.1006/jmbi.1994.0117; Shaw AL, 1996, STRUCTURE, V4, P957, DOI 10.1016/S0969-2126(96)00102-5; STEHLE T, 1994, NATURE, V369, P160, DOI 10.1038/369160a0; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; XU PT, 1993, VIROLOGY, V197, P726, DOI 10.1006/viro.1993.1648; Zhang H, 1999, J VIROL, V73, P1624, DOI 10.1128/JVI.73.2.1624-1629.1999	46	358	391	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2000	404	6781					960	967		10.1038/35010041	http://dx.doi.org/10.1038/35010041			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801118				2022-12-24	WOS:000086762000046
J	Tang, MJ; Pham, P; Shen, X; Taylor, JS; O'Donnell, M; Woodgate, R; Goodman, MF				Tang, MJ; Pham, P; Shen, X; Taylor, JS; O'Donnell, M; Woodgate, R; Goodman, MF			Roles of E-coli DNA polymerases IV and V in lesion-targeted and untargeted SOS mutagenesis	NATURE			English	Article							SINGLE-STRANDED VECTOR; ESCHERICHIA-COLI; RECA PROTEIN; CIS-SYN; ULTRAVIOLET-LIGHT; MOUSE HOMOLOGS; REPLICATION; MUTATION; BYPASS; PHOTOPRODUCTS	The expression of the Escherichia coli DNA polymerases pol V (UmuD'(2) C complex)(1,2) and pol IV (DinB)(3) increases in response to DNA damage(4). The induction of pol V is accompanied by a substantial increase in mutations targeted at DNA template lesions in a process called SOS-induced error-prone repair(4). Here we show that the common DNA template lesions, TT (6-4) photoproducts, TT cis-syn photodimers and abasic sites, are efficiently bypassed within 30 seconds by pol V in the presence of activated RecA protein (RecA*), single-stranded binding protein (SSB) and pol III's processivity beta,gamma-complex. There is no detectable bypass by either pol IV or pol III on this time scale. A mutagenic 'signature' for pol V is its incorporation of guanine opposite the 3'-thymine of a TT (6-4) photoproduct, in agreement with mutational spectra. In contrast, pol III and pol IV incorporate adenine almost exclusively. When copying undamaged DNA, pol V exhibits low fidelity with error rates of around 10(-3) to 10(-4), with pol IV being 5- to 10-fold more accurate. The effects of RecA protein on pol V, and beta,gamma-complex on pol IV, cause a 15,000- and 3,000-fold increase in DNA synthesis efficiency, respectively. However, both polymerases exhibit low processivity, adding 6 to 8 nucleotides before dissociating. Lesion bypass by pol V does not require beta,gamma-complex in the presence of non-hydrolysable ATP gamma S, indicating that an intact RecA filament may be required for translesion synthesis.	Univ So Calif, Dept Biol Sci & Chem, Los Angeles, CA 90089 USA; Washington Univ, Dept Chem, St Louis, MO 63130 USA; Rockefeller Univ, New York, NY 10021 USA; Howard Hughes Med Inst, New York, NY 10021 USA; NICHHD, Sect DNA Replicat Repair & Mutagenesis, NIH, Bethesda, MD 20892 USA	University of Southern California; Washington University (WUSTL); Rockefeller University; Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci & Chem, Univ Pk, Los Angeles, CA 90089 USA.		Taylor, John-Stephen/AAA-3218-2020	Taylor, John-Stephen/0000-0002-8615-7257; Woodgate, Roger/0000-0001-5581-4616	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001500] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001500] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bambara RA, 1995, METHOD ENZYMOL, V262, P270; BANERJEE SK, 1988, P NATL ACAD SCI USA, V85, P8141, DOI 10.1073/pnas.85.21.8141; Bloom LB, 1997, J BIOL CHEM, V272, P27919, DOI 10.1074/jbc.272.44.27919; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; BROTCORNELANNOYE A, 1986, P NATL ACAD SCI USA, V83, P3904, DOI 10.1073/pnas.83.11.3904; Bruck I, 1996, J BIOL CHEM, V271, P10767, DOI 10.1074/jbc.271.18.10767; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Fijalkowska IJ, 1997, J BACTERIOL, V179, P7435, DOI 10.1128/jb.179.23.7435-7445.1997; Friedberg E.C., 1995, DNA REPAIR MUTAGENES, P407; Gerlach VL, 1999, P NATL ACAD SCI USA, V96, P11922, DOI 10.1073/pnas.96.21.11922; Jing YQ, 1998, NUCLEIC ACIDS RES, V26, P3845, DOI 10.1093/nar/26.16.3845; KATO T, 1977, MOL GEN GENET, V156, P121, DOI 10.1007/BF00283484; Kim SR, 1997, P NATL ACAD SCI USA, V94, P13792, DOI 10.1073/pnas.94.25.13792; KNIPPERS R, 1970, NATURE, V228, P1050, DOI 10.1038/2281050a0; LAWRENCE CW, 1990, MOL GEN GENET, V222, P166, DOI 10.1007/BF00283040; LAWRENCE CW, 1990, NUCLEIC ACIDS RES, V18, P2153, DOI 10.1093/nar/18.8.2153; LECLERC JE, 1991, P NATL ACAD SCI USA, V88, P9685, DOI 10.1073/pnas.88.21.9685; LINDAHL T, 1982, ANNU REV BIOCHEM, V51, P61, DOI 10.1146/annurev.bi.51.070182.000425; McDonald JP, 1999, GENOMICS, V60, P20, DOI 10.1006/geno.1999.5906; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; Naktinis V, 1996, CELL, V84, P137, DOI 10.1016/S0092-8674(00)81000-4; Radman M, 1999, NATURE, V401, P866, DOI 10.1038/44738; RAJAGOPALAN M, 1992, P NATL ACAD SCI USA, V89, P10777, DOI 10.1073/pnas.89.22.10777; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Reuven NB, 1999, J BIOL CHEM, V274, P31763, DOI 10.1074/jbc.274.45.31763; Smith CA, 1996, BIOCHEMISTRY-US, V35, P4146, DOI 10.1021/bi951975c; Sommer S, 1998, MOL MICROBIOL, V28, P281, DOI 10.1046/j.1365-2958.1998.00803.x; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7	30	367	387	1	25	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2000	404	6781					1014	1018		10.1038/35010020	http://dx.doi.org/10.1038/35010020			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801133				2022-12-24	WOS:000086762000061
J	Morris, AAM; Lightowlers, RN				Morris, AAM; Lightowlers, RN			Can paternal mtDNA be inherited?	LANCET			English	Editorial Material							MITOCHONDRIAL-DNA; RECOMBINATION		Newcastle Univ, Royal Victoria Infirm, Dept Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Newcastle Univ, Royal Victoria Infirm, Dept Neurol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Morris, AAM (corresponding author), Newcastle Univ, Royal Victoria Infirm, Dept Child Hlth, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England.							Awadalla P, 1999, SCIENCE, V286, P2524, DOI 10.1126/science.286.5449.2524; Eyre-Walker A, 1999, P ROY SOC B-BIOL SCI, V266, P477, DOI 10.1098/rspb.1999.0662; Hagelberg E, 1999, P ROY SOC B-BIOL SCI, V266, P485, DOI 10.1098/rspb.1999.0663; KAMIMURA N, 1989, J MOL BIOL, V210, P703, DOI 10.1016/0022-2836(89)90103-4; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Macaulay V, 1999, P ROY SOC B-BIOL SCI, V266, P2037, DOI 10.1098/rspb.1999.0883; Sutovsky P, 1999, NATURE, V402, P371, DOI 10.1038/46466; THORSNESS PE, 1990, NATURE, V346, P376, DOI 10.1038/346376a0; Thyagarajan B, 1996, J BIOL CHEM, V271, P27536, DOI 10.1074/jbc.271.44.27536	9	11	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 15	2000	355	9212					1290	1291						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LJ	10776737				2022-12-24	WOS:000086829400004
J	Li, MW; Ona, VO; Guegan, C; Chen, MH; Jackson-Lewis, V; Andrews, LJ; Olszewski, AJ; Stieg, PE; Lee, JP; Przedborski, S; Friedlander, RM				Li, MW; Ona, VO; Guegan, C; Chen, MH; Jackson-Lewis, V; Andrews, LJ; Olszewski, AJ; Stieg, PE; Lee, JP; Przedborski, S; Friedlander, RM			Functional role of caspase-1 and caspase-3 in an ALS transgenic mouse model	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; INTERLEUKIN-1-BETA CONVERTING-ENZYME; CU,ZN SUPEROXIDE-DISMUTASE; TROPHIC FACTOR WITHDRAWAL; MEDIATED APOPTOSIS; NEURONAL APOPTOSIS; FAMILY PROTEASES; BRAIN INJURY; CELL-DEATH; MICE	Mutations in the copper/zinc superoxide dismutase (SOD1) gene produce an animal model of familiar amyotrophic Lateral sclerosis (ALS), a fatal neurodegenerative disorder., To test a new therapeutic strategy for ALS, we examined the effect of caspase inhibition in transgenic mice expressing mutant human SOD1 with a substitution of glycine to alanine in position 93 (mSOD1(G93A)). Intracerebroventricular administration of zVAD-fmk, a broad caspase inhibitor. delays disease onset and mortality. Moreover, zVAD-fmk inhibits caspase-1 activity as well as caspase-1 and caspase-3 mRNA up-regulation, providing evidence for a non-cell-autonomous pathway regulating caspase expression. Caspases play an instrumental role in neurodegeneration in transgenic mSOD1(G93A) mice, which suggests that caspase inhibition may have a protective role in ALS.	Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg,Neuroapoptosis Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg,Neurosurg Serv, Boston, MA 02115 USA; Columbia Univ, Dept Neurol, New York, NY 10032 USA; Columbia Univ, Dept Pathol, New York, NY 10032 USA; Univ Chicago, Dept Med, Chicago, IL 60637 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Columbia University; Columbia University; University of Chicago	Friedlander, RM (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Surg,Neuroapoptosis Lab, Boston, MA 02115 USA.		Guegan, Christelle/AAD-5377-2020; Friedlander, Robert M/A-2845-2016; Olszewski, Adam J/F-8449-2013	Friedlander, Robert M/0000-0003-4423-9219; Olszewski, Adam J/0000-0002-6472-6658	NINDS NIH HHS [P50 NS38370, R29 NS37345, R01 NS38586] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R29NS037345, R01NS038586, P50NS038370] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ali A, 1999, J HEMATOTH STEM CELL, V8, P343, DOI 10.1089/152581699320108; Borchelt DR, 1998, NEUROBIOL DIS, V5, P27, DOI 10.1006/nbdi.1998.0178; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Fink KB, 1999, NEUROSCIENCE, V94, P1213, DOI 10.1016/S0306-4522(99)00345-0; Friedlander RM, 1997, NATURE, V388, P31, DOI 10.1038/40299; Friedlander RM, 1996, J EXP MED, V184, P717, DOI 10.1084/jem.184.2.717; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Friedlander RM, 1998, CELL DEATH DIFFER, V5, P823, DOI 10.1038/sj.cdd.4400433; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Holmin S, 2000, J NEUROSURG, V92, P108, DOI 10.3171/jns.2000.92.1.0108; Kostic V, 1997, SCIENCE, V277, P559, DOI 10.1126/science.277.5325.559; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Liberatore GT, 1999, NAT MED, V5, P1403; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Martin LJ, 2000, INT J MOL MED, V5, P3; Namura S, 1998, J NEUROSCI, V18, P3659; Ona VO, 1999, NATURE, V399, P263, DOI 10.1038/20446; Pasinelli P, 1998, P NATL ACAD SCI USA, V95, P15763, DOI 10.1073/pnas.95.26.15763; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland L. P., 1995, MERRITTS TXB NEUROLO, P742; Springer JE, 1999, NAT MED, V5, P943, DOI 10.1038/11387; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Troy CM, 1996, P NATL ACAD SCI USA, V93, P5635, DOI 10.1073/pnas.93.11.5635; Vukosavic Slobodanka, 1999, Society for Neuroscience Abstracts, V25, P1304; WILLIAMS DB, 1993, PERIPHERAL NEUROPATH; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; YUAN JY, 1990, DEV BIOL, V138, P33, DOI 10.1016/0012-1606(90)90174-H	30	576	602	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					335	339		10.1126/science.288.5464.335	http://dx.doi.org/10.1126/science.288.5464.335			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764647				2022-12-24	WOS:000086454300038
J	Felker, GM; Thompson, RE; Hare, JM; Hruban, RH; Clemetson, DE; Howard, DL; Baughman, KL; Kasper, EK				Felker, GM; Thompson, RE; Hare, JM; Hruban, RH; Clemetson, DE; Howard, DL; Baughman, KL; Kasper, EK			Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; PERIPARTUM CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; MORTALITY; MORBIDITY	Background: Previous studies of the prognosis of patients with heart failure due to cardiomyopathy categorized patients according to whether they had ischemic or nonischemic disease. The prognostic value of identifying more specific underlying causes of cardiomyopathy is unknown. Methods: We evaluated the outcomes of 1230 patients with cardiomyopathy. The patients were grouped into the following categories according to underlying cause: idiopathic cardiomyopathy (616 patients); peripartum cardiomyopathy (51); and cardiomyopathy due to myocarditis (111), ischemic heart disease (91), infiltrative myocardial disease (59), hypertension (49), human immunodeficiency virus (HIV) infection (45), connective-tissue disease (39), substance abuse (37), therapy with doxorubicin (15), and other causes (117). Cox proportional-hazards analysis was used to assess the association between the underlying cause of cardiomyopathy and survival. Results: During a mean follow-up of 4.4 years, 417 patients died and 57 underwent cardiac transplantation. As compared with the patients with idiopathic cardiomyopathy, the patients with peripartum cardiomyopathy had better survival (adjusted hazard ratio for death, 0.31; 95 percent confidence interval, 0.09 to 0.98), and survival was significantly worse among the patients with cardiomyopathy due to infiltrative myocardial disease (adjusted hazard ratio, 4.40; 95 percent confidence interval, 3.04 to 6.39), HIV infection (adjusted hazard ratio, 5.86; 95 percent confidence interval, 3.92 to 8.77), therapy with doxorubicin (adjusted hazard ratio, 3.46; 95 percent confidence interval, 1.67 to 7.18), and ischemic heart disease (adjusted hazard ratio, 1.52; 95 percent confidence interval, 1.07 to 2.17). Conclusions: The underlying cause of heart failure has prognostic value in patients with unexplained cardiomyopathy. Patients with peripartum cardiomyopathy appear to have a better prognosis than those with other forms of cardiomyopathy. Patients with cardiomyopathy due to infiltrative myocardial diseases, HIV infection, or doxorubicin therapy have an especially poor prognosis. (N Engl J Med 2000;342:1077-84.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Kasper, EK (corresponding author), Johns Hopkins Univ Hosp, Div Cardiol, Carnegie 568,600 N Wolfe St, Baltimore, MD 21287 USA.	ekasper@jhmi.edu	Felker, Michael/AAX-2288-2021; Howard, David L/H-8288-2019	Howard, David L/0000-0002-4907-4292; Felker, Gary/0000-0002-5931-1239				Adams KF, 1999, CIRCULATION, V99, P1816, DOI 10.1161/01.CIR.99.14.1816; Adams KF, 1996, J AM COLL CARDIOL, V28, P1781, DOI 10.1016/S0735-1097(96)00380-4; *AM COLL CARD AM H, 1995, CIRCULATION, V92, P2794; BILGRAD R, 1995, NATL DEATH INDEX USE; BOURASSA MG, 1993, J AM COLL CARDIOL, V22, pA14, DOI 10.1016/0735-1097(93)90456-B; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; COHN JN, 1986, NEW ENGL J MED, V314, P1547, DOI 10.1056/NEJM198606123142404; COHN JN, 1984, NEW ENGL J MED, V311, P819, DOI 10.1056/NEJM198409273111303; COHN JN, 1988, AM J CARDIOL, V62, pA25, DOI 10.1016/S0002-9149(88)80081-X; Cooper LT, 1997, NEW ENGL J MED, V336, P1860, DOI 10.1056/NEJM199706263362603; DEMAKIS JG, 1971, CIRCULATION, V44, P1053, DOI 10.1161/01.CIR.44.6.1053; Felker GM, 1999, MEDICINE, V78, P270, DOI 10.1097/00005792-199907000-00005; FRANCIOSA JA, 1983, AM J CARDIOL, V51, P831, DOI 10.1016/S0002-9149(83)80141-6; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; GARG R, 1995, JAMA-J AM MED ASSOC, V274, P462; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; HOMANS DC, 1985, NEW ENGL J MED, V312, P1432, DOI 10.1056/NEJM198505303122206; KASPER EK, 1994, J AM COLL CARDIOL, V23, P586, DOI 10.1016/0735-1097(94)90740-4; KYLE RA, 1995, SEMIN HEMATOL, V32, P45; LIKOFF MJ, 1987, AM J CARDIOL, V59, P634; MANCINI DM, 1991, CIRCULATION, V83, P778, DOI 10.1161/01.CIR.83.3.778; OAKLEY CM, 1980, BRIT HEART J, V44, P672; Packer M, 1996, NEW ENGL J MED, V335, P1107, DOI 10.1056/NEJM199610103351504; Packer M, 1999, AM J CARDIOL, V83, p1A; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; SCHOCKEN DD, 1992, J AM COLL CARDIOL, V20, P301, DOI 10.1016/0735-1097(92)90094-4	26	1048	1095	2	25	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 13	2000	342	15					1077	1084		10.1056/NEJM200004133421502	http://dx.doi.org/10.1056/NEJM200004133421502			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303DZ	10760308				2022-12-24	WOS:000086406700002
J	Rocheville, M; Lange, DC; Kumar, U; Patel, SC; Patel, RC; Patel, YC				Rocheville, M; Lange, DC; Kumar, U; Patel, SC; Patel, RC; Patel, YC			Receptors for dopamine and somatostatin: Formation of hetero-oligomers with enhanced functional activity	SCIENCE			English	Article							ADENYLYL-CYCLASE; RAT-BRAIN; INTERNALIZATION; SYSTEM; CELLS; D1	Somatostatin and dopamine are two major neurotransmitter systems that share a number of structural and functional characteristics. Somatostatin receptors and dopamine receptors are colocalized in neuronal subgroups, and somatostatin is involved in modulating dopamine-mediated control of motor activity. However, the molecular basis for such interaction between the two systems is unclear. Here, we show that dopamine receptor D2R and somatostatin receptor SSTR5 interact physically through hetero-oligomerization to create a novel receptor with enhanced functional activity. Our results provide evidence that receptors from different G protein (heterotrimeric guanine nucleotide binding protein)-coupled receptor families interact through oligomerization. Such direct intramembrane association defines a new level of molecular crosstalk between related G protein-coupled receptor subfamilies.	McGill Univ, Dept Med, Fraser Labs, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Pharmacol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Therapeut, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Neurol, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Neurosurg, Montreal, PQ H3A 1A1, Canada; Royal Victoria Hosp, Montreal, PQ H3A 1A1, Canada; Clarkson Univ, Dept Phys, Potsdam, NY 13699 USA; Clarkson Univ, Dept Chem, Potsdam, NY 13699 USA; VA Connecticut Healthcare Syst, Newington, CT 06111 USA; New England Biomed Res Ctr, Newington, CT 06111 USA	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Royal Victoria Hospital; Clarkson University; Clarkson University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Patel, YC (corresponding author), McGill Univ, Dept Med, Fraser Labs, Montreal, PQ H3A 1A1, Canada.				NINDS NIH HHS [NS32160-05, NS34339] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034339, R01NS032160] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHNEIWEISS H, 1985, J NEUROCHEM, V44, P1825, DOI 10.1111/j.1471-4159.1985.tb07175.x; Clegg R.M., 1996, FLUORESCENCE IMAGING; COHN L, 1975, BRAIN RES, V96, P138; Cvejic S, 1997, J BIOL CHEM, V272, P26959, DOI 10.1074/jbc.272.43.26959; EPELBAUM J, 1986, PROG NEUROBIOL, V27, P63, DOI 10.1016/0301-0082(86)90012-2; Forster T, 1948, NATURWISSENSCHAFTEN, V6, P166; GADELLA TWJ, 1995, J CELL BIOL, V129, P1543, DOI 10.1083/jcb.129.6.1543; George SR, 1998, J BIOL CHEM, V273, P30244, DOI 10.1074/jbc.273.46.30244; HAVLICEK V, 1976, PHARMACOL BIOCHEM BE, V4, P455, DOI 10.1016/0091-3057(76)90063-0; Hebert TE, 1998, BIOCHEM CELL BIOL, V76, P1, DOI 10.1139/bcb-76-1-1; HOYER D, 1994, ARCH PHARM, V350, P1; Hukovic N, 1998, J BIOL CHEM, V273, P21416, DOI 10.1074/jbc.273.33.21416; IzquierdoClaros RM, 1997, MOL BRAIN RES, V47, P99, DOI 10.1016/S0169-328X(97)00063-6; Jordan BA, 1999, NATURE, V399, P697, DOI 10.1038/21441; JOVIN TM, 1989, CELL STRUCTURE FUNCT; KASTIN AJ, 1978, METABOLISM, V27, P1247, DOI 10.1016/0026-0495(78)90053-7; Kumar U, 1999, DIABETES, V48, P77, DOI 10.2337/diabetes.48.1.77; LEBLANC R, 1988, NEUROLOGY, V38, P1887, DOI 10.1212/WNL.38.12.1887; Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8; MARTINIVERSON MT, 1986, PHARM BIOCH BEHAV, V24, P17; Marzullo P, 1999, Pituitary, V1, P115, DOI 10.1023/A:1009932521242; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Ng GYK, 1996, BIOCHEM BIOPH RES CO, V227, P200, DOI 10.1006/bbrc.1996.1489; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; PATEL YC, 1992, BASIC CLIN ASPECTS N, V4, P1; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; Rocheville M, 2000, J BIOL CHEM, V275, P7862, DOI 10.1074/jbc.275.11.7862; RodriguezSanchez MN, 1997, J NEUROSCI RES, V48, P238, DOI 10.1002/(SICI)1097-4547(19970501)48:3<238::AID-JNR6>3.0.CO;2-G; SRIKANT CB, 1981, P NATL ACAD SCI-BIOL, V78, P3930, DOI 10.1073/pnas.78.6.3930; WEINER DM, 1991, P NATL ACAD SCI USA, V88, P1859, DOI 10.1073/pnas.88.5.1859; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487	31	704	724	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					154	157		10.1126/science.288.5463.154	http://dx.doi.org/10.1126/science.288.5463.154			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753124				2022-12-24	WOS:000086387700056
J	de Waal, FBM; Berger, ML				de Waal, FBM; Berger, ML			Payment for labour in monkeys	NATURE			English	Article							FOOD; CHIMPANZEES; CEBUS		Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA; Emory Univ, Dept Psychol, Atlanta, GA 30329 USA	Emory University; Emory University	de Waal, FBM (corresponding author), Emory Univ, Yerkes Reg Primate Res Ctr, Atlanta, GA 30329 USA.			Berger, Michelle/0000-0002-6679-6756				BOESCH C, 1989, AM J PHYS ANTHROPOL, V78, P547, DOI 10.1002/ajpa.1330780410; Crawford M.P., 1937, COMP PSYCHOL MONOGR, V14, P1; De Waal F., 1996, GOOD NATURED; de Waal FBM, 1997, J COMP PSYCHOL, V111, P370, DOI 10.1037/0735-7036.111.4.370; de Waal FBM, 1997, EVOL HUM BEHAV, V18, P375, DOI 10.1016/S1090-5138(97)00085-8; DEWAAL FBM, IN PRESS ANIM BEHAV; Dugatkin L.A., 1997, COOPERATION ANIMALS; Goodall J., 1965, P425; PERRY S, 1994, PRIMATES, V35, P409, DOI 10.1007/BF02381950; Rose LM, 1997, INT J PRIMATOL, V18, P727, DOI 10.1023/A:1026343812980; Stanford CB, 1999, HUNTING APES; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; [No title captured]	13	145	150	1	46	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					563	563		10.1038/35007138	http://dx.doi.org/10.1038/35007138			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766228	Bronze			2022-12-24	WOS:000086400100039
J	Polleux, F; Morrow, T; Ghosh, A				Polleux, F; Morrow, T; Ghosh, A			Semaphorin 3A is a chemoattractant for cortical apical dendrites	NATURE			English	Article							VISUAL-CORTEX; GROWTH; PROJECTIONS; EXPRESSION; NEUROPILIN; RECEPTOR; CELLS; IV	The apical dendrites of pyramidal neurons integrate inputs from various cortical layers and are central to information processing. Here we show that the growth of apical dendrites towards the pial surface is regulated by a diffusible chemoattractant present at high levels near the marginal zone. A major component of this signal is semaphorin 3A (Sema3A), which was previously characterized as a chemorepellant for cortical axons. Soluble guanylate cyclase is asymmetrically localized to the developing apical dendrite, and is required for the chemoattractive effect of Sema3A. Thus the asymmetric localization of soluble guanylate cyclase confers distinct Sema3A responses to axons and dendrites. These observations reveal a mechanism by which a single chemotropic signal can pattern both axons and dendrites during development.	Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Ghosh, A (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurosci, 725 N Wolfe St, Baltimore, MD 21205 USA.		Polleux, Franck/H-9948-2014	Polleux, Franck/0000-0003-4313-0481				Baas PW, 1999, NEURON, V22, P23, DOI 10.1016/S0896-6273(00)80675-3; Bagnard D, 1998, DEVELOPMENT, V125, P5043; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; BUTTS NK, 1994, J STRENGTH COND RES, V8, P265; Catalano SM, 1998, MOL CELL NEUROSCI, V11, P173, DOI 10.1006/mcne.1998.0687; Chedotal A, 1998, DEVELOPMENT, V125, P4313; FISHELL G, 1995, DEVELOPMENT, V121, P803; FLANAGAN JG, 1990, CELL, V63, P185, DOI 10.1016/0092-8674(90)90299-T; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Giger RJ, 1998, NEURON, V21, P1079, DOI 10.1016/S0896-6273(00)80625-X; Giger RJ, 1996, J COMP NEUROL, V375, P378, DOI 10.1002/(SICI)1096-9861(19961118)375:3<378::AID-CNE3>3.0.CO;2-#; GILBERT CD, 1983, ANNU REV NEUROSCI, V6, P217, DOI 10.1146/annurev.ne.06.030183.001245; HARRIS DN, 1979, J CYCLIC NUCL PROT, V5, P125; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hong KS, 1999, CELL, V97, P927, DOI 10.1016/S0092-8674(00)80804-1; Kolodkin AL, 1998, PROG BRAIN RES, V117, P115; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; MILLER MW, 1988, CEREB CORTEX, V7, P133; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Parente CA, 1998, CELL, V95, P81, DOI 10.1016/S0092-8674(00)81784-5; Polleux F, 1998, SCIENCE, V282, P1904, DOI 10.1126/science.282.5395.1904; Robinson KR, 1997, DEV BIOL, V187, P125, DOI 10.1006/dbio.1997.8600; Skaliora I, 1998, EUR J NEUROSCI, V10, P1215, DOI 10.1046/j.1460-9568.1998.00128.x; Song HJ, 1998, SCIENCE, V281, P1515, DOI 10.1126/science.281.5382.1515; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222	30	553	565	0	20	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					567	573		10.1038/35007001	http://dx.doi.org/10.1038/35007001			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766232				2022-12-24	WOS:000086400100043
J	Arbeitman, MN; Hogness, DS				Arbeitman, MN; Hogness, DS			Molecular chaperones activate the Drosophila ecdysone receptor, an RXR heterodimer	CELL			English	Article							RETINOID-X-RECEPTOR; NUCLEAR RECEPTORS; STEROID-RECEPTORS; DNA-BINDING; ULTRASPIRACLE; MELANOGASTER; HSP90; PROTEINS; COMPLEX; LOCALIZATION	The steroid hormone 20-hydroxyecdysone coordinates the stages of Drosophila development by activating a nuclear receptor heterodimer consisting of the ecdysone receptor, EcR, and the Drosophila RXR receptor, USP. We show that EcR/USP DNA binding activity requires activation by a chaperone heterocomplex like that required for activation of the vertebrate steroid receptors, but not previously shown to be required far activation of RXR heterodimers. Six proteins normally present in the chaperone complex were individually purified and shown to be sufficient for this activation. We also show that two of the six (Hsp90 and Hsc70) are required in vivo for ecdysone receptor activity, and that EcR is the primary target of the chaperone complex.	Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA	Stanford University	Hogness, DS (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Stanford, CA 94305 USA.			Arbeitman, Michelle/0000-0002-2437-4352				ARBEITMAN MN, 1998, THESIS STANFORD U ST; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; CHRISTIANSON AMK, 1992, P NATL ACAD SCI USA, V89, P11503, DOI 10.1073/pnas.89.23.11503; Craig TA, 1999, BIOCHEM BIOPH RES CO, V260, P446, DOI 10.1006/bbrc.1999.0931; DALMAN FC, 1990, J BIOL CHEM, V265, P3615; DALMAN FC, 1991, BIOCHEMISTRY-US, V30, P5605, DOI 10.1021/bi00236a038; DeFranco DB, 1998, J STEROID BIOCHEM, V65, P51, DOI 10.1016/S0960-0760(97)00177-5; DING D, 1993, MOL CELL BIOL, V13, P3773, DOI 10.1128/MCB.13.6.3773; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; HENRICH VC, 1994, DEV BIOL, V165, P38, DOI 10.1006/dbio.1994.1232; Hing HK, 1999, EUR J CELL BIOL, V78, P690, DOI 10.1016/S0171-9335(99)80037-5; HOLLEY SJ, 1995, MOL BIOL CELL, V6, P1833, DOI 10.1091/mbc.6.12.1833; JOHNSON JL, 1994, J BIOL CHEM, V269, P24989; KISS I, 1988, GENETICS, V118, P247; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; KOELLE MR, 1992, THESIS STANFORD U ST; Li C, 1997, P NATL ACAD SCI USA, V94, P2278, DOI 10.1073/pnas.94.6.2278; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MAROY P, 1978, P NATL ACAD SCI USA, V75, P6035, DOI 10.1073/pnas.75.12.6035; ORO AE, 1990, NATURE, V347, P298, DOI 10.1038/347298a0; PALTER KB, 1986, MOL CELL BIOL, V6, P1187, DOI 10.1128/MCB.6.4.1187; PERRIMON N, 1985, GENETICS, V111, P23; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; RIDDIFORD LM, 1993, HORMONES DROSOPHILA; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; White KP, 1997, SCIENCE, V276, P114, DOI 10.1126/science.276.5309.114; Xu L, 1999, CURR OPIN GENET DEV, V9, P140, DOI 10.1016/S0959-437X(99)80021-5; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Ylikomi T, 1998, CRIT REV BIOCHEM MOL, V33, P437, DOI 10.1080/10409239891204279; YUND MA, 1978, P NATL ACAD SCI USA, V75, P6039, DOI 10.1073/pnas.75.12.6039	38	116	131	2	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 31	2000	101	1					67	77		10.1016/S0092-8674(00)80624-8	http://dx.doi.org/10.1016/S0092-8674(00)80624-8			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	300JM	10778857	Bronze			2022-12-24	WOS:000086249900009
J	Walker, RG; Willingham, AT; Zuker, CS				Walker, RG; Willingham, AT; Zuker, CS			A Drosophila mechanosensory transduction channel	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; HAIR-CELLS; MECHANOELECTRICAL TRANSDUCTION; ADAPTATION; MUTATIONS; RECEPTOR; GENETICS; NEURONS; EAR	Mechanosensory transduction underlies a wide range of senses, including proprioception, touch, balance, and hearing. The pivotal element of these senses is a mechanically gated ion channel that transduces sound, pressure, or movement into changes in excitability of specialized sensory cells. Despite the prevalence of mechanosensory systems, Little is known about the molecular nature of the transduction channels. To identify such a channel, we analyzed Drosophila melanogaster mechanoreceptive mutants for defects in mechanosensory physiology, Loss-of-function mutations in the no mechanoreceptor potential C (nompC) gene virtually abolished mechanosensory signaling. nompC encodes a new ion channel that is essential for mechanosensory transduction. As expected for a transduction channel, D, melanogaster NOMPC and a Caenorhabditis elegans homolog were selectively expressed in mechanosensory organs.	Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zuker, CS (corresponding author), Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	charles@flyeye.ucsd.edu			NIGMS NIH HHS [5T32GM08107] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008107] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; CHALFIE M, 1981, DEV BIOL, V82, P358, DOI 10.1016/0012-1606(81)90459-0; CHALFIE M, 1989, SCIENCE, V243, P1027, DOI 10.1126/science.2646709; Colbert HA, 1997, J NEUROSCI, V17, P8259; COREY DP, 1979, BIOPHYS J, V26, P499, DOI 10.1016/S0006-3495(79)85267-4; CORFAS G, 1990, J NEUROSCI, V10, P491; CRAWFORD AC, 1989, J PHYSIOL-LONDON, V419, P405, DOI 10.1113/jphysiol.1989.sp017878; EATOCK RA, 1987, J NEUROSCI, V7, P2821; Eberl DF, 1997, P NATL ACAD SCI USA, V94, P14837, DOI 10.1073/pnas.94.26.14837; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; GarciaAnoveros J, 1997, ANNU REV NEUROSCI, V20, P567, DOI 10.1146/annurev.neuro.20.1.567; George H, 1997, GENETICS, V146, P1345; HOWARD J, 1988, NEURON, V1, P189, DOI 10.1016/0896-6273(88)90139-0; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Kanzaki M, 1999, SCIENCE, V285, P882, DOI 10.1126/science.285.5429.882; Keil TA, 1997, MICROSC RES TECHNIQ, V39, P506, DOI 10.1002/(SICI)1097-0029(19971215)39:6<506::AID-JEMT5>3.0.CO;2-B; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; KERNAN M, 1995, CURR OPIN NEUROBIOL, V5, P443, DOI 10.1016/0959-4388(95)80003-4; KERNAN M, UNPUB; Luna EJ, 1991, CURR OPIN CELL BIOL, V3, P120, DOI 10.1016/0955-0674(91)90174-W; Mano I, 1999, BIOESSAYS, V21, P568, DOI 10.1002/(SICI)1521-1878(199907)21:7&lt;568::AID-BIES5&gt;3.0.CO;2-L; MARKIN VS, 1995, ANNU REV BIOPH BIOM, V24, P59, DOI 10.1146/annurev.bb.24.060195.000423; Morrison A, 1999, MECH DEVELOP, V84, P169, DOI 10.1016/S0925-4773(99)00066-0; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; SAIMI Y, 1987, ANNU REV GENET, V21, P47, DOI 10.1146/annurev.genet.21.1.47; Sawin E.R., 1996, SELECTED WORKS MAO T, V151, P135; Scott K, 1998, CURR OPIN NEUROBIOL, V8, P383, DOI 10.1016/S0959-4388(98)80065-2; Sedgwick SG, 1999, TRENDS BIOCHEM SCI, V24, P311, DOI 10.1016/S0968-0004(99)01426-7; THURM U, 1965, COLD SPRING HARB SYM, V30, P75, DOI 10.1101/SQB.1965.030.01.011; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WALKER RB, UNPUB; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Whitfield TT, 1996, DEVELOPMENT, V123, P241; WU L, 1995, NATURE, V373, P216, DOI 10.1038/373216a0	35	489	529	3	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2229	2234		10.1126/science.287.5461.2229	http://dx.doi.org/10.1126/science.287.5461.2229			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10744543				2022-12-24	WOS:000086049100041
J	Raber, J; Wong, D; Yu, GQ; Buttini, M; Mahley, RW; Pitas, RE; Mucke, L				Raber, J; Wong, D; Yu, GQ; Buttini, M; Mahley, RW; Pitas, RE; Mucke, L			Alzheimer's disease - Apolipoprotein E and cognitive performance	NATURE			English	Article									Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Dept Med, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Dept Neurol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Dept Pathol, San Francisco, CA 94141 USA; Univ Calif San Francisco, Inst Cardiovasc Res, Program Neurosci, San Francisco, CA 94141 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Raber, J (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94141 USA.			Buttini, Manuel/0000-0003-1805-0279				Buttini M, 1999, J NEUROSCI, V19, P4867; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Hartley DM, 1999, J NEUROSCI, V19, P8876, DOI 10.1523/JNEUROSCI.19-20-08876.1999; Holcomb LA, 1999, BEHAV GENET, V29, P177, DOI 10.1023/A:1021691918517; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Jensen M, 1999, ANN NEUROL, V45, P504, DOI 10.1002/1531-8249(199904)45:4<504::AID-ANA12>3.0.CO;2-9; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Price DL, 1998, ANNU REV NEUROSCI, V21, P479, DOI 10.1146/annurev.neuro.21.1.479; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Wilson CA, 1999, J NEUROPATH EXP NEUR, V58, P787, DOI 10.1097/00005072-199908000-00001	13	189	199	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					352	354		10.1038/35006165	http://dx.doi.org/10.1038/35006165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746713				2022-12-24	WOS:000086119000038
J	Weingart, SN; Wilson, RM; Gibberd, RW; Harrison, B				Weingart, SN; Wilson, RM; Gibberd, RW; Harrison, B			Epidemiology of medical error	BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; INTENSIVE-CARE UNIT; HOSPITALIZED-PATIENTS; QUALITY; PREVENTION; MORTALITY; MISTAKES; COSTS		Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; Royal N Shore Hosp, Qual Assurance Royal N Shore, St Leonards, NSW 2065, Australia; Univ Newcastle, Dept Stat, Newcastle, NSW 2308, Australia	Harvard University; Beth Israel Deaconess Medical Center; Royal North Shore Hospital; University of Newcastle	Weingart, SN (corresponding author), Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, 330 Brookline Ave, Boston, MA 02215 USA.							Andrews LB, 1997, LANCET, V349, P309, DOI 10.1016/S0140-6736(96)08268-2; Bates DW, 1999, ARCH INTERN MED, V159, P2553, DOI 10.1001/archinte.159.21.2553; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bhasale AL, 1998, MED J AUSTRALIA, V169, P73, DOI 10.5694/j.1326-5377.1998.tb140186.x; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brennan TA, 1996, NEW ENGL J MED, V335, P1963, DOI 10.1056/NEJM199612263352606; BURNUM JF, 1976, ANN INTERN MED, V85, P80, DOI 10.7326/0003-4819-85-1-80; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; COOK RI, 1998, TALE I STORIES CONTR; COOPER JB, 1984, ANESTHESIOLOGY, V60, P34, DOI 10.1097/00000542-198401000-00008; Darchy B, 1999, ARCH INTERN MED, V159, P71, DOI 10.1001/archinte.159.1.71; DONCHIN Y, 1995, CRIT CARE MED, V23, P294, DOI 10.1097/00003246-199502000-00015; GANDHI TK, IN PRESS J GEN INTER; Garcia-Martin M, 1997, J CLIN EPIDEMIOL, V50, P1319, DOI 10.1016/S0895-4356(97)00219-9; Gawande AA, 1999, SURGERY, V126, P66, DOI 10.1067/msy.1999.98664; Johnson JA, 1997, AM J HEALTH-SYST PH, V54, P554, DOI 10.1093/ajhp/54.5.554; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; LANSHMANAN MC, 1986, ARCH INTERN MED, V146, P1931; Leape L L, 1993, QRB Qual Rev Bull, V19, P144; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LESAR TS, 1990, JAMA-J AM MED ASSOC, V263, P2329, DOI 10.1001/jama.263.17.2329; Lundberg GD, 1998, JAMA-J AM MED ASSOC, V280, P1273, DOI 10.1001/jama.280.14.1273; Macklis RM, 1998, J CLIN ONCOL, V16, P551, DOI 10.1200/JCO.1998.16.2.551; MARTINEZ JVB, 1998, AN MED INTERNA, V15, P179; MITCHELL H, 1990, BRIT MED J, V300, P1622, DOI 10.1136/bmj.300.6740.1622; ONEIL AC, 1993, ANN INTERN MED, V119, P370, DOI 10.7326/0003-4819-119-5-199309010-00004; Plebani M, 1997, CLIN CHEM, V43, P1348; SHIMMEL EM, 1964, ANN INTERN MED, V60, P100; Stambouly JJ, 1996, INTENS CARE MED, V22, P1098, DOI 10.1007/BF01699236; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; TRUNET P, 1980, JAMA-J AM MED ASSOC, V244, P2617, DOI 10.1001/jama.244.23.2617; Wilson DG, 1998, EUR J PEDIATR, V157, P769, DOI 10.1007/s004310050932; Wilson RM, 1999, MED J AUSTRALIA, V170, P411, DOI 10.5694/j.1326-5377.1999.tb127814.x; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x; Windsor JA, 1998, AUST NZ J SURG, V68, P186, DOI 10.1111/j.1445-2197.1998.tb04742.x; WU AW, 1991, JAMA-J AM MED ASSOC, V265, P2089, DOI 10.1001/jama.265.16.2089	39	351	376	0	32	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	2000	320	7237					774	777		10.1136/bmj.320.7237.774	http://dx.doi.org/10.1136/bmj.320.7237.774			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720365	Green Published			2022-12-24	WOS:000086054700030
J	Shaw, PJ; Cirelli, C; Greenspan, RJ; Tononi, G				Shaw, PJ; Cirelli, C; Greenspan, RJ; Tononi, G			Correlates of sleep and waking in Drosophila melanogaster	SCIENCE			English	Article							RATS; EXPRESSION; LOCUS; DEPRIVATION; COCKROACH; NEURONS; LESIONS; CYCLE	Drosophila exhibits a circadian rest-activity cycle, but it is not known whether fly rest constitutes sleep or is mere inactivity. it is shown here that, like mammalian sleep, rest in Drosophila is characterized by an increased arousal threshold and is homeostatically regulated independently of the circadian clock. As in mammals, rest is abundant in young flies, is reduced in older flies, and is modulated by stimulants and hypnotics. Several molecular markers modulated by sleep and waking in mammals are modulated by rest and activity in Drosophila, including cytochrome oxidase C, the endoplasmic reticulum chaperone protein BiP, and enzymes implicated in the catabolism of monoamines. Flies Lacking one such enzyme, arylalkylamine N-acetyltransferase, show increased rest after rest deprivation. These results implicate the catabolism of monoamines in the regulation of sleep and waking in the fly and suggest that Drosophila may serve as a model system for the genetic dissection of sleep.	Inst Neurosci, San Diego, CA 92121 USA		Tononi, G (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.							Aronstein K, 1996, INVERTEBR NEUROSCI, V2, P115, DOI 10.1007/BF02214114; ASTONJONES G, 1981, J NEUROSCI, V1, P876; BRIDGES C. B., 1937, Cytologia, P745, DOI 10.1508/cytologia.FujiiJubilaei.745; Brodbeck D, 1998, DNA CELL BIOL, V17, P621, DOI 10.1089/dna.1998.17.621; CAMPBELL SS, 1984, NEUROSCI BIOBEHAV R, V8, P269, DOI 10.1016/0149-7634(84)90054-X; Cirelli C, 1998, MOL BRAIN RES, V56, P293, DOI 10.1016/S0169-328X(98)00057-6; CIRELLI C, 1999, SLEEP S, V22, P113; Dijk DJ, 1999, J PHYSIOL-LONDON, V516, P611, DOI 10.1111/j.1469-7793.1999.0611v.x; Dunkov BC, 1996, MOL GEN GENET, V251, P290, DOI 10.1007/s004380050169; EDGAR DM, 1993, J NEUROSCI, V13, P1065; HAMBLEN M, 1986, J NEUROGENET, V3, P249, DOI 10.3109/01677068609106855; Hartmann E.L., 1973, FUNCTIONS SLEEP; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; KAISER W, 1983, NATURE, V301, P707, DOI 10.1038/301707a0; KAISER W, 1988, J COMP PHYSIOL A, V163, P565, DOI 10.1007/BF00603841; KUHL D, 1992, J CELL BIOL, V119, P1069, DOI 10.1083/jcb.119.5.1069; MCGINTY DJ, 1976, BRAIN RES, V101, P569, DOI 10.1016/0006-8993(76)90480-7; MISTLBERGER RE, 1983, SLEEP, V6, P217, DOI 10.1093/sleep/6.3.217; Rechtschaffen A, 1998, PERSPECT BIOL MED, V41, P359, DOI 10.1353/pbm.1998.0051; RUBIN DM, 1993, GENE, V128, P155, DOI 10.1016/0378-1119(93)90558-K; SIEGEL JM, 1988, BRAIN RES REV, V13, P213, DOI 10.1016/0165-0173(88)90007-0; Stone W S, 1989, Clin Geriatr Med, V5, P363; TOBLER I, 1992, J SLEEP RES, V1, P231, DOI 10.1111/j.1365-2869.1992.tb00044.x; TOBLER I, 1983, NEUROSCI LETT, V42, P49, DOI 10.1016/0304-3940(83)90420-2; TOBLER I, 1988, J COMP PHYSIOL A, V163, P227, DOI 10.1007/BF00612431; TOBLER I, 1983, BEHAV BRAIN RES, V8, P351, DOI 10.1016/0166-4328(83)90180-8; YANIK G, 1987, BRAIN RES, V403, P177, DOI 10.1016/0006-8993(87)90141-7; Yehuda S, 1998, PEPTIDES, V19, P407, DOI 10.1016/S0196-9781(97)00295-7; ZEPELIN H, 1974, BRAIN BEHAV EVOLUT, V10, P425, DOI 10.1159/000124330	29	809	831	8	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1834	1837		10.1126/science.287.5459.1834	http://dx.doi.org/10.1126/science.287.5459.1834			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710313				2022-12-24	WOS:000085775300045
J	Bida, TA; Killen, RM; Morgan, TH				Bida, TA; Killen, RM; Morgan, TH			Discovery of calcium in Mercury's atmosphere	NATURE			English	Article							SURFACE; SODIUM; MOON	The composition and evolutionary history of Mercury's crust are not well determined(1,2). The planet as a whole has been predicted(3) to have a refractory, anhydrous composition: rich in Ca, Al, Mg and Fe, but poor in Na, K, OH, and S. Its atmosphere is believed to be derived in large part from the surface materials. A combination of effects that include impact vaporization (from infalling material), volatile evaporation, photon-stimulated desorption and sputtering releases material from the surface to form the atmosphere. Sodium and potassium have already been observed in Mercury's atmosphere(4-6), with abundances that require a volatile-rich crust(7). The sodium probably results from photon-stimulated desorption(8,9), and has a temperature of 1,500 K (ref. 10). Here we report the discovery of calcium in the atmosphere near Mercury's poles. The column density is very low and the temperature is apparently very high (12,000 K). The localized distribution and high temperature, if confirmed, suggest that the atmospheric calcium may arise from surface sputtering by ions, which enter Mercury's auroral zone. The low abundance of atmospheric Ca may indicate that the regolith is rarefied in calcium.	CARA, WM Keck Observ, Kamuela, HI 96743 USA; SW Res Inst, San Antonio, TX 78228 USA; NASA Headquarters, Washington, DC 20546 USA	Southwest Research Institute; National Aeronautics & Space Administration (NASA)	Bida, TA (corresponding author), CARA, WM Keck Observ, 65-1120 Mamalahoa Highway, Kamuela, HI 96743 USA.		Killen, Rosemary M/E-7127-2012; Morgan, Thomas/I-5943-2013					CHAMBERLAIN J.W., 1987, THEORY PLANETARY ATM; CHAMBERLAIN JW, 1976, J GEOPHYS RES-SPACE, V81, P1774, DOI 10.1029/JA081i010p01774; CHENG AF, 1987, ICARUS, V71, P430, DOI 10.1016/0019-1035(87)90038-8; ELPHIC RC, 1991, GEOPHYS RES LETT, V18, P2165, DOI 10.1029/91GL02669; Goettel K.A., 1988, MERCURY, P613; JEANLOZ R, 1995, SCIENCE, V268, P1455, DOI 10.1126/science.7770770; KIILEN RM, 1993, ICARUS, V101, P293; Killen RM, 1999, PLANET SPACE SCI, V47, P1449, DOI 10.1016/S0032-0633(99)00071-9; Kurucz R. L., 1984, Solar flux atlas from 296 to 1300 nm; Lewis J.S., 1988, MERCURY, P651; LEWIS JS, 1972, EARTH PLANET SC LETT, V15, P286, DOI 10.1016/0012-821X(72)90174-4; Madey TE, 1998, J GEOPHYS RES-PLANET, V103, P5873, DOI 10.1029/98JE00230; MCGRATH MA, 1986, NATURE, V323, P694, DOI 10.1038/323694a0; Morgan TH, 1997, PLANET SPACE SCI, V45, P81, DOI 10.1016/S0032-0633(96)00099-2; POTTER A, 1985, SCIENCE, V229, P651, DOI 10.1126/science.229.4714.651; POTTER AE, 1986, ICARUS, V67, P336, DOI 10.1016/0019-1035(86)90113-2; Sprague AL, 1998, ICARUS, V136, P60, DOI 10.1006/icar.1998.6009; Sprague AL, 1997, ICARUS, V129, P506, DOI 10.1006/icar.1997.5784; Sprague AL, 1997, ADV SPACE RES-SERIES, V19, P1507, DOI 10.1016/S0273-1177(97)00363-3; SPRAGUE AL, 1993, ICARUS, V104, P33, DOI 10.1006/icar.1993.1080; SUGITA S, 1997, P LUNAR PLANET SCI C, V28, P1393; VOGT S, 1994, P SOC PHOTO-OPT INS, V2198, P362, DOI 10.1117/12.176725; Yakshinskiy BV, 1999, NATURE, V400, P642, DOI 10.1038/23204	23	135	135	0	8	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					159	161		10.1038/35004521	http://dx.doi.org/10.1038/35004521			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724161				2022-12-24	WOS:000085870900042
J	Cocheo, V; Sacco, P; Boaretto, C; De Saeger, E; Ballesta, PP; Skov, H; Goelen, E; Gonzalez, N; Caracena, AB				Cocheo, V; Sacco, P; Boaretto, C; De Saeger, E; Ballesta, PP; Skov, H; Goelen, E; Gonzalez, N; Caracena, AB			Urban benzene and population exposure	NATURE			English	Article									IRCCS, Fdn Salvatore Maugeri, I-35127 Padua, Italy; Commiss European Communities, Joint Res Ctr, I-21020 Ispra, Italy; Natl Environm Res Inst, DK-4000 Roskilde, Denmark; Vlaamse Instelling Technol Onderzoek, B-2400 Mol, Belgium; Inst Natl Environm Ind & Risques, F-60550 Verneuil En Halatte, France; Univ Murcia, Dept Ingn Quim Murcia, E-30071 Murcia, Spain	Istituti Clinici Scientifici Maugeri IRCCS; European Commission Joint Research Centre; EC JRC ISPRA Site; Aarhus University; VITO; Institut National de l'Environnement Industriel et des Risques (INERIS); University of Murcia	Cocheo, V (corresponding author), IRCCS, Fdn Salvatore Maugeri, Via Svizzera 16, I-35127 Padua, Italy.		Caracena, Antonia Baeza/L-7529-2014	Caracena, Antonia Baeza/0000-0002-8207-0453; Skov, Henrik/0000-0003-1167-8696				BOND GG, 1986, BRIT J IND MED, V43, P685; Cocheo V, 1996, AM IND HYG ASSOC J, V57, P897, DOI 10.1202/0002-8894(1996)057<0897:HURRDS>2.0.CO;2; Kumar N, 1996, ATMOS ENVIRON, V30, P1099, DOI 10.1016/1352-2310(95)00317-7; Rinsky R A, 1981, Am J Ind Med, V2, P217, DOI 10.1002/ajim.4700020305; SNYDER R, 1993, ENVIRON HEALTH PERSP, V100, P293, DOI 10.2307/3431535; VIGLIANI EC, 1964, NEW ENGL J MED, V271, P872, DOI 10.1056/NEJM196410222711703; WARD JB, 1992, MUTAT RES, V268, P49, DOI 10.1016/0027-5107(92)90082-D; *WHO, 1996, EURICPEHAZ9405MT12 R	8	99	101	1	32	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					141	142		10.1038/35004651	http://dx.doi.org/10.1038/35004651			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724154				2022-12-24	WOS:000085870900034
J	Steinmetz, PN; Roy, A; Fitzgerald, PJ; Hsiao, SS; Johnson, KO; Niebur, E				Steinmetz, PN; Roy, A; Fitzgerald, PJ; Hsiao, SS; Johnson, KO; Niebur, E			Attention modulates synchronized neuronal firing in primate somatosensory cortex	NATURE			English	Article							CORTICAL ACTIVITY; MONKEYS; OSCILLATIONS; PATTERNS	A potentially powerful information processing strategy in the brain is to take advantage of the;temporal structure of neuronal spike trains. An increase in synchrony within the neural representation of an object or location increases the efficacy of that neural representation at the next synaptic stage in the brain; thus, increasing synchrony is a candidate for the neural correlate of attentional selection(1). We investigated the synchronous firing of pairs of neurons in the secondary somatosensory cortex (SII) of three monkeys trained to switch attention between a visual task and a tactile discrimination task. We found that most neuron pairs in SII cortex fired synchronously and, furthermore, that the degree of synchrony was affected by the monkey's attentional state. In the monkey performing the most difficult task, 35% of neuron pairs that fired synchronously changed their degree of synchrony when the monkey switched attention between the tactile and visual tasks. Synchrony increased in 80% and decreased in 20% of neuron pairs affected by attention.	Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA	Johns Hopkins University	Niebur, E (corresponding author), Johns Hopkins Univ, Zanvyl Krieger Mind Brain Inst, Baltimore, MD 21218 USA.	niebur@jhu.edu	Steinmetz, Peter/H-3151-2011					ABELES M, 1993, J NEUROPHYSIOL, V70, P1629, DOI 10.1152/jn.1993.70.4.1629; Abeles M., 1982, LOCAL CORTICAL CIRCU; Brody CD, 1998, J NEUROPHYSIOL, V80, P3345, DOI 10.1152/jn.1998.80.6.3345; Burton H, 1997, SOMATOSENS MOT RES, V14, P237, DOI 10.1080/08990229770971; Craig JC, 1996, SOMATOSENS MOT RES, V13, P199, DOI 10.3109/08990229609052576; Crick F., 1990, Seminars in the Neurosciences, V2, P263; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; DiCarlo JJ, 1996, J NEUROSCI METH, V64, P75, DOI 10.1016/0165-0270(95)00113-1; ECKHORN R, 1988, BIOL CYBERN, V60, P121, DOI 10.1007/BF00202899; Efron Bradley., 1994, INTRO BOOTSTRAP; Haalman I, 1998, Z NATURFORSCH C, V53, P657; HSIAO SS, 1993, J NEUROPHYSIOL, V70, P444, DOI 10.1152/jn.1993.70.1.444; MOUNTCASTLE VB, 1991, J NEUROSCI METH, V36, P77, DOI 10.1016/0165-0270(91)90140-U; Murthy VN, 1996, J NEUROPHYSIOL, V76, P3968, DOI 10.1152/jn.1996.76.6.3968; Niebur E, 1994, J Comput Neurosci, V1, P141, DOI 10.1007/BF00962722; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; POGGIO GF, 1964, J NEUROPHYSIOL, V27, P517, DOI 10.1152/jn.1964.27.4.517; PORANEN A, 1982, ELECTROEN CLIN NEURO, V53, P525, DOI 10.1016/0013-4694(82)90065-7; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; ROY A, IN PRESS NEUROCOMPUT; Roy S, 1999, J NEUROPHYSIOL, V81, P999, DOI 10.1152/jn.1999.81.3.999; SCHNEIDER W, 1977, PSYCHOL REV, V84, P1, DOI 10.1037/0033-295X.84.1.1; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SINGER W, 1993, ANNU REV PHYSIOL, V55, P349, DOI 10.1146/annurev.physiol.55.1.349; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0	25	556	576	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2000	404	6774					187	190		10.1038/35004588	http://dx.doi.org/10.1038/35004588			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724171				2022-12-24	WOS:000085870900052
J	Thompson, PM; Giedd, JN; Woods, RP; MacDonald, D; Evans, AC; Toga, AW				Thompson, PM; Giedd, JN; Woods, RP; MacDonald, D; Evans, AC; Toga, AW			Growth patterns in the developing brain detected by using continuum mechanical tensor maps	NATURE			English	Article							ALZHEIMERS-DISEASE; IMAGES	The dynamic nature of growth and degenerative disease processes requires the design of sensitive strategies to detect, track and quantify structural change in the brain in its full spatial and temporal complexity(1). Although volumes of brain substructures are known to change during development(2), detailed maps of these dynamic growth processes have been unavailable. Here we report the creation of spatially complex, four-dimensional quantitative maps of growth patterns in the developing human brain, detected using a tensor mapping strategy with greater spatial detail and sensitivity than previously obtainable. By repeatedly scanning children (aged 3-15 years) across time spans of up to four years, a rostro-caudal wave of growth was detected at the corpus callosum, a fibre system that relays information between brain hemispheres. Peak growth rates, in fibres innervating association and language cortices, were attenuated after puberty, and contrasted sharply with a severe, spatially localized loss of subcortical grey matter. Conversely, at ages 3-6 years, the fastest growth rates occurred in frontal networks that regulate the planning of new actions. Local rates, profiles, and principal directions of growth were visualized in each individual child.	Univ Calif Los Angeles, Sch Med, Div Brain Mapping, Dept Neurol,Lab Neuroimaging, Los Angeles, CA 90095 USA; NIMH, Child Psychiat Branch, NIH, Bethesda, MD 20892 USA; McGill Univ, Montreal Neurol Inst, Montreal, PQ H3A 2B4, Canada	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); McGill University	Thompson, PM (corresponding author), Univ Calif Los Angeles, Sch Med, Div Brain Mapping, Dept Neurol,Lab Neuroimaging, 710 Westwood Plaza, Los Angeles, CA 90095 USA.	thompson@loni.ucla.edu	Giedd, Jay N/B-7302-2012; Thompson, Paul M/C-4194-2018; Giedd, Jay/J-9644-2015; Giedd, Jay N./A-3080-2008	Giedd, Jay N/0000-0003-0827-3460; Thompson, Paul M/0000-0002-4720-8867; Giedd, Jay/0000-0003-2002-8978; 				CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Davatzikos C, 1996, J COMPUT ASSIST TOMO, V20, P656, DOI 10.1097/00004728-199607000-00031; Fox NC, 1996, LANCET, V348, P94, DOI 10.1016/S0140-6736(96)05228-2; Freeborough PA, 1996, J COMPUT ASSIST TOMO, V20, P1012, DOI 10.1097/00004728-199611000-00030; Giedd JN, 1996, CEREB CORTEX, V6, P551, DOI 10.1093/cercor/6.4.551; Grenander U, 1998, Q APPL MATH, V56, P617, DOI 10.1090/qam/1668732; Grimshaw GM, 1998, BRAIN LANG, V63, P237, DOI 10.1006/brln.1997.1943; MacDonald D, 1994, P SOC PHOTO-OPT INS, V2359, P160; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Thomas HC, 1996, J VIRAL HEPATITIS, V3, P1; Thompson JS, 1996, IEEE PERS COMMUN, V3, P16, DOI 10.1109/98.542234; Thompson P M, 1997, Med Image Anal, V1, P271; Thompson PM, 1997, J COMPUT ASSIST TOMO, V21, P567, DOI 10.1097/00004728-199707000-00008; Thompson PM, 1998, CEREB CORTEX, V8, P492, DOI 10.1093/cercor/8.6.492; THOMPSON PM, 1998, BRAIN WARPING, P311; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Yakovlev PL, 1967, REGIONAL DEV BRAIN E, P3; Zijdenbos Alex P., 1994, Critical Reviews in Biomedical Engineering, V22, P401	18	647	650	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2000	404	6774					190	193		10.1038/35004593	http://dx.doi.org/10.1038/35004593			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724172				2022-12-24	WOS:000085870900053
J	Manabe, M; Barrett, PM; Isaji, S				Manabe, M; Barrett, PM; Isaji, S			Palaeontology - A refugium for relicts?	NATURE			English	Article									Museum Nat Sci, Dept Geol, Shinjuku Ku, Tokyo 1690073, Japan; Univ Oxford, Dept Zool, Oxford OX1 3PS, England; Chiba Prefectural Museum Nat Hist, Chiba 2600682, Japan	University of Oxford	Manabe, M (corresponding author), Museum Nat Sci, Dept Geol, Shinjuku Ku, 3-23-1 Hyakunin Cho, Tokyo 1690073, Japan.	paul.barrett@zoo.ox.ac.uk	Barrett, Paul M/A-2648-2010	Barrett, Paul M/0000-0003-0412-3000; Manabe, Makoto/0000-0003-2490-6125				BAKKER RT, 1978, NATURE, V274, P661, DOI 10.1038/274661a0; Evans Susan E., 1998, Bulletin of the New Mexico Museum of Natural History and Science, V14, P183; Luo ZX, 1999, NATURE, V400, P23, DOI 10.1038/21790; MAEDA SHIRO, 1961, JOUR COLL ARTS AND SCI CHIBA UNIV, V3, P369; Makovicky Peter J., 1998, American Museum Novitates, V3240, P1; Manabe M, 1999, J PALEONTOL, V73, P1176, DOI 10.1017/S002233600003105X; Manabe M., 1995, 6 S MES TERR EC BIOT, P179; NORMAN DB, IN PRESS SPEC PAP PA; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; Setoguchi T., 1999, P 7 ANN M CHIN SOC V, P117; Xu X, 1999, NATURE, V399, P350, DOI 10.1038/20670; Xu Xing, 1998, Vertebrata Palasiatica, V36, P147; Zhao XJ, 1998, NATURE, V394, P234, DOI 10.1038/28300	13	41	50	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2000	404	6781					953	953		10.1038/35010199	http://dx.doi.org/10.1038/35010199			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801116	Bronze			2022-12-24	WOS:000086762000044
J	Hutter, JC; Kuehnert, MJ; Wallis, RR; Lucas, DD; Sen, S; Jarvis, WR				Hutter, JC; Kuehnert, MJ; Wallis, RR; Lucas, DD; Sen, S; Jarvis, WR			Acute onset of decreased vision and hearing traced to hemodialysis treatment with aged dialyzers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DIALYSIS CENTER; CELLULOSE; INTOXICATION; OXIDATION; MEMBRANES	Context A recent event in which 7 patients at 1 hospital developed decreased vision and hearing, conjunctivitis, headache, and other severe neurologic symptoms 7 to 24 hours after hemodialysis drew attention to the issue of the long-term integrity of dialysis machines and materials. Objective To determine the cause of the adverse reactions that occurred during this event. Design, Patients, and Setting Retrospective cohort study of all 9 patients who received hemodialysis at hospital A on September 18, 1996, the day of the outbreak. A case-patient was defined as any hospital A patient with acute onset of decreased vision and hearing and conjunctivitis after dialysis on that day. Non-case-patients were all others who underwent dialysis at hospital A on that day but did not develop adverse reactions. in an attempt to reproduce the conditions of the event, cellulose acetate dialysis membranes of various ages were retrieved from other sources and tested for physical and chemical degradation, and degradation products were identified, characterized, and injected intravenously into rabbits. Main Outcome Measures Clinical signs and symptoms, time to resolution of symptoms, mortality, and dialyzer type and age, for case- vs non-case-patients. Results Seven of the 9 patients met the case definition. In addition to diminished vision and hearing, conjunctivitis, and headache, some case-patients had blood leak alarm activation (n=6), confusion/lethargy (n=5), corneal opacification (n=4), cardiac arrest (n=2), or other neurologic signs and symptoms. One case-patient died during hospitalization after the event; 5 of 7 case-patients died within 13 months. Resolution of signs and symptoms varied but persisted more than 3 years or until death in 3 of the 6 patients who survived hospitalization. All case-patients but no non-case-patients were exposed to 11.5-year-old cellulose acetate dialyzers (all of these dialyzers were discarded by the hospital before our investigation). Laboratory investigation of field-retrieved 0- to 13.6-year-old dialyzers of similar type indicated significant chemical degradation in the older membranes. In vivo injection of extracts of membrane degradation products produced iritis and hemorrhages in rabbits' eyes. Conclusions Severe patient injury was associated with exposure to aged cellulose acetate membranes of dialyzers, allowing cellulose acetate degradation products to enter the blood. Clinicians should be aware that aged cellulose acetate membranes may cause severe adverse reactions.	US FDA, Ctr Devices & Radiol Hlth, Rockville, MD 20852 USA; Ctr Dis Control & Prevent, Hosp Infect Program, Natl Ctr Infect Dis, Atlanta, GA USA	US Food & Drug Administration (FDA); Centers for Disease Control & Prevention - USA	Hutter, JC (corresponding author), US FDA, Ctr Devices & Radiol Hlth, 12725 Twinbrook Pkwy,HFZ 150, Rockville, MD 20852 USA.							ARNOW PM, 1994, ANN INTERN MED, V121, P339, DOI 10.7326/0003-4819-121-5-199409010-00005; *ASTM, 1983, STAND METH TEST CELL; Brandrup J., 1989, POLYM HDB, V3rd ed.; BURWEN DR, 1995, KIDNEY INT, V48, P469, DOI 10.1038/ki.1995.315; CHURCHILL DN, 1988, NEPHRON, V50, P325, DOI 10.1159/000185197; DAKA JN, 1994, 20 ANN M SOC BIOM AP; DAUGIRDAS JT, 1988, KIDNEY INT S24, V33, pS37; DEAN AG, 1990, EPI INFO VERSION 6 W; Favero MS, 1996, HOSP EPIDEMIOLOGY IN, P693; FUJIWARA N, 1994, DESALINATION, V96, P431, DOI 10.1016/0011-9164(94)85192-1; GLATER J, 1983, DESALINATION, V46, P389, DOI 10.1016/0011-9164(83)87181-1; GORDON SM, 1990, AM J NEPHROL, V10, P123, DOI 10.1159/000168066; GORDON SM, 1990, KIDNEY INT, V37, P110, DOI 10.1038/ki.1990.15; HENDERSON LW, 1993, YB NEPHROLOGY, P210; KESSLER LG, 1996, NOTICE MANUFACTURERS; KROSCHWITZ J, 1985, ENCY POLYM SCI ENG; KUMANO A, 1994, DESALINATION, V96, P451, DOI 10.1016/0011-9164(94)85194-8; MCCRAY SB, 1991, J MEMBRANE SCI, V59, P305; MURPHY AP, 1991, DESALINATION, V85, P45, DOI 10.1016/0011-9164(91)85145-K; OBA T, 1984, ARTIF ORGANS, V8, P429, DOI 10.1111/j.1525-1594.1984.tb04319.x; PEGUES DA, 1992, KIDNEY INT, V42, P1232, DOI 10.1038/ki.1992.409; PEGUES DA, 1992, J AM SOC NEPHROL, V3, P1002; Perry RH., 1984, PERRYS CHEM ENG HDB; PHILIPP B, 1984, PURE APPL CHEM, V56, P391, DOI 10.1351/pac198456030391; RANBY RG, 1959, J POLYM SCI, V36, P561; VOS KD, 1966, J APPL POLYM SCI, V10, P825, DOI 10.1002/app.1966.070100515; YIN L, 1997, NOTICE MANUFACTURERS	27	32	32	1	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2000	283	16					2128	2134		10.1001/jama.283.16.2128	http://dx.doi.org/10.1001/jama.283.16.2128			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	305MA	10791505				2022-12-24	WOS:000086542800029
J	Bailis, JM; Roeder, GS				Bailis, JM; Roeder, GS			Pachytene exit controlled by reversal of Mek1-dependent phosphorylation	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; MEIOTIC RECOMBINATION; CHECKPOINT GENES; CELL-CYCLE; DNA-DAMAGE; PROTEIN PHOSPHATASE; CHROMOSOME SYNAPSIS; SHUTTLE VECTORS; YEAST; MEIOSIS	During yeast meiosis, a checkpoint prevents exit from pachytene in response to defects in meiotic recombination and chromosome synapsis. This pachytene checkpoint requires two meiotic chromosomal proteins, Red1 and Mek1; Mek1 is a kinase that phosphorylates Red1. In mutants that undergo checkpoint-mediated pachytene arrest, Mek1 is active and Red1 remains phosphorylated. Activation of Mek1 requires the initiation of meiotic recombination and certain DNA damage checkpoint proteins. Mek1 kinase activity and checkpoint-induced pachytene arrest are counteracted by protein phosphatase type 1 (Glc7). Glc7 coimmunoprecipitates with Red1,colocalizes with Red1 on chromosomes, and dephosphorylates Red1 in vitro. We speculate that phosphorylated Red1 prevents exit from pachytene and that completion of meiotic recombination triggers Glc7-dependent dephosphorylation of Red1.	Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; Yale Univ, Dept Genet, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Roeder, GS (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA.	shirleen.roeder@yale.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028904] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM28904] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALANI E, 1987, GENETICS, V116, P541, DOI 10.1534/genetics.112.541.test; Bailis JM, 1998, GENE DEV, V12, P3551, DOI 10.1101/gad.12.22.3551; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Bloecher A, 1999, GENE DEV, V13, P517, DOI 10.1101/gad.13.5.517; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CAO L, 1990, CELL, V61, P1089, DOI 10.1016/0092-8674(90)90072-M; Cherry JM, 1998, NUCLEIC ACIDS RES, V26, P73, DOI 10.1093/nar/26.1.73; Chu S, 1998, MOL CELL, V1, P685, DOI 10.1016/S1097-2765(00)80068-4; de los Santos T, 1999, J BIOL CHEM, V274, P1783, DOI 10.1074/jbc.274.3.1783; ESPOSITO RE, 1974, P NATL ACAD SCI USA, V71, P3172, DOI 10.1073/pnas.71.8.3172; Grushcow JM, 1999, GENETICS, V153, P607; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; HUANG WD, 1994, P NATL ACAD SCI USA, V91, P8960, DOI 10.1073/pnas.91.19.8960; Kondo T, 1999, MOL CELL BIOL, V19, P1136; LEEM SH, 1992, NUCLEIC ACIDS RES, V20, P449, DOI 10.1093/nar/20.3.449; Leu JY, 1999, MOL CELL, V4, P805, DOI 10.1016/S1097-2765(00)80390-1; Leu JY, 1998, CELL, V94, P375, DOI 10.1016/S0092-8674(00)81480-4; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; Lydall D, 1996, NATURE, V383, P840, DOI 10.1038/383840a0; LYDALL D, 1995, SCIENCE, V270, P1488, DOI 10.1126/science.270.5241.1488; Lydall D, 1997, MOL GEN GENET, V256, P638, DOI 10.1007/s004380050612; Ramaswamy NT, 1998, GENETICS, V149, P57; ROCKMILL B, 1990, GENETICS, V126, P563; ROCKMILL B, 1991, GENE DEV, V5, P2392, DOI 10.1101/gad.5.12b.2392; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Sambrook JFE, 1989, MOL CLONING LAB MANU; San-Segundo PA, 1999, CELL, V97, P313, DOI 10.1016/S0092-8674(00)80741-2; Sassoon I, 1999, GENE DEV, V13, P545, DOI 10.1101/gad.13.5.545; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Sherman F., 1986, METHODS YEAST GENETI; SHUSTER EO, 1989, GENETICS, V123, P29; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; STOTZ A, 1990, GENE, V95, P91, DOI 10.1016/0378-1119(90)90418-Q; Sun ZX, 1996, GENE DEV, V10, P395, DOI 10.1101/gad.10.4.395; Sun ZX, 1998, SCIENCE, V281, P272, DOI 10.1126/science.281.5374.272; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; Tarsounas M, 1999, J CELL SCI, V112, P423; Tu JL, 1996, MOL CELL BIOL, V16, P4199; Weinert T, 1998, CURR OPIN GENET DEV, V8, P185, DOI 10.1016/S0959-437X(98)80140-8; Xu LH, 1997, GENE DEV, V11, P106, DOI 10.1101/gad.11.1.106; ZHENG CF, 1994, EMBO J, V13, P1123, DOI 10.1002/j.1460-2075.1994.tb06361.x	47	71	75	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	APR 14	2000	101	2					211	221		10.1016/S0092-8674(00)80831-4	http://dx.doi.org/10.1016/S0092-8674(00)80831-4			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	305DP	10786836	Bronze			2022-12-24	WOS:000086524400007
J	Bishop, KM; Goudreau, G; O'Leary, DDM				Bishop, KM; Goudreau, G; O'Leary, DDM			Regulation of area identity in the mammalian neocortex by Emx2 and Pax6	SCIENCE			English	Article							EMBRYONIC CEREBRAL-CORTEX; DROSOPHILA EMBRYO; VISUAL-CORTEX; CORTICAL-NEURONS; MOUSE; EXPRESSION; GENE; MICE; DIFFERENTIATION; PROJECTIONS	The contribution of extrinsic and genetic mechanisms in determining areas of the mammalian neocortex has been a contested issue. This study analyzes the roles of the regulatory genes Emx2 and Pax6, which are expressed in opposing gradients in the neocortical ventricular zone, in specifying areas. Changes in the patterning of molecular markers and area-specific connections between the colter and thalamus suggest that arealization of the neocortex is disproportionately altered in Emx2 and Pax6 mutant mice in opposing manners predicted from their countergradients of expression: rostral areas expand and caudal areas contract in Emx2 mutants, whereas the opposite effect is seen in Pax6 mutants. These findings suggest that Emx2 and Pax6 cooperate to regulate arealization of the neocortex and to confer area identity to cortical cells.	Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37077 Gottingen, Germany	Salk Institute; Max Planck Society	O'Leary, DDM (corresponding author), Salk Inst Biol Studies, Mol Neurobiol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	doleary@salk.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031558, R37NS031558] Funding Source: NIH RePORTER; NINDS NIH HHS [NS31558] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALTMAN J, 1988, J COMP NEUROL, V275, P346, DOI 10.1002/cne.902750304; BISHOP KM, UNPUB; CHENN A, 1997, MOL CELLULAR APPROAC, P440; CRANDALL JE, 1984, J COMP NEUROL, V228, P542, DOI 10.1002/cne.902280407; CROSSLEY PH, 1995, DEVELOPMENT, V121, P439; DEHAY C, 1989, NATURE, V337, P265, DOI 10.1038/337265a0; Donoghue MJ, 1999, J NEUROSCI, V19, P5967, DOI 10.1523/JNEUROSCI.19-14-05967.1999; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Grove EA, 1998, DEVELOPMENT, V125, P2315; Gulisano M, 1996, EUR J NEUROSCI, V8, P1037, DOI 10.1111/j.1460-9568.1996.tb01590.x; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HILL RE, 1991, NATURE, V354, P522, DOI 10.1038/354522a0; Livy DJ, 1997, HIPPOCAMPUS, V7, P2, DOI 10.1002/(SICI)1098-1063(1997)7:1<2::AID-HIPO2>3.0.CO;2-R; Mackarehtschian K, 1999, CEREB CORTEX, V9, P601, DOI 10.1093/cercor/9.6.601; Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5; MILLER B, 1993, J COMP NEUROL, V335, P16, DOI 10.1002/cne.903350103; Miyashita-Lin EM, 1999, SCIENCE, V285, P906, DOI 10.1126/science.285.5429.906; Nakagawa Y, 1999, J NEUROSCI, V19, P10877, DOI 10.1523/JNEUROSCI.19-24-10877.1999; O'Leary DDM, 1999, CURR OPIN NEUROBIOL, V9, P65, DOI 10.1016/S0959-4388(99)80008-7; OLEARY DDM, 1989, J NEUROSCI, V9, P2230; OLEARY DDM, 1989, TRENDS NEUROSCI, V12, P400, DOI 10.1016/0166-2236(89)90080-5; Pellegrini M, 1996, DEVELOPMENT, V122, P3893; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1991, P NATL ACAD SCI USA, V88, P2083, DOI 10.1073/pnas.88.6.2083; Rubenstein JLR, 1998, CURR OPIN NEUROBIOL, V8, P18, DOI 10.1016/S0959-4388(98)80004-4; Rubenstein JLR, 1999, CEREB CORTEX, V9, P524, DOI 10.1093/cercor/9.6.524; Rusch J, 1996, CURR OPIN GENET DEV, V6, P416, DOI 10.1016/S0959-437X(96)80062-1; SCHLAGGAR BL, 1993, DEV BRAIN RES, V75, P19, DOI 10.1016/0165-3806(93)90061-E; SCHLAGGAR BL, 1991, SCIENCE, V252, P1556, DOI 10.1126/science.2047863; SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x; Small S, 1996, DEV BIOL, V175, P314, DOI 10.1006/dbio.1996.0117; STANFIELD BB, 1985, NATURE, V313, P135, DOI 10.1038/313135a0; STANOJEVIC D, 1991, SCIENCE, V254, P1385, DOI 10.1126/science.1683715; Stoykova A, 1996, DEVELOPMENT, V122, P3453; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Suzuki SC, 1997, MOL CELL NEUROSCI, V9, P433, DOI 10.1006/mcne.1997.0626; Theil T, 1999, DEVELOPMENT, V126, P3561; Tuttle R, 1999, DEVELOPMENT, V126, P1903; TUTTLE R, 1999, J COMP NEUROL, V408, P147; WALTHER C, 1991, DEVELOPMENT, V113, P1435	40	440	445	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2000	288	5464					344	349		10.1126/science.288.5464.344	http://dx.doi.org/10.1126/science.288.5464.344			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764649				2022-12-24	WOS:000086454300040
J	Davis, BM; Lawson, EH; Sandkvist, M; Ali, A; Sozhamannan, S; Waldor, MK				Davis, BM; Lawson, EH; Sandkvist, M; Ali, A; Sozhamannan, S; Waldor, MK			Convergence of the secretory pathways for cholera toxin and the filamentous phage, CTX phi	SCIENCE			English	Article							PROTEIN SECRETION; VIBRIO-CHOLERAE; MEMBRANE; GENES	Virulence of Vibrio cholerae depends on secretion of cholera toxin (CT), which is encoded within the genome of a filamentous phage, CTX phi. Release of CT is mediated by the extracellular protein secretion (eps) type II secretion system. Here. the outer membrane component of this system, EpsD, was shown to be required for secretion of the phage as well. Thus, EpsD plays a role both in pathogenicity and in horizontal transfer of a key virulence gene. Genomic analysis suggests that additional filamentous phages also exploit chromosome-encoded outer membrane channels.	Tufts Univ, Sch Med, Div Geog Med & Infect Dis, Boston, MA 02111 USA; Amer Red Cross, Holland Lab, Dept Biochem, Rockville, MD 20855 USA; Univ Maryland, Sch Med, Dept Med, Div Hosp Epidemiol, Baltimore, MD 21201 USA	Tufts University; American Red Cross; University System of Maryland; University of Maryland Baltimore	Waldor, MK (corresponding author), Tufts Univ, Sch Med, Div Geog Med & Infect Dis, Boston, MA 02111 USA.		Sozhamannan, Shanmuga/AAN-7809-2020; Sozhamannan, Shanmuga/AGF-2410-2022	Sozhamannan, Shanmuga/0000-0002-6762-7874; 	NIAID NIH HHS [AI-42347] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042347, R37AI042347] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali A, 2000, INFECT IMMUN, V68, P1967, DOI 10.1128/IAI.68.4.1967-1974.2000; Binet R, 1997, GENE, V192, P7, DOI 10.1016/S0378-1119(96)00829-3; Christie PJ, 1997, J BACTERIOL, V179, P3085, DOI 10.1128/jb.179.10.3085-3094.1997; DAVIS BD, UNPUB; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; HASE CC, 1991, J BACTERIOL, V173, P3311; JUDSON M, UNPUB; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KOONIN EV, 1992, FEBS LETT, V312, P3, DOI 10.1016/0014-5793(92)81398-6; LESSL M, 1992, J BACTERIOL, V174, P2493, DOI 10.1128/jb.174.8.2493-2500.1992; Lindeberg M, 1996, MOL MICROBIOL, V20, P175, DOI 10.1111/j.1365-2958.1996.tb02499.x; Marciano DK, 1999, SCIENCE, V284, P1516, DOI 10.1126/science.284.5419.1516; PEARSON GDN, 1993, P NATL ACAD SCI USA, V90, P3750, DOI 10.1073/pnas.90.8.3750; Pugsley AP, 1998, CELL MOL LIFE SCI, V54, P347, DOI 10.1007/s000180050162; RUSSEL M, 1995, TRENDS MICROBIOL, V3, P223, DOI 10.1016/S0966-842X(00)88929-5; RUSSEL M, 1993, J MOL BIOL, V231, P689, DOI 10.1006/jmbi.1993.1320; Russel M, 1998, J MOL BIOL, V279, P485, DOI 10.1006/jmbi.1998.1791; Sandkvist M, 1999, J BACTERIOL, V181, P3129, DOI 10.1128/JB.181.10.3129-3135.1999; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; SANDKVIST M, 1995, EMBO J, V14, P1664, DOI 10.1002/j.1460-2075.1995.tb07155.x; Waldor MK, 1996, SCIENCE, V272, P1910, DOI 10.1126/science.272.5270.1910	22	86	96	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					333	335		10.1126/science.288.5464.333	http://dx.doi.org/10.1126/science.288.5464.333			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764646				2022-12-24	WOS:000086454300037
J	Scheufler, C; Brinker, A; Bourenkov, G; Pegoraro, S; Moroder, L; Bartunik, H; Hartl, FU; Moarefi, I				Scheufler, C; Brinker, A; Bourenkov, G; Pegoraro, S; Moroder, L; Bartunik, H; Hartl, FU; Moarefi, I			Structure of TPR domain-peptide complexes: Critical elements in the assembly of the Hsp70-Hsp90 multichaperone machine	CELL			English	Article							HEAT-SHOCK PROTEINS; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONE; HSP90; BINDING; IDENTIFICATION; HOP; CRYSTALLOGRAPHY; INTERACTS; CLONING	The adaptor protein Hop mediates the association of the molecular chaperones Hsp70 and Hsp90. The TPR1 domain of Hop specifically recognizes the C-terminal heptapeptide of Hsp70 while the TPR2A domain binds the C-terminal pentapeptide of Hsp90. Both sequences end with the motif EEVD. The crystal structures of the TPR-peptide complexes show the peptides in an extended conformation, spanning a groove in the TPR domains. Peptide binding is mediated by electrostatic interactions with the EEVD motif, with the C-terminal aspartate acting as a two-carboxylate anchor, and by hydrophobic interactions with residues upstream of EEVD. The hydrophobic contacts with the peptide are critical for specificity. These results explain how TPR domains participate in the ordered assembly of Hsp70-Hsp90 multichaperone complexes.	Max Planck Inst Biochem, D-82152 Martinsried, Germany; Max Planck Res Unit Struct Mol Biol, D-22603 Hamburg, Germany	Max Planck Society; Max Planck Society	Moarefi, I (corresponding author), Max Planck Inst Biochem, D-82152 Martinsried, Germany.		Hartl, F. Ulrich/Y-8206-2019; Bourenkov, Gleb P/C-7794-2017	Bourenkov, Gleb P/0000-0002-2617-5920; Moroder, Luis/0000-0001-9570-5713; Scheufler, Clemens/0000-0002-3693-3529				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bose S, 1996, SCIENCE, V274, P1715, DOI 10.1126/science.274.5293.1715; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Buchner J, 1999, TRENDS BIOCHEM SCI, V24, P136, DOI 10.1016/S0968-0004(99)01373-0; Caplan AJ, 1999, TRENDS CELL BIOL, V9, P262, DOI 10.1016/S0962-8924(99)01580-9; Carrello A, 1999, J BIOL CHEM, V274, P2682, DOI 10.1074/jbc.274.5.2682; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Chen SY, 1996, MOL ENDOCRINOL, V10, P682, DOI 10.1210/me.10.6.682; Chen SY, 1998, J BIOL CHEM, V273, P35194, DOI 10.1074/jbc.273.52.35194; Chen SY, 1998, CELL STRESS CHAPERON, V3, P118, DOI 10.1379/1466-1268(1998)003<0118:DIOPAT>2.3.CO;2; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Demand J, 1998, MOL CELL BIOL, V18, P2023, DOI 10.1128/MCB.18.4.2023; Dolinski KJ, 1998, MOL CELL BIOL, V18, P7344, DOI 10.1128/MCB.18.12.7344; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; Freeman BC, 1996, SCIENCE, V274, P1718, DOI 10.1126/science.274.5293.1718; Frydman J, 1997, TRENDS BIOCHEM SCI, V22, P87, DOI 10.1016/S0968-0004(97)01005-0; Harrison SC, 1996, CELL, V86, P341, DOI 10.1016/S0092-8674(00)80105-1; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; HONORE B, 1992, J BIOL CHEM, V267, P8485; Johnson BD, 1998, J BIOL CHEM, V273, P3679, DOI 10.1074/jbc.273.6.3679; Johnson JL, 1997, CELL, V90, P201, DOI 10.1016/S0092-8674(00)80327-X; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kordes E, 1998, GENOMICS, V52, P90, DOI 10.1006/geno.1998.5385; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; LAMB JR, 1995, TRENDS BIOCHEM SCI, V20, P257, DOI 10.1016/S0968-0004(00)89037-4; Lassle M, 1997, J BIOL CHEM, V272, P1876, DOI 10.1074/jbc.272.3.1876; Marsh JA, 1998, MOL CELL BIOL, V18, P7353, DOI 10.1128/MCB.18.12.7353; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Murthy AE, 1996, DNA CELL BIOL, V15, P727, DOI 10.1089/dna.1996.15.727; Nagase T, 1998, DNA Res, V5, P277, DOI 10.1093/dnares/5.5.277; NICHOLLS A, 1993, BIOPHYS J, V64, pA166; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OwensGrillo JK, 1996, J BIOL CHEM, V271, P13468, DOI 10.1074/jbc.271.23.13468; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; Pratt WB, 1997, ANNU REV PHARMACOL, V37, P297, DOI 10.1146/annurev.pharmtox.37.1.297; Prodromou C, 1999, EMBO J, V18, P754, DOI 10.1093/emboj/18.3.754; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; Smith DF, 1998, PHARMACOL REV, V50, P493; SMITH DF, 1993, MOL CELL BIOL, V13, P869, DOI 10.1128/MCB.13.2.869; Stebbins CE, 1997, CELL, V89, P239, DOI 10.1016/S0092-8674(00)80203-2; Su GF, 1999, GENOMICS, V55, P157, DOI 10.1006/geno.1998.5633; Tsukahara F, 1996, J BIOCHEM-TOKYO, V120, P820; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Young JC, 1998, J BIOL CHEM, V273, P18007, DOI 10.1074/jbc.273.29.18007; ZHANG P, 1992, Journal of Dairy Science, V75, P106	50	987	1020	0	74	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 14	2000	101	2					199	210		10.1016/S0092-8674(00)80830-2	http://dx.doi.org/10.1016/S0092-8674(00)80830-2			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	305DP	10786835	Bronze			2022-12-24	WOS:000086524400006
J	Tojima, Y; Fujimoto, A; Delhase, M; Chen, Y; Hatakeyama, S; Nakayama, K; Kaneko, Y; Nimura, Y; Motoyama, N; Ikeda, K; Karin, M; Nakanishi, M				Tojima, Y; Fujimoto, A; Delhase, M; Chen, Y; Hatakeyama, S; Nakayama, K; Kaneko, Y; Nimura, Y; Motoyama, N; Ikeda, K; Karin, M; Nakanishi, M			NAK is an I kappa B kinase-activating kinase	NATURE			English	Article							TRANSCRIPTION FACTOR; ALPHA PROTEOLYSIS; CELL-DEATH; C-EPSILON; PHOSPHORYLATION; SIGNAL; APOPTOSIS; PATHWAYS; JNK; IKK	Phosphorylation of I kappa B by the I kappa B kinase (IKK) complex is a critical step leading to IkB degradation and activation of transcription factor NF-kappa B-1. The IKK complex contains two catalytic subunits, IKK alpha and IKK beta, the latter being indispensable for NF-kappa B activation by pro-inflammatory cytokines(2-7). Although IKK is activated by phosphorylation of the IKK beta activation loop(8), the physiological IKK kinases that mediate responses to extracellular stimuli remain obscure(1,9). Here we describe an IKK-related kinase, named NAK (NF-kappa B-activating kinase), that can activate IKK through direct phosphorylation. NAK induces I kappa B degradation and NF-kappa B activity through IKKb. Endogenous NAK is activated by phorbol ester tumour promoters and growth factors, whereas catalytically inactive NAK specifically inhibits activation of NF-kappa B by protein kinase C-epsilon (PKC epsilon). Thus, NAK is an IKK kinase that may mediate IKK and NF-kappa B activation in response to growth factors that stimulate PKC epsilon activity.	Natl Inst Longev Sci, Dept Geriatr Res, Aichi 4748522, Japan; Nagoya Univ, Sch Med, Dept Surg, Showa Ku, Nagoya, Aichi 4668550, Japan; Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; Kyusyu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; Japan Sci & Technol Corp, CREST, Higashi Ku, Fukuoka 8128582, Japan; Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Nagoya University; University of California System; University of California San Diego; Japan Science & Technology Agency (JST); Nagoya City University	Nakanishi, M (corresponding author), Natl Inst Longev Sci, Dept Geriatr Res, Aichi 4748522, Japan.		Delhase, Mireille/ABE-5256-2021	Delhase, Mireille/0000-0003-2312-1051				Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; BROCKMAN JA, 1995, MOL CELL BIOL, V15, P2809; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Hatakeyama S, 1999, P NATL ACAD SCI USA, V96, P3859, DOI 10.1073/pnas.96.7.3859; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Karin M, 1998, P NATL ACAD SCI USA, V95, P9067, DOI 10.1073/pnas.95.16.9067; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; Ling L, 1998, P NATL ACAD SCI USA, V95, P3792, DOI 10.1073/pnas.95.7.3792; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Mayne GC, 1998, J BIOL CHEM, V273, P24115, DOI 10.1074/jbc.273.37.24115; Moriya S, 1996, P NATL ACAD SCI USA, V93, P151, DOI 10.1073/pnas.93.1.151; NNISHIZUKA Y, 1992, SCIENCE, V258, P607; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; SUEMORI H, 1990, CELL DIFFER DEV, V29, P181, DOI 10.1016/0922-3371(90)90120-L; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Tanaka M, 1999, IMMUNITY, V10, P421, DOI 10.1016/S1074-7613(00)80042-4; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Yaron A, 1998, NATURE, V396, P590, DOI 10.1038/25159	30	303	316	0	12	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					778	782		10.1038/35008109	http://dx.doi.org/10.1038/35008109			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783893				2022-12-24	WOS:000086523600056
J	Brook, BW; O'Grady, JJ; Chapman, AP; Burgman, MA; Akcakaya, HR; Frankham, R				Brook, BW; O'Grady, JJ; Chapman, AP; Burgman, MA; Akcakaya, HR; Frankham, R			Predictive accuracy of population viability analysis in conservation biology	NATURE			English	Article							MODELS; VALIDATION; ECOLOGY; RISK	Population viability analysis (PVA) is widely applied in conservation biology to predict extinction risks for threatened species and to compare alternative options for their mangement(1-4). It can also be used as a basis for listing species as endangered under World Conservation Union criteria(5), However, there is considerable scepticism regarding the predictive accuracy of PVA, mainly because of a lack of validation in real systems(2,6-8). Here we conducted a retrospective test of PVA based on 21 long-term ecological studies-the first comprehensive and replicated evaluation of the predictive powers of PVA. Parameters were estimated from the first half of each data set and the second half was used to evaluate the performance of the model. Contrary to recent criticisms, we found that PVA predictions were surprisingly accurate. The risk of population decline closely matched observed outcomes, there was no significant bias, and population size projections did not differ significantly from reality. Furthermore, the predictions of the five PVA software packages were highly concordant. We conclude that PVA is a valid and sufficiently accurate tool for categorizing and managing endangered species.	Univ Melbourne, Sch Bot, Parkville, Vic 3052, Australia; Appl Biomath, Setauket, NY 11733 USA; Macquarie Univ, Dept Biol Sci, Key Ctr Biodivers & Bioresources, N Ryde, NSW 2109, Australia	University of Melbourne; Macquarie University	Brook, BW (corresponding author), No Terr Univ, Key Ctr Trop Wildlife Management, Darwin, NT 0909, Australia.		Akcakaya, H. Resit/A-7830-2008; Brook, Barry W./G-2686-2011	Akcakaya, H. Resit/0000-0002-8679-5929; Brook, Barry W./0000-0002-2491-1517; Burgman, Mark/0000-0003-0435-4829				Akû║akaya H.R., 1999, APPL POPULATION ECOL; ARNQVIST G, 1995, TRENDS ECOL EVOL, V10, P236, DOI 10.1016/S0169-5347(00)89073-4; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; BELOVSKY GE, 1994, OECOLOGIA, V100, P475, DOI 10.1007/BF00317870; BOYCE MS, 1992, ANNU REV ECOL SYST, V23, P481, DOI 10.1146/annurev.es.23.110192.002405; Brook BW, 1999, ANIM CONSERV, V2, P23, DOI 10.1111/j.1469-1795.1999.tb00045.x; Brook BW, 1997, BIOL CONSERV, V82, P119, DOI 10.1016/S0006-3207(97)00026-8; Burgman MA, 1993, RISK ASSESSMENT CONS; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Ginzburg LR, 1982, RISK ANAL, V2, P171, DOI 10.1111/j.1539-6924.1982.tb01379.x; GRENFELL BT, 1992, NATURE, V355, P823, DOI 10.1038/355823a0; GROEEM MJ, 1998, CONSERV BIOL, P4; HUGGARD DJ, 1994, OECOLOGIA, V100, P470, DOI 10.1007/BF00317869; International Union for the Conservation of Nature, 1994, IUCN RED LIST CAT; Ludwig D, 1999, ECOLOGY, V80, P298, DOI 10.1890/0012-9658(1999)080[0298:IIMTEA]2.0.CO;2; Mills LS, 1996, CONSERV BIOL, V10, P863, DOI 10.1046/j.1523-1739.1996.10030863.x; NORTON TW, 1995, BIOL CONSERV, V73, P91, DOI 10.1016/0006-3207(95)90027-6; ORESKES N, 1994, SCIENCE, V263, P641, DOI 10.1126/science.263.5147.641; POSSINGHAM HP, 1993, PAC CONSEV BIOL, V1, P38; Ralls Katherine, 1997, P228; Ramanathan R., 1995, INTRO ECONOMETRICS; REYNOLDS MR, 1981, FOREST SCI, V27, P349; Sokal RR., 1995, BIOMETRY, V3; Soule ME, 1989, RES PRIORITIES CONSE; TAYLOR BL, 1995, CONSERV BIOL, V9, P551, DOI 10.1046/j.1523-1739.1995.09030551.x; Wahlberg N, 1996, SCIENCE, V273, P1536, DOI 10.1126/science.273.5281.1536; WIGLEY TML, 1995, NATURE, V376, P463, DOI 10.1038/376463a0; ZECKHAUSER RJ, 1990, SCIENCE, V248, P559, DOI 10.1126/science.2333509	28	393	432	3	236	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					385	387		10.1038/35006050	http://dx.doi.org/10.1038/35006050			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746724				2022-12-24	WOS:000086119000049
J	Richmond, BG; Strait, DS				Richmond, BG; Strait, DS			Evidence that humans evolved from a knuckle-walking ancestor	NATURE			English	Article							HOMINID; QUADRUPEDALISM; MORPHOLOGY; HOMINOIDS; PLIOCENE; ETHIOPIA; RADIUS; ORIGIN; KENYA; HAND	Bipedalism has traditionally been regarded as the fundamental adaptation that sets hominids apart from other primates. Fossil I evidence demonstrates that by 4.1 million years ago(1), and perhaps earlier(2), hominids exhibited adaptations to bipedal walking. At present, however, the fossil record offers little information about the origin of bipedalism, and despite nearly a century of research on existing fossils and comparative anatomy, there is still no consensus concerning the mode of locomotion that preceded bipedalism(3-10). Here we present evidence that fossils attributed to Australopithecus anamensis (KNM-ER 20419)(11) and A. afarensis (AL 288-1)(12) retain specialized wrist morphology associated with knuckle-walking. This distal radial morphology differs from that of later hominids and non-knuckle-walking anthropoid primates, suggesting that knuckle-walking is a derived feature of the African ape and human clads. This removes key morphological evidence for a Pan-Gorilla clade, and suggests that bipedal hominids evolved from a knuckle-walking ancestor that was already partly terrestrial.	George Washington Univ, Dept Anthropol, Washington, DC 20052 USA	George Washington University	Richmond, BG (corresponding author), George Washington Univ, Dept Anthropol, 2110 G St NW, Washington, DC 20052 USA.	brich@gwu.edu						ANDREWS P, 1987, J HUM EVOL, V16, P101, DOI 10.1016/0047-2484(87)90062-5; BEGUN DR, 1992, SCIENCE, V257, P1929, DOI 10.1126/science.1411507; BEGUN DR, 1993, SCIENCE, V259, P294; Dainton M, 1999, J HUM EVOL, V36, P171, DOI 10.1006/jhev.1998.0265; FLEAGLE JG, 1981, S ZOOLOGICAL SOC LON, V48, P359; Gebo DL, 1996, AM J PHYS ANTHROPOL, V101, P55, DOI 10.1002/(SICI)1096-8644(199609)101:1<55::AID-AJPA5>3.0.CO;2-C; GRINE FE, 1991, AM J PHYS ANTHROPOL, V84, P229, DOI 10.1002/ajpa.1330840302; HEINRICH RE, 1993, AM J PHYS ANTHROPOL, V92, P139, DOI 10.1002/ajpa.1330920203; HEWES GW, 1961, AM ANTHROPOL, V63, P687, DOI 10.1525/aa.1961.63.4.02a00020; Hunt KD, 1996, S AFR J SCI, V92, P77; Jenkins F.A. Jr., 1975, P213; JOHANSON DC, 1982, AM J PHYS ANTHROPOL, V57, P403, DOI 10.1002/ajpa.1330570403; Keith A, 1923, BMJ-BRIT MED J, V1923, P669, DOI 10.1136/bmj.1.3251.669; Keith A, 1923, BRIT MED J, V1923, P624; Keith A, 1923, BRIT MED J, V1923, P587; Keith A, 1923, BRIT MED J, V1923, P545; Keith A, 1923, BRIT MED J, V1923, P499; Keith A, 1923, BMJ-BRIT MED J, V1923, P451, DOI 10.1136/bmj.1.3246.451; LEAKEY MG, 1995, NATURE, V376, P565, DOI 10.1038/376565a0; LOVEJOY CO, 1981, SCIENCE, V211, P341, DOI 10.1126/science.211.4480.341; MARZKE MW, 1971, AM J PHYS ANTHROPOL, V34, P61, DOI 10.1002/ajpa.1330340106; Napier J. R., 1959, Fossil Mammals of Africa, V16, P1; Richmond BG, 1998, THESIS STATE U NEW Y; Rose M.D., 1991, P37; Ruvolo M, 1997, MOL BIOL EVOL, V14, P248, DOI 10.1093/oxfordjournals.molbev.a025761; SCHMITT D, 1994, J HUM EVOL, V26, P441, DOI 10.1006/jhev.1994.1027; Stern J., 1975, YEARB PHYS ANTHROPOL, V19, P59; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V50, P565, DOI 10.1002/ajpa.1330500408; SUSMAN RL, 1979, AM J PHYS ANTHROPOL, V50, P215, DOI 10.1002/ajpa.1330500211; TUTTLE R, 1974, CURR ANTHROPOL, V15, P389, DOI 10.1086/201494; TUTTLE RH, 1967, AM J PHYS ANTHROPOL, V26, P171, DOI 10.1002/ajpa.1330260207; TUTTLE RH, 1969, J MORPHOL, V128, P309, DOI 10.1002/jmor.1051280304; Washburn SL, 1967, P ROYAL ANTHR I GREA, V3, P21; WHITE TD, 1994, NATURE, V371, P306, DOI 10.1038/371306a0	35	178	181	0	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					382	385		10.1038/35006045	http://dx.doi.org/10.1038/35006045			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	298BG	10746723				2022-12-24	WOS:000086119000048
J	Faber-Langendoen, K; Karlawish, JHT				Faber-Langendoen, K; Karlawish, JHT		Univ Pennsylvania	Should assisted suicide be only physician assisted?	ANNALS OF INTERNAL MEDICINE			English	Article							ATTITUDES; EUTHANASIA; DEATH; ONCOLOGISTS; RELIGION; CANCER	Discussions in the media, courts, legislatures, and professional societies generally assume assistance with suicide to be a-physician's task; in these venues it is commonly referred to as "physician-assisted suicide." This paper defines both the necessity and the limits of the physician's role in assisted suicide by asking the question: Should assisted suicide be only physician assisted? Although physician involvement is necessary, we argue that it is not sufficient to ensure that patients requesting assisted suicide receive the best care. Assisted suicide requires physician involvement, but physicians' limited competence in performing the full range of tasks, the competencies of other professions, and the possibility that other professions could expand their authority in this area suggest that physician-assisted suicide is a far too narrow construct of the task. The willingness of other professionals-including nurses, social workers, and clergy-to participate and even take the lead in assisting suicides is critical to meet society's interest that assisted suicide should be humane, effective, and confined to appropriate cases. As long as legislation and guidelines focus exclusively on the physician's role, our laws and regulations will fall short of meeting societal expectations.	Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; SUNY Hlth Sci Ctr, Syracuse, NY 13210 USA	University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Faber-Langendoen, K (corresponding author), Univ Penn, Ctr Bioeth, 3401 Market St,Suite 320, Philadelphia, PA 19104 USA.				NATIONAL INSTITUTE ON AGING [K01AG000931] Funding Source: NIH RePORTER; NIA NIH HHS [1K01-AG00931] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Admiraal P V, 1995, Ned Tijdschr Geneeskd, V139, P265; *AM MED ASS COUNC, 1932, JAMA-J AM MED ASSOC, V270, P365; *AM NURS ASS, 1994, POS STAT ASS SUIC, P1; Angell M, 1997, NEW ENGL J MED, V336, P50, DOI 10.1056/NEJM199701023360108; Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; BATTIN MP, 1996, DRUG USE ASSISTED SU, P267; BRODY H, 1992, NEW ENGL J MED, V327, P1384, DOI 10.1056/NEJM199211053271912; BRODY H, 1997, PHYSICIAN ASSISTED S, P136; BYOCK I, 1997, PHYSICIAN ASSISTED S, P107; CALLAHAN D, 1997, PHYSICIAN ASSISTED S, P69; CAPLAN AL, 2000, ANN INTERN MED, V132, P482; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; DOUKAS DJ, 1995, J CLIN ONCOL, V13, P1055, DOI 10.1200/JCO.1995.13.5.1055; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; FIELD MJ, 1997, APPROACHING DEATH IM, P363; GILLESPIE M, 1999, KEVORKIAN FACE MURDE; Goldfarb LM, 1996, AM J DRUG ALCOHOL AB, V22, P549, DOI 10.3109/00952999609001680; Humphry Derek, 1991, FINAL EXIT PRACTICAL; JAMISON S, 1995, FINAL ACTS LOVE FAMI; Koenig H G, 1991, J Pastoral Care, V45, P254; Loewy E H, 1992, J Clin Ethics, V3, P29; MAUGANS TA, 1991, J FAM PRACTICE, V32, P210; MILES SH, 1995, HASTINGS CENT REP, V25, P17, DOI 10.2307/3562108; Miller FG, 1998, ANN INTERN MED, V128, P559, DOI 10.7326/0003-4819-128-7-199804010-00007; *N CUMM FDN FETZ I, 1997, SPIR BEL DYING PROC; *NAT ASS BOARDS PH, 1997, 1997 98 SURV PHARM L, P65; *NAT ASS SOC WORK, 1994, CLIENT SELF DET END, P58; NEELEMAN J, 1993, ACTA PSYCHIAT SCAND, V88, P420, DOI 10.1111/j.1600-0447.1993.tb03484.x; *ONC NURS SOC, 1995, ONC NURS SOC END AM; RUPP MT, 1994, AM J HOSP PHARM, V51, P69, DOI 10.1093/ajhp/51.1.69; SuarezAlmazor ME, 1997, J CLIN ONCOL, V15, P418, DOI 10.1200/JCO.1997.15.2.418; Tulsky JA, 2000, ANN INTERN MED, V132, P494, DOI 10.7326/0003-4819-132-6-200003210-00012; van der Wal G, 1992, Ned Tijdschr Geneeskd, V136, P1299; 1997, OREG NURSE, V62, P5	36	22	22	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					482	487		10.7326/0003-4819-132-6-200003210-00010	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00010			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	293CV	10733449				2022-12-24	WOS:000085834700009
J	Saxon, E; Bertozzi, CR				Saxon, E; Bertozzi, CR			Cell surface engineering by a modified Staudinger reaction	SCIENCE			English	Article								Selective chemical reactions enacted within a cellular environment can be powerful tools for elucidating biological processes or engineering novel interactions. A chemical transformation that permits the selective formation of covalent adducts among richly functionalized biopolymers within a cellular context is presented. A ligation modeled after the Staudinger reaction forms an amide bond by coupling of an azide and a specifically engineered triarylphosphine. Both reactive partners are abiotic and chemically orthogonal to native cellular components. Azides installed within cell surface glycoconjugates by metabolism of a synthetic azidosugar were reacted with a biotinylated triarylphosphine to produce stable cell-surface adducts. The tremendous selectivity of the transformation should permit its execution within a cell's interior, offering new possibilities for probing intracellular interactions.	Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.				NIGMS NIH HHS [GM58867-01] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058867, R37GM058867] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CARTWRIGHT IL, 1976, NUCLEIC ACIDS RES, V3, P2331, DOI 10.1093/nar/3.9.2331; GOLOLOBOV YG, 1992, TETRAHEDRON, V48, P1353, DOI 10.1016/S0040-4020(01)92229-X; Griffin BA, 1998, SCIENCE, V281, P269, DOI 10.1126/science.281.5374.269; JACOBS AK, 1995, P NATL ACAD SCI USA, V92, P3323; Lee JH, 1999, J BIOL CHEM, V274, P21878, DOI 10.1074/jbc.274.31.21878; Lemieux GA, 1999, J AM CHEM SOC, V121, P4278, DOI 10.1021/ja984228m; Mahal LK, 1997, SCIENCE, V276, P1125, DOI 10.1126/science.276.5315.1125; NOWAK MW, 1995, SCIENCE, V268, P439, DOI 10.1126/science.7716551; Staudinger H, 1919, HELV CHIM ACTA, V2, P635, DOI 10.1002/hlca.19190020164; van Hest JCM, 1998, FEBS LETT, V428, P68, DOI 10.1016/S0014-5793(98)00489-X; Winans KA, 1998, CHEM BIOL, V5, pR313, DOI 10.1016/S1074-5521(98)90658-5; Yarema KJ, 1998, J BIOL CHEM, V273, P31168, DOI 10.1074/jbc.273.47.31168	12	1757	1951	73	651	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2007	2010		10.1126/science.287.5460.2007	http://dx.doi.org/10.1126/science.287.5460.2007			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720325				2022-12-24	WOS:000085902800059
J	Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH				Ramachandran, S; French, JM; Vanderpump, MPJ; Croft, P; Neary, RH			Should treatment recommendations for lipid lowering drugs be based on absolute coronary risk or risk reduction?	BRITISH MEDICAL JOURNAL			English	Article							HEART-DISEASE		N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England; N Staffordshire Hosp, Dept Epidemiol, Stoke On Trent ST4 7PA, Staffs, England; Univ Newcastle Upon Tyne, Dept Med Stat, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Royal Free Hosp, Dept Endocrinol, London NW3 2QG, England	Keele University; University Hospital of North Staffordshire NHS Trust; Keele University; University Hospital of North Staffordshire NHS Trust; Newcastle University - UK; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Neary, RH (corresponding author), N Staffordshire Hosp, Dept Clin Biochem, Stoke On Trent ST4 7PA, Staffs, England.							COLLINS R, 1994, BRIT MED BULL, V50, P272, DOI 10.1093/oxfordjournals.bmb.a072892; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Meade TW, 1998, LANCET, V351, P233; Shepherd J, 1996, LANCET, V348, P1339; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001	5	13	13	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 11	2000	320	7236					677	679		10.1136/bmj.320.7236.677	http://dx.doi.org/10.1136/bmj.320.7236.677			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710575	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000085895300019
J	Kim, AS; Kakalis, LT; Abdul-Manan, M; Liu, GA; Rosen, MK				Kim, AS; Kakalis, LT; Abdul-Manan, M; Liu, GA; Rosen, MK			Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein	NATURE			English	Article							X-LINKED THROMBOCYTOPENIA; TYROSINE PHOSPHORYLATION; WASP GENE; NMR; CDC42; BINDING; MUTATIONS; DOMAIN; C-13; IDENTIFICATION	The Rho-family GTPase, Cdc42, can regulate the actin cytoskeleton through activation of Wiskott-Aldrich syndrome protein (WASP) family members. Activation relieves an autoinhibitory contact between the GTPase-binding domain and the carboxyterminal region of WASP proteins. Here we report the autoinhibited structure of the GTPase-binding domain of WASP, which can be induced by the C-terminal region or by organic co-solvents, In the autoinhibited complex, intramolecular interactions with the GTPase-binding domain occlude residues of the C terminus that regulate the Arp2/3 actin-nucleating complex. Binding of Cdc42 to the GTPase-binding domain causes a dramatic conformational change, resulting in disruption of the hydrophobic core and release of the C terminus, enabling its interaction with the actin regulatory machinery. These data show that 'intrinsically unstructured' peptides such as the GTPase-binding domain of WASP can be induced into distinct structural and functional states depending on context.	Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Rosen, MK (corresponding author), Mem Sloan Kettering Canc Ctr, Cellular Biochem & Biophys Program, 1275 York Ave, New York, NY 10021 USA.	rosen@mrnmrl.ski.mskcc.org						Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Baba Y, 1999, BLOOD, V93, P2003, DOI 10.1182/blood.V93.6.2003.406k13_2003_2012; Bi EF, 1999, CURR BIOL, V9, pR160, DOI 10.1016/S0960-9822(99)80102-X; Block C, 1996, NAT STRUCT BIOL, V3, P244, DOI 10.1038/nsb0396-244; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BRUNGER AT, 1993, XPLOR MANUAL; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DERRY JMJ, 1995, HUM MOL GENET, V4, P1127, DOI 10.1093/hmg/4.7.1127; DERRY JMJ, 1994, CELL, V78, P635, DOI 10.1016/0092-8674(94)90528-2; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Guinamard R, 1998, FEBS LETT, V434, P431, DOI 10.1016/S0014-5793(98)01016-3; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; KOLLURI R, 1995, HUM MOL GENET, V4, P1119, DOI 10.1093/hmg/4.7.1119; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; KWAN SP, 1995, HUM MOL GENET, V4, P1995, DOI 10.1093/hmg/4.10.1995; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; LOGAN TM, 1993, J BIOMOL NMR, V3, P225; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; Machesky LM, 1999, J CELL BIOL, V146, P267, DOI 10.1083/jcb.146.2.267; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Miki H, 1998, NATURE, V391, P93, DOI 10.1038/34208; NERI D, 1989, BIOCHEMISTRY-US, V28, P7510, DOI 10.1021/bi00445a003; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044; Oda A, 1998, BLOOD, V92, P1852, DOI 10.1182/blood.V92.6.1852.418k36_1852_1858; Rohatgi R, 1999, CELL, V97, P221, DOI 10.1016/S0092-8674(00)80732-1; Rohl CA, 1996, PROTEIN SCI, V5, P2623, DOI 10.1002/pro.5560051225; Rudolph MG, 1998, J BIOL CHEM, V273, P18067, DOI 10.1074/jbc.273.29.18067; Scherbina A, 1999, J IMMUNOL, V163, P6314; Sharman GJ, 1998, J AM CHEM SOC, V120, P5291, DOI 10.1021/ja9705405; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; STOKOE D, 1994, SCIENCE, V264, P1463, DOI 10.1126/science.7811320; VILLA A, 1995, NAT GENET, V9, P414, DOI 10.1038/ng0495-414; Winter D, 1999, CURR BIOL, V9, P501, DOI 10.1016/S0960-9822(99)80218-8; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YAMAZAKI T, 1994, J AM CHEM SOC, V116, P11655, DOI 10.1021/ja00105a005; Yarar D, 1999, CURR BIOL, V9, P555, DOI 10.1016/S0960-9822(99)80243-7; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153	44	590	601	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2000	404	6774					151	158		10.1038/35004513	http://dx.doi.org/10.1038/35004513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724160				2022-12-24	WOS:000085870900041
J	Pomeroy, VM; Tallis, RC				Pomeroy, VM; Tallis, RC			Need to focus research in stroke rehabilitation	LANCET			English	Editorial Material							CENTRALLY PARETIC HAND; MOTOR CORTEX; SUPPORT		Univ Manchester, Sch Med, Stroke Assoc Therapy Res Unit, Manchester M13 9PL, Lancs, England; Univ Manchester, Sch Med, Dept Geriatr Med, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Pomeroy, VM (corresponding author), Hope Hosp, Clin Sci Bldg,Eccles Old Rd, Salford M6 8HD, Lancs, England.	vpomeroy@fs1.ho.man.ac.uk		Pomeroy, Valerie/0000-0003-4487-823X				Ada L, 1998, J NEUROL NEUROSUR PS, V64, P628, DOI 10.1136/jnnp.64.5.628; Bonn D, 1998, LANCET, V352, P119, DOI 10.1016/S0140-6736(98)85026-5; Boult C, 1997, J AM GERIATR SOC, V45, P881, DOI 10.1111/j.1532-5415.1997.tb01519.x; BUTEFISCH C, 1995, J NEUROL SCI, V130, P59, DOI 10.1016/0022-510X(95)00003-K; DICKSTEIN R, 1986, PHYS THER, V66, P1233, DOI 10.1093/ptj/66.8.1233; Feys HM, 1998, STROKE, V29, P785, DOI 10.1161/01.STR.29.4.785; Hallett M, 1998, NEUROREHABILITATION, V10, P131, DOI 10.3233/NRE-1998-10205; Hamdy S, 1998, NAT NEUROSCI, V1, P64, DOI 10.1038/264; HESSE S, 1995, STROKE, V26, P976, DOI 10.1161/01.STR.26.6.976; HUMMELSHEIM H, 1995, ELECTROMYOGR MOTOR C, V97, P18, DOI 10.1016/0924-980X(94)00279-G; Indredavik B, 1997, STROKE, V28, P1861, DOI 10.1161/01.STR.28.10.1861; Kozlowski DA, 1996, J NEUROSCI, V16, P4776; LANGHORNE P, 1993, LANCET, V342, P395, DOI 10.1016/0140-6736(93)92813-9; Langhorne P, 1996, Physiother Res Int, V1, P75; Nudo RJ, 1996, J NEUROSCI, V16, P785; Oudega M, 1999, BRAIN RES, V818, P431, DOI 10.1016/S0006-8993(98)01314-6; POMEROY VM, IN PRESS CLIN REHABI; Tyson SF, 1998, CLIN REHABIL, V12, P395, DOI 10.1191/026921598669871795; Walker MF, 1999, LANCET, V354, P278, DOI 10.1016/S0140-6736(98)11128-5; Young J, 1996, BRIT MED J, V313, P677	20	34	34	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 4	2000	355	9206					836	837		10.1016/S0140-6736(99)08143-X	http://dx.doi.org/10.1016/S0140-6736(99)08143-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711941				2022-12-24	WOS:000085766900038
J	Cox, MM; Goodman, MF; Kreuzer, KN; Sherratt, DJ; Sandler, SJ; Marians, KJ				Cox, MM; Goodman, MF; Kreuzer, KN; Sherratt, DJ; Sandler, SJ; Marians, KJ			The importance of repairing stalled replication forks	NATURE			English	Article							STRAND-BREAK REPAIR; INDUCED DNA-REPLICATION; ESCHERICHIA-COLI; HOMOLOGOUS RECOMBINATION; RECA PROTEIN; SACCHAROMYCES-CEREVISIAE; GENETIC-RECOMBINATION; SOS RESPONSE; PRIA; BACTERIOPHAGE-T4	The bacterial SOS response to unusual levels of DNA damage has been recognized and studied for several decades. Pathways for re-establishing inactivated replication forks under normal growth conditions have received far less attention. In bacteria growing aerobically in the absence of SOS-inducing conditions, many replication forks encounter DNA damage, leading to inactivation. The pathways for fork reactivation involve the homologous recombination systems, are nonmutagenic, and integrate almost every aspect of DNA metabolism. On a frequency-of-use basis, these pathways represent the main function of bacterial DNA recombination systems, as well as the main function of a number of other enzymatic systems that are associated with replication and site-specific recombination.	Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; Univ So Calif, Dept Chem, Los Angeles, CA 90089 USA; Duke Univ, Med Ctr, Dept Microbiol, Durham, NC 27710 USA; Univ Oxford, Dept Biochem, Div Mol Genet, Oxford OX1 3QU, England; Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA	University of Southern California; University of Wisconsin System; University of Wisconsin Madison; University of Southern California; Duke University; University of Oxford; University of Massachusetts System; University of Massachusetts Amherst; Memorial Sloan Kettering Cancer Center	Goodman, MF (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM034557] Funding Source: NIH RePORTER; NIGMS NIH HHS [R37 GM034557] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; Arai K, 1981, Prog Nucleic Acid Res Mol Biol, V26, P9, DOI 10.1016/S0079-6603(08)60392-X; Bidnenko V, 1999, MOL MICROBIOL, V33, P846, DOI 10.1046/j.1365-2958.1999.01532.x; Bosco G, 1998, GENETICS, V150, P1037; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; CLARK AJ, 1994, CRIT REV MICROBIOL, V20, P125, DOI 10.3109/10408419409113552; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Cordeiro-Stone M, 1999, J MOL BIOL, V289, P1207, DOI 10.1006/jmbi.1999.2847; Courcelle J, 1997, P NATL ACAD SCI USA, V94, P3714, DOI 10.1073/pnas.94.8.3714; Cox MM, 1997, P NATL ACAD SCI USA, V94, P11764, DOI 10.1073/pnas.94.22.11764; Cox MM, 1998, GENES CELLS, V3, P65, DOI 10.1046/j.1365-2443.1998.00175.x; COX MM, 1999, PROG NUCL ACID RES M, V63, P310; FORMOSA T, 1986, CELL, V47, P793, DOI 10.1016/0092-8674(86)90522-2; Galitski T, 1997, GENETICS, V146, P751; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Haber JE, 1999, TRENDS BIOCHEM SCI, V24, P271, DOI 10.1016/S0968-0004(99)01413-9; Hanawalt P C, 1966, Photochem Photobiol, V5, P1, DOI 10.1111/j.1751-1097.1966.tb05756.x; HOWARDFLANDERS P, 1966, GENETICS, V53, P1137; KAGUNI JM, 1984, CELL, V38, P183, DOI 10.1016/0092-8674(84)90539-7; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; Kogoma T, 1996, CELL, V85, P625, DOI 10.1016/S0092-8674(00)81229-5; Kogoma T, 1996, J BACTERIOL, V178, P1258, DOI 10.1128/jb.178.5.1258-1264.1996; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; KUZMINOV A, 1995, BIOESSAYS, V17, P733, DOI 10.1002/bies.950170810; KUZMINOV A, 1995, MOL MICROBIOL, V16, P373, DOI 10.1111/j.1365-2958.1995.tb02403.x; Kuzminov A, 1999, GENE DEV, V13, P345, DOI 10.1101/gad.13.3.345; Le S, 1999, GENETICS, V152, P143; Liu J, 1999, J BIOL CHEM, V274, P25033, DOI 10.1074/jbc.274.35.25033; Liu JI, 1999, P NATL ACAD SCI USA, V96, P3552, DOI 10.1073/pnas.96.7.3552; LUDER A, 1982, P NATL ACAD SCI-BIOL, V79, P1101, DOI 10.1073/pnas.79.4.1101; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; MARIANS KJ, 1984, CRC CR REV BIOCH MOL, V17, P153, DOI 10.3109/10409238409113604; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; Marians KJ, 2000, PROG NUCLEIC ACID RE, V63, P39; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; Michel B, 1997, EMBO J, V16, P430, DOI 10.1093/emboj/16.2.430; Morrow DM, 1997, GENETICS, V147, P371; Mosig G, 1998, ANNU REV GENET, V32, P379, DOI 10.1146/annurev.genet.32.1.379; Neilson L, 1999, MOL MICROBIOL, V31, P915, DOI 10.1046/j.1365-2958.1999.01231.x; NURSE P, 1991, J BACTERIOL, V173, P6686, DOI 10.1128/jb.173.21.6686-6693.1991; Opperman T, 1999, P NATL ACAD SCI USA, V96, P9218, DOI 10.1073/pnas.96.16.9218; Rangarajan S, 1999, P NATL ACAD SCI USA, V96, P9224, DOI 10.1073/pnas.96.16.9224; Recchia GD, 1999, EMBO J, V18, P5724, DOI 10.1093/emboj/18.20.5724; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Sandler SJ, 1999, MOL MICROBIOL, V34, P91, DOI 10.1046/j.1365-2958.1999.01576.x; Sandler SJ, 1996, GENETICS, V143, P5; Saveson CJ, 1999, GENETICS, V152, P5; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; Shinagawa H, 1996, EXS, V77, P221; Skalka A., 1974, MECH RECOMBINATION, P421, DOI [10.1007/978-1-4684-2133-0_37, DOI 10.1007/978-1-4684-2133-0_37]; SKARSTAD K, 1993, J BACTERIOL, V175, P5505, DOI 10.1128/JB.175.17.5505-5509.1993; Steiner W, 1999, MOL MICROBIOL, V31, P579, DOI 10.1046/j.1365-2958.1999.01198.x; Steiner WW, 1998, MOL MICROBIOL, V27, P257, DOI 10.1046/j.1365-2958.1998.00651.x; Steiner WW, 1998, J BACTERIOL, V180, P6269; Tang MJ, 1999, P NATL ACAD SCI USA, V96, P8919, DOI 10.1073/pnas.96.16.8919; Tang MJ, 1998, P NATL ACAD SCI USA, V95, P9755, DOI 10.1073/pnas.95.17.9755; Wagner J, 1999, MOL CELL, V4, P281, DOI 10.1016/S1097-2765(00)80376-7; WEST SC, 1981, NATURE, V294, P659, DOI 10.1038/294659a0; WOODGATE R, 1991, MOL GEN GENET, V229, P10, DOI 10.1007/BF00264207; ZAVITZ KH, 1991, MOL MICROBIOL, V5, P2869, DOI 10.1111/j.1365-2958.1991.tb01846.x	62	846	874	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					37	41		10.1038/35003501	http://dx.doi.org/10.1038/35003501			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716434				2022-12-24	WOS:000085775100037
J	Dickson, D				Dickson, D			... amid calls for international biotech panel	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2000	403	6772					821	821		10.1038/35002766	http://dx.doi.org/10.1038/35002766			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	288JG	10733386	Bronze			2022-12-24	WOS:000085559200015
J	Cole, TJ; Bellizzi, MC; Flegal, KM; Dietz, WH				Cole, TJ; Bellizzi, MC; Flegal, KM; Dietz, WH			Establishing a standard definition for child overweight and obesity worldwide: international survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BODY-MASS INDEX; CARDIOVASCULAR RISK; YOUNG-ADULTS; ADOLESCENTS	Objective To develop an internationally acceptable definition of child overweight and obesity, specifying the measurement, the reference population, and the age and sex specific cut off points. Design International survey of six large nationally representative cross sectional growth studies. Setting Brazil, Great Britain, Hong Kong, the Netherlands, Singapore, and the United States. Subjects 97 876 males and 94 851 females from birth to 25 years of age. Main outcome measure Body mass index (weight/height(2)). Results For each of the surveys, centile curves were drawn that at age 18 years passed through the widely used cut off points of 25 and 30 kg/m(2) for adult overweight and obesity. The resulting curves were averaged to provide age and sex specific cut off points from 2-18 years. Conclusions The proposed cut off points, which are less arbitrary and more internationally based than current alternatives, should help to provide internationally comparable prevalence rates of overweight and obesity in children.	Inst Child Hlth, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England; Int Obes Task Force Secretariat, London NW1 2NS, England; Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA; Ctr Dis Control & Prevent, Div Nutr & Phys Act, Atlanta, GA 30341 USA	University of London; University College London; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); Centers for Disease Control & Prevention - USA	Cole, TJ (corresponding author), Inst Child Hlth, Dept Epidemiol & Publ Hlth, 30 Guilford St, London WC1N 1EH, England.	tim.cole@ich.ucl.ac.uk	Cole, Tim J/B-7883-2008; Flegal, Katherine M/A-4608-2013; lehmann, jennifer/AAB-8110-2019	Cole, Tim J/0000-0001-5711-8200; Flegal, Katherine/0000-0002-0838-469X	Medical Research Council [G9827821(62595), G9827821] Funding Source: Medline; MRC [G9827821] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; Bellizzi MC, 1999, AM J CLIN NUTR, V70, p173S; BERENSON GS, 1993, ANN NY ACAD SCI, V699, P93, DOI 10.1111/j.1749-6632.1993.tb18840.x; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; COLE TJ, 1995, ARCH DIS CHILD, V73, P25, DOI 10.1136/adc.73.1.25; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; DAMATO M, 1999, INT BIOM SOC IT REG; Dietz WH, 1998, J PEDIATR-US, V132, P191; FLEGAL KM, 1993, CRIT REV FOOD SCI, V33, P307, DOI 10.1080/10408399309527625; Mahoney LT, 1996, J AM COLL CARDIOL, V27, P277, DOI 10.1016/0735-1097(95)00461-0; Malina RM, 1999, AM J CLIN NUTR, V70, p131S; Power C, 1997, INT J OBESITY, V21, P507, DOI 10.1038/sj.ijo.0800454; ROLLANDCACHERA MF, 1982, AM J CLIN NUTR, V36, P178, DOI 10.1093/ajcn/36.1.178; *WHO, 1998, WHO CONS GEN 3 5 JAN; *WHO, 1995, PHYS STAT US NT ANTH	15	11233	11729	28	975	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2000	320	7244					1240	1243		10.1136/bmj.320.7244.1240	http://dx.doi.org/10.1136/bmj.320.7244.1240			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CF	10797032	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000086981400017
J	Field, J; Shreeves, G; Sumner, S; Casiraghi, M				Field, J; Shreeves, G; Sumner, S; Casiraghi, M			Insurance-based advantage to helpers in a tropical hover wasp	NATURE			English	Article							GROUP MEMBERS; EUSOCIALITY; EVOLUTION	The origin and maintenance of eusociality is a central problem in evolutionary biology(1,2). Eusocial groups contain individuals that forfeit their own reproduction in order to help others reproduce. In facultatively eusocial taxa, offspring can choose whether to found new nests or become helpers in their natal groups. In many facultatively eusocial insects, offspring need continuous care during development, but adult carers have life expectancies shorter than the developmental period(3-7). When a lone foundress dies, her partly reared brood are usually doomed. Here, we show that helpers in a tropical hover wasp (Liostenogaster flavolineata) have an insurance-based advantage over lone foundresses because after a helper dies, most of the brood that she has partly reared will be brought to maturity by surviving nest-mates. After some of the helpers are experimentally removed from a multi-female nest, the reduced group is left with more brood than it would normally rear. We found that larger, more valuable extra brood were reared through to maturity, but not smaller, less valuable brood. Smaller brood may be sacrificed to feed larger brood, and reduced groups probably benefited from increased short-term helper recruitment. Rearing extra brood did not increase adult mortality or brood development time.	UCL, Dept Biol, London NW1 2HE, England	University of London; University College London	Field, J (corresponding author), UCL, Dept Biol, Wolfson House,4 Stephenson Way, London NW1 2HE, England.	jeremy.field@ucl.ac.uk	Sumner, Seirian/E-6611-2011; Casiraghi, Maurizio/E-7273-2011	Casiraghi, Maurizio/0000-0002-2733-2094; Sumner, Seirian/0000-0003-0213-2018				Crawley M.J., 1993, GLIM ECOLOGISTS; Field J, 1999, ANIM BEHAV, V57, P633, DOI 10.1006/anbe.1999.0995; Field J, 1999, BEHAV ECOL SOCIOBIOL, V45, P378, DOI 10.1007/s002650050574; Field J, 1998, P ROY SOC B-BIOL SCI, V265, P973, DOI 10.1098/rspb.1998.0386; GADAGKAR R, 1990, PHILOS T ROY SOC B, V329, P17, DOI 10.1098/rstb.1990.0146; GERVET J, 1964, ANN SCI NAT ZOOL, V6, P601; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; HATCHWELL BJ, 1990, BEHAV ECOL SOCIOBIOL, V27, P199; Hatchwell BJ, 1996, P ROY SOC B-BIOL SCI, V263, P83, DOI 10.1098/rspb.1996.0014; Kukuk PF, 1998, NATURWISSENSCHAFTEN, V85, P445, DOI 10.1007/s001140050528; MEAD F, 1994, J ETHOL, V12, P43, DOI 10.1007/BF02350079; NONACS P, 1993, BEHAV PROCESS, V30, P47, DOI 10.1016/0376-6357(93)90011-F; Queller David C., 1996, P218; QUELLER DC, 1994, P ROY SOC B-BIOL SCI, V256, P105, DOI 10.1098/rspb.1994.0056; QUELLER DC, 1989, P NATL ACAD SCI USA, V86, P3224, DOI 10.1073/pnas.86.9.3224; Reeve H.K., 1991, P99; Reeve HK, 1997, BEHAV ECOL, V8, P75, DOI 10.1093/beheco/8.1.75; SCHMIDHEMPEL P, 1998, PARASITES SOCIAL INS; Smith J. M., 1995, MAJOR TRANSITIONS EV; STRASSMANN JE, 1989, WESTV STUD, P81; Turillazzi S., 1991, P74; [No title captured]	22	87	90	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					869	871		10.1038/35009097	http://dx.doi.org/10.1038/35009097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786792				2022-12-24	WOS:000086625000044
J	von Melchner, L; Pallas, SL; Sur, M				von Melchner, L; Pallas, SL; Sur, M			Visual behaviour mediated by retinal projections directed to the auditory pathway	NATURE			English	Article							CROSS-MODAL PLASTICITY; CEREBRAL-CORTEX; SPECIFICATION; THALAMUS; ORGANIZATION; MECHANISMS; KITTENS; FERRETS; HUMANS; DEAF	An unresolved issue in cortical development concerns the relative contributions of intrinsic and extrinsic factors to the functional specification of different cortical areas(1-4). Ferrets in which retinal projections are redirected neonatally to the auditory thalamus(5) have visually responsive cells in auditory thalamus and cortex, form a retinotopic map in auditory cortex and have visual receptive field properties in auditory cortex that are typical of cells in visual cortex(5-8.) Here we report that this cross-modal projection and its representation in auditory cortex can mediate visual behaviour. When light stimuli are presented in the portion of the visual field that is 'seen' only by this projection, 'rewired' ferrets respond as though they perceive the stimuli to be visual rather than auditory. Thus the perceptual modality of a neocortical region is instructed to a significant extent by its extrinsic inputs. In addition, gratings of different spatial frequencies can be discriminated by the rewired pathway, although the grating acuity is lower than that of the normal visual pathway.	MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Sur, M (corresponding author), Merck KGaA, Dept CNS Res, D-64293 Darmstadt, Germany.		Pallas, Sarah L/W-1860-2019	Pallas, Sarah L/0000-0002-1760-7437				Angelucci A, 1998, J COMP NEUROL, V400, P417, DOI 10.1002/(SICI)1096-9861(19981026)400:3<417::AID-CNE10>3.0.CO;2-O; Boring E.G., 1950, HIST EXPT PSYCHOL; DOBSON V, 1978, VISION RES, V18, P1469, DOI 10.1016/0042-6989(78)90001-9; Gao WJ, 1999, J NEUROSCI, V19, P7940; HELD R, 1989, COGNITION, V33, P139, DOI 10.1016/0010-0277(89)90008-5; Kujala T, 1997, PSYCHOPHYSIOLOGY, V34, P213, DOI 10.1111/j.1469-8986.1997.tb02134.x; Levitt P, 1997, ANNU REV NEUROSCI, V20, P1, DOI 10.1146/annurev.neuro.20.1.1; MITCHELL DE, 1991, PHILOS T R SOC B, V333, P51, DOI 10.1098/rstb.1991.0060; MITCHELL DE, 1989, CAN J PSYCHOL, V43, P141, DOI 10.1037/h0084215; NEVILLE HJ, 1983, BRAIN RES, V266, P127, DOI 10.1016/0006-8993(83)91314-8; Neville HJ, 1998, P NATL ACAD SCI USA, V95, P922, DOI 10.1073/pnas.95.3.922; Pallas SL, 1999, P NATL ACAD SCI USA, V96, P8751, DOI 10.1073/pnas.96.15.8751; PALLAS SL, 1993, J COMP NEUROL, V337, P317, DOI 10.1002/cne.903370212; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAUSCHECKER JP, 1995, TRENDS NEUROSCI, V18, P36, DOI 10.1016/0166-2236(95)93948-W; ROE AW, 1990, SCIENCE, V250, P818, DOI 10.1126/science.2237432; ROE AW, 1993, J COMP NEUROL, V334, P263, DOI 10.1002/cne.903340208; ROE AW, 1992, J NEUROSCI, V12, P3651; Sadato N, 1996, NATURE, V380, P526, DOI 10.1038/380526a0; Sharma J, 2000, NATURE, V404, P841, DOI 10.1038/35009043; SHERMAN SM, 1982, PHYSIOL REV, V62, P738, DOI 10.1152/physrev.1982.62.2.738; Sur M, 1999, J NEUROBIOL, V41, P33, DOI 10.1002/(SICI)1097-4695(199910)41:1<33::AID-NEU6>3.0.CO;2-1; SUR M, 1988, SCIENCE, V242, P1437, DOI 10.1126/science.2462279; SUR M, 1990, TRENDS NEUROSCI, V13, P227, DOI 10.1016/0166-2236(90)90165-7; ZAHS KR, 1985, J COMP NEUROL, V241, P210, DOI 10.1002/cne.902410208	25	231	235	1	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					871	876		10.1038/35009102	http://dx.doi.org/10.1038/35009102			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786793				2022-12-24	WOS:000086625000045
J	Ryder, OA; McLaren, A; Brenner, S; Zhang, YP; Benirschke, K				Ryder, OA; McLaren, A; Brenner, S; Zhang, YP; Benirschke, K			Ecology - DNA banks for endangered animal species	SCIENCE			English	Article							FLORIDA PANTHER; GENETIC DIVERSITY; IDENTIFICATION; CONSERVATION; WHALE		Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA; Univ Cambridge, Wellcome CRC Inst, Cambridge CB2 1QR, England; Chinese Acad Sci, Kunming Inst Zool, Key Lab Cellular & Mol Evolut, Kunming, Peoples R China; Mol Sci Lab, Berkeley, CA 94720 USA; Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	Zoological Society of San Diego; University of Cambridge; Chinese Academy of Sciences; Kunming Institute of Zoology; The Molecular Sciences Institute; University of California System; University of California San Diego	Ryder, OA (corresponding author), Zool Soc San Diego, Ctr Reprod Endangered Species, San Diego, CA 92112 USA.							Amato George, 1998, P177; Baker CS, 1996, MOL ECOL, V5, P671, DOI 10.1111/j.1365-294X.1996.tb00362.x; BENFORD G, 1992, P NATL ACAD SCI USA, V89, P11098, DOI 10.1073/pnas.89.22.11098; BOWEN BW, 1994, EVOLUTION, V48, P1820, DOI 10.1111/j.1558-5646.1994.tb02217.x; Cipriano F, 1999, NATURE, V397, P307, DOI 10.1038/16823; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; GEYER CJ, 1993, MOL BIOL EVOL, V10, P571; Hacia JG, 1999, NAT GENET, V22, P164, DOI 10.1038/9674; HEDRICK PW, 1995, CONSERV BIOL, V9, P996, DOI 10.1046/j.1523-1739.1995.9050988.x-i1; *IUCN, 1997, LIST THREAT AN; JAMA M, UNPUB; Kirchner JW, 2000, NATURE, V404, P177, DOI 10.1038/35004564; Mayer WE, 1998, HEREDITY, V80, P702, DOI 10.1046/j.1365-2540.1998.00347.x; MENOTTIRAYMOND M, 1993, P NATL ACAD SCI USA, V90, P3172, DOI 10.1073/pnas.90.8.3172; OBRIEN SJ, 1990, NATL GEOGR RES, V6, P485; Palumbi SR, 1998, J HERED, V89, P459; RALLS K, IN PRESS ANIM CONSER; ROELKE ME, 1993, CURR BIOL, V3, P340, DOI 10.1016/0960-9822(93)90197-V; Ruvolo M, 1997, ANNU REV ANTHROPOL, V26, P515, DOI 10.1146/annurev.anthro.26.1.515; RYDER OA, 1988, NATURE, V331, P396, DOI 10.1038/331396a0; Ryder OA, 1997, ZOO BIOL, V16, P295, DOI 10.1002/(SICI)1098-2361(1997)16:4<295::AID-ZOO1>3.0.CO;2-5; SAARENMAA H, 1999, 34 EUR ENV AG; Shimamura M, 1997, NATURE, V388, P666, DOI 10.1038/41759; Zhang YP, 1997, SCI CHINA SER C, V40, P210, DOI 10.1007/BF02882050	24	47	53	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					275	+		10.1126/science.288.5464.275	http://dx.doi.org/10.1126/science.288.5464.275			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10777408				2022-12-24	WOS:000086454300022
J	Barton, JH				Barton, JH			Financing of vaccines	LANCET			English	Editorial Material									Stanford Univ, Sch Law, Stanford, CA 94305 USA	Stanford University	Barton, JH (corresponding author), Stanford Univ, Sch Law, Stanford, CA 94305 USA.							Bloom BR, 1998, NAT MED, V4, P480, DOI 10.1038/nm0598supp-480; *CONS GROUP INT AG, 1998, CONS GROUP INT AGR R; *GLOB PROGR VACC, 1996, STAT WORLDS VACC IMM; Keohane Robert O., 1996, I ENV AID PITFALLS P; Mahoney RT, 1999, VACCINE, V17, P646, DOI 10.1016/S0264-410X(98)00246-1; Miller LH, 1998, NAT MED, V4, P520, DOI 10.1038/nm0598supp-520; MURASKIN W, 1995, WAR HEPATITIS B; SACHS J, 1999, ECONOMIST       0814, P17; *WORLD BANK, 1998, HLTH NUTR POP SECT S, P61; *WORLD BANK, 1993, WORLD DEV REP	10	10	10	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1269	1270		10.1016/S0140-6736(00)02100-0	http://dx.doi.org/10.1016/S0140-6736(00)02100-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770320				2022-12-24	WOS:000086448000041
J	Sheffield, C				Sheffield, C			The new laureate speaks - The response of this year's Nobelist in full	NATURE			English	Editorial Material																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					549	549		10.1038/35007161	http://dx.doi.org/10.1038/35007161			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766219	Bronze			2022-12-24	WOS:000086400100028
J	Leydon, GM; Boulton, M; Moynihan, C; Jones, A; Mossman, J; Boudioni, M; McPherson, K				Leydon, GM; Boulton, M; Moynihan, C; Jones, A; Mossman, J; Boudioni, M; McPherson, K			Cancer patients' information needs and information seeking behaviour: in depth interview study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREFERENCES	Objectives To explore why cancer patients do riot want or seek information about their condition beyond that volunteered by their physicians at times during their illness. Design Qualitative study based on in-depth interviews. Setting Outpatient oncology clinics at a London cancer centre. Participants 17 patients with cancer diagnosed in previous 6 months. Main outcome measures Analysis of patients narratives to identify key themes and categories. Results While all patients wanted basic information on diagnosis and treatment, not all wanted further information at all stages of their illness. Three overarching attitudes to their management of cancel limited patients' desire for and subsequent efforts to obtain further information: faith, hope, and charity: Faith in their doctor's medical expertise precluded the need for patients to seek further information themselves. Hope was essential for patients to carry on with life as normal and could be maintained through silence and avoiding information, especially too detailed or "unsafe" information. Charity to fellow patients, especially those seen as more needy than themselves, was expressed in the recognition that scarce resources-including information and explanations-had to be shared and meant that limited Information was accepted as inevitable. Conclusions Cancer patients' attitudes to cancer. and their strategies for coping with their illness can constrain their wish for information and their, efforts to obtain it. In developing recommendations, the government's cancer information strategy should attend to variations in patients' desires for information and the reasons for them.	Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Canc & Publ Hlth Unit, London WC1E 7HT, England; Oxford Brookes Univ, Sch Social Sci & Law, Oxford OX3 0BP, England; Inst Canc Res, Sutton SM2 5PT, Surrey, England; Royal Marsden NHS Trust, Sutton SM2 5PT, Surrey, England; Royal Free Hosp, Sch Med, London NW3 2QG, England; CancerBACUP, London EC2A 3JR, England	University of London; London School of Hygiene & Tropical Medicine; Oxford Brookes University; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Leydon, GM (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Canc & Publ Hlth Unit, London WC1E 7HT, England.	g.leydon@Ishtm.ac.uk	Leydon, Geraldine M/C-4968-2011; BOULTON, Mary/X-9056-2019	BOULTON, Mary/0000-0002-2247-8318; Leydon, Geraldine Marie/0000-0001-5986-3300				Boudioni M, 1999, BRIT J CANCER, V79, P138, DOI 10.1038/sj.bjc.6690023; Boudioni M, 1998, BRIT MED J, V317, P1016, DOI 10.1136/bmj.317.7164.1016; BUTOW P, 1994, BRIT J CANCER, V71, P1115; Byrne P.S., 1976, DOCTORS TALKING PATI; CASSILETH BR, 1980, ANN INTERN MED, V92, P832, DOI 10.7326/0003-4819-92-6-832; Coulter A, 1998, BMJ-BRIT MED J, V317, P225, DOI 10.1136/bmj.317.7153.225; FALLOWFIELD L, 1995, PSYCHO-ONCOLOGY, V4, P197, DOI 10.1002/pon.2960040305; FALLOWFIELD LJ, 1990, BRIT MED J, V301, P575, DOI 10.1136/bmj.301.6752.575; FORD S, 1995, SOC SCI MED, P1; HARRISON J, 1995, SOC SCI MED, V41, P1255, DOI 10.1016/0277-9536(94)00411-L; HOUTS P, 1991, J CANCER EDUC, V6, P225; INGELFINGER FJ, 1980, NEW ENGL J MED, V303, P1507, DOI 10.1056/NEJM198012253032604; LUPTON D, 1996, HLTH SOCIOLOGY EMOTI, P157; Meredith C, 1996, BMJ-BRIT MED J, V313, P724; National Cancer Alliance, 1996, PAT CTR CANC SERV WH; Orne M T, 1968, Int J Psychiatry, V5, P403; Parsons Talcott, 1951, SOCIAL SYSTEM; Pinder R., 1990, MANAGEMENT CHRONIC I; RITCHIE J, 1994, ANAL QUALITATIVE DAT, P172; Silverman D., 2015, INTERPRETING QUALITA; Slevin ML, 1996, BRIT J CANCER, V74, P1275, DOI 10.1038/bjc.1996.529; The Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales, 1995, POL FRAM COMM CANC S; WongWylie G, 1997, QUAL HEALTH RES, V7, P32, DOI 10.1177/104973239700700103	23	571	578	5	86	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2000	320	7239					909	913		10.1136/bmj.320.7239.909	http://dx.doi.org/10.1136/bmj.320.7239.909			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	301YA	10742000	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000086337100025
J	Chapman, B				Chapman, B			Necessity for afferent activity to maintain eye-specific segregation in ferret lateral geniculate nucleus	SCIENCE			English	Article							TETRODOTOXIN; INFUSION	In the adult mammal, retinal ganglion cell axon arbors are restricted to eye-specific Layers in the lateral geniculate nucleus. Blocking neuronal activity early in development prevents this segregation from occurring. To test whether activity is also required to maintain eye-specific segregation, ganglion cell activity was blocked after segregation was established. This caused desegregation, so that both eyes' axons became concentrated in lumina A, normally occupied only by contralateral afferents. These results show that an activity-dependent process is necessary for maintaining eye-specific segregation and suggest that activity-independent cues may favor Lamina A as the target for arborization of afferents from both eyes.	Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA	University of California System; University of California Davis	Chapman, B (corresponding author), Univ Calif Davis, Ctr Neurosci, 1544 Newton Court, Davis, CA 95616 USA.				NATIONAL EYE INSTITUTE [R01EY011369] Funding Source: NIH RePORTER; NEI NIH HHS [EY-11369, R01 EY011369-11, R01 EY011369] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Chapman B, 2000, J NEUROSCI, V20, P1922; Cook PM, 1999, VISUAL NEUROSCI, V16, P491, DOI 10.1017/S0952523899163107; GUILLERY RW, 1985, J NEUROSCI, V5, P1370; HUTCHINS JB, 1990, J COMP NEUROL, V298, P113, DOI 10.1002/cne.902980109; LINDEN DC, 1981, J COMP NEUROL, V203, P189, DOI 10.1002/cne.902030204; MORGAN J, 1993, VISUAL NEUROSCI, V10, P303, DOI 10.1017/S0952523800003709; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; RAKIC P, 1976, NATURE, V261, P467, DOI 10.1038/261467a0; SHATZ CJ, 1988, SCIENCE, V242, P87, DOI 10.1126/science.3175636; SHIELLS RA, 1981, NATURE, V294, P592, DOI 10.1038/294592a0; SLAUGHTER MM, 1981, SCIENCE, V211, P182, DOI 10.1126/science.6255566; SRETAVAN DW, 1986, J NEUROSCI, V6, P990; SRETAVAN DW, 1988, NATURE, V336, P468, DOI 10.1038/336468a0; WONG WC, COMMUNICATION; Wong WT, 2000, J NEUROSCI, V20, P351, DOI 10.1523/JNEUROSCI.20-01-00351.2000	15	90	97	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2479	2482		10.1126/science.287.5462.2479	http://dx.doi.org/10.1126/science.287.5462.2479			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741966	Green Accepted			2022-12-24	WOS:000086202200043
J	Zhang, HS; Gavin, M; Dahiya, A; Postigo, AA; Ma, DD; Luo, RX; Harbour, JW; Dean, DC				Zhang, HS; Gavin, M; Dahiya, A; Postigo, AA; Ma, DD; Luo, RX; Harbour, JW; Dean, DC			Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF	CELL			English	Article							CHROMATIN-REMODELING COMPLEX; SWI-SNF COMPLEX; RETINOBLASTOMA PROTEIN; HISTONE DEACETYLASE; TRANSCRIPTIONAL REPRESSION; GROWTH SUPPRESSION; PRB-FAMILY; E2F; INHIBITION; BINDING	We present evidence that Rb forms a repressor containing histone deacetylase (HDAC) and the hSWI/SNF nucleosome remodeling complex, which inhibits transcription of genes for cyclins E and A and arrests cells in the G1 phase of the cell cycle. Phosphorylation of Rb by cyclin D/cdk4 disrupts association with HDAC, relieving repression of the cyclin E gene and G1 arrest. However, the Rb-hSWI/SNF complex persists and is sufficient to maintain repression of the cyclin A and cdc2 genes, inhibiting exit from S phase. HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF then appear to maintain the order of cyclin E and A expression during the cell cycle, which in turn regulates exit from G1 and from S phase, respectively.	Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Dean, DC (corresponding author), Washington Univ, Sch Med, Dept Med, Div Mol Oncol, St Louis, MO 63110 USA.	ddean@im.wustl.edu	Harbour, J. William/B-1448-2015	Harbour, J. William/0000-0002-1104-9809; Postigo, Antonio/0000-0003-4605-2634				Adams PD, 1996, CURR TOP MICROBIOL, V208, P79; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Brandeis M, 1996, EMBO J, V15, P5280, DOI 10.1002/j.1460-2075.1996.tb00913.x; Brehm A, 1998, NATURE, V391, P597, DOI 10.1038/35404; Burns LG, 1997, MOL CELL BIOL, V17, P4811, DOI 10.1128/MCB.17.8.4811; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chow KNB, 1996, MOL CELL BIOL, V16, P7173; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dimova D, 1999, MOL CELL, V4, P75, DOI 10.1016/S1097-2765(00)80189-6; DINGWALL AK, 1995, MOL BIOL CELL, V6, P777, DOI 10.1091/mbc.6.7.777; DUNAIEF JL, 1994, CELL, V79, P119, DOI 10.1016/0092-8674(94)90405-7; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; EWEN ME, 1994, CANCER METAST REV, V13, P45, DOI 10.1007/BF00690418; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Jiang H, 1998, MOL CELL BIOL, V18, P5284, DOI 10.1128/MCB.18.9.5284; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Kornberg RD, 1999, CELL, V98, P285, DOI 10.1016/S0092-8674(00)81958-3; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; LAM EWF, 1994, CURR OPIN CELL BIOL, V6, P859; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lee JO, 1998, NATURE, V391, P859, DOI 10.1038/36038; Leng XH, 1997, CURR BIOL, V7, P709, DOI 10.1016/S0960-9822(06)00301-0; Lorch Y, 1999, CELL, V96, P389, DOI 10.1016/S0092-8674(00)80551-6; Lukas C, 1999, NATURE, V401, P815, DOI 10.1038/44611; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Luo RX, 1998, CELL, V92, P463, DOI 10.1016/S0092-8674(00)80940-X; Magnaghi-Jaulin L, 1998, NATURE, V391, P601, DOI 10.1038/35410; Mitra J, 1999, MOL CELL BIOL, V19, P3916; Muchardt C, 1996, EMBO J, V15, P3394, DOI 10.1002/j.1460-2075.1996.tb00705.x; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Murphy DJ, 1999, MOL CELL BIOL, V19, P2724; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; NEVINS JR, 1992, SCIENCE, V258, P424; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Papoulas O, 1998, DEVELOPMENT, V125, P3955; Phelan ML, 1999, MOL CELL, V3, P247, DOI 10.1016/S1097-2765(00)80315-9; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; Shanahan F, 1999, MOL CELL BIOL, V19, P1460; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Sif S, 1998, GENE DEV, V12, P2842, DOI 10.1101/gad.12.18.2842; Slansky JE, 1996, CURR TOP MICROBIOL, V208, P1; Strober BE, 1996, MOL CELL BIOL, V16, P1576; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Trouche D, 1997, P NATL ACAD SCI USA, V94, P11268, DOI 10.1073/pnas.94.21.11268; Utley RT, 1997, J BIOL CHEM, V272, P12642, DOI 10.1074/jbc.272.19.12642; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Wade PA, 1998, COLD SPRING HARB SYM, V63, P435, DOI 10.1101/sqb.1998.63.435; Wade PA, 1999, CURR BIOL, V9, pR221, DOI 10.1016/S0960-9822(99)80134-1; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1992, NATURE, V358, P259, DOI 10.1038/358259a0; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Whitehouse I, 1999, NATURE, V400, P784, DOI 10.1038/23506; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4; ZHU L, 1993, GENE DEV, V7, P1111, DOI 10.1101/gad.7.7a.1111	72	524	533	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2000	101	1					79	89		10.1016/S0092-8674(00)80625-X	http://dx.doi.org/10.1016/S0092-8674(00)80625-X			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	300JM	10778858	Bronze			2022-12-24	WOS:000086249900010
J	Pienitz, R; Vincent, WF				Pienitz, R; Vincent, WF			Effect of climate change relative to ozone depletion on UV exposure in subarctic lakes	NATURE			English	Article							ULTRAVIOLET-RADIATION; NORTHWEST-TERRITORIES; BOREAL FOREST; B PENETRATION; VEGETATION; TREELINE; CANADA; ACIDIFICATION; YELLOWKNIFE	The effect of stratospheric ozone depletion on increases in ambient levels of solar ultraviolet (UV) radiation in high-latitude regions' has raised concerns about the response of northern ecosystems to environmental change. The concentration of coloured dissolved organic material, which is derived from terrestrial vegetation and acts as a screen for ultraviolet radiation, is low in high-latitude lakes(2). The underwater light environment in these lakes is therefore likely to be sensitive to small variations in the supply of this material, in addition to the effects of ozone depletion(2-5). Here we use fossil diatom assemblages in combination with bio-optical models to estimate the magnitude of past variations in the underwater light regime of a lake at the boreal tree line. We find large shifts in underwater UV-B, UV-A and photosynthetically available radiation associated with changes in the input of coloured dissolved organic material into subarctic lakes during the Holocene. The inferred changes in biological exposure to UV radiation were at least two orders of magnitude greater than those associated with moderate (30%) ozone depletion. Our findings indicate that freshwater ecosystems at present located across vegetation gradients will experience significant shifts in underwater spectral irradiance through the effects of climate change on catchment vegetation and the export of coloured dissolved organic material.	Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada	Laval University	Pienitz, R (corresponding author), Univ Laval, Ctr Etud Nord, Quebec City, PQ G1K 7P4, Canada.	reinhard.pienitz@cen.ulaval.ca; warwick.vincent@bio.ulaval.ca	Vincent, Warwick/AAH-6152-2019; Vincent, Warwick F/C-9522-2009	Vincent, Warwick/0000-0001-9055-1938; 				Arrow Kenneth J., 1996, CLIMATE CHANGE 1995; Battarbee RW, 1997, HYDROBIOLOGIA, V348, P69, DOI 10.1023/A:1003085116632; CULLEN JJ, 1992, SCIENCE, V258, P646, DOI 10.1126/science.258.5082.646; ENGSTROM DR, 1987, CAN J FISH AQUAT SCI, V44, P1306, DOI 10.1139/f87-154; Fallu MA, 1999, ECOSCIENCE, V6, P603, DOI 10.1080/11956860.1999.11682553; FOLEY JA, 1994, NATURE, V371, P52, DOI 10.1038/371052a0; FREDERICK JE, 1988, SCIENCE, V241, P438, DOI 10.1126/science.241.4864.438; Hansen G, 1999, J GEOPHYS RES-ATMOS, V104, P1837, DOI 10.1029/1998JD100021; *INT ARCT SCI COMM, 1995, EFF INCR ULTR RAD AR, V2; Korsman T., 1994, Holocene, V4, P132, DOI 10.1177/095968369400400203; Laurion I, 1997, PHOTOCHEM PHOTOBIOL, V65, P107; Leavitt PR, 1997, NATURE, V388, P457, DOI 10.1038/41296; MACDONALD GM, 1993, NATURE, V361, P243, DOI 10.1038/361243a0; MacDonald GM, 1998, ANN ASSOC AM GEOGR, V88, P183, DOI 10.1111/1467-8306.00090; MOSER KA, 1990, QUATERNARY RES, V34, P227, DOI 10.1016/0033-5894(90)90033-H; Pielke RA, 1995, J GEOPHYS RES-ATMOS, V100, P25755, DOI 10.1029/95JD02418; Pienitz R, 1999, ARCT ANTARCT ALP RES, V31, P82, DOI 10.2307/1552625; PIENITZ R, 1993, HYDROBIOLOGIA, V269, P391, DOI 10.1007/BF00028037; PLENITZ R, 1997, CAN J FISH AQUAT SCI, V54, P347; Schindler DW, 1996, NATURE, V379, P705, DOI 10.1038/379705a0; SETLOW RB, 1974, P NATL ACAD SCI USA, V71, P3363, DOI 10.1073/pnas.71.9.3363; SMITH TM, 1992, ADV ECOL RES, V22, P93, DOI 10.1016/S0065-2504(08)60134-8; URBAN NR, 1989, WATER RESOUR RES, V25, P1619, DOI 10.1029/WR025i007p01619; Vincent WF, 1996, GEOSCI CAN, V23, P231; Vincent WF, 1998, ANN GLACIOL, V27, P691; Vinebrooke RD, 1996, LIMNOL OCEANOGR, V41, P1035, DOI 10.4319/lo.1996.41.5.1035; Williamson CE, 1996, LIMNOL OCEANOGR, V41, P1024, DOI 10.4319/lo.1996.41.5.1024; Wolfe BB, 1996, J PALEOLIMNOL, V15, P171; Yan ND, 1996, NATURE, V381, P141, DOI 10.1038/381141a0	29	155	161	1	68	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 30	2000	404	6777					484	487		10.1038/35006616	http://dx.doi.org/10.1038/35006616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761913				2022-12-24	WOS:000086257700044
J	Ridker, PM; Hennekens, CH; Buring, JE; Rifai, N				Ridker, PM; Hennekens, CH; Buring, JE; Rifai, N			C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY HEART-DISEASE; AVERAGE CHOLESTEROL LEVELS; SEVERE UNSTABLE ANGINA; APPARENTLY HEALTHY-MEN; MYOCARDIAL-INFARCTION; RISK; EVENTS; ATHEROSCLEROSIS; PRAVASTATIN; PREVENTION	Background: Since inflammation is believed to have a role in the pathogenesis of cardiovascular events, measurement of markers of inflammation has been proposed as a method to improve the prediction of the risk of these events. Methods: We conducted a prospective, nested case-control study among 28,263 apparently healthy postmenopausal women over a mean follow-up period of three years to assess the risk of cardiovascular events associated with base-line levels of markers of inflammation. The markers included high-sensitivity C-reactive protein (hs-CRP), serum amyloid A, interleukin-6, and soluble intercellular adhesion molecule type 1 (sICAM-1). We also studied homocysteine and several lipid and lipoprotein measurements. Cardiovascular events were defined as death from coronary heart disease, nonfatal myocardial infarction or stroke, or the need for coronary-revascularization procedures. Results: Of the 12 markers measured, hs-CRP was the strongest univariate predictor of the risk of cardiovascular events; the relative risk of events for women in the highest as compared with the lowest quartile for this marker was 4.4 (95 percent confidence interval, 2.2 to 8.9). Other markers significantly associated with the risk of cardiovascular events were serum amyloid A (relative risk for the highest as compared with the lowest quartile, 3.0), sICAM-1 (2.6), interleukin-6 (2.2), homocysteine (2.0), total cholesterol (2.4), low-density lipoprotein (LDL) cholesterol (2.4), apolipoprotein B-100 (3.4), high-density lipoprotein (HDL) cholesterol (0.3), and the ratio of total cholesterol to HDL cholesterol (3.4). Prediction models that incorporated markers of inflammation in addition to lipids were significantly better at predicting risk than models based on lipid levels alone (P<0.001). The levels of hs-CRP and serum amyloid A were significant predictors of risk even in the subgroup of women with LDL cholesterol levels below 130 mg per deciliter (3.4 mmol per liter), the target for primary prevention established by the National Cholesterol Education Program. In multivariate analyses, the only plasma markers that independently predicted risk were hs-CRP (relative risk for the highest as compared with the lowest quartile, 1.5; 95 percent confidence interval, 1.1 to 2.1) and the ratio of total cholesterol to HDL cholesterol (relative risk, 1.4; 95 percent confidence interval, 1.1 to 1.9). Conclusions: The addition of the measurement of C-reactive protein to screening based on lipid levels may provide an improved method of identifying women at risk for cardiovascular events. (N Engl J Med 2000;342:836-43.) (C)2000, Massachusetts Medical Society.	Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Cardiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Childrens Hosp, Med Ctr, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Ridker, PM (corresponding author), Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, 75 Francis St, Boston, MA 02115 USA.				NCI NIH HHS [CA47988] Funding Source: Medline; NHLBI NIH HHS [HL43851, HL58755] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058755, R01HL043851] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Biasucci LM, 1999, CIRCULATION, V99, P855, DOI 10.1161/01.CIR.99.7.855; Biasucci LM, 1999, CIRCULATION, V99, P2079, DOI 10.1161/01.CIR.99.16.2079; Braunwald E, 1997, NEW ENGL J MED, V337, P1360, DOI 10.1056/NEJM199711063371906; Buring JE, 1992, J MYOCARDIAL ISCHEMI, V4, P27; Downs JR, 1998, JAMA-J AM MED ASSOC, V279, P1615, DOI 10.1001/jama.279.20.1615; GRUNDY SM, 1993, JAMA-J AM MED ASSOC, V269, P3015, DOI 10.1001/jama.269.23.3015; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Haverkate F, 1997, LANCET, V349, P462, DOI 10.1016/S0140-6736(96)07591-5; Hwang SJ, 1997, CIRCULATION, V96, P4219; Koenig W, 1999, CIRCULATION, V99, P237, DOI 10.1161/01.CIR.99.2.237; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Liuzzo G, 1998, CIRCULATION, V98, P2370, DOI 10.1161/01.CIR.98.22.2370; Macy EM, 1997, CLIN CHEM, V43, P52; Maseri A, 1997, NEW ENGL J MED, V336, P1014, DOI 10.1056/NEJM199704033361409; Morrow DA, 1998, J AM COLL CARDIOL, V31, P1460, DOI 10.1016/S0735-1097(98)00136-3; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Ridker PM, 1997, NEW ENGL J MED, V337, P356; Ridker PM, 1999, ANN INTERN MED, V131, P573, DOI 10.7326/0003-4819-131-8-199910190-00004; Ridker PM, 1999, JAMA-J AM MED ASSOC, V281, P1817, DOI 10.1001/jama.281.19.1817; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 1999, ANN INTERN MED, V130, P933, DOI 10.7326/0003-4819-130-11-199906010-00018; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Ridker PM, 1998, LANCET, V351, P88, DOI 10.1016/S0140-6736(97)09032-6; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; RIDKER PM, IN PRESS CIRCULATION; Rifai N, 1999, CLIN CHEM, V45, P2136; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SHEPHERD J, 1995, NEW ENGL J MED, V333, P1301, DOI 10.1056/NEJM199511163332001; Toss H, 1997, CIRCULATION, V96, P4204; Tracy RP, 1997, ARTERIOSCL THROM VAS, V17, P1121, DOI 10.1161/01.ATV.17.6.1121; *WHO, 1971, ISCH HEART DIS REG R	33	4450	4726	2	387	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 23	2000	342	12					836	843		10.1056/NEJM200003233421202	http://dx.doi.org/10.1056/NEJM200003233421202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296FU	10733371				2022-12-24	WOS:000086014100002
J	Goshima, G; Yanagida, M				Goshima, G; Yanagida, M			Establishing biorientation occurs with precocious separation of the sister kinetochores, but not the arms, in the early spindle of budding yeast	CELL			English	Article							FISSION YEAST; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; MITOTIC SPINDLE; CENTROMERE; PROTEIN; CHROMOSOMES; ANAPHASE; MITOSIS	Sister kinetochores are bioriented toward the spindle poles in higher eukaryotic prometaphase before chromosome segregation. We show that, in budding yeast, the sister kinetochores are separated in the very early spindle, while the sister arms remain associated. Biorientation of the separated kinetochores is achieved already after replication. Mtw1p, a homolog of fission yeast Mis12 required for biorientation, locates at the centromeres in an Ndc10p-dependent manner. Mtw1p and the sequences 1.8 and 3.8 kb from CEN3 and CEN15, respectively, behave like the precociously separated kinetochores, whereas the sequences 23 and 35 kb distant from CEN3 and CEN5 previously used as the centromere markers behave like a part of the arm. Mtw1p and Ndc10p are identically located except for additional spindle localization of Ndc10p. A model explaining small centromeres and early spindle formation in budding yeast is proposed.	Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, CREST Res Proj, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Gene Mechanisms, Sakyo Ku, Kyoto 6068502, Japan	Kyoto University; Kyoto University; Kyoto University	Yanagida, M (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.	yanagida@kozo.biophys.kyoto-u.ac.jp						ADACHI Y, 1989, J CELL BIOL, V108, P1195, DOI 10.1083/jcb.108.4.1195; Allshire RC, 1997, CURR OPIN GENET DEV, V7, P264, DOI 10.1016/S0959-437X(97)80137-2; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975; Chibana H, 1996, GENES CELLS, V1, P727, DOI 10.1111/j.1365-2443.1996.tb00013.x; CHIKASHIGE Y, 1989, CELL, V57, P739, DOI 10.1016/0092-8674(89)90789-7; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; FITZGERALDHAYES M, 1982, CELL, V29, P235, DOI 10.1016/0092-8674(82)90108-8; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; GOH PY, 1993, J CELL BIOL, V121, P503, DOI 10.1083/jcb.121.3.503; Gorbsky GJ, 1997, BIOESSAYS, V19, P193, DOI 10.1002/bies.950190303; Goshima G, 1999, GENE DEV, V13, P1664, DOI 10.1101/gad.13.13.1664; HAGAN IM, 1988, J CELL SCI, V89, P343; Haraguchi T, 1999, CELL STRUCT FUNCT, V24, P291, DOI 10.1247/csf.24.291; Hyland KM, 1999, J CELL BIOL, V145, P15, DOI 10.1083/jcb.145.1.15; Ikeno M, 1998, NAT BIOTECHNOL, V16, P431, DOI 10.1038/nbt0598-431; IMIGER S, 1995, CELL, V81, P269; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; MASUDA H, 1992, J CELL BIOL, V117, P1055, DOI 10.1083/jcb.117.5.1055; MCCARROLL RM, 1988, CELL, V54, P505, DOI 10.1016/0092-8674(88)90072-4; Megee PC, 1999, MOL CELL, V4, P445, DOI 10.1016/S1097-2765(00)80347-0; Meluh PB, 1997, GENE DEV, V11, P3401, DOI 10.1101/gad.11.24.3401; Meluh PB, 1998, CELL, V94, P607, DOI 10.1016/S0092-8674(00)81602-5; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; MORENO S, 1989, CELL, V58, P361, DOI 10.1016/0092-8674(89)90850-7; Nabeshima K, 1998, MOL BIOL CELL, V9, P3211, DOI 10.1091/mbc.9.11.3211; O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017; Ortiz J, 1999, GENE DEV, V13, P1140, DOI 10.1101/gad.13.9.1140; Pereira G, 1997, J CELL SCI, V110, P295; PRINGLE JR, 1991, METHOD ENZYMOL, V194, P565; RIEDER CL, 1994, J CELL BIOL, V124, P223, DOI 10.1083/jcb.124.3.223; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Saitoh S, 1997, CELL, V90, P131, DOI 10.1016/S0092-8674(00)80320-7; Sorger PK, 1995, P NATL ACAD SCI USA, V92, P12026, DOI 10.1073/pnas.92.26.12026; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Straight AF, 1997, SCIENCE, V277, P574, DOI 10.1126/science.277.5325.574; Straight AF, 1998, J CELL BIOL, V143, P687, DOI 10.1083/jcb.143.3.687; Sun XP, 1997, CELL, V91, P1007, DOI 10.1016/S0092-8674(00)80491-2; TAKAHASHI K, 1994, MOL BIOL CELL, V5, P1145, DOI 10.1091/mbc.5.10.1145; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Tanaka TU, 1999, CELL, V98, P847, DOI 10.1016/S0092-8674(00)81518-4; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Waters JC, 1996, J CELL SCI, V109, P2823; WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601; WOODS A, 1989, J CELL SCI, V93, P491	46	252	255	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					619	633		10.1016/S0092-8674(00)80699-6	http://dx.doi.org/10.1016/S0092-8674(00)80699-6			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761928	Bronze			2022-12-24	WOS:000085983800005
J	Lieu, TA; Ray, GT; Black, SB; Butler, JC; Klein, JO; Breiman, RF; Miller, MA; Shinefield, HR				Lieu, TA; Ray, GT; Black, SB; Butler, JC; Klein, JO; Breiman, RF; Miller, MA; Shinefield, HR			Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE OTITIS-MEDIA; UNITED-STATES; BACTERIAL-MENINGITIS; IMMUNIZATION; INFECTIONS; EPIDEMIOLOGY; PREVENTION; EFFICACY; PROGRAM	Context Pneumococcal conjugate vaccine for infants has recently been found effective against meningitis, bacteremia, pneumonia, and otitis media. Objective Tc,evaluate the projected health and economic impact: of pneumococcal conjugate vaccination of healthy US infants and young children. Design Cost-effectiveness analysis based on data from the Northern California Kaiser Permanente randomized trial and other published and unpublished sources. Setting and Patients A hypothetical US birth cohort of 3.8 million infants, Interventions Hypothetical comparisons of routine vaccination of healthy infants, requiring 4 doses of pneumococcal conjugate vaccine (at 2, 4, 6, and 12-15 months), and catch-up vaccination of children aged 2 to 4.9 years requiring 1 dose, with children receiving no intervention. Main Outcome Measures Cost per life-year saved and cost per-episode of meningitis, bacteremia, pneumonia, and otitis media prevented. Results Vaccination of healthy infants would prevent more than 12 000 cases of meningitis and bacteremia, 53 000 cases of pneumonia, 1 million episodes of otitis media, and 116 deaths due to pneumococcal infection. Before accounting for vaccine costs, the vaccination program would save $342 million in medical and $415 million in work-loss and other costs from averted pneumococcal disease. Vaccination of healthy infants would result in net savings for society if the vaccine cost less than $46 per dose, and net savings for the health care payer if the vaccine cost less than $18 pet dose. At the manufacturer's list price of $58 per dose, infant vaccination would cost society $80 000 per life-year saved or $160 per otitis media episode prevented (other estimated costs would be $3200 per pneumonia case prevented, $15 000 for bacteremia, and $280 000 for meningitis). The cost-effectiveness of an additional program to administer 1 dose of vaccine to children aged 2 to 4.9 years would vary depending on the children's ages, relative risks of pneumococcal disease, and vaccine cost Conclusions Pneumococcal conjugate vaccination of healthy US infants has the potential to be cost-effective, To achieve cost savings, its cost would need to be lower than the manufacturer's list price. In addition to tangible costs, the vaccine should be appraised based on the less tangible value of preventing mortality and morbidity from pneumococcal disease.	Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, Boston, MA 02215 USA; Harvard Univ, Sch Med, Boston, MA 02215 USA; Kaiser Permanente, Div Res, Vaccine Study Ctr, Oakland, CA USA; Boston Univ, Med Ctr, Boston City Hosp, Dept Pediat, Boston, MA USA; Natl Ctr Infect Dis, Arctic Invest Program, Anchorage, AK USA; Ctr Dis Control & Prevent, Natl Vaccine Program Off, Atlanta, GA USA; Childrens Vaccine Initiat, Geneva, Switzerland	Harvard Pilgrim Health Care; Harvard University; Harvard Medical School; Kaiser Permanente; Boston Medical Center; Boston University; Centers for Disease Control & Prevention - USA	Lieu, TA (corresponding author), Harvard Pilgrim Hlth Care, Dept Ambulatory Care & Prevent, 126 Brookline Ave,Suite 200, Boston, MA 02215 USA.	tracy_lieu@hphc.org						Alsarraf R, 1998, ANN OTO RHINOL LARYN, V107, P120, DOI 10.1177/000348949810700207; *AM MED ASS, 1998, PHYS MED GUID; Black S, 1999, PEDIATR RES, V45, p157A, DOI 10.1203/00006450-199904020-00932; BLACK S, 1998, CONT PEDIAT S    NOV, P12; BLACK S, IN PRESS PEDIAT INFE; BLUESTONE CD, 1995, OTITIS MEDIA INFANTS, P229; BREIMAN RF, 1994, JAMA-J AM MED ASSOC, V271, P1831, DOI 10.1001/jama.271.23.1831; *BUR LAB STAT, 1999, CONS PRIC IND ALL UR; BUTLER JC, 1995, J INFECT DIS, V171, P885, DOI 10.1093/infdis/171.4.885; BYMS PJ, 1997, ARCH PEDIAT ADOLESC, V151, P407; CAPRA AM, IN PRESS PEDIAT INFE; CASPER LM, 1999, WHOS MINDING OUR PRE; *CDCP, 1997, VITAL HLTH STAT, V23, P69; *CDCP, 1999, MMWR-MORBID MORTAL W, V48, P829; Centers for Disease Control and Prevention, 2000, ACT BACT COR SURV AB; COCHI SL, 1988, AM J DIS CHILD, V142, P499, DOI 10.1001/archpedi.1988.02150050037025; Eskola J, 1999, PEDIATR INFECT DIS J, V18, P543, DOI 10.1097/00006454-199906000-00015; Fiore AE, 1999, EMERG INFECT DIS, V5, P828, DOI 10.3201/eid0506.990616; Freed GL, 1996, ARCH PEDIAT ADOL MED, V150, P421, DOI 10.1001/archpedi.1996.02170290087014; Gold MR, 1996, COST EFFECTIVENESS H; GRABOWSKY M, 1991, J INFECT DIS, V164, P1237, DOI 10.1093/infdis/164.6.1237; HADDIX A, 1994, PRACTICAL GUIDE PREV; HALL MJ, 1998, ADV DATA VITAL HLTH, V300, P8; HALLORAN ME, 1991, AM J EPIDEMIOL, V133, P323, DOI 10.1093/oxfordjournals.aje.a115884; HARDY AM, 1991, VITAL HLTH STAT, V10, P10; Joffe S, 1999, PEDIATRICS, V104, P419, DOI 10.1542/peds.104.3.419; Kaplan SL, 1998, PEDIATRICS, V102, P538, DOI 10.1542/peds.102.3.538; KLEIN JO, 1994, CLIN INFECT DIS, V19, P823, DOI 10.1093/clinids/19.5.823; Levine OS, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.3.e28; LIEU TA, 1994, JAMA-J AM MED ASSOC, V271, P375, DOI 10.1001/jama.271.5.375; LIEU TA, 1994, JAMA-J AM MED ASSOC, V217, P375; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; MAKELA PH, 1981, REV INFECT DIS, V3, pS124; MARGOLIS HS, 1995, JAMA-J AM MED ASSOC, V274, P1201, DOI 10.1001/jama.274.15.1201; Mbelle N, 1999, J INFECT DIS, V180, P1171, DOI 10.1086/315009; McIntyre PB, 1997, JAMA-J AM MED ASSOC, V278, P925, DOI 10.1001/jama.278.11.925; Miller MA, 1996, JAMA-J AM MED ASSOC, V276, P967, DOI 10.1001/jama.276.12.967; Mulholland K, 1999, PEDIATR INFECT DIS J, V18, pS17; Nieminen T, 1999, PEDIATR INFECT DIS J, V18, P764, DOI 10.1097/00006454-199909000-00005; Obaro S, 1998, LANCET, V351, P1284, DOI 10.1016/S0140-6736(05)79345-4; Oh PI, 1996, CLIN THER, V18, P160, DOI 10.1016/S0149-2918(96)80188-3; POMEROY SL, 1990, NEW ENGL J MED, V323, P1651, DOI 10.1056/NEJM199012133232402; *PRACT MAN INF COR, 1999, MED FEES US; Salzmann P, 1997, ANN INTERN MED, V127, P955, DOI 10.7326/0003-4819-127-11-199712010-00001; Schuchat A, 1997, NEW ENGL J MED, V337, P970, DOI 10.1056/NEJM199710023371404; Severens JL, 1997, AM J OTOL, V18, P714; Shinefield HR, 1999, PEDIATR INFECT DIS J, V18, P757, DOI 10.1097/00006454-199909000-00004; Sorum PC, 1999, MED DECIS MAKING, V19, P27, DOI 10.1177/0272989X9901900104; TEELE DW, 1989, J INFECT DIS, V160, P83, DOI 10.1093/infdis/160.1.83; Thompson D, 1999, PEDIATR INFECT DIS J, V18, P239, DOI 10.1097/00006454-199903000-00006; Tucker AW, 1998, JAMA-J AM MED ASSOC, V279, P1371, DOI 10.1001/jama.279.17.1371; WAITZMAN NJ, 1996, COST BIRTH DEFECTS; Zangwill KM, 1996, J INFECT DIS, V174, P752, DOI 10.1093/infdis/174.4.752; 1998, FED REG, V63, P40954	54	202	204	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2000	283	11					1460	1468		10.1001/jama.283.11.1460	http://dx.doi.org/10.1001/jama.283.11.1460			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290UR	10732936				2022-12-24	WOS:000085696700031
J	Clyne, PJ; Warr, CG; Carlson, JR				Clyne, PJ; Warr, CG; Carlson, JR			Candidate taste receptors in Drosophila	SCIENCE			English	Article							POX-NEURO; GENE POXN; MELANOGASTER; ORGANS; BEHAVIOR	Little is known about the molecular mechanisms of taste perception in animals, particularly the initial events of taste signaling. A large and diverse family of seven transmembrane domain proteins was identified from the Drosophila genome database with a computer algorithm that identifies proteins on the basis of structure. Eighteen of 19 genes examined were expressed in the Drosophila labellum, a gustatory organ of the proboscis. Expression was not detected in a variety of other tissues. The genes were not expressed in the labellum of a Drosophila mutant, pox-neuro(70), in which taste neurons are eliminated. Tissue specificity of expression of these genes, along with their structural similarity, supports the possibility that the family encodes a Large and divergent family of taste receptors.	Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University	Carlson, JR (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, POB 208103, New Haven, CT 06520 USA.			Warr, Coral/0000-0002-5289-3950	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002174] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC-02174] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Awasaki T, 1997, J NEUROBIOL, V32, P707, DOI 10.1002/(SICI)1097-4695(19970620)32:7<707::AID-NEU6>3.0.CO;2-8; Carlson JR, 1996, TRENDS GENET, V12, P175, DOI 10.1016/0168-9525(96)10015-9; CHAPMAN RF, 1991, J EXP BIOL, V158, P241; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; DAMBLYCHAUDIERE C, 1992, CELL, V69, P159, DOI 10.1016/0092-8674(92)90127-X; DETHIER VG, 1955, Q REV BIOL, V30, P348, DOI 10.1086/401030; Dethier VG, 1976, HUNGRY FLY; FALK R, 1976, J MORPHOL, V150, P327, DOI 10.1002/jmor.1051500206; Glendinning JI, 1997, J NEUROPHYSIOL, V78, P734, DOI 10.1152/jn.1997.78.2.734; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; NAYAK SV, 1983, INT J INSECT MORPHOL, V12, P273, DOI 10.1016/0020-7322(83)90023-5; NOTTEBOHM E, 1992, NATURE, V359, P829, DOI 10.1038/359829a0; NOTTEBOHM E, 1994, NEURON, V12, P25, DOI 10.1016/0896-6273(94)90149-X; PERIN MS, 1991, J BIOL CHEM, V266, P615; PIKIELNY CW, 1994, NEURON, V12, P35, DOI 10.1016/0896-6273(94)90150-3; SHIRAISHI A, 1970, J GEN PHYSIOL, V56, P768, DOI 10.1085/jgp.56.6.768; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; TOMPKINS L, 1979, P NATL ACAD SCI USA, V76, P884, DOI 10.1073/pnas.76.2.884; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431, DOI 10.1177/002215549904700402	20	438	490	10	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1830	1834		10.1126/science.287.5459.1830	http://dx.doi.org/10.1126/science.287.5459.1830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710312				2022-12-24	WOS:000085775300044
J	Blackwood, D				Blackwood, D			P300, a state and a trait marker in schizophrenia	LANCET			English	Editorial Material							SUBCOMPONENT ABNORMALITIES		Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Blackwood, D (corresponding author), Univ Edinburgh, Royal Edinburgh Hosp, Dept Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland.							Adler LE, 1999, BIOL PSYCHIAT, V46, P8, DOI 10.1016/S0006-3223(99)00085-2; Almasy L, 1999, AM J MED GENET, V88, P383; Bauer LO, 1999, BIOL PSYCHIAT, V46, P263, DOI 10.1016/S0006-3223(98)00335-7; Blackwood DHR, 1999, BRIT J PSYCHIAT, V175, P357, DOI 10.1192/bjp.175.4.357; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, pP357; Ford JM, 1999, BIOL PSYCHIAT, V46, P94, DOI 10.1016/S0006-3223(98)00290-X; Frodl-Bauch T, 1999, BIOL PSYCHIAT, V45, P116, DOI 10.1016/S0006-3223(98)00108-5; Higashima M, 1998, BIOL PSYCHIAT, V44, P115, DOI 10.1016/S0006-3223(97)00359-4; O'Donnell BF, 1999, PSYCHOPHYSIOLOGY, V36, P388, DOI 10.1017/S0048577299971688; ROTH WT, 1972, ARCH GEN PSYCHIAT, V27, P466; Salisbury DF, 1998, ARCH GEN PSYCHIAT, V55, P173, DOI 10.1001/archpsyc.55.2.173; Turetsky B, 1998, BIOL PSYCHIAT, V43, P31, DOI 10.1016/S0006-3223(97)00261-8; Turetsky BI, 1998, BIOL PSYCHIAT, V43, P84, DOI 10.1016/S0006-3223(97)00258-8; Umbricht D, 1998, BIOL PSYCHIAT, V44, P716, DOI 10.1016/S0006-3223(97)00524-6; Weir N, 1998, SCHIZOPHR RES, V31, P151, DOI 10.1016/S0920-9964(98)00017-6; Weisbrod M, 1999, BIOL PSYCHIAT, V46, P721, DOI 10.1016/S0006-3223(99)00022-0	16	50	52	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 4	2000	355	9206					771	772		10.1016/S0140-6736(99)00261-5	http://dx.doi.org/10.1016/S0140-6736(99)00261-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711922				2022-12-24	WOS:000085766900006
J	Vielle-Calzada, JP; Baskar, R; Grossniklaus, U				Vielle-Calzada, JP; Baskar, R; Grossniklaus, U			Delayed activation of the paternal genome during seed development	NATURE			English	Article							ARABIDOPSIS-THALIANA; PATTERN-FORMATION; GENE; EMBRYO; EMBRYOGENESIS; PROTEIN; GNOM; TRAP	Little is known about the timing of the maternal-to-zygotic transition during seed development in flowering plants. Because plant embryos can develop from somatic cells or microspores(1), maternal contributions are not considered to be crucial in early embryogensis(2). Early-acting embryo-lethal mutants in Arabidopsis, including emb30/gnom which affects the first zygotic division(3,4) have fuelled the perception that both maternal and paternal genomes are active immediately after fertilization. Here we show that none of the paternally inherited alleles of 20 loci that we tested is expressed during early seed development in Arabidopsis. For genes that are expressed at later stages, the paternally inherited allele becomes active three to four days after fertilization. The genes that we tested are involved in various processes and distributed throughout the genome, indicating that most, if not all, of the paternal genome may be initially silenced. Our findings are corroborated by genetic studies showing that emb30/gnom has a maternal-effect phenotype that is paternally rescuable in addition to its zygotic lethality. Thus, contrary to previous interpretations, early embryo and endosperm development are mainly under maternal control.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Grossniklaus, U (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.		Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Grossniklaus, Ueli/A-2736-2012; Grossniklaus, Ueli/E-9995-2016	Grossniklaus, Ueli/0000-0002-0522-8974; Ramamurthy, Baskar/0000-0001-5705-9976; Vielle-Calzada, Jean-Philippe/0000-0002-3017-2490				BENSAUDE O, 1983, NATURE, V305, P331, DOI 10.1038/305331a0; Berger F, 1999, CURR OPIN PLANT BIOL, V2, P28, DOI 10.1016/S1369-5266(99)80006-5; BOWMAN JL, 1994, ARABIDOPSIS ATLAS MO, P351; Buglia G, 1999, CHROMOSOME RES, V7, P71, DOI 10.1023/A:1009231529635; Busch M, 1996, MOL GEN GENET, V250, P681, DOI 10.1007/BF02172979; Goto T, 1998, MICROBIOL MOL BIOL R, V62, P362, DOI 10.1128/MMBR.62.2.362-378.1998; Grossniklaus U, 1998, SCIENCE, V280, P446, DOI 10.1126/science.280.5362.446; HOWELL SH, 1999, MOL GENETICS PLANT D; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; MAYER U, 1993, DEVELOPMENT, V117, P149; MEINKE DW, 1985, THEOR APPL GENET, V69, P543, DOI 10.1007/BF00251102; Meinke DW, 1994, ARABIDOPSIS THALIANA, P253; Moore JM, 1997, COLD SPRING HARB SYM, V62, P35, DOI 10.1101/SQB.1997.062.01.007; Mordhorst AP, 1997, CRIT REV PLANT SCI, V16, P535, DOI 10.1080/713608156; Newman-Smith ED, 1998, CURR OPIN GENET DEV, V8, P472, DOI 10.1016/S0959-437X(98)80120-2; NUR U, 1990, DEVELOPMENT S, V1, P29; Oakeley EJ, 1997, P NATL ACAD SCI USA, V94, P11721, DOI 10.1073/pnas.94.21.11721; SHEVELL DE, 1994, CELL, V77, P1051, DOI 10.1016/0092-8674(94)90444-8; SPRINGER PS, 1995, SCIENCE, V268, P877, DOI 10.1126/science.7754372; Steinmann T, 1999, SCIENCE, V286, P316, DOI 10.1126/science.286.5438.316; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; Torii KU, 1999, J BIOL CHEM, V274, P27674, DOI 10.1074/jbc.274.39.27674; UEDA K, 1995, DEV BIOL, V169, P210, DOI 10.1006/dbio.1995.1138; VAN WENT J. L., 1984, EMBRYOLOGY ANGIOSPER, P273, DOI [10.1007/978-3-642-69302-1_6, DOI 10.1007/978-3-642-69302-1_6]; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Walbot V, 1996, TRENDS PLANT SCI, V1, P27, DOI 10.1016/S1360-1385(96)80020-3; Xu HL, 1999, PLANT MOL BIOL, V39, P607, DOI 10.1023/A:1006162120037; ZALOKAR M, 1976, DEV BIOL, V49, P425, DOI 10.1016/0012-1606(76)90185-8; ZIMMERMAN JL, 1991, NEW BIOL, V3, P641	29	239	257	2	34	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					91	94		10.1038/35003595	http://dx.doi.org/10.1038/35003595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716449				2022-12-24	WOS:000085775100052
J	Dowell, SF; Kupronis, BA; Zell, ER; Shay, DK				Dowell, SF; Kupronis, BA; Zell, ER; Shay, DK			Mortality from pneumonia in children in the United States, 1939 through 1996	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	37th Annual Meeting of the Infectious-Diseases-Society-of-America	NOV 18-21, 1999	PHILADELPHIA, PA	Infect Dis Soc Amer			US CHILDREN; DISEASE; MANAGEMENT; INFECTIONS; REDUCTION; INFLUENZA; MEDICAID; CARE	Background and Methods: Pneumonia remains an important cause of childhood deaths throughout the world, but in developed countries, the mortality rate is decreasing. We reviewed death records for children in the United States from 1939 through 1996. A plot of the annual rates of change in the number of deaths from pneumonia was used to generate hypotheses about the influence of various events and interventions. We used data from the National Hospital Discharge Survey, the Medicaid program, and published reports to test these hypotheses. Results: During the 58-year study period, the number of children who died from pneumonia declined by 97 percent, from 24,637 in 1939 to 800 in 1996. During the same period, the rate of mortality from other causes declined by 82 percent. There were steep declines in the mortality rates for pneumonia from 1944 to 1950, although the rate increased among older children in 1957, and there were sustained declines in all age groups from 1966 to 1982. From 1966 to 1982, the mortality declined by an average of 13.0 percent annually, and these decreases coincided with increases in the proportion of poor children covered by Medicaid, increases in rates of hospitalization for pneumonia, a narrowing of the gap between the mortality rate for black children and the rate for white children, and a convergence between the mortality rate in the South and the rates in the other three census regions. Conclusions: Since 1939, the rate of mortality from pneumonia in children in the United States has declined markedly. We hypothesize that the steep declines in the late 1940s are attributable to the use of penicillin, that the peak in 1957 was due to the influenza A pandemic, and that the sustained decline from 1966 through 1982 may be attributable in part to improved access to medical care for poor children. (N Engl J Med 2000;342:1399-407.) (C)2000, Massachusetts Medical Society.	Natl Ctr Infect Dis, Resp Dis Branch, Atlanta, GA USA; Natl Ctr Infect Dis, Biostat & Informat Management Branch, Div Bacterial & Mycot Dis, Atlanta, GA USA; Natl Ctr Infect Dis, Div Viral & Rickettsial Dis, Res & Enter Viruses Branch, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Dowell, SF (corresponding author), Ctr Dis Control & Prevent, Mailstop C-23,1600 Clifton Rd NE, Atlanta, GA 30333 USA.	sfd2@cdc.gov		Kupronis, Benjamin/0000-0001-6437-4843; Shay, David/0000-0001-9619-4820				AUSTRIAN R, 1964, ANN INTERN MED, V60, P759, DOI 10.7326/0003-4819-60-5-759; BANG AT, 1994, B WORLD HEALTH ORGAN, V72, P897; BANG AT, 1990, LANCET, V336, P201, DOI 10.1016/0140-6736(90)91733-Q; Berkelhamer J E, 1982, Adv Pediatr, V29, P211; Berman S, 1998, PEDIATRICS, V101, P944; Black S, 1997, PEDIATR ANN, V26, P355, DOI 10.3928/0090-4481-19970601-04; COLLINS SD, 1951, PUBLIC HEALTH REP, V66, P1487, DOI 10.2307/4587915; Cox NJ, 1998, INFECT DIS CLIN N AM, V12, P27, DOI 10.1016/S0891-5520(05)70406-2; Davis K, 1978, HLTH WAR POVERTY 10; DUFIFN J, 1993, CAMBRIDGE WORLD HIST, P938; FAUST MM, 1964, VIT STAT SPEC REP SE, V51; FAUST MM, 1965, VIT STAT SPEC REP SE, V51; FAUVEAU V, 1992, B WORLD HEALTH ORGAN, V70, P109; FINKE W, 1952, AMA AM J DIS CHILD, V83, P755, DOI 10.1001/archpedi.1952.02040100053004; FOTZ AM, 1975, MED CARE, V13, P630; GRAHAM GG, 1985, PEDIATRICS, V75, P117; HETZEL AM, 1997, DHHS PUBL PHS, P1; HUANG NN, 1980, CLIN CHEST MED, V1, P385; Iglehart JK, 1999, NEW ENGL J MED, V340, P403, DOI 10.1056/NEJM199902043400525; Kayhty H, 1996, EMERG INFECT DIS, V2, P289, DOI 10.3201/eid0204.9604; KILGORE PE, 1995, JAMA-J AM MED ASSOC, V274, P1143, DOI 10.1001/jama.274.14.1143; King JC, 1998, J INFECT DIS, V177, P1394, DOI 10.1086/517822; KLEBBA AJ, 1980, MON VITAL STAT REP, V28; Lloyd-Jones DM, 1998, ANN INTERN MED, V129, P1020, DOI 10.7326/0003-4819-129-12-199812150-00005; MALDONADO YA, 1997, PRINCIPLES PRACTICE, P1254; MARKOWITZ LE, 1991, REV INFECT DIS, V13, pS555; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; *NAT CTR HLTH STAT, 1975, VIT HLTH STAT, V2; NELSON JD, 1983, PEDIATR INFECT DIS J, V2, P394, DOI 10.1097/00006454-198309000-00017; Newacheck PW, 1998, JAMA-J AM MED ASSOC, V280, P1789, DOI 10.1001/jama.280.20.1789; OBERG CN, 1990, J SCHOOL HEALTH, V60, P493, DOI 10.1111/j.1746-1561.1990.tb05888.x; PANDEY MR, 1991, LANCET, V338, P993, DOI 10.1016/0140-6736(91)91847-N; ROGHMANN KJ, 1971, NEW ENGL J MED, V285, P1053, DOI 10.1056/NEJM197111042851904; SAZAWAL S, 1992, LANCET, V340, P528, DOI 10.1016/0140-6736(92)91720-S; SERFLING RE, 1967, AM J EPIDEMIOL, V86, P433, DOI 10.1093/oxfordjournals.aje.a120753; Shay DK, 1999, JAMA-J AM MED ASSOC, V282, P1440, DOI 10.1001/jama.282.15.1440; 1993, MMWR MORB MORTAL WKL, V42, P70	37	53	59	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2000	342	19					1399	1407		10.1056/NEJM200005113421904	http://dx.doi.org/10.1056/NEJM200005113421904			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	312JR	10805825				2022-12-24	WOS:000086940600004
J	Martinez-Garcia, JF; Huq, E; Quail, PH				Martinez-Garcia, JF; Huq, E; Quail, PH			Direct targeting of light signals to a promoter element-bound transcription factor	SCIENCE			English	Article							DISRUPTS CIRCADIAN-RHYTHMS; LOOP-HELIX PROTEIN; PHYTOCHROME-A; GENE-EXPRESSION; G-BOX; CONSTITUTIVE EXPRESSION; ARABIDOPSIS-THALIANA; BZIP PROTEIN; TRANSDUCTION; SPECIFICITY	Light signals perceived by the phytochrome family of sensory photoreceptors are transduced to photoresponsive genes by an unknown mechanism. Here, we show that the basic helix-loop-helix transcription factor PIF3 binds specifically to a G-box DNA-sequence motif present in various Light-regulated gene promoters, and that phytochrome B binds reversibly to G-box-bound PIF3 specifically upon light-triggered conversion of the photoreceptor to its biologically active conformer. We suggest that the phytochromes may function as integral Light-switchable components of transcriptional regulator complexes, permitting continuous and immediate sensing of changes in this environmental signal directly at target gene promoters.	Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA; ARS, USDA, Ctr Plant Gene Express, Albany, CA 94710 USA	University of California System; University of California Berkeley; United States Department of Agriculture (USDA)	Quail, PH (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.		Martinez-Garcia, Jaime F/H-6868-2015	Martinez-Garcia, Jaime F/0000-0003-1516-0341; Huq, Enamul/0000-0001-7692-5139				Ahmad M, 1996, PLANT J, V10, P1103, DOI 10.1046/j.1365-313X.1996.10061103.x; Ang LH, 1998, MOL CELL, V1, P213, DOI 10.1016/S1097-2765(00)80022-2; ARGNELLOASTORGA G, 1998, ANNU REV PLANT PHYS, V49, P525; Atchley WR, 1997, P NATL ACAD SCI USA, V94, P5172, DOI 10.1073/pnas.94.10.5172; BLACKWELL TK, 1990, SCIENCE, V250, P1104, DOI 10.1126/science.2174572; Canton FR, 1999, PLANT PHYSIOL, V121, P1207, DOI 10.1104/pp.121.4.1207; Chattopadhyay S, 1998, PLANT CELL, V10, P673, DOI 10.1105/tpc.10.5.673; Choi G, 1999, NATURE, V401, P610, DOI 10.1038/44176; Deng XW, 1999, SEMIN CELL DEV BIOL, V10, P121, DOI 10.1006/scdb.1999.0287; DONALD RGK, 1990, EMBO J, V9, P1717, DOI 10.1002/j.1460-2075.1990.tb08295.x; Fankhauser C, 1999, SCIENCE, V284, P1539, DOI 10.1126/science.284.5419.1539; FISHER F, 1992, EMBO J, V11, P4103, DOI 10.1002/j.1460-2075.1992.tb05503.x; Hoecker U, 1998, PLANT CELL, V10, P19, DOI 10.1105/tpc.10.1.19; Hoecker U, 1999, SCIENCE, V284, P496, DOI 10.1126/science.284.5413.496; Hudson M, 1999, GENE DEV, V13, P2017, DOI 10.1101/gad.13.15.2017; Ishige F, 1999, PLANT J, V18, P443, DOI 10.1046/j.1365-313X.1999.00456.x; Kendrick RE, 1994, PHOTOMORPHOGENESIS P; Kircher S, 1999, PLANT CELL, V11, P1445, DOI 10.1105/tpc.11.8.1445; Littlewood TD., 1998, HELIX LOOP HELIX TRA; MARTINEZGARCIA JF, UNPUB; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Ni M, 1998, CELL, V95, P657, DOI 10.1016/S0092-8674(00)81636-0; Ni M, 1999, NATURE, V400, P781, DOI 10.1038/23500; Niu XP, 1999, PLANT MOL BIOL, V41, P1, DOI 10.1023/A:1006206011502; Oyama T, 1997, GENE DEV, V11, P2983, DOI 10.1101/gad.11.22.2983; Patikoglou G, 1997, ANNU REV BIOPH BIOM, V26, P289, DOI 10.1146/annurev.biophys.26.1.289; Puente P, 1996, EMBO J, V15, P3732, DOI 10.1002/j.1460-2075.1996.tb00743.x; Quail PH, 1997, PLANT CELL ENVIRON, V20, P657, DOI 10.1046/j.1365-3040.1997.d01-108.x; QUAIL PH, 1995, T R SOC LONDON, V353, P1399; Schafer E, 1997, PLANT CELL ENVIRON, V20, P722, DOI 10.1046/j.1365-3040.1997.d01-98.x; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Shimizu T, 1997, EMBO J, V16, P4689, DOI 10.1093/emboj/16.15.4689; Soh MS, 1998, PLANT J, V16, P411, DOI 10.1046/j.1365-313x.1998.00307.x; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.pp.46.060195.002305; Wagner D, 1997, PLANT CELL, V9, P731, DOI 10.1105/tpc.9.5.731; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Whitelam GC, 1997, PLANT CELL ENVIRON, V20, P752, DOI 10.1046/j.1365-3040.1997.d01-100.x; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Whitelam GC, 1998, PHILOS T ROY SOC B, V353, P1445, DOI 10.1098/rstb.1998.0300; WILLIAMS ME, 1992, PLANT CELL, V4, P485, DOI 10.1105/tpc.4.4.485; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437	43	486	537	3	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2000	288	5467					859	863		10.1126/science.288.5467.859	http://dx.doi.org/10.1126/science.288.5467.859			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797009				2022-12-24	WOS:000086869600039
J	Boyd, J; Sonoda, Y; Federici, MG; Bogomolniy, F; Rhei, E; Maresco, DL; Saigo, PE; Almadrones, LA; Barakat, RR; Brown, CL; Chi, DS; Curtin, JP; Poynor, EA; Hoskins, WJ				Boyd, J; Sonoda, Y; Federici, MG; Bogomolniy, F; Rhei, E; Maresco, DL; Saigo, PE; Almadrones, LA; Barakat, RR; Brown, CL; Chi, DS; Curtin, JP; Poynor, EA; Hoskins, WJ			Clinicopathologic features of BRCA-linked and sporadic ovarian cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASHKENAZI-JEWISH INDIVIDUALS; GERM-LINE MUTATIONS; TRANSCRIPTIONAL ACTIVATION; GENETIC-HETEROGENEITY; CARRIER FREQUENCY; SEQUENCE-ANALYSIS; FAMILY HISTORY; DNA-DAMAGE; BREAST; HEREDITARY	Context Most hereditary ovarian cancers are associated with germline mutations in BRCA1 or BRCA2. Attempts to define the clinical significance of BRCA mutation status in ovarian cancer have produced conflicting results, especially regarding survival. Objective To determine whether hereditary ovarian cancers have distinct clinical and pathological features compared with sporadic (nonhereditary) ovarian cancers. Design and Setting Retrospective cohort study of a consecutive series of 933 ovarian cancers diagnosed and treated at our institution, which is a comprehensive cancer center as designated by the National Cancer Institute, over a 12-year period (December 1986 to August 1998). Patients The study was restricted to patients of Jewish origin because of the ease of BRCA1 and BRCA2 genotyping in this ethnic group. From the 189 patients who identified themselves as Jewish, 88 hereditary cases were identified with the presence of a germline founder mutation in BRCA1 or BRCA2, The remaining 101 cases from the same series not associated with a BRCA mutation and 2 additional groups (Gynecologic Oncology Group protocols 52 and 111) with ovarian cancer from clinical trials (for the survival analysis) were included for comparison. Main Outcome Measures Age at diagnosis, surgical stage, histologic cell type and grade, and surgical outcome; and response to chemotherapy and survival for advanced-stage (III and IV) cases. Results Hereditary cancers were rarely diagnosed before age 40 years and were common after age 60 years, with mean age at diagnosis being significantly younger for BRCA1- vs BRCA2-linked patients (54 vs 62 years; P=.04). Histology, grade, stage, and success of cytoreductive surgery were similar for hereditary and sporadic cases. The hereditary group had a longer disease-free interval following primary chemotherapy in comparison with the nonhereditary group, with a median time to recurrence of 14 months and 7 months, respectively (P<.001). Those with hereditary cancers had improved survival compared with the nonhereditary group (P=.004). For stage III cancers, BRCA mutation status was an independent prognostic variable (P=.03). Conclusions Although BRCA-associated hereditary ovarian cancers in this population have surgical and pathological characteristics similar to those of sporadic cancers, advanced-stage hereditary cancer patients survive longer than nonhereditary cancer patients, Age penetrance is greater for BRCA1-linked than for BRCA2-linked cancers in this population.	Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Human Genet, New York, NY 10021 USA; Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Boyd, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Box 201,1275 York Ave, New York, NY 10021 USA.	boydj@mskcc.org		Curtin, John/0000-0002-9370-5119; Boyd, Jeff/0000-0002-3517-7637	NCI NIH HHS [R01-CA71840] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071840] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aida H, 1998, CLIN CANCER RES, V4, P235; Beller U, 1997, GYNECOL ONCOL, V67, P123, DOI 10.1006/gyno.1997.4844; BEWTRA C, 1992, INT J GYNECOL PATHOL, V11, P180, DOI 10.1097/00004347-199207000-00003; Boyd J, 1998, ONCOLOGY-NY, V12, P399; Brugarolas J, 1997, NAT MED, V3, P721, DOI 10.1038/nm0797-721; Chapman MS, 1996, NATURE, V382, P678, DOI 10.1038/382678a0; EASTON DF, 1995, AM J HUM GENET, V56, P265; EASTON DF, 1993, AM J HUM GENET, V52, P678; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Frank TS, 1998, J CLIN ONCOL, V16, P2417, DOI 10.1200/JCO.1998.16.7.2417; FRIEDLANDER ML, 1991, SEMIN ONCOL, V18, P205; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Johannsson OT, 1998, J CLIN ONCOL, V16, P397, DOI 10.1200/JCO.1998.16.2.397; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LevyLahad E, 1997, AM J HUM GENET, V60, P1059; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Milner J, 1997, NATURE, V386, P772, DOI 10.1038/386772a0; Monteiro ANA, 1996, P NATL ACAD SCI USA, V93, P13595, DOI 10.1073/pnas.93.24.13595; NAROD S, 1994, LANCET, V343, P236, DOI 10.1016/S0140-6736(94)91021-9; NAROD SA, 1994, CANCER-AM CANCER SOC, V74, P2341, DOI 10.1002/1097-0142(19941015)74:8<2341::AID-CNCR2820740819>3.0.CO;2-Z; NAROD SA, 1995, AM J HUM GENET, V56, P254; Oddoux C, 1996, NAT GENET, V14, P188, DOI 10.1038/ng1096-188; OMURA GA, 1989, J CLIN ONCOL, V7, P457, DOI 10.1200/JCO.1989.7.4.457; Ozols Robert F., 1997, P919; Pharoah PDP, 1999, CANCER RES, V59, P868; PIVER MS, 1993, CANCER-AM CANCER SOC, V71, P582; Randall TC, 1998, GYNECOL ONCOL, V70, P432, DOI 10.1006/gyno.1998.5081; Rhei E, 1998, CANCER RES, V58, P3193; Roa BB, 1996, NAT GENET, V14, P185, DOI 10.1038/ng1096-185; Robson M, 1999, JNCI-J NATL CANCER I, V91, P2112, DOI 10.1093/jnci/91.24.2112; Robson ME, 1997, LANCET, V350, P117, DOI 10.1016/S0140-6736(05)61821-1; Rubin SC, 1996, NEW ENGL J MED, V335, P1413, DOI 10.1056/NEJM199611073351901; Scully R, 1997, P NATL ACAD SCI USA, V94, P5605, DOI 10.1073/pnas.94.11.5605; ShattuckEidens D, 1997, JAMA-J AM MED ASSOC, V278, P1242, DOI 10.1001/jama.278.15.1242; STRAUSS W, 1998, CURRENT PROTOCOLS MO, V1; STRUEWING JP, 1995, NAT GENET, V11, P198, DOI 10.1038/ng1095-198; Tapper J, 1998, CANCER RES, V58, P2715; van der Heijden O, 1998, MOL CARCINOGEN, V23, P243, DOI 10.1002/(SICI)1098-2744(199812)23:4<243::AID-MC7>3.0.CO;2-E; Zhang HB, 1998, CELL, V92, P433, DOI 10.1016/S0092-8674(00)80936-8; Zweemer RP, 1998, AM J OBSTET GYNECOL, V178, P85, DOI 10.1016/S0002-9378(98)70632-5	41	410	425	1	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2000	283	17					2260	2265		10.1001/jama.283.17.2260	http://dx.doi.org/10.1001/jama.283.17.2260			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307UB	10807385	Bronze			2022-12-24	WOS:000086671600033
J	Brancati, FL; Kao, WHL; Folsom, AR; Watson, RL; Szklo, M				Brancati, FL; Kao, WHL; Folsom, AR; Watson, RL; Szklo, M			Incident type 2 diabetes mellitus in African American and white adults - The atherosclerosis risk in communities study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMPAIRED GLUCOSE-TOLERANCE; ENZYMATIC DETERMINATION; SOCIOECONOMIC-STATUS; ALCOHOL-USE; PREVALENCE; BLACKS; CHOLESTEROL; REAGENT; HEALTH; RACE	Context Although the excess prevalence of type 2 diabetes mellitus in African Americans is well established, few studies have compared incident diabetes in African American and white persons. Objectives To compare risk of incident diabetes in African American vs white adults and to identify explanatory factors for racial disparities. Design Prospective cohort study using baseline data collected from 1986 to 1989 from the ongoing Atherosclerosis Risk in Communities (ARIC) Study, with 9 years of follow-up. Setting and Participants A total of 2646 African American and 9461 white adults aged 45 to 64 years without diabetes at baseline, sampled from 4 US communities. Main Outcome Measures Incident type 2 diabetes, ascertained by self-report of physician diagnosis, use of diabetes medications, or fasting glucose level of at least 7.0 mmol/L (126 mg/dL), compared among white and African American subjects and by presence of potentially modifiable risk factors. Results Diabetes incidence per 1000 person-years was about 2.4-fold greater in African American women (25.1 [95% confidence interval {CI}, 22.4-28.1] vs 10.4 [95% CI, 9.4-11.4]) and about 1.5-fold greater in men (23.4 [95% CI, 19.9-27.2] vs 15.9 [95% CI, 14.6-17.2]) than in their white counterparts (P<.001). Results from proportional hazards regression models indicated that racial differences in potentially modifiable risk factors, particularly adiposity, accounted for 47.8% of the excess risk in African American women but accounted for little excess risk in African American men. Compared with their white counterparts, African American men and women had higher blood pressures before diabetes onset (diastolic blood pressure difference=5.6 mm Hg in women and 8.4 mm Hg in men; P=.005). Conclusions Our data indicate that compared with their white counterparts, middle-aged African Americans are at greater risk of developing type 2 diabetes and have higher blood pressure prior to development of diabetes. In women, almost 50% of this excess risk might be related to potentially modifiable factors.	Johns Hopkins Univ, Dept Med, Baltimore, MD USA; Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; Univ Minnesota, Div Epidemiol, Minneapolis, MN 55455 USA; Univ Mississippi, Med Ctr, Dept Prevent Med, Jackson, MS 39216 USA; Univ Mississippi, Med Ctr, Dept Med, Jackson, MS 39216 USA	Johns Hopkins University; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	Brancati, FL (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	fbrancat@jhmi.edu		Szklo, Moyses/0000-0001-9433-6266	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC055016, N01HC055015] Funding Source: NIH RePORTER; NHLBI NIH HHS [N01 HC55016, N01 HC55018, N01 HC55015] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1995, DIABETES AM; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BONHAM GS, 1985, AM J CLIN NUTR, V41, P776, DOI 10.1093/ajcn/41.4.776; Brancati FL, 1996, ANN EPIDEMIOL, V6, P67, DOI 10.1016/1047-2797(95)00095-X; BRESLOW NE, 1990, IARC PUBLICATION, V32, P76; Burke JP, 1999, ARCH INTERN MED, V159, P1450, DOI 10.1001/archinte.159.13.1450; COWIE CC, 1993, AM J EPIDEMIOL, V137, P719, DOI 10.1093/oxfordjournals.aje.a116732; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gavin JR, 1999, DIABETES CARE, V22, pS5; Gress TW, 2000, NEW ENGL J MED, V342, P905, DOI 10.1056/NEJM200003303421301; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; HOLBROOK TL, 1990, AM J EPIDEMIOL, V132, P902, DOI 10.1093/oxfordjournals.aje.a115733; Kaufman JS, 1997, EPIDEMIOLOGY, V8, P621, DOI 10.1097/00001648-199710000-00002; Kenny S. J., 1995, DIABETES AM, P47; Lei HH, 1999, DIABETES, V48, P1868, DOI 10.2337/diabetes.48.9.1868; LIPTON RB, 1993, AM J EPIDEMIOL, V138, P826, DOI 10.1093/oxfordjournals.aje.a116786; MCPHILLIPS JB, 1990, AM J EPIDEMIOL, V131, P443, DOI 10.1093/oxfordjournals.aje.a115519; MELTON LJ, 1983, DIABETES CARE, V6, P75, DOI 10.2337/diacare.6.1.75; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; OBRIEN TR, 1989, JAMA-J AM MED ASSOC, V262, P1485, DOI 10.1001/jama.262.11.1485; Pavlik Valory N., 1996, Ethnicity and Disease, V6, P213; Ray NF, 1998, DIABETES CARE, V21, P296; Resnick HE, 1998, DIABETES CARE, V21, P1828, DOI 10.2337/diacare.21.11.1828; RIMM EB, 1995, BRIT MED J, V310, P555, DOI 10.1136/bmj.310.6979.555; Schmidt MI, 1996, DIABETES CARE, V19, P414, DOI 10.2337/diacare.19.5.414; SHATEN BJ, 1993, DIABETES CARE, V16, P1331, DOI 10.2337/diacare.16.10.1331; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stern MP, 1996, ANN INTERN MED, V124, P110, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00006; TULL ES, 1995, DIABETES AM, P613; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *UK PROSP DIAB STU, 1999, BMJ-BRIT MED J, V318, P291; WARNICK GR, 1982, CLIN CHEM, V28, P1574; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	36	385	386	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2000	283	17					2253	2259		10.1001/jama.283.17.2253	http://dx.doi.org/10.1001/jama.283.17.2253			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307UB	10807384	Bronze			2022-12-24	WOS:000086671600032
J	Bauchner, H; Wise, PH				Bauchner, H; Wise, PH			Antibiotics without prescription: "bacterial or medical resistance"?	LANCET			English	Editorial Material									Boston Univ, Boston Med Ctr, Sch Med, Dept Pediat, Boston, MA 02118 USA; Boston Univ, Boston Med Ctr, Sch Med, Dept Publ Hlth, Boston, MA 02118 USA	Boston Medical Center; Boston University; Boston Medical Center; Boston University	Bauchner, H (corresponding author), Boston Univ, Boston Med Ctr, Sch Med, Dept Pediat, Boston, MA 02118 USA.			Bauchner, Howard/0000-0002-8368-9805				BAUCHNER H, 2000, PED AC SOC M MAY BOS, pA173; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Holman H, 2000, BRIT MED J, V320, P526, DOI 10.1136/bmj.320.7234.526; Lee AJ, 1997, MED CARE, V35, P1173, DOI 10.1097/00005650-199712000-00002; Reeves DS, 1999, J ANTIMICROB CHEMOTH, V44, P163, DOI 10.1093/jac/44.2.163; Watson RL, 1999, PEDIATRICS, V104, P1251, DOI 10.1542/peds.104.6.1251; Wood MJ, 1999, J ANTIMICROB CHEMOTH, V44, P149, DOI 10.1093/jac/44.2.149	7	23	23	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 29	2000	355	9214					1480	1480		10.1016/S0140-6736(00)02160-7	http://dx.doi.org/10.1016/S0140-6736(00)02160-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LR	10801167				2022-12-24	WOS:000086830100007
J	Dawson, VL				Dawson, VL			Neurobiology - Of flies and mice	SCIENCE			English	Editorial Material							PARKINSONS-DISEASE		Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21287 USA	Johns Hopkins University	Dawson, VL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 600 N Wolfe St Carnegie 214, Baltimore, MD 21287 USA.		Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970				Dawson TM, 2000, CELL, V101, P115, DOI 10.1016/S0092-8674(00)80629-7; Dunnett SB, 1999, NATURE, V399, pA32, DOI 10.1038/399a032; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Mizuno Y, 1999, BIOMED PHARMACOTHER, V53, P109, DOI 10.1016/S0753-3322(99)80075-4; Orr HT, 2000, CELL, V101, P1, DOI 10.1016/S0092-8674(00)80617-0; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432	9	13	14	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2000	288	5466					631	632		10.1126/science.288.5466.631	http://dx.doi.org/10.1126/science.288.5466.631			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308RR	10799001				2022-12-24	WOS:000086727100033
J	Lugg, DJ				Lugg, DJ			Antarctic medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CELL-MEDIATED-IMMUNITY; BLOOD-PRESSURE; EXPEDITION		Australian Antarctic Div, Kingston, Tas 7050, Australia	Australian Antarctic Division	Lugg, DJ (corresponding author), Australian Antarctic Div, Channel Highway, Kingston, Tas 7050, Australia.	des.lugg@antdiv.gov.au						Cattermole TJ, 1999, INJURY, V30, P491, DOI 10.1016/S0020-1383(99)00139-4; Cattermole TJ, 1999, AVIAT SPACE ENVIR MD, V70, P135; COOK FA, 1990, 1 ANTARCTIC NIGHT 18; Cugini P, 1997, AVIAT SPACE ENVIR MD, V68, P795; DEAKIN C, 1992, ANARE RES NOTES, V84, P1; EDHOLM OG, 1973, POLAR HUMAN BIOL; Farrace S, 1999, PHYSIOL BEHAV, V66, P613, DOI 10.1016/S0031-9384(98)00341-2; Gunderson E., 1974, ANTARCT RES SER, V22, P1; Ikegawa M, 1998, AVIAT SPACE ENVIR MD, V69, P452; JENNINGS GL, 1991, ANN MED, V23, P313, DOI 10.3109/07853899109148066; LEVINSON JM, 1998, SAFE PASSAGE QUESTIO; Lloyd RM, 1973, POLAR HUMAN BIOL, P71; LUGG DJ, 1998, PROBLEMS COLD WORK, P224; Lugg DJ., 1973, POLAR HUMAN BIOL, P93; LUGG DJ, 1997, P ANARE JUB SCI S JU; Lugg DJ, 1993, ANTARCTIC DIVISION, P12; MULLER HK, 1995, IMMUNOL CELL BIOL, V73, P316, DOI 10.1038/icb.1995.48; Palinkas LA, 1996, J NERV MENT DIS, V184, P530, DOI 10.1097/00005053-199609000-00003; PARDOE R, 1965, Med J Aust, V1, P344; Pitson GA, 1996, EUR J APPL PHYSIOL O, V72, P231, DOI 10.1007/BF00838644; PODKOLINSKI MT, 1979, MED J AUSTRALIA, V2, P275, DOI 10.5694/j.1326-5377.1979.tb125705.x; Reed H L, 1995, Arctic Med Res, V54 Suppl 2, P9; REED HL, 1990, J CLIN ENDOCR METAB, V70, P965, DOI 10.1210/jcem-70-4-965; ROBERTSTHOMSON PJ, 1985, J CLIN LAB IMMUNOL, V17, P115; SAVOUREY G, 1993, CR ACAD SCI III-VIE, V316, P607; Savourey G, 1996, EUR J APPL PHYSIOL O, V73, P237, DOI 10.1007/BF02425482; Sawhney RC, 1998, INT J BIOMETEOROL, V42, P51, DOI 10.1007/s004840050083; *SCAR, 1999, SCAR B, V135, P1; Sullivan P, 1991, Arctic Med Res, VSuppl, P502; SULLIVAN P, 1995, 25 INT C ENV SYST SA; Taylor A J, 1998, Int J Circumpolar Health, V57, P56; Tingate TR, 1997, IMMUNOL CELL BIOL, V75, P275, DOI 10.1038/icb.1997.42; WILLIAMS DL, 1986, J CLIN LAB IMMUNOL, V20, P43; Wood J, 1999, ENVIRON BEHAV, V31, P299, DOI 10.1177/00139169921972128; Yonei T, 1999, BONE, V24, P145, DOI 10.1016/S8756-3282(98)00162-8; Zerath E, 1999, EUR J APPL PHYSIOL, V79, P141, DOI 10.1007/s004210050487; [No title captured]	38	18	18	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2000	283	16					2082	2084		10.1001/jama.283.16.2082	http://dx.doi.org/10.1001/jama.283.16.2082			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	305MA	10791487				2022-12-24	WOS:000086542800002
J	Lowrey, PL; Shimomura, K; Antoch, MP; Yamazaki, S; Zemenides, PD; Ralph, MR; Menaker, M; Takahashi, JS				Lowrey, PL; Shimomura, K; Antoch, MP; Yamazaki, S; Zemenides, PD; Ralph, MR; Menaker, M; Takahashi, JS			Positional syntenic cloning and functional characterization of the mammalian circadian mutation tau	SCIENCE			English	Article							CASEIN KINASE-I; REPRESENTATIONAL DIFFERENCE ANALYSIS; DROSOPHILA PERIOD GENE; DIRECTED PROTEIN-KINASE; CLOCK GENE; SUPRACHIASMATIC NUCLEUS; SUBSTRATE DETERMINANTS; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; DOUBLE-TIME	The tau mutation is a semidominant autosomal allele that dramatically shortens period Length of circadian rhythms in Syrian hamsters. We report the molecular identification of the tau Locus using genetically directed representational difference analysis to define a region of conserved synteny in hamsters with both the mouse and human genomes. The tau Locus is encoded by casein kinase I epsilon (CKl epsilon), a homolog of the Drosophila circadian gene double-time. in vitro expression and functional studies of wild-type and tau mutant CKl epsilon enzyme reveal that the mutant enzyme has a markedly reduced maximal velocity and autophosphorylation state. In addition, in vitro CKl epsilon can interact with mammalian PERIOD proteins, and the mutant enzyme is deficient in its ability to phosphorylate PERIOD. We conclude that tau is an allele of hamster CKl epsilon and propose a mechanism by which the mutation Leads to the observed aberrant circadian phenotype in mutant animals.	Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; Univ Virginia, Dept Biol, Natl Sci Fdn, Ctr Biol Timing, Charlottesville, VA 22903 USA; Univ Toronto, Dept Psychol, Toronto, ON M5S 3G3, Canada	Northwestern University; Howard Hughes Medical Institute; Northwestern University; National Science Foundation (NSF); NSF - Center for Biological Timing; University of Virginia; University of Toronto	Takahashi, JS (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Yamazaki, Shin/0000-0002-6691-1531; Antoch, mantoch/0000-0003-3001-8511	NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH039592, R01MH056647] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [R01MH56647, R37MH39592] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		ADLER S, 1948, NATURE, V162, P256, DOI 10.1038/162256b0; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Allada R, 1998, CELL, V93, P791, DOI 10.1016/S0092-8674(00)81440-3; Anderson SL, 1997, ADV GENET, V35, P1, DOI 10.1016/S0065-2660(08)60446-0; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Aschoff J., 1981, HDB BEHAV NEUROBIOLO, V4; Ausubel F.M., 1993, CURRENT PROTOCOLS MO; Bae K, 2000, J NEUROSCI, V20, P1746; Cegielska A, 1998, J BIOL CHEM, V273, P1357, DOI 10.1074/jbc.273.3.1357; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; DIETRICH W, 1992, GENETICS, V131, P423; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; EDERY I, 1994, P NATL ACAD SCI USA, V91, P2260, DOI 10.1073/pnas.91.6.2260; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; FISH KJ, 1995, J BIOL CHEM, V270, P14875, DOI 10.1074/jbc.270.25.14875; FLOTOW H, 1991, J BIOL CHEM, V266, P3724; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; GRAVES PR, 1995, J BIOL CHEM, V270, P21689, DOI 10.1074/jbc.270.37.21689; Grietzen KF, 1999, J BIOL CHEM, V274, P32063, DOI 10.1074/jbc.274.45.32063; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Gross SD, 1998, CELL SIGNAL, V10, P699, DOI 10.1016/S0898-6568(98)00042-4; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hao HP, 1997, MOL CELL BIOL, V17, P3687, DOI 10.1128/MCB.17.7.3687; HARDIN PE, 1990, NATURE, V343, P536, DOI 10.1038/343536a0; Hastings M H, 1999, J Neurosci, V19, pRC11; Ikeda M, 1997, BIOCHEM BIOPH RES CO, V233, P258, DOI 10.1006/bbrc.1997.6371; Johnson CH, 1999, ANNU REV MICROBIOL, V53, P389, DOI 10.1146/annurev.micro.53.1.389; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; King DP, 2000, ANNU REV NEUROSCI, V23, P713, DOI 10.1146/annurev.neuro.23.1.713; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Koike N, 1998, FEBS LETT, V441, P427, DOI 10.1016/S0014-5793(98)01597-X; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LANDER ES, 1993, NAT GENET, V4, P5, DOI 10.1038/ng0593-5; Lee C, 1999, MOL CELL BIOL, V19, P5316; LISITSYN N, 1995, METHOD ENZYMOL, V254, P291; LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152; LISITSYN NA, 1994, NAT GENET, V6, P57, DOI 10.1038/ng0194-57; LISITSYN NA, 1995, TRENDS GENET, V11, P303, DOI 10.1016/S0168-9525(00)89087-3; Longenecker KL, 1998, ACTA CRYSTALLOGR D, V54, P473, DOI 10.1107/S0907444997011724; Longenecker KL, 1996, J MOL BIOL, V257, P618, DOI 10.1006/jmbi.1996.0189; Manly KF, 1999, MAMM GENOME, V10, P327, DOI 10.1007/s003359900997; MEGGIO F, 1991, FEBS LETT, V283, P303, DOI 10.1016/0014-5793(91)80614-9; MORGAN DO, 1994, CURR OPIN CELL BIOL, V6, P239, DOI 10.1016/0955-0674(94)90142-2; Murphy M.R., 1985, P3; Myers MP, 1996, SCIENCE, V271, P1736, DOI 10.1126/science.271.5256.1736; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Okuizumi H, 1997, MAMM GENOME, V8, P121, DOI 10.1007/s003359900370; Ott J., 1991, ANAL HUMAN GENETIC L; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; ROWE LB, 1994, MAMM GENOME, V5, P253, DOI 10.1007/BF00389540; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Saez L, 1996, NEURON, V17, P911, DOI 10.1016/S0896-6273(00)80222-6; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; SEHGAL A, 1995, SCIENCE, V270, P808, DOI 10.1126/science.270.5237.808; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shigeyoshi Y, 1997, CELL, V91, P1043, DOI 10.1016/S0092-8674(00)80494-8; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; So WV, 1997, EMBO J, V16, P7146, DOI 10.1093/emboj/16.23.7146; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Takumi T, 1999, GENES CELLS, V4, P67, DOI 10.1046/j.1365-2443.1999.00238.x; Takumi T, 1998, EMBO J, V17, P4753, DOI 10.1093/emboj/17.16.4753; Takumi T, 1998, GENES CELLS, V3, P167, DOI 10.1046/j.1365-2443.1998.00178.x; TAYLOR SS, 1994, STRUCTURE, V2, P345, DOI 10.1016/S0969-2126(00)00036-8; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Tischkau S A, 1999, J Neurosci, V19, pRC15; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wilsbacher LD, 1998, CURR OPIN GENET DEV, V8, P595, DOI 10.1016/S0959-437X(98)80017-8; XU RM, 1995, EMBO J, V14, P1015, DOI 10.1002/j.1460-2075.1995.tb07082.x; Young MW, 1998, ANNU REV BIOCHEM, V67, P135, DOI 10.1146/annurev.biochem.67.1.135; Zylka MJ, 1998, NEURON, V21, P1115, DOI 10.1016/S0896-6273(00)80628-5; Zylka MJ, 1998, NEURON, V20, P1103, DOI 10.1016/S0896-6273(00)80492-4	80	645	667	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2000	288	5465					483	491		10.1126/science.288.5465.483	http://dx.doi.org/10.1126/science.288.5465.483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775102	Green Accepted			2022-12-24	WOS:000086626000037
J	Zennou, V; Petit, C; Guetard, D; Nerhbass, U; Montagnier, L; Charneau, P				Zennou, V; Petit, C; Guetard, D; Nerhbass, U; Montagnier, L; Charneau, P			HIV-1 genome nuclear import is mediated by a central DNA flap	CELL			English	Article							TYPE-1 PREINTEGRATION COMPLEXES; VIRAL MATRIX PROTEIN; NONDIVIDING CELLS; MACROPHAGE INFECTION; LOCALIZATION SIGNAL; POLYPURINE TRACT; VIRUS-DNA; REPLICATION; PHOSPHORYLATION; INTEGRATION	HIV-1 and other lentiviruses have the unique property among retroviruses to replicate in nondividing cells. This property relies on the use of a nuclear import pathway enabling the viral DNA to cross the nuclear membrane of the host cell. In HIV-1 reverse transcription, a central strand displacement event consecutive to central initiation and termination of plus strand synthesis creates a plus strand overlap: the central DNA flap. We show here that the central DNA flap acts as a cia-determinant of HIV-1 DNA nuclear import. Wildtype viral linear DNA is almost entirely imported into the nucleus where it integrates or circularizes. In contrast, mutant viral DNA, which lacks the DNA flap, accumulates in infected cells as unintegrated linear DNA, at the vicinity of the nuclear membrane. Consistently, HIV-1 vectors devoid of DNA flap exhibit a strong defect of nuclear import, which can be corrected to wild-type levels by reinsertion of the DNA flap sequence.	Inst Pasteur, Unite Oncol Virale, F-75724 Paris 15, France; Inst Pasteur, Unite Biol Cellulaire Noyau, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Charneau, P (corresponding author), Inst Pasteur, Unite Oncol Virale, 25-28 Rue Dr Roux, F-75724 Paris 15, France.		CHARNEAU, Pierre/M-1565-2017	CHARNEAU, Pierre/0000-0003-1184-5773				BARBOSA P, 1994, AIDS RES HUM RETROV, V10, P53, DOI 10.1089/aid.1994.10.53; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; BUKRINSKY MI, 1992, P NATL ACAD SCI USA, V89, P6580, DOI 10.1073/pnas.89.14.6580; CHARNEAU P, 1991, J VIROL, V65, P2415, DOI 10.1128/JVI.65.5.2415-2421.1991; CHARNEAU P, 1992, J VIROL, V66, P2814, DOI 10.1128/JVI.66.5.2814-2820.1992; CHARNEAU P, 1994, J MOL BIOL, V241, P651, DOI 10.1006/jmbi.1994.1542; EMERMAN M, 1994, NATURE, V369, P108, DOI 10.1038/369108a0; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Fouchier RAM, 1997, EMBO J, V16, P4531, DOI 10.1093/emboj/16.15.4531; Freed EO, 1997, CELL, V88, P171, DOI 10.1016/S0092-8674(00)81836-X; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; FREED EO, 1994, NATURE, V369, P107, DOI 10.1038/369107b0; GALLAY P, 1995, CELL, V80, P379, DOI 10.1016/0092-8674(95)90488-3; Gallop MA, 1997, CURR OPIN CHEM BIOL, V1, P94, DOI 10.1016/S1367-5931(97)80114-7; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Hagstrom JE, 1997, J CELL SCI, V110, P2323; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; HARRIS JD, 1981, VIROLOGY, V113, P573, DOI 10.1016/0042-6822(81)90185-9; HEINZINGER NK, 1994, P NATL ACAD SCI USA, V91, P7311, DOI 10.1073/pnas.91.15.7311; HUNGNES O, 1992, VIROLOGY, V190, P440, DOI 10.1016/0042-6822(92)91230-R; KARAGEORGOS L, 1993, AIDS RES HUM RETROV, V9, P817, DOI 10.1089/aid.1993.9.817; KLARMANN GJ, 1993, J BIOL CHEM, V268, P9793; Miller MD, 1997, J VIROL, V71, P5382, DOI 10.1128/JVI.71.7.5382-5390.1997; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; POZNANSKY M, 1991, J VIROL, V65, P532, DOI 10.1128/JVI.65.1.532-536.1991; ROE TY, 1993, EMBO J, V12, P2099, DOI 10.1002/j.1460-2075.1993.tb05858.x; Stetor SR, 1999, BIOCHEMISTRY-US, V38, P3656, DOI 10.1021/bi982764l; THORMAR H, 1963, VIROLOGY, V19, P273, DOI 10.1016/0042-6822(63)90064-3; VONSCHWEDLER U, 1994, P NATL ACAD SCI USA, V91, P6992, DOI 10.1073/pnas.91.15.6992; WEINBERG JB, 1991, J EXP MED, V174, P1477, DOI 10.1084/jem.174.6.1477; Whittaker GR, 1998, VIROLOGY, V246, P1, DOI 10.1006/viro.1998.9165; YEE JK, 1994, P NATL ACAD SCI USA, V91, P9564, DOI 10.1073/pnas.91.20.9564	32	667	762	0	26	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 14	2000	101	2					173	185		10.1016/S0092-8674(00)80828-4	http://dx.doi.org/10.1016/S0092-8674(00)80828-4			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	305DP	10786833	Bronze			2022-12-24	WOS:000086524400004
J	Gress, TW; Nieto, FJ; Shahar, E; Wofford, MR; Brancati, FL				Gress, TW; Nieto, FJ; Shahar, E; Wofford, MR; Brancati, FL		Atherosclerosis Risk Communities S	Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IMPAIRED GLUCOSE-TOLERANCE; HIGH-BLOOD-PRESSURE; FOLLOW-UP; MILD HYPERTENSION; PREVENTION TRIAL; LONG-TERM; MEN; DIURETICS; HEALTH; AGENTS	Background: Previous research has suggested that thiazide diuretics and beta-blockers may promote the development of type 2 diabetes mellitus. However, the results of these studies have been inconsistent, and many studies have been limited by inadequate data on outcomes and by potential confounding. Methods: We conducted a prospective study of 12,550 adults 45 to 64 years old who did not have diabetes. An extensive health evaluation conducted at base line included assessment of medication use and measurement of blood pressure with a random-zero sphygmomanometer. The incidence of new cases of diabetes was assessed after three years and after six years by measurement of serum glucose concentrations while the subjects were fasting. Results: After simultaneous adjustment for age, sex, race, education, adiposity, family history with respect to diabetes, physical-activity level, other health-related behavior, and coexisting illnesses, subjects with hypertension who were taking thiazide diuretics were not at greater risk for the subsequent development of diabetes than were subjects with hypertension who were not receiving any antihypertensive therapy (relative hazard, 0.91; 95 percent confidence interval, 0.73 to 1.13). Likewise, subjects who were taking angiotensin-converting-enzyme inhibitors and calcium-channel antagonists were not at greater risk than those not taking any medication. In contrast, subjects with hypertension who were taking beta-blockers had a 28 percent higher risk of subsequent diabetes (relative hazard, 1.28; 95 percent confidence interval, 1.04 to 1.57). Conclusions: Concern about the risk of diabetes should not discourage physicians from prescribing thiazide diuretics to nondiabetic adults who have hypertension. The use of beta-blockers appears to increase the risk of diabetes, but this adverse effect must be weighed against the proven benefits of beta-blockers in reducing the risk of cardiovascular events. (N Engl J Med 2000;342:905-12.) (C) 2000, Massachusetts Medical Society.	Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD USA; Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; Univ Mississippi, Med Ctr, Div Hypertens, Jackson, MS USA	Johns Hopkins University; Johns Hopkins University; University of Minnesota System; University of Minnesota Twin Cities; University of Mississippi; University of Mississippi Medical Center	Brancati, FL (corresponding author), Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA.	fbrancat@welch.jhu.edu			NHLBI NIH HHS [N01-HC-55018, N01-HC-55015, N01-HC-55016] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055018, N01HC055016, N01HC055015] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		[Anonymous], 1995, DIABETES AM; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; *ATH RISK COMM STU, 1987, OP MAN; AUBERT RE, 1995, NIH PUBLICATION, P553; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; BENGTSSON C, 1984, BMJ-BRIT MED J, V289, P1495, DOI 10.1136/bmj.289.6457.1495; BERGLUND G, 1986, ACTA MED SCAND, V220, P419; Black HR, 1998, ARCH INTERN MED, V158, P573; Bray GA, 1999, DIABETES CARE, V22, P623; BRECKENR.A, 1967, LANCET, V1, P61; BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305; CHIANG CL, 1961, VITAL STAT SPECIAL R, V47; FLETCHER AE, 1991, AM J MED, V90, pS42, DOI 10.1016/0002-9343(91)90435-Z; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; GURWITZ JH, 1993, ANN INTERN MED, V118, P273, DOI 10.7326/0003-4819-118-4-199302150-00005; GURWITZ JH, 1994, J AM GERIATR SOC, V42, P1235, DOI 10.1111/j.1532-5415.1994.tb06503.x; Hammersley MS, 1997, METABOLISM, V46, P44, DOI 10.1016/S0026-0495(97)90317-6; HARDMAN JG, 1996, GOODMAN GILMANS PHAR, P1465; HELGELAND A, 1984, AM J MED, V76, P802, DOI 10.1016/0002-9343(84)90990-2; HELGELAND A, 1980, AM J MED, V69, P725, DOI 10.1016/0002-9343(80)90438-6; Jacob S, 1998, AM J HYPERTENS, V11, P1258, DOI 10.1016/S0895-7061(98)00141-1; JAVITT JC, 1995, DIABETES AM, P601; Kenny S.J., 1995, NIH PUBLICATION, P47; KOHNER EM, 1971, LANCET, V1, P986; LUSTGARTEN JA, 1972, CLIN CHEM, V18, P1419; MORALES PA, 1993, DIABETES, V42, P154, DOI 10.2337/diabetes.42.1.154; MURPHY MB, 1982, LANCET, V2, P1293; MYKKANEN L, 1994, J HYPERTENS, V12, P1425; NEATON JD, 1993, JAMA-J AM MED ASSOC, V270, P713, DOI 10.1001/jama.270.6.713; NEESE JW, 1976, DEHW PUBLICATION; Psaty BM, 1997, JAMA-J AM MED ASSOC, V277, P739, DOI 10.1001/jama.277.9.739; RAMIREZ EA, 1985, HYPERTENSION, V7, P1008; ROSE GA, 1968, WHO MONOGRAPH SERIES, V56; SAMUELSSON O, 1994, J HUM HYPERTENS, V8, P257; SARTOR G, 1980, DIABETES, V29, P41, DOI 10.2337/diabetes.29.1.41; Savage PJ, 1998, ARCH INTERN MED, V158, P741, DOI 10.1001/archinte.158.7.741; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; SHAPIRO AP, 1961, NEW ENGL J MED, V265, P1028, DOI 10.1056/NEJM196111232652102; SIEDEL J, 1983, CLIN CHEM, V29, P1075; SKARFORS ET, 1989, BRIT MED J, V298, P1147, DOI 10.1136/bmj.298.6681.1147; SKARFORS ET, 1991, BRIT MED J, V303, P755, DOI 10.1136/bmj.303.6805.755; *STAT, 1997, STAT STAT SOFTW; STOLK RP, 1993, EUR J EPIDEMIOL, V9, P134, DOI 10.1007/BF00158782; STRUTHERS AD, 1985, HYPERTENSION, V7, P95; Teuscher AU, 1997, J HYPERTENS, V15, pS67, DOI 10.1097/00004872-199715022-00006; TURNER R, 1999, EARLY DIABETES INTER; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; WOLFF FW, 1963, JAMA-J AM MED ASSOC, V185, P568, DOI 10.1001/jama.1963.03060070036019; [No title captured]	50	795	852	1	40	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 30	2000	342	13					905	912		10.1056/NEJM200003303421301	http://dx.doi.org/10.1056/NEJM200003303421301			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DC	10738048				2022-12-24	WOS:000086179700001
J	Nowak, MA; Plotkin, JB; Jansen, VAA				Nowak, MA; Plotkin, JB; Jansen, VAA			The evolution of syntactic communication	NATURE			English	Article							LANGUAGE	Animal communication is typically non-syntactic, which means that signals refer to whole situations(1-7). Human language is syntactic, and signals consist of discrete components that have their own meaning(8). Syntax is a prerequisite for taking advantage of combinatorics, that is, "making infinite use of finite means"(9-11) The vast expressive power of human language would be impossible without syntax, and the transition from non-syntactic to syntactic communication was an essential step in the evolution of human language(12-16). We aim to understand the evolutionary dynamics of this transition and to analyse how natural selection can guide it. Here we present a model for the population dynamics of language evolution, define the basic reproductive ratio of words and calculate the maximum size of a lexicon. Syntax allows larger repertoires and the possibility to formulate messages that have not been learned beforehand. Nevertheless, according to our model natural selection can only favour the emergence of syntax if the number of required signals exceeds a threshold value. This result might explain why only humans evolved syntactic communication and hence complex language.	Inst Adv Study, Princeton, NJ 08540 USA; Univ London Royal Holloway & Bedford New Coll, Sch Biol Sci, Egham TW20 0EX, Surrey, England	Institute for Advanced Study - USA; University of London; Royal Holloway University London	Nowak, MA (corresponding author), Inst Adv Study, Olden Lane, Princeton, NJ 08540 USA.		Nowak, Martin A/A-6977-2008; Plotkin, Joshua B/E-6947-2013; Galantucci, Bruno/E-5770-2010; Jansen, Vincent A A/C-8353-2009	Jansen, Vincent A.A./0000-0002-6518-2090				Batali J., 1998, APPROACHES EVOLUTION; BATES E, 1991, BIOL BEHAV DETERMINA; BICKERTON D, 1990, SPECIES LANGUAGE; BURLING R, 1993, CURR ANTHROPOL, V34, P25, DOI 10.1086/204132; Cheney D. L., 1990, MONKEYS SEE WORLD IN; CHOMSKY N., 1972, LANGUAGE MIND; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; Chomsky Noam, 1988, LANGUAGE PROBLEMS KN; Dunbar RIM, 1996, GROOMING GOSSIP EVOL; GOULD JL, 1987, SCI AM, V256, P74, DOI 10.1038/scientificamerican0187-74; Hauser, 1996, EVOL COMMUN; Jackendoff R., 1997, ARCHITECTURE LANGUAG; Lieberman P., 1984, BIOL EVOLUTION LANGU; MARLER P, 1970, AM SCI, V58, P669; Miller George A., 1963, HDB MATH PSYCHOL, P419; Nowak MA, 1999, P NATL ACAD SCI USA, V96, P8028, DOI 10.1073/pnas.96.14.8028; PINKER S, 1990, BEHAV BRAIN SCI, V13, P707, DOI 10.1017/S0140525X00081061; Pinker S., 1994, LANGUAGE INSTINCT MI; PREMACK D, 1985, COGNITION, V19, P207, DOI 10.1016/0010-0277(85)90036-8; Smith J. M., 1995, MAJOR TRANSITIONS EV; von Frisch K., 1967, DANCE LANGUAGE ORIEN; VONHUMBOLDT W, 1972, LINGUISTIC VARIABILI; WILSON EO, 1972, SCI AM, V227, P52, DOI 10.1038/scientificamerican0972-52; Zipf G. K., 1935, PSYCHOBIOLOGY LANGUA	24	196	202	0	41	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					495	498		10.1038/35006635	http://dx.doi.org/10.1038/35006635			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761917				2022-12-24	WOS:000086257700048
J	Schiller, J; Major, G; Koester, HJ; Schiller, Y				Schiller, J; Major, G; Koester, HJ; Schiller, Y			NMDA spikes in basal dendrites of cortical pyramidal neurons	NATURE			English	Article							RAT HIPPOCAMPAL SLICES; ACTION-POTENTIALS; CELLS; ACTIVATION; COMPONENTS; SPINES; MODEL	Basal dendrites are a major target for synaptic inputs innervating cortical pyramidal neurons(1). At present little is known about signal processing in these fine dendrites. Here we show that coactivation of clustered neighbouring basal inputs initiated local dendritic spikes, which resulted in a 5.9 +/- 1.5 mV (peak) and 64.4 +/- 19.8 ms (half-width) cable-filtered voltage change at the soma that amplified the somatic voltage response by 226 +/- 46%. These spikes were accompanied by large calcium transients restricted to the activated dendritic segment. In contrast to conventional sodium or calcium spikes, these spikes were mediated mostly by NMDA (N-methyl-D-aspartate) receptor channels, which contributed at least 80% of the total charge. The ionic mechanism of these NMDA spikes may allow 'dynamic spike-initiation zones', set by the spatial distribution of glutamate pre-bound to NMDA receptors, which in turn would depend on recent and ongoing activity in the cortical network. In addition, NMDA spikes may serve as a powerful mechanism for modification of the cortical network by inducing long-term strengthening of co-activated neighbouring inputs.	Technion Med Sch, Dept Physiol, IL-31096 Haifa, Israel; Technion Med Sch, Dept Biophys, IL-31096 Haifa, Israel; Lucent Technol, Biol Computat Res Bell Labs, Murray Hill, NJ USA; Univ Lab Physiol, Oxford, England; Max Planck Inst Med Res, Dept Cell Physiol, Heidelberg, Germany; Rambam Med Ctr, Dept Neurol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Alcatel-Lucent; Lucent Technologies; University of Oxford; Max Planck Society; Rambam Health Care Campus; Technion Israel Institute of Technology	Schiller, J (corresponding author), Technion Med Sch, Dept Physiol, Bat Galim, IL-31096 Haifa, Israel.	Jackie@tx.technion.ac.il	Major, Guy/A-4335-2010					ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BRODIN L, 1991, J NEUROPHYSIOL, V66, P473, DOI 10.1152/jn.1991.66.2.473; BROWN AM, 1993, J NEUROPHYSIOL, V70, P1530, DOI 10.1152/jn.1993.70.4.1530; Cash S, 1998, J NEUROSCI, V18, P10; Cash S, 1999, NEURON, V22, P383, DOI 10.1016/S0896-6273(00)81098-3; Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596; LARKMAN AU, 1991, J COMP NEUROL, V306, P332, DOI 10.1002/cne.903060209; MAJOR G, 1994, J NEUROSCI, V14, P4613; Martina M, 1997, J PHYSIOL-LONDON, V505, P593, DOI 10.1111/j.1469-7793.1997.593ba.x; Schiller J, 1998, NAT NEUROSCI, V1, P114, DOI 10.1038/363; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949	17	459	466	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					285	289		10.1038/35005094	http://dx.doi.org/10.1038/35005094			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749211				2022-12-24	WOS:000086022200049
J	O'Brien, CM; Fox, CJ; Planque, B; Casey, J				O'Brien, CM; Fox, CJ; Planque, B; Casey, J			Fisheries - Climate variability and North Sea cod	NATURE			English	Article									Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Lowestoft NR33 0HT, Suffolk, England	Centre for Environment Fisheries & Aquaculture Science	O'Brien, CM (corresponding author), Ctr Environm Fisheries & Aquaculture Sci, Lowestoft Lab, Pakefield Rd, Lowestoft NR33 0HT, Suffolk, England.		Planque, Benjamin/D-2729-2013; Fox, Clive/C-5935-2012	Planque, Benjamin/0000-0002-0557-7410; 				Cook RM, 1997, NATURE, V385, P521, DOI 10.1038/385521a0; COUTANT CC, 1987, ENVIRON BIOL FISH, V18, P161, DOI 10.1007/BF00000356; CUSHING DH, 1996, EXCELLENCE ECOLOGY, V7; *ICES COOP RES REP, 1999, REP ICES ADV COMM FI; Longhurst A, 1998, FISH RES, V38, P101, DOI 10.1016/S0165-7836(98)00152-0; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069	6	222	229	0	43	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					142	142		10.1038/35004654	http://dx.doi.org/10.1038/35004654			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724155	Bronze			2022-12-24	WOS:000085870900035
J	Cunningham, EJA; Russell, AF				Cunningham, EJA; Russell, AF			Egg investment is influenced by male attractiveness in the mallard	NATURE			English	Article							DIFFERENTIAL-ALLOCATION HYPOTHESIS; EXTRA-PAIR PATERNITY; REPRODUCTIVE EFFORT; BLUE TIT; SURVIVAL; SIZE; QUALITY; VIABILITY; PEACOCKS; TRAINS	Why females prefer to copulate with particular males is a contentious issue. Attention is currently focused on whether females choose males on the basis of their genetic quality, in order to produce more viable offspring(1). Support for this hypothesis in birds has come from studies showing that preferred males tend to father offspring of better condition or with increased survivorship(2-8). Before attributing greater offspring viability to a male's heritable genetic quality, however, it is important: to discount effects arising from confounding sources, including maternal effects. This has generally been addressed by comparing offspring viability from two different breeding attempts by the same female: one when offspring; are sired by a preferred male, and one when offspring are sired by a less preferred male, However, here we show that individual female mallard (Anas platyrhynchos) lay larger eggs after copulating: with preferred males and smaller eggs after copulating with less preferred males. As a result, females produced offspring of better body condition when paired with preferred males. After controlling: for these differences in maternal investment, we found no effect: of paternity on offspring condition. This shows that differences between half-sibs cannot always be attributed to paternal or maternal genetic effects.	Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Cunningham, EJA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	ejac3@hermes.cam.ac.uk	Cunningham, Emma/I-9190-2012	Russell, Andy/0000-0002-1299-8555				Andersson Malte, 1994; Balzer AL, 1998, BEHAVIOUR, V135, P297, DOI 10.1163/156853998793066230; BERGER J, 1983, NATURE, V303, P59, DOI 10.1038/303059a0; BOLTON M, 1991, J ANIM ECOL, V60, P949, DOI 10.2307/5424; BURLEY N, 1988, AM NAT, V132, P611, DOI 10.1086/284877; CluttonBrock T, 1997, BEHAV ECOL, V8, P392, DOI 10.1093/beheco/8.4.392; CUNNINGHAM EJA, 1997, FORCED COPULATION SP; DELOPE F, 1993, EVOLUTION, V47, P1152, DOI 10.1111/j.1558-5646.1993.tb02142.x; ELDER WH, 1954, J WILDLIFE MANAGE, V18, P495, DOI 10.2307/3797084; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Hasselquist D, 1996, NATURE, V381, P229, DOI 10.1038/381229a0; HOYT DF, 1979, AUK, V96, P73; Kempenaers B, 1997, BEHAV ECOL, V8, P481, DOI 10.1093/beheco/8.5.481; KEMPENAERS B, 1992, NATURE, V357, P494, DOI 10.1038/357494a0; Lorenz K., 1951, Avicultural Magazine, V57, P157; Mjelstad Hermund, 1990, Wildfowl, V41, P150; MOLLER AP, 1994, P NATL ACAD SCI USA, V91, P6929, DOI 10.1073/pnas.91.15.6929; NORRIS K, 1993, NATURE, V362, P537, DOI 10.1038/362537a0; Omland KE, 1996, BEHAV ECOL SOCIOBIOL, V39, P353, DOI 10.1007/s002650050300; PETRIE M, 1993, P ROY SOC B-BIOL SCI, V251, P127, DOI 10.1098/rspb.1993.0018; PETRIE M, 1994, NATURE, V371, P598, DOI 10.1038/371598a0; RHYMER JM, 1988, OECOLOGIA, V75, P20, DOI 10.1007/BF00378809; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Sheldon BC, 1997, P ROY SOC B-BIOL SCI, V264, P297, DOI 10.1098/rspb.1997.0042; SORENSON LG, 1994, BEHAV ECOL SOCIOBIOL, V35, P389, DOI 10.1007/s002650050111; WILLIAMS GC, 1966, AM NAT, V100, P687, DOI 10.1086/282461; WILLIAMS TD, 1994, BIOL REV, V69, P35, DOI 10.1111/j.1469-185X.1994.tb01485.x; Witte K, 1995, EVOLUTION, V49, P1289, DOI 10.1111/j.1558-5646.1995.tb04458.x	29	288	292	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					74	77		10.1038/35003565	http://dx.doi.org/10.1038/35003565			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716444				2022-12-24	WOS:000085775100047
J	da Silva, JMC; Tabarelli, M				da Silva, JMC; Tabarelli, M			Tree species impoverishment and the future flora of the Atlantic forest of northeast Brazil	NATURE			English	Article								Estimates of species extinction due to human impact on tropical forests have previously been based on the relationship between species number and area(1). Here we use a different approach to estimate loss of tree species in the Atlantic forest of northeast Brazil. We evaluate the characteristics of plant species, their avian dispersers and the distribution of the forest remnants on the landscape to estimate that about 33.9% of tree species in this region will become extinct on a regional scale. Because northeast Brazil is the most threatened sector of South American Atlantic forest(2), our results highlight the need. to change the current conservation paradigm for this region. Rather than focus on the creation of isolated reserves in any medium-to-large forest remnant, a bioregional planning approach is urgently required to rescue this unique biota from extinction.	Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Zool, BR-50670020 Recife, PE, Brazil; Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Bot, BR-50670020 Recife, PE, Brazil	Universidade Federal de Pernambuco; Universidade Federal de Pernambuco	da Silva, JMC (corresponding author), Univ Fed Pernambuco, Ctr Ciencias Biol, Dept Zool, Av Prof Moraes Rego 1235, BR-50670020 Recife, PE, Brazil.		da Silva, José Maria Cardoso/K-3479-2016; Tabarelli, Marcelo/F-1088-2010	da Silva, José Maria Cardoso/0000-0002-7229-6694; Tabarelli, Marcelo/0000-0001-7573-7216				Almeida Roberval T., 1995, Neotropical Primates, V3, P174; Bierregaard Richard O. Jr., 1996, P187; Brooks T, 1996, NATURE, V380, P115, DOI 10.1038/380115a0; Caro TM, 1999, CONSERV BIOL, V13, P805, DOI 10.1046/j.1523-1739.1999.98338.x; Corlett Richard T., 1997, P333; DIAS IS, 1990, WORKSH MAT ATL PROBL; Galetti M, 1997, BIOL CONSERV, V82, P31, DOI 10.1016/S0006-3207(97)00004-9; GUIDON FC, 1996, FOREST PATCHES TROPI, P163; Laurance WF, 1997, TROPICAL FOREST REMN, P275; LIMA D, 1997, RAIN REV, V4, P1; Moermond T.C., 1985, ORNITHOL MONOGR, V36, P865, DOI [10.2307/40168322, DOI 10.2307/40168322]; MORAES P. L. R., 1992, REV I FLORESTAL, V4, P1206; Muller P, 1973, DISPERSAL CTR TERRES; Murcia Carolina, 1996, P19; Offerman Holly L., 1995, Environmental Reviews, V3, P191, DOI 10.1139/a95-009; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Pijl L., 1982, PRINCIPLES DISPERSAL; PRANCE G. T, 1982, BIOL DIVERSIFICATION, P137; Ranta P, 1998, BIODIVERS CONSERV, V7, P385, DOI 10.1023/A:1008885813543; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Robinson John G., 1996, P111; Sick H., 1985, ORNITOLOGIA BRASILEI; Silva Jose Maria Cardoso Da, 1996, Conservation Biology, V10, P491; Soule Michael E., 1999, P1; Tabarelli M, 1999, BIOL CONSERV, V91, P119, DOI 10.1016/S0006-3207(99)00085-3; Viana Virgilio M., 1997, P351; WILLIS E O, 1979, Papeis Avulsos de Zoologia (Sao Paulo), V33, P1; WUNDERLEE JM, 1997, FOREST ECOL MANAGMT, V9, P223	28	284	308	1	52	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					72	74		10.1038/35003563	http://dx.doi.org/10.1038/35003563			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716443				2022-12-24	WOS:000085775100046
J	Rahel, FJ				Rahel, FJ			Homogenization of fish faunas across the United States	SCIENCE			English	Article							BIOLOGICAL INVASIONS; FRESH-WATER	Fish faunas across the continental United States have become more similar through time because of widespread introductions of a group of cosmopolitan species intended to enhance food and sport fisheries. On average, pairs of states have 15.4 more species in common now than before European settlement of North America. The 89 pairs of states that formerly had no species in common now share an average of 25.2 species. Introductions have played a Larger role than extirpations in homogenizing fish faunas. Western and New England states have received the most introductions, which is a reflection of the small number of native fishes in these areas considered desirable gamefish by settlers.	Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA	University of Wyoming	Rahel, FJ (corresponding author), Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA.		Ebersole, Joseph L/A-8371-2009					COURTENAY W R JR, 1990, Journal of the World Aquaculture Society, V21, P145, DOI 10.1111/j.1749-7345.1990.tb01017.x; Courtenay WR., 1996, BIODIVERSITY MANAGED, P239; Fuller PL, 1999, SPECIAL PUBLICATION, V27; Krebs C.J., 1999, ECOLOGICAL METHODOLO; LEE DS, 1980, PUBLICATION N CAROLI, P407; LEVER C, 1996, NATURALIZED FISH WOR; LITVAK MK, 1993, FISHERIES, V18, P6, DOI 10.1577/1548-8446(1993)018<0006:EOFBUI>2.0.CO;2; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; McMahon TE, 1996, FISHERIES, V21, P6, DOI 10.1577/1548-8446(1996)021<0006:WANP>2.0.CO;2; Minckley W.L., 1987, P93; Moyle PB, 1996, BIOL CONSERV, V78, P149, DOI 10.1016/0006-3207(96)00024-9; Rahel FJ, 1997, FISHERIES, V22, P8; Ricciardi A, 2000, TRENDS ECOL EVOL, V15, P62, DOI 10.1016/S0169-5347(99)01745-0; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Vitousek PM, 1996, AM SCI, V84, P468; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	16	515	537	3	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2000	288	5467					854	856		10.1126/science.288.5467.854	http://dx.doi.org/10.1126/science.288.5467.854			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797007				2022-12-24	WOS:000086869600037
J	Wei, M; Gibbons, LW; Kampert, JB; Nichaman, MZ; Blair, SN				Wei, M; Gibbons, LW; Kampert, JB; Nichaman, MZ; Blair, SN			Low cardiorespiratory fitness and physical inactivity as predictors of mortality in men with type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Article						diabetes mellitus, non-insulin-dependent; exercise; exercise tolerance; oxygen uptake	ALL-CAUSE MORTALITY; INSULIN SENSITIVITY; GLUCOSE-TOLERANCE; EXERCISE; WOMEN; DISEASE; HEALTHY; PROGRAM; CANCER; NIDDM	Background: Although physical activity is recommended as a basic treatment for patients with diabetes, its longterm association with mortality in these patients is unknown. Objective: To evaluate the association of low cardiorespiratory fitness and physical inactivity with mortality in men with type 2 diabetes. Design: Prospective cohort study. Setting: Preventive medicine clinic. Patients: 1263 men (50 +/- 10 years of age) with type 2 diabetes who received a thorough medical examination between 1970 and 1993 and were followed for mortality up to 31 December 1994. Measurements: Cardiorespiratory fitness measured by a maximal exercise test, self-reported physical inactivity at baseline, and subsequent death determined by using the National Death Index. Results: During an average follow-up of 12 years, 180 patients died. After adjustment for age, baseline cardiovascular disease, fasting plasma glucose level, high cholesterol level, overweight, current smoking, high blood pressure, and parental history of cardiovascular disease, men in the low-fitness group had an adjusted risk for all-cause mortality of 2.1 (95% Cl, 1.5 to 2.9) compared with fit men. Men who reported being physically inactive had an adjusted risk for mortality that was 1.7-fold (Cl, 1.2-fold to 2.3-fold) higher than that in men who reported being physically active. Conclusions: Low cardiorespiratory fitness and physical inactivity are independent predictors of all-cause mortality in men with type 2 diabetes. Physicians should encourage patients with type 2 diabetes to participate in regular physical activity and improve cardiorespiratory fitness.	Cooper Inst, Dallas, TX 75230 USA; Cooper Clin, Dallas, TX USA; Westat Corp, Rockville, MD USA	Cooper Institute; Cooper Institute; Westat	Wei, M (corresponding author), Cooper Inst, 12330 Preston Rd, Dallas, TX 75230 USA.	mwei@cooperinst.org			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006945, R01AG006945] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL62508] Funding Source: Medline; NIA NIH HHS [AG06945] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		*AM DIAB ASS, 1999, DIABETES CARE S1, V22, pS49; [Anonymous], 1996, JAMA, V276, P241; BAKTH S, 1986, J CLIN INVEST, V77, P382, DOI 10.1172/JCI112316; BALKE B, 1959, U S Armed Forces Med J, V10, P675; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; BLAIR SN, 1989, AM J EPIDEMIOL, V129, P1145, DOI 10.1093/oxfordjournals.aje.a115236; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; BURCHFIEL CM, 1995, AM J EPIDEMIOL, V141, P360, DOI 10.1093/aje/141.4.360; Chalmers J, 1999, J HYPERTENS, V17, P151; Coupland CAC, 1999, INT J EPIDEMIOL, V28, P241, DOI 10.1093/ije/28.2.241; Cowie CC, 1995, NIH PUBLICATION, V95-1468, P117; DEVLIN JT, 1987, DIABETES, V36, P434, DOI 10.2337/diabetes.36.4.434; Erikssen G, 1998, LANCET, V352, P759, DOI 10.1016/S0140-6736(98)02268-5; Eriksson J, 1997, DIABETOLOGIA, V40, P125; GARBER AJ, 1998, INTERNAL MED, P1850; Gavin JR, 1997, DIABETES CARE, V20, P1183; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Gu K, 1999, JAMA-J AM MED ASSOC, V281, P1291, DOI 10.1001/jama.281.14.1291; Kampert JB, 1996, ANN EPIDEMIOL, V6, P452, DOI 10.1016/S1047-2797(96)00059-2; Kiningham RB, 1998, PRIMARY CARE, V25, P515, DOI 10.1016/S0095-4543(05)70080-4; KOHL HW, 1992, DIABETES CARE, V15, P184, DOI 10.2337/diacare.15.2.184; KUUSISTO J, 1994, STROKE, V25, P1157, DOI 10.1161/01.STR.25.6.1157; LICHTMAN SW, 1992, NEW ENGL J MED, V327, P1893, DOI 10.1056/NEJM199212313272701; Martynenko OG, 1997, INT J HEAT MASS TRAN, V40, P1; McGovern PG, 1996, NEW ENGL J MED, V334, P884, DOI 10.1056/NEJM199604043341403; *NIH, 1988, LIP RES CLIN POP STU; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; POLLOCK ML, 1976, AM HEART J, V92, P39, DOI 10.1016/S0002-8703(76)80401-2; REWERS M, 1995, NIH PUBLICATION, P179; ROGERS MA, 1988, DIABETES CARE, V11, P613, DOI 10.2337/diacare.11.8.613; ROGERS MA, 1989, MED SCI SPORT EXER, V21, P362; *SAS I, 1989, SAS STAT US GUID VER; SCHNEIDER SH, 1992, DIABETES CARE, V15, P1800, DOI 10.2337/diacare.15.11.1800; SEGAL KR, 1991, J APPL PHYSIOL, V71, P2402, DOI 10.1152/jappl.1991.71.6.2402; STAMPFER MJ, 1984, AM J EPIDEMIOL, V119, P837, DOI 10.1093/oxfordjournals.aje.a113804; Stofan JR, 1998, AM J PUBLIC HEALTH, V88, P1807, DOI 10.2105/AJPH.88.12.1807; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Wei M, 1999, JAMA-J AM MED ASSOC, V282, P1547, DOI 10.1001/jama.282.16.1547; Wei M, 1997, J CLIN EPIDEMIOL, V50, P1137, DOI 10.1016/S0895-4356(97)00150-9; 1981, CANADA FITNESS SURVE	43	440	452	1	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2000	132	8					605	+		10.7326/0003-4819-132-8-200004180-00002	http://dx.doi.org/10.7326/0003-4819-132-8-200004180-00002			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304RG	10766678				2022-12-24	WOS:000086497500001
J	Reits, EAJ; Vos, JC; Gromme, M; Neefjes, J				Reits, EAJ; Vos, JC; Gromme, M; Neefjes, J			The major substrates for TAP in vivo are derived from newly synthesized proteins	NATURE			English	Article							MHC CLASS-I; LATERAL MOBILITY; MEMBRANES; TRANSPORT; TRANSLOCATION; FLUORESCENCE; MOLECULES; SUBUNIT; DOMAIN; CELLS	The transporter associated with antigen processing (TAP) is a member of the family of ABC transporters that translocate a large variety of substrates across membranes(1). TAP transports peptides from the cytosol into the endoplasmic reticulum for binding to MHC class I molecules and for subsequent presentation to the immune system(2). Here we follow the lateral mobility of TAP in living cells. TAP's mobility increases when it is inactive and decreases when it translocates peptides. Because TAP activity is dependent on substrate, the mobility of TAP is used to monitor the intracellular peptide content in vivo. Comparison of the diffusion rates in peptide-free and peptide-saturated cells indicates that normally about one-third of all TAP molecules actively translocate peptides. However, during an acute influenza infection TAP becomes fully employed owing to the production and degradation of viral proteins. Furthermore, TAP activity depends on continuing protein translation. This implies that MHC class I molecules mainly sample peptides that originate from newly synthesized proteins, to ensure rapid presentation to the immune system.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Neefjes, J (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	jneefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Vos, J. Chris/0000-0003-3737-9942				Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; DELEIJ L, 1985, CANCER RES, V45, P6024; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Gromme M, 1997, EUR J IMMUNOL, V27, P898, DOI 10.1002/eji.1830270415; Gromme M, 1999, P NATL ACAD SCI USA, V96, P10326, DOI 10.1073/pnas.96.18.10326; HAYDEN FG, 1990, ANTIVIR RES, V14, P25, DOI 10.1016/0166-3542(90)90063-D; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cellbio.8.1.67; JOVIN TM, 1989, METHOD ENZYMOL, V172, P471; KRUG RM, 1989, INFLUENZA VIRUSES, P89; KWON G, 1994, CELL SIGNAL, V6, P663, DOI 10.1016/0898-6568(94)90049-3; Lehner PJ, 1998, CURR BIOL, V8, pR605, DOI 10.1016/S0960-9822(98)70387-2; LIVNEH E, 1986, J CELL BIOL, V103, P327, DOI 10.1083/jcb.103.2.327; Marguet D, 1999, IMMUNITY, V11, P231, DOI 10.1016/S1074-7613(00)80098-9; NEEFJES JJ, 1993, SCIENCE, V261, P769, DOI 10.1126/science.8342042; Neisig A, 1996, J IMMUNOL, V156, P3196; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Reits EAJ, 1997, EMBO J, V16, P6087, DOI 10.1093/emboj/16.20.6087; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; SCHLESSINGER J, 1976, P NATL ACAD SCI USA, V73, P2409, DOI 10.1073/pnas.73.7.2409; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; STAM NJ, 1986, J IMMUNOL, V137, P2299; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; Vos JC, 1999, J IMMUNOL, V163, P6679; Vos JC, 2000, CURR BIOL, V10, P1, DOI 10.1016/S0960-9822(99)00257-2; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611	29	324	327	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2000	404	6779					774	778		10.1038/35008103	http://dx.doi.org/10.1038/35008103			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783892				2022-12-24	WOS:000086523600055
J	Babiker, A; Darby, S; De Angelis, D; Kwart, D; Porter, K; Beral, V; Darbyshire, J; Day, N; Gill, N; Coutinho, R; Prins, M; van Benthem, B; Coutinho, R; Dabis, F; Marimoutou, C; Ruiz, I; Tusell, J; Altisent, C; Evatt, B; Jaffe, H; Kirk, O; Pedersen, C; Rosenberg, P; Goedert, J; Biggar, R; Melbye, M; Brettie, R; Downs, A; Hamouda, O; Touloumi, G; Karafoulidou, A; Katsarou, O; Donfield, S; Gomperts, E; Hilgartner, M; Hoots, K; Schoenbaum, E; Beral, V; Zangerle, R; Del Amo, J; Pezzotti, P; Rezza, G; Hutchinson, S; Day, N; De Angelis, D; Gore, S; Kingsley, L; Schrager, L; Rosenberg, P; Goedert, J; Melnick, S; Koblin, B; Eskild, A; Bruun, J; Sannes, M; Evans, B; Lepri, AC; Sabin, C; Buchbinder, S; Vittinghoff, E; Moss, A; Osmond, D; Winkelstein, W; Goldberg, D; Boufassa, F; Meyer, L; Egger, M; Francioli, P; Rickenbach, M; Cooper, D; Tindall, B; Sharkey, T; Vizzard, J; Kaldor, J; Cunningham, P; Vanhems, P; Vizzard, J; Kaldor, J; Learmont, J; Farewell, V; Berglund, O; Mosley, J; Operskalski, E; van den Berg, M; Metzger, D; Tobin, D; Woody, G; Rusnak, J; Hendrix, C; Garner, R; Hawkes, C; Renzullo, P; Garland, F; Darby, S; Ewart, D; Giangrande, P; Lee, C; Phillips, A; Spooner, R; Wilde, J; Winter, M; Babiker, A; Darbyshire, J; Evans, B; Gill, N; Johnson, A; Phillips, A; Porter, K; Lorenzo, JI; Schechter, M				Babiker, A; Darby, S; De Angelis, D; Kwart, D; Porter, K; Beral, V; Darbyshire, J; Day, N; Gill, N; Coutinho, R; Prins, M; van Benthem, B; Coutinho, R; Dabis, F; Marimoutou, C; Ruiz, I; Tusell, J; Altisent, C; Evatt, B; Jaffe, H; Kirk, O; Pedersen, C; Rosenberg, P; Goedert, J; Biggar, R; Melbye, M; Brettie, R; Downs, A; Hamouda, O; Touloumi, G; Karafoulidou, A; Katsarou, O; Donfield, S; Gomperts, E; Hilgartner, M; Hoots, K; Schoenbaum, E; Beral, V; Zangerle, R; Del Amo, J; Pezzotti, P; Rezza, G; Hutchinson, S; Day, N; De Angelis, D; Gore, S; Kingsley, L; Schrager, L; Rosenberg, P; Goedert, J; Melnick, S; Koblin, B; Eskild, A; Bruun, J; Sannes, M; Evans, B; Lepri, AC; Sabin, C; Buchbinder, S; Vittinghoff, E; Moss, A; Osmond, D; Winkelstein, W; Goldberg, D; Boufassa, F; Meyer, L; Egger, M; Francioli, P; Rickenbach, M; Cooper, D; Tindall, B; Sharkey, T; Vizzard, J; Kaldor, J; Cunningham, P; Vanhems, P; Vizzard, J; Kaldor, J; Learmont, J; Farewell, V; Berglund, O; Mosley, J; Operskalski, E; van den Berg, M; Metzger, D; Tobin, D; Woody, G; Rusnak, J; Hendrix, C; Garner, R; Hawkes, C; Renzullo, P; Garland, F; Darby, S; Ewart, D; Giangrande, P; Lee, C; Phillips, A; Spooner, R; Wilde, J; Winter, M; Babiker, A; Darbyshire, J; Evans, B; Gill, N; Johnson, A; Phillips, A; Porter, K; Lorenzo, JI; Schechter, M		Collaborative Grp AIDS Incubation	Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INJECTING DRUG-USERS; HOMOSEXUAL MEN; HEPATITIS-C; DISEASE PROGRESSION; TYPE-1 INFECTION; NATURAL-HISTORY; AGE; HEMOPHILIA; SURVIVAL	Background We used data from Europe, North America, and Australia to assess the effect of exposure category on the AIDS incubation period and HIV-1 survival and whether the effect of age at seroconversion varies with exposure category and with time since seroconversion. Methods 38 studies of HIV-1-infected individuals whose dates of seroconversion could be reliably estimated were included in the analysis. Individual data on 13 030 HIV-1-infected individuals from 15 countries were collated, checked, and analysed centrally. We calculated estimates of mortality and AIDS incidence rates and estimated the proportions of individuals surviving and developing AIDS at each year after seroconversion from the numbers of observed deaths or cases of AIDS and the corresponding person-years at risk. Analyses were adjusted for age at seroconversion, time since seroconversion, and other factors as appropriate. Findings Mortality and AIDS incidence increased strongly with time since seroconversion and age at seroconversion. Median survival varied from 12.5 years (95% CI 12.1-12.9) for those aged 15-24 years at seroconversion to 7.9 years (7.4-8.5) for those aged 45-54 years at seroconversion, whereas for development of AIDS the corresponding values were 11.0 years (10.7-11.7) and 7.7 years (7.1-8.6). There was no appreciable effect of exposure category on survival. For AIDS incidence, the exposure category effect that we noted was explained by the high incidence of Kaposi's sarcoma in those infected through sex between men. We estimated that among people aged 25-29 years at seroconversion 90% (89-91) and 60% (57-62) survived to 5 years and 10 years, respectively, after seroconversion, whereas 13% (12-15) and 46% (44-49), respectively, developed AIDS (excluding Kaposi's sarcoma). Interpretation Before widespread use of highly-active antiretroviral therapy (before 1996), time since seroconversion and age at seroconversion were the major determinants of survival and development of AIDS in Europe, North America, and Australia.	Radcliffe Infirm, Imperial Canc Res Fund, Canc Epidemiol Unit, Oxford OX2 6HE, England; Amsterdam Cohort Study Drug Users, Amsterdam, Netherlands; Amsterdam Cohort Study Homosexual Men, Amsterdam, Netherlands; Barcelona Haemophillia Cohort, Barcelona, Spain; Ctr Dis Control & Prevent, Atlanta, GA USA; Copenhagen Cohort, Copenhagen, Denmark; Aquitaine Cohort, Aquitaine, France; Edinburgh City Hosp Cohort, Edinburgh, Midlothian, Scotland; European Ctr Epidemiol Monitoring AIDS, St Maurice, France; HERO Study, Birmingham, AL USA; Imperial Canc Res Fund, Canc Epidemiol Unit, Oxford, England; Innsbruck AIDS Study, Innsbruck, Austria; Inst Salud Carlos III, Madrid, Spain; MRC BIAS, Edinburgh, Midlothian, Scotland; MRC, Biostat Unit, Cambridge CB2 2BW, England; NCI, Bethesda, MD 20892 USA; New York Blood Ctr, New York Prospect AIDS Study, New York, NY 10021 USA; Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England; Royal Free Hosp, Sch Med, London, England; San Francisco City Clin Cohort, San Francisco, CA USA; San Francisco Gen Hosp Cohort, San Francisco, CA USA; San Francisco Mens Hlth Study, San Francisco, CA USA; Scottish Ctr Infect & Environm Hlth, Glasgow, Lanark, Scotland; Swiss HIV Cohort Study, Lausanne, Switzerland; Sydney AIDS Prospect Study, Sydney, NSW, Australia; Sydney Primary HIV Infect Cohort, Sydney, NSW, Australia; Sydney Primary HIV Infect Working Party, Sydney, NSW, Australia; Sydney Red Cross Cohort, Sydney, NSW, Australia; Toronto Sexual Hlth Study, Toronto, ON, Canada; Univ Utrecht Hosp, Utrecht, Netherlands; Univ Penn, Risk Assessment Project, Philadelphia, PA 19104 USA; USAF, HIV Nat Hist Study, Washington, DC 20330 USA; USA, Data Syst Cohort, Washington, DC 20310 USA; USN, HIV Cohort, Washington, DC 20350 USA; Valencia Haemophilia Cohort, Valencia, Spain; Vancouver Lymphadenopathy AIDS Study, Vancouver, BC, Canada	Radcliffe Infirmary; University of Oxford; Centers for Disease Control & Prevention - USA; University of Oxford; Instituto de Salud Carlos III; MRC Biostatistics Unit; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); New York Blood Center; Public Health England; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; San Francisco General Hospital Medical Center; Utrecht University; Utrecht University Medical Center; University of Pennsylvania; United States Department of Defense; United States Air Force; United States Department of Defense; United States Navy	Beral, V (corresponding author), Radcliffe Infirm, Imperial Canc Res Fund, Canc Epidemiol Unit, Gibson Bldg, Oxford OX2 6HE, England.		rezza, giovanni/D-4393-2016; PEZZOTTI, PATRIZIO/C-6480-2016; Hendrix, Craig W/G-4182-2014; Metzger, David/D-9499-2012; Schechter, Mauro/AAG-7445-2020; kirk, ole/ABB-4746-2021; Phillips, Andrew N/B-4427-2008; DABIS, FRANCOIS/S-9298-2019; Sabin, Caroline/C-2464-2008; DEL AMO VALERO, JULIA/M-7020-2015; Kaldor, John M/D-4545-2011	rezza, giovanni/0000-0003-0268-6790; PEZZOTTI, PATRIZIO/0000-0002-0805-2927; Hendrix, Craig W/0000-0002-5696-8665; Phillips, Andrew N/0000-0003-2384-4807; DABIS, FRANCOIS/0000-0002-1614-8857; Sabin, Caroline/0000-0001-5173-2760; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Porter, Kholoud/0000-0002-9226-6206; Johnson, Anne/0000-0003-1330-7100				Altisent C, 1996, NEW ENGL J MED, V334, P1065, DOI 10.1056/NEJM199604183341616; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Beral V, 1998, AIDS, V12, P659; BIRD G, 1994, AIDS, V8, P911; Brettle RP, 1996, AIDS, V10, P419, DOI 10.1097/00002030-199604000-00011; Carre N, 1996, AIDS, V10, P77, DOI 10.1097/00002030-199601000-00011; CARRE N, 1994, AIDS, V8, P797, DOI 10.1097/00002030-199406000-00012; CROWE SM, 1991, J ACQ IMMUN DEF SYND, V4, P770; Darby SC, 1996, LANCET, V347, P1573, DOI 10.1016/S0140-6736(96)91073-9; Darby SC, 1997, LANCET, V350, P1425, DOI 10.1016/S0140-6736(97)05413-5; EYSTER ME, 1993, J ACQ IMMUN DEF SYND, V6, P602; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; HESSOL NA, 1994, AM J EPIDEMIOL, V139, P1077, DOI 10.1093/oxfordjournals.aje.a116951; LONGINI IM, 1991, J ACQ IMMUN DEF SYND, V4, P1141; MARIOTTO AB, 1992, AM J EPIDEMIOL, V135, P428, DOI 10.1093/oxfordjournals.aje.a116303; *OFF POP CENS SURV, 1990, SER DH1, V24; OPERSKALSKI EA, 1995, J INFECT DIS, V172, P648, DOI 10.1093/infdis/172.3.648; Pehrson P, 1997, AIDS, V11, P1007, DOI 10.1097/00002030-199708000-00009; PHILLIPS AN, 1991, J ACQ IMMUN DEF SYND, V4, P970; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; ROSENBERG PS, 1994, AIDS, V8, P803, DOI 10.1097/00002030-199406000-00013; SCHRADER EK, 1993, AIDS, V7, P1009; Touloumi G, 1998, AIDS, V12, P1691, DOI 10.1097/00002030-199813000-00018; VEUGELERS PJ, 1994, AM J EPIDEMIOL, V140, P747, DOI 10.1093/oxfordjournals.aje.a117322; VONOVERBECK J, 1994, AIDS, V8, P1307, DOI 10.1097/00002030-199409000-00014; 1993, LANCET, V341, P441	26	329	339	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2000	355	9210					1131	1137						7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TC	10791375				2022-12-24	WOS:000086380900010
J	Batchelor, T				Batchelor, T			Temozolomide for malignant brain tumours	LANCET			English	Editorial Material							GLIOMA; TRIAL		Massachusetts Gen Hosp, Brain Tumor Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Batchelor, T (corresponding author), Massachusetts Gen Hosp, Brain Tumor Ctr, Boston, MA 02114 USA.							Bower M, 1997, CANCER CHEMOTH PHARM, V40, P484, DOI 10.1007/s002800050691; Brock CS, 1998, CANCER RES, V58, P4363; *CENTR BRAIN TUM R, 1997, ANN REP; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; HARRAS E, 1996, CANC RATES RISKS; Newlands ES, 1996, EUR J CANCER, V32A, P2236, DOI 10.1016/S0959-8049(96)00258-4; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Schold SC, 2000, NEURO-ONCOLOGY, V2, P34, DOI 10.1093/neuonc/2.1.34; Wedge SR, 1996, BRIT J CANCER, V73, P1049, DOI 10.1038/bjc.1996.203; YUNG A, 1999, P AN M AM SOC CLIN, V18, pA139; Yung WKA, 1999, J CLIN ONCOL, V17, P2762, DOI 10.1200/JCO.1999.17.9.2762	11	24	25	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 1	2000	355	9210					1115	1116		10.1016/S0140-6736(00)02055-9	http://dx.doi.org/10.1016/S0140-6736(00)02055-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TC	10791369				2022-12-24	WOS:000086380900004
J	Sharp, PA; Zamore, PD				Sharp, PA; Zamore, PD			Molecular biology - RNA interference	SCIENCE			English	Editorial Material									MIT, Ctr Canc Res, Cambridge, MA 02139 USA; Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01655 USA	Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Worcester	Sharp, PA (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.		Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618				Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hunter CP, 2000, CURR BIOL, V10, pR137, DOI 10.1016/S0960-9822(00)00325-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Schmidt A, 1999, GENETICS, V151, P749; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; ZAMORE PD, IN PRESS CELL	12	91	173	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2431	+		10.1126/science.287.5462.2431	http://dx.doi.org/10.1126/science.287.5462.2431			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10766620				2022-12-24	WOS:000086202200030
J	Tulsky, JA; Ciampa, R; Rosen, EJ				Tulsky, JA; Ciampa, R; Rosen, EJ		Univ Pennsylvania	Responding to legal requests for physician-assisted suicide	ANNALS OF INTERNAL MEDICINE			English	Article							WASHINGTON-STATE; PATIENT REQUESTS; EUTHANASIA; ATTITUDES; CARE; AUTONOMY; PERSPECTIVE; CHOICE; WILL; DIE	In 1998, 15 terminally ill Oregon residents ended their lives with overdoses of medications supplied legally by their physicians. Many more people consider this possibility. This paper examines the ways in which the physician's response to requests for assisted suicide may change in an era of legalization, articulates some of the resulting conceptual challenges, and provides practical advice to physicians facing such requests. In areas where it is legal, assisted dying becomes one of the many options that can be freely considered for terminally ill patients with extreme suffering. Some patients even view assisted death as a right that can be expected on demand. We consider the ethical implications of disclosing assisted dying to patients as an option of last resort: and suggest that physicians working in environments where assisted dying is legal are obliged to do so. However, we conclude that physicians should not encourage patients to hasten death even when practicing in jurisdictions that allow assisted dying. Furthermore, without abandoning the model, we suggest that strict informed consent does not fully address patients' needs at this time. Physicians must also focus on patients' broader biopsychosocial concerns and help them identify solutions through empathic listening and emotional support. We provide a framework and vocabulary for physicians to use when responding to requests for assisted suicide. Physicians should clarify the request, explore and address the patient's concerns, achieve a shared understanding of the goals of treatment, search for less harmful alternatives, express to the patient what they are willing to do, discuss the relevant legal issues, and share their decision making with colleagues.	Vet Affairs Med Ctr, Durham, NC 27705 USA; Duke Univ, Med Ctr, Durham, NC USA; Hosp Univ Penn, Philadelphia, PA 19104 USA; Family Inst Westchester, Scarsdale, NY USA; Phelps Mem Hospice, Scarsdale, NY USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University; University of Pennsylvania; Northwell Health	Tulsky, JA (corresponding author), Univ Penn, Ctr Bioeth, 3401 Market St,Suite 320, Philadelphia, PA 19104 USA.							APPELBAUM P, 1987, INFORMED CONSENT LEG; Bachman JG, 1996, NEW ENGL J MED, V334, P303, DOI 10.1056/NEJM199602013340506; Back AL, 1996, JAMA-J AM MED ASSOC, V275, P919, DOI 10.1001/jama.275.12.919; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; BLENDON RJ, 1992, JAMA-J AM MED ASSOC, V267, P2658, DOI 10.1001/jama.267.19.2658; BLOCH SD, 1994, ARCH INTERN MED, V154, P2039, DOI 10.1001/archinte.154.18.2039; BRODY H, 1992, HEALERS POWER; Byock I, 1997, DYING WELL PROSPECT; CAPLAN AL, 1993, PRESCRIBING OUR FUTU, P149; CARRESE JA, 1995, JAMA-J AM MED ASSOC, V274, P826, DOI 10.1001/jama.274.10.826; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; COHEN JS, 1994, NEW ENGL J MED, V331, P89, DOI 10.1056/NEJM199407143310206; Cole Roger M., 1993, Palliative Medicine, V7, P139, DOI 10.1177/026921639300700208; Drickamer MA, 1997, ANN INTERN MED, V126, P146, DOI 10.7326/0003-4819-126-2-199701150-00009; Dunn PM, 1996, J GEN INTERN MED, V11, P689, DOI 10.1007/BF02600161; EDWARDS MJ, 1992, ANN INTERN MED, V117, P254, DOI 10.7326/0003-4819-117-3-254; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; EMANUEL L, 1999, ED PHYSICIANS END OF; Emanuel LL, 1998, JAMA-J AM MED ASSOC, V280, P643, DOI 10.1001/jama.280.7.643; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Lee MA, 1996, ANN INTERN MED, V124, P267, DOI 10.7326/0003-4819-124-2-199601150-00014; Maguire P, 1996, EUR J CANCER, V32A, P78, DOI 10.1016/0959-8049(95)00527-7; Martin DK, 1999, ARCH INTERN MED, V159, P86, DOI 10.1001/archinte.159.1.86; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; QUILL TE, 1993, JAMA-J AM MED ASSOC, V270, P870, DOI 10.1001/jama.270.7.870; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; QUILL TE, 1995, ANN INTERN MED, V122, P368, DOI 10.7326/0003-4819-122-5-199503010-00008; Rose PG, 1998, J CLIN ONCOL, V16, P405, DOI 10.1200/JCO.1998.16.2.405; Singer PA, 1998, ARCH INTERN MED, V158, P879, DOI 10.1001/archinte.158.8.879; Teno JM, 1996, J CLIN ETHIC, V7, P205; Tolle SW, 1998, ANN INTERN MED, V128, P567, DOI 10.7326/0003-4819-128-7-199804010-00009; Tulsky JA, 1998, ANN INTERN MED, V129, P441, DOI 10.7326/0003-4819-129-6-199809150-00003; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683	34	18	18	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					494	499		10.7326/0003-4819-132-6-200003210-00012	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00012			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293CV	10733451				2022-12-24	WOS:000085834700011
J	Adler, E; Hoon, MA; Mueller, KL; Chandrashekar, J; Ryba, NJP; Zuker, CS				Adler, E; Hoon, MA; Mueller, KL; Chandrashekar, J; Ryba, NJP; Zuker, CS			A novel family of mammalian taste receptors	CELL			English	Article							ALPHA-GUSTDUCIN; CHORDA TYMPANI; G-PROTEIN; RAT; TRANSDUCTION; CELLS; AMILORIDE; GENES; NERVE; MICE	In mammals, taste perception is a major mode of sensory input. We have identified a novel family of 40-80 human and rodent G protein-coupled receptors expressed in subsets of taste receptor cells of the tongue and palate epithelia. These candidate taste receptors (T2Rs) are organized in the genome in clusters and are genetically linked to loci that influence bitter perception in mice and humans. Notably, a single taste receptor cell expresses a large repertoire of T2Rs, suggesting that each cell may be capable of recognizing multiple tastants. T2Rs are exclusively expressed in taste receptor cells that contain the G protein alpha subunit gustducin, implying that they function as gustducin-linked receptors. In the accompanying paper, we demonstrate that T2Rs couple to gustducin in vitro, and respond to bitter tastants in a functional expression assay.	NIH, Natl Inst Dent & Craniofacial Res, Bethesda, MD 20892 USA; Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Biol, Dept Neurosci, La Jolla, CA 92093 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Ryba, NJP (corresponding author), NIH, Natl Inst Dent & Craniofacial Res, Bldg 10, Bethesda, MD 20892 USA.	nr13k@nih.gov; czucker@flyeye.ucsd.edu		Chandrashekar, jayaram/0000-0001-6412-0114; Ryba, Nicholas/0000-0002-2060-8393	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000561] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		AVENET P, 1988, J MEMBRANE BIOL, V105, P245, DOI 10.1007/BF01871001; AZEN EA, 1986, TRENDS GENET, V2, P199, DOI 10.1016/0168-9525(86)90228-3; Boughter JD, 1997, J NEUROSCI, V17, P2852; BRAND JG, 1985, BRAIN RES, V334, P207, DOI 10.1016/0006-8993(85)90212-4; CAPELESS CG, 1992, BEHAV GENET, V22, P655, DOI 10.1007/BF01066636; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chaudhari N, 2000, NAT NEUROSCI, V3, P113, DOI 10.1038/72053; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; CONNEALLY PM, 1976, HUM HERED, V26, P267, DOI 10.1159/000152813; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; FRANK ME, 1991, J NEUROPHYSIOL, V65, P1452, DOI 10.1152/jn.1991.65.6.1452; FRANK ME, 1983, J NEUROPHYSIOL, V50, P941, DOI 10.1152/jn.1983.50.4.941; FULLER JL, 1974, J HERED, V65, P33, DOI 10.1093/oxfordjournals.jhered.a108452; GILBERTSON TA, 1992, J GEN PHYSIOL, V100, P803, DOI 10.1085/jgp.100.5.803; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hofer D, 1996, P NATL ACAD SCI USA, V93, P6631, DOI 10.1073/pnas.93.13.6631; Hofer D, 1998, HISTOCHEM CELL BIOL, V110, P303, DOI 10.1007/s004180050292; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; KINNAMON SC, 1988, P NATL ACAD SCI USA, V85, P7023, DOI 10.1073/pnas.85.18.7023; KINNAMON SC, 1992, ANNU REV PHYSIOL, V54, P715, DOI 10.1146/annurev.physiol.54.1.715; Lindemann B, 1996, PHYSIOL REV, V76, P719, DOI 10.1152/physrev.1996.76.3.719; LUSH IE, 1986, GENET RES, V47, P117, DOI 10.1017/S0016672300022941; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; MCBURNEY DH, 1972, PERCEPT PSYCHOPHYS, V11, P228, DOI 10.3758/BF03206255; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; MILLER IJ, 1974, J COMP NEUROL, V158, P155, DOI 10.1002/cne.901580204; Ming D, 1998, P NATL ACAD SCI USA, V95, P8933, DOI 10.1073/pnas.95.15.8933; Mombaerts P, 1996, COLD SPRING HARB SYM, V61, P135; NEJAD MS, 1986, CHEM SENSES, V11, P283, DOI 10.1093/chemse/11.3.283; PROBST WC, 1992, DNA CELL BIOL, V11, P1, DOI 10.1089/dna.1992.11.1; Reed DR, 1999, AM J HUM GENET, V64, P1478, DOI 10.1086/302367; Rouquier S, 1998, NAT GENET, V18, P243, DOI 10.1038/ng0398-243; Rubin BD, 1999, NEURON, V23, P499, DOI 10.1016/S0896-6273(00)80803-X; Stewart RE, 1997, AM J PHYSIOL-CELL PH, V272, pC1, DOI 10.1152/ajpcell.1997.272.1.C1; STRIEM BJ, 1989, BIOCHEM J, V260, P121, DOI 10.1042/bj2600121; Sullivan SL, 1996, P NATL ACAD SCI USA, V93, P884, DOI 10.1073/pnas.93.2.884; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; WARREN RP, 1970, NATURE, V227, P77, DOI 10.1038/227077a0; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0	40	972	1082	3	224	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					693	702		10.1016/S0092-8674(00)80705-9	http://dx.doi.org/10.1016/S0092-8674(00)80705-9			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761934	Bronze			2022-12-24	WOS:000085983800011
J	Merz, CNB; Paul-Labrador, M; Vongvanich, P				Merz, CNB; Paul-Labrador, M; Vongvanich, P			Time to reevaluate risk stratification guidelines for medically supervised exercise training in patients with coronary artery disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; MULTIFACTORIAL INTERVENTION PROGRAM; CARDIAC REHABILITATION; SUDDEN DEATHS; REDUCTION; TRIALS		Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Prevent & Rehabil Cardiac Ctr, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Burns & Allen Res Inst, Los Angeles, CA 90048 USA; Univ Calif Los Angeles, Sch Med, Dept Med, Los Angeles, CA 90024 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Merz, CNB (corresponding author), Cedars Sinai Med Ctr, Dept Med, Div Cardiol, Prevent & Rehabil Cardiac Ctr, 444 S San Vicente Blvd,Suite 901, Los Angeles, CA 90048 USA.	merz@cshs.org						*AG HLTH CAR POL R, 1995, CARD REH GUID; *AM ASS CARD PULM, 1995, GUID CARD REH PROGR; *ANT TRIAL COLL, 1983, BMJ-BRIT MED J, V296, P320; BONDESTAM E, 1995, AM J CARDIOL, V75, P767, DOI 10.1016/S0002-9149(99)80408-1; DEBUSK RF, 1994, ANN INTERN MED, V120, P721, DOI 10.7326/0003-4819-120-9-199405010-00001; Dorn J, 1999, CIRCULATION, V100, P1764, DOI 10.1161/01.CIR.100.17.1764; FLETCHER GF, 1990, CIRCULATION, V82, P2286, DOI 10.1161/01.CIR.82.6.2286; Gordon NF, 1997, AM J CARDIOL, V80, pH69, DOI 10.1016/S0002-9149(97)00825-4; HAMALAINEN H, 1989, EUR HEART J, V10, P55; Hambrecht R, 1993, J AM COLL CARDIOL, V22, P468, DOI 10.1016/0735-1097(93)90051-2; KALLIO V, 1979, LANCET, V2, P1091; LEIZOROVICZ A, 1988, EUR HEART J, V9, P8; LEVIN LA, 1991, J INTERN MED, V230, P427, DOI 10.1111/j.1365-2796.1991.tb00468.x; Merz CNB, 1996, AM HEART J, V132, P418; MILLER NH, 1984, CIRCULATION, V70, P645, DOI 10.1161/01.CIR.70.4.645; OCONNOR GT, 1989, CIRCULATION, V80, P234, DOI 10.1161/01.CIR.80.2.234; OLDRIDGE N, 1993, AM J CARDIOL, V72, P154, DOI 10.1016/0002-9149(93)90152-3; OLDRIDGE N, 1991, AM J CARDIOL, V67, P1084, DOI 10.1016/0002-9149(91)90870-Q; OLDRIDGE NB, 1988, JAMA-J AM MED ASSOC, V260, P945, DOI 10.1001/jama.260.7.945; PASHKOW FJ, 1993, J AM COLL CARDIOL, V21, P822, DOI 10.1016/0735-1097(93)90116-I; Paul-Labrador M, 1999, J Cardiopulm Rehabil, V19, P118, DOI 10.1097/00008483-199903000-00006; PAULLABRADOR M, 1994, J CARDIOPULM REHABIL, V14, P328; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; SCHULER G, 1988, CIRCULATION, V77, P172, DOI 10.1161/01.CIR.77.1.172; THOMPSON PD, 1982, JAMA-J AM MED ASSOC, V247, P2535, DOI 10.1001/jama.247.18.2535; VANCAMP SP, 1986, JAMA-J AM MED ASSOC, V256, P1160, DOI 10.1001/jama.256.9.1160; Vongvanich P, 1996, AM J CARDIOL, V77, P1383, DOI 10.1016/S0002-9149(96)00215-9; Vongvanich P, 1996, J Cardiopulm Rehabil, V16, P233, DOI 10.1097/00008483-199607000-00004; Wenger N K, 1992, Ann Acad Med Singap, V21, P141; WHITE LJ, 1988, ANN INTERN MED, V109, P671, DOI 10.7326/0003-4819-109-8-671; [No title captured]	31	2	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2000	283	11					1476	1478						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290UR	10732938				2022-12-24	WOS:000085696700033
J	Zhong, TP; Rosenberg, M; Mohideen, MAPK; Weinstein, B; Fishman, MC				Zhong, TP; Rosenberg, M; Mohideen, MAPK; Weinstein, B; Fishman, MC			gridlock, an HLH gene required for assembly of the aorta in zebrafish	SCIENCE			English	Article							REPRESSION; RECEPTOR; HOMOLOG; DOMAIN; CLOCHE; ACTS	The first artery and vein of the vertebrate embryo assemble in the trunk by migration and coalescence of angioblasts to form endothelial tubes. The gridlock (grl) mutation in zebrafish selectively perturbs assembly of the artery (the aorta). Here it is shown that grl encodes a basic helix-loop-helix (bHLH) protein belonging to the Hairy/Enhancer of the split family of bHLH proteins. The grl gene is expressed in Lateral plate mesoderm before vessel formation, and thereafter in the aorta and not in the vein. These results suggest that the arterial endothelial identity is established even before the onset of blood flow and implicate the grl gene in assignment of vessel-specific cell fate.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02129 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Fishman, MC (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, 149 13th St,4th Floor, Boston, MA 02129 USA.	fishman@cvrc.mgh.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055383] Funding Source: NIH RePORTER; NCRR NIH HHS [R01RR0888] Funding Source: Medline; NHLBI NIH HHS [T32HL07208] Funding Source: Medline; NIDDK NIH HHS [R01DK55383] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AMEMIYA CT, 1999, ZEBRAFISH GENETICS G, P236; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Burge CB, 1998, N COMP BIOC, V32, P129; Carmeliet P, 1999, NATURE, V401, P657, DOI 10.1038/44304; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Leimeister C, 1999, MECH DEVELOP, V85, P173, DOI 10.1016/S0925-4773(99)00080-5; Liao W, 1997, DEVELOPMENT, V124, P381; Nakagawa O, 1999, DEV BIOL, V216, P72, DOI 10.1006/dbio.1999.9454; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; PIERPONT MEM, 1986, GENETICS CARDIOVASCU, P13; POSTLETHWAIT JH, 1994, SCIENCE, V264, P699, DOI 10.1126/science.8171321; Purdue PE, 1997, NAT GENET, V15, P381, DOI 10.1038/ng0497-381; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143; Zhang JJ, 1998, CELL, V92, P241, DOI 10.1016/S0092-8674(00)80918-6; Zhong TP, 1998, GENOMICS, V48, P136, DOI 10.1006/geno.1997.5155	24	323	332	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1820	1824		10.1126/science.287.5459.1820	http://dx.doi.org/10.1126/science.287.5459.1820			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710309				2022-12-24	WOS:000085775300041
J	Gabashvili, IS; Agrawal, RK; Spahn, CMT; Grassucci, RA; Svergun, DI; Frank, J; Penczek, P				Gabashvili, IS; Agrawal, RK; Spahn, CMT; Grassucci, RA; Svergun, DI; Frank, J; Penczek, P			Solution structure of the E. coli 70S ribosome at 11.5 angstrom resolution	CELL			English	Article							CONTRAST TRANSFER-FUNCTION; ELONGATION-FACTOR-G; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CRYOELECTRON MICROSCOPY; TRANSFER-RNA; 3-DIMENSIONAL RECONSTRUCTION; ELECTRON CRYOMICROSCOPY; THERMUS-THERMOPHILUS; PROTEIN S7	Over 73,000 projections of the E. coli ribosome bound with formyl-methionyl initiator tRNA(f)(Met) were used to obtain an 11.5 Angstrom cryo-electron microscopy map of the complex. This map allows identification of RNA helices, peripheral proteins, and intersubunit bridges. Comparison of double-stranded RNA regions and positions of proteins identified in both cryo-EM and X-ray maps indicates good overall agreement but points to rearrangements of ribosomal components required for the subunit association. Fitting of known components of the 50S stalk base region into the map defines the architecture of the GTPase-associated center and reveals a major change in the orientation of the alpha-sarcin-ricin loop. Analysis of the bridging connections between the subunits provides insight into the dynamic signaling mechanism between the ribosomal subunits.	Hlth Res Inc, Howard Hughes Med Inst, Albany, NY 12201 USA; Wadsworth Ctr, Albany, NY 12201 USA; SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA; DESY, European Mol Biol Lab, D-22603 Hamburg, Germany; Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	Health Research Inc; Howard Hughes Medical Institute; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Frank, J (corresponding author), Hlth Res Inc, Howard Hughes Med Inst, Empire State Plaza, Albany, NY 12201 USA.	joachim@wadsworth.org	Gabashvili, Irene/S-8737-2019	Gabashvili, Irene/0000-0002-0097-1478; Svergun, Dmitri/0000-0003-0830-5696	NIGMS NIH HHS [R01 GM55440, R37 GM29169, R37 GM029169] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM029169, R01GM055440] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agrawal RK, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P53; Agrawal RK, 1999, J BIOL CHEM, V274, P8723, DOI 10.1074/jbc.274.13.8723; Agrawal RK, 1999, INT J BIOCHEM CELL B, V31, P243, DOI 10.1016/S1357-2725(98)00149-6; Agrawal RK, 1996, SCIENCE, V271, P1000, DOI 10.1126/science.271.5251.1000; Agrawal RK, 1998, P NATL ACAD SCI USA, V95, P6134, DOI 10.1073/pnas.95.11.6134; Agrawal RK, 1999, NAT STRUCT BIOL, V6, P643, DOI 10.1038/10695; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Ban N, 1999, NATURE, V400, P841, DOI 10.1038/23641; BASAVAPPA R, 1991, EMBO J, V10, P3105, DOI 10.1002/j.1460-2075.1991.tb07864.x; Bottcher B, 1998, J MOL BIOL, V281, P757, DOI 10.1006/jmbi.1998.1957; BOULIN CJ, 1988, NUCL INSTRUM METH A, V269, P312, DOI 10.1016/0168-9002(88)90895-9; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Clemons WM, 1998, STRUCT FOLD DES, V6, P429, DOI 10.1016/S0969-2126(98)00045-8; Clemons WM, 1999, NATURE, V400, P833, DOI 10.1038/23631; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Correll CC, 1999, J MOL BIOL, V292, P275, DOI 10.1006/jmbi.1999.3072; Correll CC, 1998, P NATL ACAD SCI USA, V95, P13436, DOI 10.1073/pnas.95.23.13436; Culver GM, 1999, SCIENCE, V285, P2133, DOI 10.1126/science.285.5436.2133; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; FANNING TG, 1978, NUCLEIC ACIDS RES, V5, P933, DOI 10.1093/nar/5.3.933; Frank J, 1995, BIOCHEM CELL BIOL, V73, P757, DOI 10.1139/o95-084; Frank J, 2000, RIBOSOME: STRUCTURE, FUNCTION, ANTIBIOTICS, AND CELLULAR INTERACTIONS, P45; FRANK J, 1995, OPTIK, V98, P125; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; Frank J, 2000, METHOD ENZYMOL, V317, P276; Gabashvili IS, 1999, EMBO J, V18, P6501, DOI 10.1093/emboj/18.22.6501; Gabashvili IS, 1999, J MOL BIOL, V286, P1285, DOI 10.1006/jmbi.1999.2538; GLAESER RM, 1992, ULTRAMICROSCOPY, V47, P256, DOI 10.1016/0304-3991(92)90201-T; Harms J, 1999, STRUCTURE, V7, P931, DOI 10.1016/S0969-2126(99)80120-8; Hosaka H, 1997, STRUCTURE, V5, P1199, DOI 10.1016/S0969-2126(97)00270-0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOCH MHJ, 1983, NUCL INSTRUM METHODS, V208, P461, DOI 10.1016/0167-5087(83)91169-9; LAMBERT JM, 1981, J MOL BIOL, V149, P451, DOI 10.1016/0022-2836(81)90481-2; LATA KR, 1995, ULTRAMICROSCOPY, V58, P381, DOI 10.1016/0304-3991(95)00002-I; Lata KR, 1996, J MOL BIOL, V262, P43, DOI 10.1006/jmbi.1996.0497; Li YH, 1997, J STRUCT BIOL, V120, P266, DOI 10.1006/jsbi.1997.3917; LINDAHL M, 1994, EMBO J, V13, P1249, DOI 10.1002/j.1460-2075.1994.tb06376.x; Lodmell JS, 1997, SCIENCE, V277, P1262, DOI 10.1126/science.277.5330.1262; Malhotra A, 1998, J MOL BIOL, V280, P103, DOI 10.1006/jmbi.1998.1859; Nikonov S, 1996, EMBO J, V15, P1350, DOI 10.1002/j.1460-2075.1996.tb00477.x; Orlova EV, 1997, J MOL BIOL, V271, P417, DOI 10.1006/jmbi.1997.1182; OSSWALD M, 1995, NUCLEIC ACIDS RES, V23, P4635, DOI 10.1093/nar/23.22.4635; OSSWALD M, 1990, NUCLEIC ACIDS RES, V18, P6755; Peltz SW, 1999, MOL CELL BIOL, V19, P384; Penczek P, 1999, J STRUCT BIOL, V128, P44, DOI 10.1006/jsbi.1999.4157; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; RAMAKRISHNAN V, 1992, NATURE, V358, P768, DOI 10.1038/358768a0; Schlunzen F, 1999, J SYNCHROTRON RADIAT, V6, P928, DOI 10.1107/S0909049599006664; Schmitt E, 1998, EMBO J, V17, P6819, DOI 10.1093/emboj/17.23.6819; Spahn CMT, 1999, STRUCT FOLD DES, V7, P1567, DOI 10.1016/S0969-2126(00)88347-1; Stark H, 1997, CELL, V88, P19, DOI 10.1016/S0092-8674(00)81854-1; Stark H, 1997, NATURE, V389, P403, DOI 10.1038/38770; STARK H, 1995, STRUCTURE, V3, P815, DOI 10.1016/S0969-2126(01)00216-7; Stemmer C, 1997, J MOL BIOL, V273, P52, DOI 10.1006/jmbi.1997.1270; SVERGUN DI, 1988, ACTA CRYSTALLOGR A, V44, P244, DOI 10.1107/S0108767387011255; VANHEEL M, 1986, OPTIK, V73, P83; Wilson KS, 1998, CELL, V92, P131, DOI 10.1016/S0092-8674(00)80905-8; Wimberly BT, 1997, STRUCTURE, V5, P1187, DOI 10.1016/S0969-2126(97)00269-4; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; WITTMANN HG, 1982, FEBS LETT, V146, P217, DOI 10.1016/0014-5793(82)80739-4; WittmannLiebold B, 1995, BIOCHEM CELL BIOL, V73, P1187, DOI 10.1139/o95-128; Zhu J, 1997, J STRUCT BIOL, V118, P197, DOI 10.1006/jsbi.1997.3845	63	336	352	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 3	2000	100	5					537	549		10.1016/S0092-8674(00)80690-X	http://dx.doi.org/10.1016/S0092-8674(00)80690-X			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721991	Bronze			2022-12-24	WOS:000085700000007
J	Patel, AD; Balaban, E				Patel, AD; Balaban, E			Temporal patterns of human cortical activity reflect tone sequence structure	NATURE			English	Article							STEADY-STATE RESPONSES; TONOTOPIC ORGANIZATION; MUSIC; PERCEPTION; PITCH	Despite growing interest in temporal aspects of auditory neural processing(1,2), little is known about large-scale timing patterns of brain activity during the perception of auditory sequences(3). This is partly because it has not been possible ro distinguish stimulus-related activity from other, endogenous brain signals recorded by electrical or magnetic sensors. Here we use amplitude modulation of unfamiliar, unfamiliar, similar to 1-minute-long tone sequences to label stimulus-related magnetoencephalographic neural activity in human subjects(4-9). We show that temporal patterns of activity recorded over particular brain regions track the pitch contour of tone sequences, with the accuracy of tracking increasing as tone sequences become more predictable in structure. In contrast, temporal synchronization between recording locations, particularly between sites over the left posterior hemisphere and the rest of the brain, is greatest when sequences have melody-like statistical properties(10,11) which may reflect the perceptual integration of local ant; global pitch patterns in melody-like sequences(12). This method is particularly well suited to studying temporal neural correlates of complex auditory sequences (such as speech or music) which engage multiple brain areas as perception unfolds in time.	Inst Neurosci, San Diego, CA 92121 USA		Patel, AD (corresponding author), Inst Neurosci, 10640 John Jay Hopkins Dr, San Diego, CA 92121 USA.	apatel@nsi.edu; evan@nsi.edu	Balaban, Evan/AAV-2353-2020	Balaban, Evan/0000-0002-0391-3433				[Anonymous], 1993, ENG APPL CORRELATION; BOON JP, 1995, CHAOS, V5, P501, DOI 10.1063/1.166145; Cariani PA, 1996, J NEUROPHYSIOL, V76, P1698, DOI 10.1152/jn.1996.76.3.1698; deCharms RC, 1996, NATURE, V381, P610, DOI 10.1038/381610a0; GREENBERG S, **NON-TRADITIONAL**; Gutschalk A, 1999, CLIN NEUROPHYSIOL, V110, P856, DOI 10.1016/S1388-2457(99)00019-X; HARI R, 1989, J ACOUST SOC AM, V86, P1033, DOI 10.1121/1.398093; Ligeois-Chauvel C, 1998, BRAIN, V121, P1853, DOI 10.1093/brain/121.10.1853; Makeig S, 1997, P NATL ACAD SCI USA, V94, P10979, DOI 10.1073/pnas.94.20.10979; NETTHEIM N, 1992, INTERFACE-J NEW MUS, V21, P135, DOI 10.1080/09298219208570604; PANTEV C, 1993, ELECTROEN CLIN NEURO, V88, P389, DOI 10.1016/0168-5597(93)90015-H; Pantev C, 1996, HEARING RES, V101, P62, DOI 10.1016/S0378-5955(96)00133-5; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; PETSCHE H, 1993, MUSIC PERCEPT, V11, P117; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770; SCHMUCKLER MA, 1993, J EXP PSYCHOL HUMAN, V19, P641; SIEGEL S, 1988, MONPARAMETRIC STAT B; Srinivasan R, 1999, J NEUROSCI, V19, P5435; VOSS RF, 1978, J ACOUST SOC AM, V63, P258, DOI 10.1121/1.381721; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; [No title captured]	23	82	83	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					80	84		10.1038/35003577	http://dx.doi.org/10.1038/35003577			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716446				2022-12-24	WOS:000085775100049
J	Yang, Y; Fang, SY; Jensen, JP; Weissman, AM; Ashwell, JD				Yang, Y; Fang, SY; Jensen, JP; Weissman, AM; Ashwell, JD			Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli	SCIENCE			English	Article							TUMOR-SUPPRESSOR PROTEIN; PROGRAMMED CELL-DEATH; BACULOVIRUS INHIBITOR; C-CBL; E3; FINGER; P53	To determine why proteasome inhibitors prevent thymocyte death, we examined whether proteasomes degrade anti-apoptotic molecules in cells induced to undergo apoptosis, The c-IAP1 and XIAP inhibitors of apoptosis were selectively lost in glucocorticoid- or etoposide-treated thymocytes in a proteasome-dependent manner before death. IAPs catalyzed their own ubiquitination in vitro, an activity requiring the RING domain. Overexpressed wild-type c-IAP1, but not a RING domain mutant, was spontaneously ubiquitinated and degraded, and stably expressed XIAP lacking the RING domain was relatively resistant to apoptosis-induced degradation and, correspondingly, more effective at preventing apoptosis than wild-type XIAP. Autoubiquitination and degradation of IAPs may be a key event in the apoptotic program.	NCI, Lab Immune Cell Biol, Div Basic Sci, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, Div Basic Sci, NIH, Bethesda, MD 20892 USA.		Fang, Shengyun/H-3802-2011	Fang, Shengyun/0000-0001-7280-5463	DIVISION OF BASIC SCIENCES - NCI [Z01BC009290] Funding Source: NIH RePORTER	DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; COHEN JJ, 1992, ANNU REV IMMUNOL, V10, P267, DOI 10.1146/annurev.immunol.10.1.267; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; ELBEN LJ, 1998, RESULTS PROBL CELL D, V24, P91; Fang SY, 2000, J BIOL CHEM, V275, P8945, DOI 10.1074/jbc.275.12.8945; Grimm LM, 1996, EMBO J, V15, P3835, DOI 10.1002/j.1460-2075.1996.tb00757.x; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; KRAJEWSKI S, 1994, CANCER RES, V54, P5501; Lisztwan J, 1999, GENE DEV, V13, P1822, DOI 10.1101/gad.13.14.1822; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Vucic D, 1998, J BIOL CHEM, V273, P33915, DOI 10.1074/jbc.273.51.33915; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Weissman AM, 1997, IMMUNOL TODAY, V18, P189, DOI 10.1016/S0167-5699(97)84666-X; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Young SS, 1999, MAMM GENOME, V10, P44	23	828	859	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2000	288	5467					874	877		10.1126/science.288.5467.874	http://dx.doi.org/10.1126/science.288.5467.874			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797013				2022-12-24	WOS:000086869600043
J	Cousineau, B; Lawrence, S; Smith, D; Belfort, M				Cousineau, B; Lawrence, S; Smith, D; Belfort, M			Retrotransposition of a bacterial group II intron	NATURE			English	Article							RIBOSOMAL-RNA; REVERSE-TRANSCRIPTASE; TRANSPOSITION; MOBILITY; RECOMBINATION; INTEGRATION; EVOLUTION; INVITRO; PIECES	Self-splicing group II introns may be the evolutionary progenitors of eukaryotic spliceosomal introns(1-7), but the route by which they invade new chromosomal sites is unknown. To address the mechanism by which group II introns are disseminated, we have studied the bacterial Ll.LtrB intron from Lactococcus lactis(8). The protein product of this intron, LtrA, possesses maturase, reverse transcriptase and endonuclease enzymatic activities(9-11). Together with the intron, LtrA forms a ribonucleoprotein (RNP) complex which mediates a process known as retrohoming(11). In retrohoming, the intron reverse splices into a cognate intronless DNA site. Integration of a DNA copy of the intron is recombinase independent but requires all three activities of LtrA(11). Here we report the first experimental demonstration of a group II intron invading ectopic chromosomal sites, which occurs by a distinct retrotransposition mechanism. This retrotransposition process is endonuclease-independent and recombinase-dependent, and is likely to involve reverse splicing of the intron RNA into cellular RNA targets. These retrotranspositions suggest a mechanism by which splicesomal introns may have become widely dispersed.	New York State Dept Hlth, Wadsworth Ctr, Mol Genet Program, Albany, NY 12201 USA; SUNY Albany, Sch Publ Hlth, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Belfort, M (corresponding author), New York State Dept Hlth, Wadsworth Ctr, Mol Genet Program, POB 22002, Albany, NY 12201 USA.			Belfort, Marlene/0000-0002-1592-5618				AUGUSTIN S, 1990, NATURE, V343, P383, DOI 10.1038/343383a0; BISWAS I, 1993, J BACTERIOL, V175, P3628, DOI 10.1128/JB.175.11.3628-3635.1993; CAVALIERSMITH T, 1991, TRENDS GENET, V7, P145, DOI 10.1016/0168-9525(91)90102-V; Cousineau B, 1998, CELL, V94, P451, DOI 10.1016/S0092-8674(00)81586-X; Curcio MJ, 1996, CELL, V84, P9, DOI 10.1016/S0092-8674(00)80987-3; Eickbush TH, 1999, CURR BIOL, V9, pR11, DOI 10.1016/S0960-9822(99)80034-7; FERAT JL, 1993, NATURE, V364, P358, DOI 10.1038/364358a0; Hetzer M, 1997, NATURE, V386, P417, DOI 10.1038/386417a0; JACQUIER A, 1990, TRENDS BIOCHEM SCI, V15, P351, DOI 10.1016/0968-0004(90)90075-M; KUIPERS OP, 1995, J BIOL CHEM, V270, P27299, DOI 10.1074/jbc.270.45.27299; Lambowitz AM., 1999, GROUP GROUP 2 RIBOZY, P451; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Mills DA, 1997, J BACTERIOL, V179, P6107, DOI 10.1128/jb.179.19.6107-6111.1997; Mohr G, 2000, GENE DEV, V14, P559; MOHR G, 1991, NATURE, V354, P164, DOI 10.1038/354164a0; MORL M, 1990, CELL, V60, P629, DOI 10.1016/0092-8674(90)90666-3; MUELLER MW, 1993, NATURE, V366, P174, DOI 10.1038/366174a0; ROGER AJ, 1993, NATURE, V364, P289, DOI 10.1038/364289a0; ROMAN J, 1995, RNA, V1, P478; Roman J, 1999, RNA, V5, P1, DOI 10.1017/S1355838299981244; SELLEM CH, 1993, NATURE, V366, P176, DOI 10.1038/366176a0; SHARP PA, 1991, SCIENCE, V254, P663, DOI 10.1126/science.1948046; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; THOMPSON AJ, 1994, J MOL BIOL, V236, P455, DOI 10.1006/jmbi.1994.1157; WEINER AM, 1993, CELL, V72, P161, DOI 10.1016/0092-8674(93)90654-9; WOODSON SA, 1989, CELL, V57, P335, DOI 10.1016/0092-8674(89)90971-9; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; ZIMMERLY S, 1995, CELL, V82, P545, DOI 10.1016/0092-8674(95)90027-6	29	111	114	0	5	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2000	404	6781					1018	1021		10.1038/35010029	http://dx.doi.org/10.1038/35010029			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801134				2022-12-24	WOS:000086762000062
J	Doll, R; Peto, R; Boreham, J; Sutherland, I				Doll, R; Peto, R; Boreham, J; Sutherland, I			Smoking and dementia in male British doctors: prospective study	BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMERS-DISEASE; RISK-FACTORS; POPULATION; COHORT	Objective To assess the possible association between smoking and dementia. Design Prospective study Setting Cohort of British male doctors followed up since 1951. Subjects 34 439 male British doctors, with 24 133 deaths recorded. Results For all types of dementia combined the relative risk was 0.96 (95% confidence interval 0.78 to 1.18), based on 473 deaths at a mean age of 81 years. For probable or definite Alzheimer's disease, the relative risk in continuing smokers was 0.99 (0.78 to 1.25), based on 370 deaths at a mean age of 82 years. In aggregate, however, the other prospective studies indicate a direct, although not clearly significant, association between smoking and the onset of dementia in general and of Alzheimer's disease in particular. Conclusions Contrary to previous suggestions persistent smoking does not substantially reduce the age specific onset rate of Alzheimer's disease or of dementia in general. If anything, it might increase rather than decrease the rate, but any net effect on severe dementia cannot be large in either direction.	Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England; Radcliffe Infirm, Epidemiol Studies Unit, Oxford OX2 6HE, England	Radcliffe Infirmary; University of Oxford; Radcliffe Infirmary; University of Oxford	Doll, R (corresponding author), Radcliffe Infirm, Clin Trial Serv Unit, Oxford OX2 6HE, England.							Baron JA, 1996, BRIT MED BULL, V52, P58, DOI 10.1093/oxfordjournals.bmb.a011533; Braak H, 1996, J NEURAL TRANSM, V103, P455, DOI 10.1007/BF01276421; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; DOLL R, 1956, BRIT MED J, V2, P1071, DOI 10.1136/bmj.2.5001.1071; Graves A.B, 1994, J SMOKING RELATED S1, V5, P79; HEBERT LE, 1992, AM J EPIDEMIOL, V135, P347, DOI 10.1093/oxfordjournals.aje.a116296; Hirayama T, 1992, TOB CONTROL, V1, P176; HOFMAN A, 1991, INT J EPIDEMIOL, V20, P736, DOI 10.1093/ije/20.3.736; Jellinger K. A., 1997, Journal of Neural Transmission Supplement, V51, P57; KATZMAN R, 1989, ANN NEUROL, V25, P317, DOI 10.1002/ana.410250402; Launer LJ, 1999, NEUROLOGY, V52, P78, DOI 10.1212/WNL.52.1.78; LEE PN, 1994, NEUROEPIDEMIOL, V13, P44; McKahnn G., 1984, NEUROLOGY, V34, P939; Merchant C, 1999, NEUROLOGY, V52, P1408, DOI 10.1212/WNL.52.7.1408; *OFF POP CENS SURV, 1995, 1993 MORT STAT ENGL, pR11; Ott A, 1998, LANCET, V351, P1840, DOI 10.1016/S0140-6736(97)07541-7; PRINCE M, 1994, NEUROLOGY, V44, P97; Wang HX, 1999, AM J EPIDEMIOL, V149, P640; YOSHITAKE T, 1995, NEUROLOGY, V45, P1161, DOI 10.1212/WNL.45.6.1161	19	80	86	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 22	2000	320	7242					1097	1102		10.1136/bmj.320.7242.1097	http://dx.doi.org/10.1136/bmj.320.7242.1097			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	309RJ	10775216	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000086782800014
J	Fratiglioni, L; Wang, HX; Ericsson, K; Maytan, M; Winblad, B				Fratiglioni, L; Wang, HX; Ericsson, K; Maytan, M; Winblad, B			Influence of social network on occurrence of dementia: a community-based longitudinal study	LANCET			English	Article							ALZHEIMERS-DISEASE; LEISURE ACTIVITIES; FOLLOW-UP; MORTALITY; HEALTH; DEPRESSION; QUALITY; SUPPORT; WOMEN; ONSET	Background Few data are available on the effect of social ties on dementia development. This study explored whether single social network components and different degrees of the social connections affect dementia incidence. Methods A community-based cohort of 1203 non-demented people, living at home in the Kungsholmen district of Stockholm, Sweden, and who had good cognition, was followed for an average period of 3 years. On the basis of medical and psychological data, 176 patients were diagnosed with dementia according to the criteria of the third edition revision of the Diagnostic and Statistical Manual of Mental Disorders. Information on social network was obtained by personal interview by trained nurses at baseline. The covariates included in the analysis were age, sex, education, cognitive and functional status, depressive symptoms, and vascular diseases. Findings Those individuals living alone, and those without any close social ties, both had an adjusted relative risk for developing dementia of 1.5 (95% CI 1.0-2.1 and 1.0-2.4, respectively). Compared with married people living with someone, single people and those living alone had an adjusted relative risk of 1.9 (95% CI 1.2-3.1). Infrequent contacts with network resources did not increase the risk of the disease if such contacts were experienced as satisfying. When all components were combined in an index, a poor or limited social network increased the risk of dementia by 60% (95% CI 1.2-2.1), and a significant gradient was found for the four degrees of social connections (p=0.0009). Interpretation An extensive social network seems to protect against dementia. Confirmation of this finding and further investigation to clarify the mechanisms are worthwhile due to the implications for prevention.	Stockholm Gerontol Res Ctr, S-11382 Stockholm, Sweden; Karolinska Inst, Div Geriatr Med, NEUROTEC, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Fratiglioni, L (corresponding author), Stockholm Gerontol Res Ctr, Box 6401, S-11382 Stockholm, Sweden.			Wang, Hui-Xin/0000-0002-5051-4929				Aguero-Torres H, 1999, J CLIN EPIDEMIOL, V52, P737, DOI 10.1016/S0895-4356(99)00067-0; *AM PSYCH ASS, 1987, DIAGN STAT MAN MENT, P97; Becker T, 1998, SOC PSYCH PSYCH EPID, V33, P299, DOI 10.1007/s001270050058; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cervilla JA, 1997, INT J GERIATR PSYCH, V12, P995; FABRIGOULE C, 1995, J AM GERIATR SOC, V43, P485, DOI 10.1111/j.1532-5415.1995.tb06093.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FRATIGLIONI L, 1991, NEUROLOGY, V41, P1886, DOI 10.1212/WNL.41.12.1886; Fratiglioni L, 1997, NEUROLOGY, V48, P132, DOI 10.1212/WNL.48.1.132; FRATIGLIONI L, 1997, NEUROBIOL AGING, V46, pS214; Grundy A, 1998, REV CLIN GERONTOLOGY, V8, P353, DOI [10.1017/S095925989800848X, DOI 10.1017/S095925989800848X]; HENDERSON AS, 1986, PSYCHOL MED, V16, P379, DOI 10.1017/S0033291700009211; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; JOHNSON TP, 1991, J HEALTH SOC BEHAV, V32, P408, DOI 10.2307/2137107; KASPER J, 1995, J MENTAL HLTH AGING, V0001; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; KATZMAN R, 1995, J AM GERIATR SOC, V43, P583, DOI 10.1111/j.1532-5415.1995.tb06112.x; Kawachi I, 1996, J EPIDEMIOL COMMUN H, V50, P245, DOI 10.1136/jech.50.3.245; KONDO K, 1990, PSYCHOGERIATRICS BIO, P49; Litwin H, 1998, SOC SCI MED, V46, P599, DOI 10.1016/S0277-9536(97)00207-4; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; Ren XS, 1997, SOC SCI MED, V44, P241, DOI 10.1016/S0277-9536(96)00158-X; Seeman T E, 1993, Ann Epidemiol, V3, P325; Seeman TE, 1996, ANN EPIDEMIOL, V6, P442, DOI 10.1016/S1047-2797(96)00095-6; Seeman TE, 1996, J GERONTOL B-PSYCHOL, V51, pS191, DOI 10.1093/geronb/51B.4.S191; SHYE D, 1995, SOC SCI MED, V41, P935, DOI 10.1016/0277-9536(94)00404-H; Small BJ, 1997, J GERONTOL MED SCI, V52, P299; WELIN L, 1992, J EPIDEMIOL COMMUN H, V46, P127, DOI 10.1136/jech.46.2.127; *WHO, 1967, INT CLASS DIS MAN IN, V1; Yasuda N, 1997, AM J EPIDEMIOL, V145, P516	30	864	880	3	147	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2000	355	9212					1315	1319		10.1016/S0140-6736(00)02113-9	http://dx.doi.org/10.1016/S0140-6736(00)02113-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	310LJ	10776744				2022-12-24	WOS:000086829400011
J	Hanski, I; Ovaskainen, O				Hanski, I; Ovaskainen, O			The metapopulation capacity of a fragmented landscape	NATURE			English	Article							ENVIRONMENTAL STOCHASTICITY; DYNAMICS; EXTINCTION; PERSISTENCE; POPULATIONS; PATTERNS; MODEL	Ecologists and conservation biologists have used many measures of landscape structure(1-5) to predict the population dynamic consequences of habitat loss and fragmentation(6-8), but these measures are not well justified by population dynamic theory. Here we introduce a new measure for highly fragmented landscapes, termed the metapopulation capacity, which is rigorously derived from metapopulation theory and can easily be applied to real networks of habitat fragments with known areas and connectivities. Technically, metapopulation capacity is the leading eigenvalue of an appropriate 'landscape' matrix. A species is predicted to persist in a landscape if the metapopulation capacity of that landscape is greater than a threshold value determined by the properties of the species. Therefore, metapopulation capacity can conveniently be used to rank different landscapes in terms of their capacity to support viable metapopulations. We present an empirical example on multiple networks occupied by an endangered species of butterfly. Using this theory, we may also calculate how the metapopulation capacity is changed by removing habitat fragments from or adding new ones into specific spatial locations, or by changing their areas. The metapopulation capacity should rnd many applications in metapopulation ecology, landscape ecology and conservation biology.	Univ Helsinki, Dept Ecol & Systemat, FIN-00014 Helsinki, Finland	University of Helsinki	Hanski, I (corresponding author), Univ Helsinki, Dept Ecol & Systemat, POB 17,Arkadiankatu 7, FIN-00014 Helsinki, Finland.	ilkka.hanski@helsinki.fi	Ovaskainen, Otso/AGN-4838-2022; Ovaskainen, Otso/D-9119-2012	Ovaskainen, Otso/0000-0001-9750-4421; Ovaskainen, Otso/0000-0001-9750-4421				ADLER FR, 1994, THEOR POPUL BIOL, V45, P41, DOI 10.1006/tpbi.1994.1003; ANDERSON R M, 1991; BASCOMPTE J, 1994, J ANIM ECOL, V63, P256, DOI 10.2307/5544; FOLEY P, 1994, CONSERV BIOL, V8, P124, DOI 10.1046/j.1523-1739.1994.08010124.x; Freitag S, 1998, P ROY SOC B-BIOL SCI, V265, P1475, DOI 10.1098/rspb.1998.0460; Gardner R. H., 1991, QUANTITATIVE METHODS; GARDNER RH, 1993, HUMANS AS COMPONENTS OF ECOSYSTEMS, P208; Grenfell B. T., 1995, ECOLOGY INFECT DIS N; Gustafson EJ, 1996, ECOLOGY, V77, P94, DOI 10.2307/2265659; Gustafson EJ, 1998, ECOSYSTEMS, V1, P143, DOI 10.1007/s100219900011; HANSKI I, 1994, J ANIM ECOL, V63, P151, DOI 10.2307/5591; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; Hanski I, 1997, SCIENCE, V275, P397, DOI 10.1126/science.275.5298.397; Hanski I, 1996, CONSERV BIOL, V10, P578, DOI 10.1046/j.1523-1739.1996.10020578.x; Hanski I., 1999, METAPOPULATION ECOLO; Hanski Ilkka, 1997, P217; Hill MF, 1999, ECOL LETT, V2, P121, DOI 10.1046/j.1461-0248.1999.22061.x; LANDE R, 1987, AM NAT, V130, P624, DOI 10.1086/284734; LANDE R, 1993, AM NAT, V142, P911, DOI 10.1086/285580; LAVOREL S, 1993, OIKOS, V67, P521, DOI 10.2307/3545364; Lawton John H., 1994, P41; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Lindenmayer D. B., 1994, RISK EXTINCTION RANK; MAY RM, 1991, S ZOOLOGICAL SOC LON, V62, P145; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; NEE S, 1994, NATURE, V367, P123, DOI 10.1038/367123b0; Pressey RL, 1996, BIOL CONSERV, V76, P259, DOI 10.1016/0006-3207(95)00120-4; Turner MG, 1989, LANDSCAPE ECOL, V3, P153, DOI 10.1007/BF00131534; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; With KA, 1997, OIKOS, V78, P151, DOI 10.2307/3545811	30	731	756	12	494	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2000	404	6779					755	758		10.1038/35008063	http://dx.doi.org/10.1038/35008063			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783887				2022-12-24	WOS:000086523600050
J	Ollmann, M; Young, LM; Di Como, CJ; Karim, F; Belvin, M; Robertson, S; Whittaker, K; Demsky, M; Fisher, WW; Buchman, A; Duyk, G; Friedman, L; Prives, C; Kopczynski, C				Ollmann, M; Young, LM; Di Como, CJ; Karim, F; Belvin, M; Robertson, S; Whittaker, K; Demsky, M; Fisher, WW; Buchman, A; Duyk, G; Friedman, L; Prives, C; Kopczynski, C			Drosophila p53 is a structural and functional homolog of the tumor suppressor p53	CELL			English	Article							P53-MEDIATED TRANSCRIPTIONAL REPRESSION; DEPENDENT KINASE INHIBITOR; CELL-CYCLE CHECKPOINTS; ATAXIA-TELANGIECTASIA; CRYSTAL-STRUCTURE; APOPTOSIS; GENE; PROTEIN; DEATH; EXPRESSION	The importance of p53 in carcinogenesis stems from its central role in inducing cell cycle arrest or apoptosis in response to cellular stresses. We have identified a Drosophila homolog of p53 ("Dmp53"). Like mammalian p53, Dmp53 binds specifically to human p53 binding sites, and overexpression of Dmp53 induces apoptosis. Importantly, inhibition of Dmp53 function renders cells resistant to X ray-induced apoptosis, suggesting that Dmp53 is required for the apoptotic response to DNA damage. Unlike mammalian p53, Dmp53 appears unable to induce a G1 cell cycle block when overexpressed, and inhibition of Dmp53 activity does not affect X ray-induced cell cycle arrest. These data reveal an ancestral proapoptotic function for p53 and identify Drosophila as an ideal model system for elucidating the p53 apoptotic pathway(s) induced by DNA damage.	Exelixis Inc, San Francisco, CA 94080 USA; Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Exelixis, Inc.; Columbia University	Kopczynski, C (corresponding author), Exelixis Inc, 260 Littlefield Ave, San Francisco, CA 94080 USA.	caseyk@exelixis.com		DiComo, Charles/0000-0003-2818-9215	NCI NIH HHS [CA58316, CA777742] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA058316, R01CA058316] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; Agami R, 1999, NATURE, V399, P809; AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Barker CM, 1997, EXP CELL RES, V232, P240, DOI 10.1006/excr.1997.3513; Barlow C, 1998, NAT GENET, V18, P298, DOI 10.1038/ng0398-298b; Barlow C, 1997, NAT GENET, V17, P453, DOI 10.1038/ng1297-453; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Bissonnette N, 1998, ONCOGENE, V16, P3461, DOI 10.1038/sj.onc.1201899; Brachmann RK, 1996, P NATL ACAD SCI USA, V93, P4091, DOI 10.1073/pnas.93.9.4091; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; BRODSKY MH, 2000, IN PRESS GENES DEV; BUCKBINDER L, 1995, NATURE, V377, P646, DOI 10.1038/377646a0; BUKOVSKY A, 1995, J ASSIST REPROD GEN, V12, P123, DOI 10.1007/BF02211381; Chehab NH, 2000, GENE DEV, V14, P278; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; CLORE GM, 1995, SCIENCE, V267, P1515, DOI 10.1126/science.7878474; CLORE GM, 1994, SCIENCE, V265, P386, DOI 10.1126/science.8023159; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; deNooij JC, 1996, CELL, V87, P1237, DOI 10.1016/S0092-8674(00)81819-X; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Di Como CJ, 1999, MOL CELL BIOL, V19, P1438; Di Como CJ, 1998, ONCOGENE, V16, P2527; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gong JG, 1999, NATURE, V399, P806; Gorospe M, 1997, ONCOGENE, V14, P929, DOI 10.1038/sj.onc.1200897; Gottlieb TM, 1996, BBA-REV CANCER, V1287, P77, DOI 10.1016/0304-419X(95)00019-C; Graeber TG, 1996, NATURE, V379, P88, DOI 10.1038/379088a0; Hainaut P, 1998, NUCLEIC ACIDS RES, V26, P205, DOI 10.1093/nar/26.1.205; Hall PA, 1997, CURR BIOL, V7, pR144, DOI 10.1016/S0960-9822(97)70074-5; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; HARPER JW, 1993, CELL, V75, P805; HAY BA, 1994, DEVELOPMENT, V120, P2121; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Kaelin WG, 1999, ONCOGENE, V18, P7701, DOI 10.1038/sj.onc.1202955; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Kamijo T, 1998, P NATL ACAD SCI USA, V95, P8292, DOI 10.1073/pnas.95.14.8292; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kinzler KW, 1996, NATURE, V379, P19, DOI 10.1038/379019a0; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lane ME, 1996, CELL, V87, P1225, DOI 10.1016/S0092-8674(00)81818-8; LEE W, 1995, NAT STRUCT BIOL, V2; LEE WT, 1994, NAT STRUCT BIOL, V1, P877, DOI 10.1038/nsb1294-877; Levin JM, 1997, PROTEIN ENG, V10, P771, DOI 10.1093/protein/10.7.771; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liao MJ, 1999, MOL CELL BIOL, V19, P3095; LIN JY, 1994, GENE DEV, V8, P1235, DOI 10.1101/gad.8.10.1235; Lowe Scott W., 1995, Current Opinion in Oncology, V7, P547, DOI 10.1097/00001622-199511000-00013; McCall K, 1997, TRENDS GENET, V13, P222, DOI 10.1016/S0168-9525(97)01126-8; MIYASHITA T, 1995, CELL, V80, P293; Morgan SE, 1997, ADV CANCER RES, V71, P1, DOI 10.1016/S0065-230X(08)60095-0; Nevins JR, 1997, J CELL PHYSIOL, V173, P233, DOI 10.1002/(SICI)1097-4652(199711)173:2<233::AID-JCP27>3.0.CO;2-F; NICOL CJ, 1995, NAT GENET, V11, P104, DOI 10.1038/ng0995-104b; NICOL CJ, 1995, NAT GENET, V10, P181, DOI 10.1038/ng0695-181; Norimura T, 1996, NAT MED, V2, P577, DOI 10.1038/nm0596-577; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prikhod'ko GG, 1999, J VIROL, V73, P1227; Prives C, 1999, J PATHOL, V187, P112; Quenby SM, 1999, MOL HUM REPROD, V5, P737, DOI 10.1093/molehr/5.8.737; SABBATINI P, 1995, MOL CELL BIOL, V15, P1060; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 1997, PROTEINS, P50; Schmale H, 1997, ONCOGENE, V15, P1363, DOI 10.1038/sj.onc.1201500; SHEN YQ, 1994, P NATL ACAD SCI USA, V91, P8940, DOI 10.1073/pnas.91.19.8940; Shieh SY, 2000, GENE DEV, V14, P289; STEWART N, 1995, ONCOGENE, V10, P109; Su TT, 1998, DEV BIOL, V196, P160, DOI 10.1006/dbio.1998.8855; Suzuki A, 1999, MOL CELL BIOL, V19, P3842; Suzuki A, 1999, ONCOGENE, V18, P1239, DOI 10.1038/sj.onc.1202409; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOMLINSON A, 1987, DEV BIOL, V123, P264, DOI 10.1016/0012-1606(87)90448-9; VanBeneden RJ, 1997, MOL MAR BIOL BIOTECH, V6, P116; VANVACTOR D, 1999, ANATOMICAL TECHNIQUE; VOGELSTEIN B, 1992, CELL, V70, P523, DOI 10.1016/0092-8674(92)90421-8; WAGNER AJ, 1994, GENE DEV, V8, P2817, DOI 10.1101/gad.8.23.2817; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; WOLFF T, 1991, DEVELOPMENT, V113, P841; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113; Yin YZ, 1998, DEV BIOL, V204, P165, DOI 10.1006/dbio.1998.9074; Yu DH, 1998, MOL CELL, V2, P581, DOI 10.1016/S1097-2765(00)80157-4; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; YUAN ZM, 1999, NATURE, V19	94	322	333	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2000	101	1					91	101		10.1016/S0092-8674(00)80626-1	http://dx.doi.org/10.1016/S0092-8674(00)80626-1			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	300JM	10778859	Bronze			2022-12-24	WOS:000086249900011
J	Solomon, T; Dung, NM; Vaughn, DW; Kneen, R; Thao, LTT; Raengsakulrach, B; Loan, HT; Day, NPJ; Farrar, J; Myint, KSA; Warrell, MJ; James, WS; Nisalak, A; White, NJ				Solomon, T; Dung, NM; Vaughn, DW; Kneen, R; Thao, LTT; Raengsakulrach, B; Loan, HT; Day, NPJ; Farrar, J; Myint, KSA; Warrell, MJ; James, WS; Nisalak, A; White, NJ			Neurological manifestations of dengue infection	LANCET			English	Article							JAPANESE ENCEPHALITIS; VIRUSES; FEVER; IDENTIFICATION; CHILDREN; ANTIGEN; TYPE-2; LIVER; PCR	Background Severe forms of dengue, the most important arboviral infection of man, are associated with haemorrhagic disease and a generalised Vascular leak syndrome. The importance of dengue as a cause of neurological disease is uncertain. Methods During 1995, all patients with suspected CNS infections admitted to a referral hospital in southern Vietnam were investigated by culture, PCR, and antibody measurement in serum and CSF for dengue and other viruses. Findings Of 378 patients, 16 (4.2%) were infected with dengue viruses, compared with four (1.4%) of 286 hospital controls (odds ratio [95% CI] 3.1[1.7-5.8]). Five additional dengue positive patients with CNS abnormalities were studied subsequently. No other cause of CNS infection was identified. Seven infections were primary dengue, 13 secondary, and one was not classified. Ten patients had dengue viruses isolated or detected by PCR, and three had dengue antibody in the CSF. 12 of the 21 had no characteristic features of dengue on admission. The most frequent neurological manifestations were reduced consciousness and convulsions. Nine patients had encephalitis. No patient died, but six had neurological sequelae at discharge. Phylogenetic analysis of the four DEN-2 strains isolated mapped them with a DEN-2 strain isolated from a patient with dengue haemorhagic fever, and with other strains previously isolated in southern Vietnam. Interpretation In dengue endemic areas patients with encephalitis and encephalopathy should be investigated for this infection, whether or not they have other features of the disease.	Cho Quan Hosp, Wellcome Trust Clin Res Unit, Ho Chi Minh City, Vietnam; Cho Quan Hosp, Ctr Trop Dis, Ho Chi Minh City, Vietnam; Armed Forces Res Inst Med Sci, USA, Med Component, Dept Virol, Bangkok 10400, Thailand; Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 2JD, England; John Radcliffe Hosp, Nuffield Dept Clin Med, Ctr Trop Med & Infect Dis, Oxford OX3 9DU, England	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); University of Oxford; University of Oxford	Solomon, T (corresponding author), Univ Liverpool, Walton Ctr Neurol & Neurosurg, Dept Neurol Sci, Lower Lane, Liverpool L9 7LJ, Merseyside, England.		james, william/H-4289-2013; Myint, Khin/HHS-2027-2022; White, Nicholas J/I-4629-2012; White, Nick/AAC-6527-2019	james, william/0000-0002-2506-1198; Myint, Khin/0000-0002-2087-7331; White, Nick/0000-0002-1897-1978; Solomon, Tom/0000-0001-7266-6547				BHAMARAP.N, 1967, ANN TROP MED PARASIT, V61, P500, DOI 10.1080/00034983.1967.11686519; BURKE DS, 1985, AM J TROP MED HYG, V34, P1203, DOI 10.4269/ajtmh.1985.34.1203; BURKE T, 1968, T ROY SOC TROP MED H, V62, P682, DOI 10.1016/0035-9203(68)90120-X; CHEN W-J, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P659; CHIMELLI L, 1990, CLIN NEUROPATHOL, V9, P157; COYLE PK, 1999, NEUROBASE; DAVIS LE, 1987, INFECTIONS NERVOUS S, P156; Fong MY, 1998, RES VIROLOGY, V149, P457, DOI 10.1016/S0923-2516(99)80014-4; GUBLER DJ, 1985, AM J TROP MED HYG, V34, P170, DOI 10.4269/ajtmh.1985.34.170; Halstead Scott B., 1992, World Health Statistics Quarterly, V45, P292; Innis B. L., 1990, Southeast Asian Journal of Tropical Medicine and Public Health, V21, P695; INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418; IYNGKARAN N, 1992, LANCET, V340, P1466, DOI 10.1016/0140-6736(92)92653-W; KHO LK, 1981, SE ASIAN J TROP MED, V12, P583; KUBERSKI TT, 1977, AM J TROP MED HYG, V26, P533, DOI 10.4269/ajtmh.1977.26.533; KUNO G, 1985, J VIROL METHODS, V12, P93, DOI 10.1016/0166-0934(85)90011-4; KUO CH, 1992, AM J TROP MED HYG, V47, P265, DOI 10.4269/ajtmh.1992.47.265; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Letocart M, 1997, J CLIN MICROBIOL, V35, P248, DOI 10.1128/JCM.35.1.248-253.1997; Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256; MOLYNEUX ME, 1989, Q J MED, V71, P441; MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395; NIMMANNITA S, 1987, T R SOC TROP MED HYG, V18, P292; NIMMANNITYA S, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P398; PATEY O, 1993, AM J TROP MED HYG, V48, P793, DOI 10.4269/ajtmh.1993.48.793; Plum F, 1982, DIAGNOSIS STUPOR COM, P177; Read SJ, 1997, J CLIN MICROBIOL, V35, P691, DOI 10.1128/JCM.35.3.691-696.1997; RICOHESSE R, 1990, VIROLOGY, V174, P479, DOI 10.1016/0042-6822(90)90102-W; RicoHesse R, 1997, VIROLOGY, V230, P244, DOI 10.1006/viro.1997.8504; ROSEN L, 1989, RES VIROLOGY, V140, P351, DOI 10.1016/S0923-2516(89)80115-3; Row D, 1996, AM J TROP MED HYG, V54, P253, DOI 10.4269/ajtmh.1996.54.253; Solomon T, 1998, J CLIN MICROBIOL, V36, P2030, DOI 10.1128/JCM.36.7.2030-2034.1998; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Solomon T, 1996, 7 INT C INF DIS, P132; Solomon T, 1997, NEUROL INFECT EPIDEM, V2, P191; THANH ND, 1994, TROP MED, V36, P177; World Health Organization, 1997, DENG HAEM FEV DIAGN; World Health Organization, 1975, TECHN GUID DIAGN TRE; WULUR HS, 1978, LANCET, V1, P449	39	394	421	0	11	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1053	1059		10.1016/S0140-6736(00)02036-5	http://dx.doi.org/10.1016/S0140-6736(00)02036-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744091				2022-12-24	WOS:000086380800012
J	Tchernov, E; Rieppel, O; Zaher, H; Polcyn, MJ; Jacobs, LL				Tchernov, E; Rieppel, O; Zaher, H; Polcyn, MJ; Jacobs, LL			A fossil snake with limbs	SCIENCE			English	Article							PACHYRHACHIS	A 95-million-year-old fossil snake from the Middle East documents the most extreme hindlimb development of any known member of that group, as it preserves the tibia, fibula, tarsals, metatarsals, and phalanges. It is more complete than Pachyrhachis, a second fossil snake with hindlimbs that was recently portrayed to be basal to all other snakes. Phylogenetic analysis of the relationships of the new taxon, as well as reanalysis of Pachyrhachis, shows both to be related to macrostomatans, a group that includes relatively advanced snakes such as pythons, boas, and colubroids to the exclusion of more primitive snakes such as blindsnakes and pipesnakes.	Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; Hebrew Univ Jerusalem, Dept Evolut Syst & Ecol, IL-91904 Jerusalem, Israel; Univ Sao Paulo, Dept Zool, Inst Biociencias, BR-05508900 Sao Paulo, Brazil; So Methodist Univ, Shuler Museum Paleontol, Dallas, TX 75275 USA	Field Museum of Natural History (Chicago); Hebrew University of Jerusalem; Universidade de Sao Paulo; Southern Methodist University	Rieppel, O (corresponding author), Field Museum Nat Hist, Dept Geol, 1400 S Lake Shore Dr, Chicago, IL 60605 USA.	rieppel@fmnh.org	Zaher, Hussam/ABC-1701-2021; Zaher, Hussam/D-4000-2012	Zaher, Hussam/0000-0002-6994-489X; Zaher, Hussam/0000-0002-6994-489X				BARRIE DJ, 1990, MEMOIRS QUEENSLAND M, V28, P139; Caldwell MW, 1997, NATURE, V386, P705, DOI 10.1038/386705a0; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Greene HW., 1997, SNAKES; GREER AE, 1991, J HERPETOL, V25, P166, DOI 10.2307/1564644; Haas G., 1980, P177; HAAS G, 1980, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V2, P87; HAAS G, 1979, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V1, P51; Kluge A.G., 1991, MISCELLANEOUS PUBLIC, V178, P1; Lee MSY, 1999, NATURE, V400, P655, DOI 10.1038/23236; Lee MSY, 1999, J ZOOL, V248, P509, DOI 10.1017/S0952836999008109; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Lee MSY, 1998, PHILOS T ROY SOC B, V353, P1521, DOI 10.1098/rstb.1998.0308; Nopcsa, 1923, PALAEONTOGRAPHICA, V65, P99; Polcyn Michael J., 1999, National Science Museum Monographs, V15, P259; Rage J.C., 1984, ENCY PALEOHERPETOLOG, P1; RAGE JC, 1982, CR ACAD SCI II, V294, P563; RIEPPEL O, IN PRESS ZOOL J LINN; RIEPPEL O, 2000, FIELDIANA GEOL, V43, P1, DOI DOI 10.5962/BHL.TITLE.3584; Scanlon J.D., 1999, Historical Biology, V13, P127; Scanlon JD, 2000, NATURE, V403, P416, DOI 10.1038/35000188; Zaher H, 1998, J VERTEBR PALEONTOL, V18, P1, DOI 10.1080/02724634.1998.10011029; Zaher H, 1999, CR ACAD SCI II A, V329, P831, DOI 10.1016/S1251-8050(00)88639-5; Zaher Hussam, 1999, American Museum Novitates, V3271, P1	24	172	176	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2010	2012		10.1126/science.287.5460.2010	http://dx.doi.org/10.1126/science.287.5460.2010			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720326				2022-12-24	WOS:000085902800060
J	Dalakas, MC; Park, KY; Semino-Mora, C; Lee, HS; Sivakumar, K; Goldfarb, LG				Dalakas, MC; Park, KY; Semino-Mora, C; Lee, HS; Sivakumar, K; Goldfarb, LG			Desmin myopathy, a skeletal myopathy with cardiomyopathy caused by mutations in the desmin gene.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MICE LACKING DESMIN; ALPHA-B-CRYSTALLIN; MYOFIBRILLAR MYOPATHY; INTERMEDIATE FILAMENTS; NULL MUTATION; MUSCLE; POSITIVITY; EXPRESSION; PROTEINS; VACUOLES	Background: Myofibrillar myopathies are a heterogeneous group of inherited or sporadic skeletal myopathies associated with cardiomyopathy. Among the myofibrillar proteins that accumulate within the muscle fibers of affected patients, the one found most consistently is desmin, an intermediate-filament protein responsible for the structural integrity of the myofibrils. Skeletal and cardiac myopathy develops in mice that lack desmin, suggesting that mutations in the desmin gene may be pathogenic. Methods: We examined 22 patients from 8 families with dominantly inherited myofibrillar or desmin-related myopathy and 2 patients with sporadic disease and analyzed the desmin gene for mutations, using complementary DNA (cDNA) amplified from muscle-biopsy specimens and genomic DNA extracted from blood lymphocytes. Restriction-enzyme analysis was used to confirm the mutations. Expression vectors containing normal or mutant desmin cDNA were introduced into cultured cells to determine whether the mutant desmin formed intermediate filaments. Results: Six missense mutations in the coding region of the desmin gene that cause the substitution of an amino acid were identified in 11 patients (10 members of 4 families and 1 patient with sporadic disease); a splicing defect that resulted in the deletion of exon 3 was identified in the other patient with sporadic disease. Mutations were clustered in the carboxy-terminal part of the rod domain, which is critical for filament assembly. In transfected cells, the mutant desmin was unable to form a filamentous network. Seven of the 12 patients with mutations in the desmin gene had cardiomyopathy. Conclusions: Mutations in the desmin gene affecting intermediate filaments cause a distinct myopathy that is often associated with cardiomyopathy and is termed "desmin myopathy.'' The mutant desmin interferes with the normal assembly of intermediate filaments, resulting in fragility of the myofibrils and severe dysfunction of skeletal and cardiac muscles. (N Engl J Med 2000;342:770-80.) (C)2000, Massachusetts Medical Society.	NINDS, Neuromuscular Dis Sect, NIH, Bethesda, MD 20892 USA; NINDS, Clin Neurogenet Unit, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Dalakas, MC (corresponding author), NINDS, Neuromuscular Dis Sect, NIH, Bldg 10,Rm 4N248,10 Ctr Dr,MSC 1382, Bethesda, MD 20892 USA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002038, ZIANS002973, Z01NS002973] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amato AA, 1998, NEUROLOGY, V51, P1646, DOI 10.1212/WNL.51.6.1646; Banwell BL, 1999, J NEUROPATH EXP NEUR, V58, P832, DOI 10.1097/00005072-199908000-00006; BENNARDINI F, 1992, CIRC RES, V71, P288, DOI 10.1161/01.RES.71.2.288; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; DALAKAS MC, 1997, SCI AM MED, V3; DeBleecker JL, 1996, J NEUROPATH EXP NEUR, V55, P563, DOI 10.1097/00005072-199605000-00009; Fatkin D, 1999, NEW ENGL J MED, V341, P1715, DOI 10.1056/NEJM199912023412302; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Goebel HH, 1997, CURR OPIN NEUROL, V10, P426, DOI 10.1097/00019052-199710000-00012; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Hijikata T, 1999, J CELL SCI, V112, P867; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LETAI A, 1992, J CELL BIOL, V116, P1181, DOI 10.1083/jcb.116.5.1181; Li DX, 1999, CIRCULATION, V100, P461, DOI 10.1161/01.CIR.100.5.461; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312; Nakano S, 1997, J NEUROPATH EXP NEUR, V56, P850, DOI 10.1097/00005072-199708000-00002; Nakano S, 1996, J NEUROPATH EXP NEUR, V55, P549, DOI 10.1097/00005072-199605000-00008; RAATS JMH, 1991, EUR J CELL BIOL, V56, P84; Raats JMH, 1996, EUR J CELL BIOL, V71, P221; Semino-Mora C, 1998, HUM PATHOL, V29, P1128, DOI 10.1016/S0046-8177(98)90425-7; Sivakumar K, 1996, NEUROLOGY, V46, P1337, DOI 10.1212/WNL.46.5.1337; Sjoberg G, 1999, HUM MOL GENET, V8, P2191, DOI 10.1093/hmg/8.12.2191; Sjuve R, 1998, J MUSCLE RES CELL M, V19, P415, DOI 10.1023/A:1005353805699; Thornell LE, 1997, J MOL CELL CARDIOL, V29, P2107, DOI 10.1006/jmcc.1997.0446; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Vicart P, 1996, HUM GENET, V98, P422, DOI 10.1007/s004390050233; Watson PA, 1996, AM J PHYSIOL-CELL PH, V270, pC1228, DOI 10.1152/ajpcell.1996.270.4.C1228; Weitzer G, 1995, DEV BIOL, V172, P422, DOI 10.1006/dbio.1995.8070; YU KR, 1994, P NATL ACAD SCI USA, V91, P2497, DOI 10.1073/pnas.91.7.2497	31	322	337	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2000	342	11					770	780		10.1056/NEJM200003163421104	http://dx.doi.org/10.1056/NEJM200003163421104			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293HW	10717012				2022-12-24	WOS:000085846900004
J	Anderson, MM; Lauring, AS; Burns, CC; Overbaugh, J				Anderson, MM; Lauring, AS; Burns, CC; Overbaugh, J			Identification of a cellular cofactor required for infection by feline leukemia virus	SCIENCE			English	Article							IMMUNODEFICIENCY DISEASE; RECEPTOR; INTERFERENCE; CELLS; RETROVIRUS; CLONING	Retroviral infection involves continued genetic variation, Leading to phenotypic and immunological selection for more fit virus variants in the host. For retroviruses that cause immunodeficiency, pathogenesis is linked to the emergence of T cell-tropic, cytopathic viruses. Here we show that an immunodeficiency-inducing, T cell-tropic feline Leukemia virus (FeLV) has evolved such that it cannot infect cells unless both a classic multiple membrane-spanning receptor molecule (Pit1) and a second coreceptor or entry factor are present. This second receptor component, which we call FeLIX, was identified as an endogenously expressed protein that is similar to a portion of the FeLV envelope protein. This cellular protein can function either as a transmembrane protein or as a soluble component to facilitate infection.	Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA; Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Mol & Cellular Biol Program, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Overbaugh, J (corresponding author), Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA.							ALLAN JS, 1990, SCIENCE, V247, P1084, DOI 10.1126/science.2309120; Boomer S, 1997, J VIROL, V71, P8116, DOI 10.1128/JVI.71.11.8116-8123.1997; Deng HK, 1997, NATURE, V388, P296, DOI 10.1038/40894; DONAHUE PR, 1991, J VIROL, V65, P4461, DOI 10.1128/JVI.65.8.4461-4469.1991; EGLITIS MA, 1993, J VIROL, V67, P5472, DOI 10.1128/JVI.67.9.5472-5477.1993; JOHANN SV, 1992, J VIROL, V66, P1635, DOI 10.1128/JVI.66.3.1635-1640.1992; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; KITAMURA T, 1995, P NATL ACAD SCI USA, V92, P9146, DOI 10.1073/pnas.92.20.9146; KUMAR DV, 1989, J VIROL, V63, P2379, DOI 10.1128/JVI.63.5.2379-2384.1989; MCDOUGALL AS, 1994, J VIROL, V68, P2151, DOI 10.1128/JVI.68.4.2151-2160.1994; Moser M, 1998, VIROLOGY, V242, P366, DOI 10.1006/viro.1997.9008; OVERBAUGH J, 1988, SCIENCE, V239, P906, DOI 10.1126/science.2893454; OVERBAUGH J, 1988, NATURE, V332, P731, DOI 10.1038/332731a0; Quigley JG, 2000, BLOOD, V95, P1093, DOI 10.1182/blood.V95.3.1093.003k01_1093_1099; Rasko JEJ, 1999, P NATL ACAD SCI USA, V96, P2129, DOI 10.1073/pnas.96.5.2129; Rohn JL, 1998, J VIROL, V72, P2686, DOI 10.1128/JVI.72.4.2686-2696.1998; SARMA PS, 1971, VIROLOGY, V44, P352, DOI 10.1016/0042-6822(71)90266-2; SOMMERFELT MA, 1990, VIROLOGY, V176, P58, DOI 10.1016/0042-6822(90)90230-O; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; TAKEUCHI Y, 1992, J VIROL, V66, P1219, DOI 10.1128/JVI.66.2.1219-1222.1992; Weiss R, 1985, RNA TUMOR VIRUSES; WEISS RA, 1995, CELL, V82, P531, DOI 10.1016/0092-8674(95)90024-1; [No title captured]	23	95	96	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1828	1830		10.1126/science.287.5459.1828	http://dx.doi.org/10.1126/science.287.5459.1828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710311				2022-12-24	WOS:000085775300043
J	Fagiolini, M; Hensch, TK				Fagiolini, M; Hensch, TK			Inhibitory threshold for critical-period activation in primary visual cortex	NATURE			English	Article							EXPERIENCE-DEPENDENT PLASTICITY; OCULAR DOMINANCE PLASTICITY; LONG-TERM POTENTIATION; ORIENTATION SELECTIVITY; MONOCULAR DEPRIVATION; RAT; MATURATION; DEFICIENT; SYNAPSES; SYSTEM	Neuronal circuits across several systems display remarkable plasticity to sensory input during postnatal development(1-10) Experience-dependent refinements are often restricted to well-defined critical periods in early life, but how these are established remains mostly unknown. A representative example is the loss of responsiveness in neocortex to an eye deprived of vision(2-6). Here we show that the potential for plasticity is retained throughout life until an inhibitory threshold is attained. In mice of all ages lacking an isoform of GABA (gamma-aminobutyric acid) synthetic enzyme (GAD65), as well as in immature wild-type animals before the onset of their natural critical period, benzodiazepines selectively reduced a prolonged discharge phenotype to unmask plasticity. Enhancing GABA-mediated transmission early in life rendered mutant animals insensitive to monocular deprivation as adults, similar to normal wild-type mice. Short-term presynaptic dynamics reflected a synaptic reorganization in GAD65 knockout mice after chronic diazepam treatment. A threshold level of inhibition within the visual cortex may thus trigger, once in life, an experience-dependent critical period for circuit consolidation, which may otherwise lie dormant.	RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, Wako, Saitama 3510198, Japan	RIKEN	Hensch, TK (corresponding author), RIKEN, Brain Sci Inst, Lab Neuronal Circuit Dev, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Hensch, Takao/L-4182-2019	fagiolini, michela/0000-0003-2807-803X				Bear M F, 1993, Curr Opin Neurobiol, V3, P197, DOI 10.1016/0959-4388(93)90210-P; BLUE ME, 1983, J NEUROCYTOL, V12, P697, DOI 10.1007/BF01181531; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; CYNADER M, 1980, J NEUROPHYSIOL, V43, P1026, DOI 10.1152/jn.1980.43.4.1026; DAW N, 1995, VISUAL DEV; DELCERRO S, 1992, NEUROSCIENCE, V49, P1, DOI 10.1016/0306-4522(92)90071-9; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; FAGIOLINI M, 1994, VISION RES, V34, P709, DOI 10.1016/0042-6989(94)90210-0; Feldman DE, 1998, NEURON, V20, P1067, DOI 10.1016/S0896-6273(00)80488-2; Ferster D, 1996, NATURE, V380, P249, DOI 10.1038/380249a0; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; FOX K, 1992, J NEUROSCI, V12, P1826; Gordon JA, 1996, J NEUROSCI, V16, P3274; GU Q, 1994, P NATL ACAD SCI USA, V91, P8408, DOI 10.1073/pnas.91.18.8408; Hensch TK, 1998, J NEUROSCI, V18, P2108; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; HUBEL DH, 1970, J PHYSIOL-LONDON, V206, P419, DOI 10.1113/jphysiol.1970.sp009022; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Knudsen EI, 1998, SCIENCE, V279, P1531, DOI 10.1126/science.279.5356.1531; LUHMANN HJ, 1991, J NEUROPHYSIOL, V65, P247, DOI 10.1152/jn.1991.65.2.247; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.ne.17.030194.003033; MALINOW R, 1986, NATURE, V320, P529, DOI 10.1038/320529a0; MATAGA N, 1992, NEUROSCI LETT, V142, P115, DOI 10.1016/0304-3940(92)90352-8; Maurer D, 1999, SCIENCE, V286, P108, DOI 10.1126/science.286.5437.108; MOWER GD, 1985, J NEUROPHYSIOL, V53, P572, DOI 10.1152/jn.1985.53.2.572; MULLER CM, 1989, NATURE, V342, P427, DOI 10.1038/342427a0; NELSON S, 1994, SCIENCE, V265, P774, DOI 10.1126/science.8047882; PETTIGREW JD, 1978, NATURE, V271, P761, DOI 10.1038/271761a0; SCOTT JP, 1962, SCIENCE, V138, P949, DOI 10.1126/science.138.3544.949; Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1	30	478	489	1	37	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					183	186		10.1038/35004582	http://dx.doi.org/10.1038/35004582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724170				2022-12-24	WOS:000085870900051
J	de Silva, S; Fisher, CA; Premawardhena, A; Lamabadusuriya, SP; Peto, TEA; Perera, G; Old, JM; Clegg, JB; Olivieri, NF; Weatherall, DJ				de Silva, S; Fisher, CA; Premawardhena, A; Lamabadusuriya, SP; Peto, TEA; Perera, G; Old, JM; Clegg, JB; Olivieri, NF; Weatherall, DJ		Sri Lanka Thalassaemia Study Grp	Thalassaemia in Sri Lanka: implications for the future health burden of Asian populations	LANCET			English	Article							THALASSEMIA	Background Thalassaemias pose an increasing problem for the Indian subcontinent and many Asian countries. We analysed the different types of thalassaemia in the Sri Lankan population, surveyed gene frequencies in schoolchildren. and estimated the burden of disease and requirements for its control. Methods We analysed blood samples from patients attending clinics in nine hospitals and defined the different types of beta thalassaemia by high-performance liquid chromatography (HPLC) and DNA analysis. The range of mutations was obtained by analysis of beta-globin genes. Capillary blood was obtained from schoolchildren from different parts of the island and analysed by HPLC to provide an approximate assessment of the carrier frequency of beta thalassaemia and haemoglobin E (HbE). To estimate the frequency of or thalassaemia the cr-globin genotypes were also analysed when it was possible. Findings Blood samples were obtained from 703 patients with beta thalassaemia and from 1600 schoolchildren. The thalassaemia mutations were unevenly spread. Although 23 different beta-thalassaemia mutations were found, three accounted for the thalassaemia phenotype in about 70% of the patients, most whom are homozygotes or compound heterozygotes for IVS1-5 (G-->C) or IVS1-1 (G-->A). The third common mutation, codon 26 (G-->A), which produces HbE, interacts with one or other of these mutations to produce HbE/beta thalassaemia; this comprises 13.0-30.9% of cases in the main centres. Samples from 472 patients were analysed to determine the alpha-globin genotype. Overall, 15.5% patients were carriers for deletion forms of alpha(+) thalassaemia. Average gene frequencies showed that there will be more than 2000 patients requiring treatment at any one time, in the future, of whom those with HbE/beta thalassaemia will account for about 40%. Interpretation In Sri Lanka, interactions of the two common beta-thalassaemia alleles will nearly always result in a transfusion-dependent disorder. However, about 40% of patients will have HbE/beta thalassaemia, which has a variable course. The management of these disorders could require about 5% of the total health budget. We need to learn more about the natural history and appropriate management of HbE/beta thalassaemia if resources are to be used effectively.	John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England; Gen Hosp, Thalassaemia Unit, Kurunegala, Sri Lanka; John Radcliffe Hosp, Natl Haemoglobin Reference Lab, Oxford OX3 9DU, England; John Radcliffe Hosp, MRC, Mol Haematol Unit, Oxford OX3 9DU, England; Univ Colombo, Dept Paediat, Colombo, Sri Lanka; Hosp Sick Children, Toronto, ON M5G 1X8, Canada; Toronto Gen Hosp, Toronto, ON, Canada	University of Oxford; University of Oxford; University of Oxford; University of Colombo; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Weatherall, DJ (corresponding author), John Radcliffe Hosp, Inst Mol Med, Oxford OX3 9DS, England.		Premawardhena, Anuja/GLN-5388-2022; Olivieri, Nancy/AAI-2250-2020	Premawardhena, Anuja/0000-0003-0605-9081; 				[Anonymous], 1993, WORLD DEV REPORT; BLACKWELL RQ, 1974, TROP GEOGR MED, V26, P214; Bodmer W. F., 1976, GENETICS EVOLUTION M; DESILVA CC, 1951, ARCH DIS CHILD, V26, P99; DESILVA CC, 1959, ABNORMAL HAEMOGLOBIN, P340; *EEC, 1999, PREV GEN VAR THAL IN; Ellepola S B, 1980, Ceylon Med J, V25, P29; HIGGS DR, 1993, BAILLIERE CLIN HAEM, V6, P117, DOI 10.1016/S0950-3536(05)80068-X; HUISMAN THJ, 1997, SYLLABUS THALASSAEMI; *MIN HLTH SRI LANK, 1996, ANN HLTH B; NAGARATNAM N, 1989, HEMOGLOBIN, V13, P201, DOI 10.3109/03630268908998074; Old J. M, 1983, METHODS HAEMATOLOGY, P74; OLD JM, 1990, LANCET, V336, P834, DOI 10.1016/0140-6736(90)92338-I; Rees DC, 1998, ANN NY ACAD SCI, V850, P334, DOI 10.1111/j.1749-6632.1998.tb10490.x; Weatherall DJ, 1996, NAT MED, V2, P847, DOI 10.1038/nm0896-847; WEATHERALL DJ, IN PRESS THALASSAEMI; WICKREMASINGHE RL, 1963, J R ANTHR I, V93, P117; World Health Organization, 1994, GUID CONTR HAEM DIS	18	109	110	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 4	2000	355	9206					786	791		10.1016/S0140-6736(99)08246-X	http://dx.doi.org/10.1016/S0140-6736(99)08246-X			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711926				2022-12-24	WOS:000085766900010
J	Turney, JH				Turney, JH			Renal conservation for gas-forming infections	LANCET			English	Editorial Material							EMPHYSEMATOUS PYELONEPHRITIS		Gen Infirm, Dept Renal Med, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary	Turney, JH (corresponding author), Gen Infirm, Dept Renal Med, Leeds LS1 3EX, W Yorkshire, England.							Best CD, 1999, J UROLOGY, V162, P1273, DOI 10.1016/S0022-5347(05)68263-8; Chen MT, 1997, J UROLOGY, V157, P1569, DOI 10.1016/S0022-5347(01)64797-9; EVANOFF GV, 1987, AM J MED, V83, P149, DOI 10.1016/0002-9343(87)90511-0; Kelly HA, 1898, JAMA-J AM MED ASSOC, V31, P375, DOI [10.1001/jama.1898.92450080001001, DOI 10.1001/JAMA.1898.92450080001001]; MICHAELI J, 1984, J UROLOGY, V131, P203, DOI 10.1016/S0022-5347(17)50309-2; Patterson JE, 1997, INFECT DIS CLIN N AM, V11, P735, DOI 10.1016/S0891-5520(05)70383-4; Wan YL, 1998, J UROLOGY, V159, P369, DOI 10.1016/S0022-5347(01)63919-3; Wan YL, 1996, RADIOLOGY, V198, P433, DOI 10.1148/radiology.198.2.8596845	8	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 4	2000	355	9206					770	771		10.1016/S0140-6736(99)00351-7	http://dx.doi.org/10.1016/S0140-6736(99)00351-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711921				2022-12-24	WOS:000085766900005
J	Wuite, GJL; Smith, SB; Young, M; Keller, D; Bustamante, C				Wuite, GJL; Smith, SB; Young, M; Keller, D; Bustamante, C			Single-molecule studies of the effect of template tension on T7 DNA polymerase activity	NATURE			English	Article							BACTERIOPHAGE-T7; EXONUCLEASE; FIDELITY; ENZYME	T7 DNA polymerase(1,2) catalyses DNA replication in vitro at rates of more than 100 bases per second and has a 3'--> 5' exonuclease (nucleotide removing) activity at a separate active site. This enzyme possesses a 'right hand' shape which is common to most polymerases with fingers, palm and thumb domains(3,4). The rate-limiting step for replication is thought to involve a conformational change between an 'open fingers' state in which the active site samples nucleotides, and a 'closed' state in which nucleotide incorporation occurs(3,5). DNA polymerase must function as a molecular motor converting chemical energy into mechanical force as it moves over the template. Here we show, using a single-molecule assay based on the differential elasticity of single-stranded and double-stranded DNA, that mechanical force is generated during the rate-limiting step and that the motor can work against a maximum template tension of similar to 34 pN. Estimates of the mechanical and entropic work done by the enzyme show that T7 DNA polymerase organizes two template bases in the polymerization site during each catalytic cycle. We also find a force-induced 100-fold increase in exonucleolysis above 40pN.	Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; Univ New Mexico, Dept Chem, Albuquerque, NM 87131 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Oregon; University of New Mexico	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA.			Bustamante, Carlos/0000-0002-2970-0073; wuite, gijs/0000-0002-5706-043X				BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cluzel P, 1996, SCIENCE, V271, P792, DOI 10.1126/science.271.5250.792; DONLIN MJ, 1991, BIOCHEMISTRY-US, V30, P538, DOI 10.1021/bi00216a031; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Doublie S, 1998, CURR OPIN STRUC BIOL, V8, P704, DOI 10.1016/S0959-440X(98)80089-4; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Gurrieri S, 1999, P NATL ACAD SCI USA, V96, P453, DOI 10.1073/pnas.96.2.453; Hegner M, 1999, P NATL ACAD SCI USA, V96, P10109, DOI 10.1073/pnas.96.18.10109; HUBER HE, 1987, J BIOL CHEM, V262, P16224; JOHNSON KA, 1993, ANNU REV BIOCHEM, V62, P685, DOI 10.1146/annurev.bi.62.070193.003345; LEHMAN IR, 1964, J BIOL CHEM, V239, P2628; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008; MODRICH P, 1975, J BIOL CHEM, V250, P5515; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Smith SB, 1996, SCIENCE, V271, P795, DOI 10.1126/science.271.5250.795; TABOR S, 1987, J BIOL CHEM, V262, P16212; WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0	19	394	410	2	73	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					103	106		10.1038/35003614	http://dx.doi.org/10.1038/35003614			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716452				2022-12-24	WOS:000085775100055
J	Kawabuchi, M; Satomi, Y; Takao, T; Shimonishi, Y; Nada, S; Nagai, K; Tarakhovsky, A; Okada, M				Kawabuchi, M; Satomi, Y; Takao, T; Shimonishi, Y; Nada, S; Nagai, K; Tarakhovsky, A; Okada, M			Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases	NATURE			English	Article							T-CELL ACTIVATION; PHOSPHORYLATED PROTEINS; CSK; SUPPRESSION; MEMBRANES; DOMAINS; RAFTS	The Src family of protein tyrosine kinases (Src-PTKs) is important in the regulation of growth and differentiation of eukaryotic cells. The activity of Src-PTKs in cells of different types is negatively controlled by Csk, which specifically phosphorylates a conserved regulatory tyrosine residue at the carboxy-terminal tail of the Src-PTKs(1-3). Csk is mainly cytoplasmic and Src-PTKs are predominantly membrane-associated. This raises a question about the mechanism of interaction between these enzymes. Here we present Cbp-a transmembrane phosphoprotein that is ubiquitously expressed and binds specifically to the SH2 domain of Csk. Cbp is involved in the membrane localization of Csk and in the Csk-mediated inhibition of c-Src. In the plasma membrane Cbp is exclusively localized in the GM1 ganglioside-enriched detergent-insoluble membrane domain, which is important in receptor-mediated signalling(4-8). These findings reveal Cbp as a new component of the regulatory mechanism controlling the activity of membrane-associated Src-PTKs.	Osaka Univ, Inst Prot Res, Div Prot Metab, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Prot Res, Div Organ Chem, Suita, Osaka 5650871, Japan; Osaka Univ, Inst Sci & Ind Res, Dept Cell Membrane Biol, Div Biol Sci, Osaka 5670047, Japan; Univ Cologne, Inst Genet, Lab Lymphocyte Signalling, D-50931 Cologne, Germany	Osaka University; Osaka University; Osaka University; University of Cologne	Tarakhovsky, A (corresponding author), Osaka Univ, Inst Prot Res, Div Prot Metab, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sasha@mac.genetik.uni-koeln.de; okadam@protein.osaka-u.ac.jp		Satomi, Yoshinori/0000-0002-8991-1040				Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937; Hakak Y, 1999, CURR BIOL, V9, P1039, DOI 10.1016/S0960-9822(99)80453-9; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Harder KW, 1998, J BIOL CHEM, V273, P31890, DOI 10.1074/jbc.273.48.31890; Harlow E, 1988, ANTIBODIES LABORATOR, P359; HOWELL BW, 1994, MOL CELL BIOL, V14, P5402, DOI 10.1128/MCB.14.8.5402; Jensen ON, 1999, METH MOL B, V112, P513; Kobayashi S, 1998, J BIOCHEM-TOKYO, V123, P624; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; NADA S, 1994, ONCOGENE, V9, P3571; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; NADA S, 1991, NATURE, V351, P69, DOI 10.1038/351069a0; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Tsuda M, 1998, J BIOL CHEM, V273, P13223, DOI 10.1074/jbc.273.21.13223; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Zhang WG, 1998, IMMUNITY, V9, P239, DOI 10.1016/S1074-7613(00)80606-8; Zhang YQ, 1998, IEEE T NEURAL NETWOR, V9, P83, DOI 10.1109/72.655032	21	443	468	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2000	404	6781					999	1003		10.1038/35010121	http://dx.doi.org/10.1038/35010121			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801129				2022-12-24	WOS:000086762000057
J	van Dellen, A; Blakemore, C; Deacon, R; York, D; Hannan, AJ				van Dellen, A; Blakemore, C; Deacon, R; York, D; Hannan, AJ			Delaying the onset of Huntington's in mice	NATURE			English	Article							SIZED SPINY NEURONS; STRIATUM; DENSITY; GENE		Univ Oxford, Physiol Lab, Oxford OX1 3PT, England; Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England; Univ Natal, Sch Med, Dept Virol, ZA-4001 Durban, South Africa	University of Oxford; University of Oxford; University of Kwazulu Natal	van Dellen, A (corresponding author), Univ Oxford, Physiol Lab, Parks Rd, Oxford OX1 3PT, England.			Hannan, Anthony/0000-0001-7532-8922; Blakemore, Colin/0000-0003-2659-7899				COMERY TA, 1995, NEUROBIOL LEARN MEM, V63, P217, DOI 10.1006/nlme.1995.1025; Comery TA, 1996, NEUROBIOL LEARN MEM, V66, P93, DOI 10.1006/nlme.1996.0049; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Deckel AW, 1998, NEUROLOGY, V51, P1576, DOI 10.1212/WNL.51.6.1576; Foster TC, 1996, BRAIN RES, V736, P243, DOI 10.1016/0006-8993(96)00707-X; Georgiou N, 1999, MOVEMENT DISORD, V14, P320, DOI 10.1002/1531-8257(199903)14:2<320::AID-MDS1018>3.0.CO;2-Z; Hodgson JG, 1999, NEURON, V23, P181, DOI 10.1016/S0896-6273(00)80764-3; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MURPHY KPS, IN PRESS J NEUROSCI; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	11	370	374	0	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					721	722		10.1038/35008142	http://dx.doi.org/10.1038/35008142			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783874				2022-12-24	WOS:000086523600037
J	Firstenberg, MS; Thomas, JD				Firstenberg, MS; Thomas, JD			Stroke-distance measurement after acute myocardial infarction	LANCET			English	Editorial Material									Cleveland Clin Fdn, Cardiovasc Imaging Ctr, Cleveland, OH 44195 USA; Cleveland Clin Fdn, Dept Cardiol, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Thomas, JD (corresponding author), Cleveland Clin Fdn, Cardiovasc Imaging Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.							Trent RJ, 1999, HEART, V82, P187, DOI 10.1136/hrt.82.2.187	1	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1204	1204		10.1016/S0140-6736(00)02084-5	http://dx.doi.org/10.1016/S0140-6736(00)02084-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770300				2022-12-24	WOS:000086448000007
J	Cavicchi, M; Beau, P; Crenn, P; Degott, C; Messing, B				Cavicchi, M; Beau, P; Crenn, P; Degott, C; Messing, B			Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure	ANNALS OF INTERNAL MEDICINE			English	Article							P-GLYCOPROTEIN GENE; URSODEOXYCHOLIC ACID; CHRONIC CHOLESTASIS; LIPID EMULSIONS; BOWEL RESECTION; FUNCTION TESTS; CHILDREN; RATS; TRANSPLANTATION; METRONIDAZOLE	Background: Liver cholestasis can be a life-threatening complication during home parenteral nutrition and may lead to combined liver-intestinal transplantation. Objective: To assess the prevalence of home parenteral nutrition-related liver disease and its contributing factors in patients with permanent intestinal failure. Design: Prospective cohort study. Setting: Two approved home parenteral nutrition centers, Patients: 90 patients with permanent intestinal failure who were receiving home parenteral nutrition were enrolled from 1985 to 1996. Intervention: Clinical, biological, endoscopic, and ultrasonographic follow-up. Histologic examination of the liver was done in 57 patients (112 liver biopsies). Measurements: The Kaplan-Meier method was used to determine the actuarial occurrence of chronic cholestasis and complicated home parenteral nutrition-related liver disease (bilirubin level greater than or equal to 60 mu mol/L [3.5 mg/dL], factor V level less than or equal to 50%, portal hypertension, encephalopathy, ascites, gastrointestinal bleeding, or histologically proven extensive fibrosis or cirrhosis). Contributing factors were assessed by using univariate and multivariate (Cox model) analysis. Results: 58 patients (65%) developed chronic cholestasis after a median of 6 months (range, 3 to 132 months), and 37 (41.5%)developed complicated home parenteral nutrition-related liver disease after a median of 17 months (range, 2 to 155 months). Of these patients, 17 showed extensive fibrosis after 26 months (range, 2 to 148 months) and 5 had cirrhosis after 37 months (range, 26 to 77 months). The prevalence of complicated home parenteral nutrition-related liver disease was 26% +/- 9% at 2 years and 50% +/- 13% at 6 years. Six patients died of liver disease (22% of all deaths). In multivariate analysis, chronic cholestasis was significantly associated with a parenteral nutrition-independent risk for liver disease, a bowel remnant shorter than 50 cm in length, and a parenteral lipid intake of 1 g/kg of body weight per day or more (omega-6-rich long-chain triglycerides), whereas complicated home parenteral nutrition-related liver disease was significantly associated with chronic cholestasis and lipid parenteral intake of 1 g/kg per day or more. Conclusion: The prevalence of complicated home parenteral nutrition-related liver disease increased with longer duration of parenteral nutrition. This condition was one of the main causes of death in patients with permanent intestinal failure. Parenteral intake of w-6-rich long-chain triglycerides lipid emulsion consisting of less than 1 g/kg per day is recommended in these patients.	Hop Lariboisiere, Serv Gastroenterol & Assistance Nutr, F-75475 Paris 10, France; Ctr Hosp La Miletrie, Poitiers, France; Hop Beaujon, Clichy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Poitiers; Universite de Poitiers; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Messing, B (corresponding author), Hop Lariboisiere, Serv Gastroenterol & Assistance Nutr, 2 Rue Ambroise Pare, F-75475 Paris 10, France.	bernard.messing@lrb.ap-hop-paris.fr	CRENN, Pascal/B-5850-2008	CRENN, Pascal/0000-0002-8213-2319				ALLARDYCE DB, 1982, SURG GYNECOL OBSTET, V154, P641; BEAU P, 1994, J HEPATOL, V20, P240, DOI 10.1016/S0168-8278(05)80064-9; BEAU P, 1994, GASTROEN CLIN BIOL, V18, P63; BELLI DC, 1987, JPEN-PARENTER ENTER, V11, P67, DOI 10.1177/014860718701100167; BENJAMIN DR, 1981, AM J CLIN PATHOL, V76, P276; BOWYER BA, 1985, JPEN-PARENTER ENTER, V9, P11, DOI 10.1177/014860718500900111; Brousse N, 1996, BRIT MED J, V312, P261; BURNES JU, 1992, JPEN-PARENTER ENTER, V16, P327, DOI 10.1177/0148607192016004327; CANO N, 1994, NUTR CLIN METAB, V8, P149; CAPRON JP, 1983, LANCET, V1, P446; CLARKE PJ, 1991, JPEN-PARENTER ENTER, V15, P54, DOI 10.1177/014860719101500154; CLAYTON PT, 1993, GASTROENTEROLOGY, V105, P1806, DOI 10.1016/0016-5085(93)91079-W; Cox DR., 1989, ANAL BINARY DATA; CRAIG RM, 1980, GASTROENTEROLOGY, V79, P131; Crenn P, 1997, CLIN NUTR, V16, P133, DOI 10.1016/S0261-5614(97)80240-3; DAHMS BB, 1981, GASTROENTEROLOGY, V81, P136; DEGOTT C, 1988, GASTROENTEROLOGY, V95, P183, DOI 10.1016/0016-5085(88)90309-5; DRONGOWSKI RA, 1989, JPEN-PARENTER ENTER, V13, P586, DOI 10.1177/0148607189013006586; FISCHER GW, 1980, LANCET, V2, P819; Forbush B, 1998, GASTROENTEROLOGY, V114, pA1241, DOI 10.1016/S0016-5085(98)85034-8; FOUINFORTUNET H, 1982, GASTROENTEROLOGY, V82, P932; GERARDBONCOMPAIN M, 1992, JPEN-PARENTER ENTER, V16, P78, DOI 10.1177/014860719201600178; GOGOS CA, 1992, NUTRITION, V8, P26; Grant D, 1999, TRANSPLANTATION, V67, P1061, DOI 10.1097/00007890-199904150-00021; GUERTIN F, 1991, JPEN-PARENTER ENTER, V15, P247, DOI 10.1177/0148607191015003247; Harris JA., 1919, BIOMETRIC STUDY BASA; INNES GK, 1988, TRANSPLANTATION, V45, P749, DOI 10.1097/00007890-198804000-00017; ITO Y, 1991, JPEN-PARENTER ENTER, V15, P271, DOI 10.1177/0148607191015003271; KAMINSKI DL, 1980, SURGERY, V88, P93; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KONO K, 1988, GASTROENTEROLOGY, V94, P787, DOI 10.1016/0016-5085(88)90255-7; LAMBERT JR, 1985, JPEN-PARENTER ENTER, V9, P501, DOI 10.1177/0148607185009004501; LEVECQ H, 1988, GASTROEN CLIN BIOL, V12, P691; MARTINEZ M, 1987, LIPIDS, V22, P133, DOI 10.1007/BF02537290; MESSING B, 1992, NUTRITION, V8, P30; Messing B, 1999, GASTROENTEROLOGY, V117, P1043, DOI 10.1016/S0016-5085(99)70388-4; MESSING B, 1995, GASTROENTEROLOGY, V108, P1005, DOI 10.1016/0016-5085(95)90196-5; MESSING B, 1990, AM J CLIN NUTR, V52, P1094, DOI 10.1093/ajcn/52.6.1094; MESSING B, 1994, TRANSPL P, V26, P1438; MESSING B, 1982, GASTROEN CLIN BIOL, V6, P740; MUGHAL M, 1986, LANCET, V2, P383; NANJI AA, 1985, JPEN-PARENTER ENTER, V9, P307, DOI 10.1177/0148607185009003307; PEDEN VH, 1971, J PEDIATR-US, V78, P180, DOI 10.1016/S0022-3476(71)80289-5; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; Piquette-Miller M, 1998, PHARMACEUT RES, V15, P706, DOI 10.1023/A:1011962818051; QUIGLEY EMM, 1993, GASTROENTEROLOGY, V104, P286, DOI 10.1016/0016-5085(93)90864-9; Quigley EMM, 1996, GASTROENTEROLOGY, V110, P2009, DOI 10.1053/gast.1996.v110.agast962009; Roth B, 1996, INTENS CARE MED, V22, P1224, DOI 10.1007/s001340050242; SCOTTCONNER CEH, 1994, J SURG RES, V57, P316, DOI 10.1006/jsre.1994.1151; SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9; Spagnuolo MI, 1996, GASTROENTEROLOGY, V111, P716, DOI 10.1053/gast.1996.v111.pm8780577; Stanko RT, 1987, GASTROENTEROLOGY, V92, P197, DOI 10.1016/0016-5085(87)90859-6; Tabachnik B.G., 1983, USING MULTIVARIATE S; TKOUB M, 1997, CLIN NUTR S1, V16, P32; Trauner M, 1997, GASTROENTEROLOGY, V113, P255, DOI 10.1016/S0016-5085(97)70103-3; VANDENBOSCH H, 1992, ANNU REV BIOCHEM, V61, P157, DOI 10.1146/annurev.bi.61.070192.001105; VANDEVENTER SJH, 1988, GASTROENTEROLOGY, V94, P825, DOI 10.1016/0016-5085(88)90261-2; vanNieuwkerk CMJ, 1996, GASTROENTEROLOGY, V111, P165, DOI 10.1053/gast.1996.v111.pm8698195; WOLFE BM, 1988, ARCH SURG-CHICAGO, V123, P1084	59	433	449	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 4	2000	132	7					525	532		10.7326/0003-4819-132-7-200004040-00003	http://dx.doi.org/10.7326/0003-4819-132-7-200004040-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	298FU	10744588				2022-12-24	WOS:000086129300002
J	Schoof, H; Lenhard, M; Haecker, A; Mayer, KFX; Jurgens, G; Laux, T				Schoof, H; Lenhard, M; Haecker, A; Mayer, KFX; Jurgens, G; Laux, T			The stem cell population of Arabidopsis shoot meristems is maintained by a regulatory loop between the CLAVATA and WUSCHEL genes	CELL			English	Article							FLORAL MERISTEMS; EXPRESSION; PROTEIN; ZWILLE; FATE	The higher-plant shoot meristem is a dynamic structure whose maintenance depends on the coordination of two antagonistic processes, organ initiation and self-renewal of the stem cell population. In Arabidopsis shoot and floral meristems, the WUSCHEL (WUS) gene is required for stem cell identity, whereas the CLAVATA1, 2, and 3 (CLV) genes promote organ initiation. Our analysis of the interactions between these key regulators indicates that (1) the CLV genes repress WUS at the transcript level and that (2) WUS expression is sufficient to induce meristem cell identity and the expression of the stem cell marker CLV3. Our data suggest that the shoot meristem has properties of a self-regulatory system in which WUS/CLV interactions establish a feedback loop between the stem cells and the underlying organizing center.	Zentrum Mol Biol Pflanzen, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Laux, T (corresponding author), Zentrum Mol Biol Pflanzen, Morgenstelle 1, D-72076 Tubingen, Germany.	thomas.laux@uni-tuebingen.de	Mayer, Klaus FX/M-7941-2015; Schoof, Heiko/Y-7073-2018; Lenhard, Michael/J-1554-2015	Mayer, Klaus FX/0000-0001-6484-1077; Schoof, Heiko/0000-0002-1527-3752; 				BECKER D, 1992, PLANT MOL BIOL, V20, P1195, DOI 10.1007/BF00028908; Bowman J., 1994, ARABIDOPSIS ATLAS MO, V102, P117; CLARK SE, 1993, DEVELOPMENT, V119, P397; Clark SE, 1996, DEVELOPMENT, V122, P1567; CLARK SE, 1995, DEVELOPMENT, V121, P2057; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Endrizzi K, 1996, PLANT J, V10, P967, DOI 10.1046/j.1365-313X.1996.10060967.x; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Jeong S, 1999, PLANT CELL, V11, P1925, DOI 10.1105/tpc.11.10.1925; Kayes JM, 1998, DEVELOPMENT, V125, P3843; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; Laufs P, 1998, PLANT CELL, V10, P1375, DOI 10.1105/tpc.10.8.1375; Laufs P, 1998, DEVELOPMENT, V125, P1253; Laux T, 1996, DEVELOPMENT, V122, P87; Lenhard M, 1999, CURR OPIN PLANT BIOL, V2, P44, DOI 10.1016/S1369-5266(99)80009-0; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Lynn K, 1999, DEVELOPMENT, V126, P469; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Moore I, 1998, P NATL ACAD SCI USA, V95, P376, DOI 10.1073/pnas.95.1.376; Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; STEWART RN, 1970, AM J BOT, V57, P816, DOI 10.2307/2441339; VANDERKROL AR, 1991, PLANT CELL, V3, P667, DOI 10.1105/tpc.3.7.667; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	25	1169	1267	17	243	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					635	644		10.1016/S0092-8674(00)80700-X	http://dx.doi.org/10.1016/S0092-8674(00)80700-X			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761929	Bronze			2022-12-24	WOS:000085983800006
J	Hsueh, YP; Wang, TF; Yang, FC; Sheng, M				Hsueh, YP; Wang, TF; Yang, FC; Sheng, M			Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/LIN-2	NATURE			English	Article							EPITHELIAL-CELLS; BASOLATERAL MEMBRANE; PROTEIN COMPLEX; BETA-CATENIN; IDENTIFICATION; LOCALIZATION; BRACHYURY; HOMOLOG; DOMAIN	Membrane-associated guanylate kinases (MAGUKs) contain multiple protein-binding domains that allow them to assemble specific multiprotein complexes in particular regions of the cell(1,2). CASK/LIN-2, a MAGUK required for EGF receptor localization and signalling in Caenorhabditis elegans, contains a calmodulin-dependent protein kinase-like domain followed by PDZ, SH3 and guanylate kinase-like domains(3-5). In adult rat brain, CASK is concentrated at neuronal synapses and binds to the cell-surface proteins neurexin and syndecan(6-8) and the cytoplasmic proteins Mint/LIN-10 and Veli/LIN-7 (refs 4, 9, 10). Here we report that, through its guanylate kinase domain, CASK interacts with Tbr-1, a T-box transcription factor that is involved in forebrain development(11,12). CASK enters the nucleus and binds to a specific DNA sequence (the T-element) in a complex with Tbr-1. CASK acts as a coactivator of Tbr-1 to induce transcription of T-element containing genes, including reelin, a gene that is essential for cerebrocortical development. Our findings show that a MAGUK which is usually associated with cell junctions has a transcription regulation function.	Howard Hughes Med Inst, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Neurobiol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA 02114 USA	Howard Hughes Medical Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheng, M (corresponding author), Howard Hughes Med Inst, Boston, MA 02114 USA.	sheng@helix.mgh.harvard.edu	Hsueh, Yi-Ping/ABH-5052-2020; Wang, Ting-Fang/ABI-3818-2020	Hsueh, Yi-Ping/0000-0002-0866-6275; Wang, Ting-Fang/0000-0001-6306-9505; Sheng, Morgan/0000-0002-8703-5366				Anderson JM, 1996, CURR BIOL, V6, P382, DOI 10.1016/S0960-9822(02)00501-8; Borg JP, 1998, J BIOL CHEM, V273, P31633, DOI 10.1074/jbc.273.48.31633; Bredt DS, 1998, CELL, V94, P691, DOI 10.1016/S0092-8674(00)81727-4; BULFONE A, 1995, NEURON, V15, P63, DOI 10.1016/0896-6273(95)90065-9; Butz S, 1998, CELL, V94, P773, DOI 10.1016/S0092-8674(00)81736-5; Cohen AR, 1998, J CELL BIOL, V142, P129, DOI 10.1083/jcb.142.1.129; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Hata Y, 1996, J NEUROSCI, V16, P2488; Hevner R. F., 1999, Society for Neuroscience Abstracts, V25, P502; Hsueh YP, 1999, J NEUROSCI, V19, P7415, DOI 10.1523/JNEUROSCI.19-17-07415.1999; Hsueh YP, 1998, J CELL BIOL, V142, P139, DOI 10.1083/jcb.142.1.139; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; HSUEH YP, 1995, J IMMUNOL, V154, P5675; Kaech SM, 1998, CELL, V94, P761, DOI 10.1016/S0092-8674(00)81735-3; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim SK, 1997, CURR OPIN CELL BIOL, V9, P853, DOI 10.1016/S0955-0674(97)80088-9; KISPERT A, 1995, EMBO J, V14, P4763, DOI 10.1002/j.1460-2075.1995.tb00158.x; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Niethammer M, 1998, METHOD ENZYMOL, V293, P104; Peifer M, 1997, SCIENCE, V275, P1752, DOI 10.1126/science.275.5307.1752	22	278	288	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					298	302		10.1038/35005118	http://dx.doi.org/10.1038/35005118			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749215				2022-12-24	WOS:000086022200053
J	Rein, M				Rein, M			Stress and genital herpes recurrences in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Background: Results of several studies suggest that psychological stress and negative mood can trigger genital herpes recurrences, but results are inconsistent. Objective: To determine whether short-term or persistent psychological stress or specific negative moods are predictive of genital herpes recurrences in women. Methods: A prospective cohort study followed up participants for 6 months using weekly assessments of stress and mood, monthly assessment of life chang events, and diary reports of genital herpes recurrences confirmed medical examination when feasible. The. community sample consisted of 58 women, aged 20 to 44 years; with a 1- to 10-year history of visible genital herpes recurrence and at least 1 recurrence in the previous 6 months. Results: Persistent stress predicted recurrence in the subsequent week (odds ratio, 1.08 per unit increase in stress; 95%, confidence interval, 1.01-1.15; P = .03). After adjusting for recurrence in the previous week, the more weekly persistent stress reported, the greater the likelihood of recurrence the following week. Also, an increased recurrence rate occurred after the month during which participants experienced their highest levels of anxiety (P = .03). There were no significant associations between recurrence and short-term stress, life events, depressive mood, anger, or phase of menstrual cycle. Conclusions: Persistent stressors and highest level of anxiety predicted genital herpes recurrence, whereas transient mood states, short-term stressors, and life change events did not. Women with herpes can be reassured that short-term stressful life experiences and dysphoric mood states do not put them at risk for increased outbreaks of recurrent genital herpes.	Univ Virginia, Hlth Sci Ctr, Div Infect Dis, Charlottesville, VA 22908 USA	University of Virginia	Rein, M (corresponding author), Univ Virginia, Hlth Sci Ctr, Div Infect Dis, Charlottesville, VA 22908 USA.	mfr6t@virginia.edu							0	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2000	283	11					1394	1394		10.1001/jama.283.11.1394	http://dx.doi.org/10.1001/jama.283.11.1394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290UR	10732915				2022-12-24	WOS:000085696700001
J	Baker, S; Priest, P; Jackson, R				Baker, S; Priest, P; Jackson, R			Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; DRUG-TREATMENT; NEW-ZEALAND; GUIDELINES; MANAGEMENT; TRIALS; METAANALYSIS; DYSLIPIDEMIA; FRAMINGHAM	Objective To estimate the impact of using thresholds based on absolute risk of cardiovascular disease to target drug treatment to lower blood pressure in the community. Design Modelling of three thresholds of treatment for hypertension based on the absolute risk of cardiovascular disease. 5 year risk of disease was estimated for each participant using an equation to predict risk. Net predicted impact of the thresholds on the number of people treated and the number of disease events averted over 5 years was calculated Setting Auckland, New Zealand. Participants 2158 men and women aged 35-79 veers randomly sampled from the general electoral rolls. Main outcome measures Predicted 5 year risk of cardiovascular disease event estimated number of people for whom treatment would be recommended and disease events averted over 5 years at different treatment thresholds. Results 46 374 (12%) Auckland residents aged 35-79 receive drug treatment to lower their blood pressure, averting an estimated 1689 disease events: over 5 years. Restricting treatment to individuals with blood pressure greater than or equal to 170/100 mm Hg and those with blood pressure between 150/90-169/99 mm Hg who have a predicted 5 year risk of disease greater than or equal to 10% would increase the net number for whom treatment would be recommended by 19 401. This 42% relative increase is predicted to avert 1139/1689 (68%) additional disease events overall over 5 years compared with current treatment. If the threshold for 5 year risk of disease is set at 15% the number recommended for treatment increases by < 10% but about 620/1689 (37%) additional events can be averted. A 20% threshold decreases the net number of patients recommended fur treatment by about 10% but averts 204/1689 (12%) more disease events than current treatment. Conclusions Implementing treatment guidelines that use treatment thresholds based on absolute risk could significantly improve the efficiency of drug treatment to lower blood pressure in primary care.	Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Auckland 1, New Zealand; Univ Oxford Wolfson Coll, Oxford OX2 6UD, England; Hlth Funding Author, Auckland, New Zealand	University of Auckland; University of Oxford	Jackson, R (corresponding author), Univ Auckland, Fac Med & Hlth Sci, Dept Community Hlth, Private Bag 92019, Auckland 1, New Zealand.	rt.jackson@auckland.co.nz		Jackson, Rod/0000-0001-5914-6934				ALLAIN CC, 1974, CLIN CHEM, V20, P470; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; BRAND RJ, 1976, CIRCULATION, V53, P348, DOI 10.1161/01.CIR.53.2.348; *COR SERV COMM, 1995, GUID MAN RAIS BLOOD; Fahey TP, 1996, BMJ-BRIT MED J, V313, P93, DOI 10.1136/bmj.313.7049.93; Gueyffier F, 1997, ANN INTERN MED, V126, P761, DOI 10.7326/0003-4819-126-10-199705150-00002; Gueyffier F, 1999, LANCET, V353, P793, DOI 10.1016/S0140-6736(98)08127-6; Haq IU, 1999, HEART, V81, P40, DOI 10.1136/hrt.81.1.40; Hingorani AD, 1999, BMJ-BRIT MED J, V318, P101, DOI 10.1136/bmj.318.7176.101; INSUA JT, 1994, ANN INTERN MED, V121, P355, DOI 10.7326/0003-4819-121-5-199409010-00008; Jackson R, 1996, J CLIN EPIDEMIOL, V49, P1441, DOI 10.1016/0895-4356(95)00047-X; JACKSON R, 1993, BRIT MED J, V307, P107, DOI 10.1136/bmj.307.6896.107; JOHANNESSON M, 1994, MED DECIS MAKING, V14, P236, DOI 10.1177/0272989X9401400305; LEAVERTON PE, 1987, J CHRON DIS, V40, P775, DOI 10.1016/0021-9681(87)90129-9; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; MACMAHON S, 1993, J VASC MED BIOL, V4, P265; Mann JI, 1996, NEW ZEAL MED J, V109, P224; MANN JI, 1993, NEW ZEAL MED J, V106, P133; MCGEE D, 1976, FRAMINGHAM STUDY EPI; MULROW CD, 1994, JAMA-J AM MED ASSOC, V272, P1932, DOI 10.1001/jama.272.24.1932; North D, 1996, NEW ZEAL MED J, V109, P134; *NZ GUID GROUP, 2000, MAN RAIS BLOOD PRESS; PEDERSEN TR, 1994, LANCET, V344, P1383; Ramsay LE, 1999, BMJ-BRIT MED J, V319, P630, DOI 10.1136/bmj.319.7210.630; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Wood D, 1998, ATHEROSCLEROSIS, V140, P199, DOI 10.1016/S0021-9150(98)90209-X; Wood D, 1998, HEART, V80, pS1	28	40	40	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 11	2000	320	7236					680	685		10.1136/bmj.320.7236.680	http://dx.doi.org/10.1136/bmj.320.7236.680			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DG	10710577	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000085895300021
J	Musters, CJM; de Graaf, HJ; ter Keurs, WJ				Musters, CJM; de Graaf, HJ; ter Keurs, WJ			Ecology - Can protected areas be expanded in Africa?	SCIENCE			English	Article									Leiden Univ, Dept Environm Biol, Inst Evolutionary & Ecol Sci, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Musters, CJM (corresponding author), Leiden Univ, Dept Environm Biol, Inst Evolutionary & Ecol Sci, POB 9516, NL-2300 RA Leiden, Netherlands.	musters@rulsfb.leidenuniv.nl	Musters, Cornelis/K-7828-2013	Musters, C.J.M./0000-0003-1321-6786				Daily G, 1998, SCIENCE, V281, P1291, DOI 10.1126/science.281.5381.1291; *FAO UN, 1997, STAT FOOD AGR 1997; FORD WR, 1999, 2 INT CULT C AFR AFR; Goklany IM, 1998, BIOSCIENCE, V48, P941, DOI 10.2307/1313298; Helmuth L, 1999, SCIENCE, V286, P1283, DOI 10.1126/science.286.5443.1283; Inamdar A, 1999, SCIENCE, V283, P1856, DOI 10.1126/science.283.5409.1856; James AN, 1999, NATURE, V401, P323, DOI 10.1038/43774; Kramer R, 1997, LAST STAND PROTECTED; Kramer Randall A., 1997, P3; LUYTEN JC, 1995, 37 RES I AGR SOIL FE; *POP DIV DEP EC SO, 1999, WOLF; *S AFR RES DOC CTR, 1994, STAT ENV SO AFR; Soule ME, 1998, SCIENCE, V279, P2060, DOI 10.1126/science.279.5359.2060; *UN ENV PROGR, 1991, STAT DES IMPL US NAT; *UN ENV PROGR, 1991, WORLD RESOURCES 1994; van Schaik Carel P., 1997, P212; Western D., 1994, NATURAL CONNECTIONS; WOLF EC, 1987, BRINK EXTEINCTION CO; *WORLD RES I, 1994, WORLD RESOURCES 1994; [No title captured]	20	33	34	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 10	2000	287	5459					1759	1760		10.1126/science.287.5459.1759	http://dx.doi.org/10.1126/science.287.5459.1759			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10755927				2022-12-24	WOS:000085775300023
J	Tromans, A				Tromans, A			Entomology - Love is not puffed up	NATURE			English	Editorial Material																		Funk DH, 2000, ANIM BEHAV, V59, P411, DOI 10.1006/anbe.1999.1310	1	0	0	0	3	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					138	138		10.1038/35004700	http://dx.doi.org/10.1038/35004700			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10755907	Bronze			2022-12-24	WOS:000085870900032
J	Bosch, X				Bosch, X			Newspaper apportions blame in Spanish hepatitis C scandal	LANCET			English	News Item																		MAESO, 1998, LANCET, V351, P1415	1	14	14	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 4	2000	355	9206					818	818		10.1016/S0140-6736(05)72446-6	http://dx.doi.org/10.1016/S0140-6736(05)72446-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	291YG	10711938				2022-12-24	WOS:000085766900034
J	Geijtenbeek, TBH; Kwon, DS; Torensma, R; van Vliet, SJ; van Duijnhoven, GCF; Middel, J; Cornelissen, ILMHA; Nottet, HSLM; KewalRamani, VN; Littman, DR; Figdor, CG; van Kooyk, Y				Geijtenbeek, TBH; Kwon, DS; Torensma, R; van Vliet, SJ; van Duijnhoven, GCF; Middel, J; Cornelissen, ILMHA; Nottet, HSLM; KewalRamani, VN; Littman, DR; Figdor, CG; van Kooyk, Y			DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; C-TYPE LECTIN; CHEMOKINE-CORECEPTORS; HIV ENTRY; IN-VITRO; PATHOGENESIS; RECEPTORS; INHIBITION; BLOOD; USAGE	Dendritic cells (DC) capture microorganisms that enter peripheral mucosal tissues and then migrate to secondary lymphoid organs, where they present these in antigenic form to resting T cells and thus initiate adaptive immune responses. Here, we describe the properties of a DC-specific C-type lectin, DC-SIGN, that is highly expressed on DC present in mucosal tissues and binds to the HIV-1 envelope glycoprotein gp120. DC-SIGN does not function as a receptor for viral entry into DC but instead promotes efficient infection in trans of cells that express CD4 and chemokine receptors. We propose that DC-SIGN efficiently captures HIV-1 in the periphery and facilitates its transport to secondary lymphoid organs rich in T cells, to enhance infection in trans of these target cells.	Univ Med Ctr St Radboud, Dept Tumor Immunol, NL-6525 EX Nijmegen, Netherlands; Univ Med Ctr St Radboud, Dept Pathol, NL-6525 EX Nijmegen, Netherlands; Univ Utrecht Hosp, Eykman Winkler Inst Microbiol, NL-3584 CX Utrecht, Netherlands; NYU, Med Ctr, Howard Hughes Med Inst, New York, NY 10016 USA; NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; Howard Hughes Medical Institute; New York University; New York University	van Kooyk, Y (corresponding author), Univ Med Ctr St Radboud, Dept Tumor Immunol, Philips van Leydenlaan 25, NL-6525 EX Nijmegen, Netherlands.		Geijtenbeek, Teunis/C-2229-2009; Torensma, Ruurd/C-2853-2009; Figdor, Carl G/A-4232-2010; KewalRamani, Vineet/V-5084-2019	Torensma, Ruurd/0000-0002-0555-7903; Figdor, Carl G/0000-0002-2366-9212; Van Kooyk, Yvette/0000-0001-5997-3665; van Vliet, Sandra/0000-0003-1811-2687	NIAID NIH HHS [AI33856] Funding Source: Medline; DIVISION OF BASIC SCIENCES - NCI [Z01BC010322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033856] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); DIVISION OF BASIC SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Ayehunie S, 1997, BLOOD, V90, P1379, DOI 10.1182/blood.V90.4.1379.1379_1379_1386; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BarrattBoyes SM, 1997, J IMMUNOL, V158, P4543; Bjorndal A, 1997, J VIROL, V71, P7478; Blauvelt A, 1997, J CLIN INVEST, V100, P2043, DOI 10.1172/JCI119737; Cameron P, 1996, J LEUKOCYTE BIOL, V59, P158, DOI 10.1002/jlb.59.2.158; CAMERON PU, 1994, J LEUKOCYTE BIOL, V56, P257, DOI 10.1002/jlb.56.3.257; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Canque B, 1999, BLOOD, V93, P3866, DOI 10.1182/blood.V93.11.3866.411k43_3866_3875; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Fauci AS, 1996, NATURE, V384, P529, DOI 10.1038/384529a0; Geijtenbeek TBH, 1999, BLOOD, V94, P754, DOI 10.1182/blood.V94.2.754.414k11_754_764; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Granelli-Piperno A, 1998, J VIROL, V72, P2733, DOI 10.1128/JVI.72.4.2733-2737.1998; Granelli-Piperno A, 1999, CURR BIOL, V9, P21, DOI 10.1016/S0960-9822(99)80043-8; GranelliPiperno A, 1996, J EXP MED, V184, P2433, DOI 10.1084/jem.184.6.2433; Grouard G, 1997, CURR OPIN IMMUNOL, V9, P563, DOI 10.1016/S0952-7915(97)80111-2; HAROUSE JM, 1991, SCIENCE, V253, P320, DOI 10.1126/science.1857969; Hladik F, 1999, J VIROL, V73, P5833, DOI 10.1128/JVI.73.7.5833-5842.1999; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Lee S, 1997, J VIROL, V71, P6037, DOI 10.1128/JVI.71.8.6037-6043.1997; Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4; Lu ZH, 1997, P NATL ACAD SCI USA, V94, P6426, DOI 10.1073/pnas.94.12.6426; Lub M, 1997, MOL BIOL CELL, V8, P719, DOI 10.1091/mbc.8.4.719; Rowland-Jones SL, 1999, CURR BIOL, V9, pR248, DOI 10.1016/S0960-9822(99)80155-9; Rubbert A, 1998, J IMMUNOL, V160, P3933; Speck RF, 1999, CURR BIOL, V9, P547, DOI 10.1016/S0960-9822(99)80241-3; Stahl-Hennig C, 1999, SCIENCE, V285, P1261, DOI 10.1126/science.285.5431.1261; Steinman RM, 1999, J LEUKOCYTE BIOL, V66, P205, DOI 10.1002/jlb.66.2.205; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; VALITUTTI S, 1995, NATURE, V375, P148, DOI 10.1038/375148a0; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WEISSMAN D, 1995, P NATL ACAD SCI USA, V92, P826, DOI 10.1073/pnas.92.3.826	37	1875	1977	2	125	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 3	2000	100	5					587	597		10.1016/S0092-8674(00)80694-7	http://dx.doi.org/10.1016/S0092-8674(00)80694-7			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721995	Bronze			2022-12-24	WOS:000085700000011
J	Farquhar, J; Savarino, J; Jackson, TL; Thiemens, MH				Farquhar, J; Savarino, J; Jackson, TL; Thiemens, MH			Evidence of atmospheric sulphur in the martian regolith from sulphur isotopes in meteorites	NATURE			English	Article							CHEMICAL-COMPOSITION; EARLY EARTH; MARS; SULFUR; CARBONATES; ALH84001; TEMPERATURE; CHONDRITES; SULFATES; SOIL	Sulphur is abundant at the martian surface, yet its origin and evolution over time remain poorly constrained(1,2). This sulphur is likely to have originated in atmospheric chemical reactions, and so should provide records of the evolution of the martian atmosphere, the cycling of sulphur between the atmosphere and crust, and the mobility of sulphur in the martian regolith(3-6). Moreover, the atmospheric deposition of oxidized sulphur species could establish chemical potential gradients in the martian near-surface environment, and so provide a potential energy source for chemolithoautotrophic organisms', Here we present measurements of sulphur isotopes in oxidized and reduced phases from the SNC meteorites-the group of related achondrite meteorites believed to have originated on Mars-together with the results of laboratory photolysis studies of two important martian atmospheric sulphur species (SO2 and H2S). The photolysis experiments can account for the observed sulphur-isotope compositions in the SNC meteorites, and so identify a mechanism for producing large abiogenic S-34 fractionations in the surface sulphur reservoirs. We conclude that the sulphur data from the SNC meteorites reflects deposition of oxidized sulphur species produced by atmospheric chemical reactions, followed by incorporation, reaction and mobilization of the sulphur within the regolith.	Univ Calif San Diego, Dept Chem 0356, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Farquhar, J (corresponding author), Univ Calif San Diego, Dept Chem 0356, La Jolla, CA 92093 USA.	jfarquha@ucsd.edu	Savarino, Joel/H-9730-2012	Savarino, Joel/0000-0002-6708-9623				Banin A, 1997, J GEOPHYS RES-PLANET, V102, P13341, DOI 10.1029/97JE01160; BOGARD DD, 1983, SCIENCE, V221, P651, DOI 10.1126/science.221.4611.651; CLARK BC, 1982, J GEOPHYS RES, V87, P59, DOI 10.1029/JB087iB12p10059; Colman JJ, 1996, SCIENCE, V273, P774, DOI 10.1126/science.273.5276.774; Cooper GW, 1997, SCIENCE, V277, P1072, DOI 10.1126/science.277.5329.1072; Farquhar J, 1998, SCIENCE, V280, P1580, DOI 10.1126/science.280.5369.1580; FARQUHAR J, 1999, 30 LUN PLAN SCI C, V30, P1675; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3159, DOI 10.1016/0016-7037(93)90300-L; GAO X, 1993, GEOCHIM COSMOCHIM AC, V57, P3171, DOI 10.1016/0016-7037(93)90301-C; Gao X., 1991, GEOCHIM COSMOCHIM AC, V55, P2671, DOI DOI 10.1016/0016-7037(91)90381-E; Greenwood JP, 1997, GEOCHIM COSMOCHIM AC, V61, P4449, DOI 10.1016/S0016-7037(97)00246-9; GREENWOOD JP, IN PRESS GEOCHIM COS; HARVEY RP, 1992, GEOCHIM COSMOCHIM AC, V56, P1655, DOI 10.1016/0016-7037(92)90232-8; Jakosky BM, 1998, J GEOPHYS RES-PLANET, V103, P19359, DOI 10.1029/98JE01892; KARLSSON KR, 1992, SCIENCE, V255, P1409, DOI 10.1126/science.11537889; KASTING JF, 1984, J ATMOS CHEM, V1, P403, DOI 10.1007/BF00053803; McSween HY, 1998, INT GEOL REV, V40, P774, DOI 10.1080/00206819809465238; Mukhin LM, 1996, NATURE, V379, P141, DOI 10.1038/379141a0; Newsom HE, 1999, J GEOPHYS RES-PLANET, V104, P8717, DOI 10.1029/1998JE900043; Okabe H., 1978, PHOTOCHEMISTRY SMALL; POLLACK JB, 1990, J GEOPHYS RES-SOLID, V95, P14595, DOI 10.1029/JB095iB09p14595; Rieder R, 1997, SCIENCE, V278, P1771, DOI 10.1126/science.278.5344.1771; SETTLE M, 1979, J GEOPHYS RES, V84, P8343, DOI 10.1029/JB084iB14p08343; Shearer CK, 1996, GEOCHIM COSMOCHIM AC, V60, P2921, DOI 10.1016/0016-7037(96)00165-2; Thiemens MH, 1999, SCIENCE, V283, P341, DOI 10.1126/science.283.5400.341; Toulmin P.  III, 1977, Journal of Geophysical Research, V82, P4625, DOI 10.1029/JS082i028p04625; WANKE H, 1994, PHILOS T R SOC A, V349, P285, DOI 10.1098/rsta.1994.0132; Warren PH, 1998, J GEOPHYS RES-PLANET, V103, P16759, DOI 10.1029/98JE01544; Yung YL, 1997, ICARUS, V130, P222, DOI 10.1006/icar.1997.5808	29	221	229	4	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 2	2000	404	6773					50	52		10.1038/35003517	http://dx.doi.org/10.1038/35003517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716436				2022-12-24	WOS:000085775100039
J	Tournier, C; Hess, P; Yang, DD; Xu, J; Turner, TK; Nimnual, A; Bar-Sagi, D; Jones, SN; Flavell, RA; Davis, RJ				Tournier, C; Hess, P; Yang, DD; Xu, J; Turner, TK; Nimnual, A; Bar-Sagi, D; Jones, SN; Flavell, RA; Davis, RJ			Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway	SCIENCE			English	Article							N-TERMINAL KINASE; CELL-DEATH; INDUCED APOPTOSIS; SIGNAL-TRANSDUCTION; CASPASE ACTIVATION; TNF RECEPTOR-1; PROTEIN; BCL-2; JUN; MITOCHONDRIA	The c-Jun NH2-terminal kinase (JNK) is activated when cells are exposed to ultraviolet (UV) radiation. However, the functional consequence of JNK activation in UV-irradiated cells has not been established. It is shown here that JNK is required for UV-induced apoptosis in primary murine embryonic fibroblasts. Fibroblasts with simultaneous targeted disruptions of all the functional Jnk genes were protected against UV-stimulated apoptosis. The absence of JNK caused a defect in the mitochondrial death signaling pathway, including the failure to release cytochrome c. These data indicate that mitochondria are influenced by proapoptotic signal transduction through the JNK pathway.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med,Howard Hughes Med Inst, Worcester, MA 01605 USA; Yale Univ, Sch Med, Immunobiol Sect, Howard Hughes Med Inst, New Haven, CT 06520 USA; Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; Yale University; University of Massachusetts System; University of Massachusetts Worcester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Davis, RJ (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Program Mol Med,Howard Hughes Med Inst, Worcester, MA 01605 USA.			Bar-Sagi, Dafna/0000-0003-2597-8948				Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Dolbeare F, 1990, Methods Cell Biol, V33, P207; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Finucane DM, 1999, J BIOL CHEM, V274, P2225, DOI 10.1074/jbc.274.4.2225; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; JOHNSON RS, 1993, GENE DEV, V7, P1309, DOI 10.1101/gad.7.7b.1309; Juo P, 1998, CURR BIOL, V8, P1001, DOI 10.1016/S0960-9822(07)00420-4; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Kuan CY, 1999, NEURON, V22, P667, DOI 10.1016/S0896-6273(00)80727-8; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; Natoli G, 1997, SCIENCE, V275, P200, DOI 10.1126/science.275.5297.200; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Siegel RM, 1998, J CELL BIOL, V141, P1243, DOI 10.1083/jcb.141.5.1243; Srinivasan A, 1998, CELL DEATH DIFFER, V5, P1004, DOI 10.1038/sj.cdd.4400449; Srivastava RK, 1999, P NATL ACAD SCI USA, V96, P3775, DOI 10.1073/pnas.96.7.3775; TOURNIER C, UNPUB; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wolf BB, 1999, J BIOL CHEM, V274, P20049, DOI 10.1074/jbc.274.29.20049; Woo M, 1998, GENE DEV, V12, P806, DOI 10.1101/gad.12.6.806; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Yang DD, 1997, NATURE, V389, P865, DOI 10.1038/39899; Yang DD, 1998, IMMUNITY, V9, P575, DOI 10.1016/S1074-7613(00)80640-8; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yuan JY, 1999, NAT CELL BIOL, V1, pE44, DOI 10.1038/10037; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	43	1484	1538	1	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2000	288	5467					870	874		10.1126/science.288.5467.870	http://dx.doi.org/10.1126/science.288.5467.870			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797012				2022-12-24	WOS:000086869600042
J	Mann, RD; Pearce, GL; Dunn, N; Shakir, S				Mann, RD; Pearce, GL; Dunn, N; Shakir, S			Sedation with "non-sedating'' antihistamines: four prescription-event monitoring studies in general practice	BRITISH MEDICAL JOURNAL			English	Article							2ND-GENERATION ANTIHISTAMINES; FEXOFENADINE; LIFE	Objectives To investigate the frequency with which sedation was reported in post-marketing surveillance studies of four second generation antihistamines: loratadine, cetirizine, fexofenadine, and acrivastine. Design Prescription-event monitoring studies. Setting Prescriptions were obtained for each cohort in the immediate post-marketing period. Subjects Event data were obtained for a total of 43 363 patients. Main outcome measure Reporting of sedation or drowsiness. Results The adds ratios (adjusted for age and sex) for the incidence of sedation were 0.63 (95% confidence interval 0.36 to 1.11; P = 0.1) for fexofenadine; 2.79 (1.69 to 4.58; p < 0.0001) for acrivastine, and 3.53 (2.07 to 5.42; P < 0.0001) for cetirizine compared with loratadine. No increased risk of accident or injury it as evident with any of the four drugs. Conclusions Although the risk of sedation was low with all four drugs, fexofenadine and loratadine may be more appropriate for people working in safety critical jobs.	Univ Southampton, Southampton, Hants, England; Drug Safety Res Unit, Southampton SO31 1AA, Hants, England	University of Southampton	Mann, RD (corresponding author), Manor Cottage, Midhurst GU29 9RL, W Sussex, England.							Gonzalez MA, 1998, INT J CLIN PHARM TH, V36, P292; Mann RD, 1998, BRIT J CLIN PHARMACO, V46, P195, DOI 10.1046/j.1365-2125.1998.00774.x; MANN RD, 1984, MODERN DRUG USE, P16; Markham A, 1998, DRUGS, V55, P269, DOI 10.2165/00003495-199855020-00012; Nightingale CH, 1996, PHARMACOTHERAPY, V16, P905; Nolen TM, 1997, CLIN THER, V19, P39, DOI 10.1016/S0149-2918(97)80071-9; Pinto YM, 1999, LANCET, V353, P980, DOI 10.1016/S0140-6736(99)01009-0; Slater JW, 1999, DRUGS, V57, P31, DOI 10.2165/00003495-199957010-00004; Wilton LV, 1998, BRIT J OBSTET GYNAEC, V105, P882, DOI 10.1111/j.1471-0528.1998.tb10234.x	9	102	106	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 29	2000	320	7243					1184	1186		10.1136/bmj.320.7243.1184	http://dx.doi.org/10.1136/bmj.320.7243.1184			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310MW	10784544	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000086832800020
J	Toft, AD				Toft, AD			Surgery for primary hyperparathyroidism - sooner rather than later	LANCET			English	Editorial Material							PARATHYROIDECTOMY; SURVIVAL		Royal Infirm, Endocrine Unit, Edinburgh EH3 9YW, Midlothian, Scotland	Royal Infirmary of Edinburgh	Toft, AD (corresponding author), Royal Infirm, Endocrine Unit, Edinburgh EH3 9YW, Midlothian, Scotland.							CHAN AK, 1995, ANN SURG, V222, P402, DOI 10.1097/00000658-199509000-00017; HEATH H, 1980, NEW ENGL J MED, V302, P189, DOI 10.1056/NEJM198001243020402; HEDBACK G, 1991, WORLD J SURG, V15, P399, DOI 10.1007/BF01658740; Nilsson IL, 1999, SURGERY, V126, P1049, DOI 10.1067/msy.2099.101422; PALMER M, 1987, LANCET, V1, P59; Richards ML, 1999, SURGERY, V126, P1160, DOI 10.1067/msy.2099.101436; SCHOLZ DA, 1981, MAYO CLIN PROC, V56, P473; Silverberg SJ, 1999, NEW ENGL J MED, V341, P1249, DOI 10.1056/NEJM199910213411701; Wermers RA, 1998, AM J MED, V104, P115, DOI 10.1016/S0002-9343(97)00270-2	9	19	23	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 29	2000	355	9214					1478	1479		10.1016/S0140-6736(00)02158-9	http://dx.doi.org/10.1016/S0140-6736(00)02158-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LR	10801165				2022-12-24	WOS:000086830100005
J	Dyck, PJ; Dyck, PJB				Dyck, PJ; Dyck, PJB			Atypical varieties of chronic inflammatory demyelinating neuropathies	LANCET			English	Editorial Material							MONOCLONAL GAMMOPATHY; UNDETERMINED SIGNIFICANCE; FOLLOW-UP; POLYRADICULONEUROPATHY		Mayo Clin & Mayo Fdn, Peripheral Neuropathy Res Ctr, Rochester, MN 55905 USA	Mayo Clinic	Dyck, PJ (corresponding author), Mayo Clin & Mayo Fdn, Peripheral Neuropathy Res Ctr, 200 1st St SW, Rochester, MN 55905 USA.							Dyck P.J., 1990, CHARCOT MARIE TOOTH, P1; DYCK PJ, 1975, MAYO CLIN PROC, V50, P621; DYCK PJ, 1991, NEW ENGL J MED, V325, P1482, DOI 10.1056/NEJM199111213252105; Dyck PJB, 1999, NEUROLOGY, V53, P2113, DOI 10.1212/WNL.53.9.2113; GOSSELIN S, 1991, ANN NEUROL, V30, P54, DOI 10.1002/ana.410300111; Katz JS, 2000, NEUROLOGY, V54, P615, DOI 10.1212/WNL.54.3.615; KYLE RA, 1993, MAYO CLIN PROC, V68, P26, DOI 10.1016/S0025-6196(12)60015-9; KYLE RA, 1993, PERIPHERAL NEUROPATH, P1275; Midroni G, 1996, NEUROLOGY, V46, P1206, DOI 10.1212/WNL.46.5.1206; PARRY GJ, 1988, MUSCLE NERVE, V11, P103, DOI 10.1002/mus.880110203; SIMMONS Z, 1995, BRAIN, V118, P359, DOI 10.1093/brain/118.2.359; Van den Berg-Vos RM, 2000, NEUROLOGY, V54, P26, DOI 10.1212/WNL.54.1.26	12	31	32	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2000	355	9212					1293	1294		10.1016/S0140-6736(00)02109-7	http://dx.doi.org/10.1016/S0140-6736(00)02109-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LJ	10776740				2022-12-24	WOS:000086829400007
J	Mackie, E; Hill, J; Kondryn, H; McNally, R				Mackie, E; Hill, J; Kondryn, H; McNally, R			Adult psychosocial outcomes in long-term survivors of acute lymphoblastic leukaemia and Wilms' tumour: a controlled study	LANCET			English	Article							CHILDHOOD-CANCER SURVIVORS; PSYCHOLOGICAL ADJUSTMENT; LEUKEMIA; LIFE; PSYCHOPATHOLOGY; CONSEQUENCES; ADAPTATION; ADOLESCENT; CHILDREN; DISEASE	Background Variability in methods and deficits in design have contributed to conflicting findings about adult psychosocial functioning after childhood cancer. We did a controlled study of psychosocial outcomes in adult survivors of childhood acute lymphoblastic leukaemia (ALL) and Wilms' tumour to address previous methods limitations. Methods We assessed 102 survivors of childhood ALL and Wilms' tumour, who had been free from relapse for 5 years and were aged 19-30 years, and 102 unrelated healthy controls. We used standard measures of adult psychiatric disorder, interpersonal and social-role performance, and intellectual ability to assess past and current functioning. Findings Cancer survivors had no increased rates of psychiatric disorder. Mean scores of cancer survivors were significantly higher (indicating poorer functioning) than those of controls for love/sex relationships (mean difference 0.87 [95% CI 0.53-1.22]), friendships (0.37 [0.07-0.67]), non-specific social contacts (0.40 [0.20-0.60]), and day-to-day coping (0.35 [0.14-0.57]). Cancer survivors were more likely than controls to have a combination of deficits in love/sex relationships and friendships (ALL survivors odds ratio 10.83 [95% CI 3.87-30.82], Wilms' tumour survivors 4.85 [1.43-16.47]), which was associated with more recent treatment (p=0.005). Poor coping was associated with lower intellectual ability scores (p=0.018). Interpretation Childhood ALL and Wilms' tumour have longterm effects on interpersonal functioning and coping, probably mediated by different mechanisms. Prospective studies with each of these tumour groups are needed with similar adolescent and adult outcome measures.	Royal Manchester Childrens Hosp, Paediat Oncol Unit, Manchester M27 1HA, Lancs, England; Alder Hey Childrens Hosp, Dept Psychiat, Liverpool L12 2AP, Merseyside, England; Univ Manchester, Dept Child Hlth, CRC Paediat & Familial Canc Res Grp, Manchester, Lancs, England	Royal Manchester Children's Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Manchester	Mackie, E (corresponding author), Southampton Gen Hosp, Dept Child Hlth, Southampton SO16 6YD, Hants, England.			McNally, Richard/0000-0001-6685-6467				BIRCH JM, 1988, IARC SCI PUBL, V87, P299; BROWN RT, 1993, J AM ACAD CHILD PSY, V32, P554, DOI 10.1097/00004583-199305000-00010; BYRNE J, 1989, JAMA-J AM MED ASSOC, V262, P2683; CELLA DF, 1986, J CONSULT CLIN PSYCH, V54, P616, DOI 10.1037/0022-006X.54.5.616; CHANG P-N, 1991, Pediatrician, V18, P20; CLARE AW, 1978, PSYCHOL MED, V8, P589, DOI 10.1017/S0033291700018808; EISER C, 1991, ARCH DIS CHILD, V66, P164, DOI 10.1136/adc.66.1.164; Everitt BS., 1992, ANAL CONTINGENCY TAB; *GOV STAT SER, 1990, STAND OCC CLASS, V1; GRAY RE, 1992, CANCER-AM CANCER SOC, V70, P2713, DOI 10.1002/1097-0142(19921201)70:11<2713::AID-CNCR2820701124>3.0.CO;2-T; GREEN DM, 1991, CANCER, V67, P206, DOI 10.1002/1097-0142(19910101)67:1<206::AID-CNCR2820670134>3.0.CO;2-2; GUDJONSSON GH, 1995, PERSON INDIVIDUAL DI, V3, P441; HARRINGTON R, 1988, PSYCHOL MED, V18, P487, DOI 10.1017/S0033291700008023; HAUPT R, 1994, JAMA-J AM MED ASSOC, V272, P1427, DOI 10.1001/jama.272.18.1427; HAWKINS MM, 1987, BRIT J CANCER, V56, P339, DOI 10.1038/bjc.1987.200; HAYS DM, 1992, J CLIN ONCOL, V10, P1397, DOI 10.1200/JCO.1992.10.9.1397; HILL J, 1989, BRIT J PSYCHIAT, P15524; Hill JM, 1998, CANCER-AM CANCER SOC, V82, P208; JANKOVIC M, 1994, LANCET, V344, P224, DOI 10.1016/S0140-6736(94)92997-1; KELAGHAN J, 1988, MED PEDIATR ONCOL, V16, P320, DOI 10.1002/mpo.2950160506; KOOCHER GP, 1980, J CHILD PSYCHOL PSYC, V21, P163, DOI 10.1111/j.1469-7610.1980.tb00028.x; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Naughton M, 1996, BRIT J PSYCHIAT, V168, P33, DOI 10.1192/bjp.168.1.33; QUINTON D, 1995, BRIT J PSYCHIAT, V167, P315, DOI 10.1192/bjp.167.3.315; Rauck AM, 1999, MED PEDIATR ONCOL, V33, P60, DOI 10.1002/(SICI)1096-911X(199907)33:1<60::AID-MPO11>3.0.CO;2-H; Raven J, 2003, STANDARD PROGR MATRI; SAHLER OJZ, 1994, J DEV BEHAV PEDIATR, V15, P353; SHALET SM, 1989, ARCH DIS CHILD, V64, P1635, DOI 10.1136/adc.64.11.1635; STILLER CA, 1990, BRIT J CANCER, V62, P806, DOI 10.1038/bjc.1990.383; TETA MJ, 1986, J CHRON DIS, V39, P751, DOI 10.1016/0021-9681(86)90158-X; Zeltzer LK, 1997, J CLIN ONCOL, V15, P547, DOI 10.1200/JCO.1997.15.2.547	31	104	105	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2000	355	9212					1310	1314		10.1016/S0140-6736(00)02112-7	http://dx.doi.org/10.1016/S0140-6736(00)02112-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	310LJ	10776743				2022-12-24	WOS:000086829400010
J	Brainard, MS; Doupe, AJ				Brainard, MS; Doupe, AJ			Interruption of a basal ganglia-forebrain circuit prevents plasticity of learned vocalizations	NATURE			English	Article							ADULT ZEBRA FINCHES; SONG DEVELOPMENT; VOCAL BEHAVIOR; NUCLEUS; LESIONS; MAINTENANCE; NEURONS; CANARY; SYSTEM; BRAIN	Birdsong, like speech, is a learned vocal behaviour that relies greatly on hearing; in both songbirds(1) and humans(2) the removal of auditory feedback by deafening leads to a gradual deterioration of adult vocal production. Here we investigate the neural mechanisms that contribute to the processing of auditory feedback during the maintenance of song in adult zebra finches. We show that the deleterious effects on song production that normally follow deafening can be prevented by a second insult to the nervous system-the lesion of a basal ganglia-forebrain circuit. The results suggest that the removal of auditory feedback leads to the generation of an instructive signal that actively drives nonadaptive changes in song; they also suggest that this instructive signal is generated within (or conveyed through) the basal ganglia-forebrain pathway. Our findings provide evidence that cortical-basal ganglia circuits may participate in the evaluation of sensory feedback during calibration of motor performance, and demonstrate that damage to such circuits can have little effect on previously learned behaviour while conspicuously disrupting the capacity to adaptively modify that behaviour.	Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Dept Psychiat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Brainard, MS (corresponding author), Univ Calif San Francisco, Keck Ctr Integrat Neurosci, Dept Physiol, San Francisco, CA 94143 USA.			Brainard, Michael/0000-0002-9425-9907				AKUTAGAWA E, 1994, P NATL ACAD SCI USA, V91, P12413, DOI 10.1073/pnas.91.26.12413; ARNOLD AP, 1975, J EXP ZOOL, V191, P261, DOI 10.1002/jez.1401910212; BOTTJER SW, 1984, SCIENCE, V224, P901, DOI 10.1126/science.6719123; Bottjer SW, 1997, J NEUROBIOL, V33, P602, DOI 10.1002/(SICI)1097-4695(19971105)33:5<602::AID-NEU8>3.0.CO;2-8; Bottjer SW, 1997, BRAIN BEHAV EVOLUT, V50, P284, DOI 10.1159/000113342; COWIE R, 1992, POSTINGUALLY ACQUIRE, P1; Doupe AJ, 1997, J NEUROSCI, V17, P1147; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hessler NA, 1999, J NEUROSCI, V19, P10461; Houde JF, 1998, SCIENCE, V279, P1213, DOI 10.1126/science.279.5354.1213; JOHNSON F, 1994, DEVELOPMENT, V120, P13; KIRN JR, 1993, J NEUROSCI, V13, P1654; KLEIN D, 1994, NEUROREPORT, V5, P2295, DOI 10.1097/00001756-199411000-00022; Knowlton BJ, 1996, SCIENCE, V273, P1399, DOI 10.1126/science.273.5280.1399; Konishi M., 1965, Zeitschrift fuer Tierpsychologie, V22, P770; Leonardo A, 1999, NATURE, V399, P466, DOI 10.1038/20933; MARLER P, 1970, J COMP PHYSIOL PSYCH, V71, P1, DOI 10.1037/h0029144; MORRISON RG, 1993, J NEUROBIOL, V24, P1045, DOI 10.1002/neu.480240805; Nakamura K, 1999, J NEUROPHYSIOL, V82, P1063, DOI 10.1152/jn.1999.82.2.1063; NORDEEN KW, 1993, BEHAV NEURAL BIOL, V59, P79, DOI 10.1016/0163-1047(93)91215-9; NORDEEN KW, 1992, BEHAV NEURAL BIOL, V57, P58, DOI 10.1016/0163-1047(92)90757-U; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; SCHARFF C, 1991, J NEUROSCI, V11, P2896; SOHRABJI F, 1990, BEHAV NEURAL BIOL, V53, P51, DOI 10.1016/0163-1047(90)90797-A; Solis MM, 1999, J NEUROSCI, V19, P4559; VICARIO DS, 1991, J NEUROBIOL, V22, P63, DOI 10.1002/neu.480220107; VU ET, 1994, J NEUROSCI, V14, P6924; Williams H, 1999, J NEUROBIOL, V39, P14, DOI 10.1002/(SICI)1097-4695(199904)39:1<14::AID-NEU2>3.0.CO;2-X; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	30	342	356	0	27	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					762	766		10.1038/35008083	http://dx.doi.org/10.1038/35008083			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783889				2022-12-24	WOS:000086523600052
J	Houlahan, JE; Findlay, CS; Schmidt, BR; Meyer, AH; Kuzmin, SL				Houlahan, JE; Findlay, CS; Schmidt, BR; Meyer, AH; Kuzmin, SL			Quantitative evidence for global amphibian population declines	NATURE			English	Article							NATURAL FLUCTUATIONS; HUMAN IMPACTS; FROG; MORTALITY; MOUNTAIN; SYNERGISM; COLORADO; FAUNA	Although there is growing concern that amphibian populations are declining globally(1-3), much of the supporting evidence is either anecdotal(4,5) or derived from short-term studies at small geographical scales(6-8). This raises questions not only about the difficulty of detecting temporal trends in populations which are notoriously variable(9,10), but also about the validity of inferring global trends from local or regional studies(11,12). Here we use data from 936 populations to assess large-scale temporal and spatial variations in amphibian population trends. On a global scale, our results indicate relatively rapid declines from the late 1950s/early 1960s to the late 1960s, followed by a reduced rate of decline to the present. Amphibian population trends during the 1960s were negative in western Europe (including the United Kingdom) and North America, but only the latter populations showed declines from the 1970s to the late 1990s. These results suggest that while large-scale trends show considerable geographical and temporal variability, amphibian populations are in fact declining-and that this decline has been happening for several decades.	Univ Ottawa, Ottawa Carleton Inst Biol, Ottawa, ON K1N 6N5, Canada; Univ Ottawa, Inst Environm, Ottawa, ON K1N 6N5, Canada; Univ Zurich, Inst Zool, CH-8057 Zurich, Switzerland; Swiss Fed Stat Off, Sekt Hsch & Wissensch, CH-2010 Neuchatel, Switzerland; Russian Acad Sci, Inst Ecol & Evolut, Moscow 117071, Russia	University of Ottawa; University of Ottawa; University of Zurich; Russian Academy of Sciences	Houlahan, JE (corresponding author), Univ Ottawa, Ottawa Carleton Inst Biol, 30 Marie Curie, Ottawa, ON K1N 6N5, Canada.		Schmidt, Benedikt R./B-8491-2008	Schmidt, Benedikt R./0000-0002-4023-1001				BEEBEE TJC, 1990, BIOL CONSERV, V37, P59; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blaustein AR, 1998, AM ZOOL, V38, P799; BLAUSTEIN AR, 1994, CONSERV BIOL, V8, P60, DOI 10.1046/j.1523-1739.1994.08010060.x; BLAUSTEIN AR, 1990, TRENDS ECOL EVOL, V5, P203, DOI 10.1016/0169-5347(90)90129-2; CAREY C, 1993, CONSERV BIOL, V7, P355, DOI 10.1046/j.1523-1739.1993.07020355.x; CORN PS, 1984, J HERPETOL, V18, P147, DOI 10.2307/1563742; CUNNINGHAM AA, 1993, VET REC, V133, P141, DOI 10.1136/vr.133.6.141; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; Englund G, 1999, ECOLOGY, V80, P1132, DOI 10.1890/0012-9658(1999)080[1132:TIODSC]2.0.CO;2; Green D.M., 1997, AMPHIBIANS DECLINE C, P291; HARTE J, 1989, CONSERV BIOL, V3, P149, DOI 10.1111/j.1523-1739.1989.tb00067.x; Hecnar SJ, 1996, ECOLOGY, V77, P2091, DOI 10.2307/2265703; Hecnar SJ, 1997, CONSERV BIOL, V11, P670, DOI 10.1046/j.1523-1739.1997.96096.x; Heyer W.R., 1994, MEASURING MONITORING; KIESECKER JM, 1995, P NATL ACAD SCI USA, V92, P11049, DOI 10.1073/pnas.92.24.11049; Laurance WF, 1996, CONSERV BIOL, V10, P406, DOI 10.1046/j.1523-1739.1996.10020406.x; Lips KR, 1998, CONSERV BIOL, V12, P106, DOI 10.1046/j.1523-1739.1998.96359.x; LONG LE, 1995, CONSERV BIOL, V9, P1301, DOI 10.1046/j.1523-1739.1995.951301.x; Meyer AH, 1998, P ROY SOC B-BIOL SCI, V265, P523, DOI 10.1098/rspb.1998.0326; PECHMANN JHK, 1994, HERPETOLOGICA, V50, P65; PECHMANN JHK, 1991, SCIENCE, V253, P892, DOI 10.1126/science.253.5022.892; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pounds JA, 1997, CONSERV BIOL, V11, P1307, DOI 10.1046/j.1523-1739.1997.95485.x; TYLER M J, 1991, Alytes (Paris), V9, P43; WAKE D B, 1991, Alytes (Paris), V9, P33; WAKE DB, 1991, SCIENCE, V253, P860, DOI 10.1126/science.253.5022.860; Wake DB, 1998, TRENDS ECOL EVOL, V13, P379, DOI 10.1016/S0169-5347(98)01428-1; WEYGOLDT P, 1989, STUD NEOTROP FAUNA E, V24, P249, DOI 10.1080/01650528909360795	30	953	1030	7	306	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					752	755		10.1038/35008052	http://dx.doi.org/10.1038/35008052			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783886				2022-12-24	WOS:000086523600049
J	Liljegren, SJ; Ditta, GS; Eshed, HY; Savidge, B; Bowman, JL; Yanofsky, MF				Liljegren, SJ; Ditta, GS; Eshed, HY; Savidge, B; Bowman, JL; Yanofsky, MF			SHATTERPROOF MADS-box genes control seed dispersal in Arabidopsis	NATURE			English	Article							FLORAL ORGAN IDENTITY; BRASSICA-NAPUS L; ECTOPIC EXPRESSION; FLOWER DEVELOPMENT; PLANT DEVELOPMENT; POD DEVELOPMENT; MESSENGER-RNA; TRANSCRIPTION; POLYGALACTURONASE; DEHISCENCE	The fruit, which mediates the maturation and dispersal of seeds, is a complex structure unique to flowering plants. Seed dispersal in plants such as Arabidopsis occurs by a process called fruit dehiscence, or pod shatter. Few studies(1-3) have focused on identifying genes that regulate this process, in spite of the agronomic value of controlling seed dispersal in crop plants such as canola(4,5). Here we show that the closely related SHATTERPROOF (SHP1) and SHATTERPROOF2 (SHP2) MADS-box genes are required for fruit dehiscence in Arabidopsis. Moreover, SHP1 and SHP2 are functionally redundant, as neither single mutant displays a novel phenotype. Our studies of shp1 shp2 fruit, and of plants constitutively expressing SHP1 and SHP2, show that these two genes control dehiscence zone differentiation and promote the lignification of adjacent cells. Our results indicate that further analysis of the molecular events underlying fruit dehiscence may allow genetic manipulation of pod shatter in crop plants.	Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; Univ Calif Davis, Plant Biol Sect, Davis, CA 95616 USA	University of California System; University of California San Diego; University of California System; University of California Davis	Yanofsky, MF (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.			Bowman, John/0000-0001-7347-3691; Eshed, Yuval/0000-0001-8290-0018				BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Bowman JL, 1999, CURR TOP DEV BIOL, V45, P155, DOI 10.1016/S0070-2153(08)60316-6; BOWMAN JL, 1991, PLANT CELL, V3, P749, DOI 10.1105/tpc.3.8.749; BOWMAN JL, 1993, DEVELOPMENT, V119, P721; Child RD, 1998, J EXP BOT, V49, P829, DOI 10.1093/jexbot/49.322.829; COUPE SA, 1993, PLANT MOL BIOL, V23, P1223, DOI 10.1007/BF00042355; Eshed Y, 1999, CELL, V99, P199, DOI 10.1016/S0092-8674(00)81651-7; Ferrandiz C, 1999, ANNU REV BIOCHEM, V68, P321, DOI 10.1146/annurev.biochem.68.1.321; Flanagan CA, 1996, PLANT J, V10, P343, DOI 10.1046/j.1365-313X.1996.10020343.x; Gu Q, 1998, DEVELOPMENT, V125, P1509; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; Jenkins ES, 1996, J EXP BOT, V47, P111, DOI 10.1093/jxb/47.1.111; KEMPIN SA, 1995, SCIENCE, V267, P522, DOI 10.1126/science.7824951; Kempin SA, 1997, NATURE, V389, P802, DOI 10.1038/39770; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; MacLeod J., 1981, Oilseed rape book., P107; MANDEL MA, 1995, PLANT CELL, V7, P1763, DOI 10.1105/tpc.7.11.1763; MEAKIN PJ, 1990, J EXP BOT, V41, P995, DOI 10.1093/jxb/41.8.995; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; Petersen M, 1996, PLANT MOL BIOL, V31, P517, DOI 10.1007/BF00042225; Purugganan MD, 1997, J MOL EVOL, V45, P392, DOI 10.1007/PL00006244; Riechmann JL, 1997, BIOL CHEM, V378, P1079; Rollins R.C., 1993, CRUCIFERAE CONTINENT; ROUNSLEY SD, 1995, PLANT CELL, V7, P1259, DOI 10.1105/tpc.7.8.1259; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; Spence J, 1996, J MICROSC-OXFORD, V181, P195, DOI 10.1046/j.1365-2818.1996.111391.x; SPENCE J, 1992, DEV SILIQUE ARABIDOP; SUNDARESAN V, 1995, GENE DEV, V9, P1797, DOI 10.1101/gad.9.14.1797; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0	30	642	703	3	116	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					766	770		10.1038/35008089	http://dx.doi.org/10.1038/35008089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783890				2022-12-24	WOS:000086523600053
J	Rembacken, BJ; Fujii, T; Cairns, A; Dixon, MF; Yoshida, S; Chalmers, DM; Axon, ATR				Rembacken, BJ; Fujii, T; Cairns, A; Dixon, MF; Yoshida, S; Chalmers, DM; Axon, ATR			Flat and depressed colonic neoplasms: a prospective study of 1000 colonoscopies in the UK	LANCET			English	Article							EARLY COLORECTAL-CARCINOMA; LARGE-BOWEL; LARGE-INTESTINE; ADENOMA; CANCER; POLYPECTOMY; PREVENTION; SEQUENCE; REMOVAL	Background Flat and depressed colorectal tumours were originally thought to be unique to the Japanese population. Recently there have been reports of flat and depressed lesions in western countries but they have been thought to be uncommon. Methods In this prospective study, 1000 consecutive patients attending for routine colonoscopy were examined for flat or depressed lesions. The examinations were done by one European colonoscopist using methods developed in Japan. Finding 321 adenomas were found: 202 (63%) were polypoid, 36% (117) were flat and 2 (0.6%) appeared depressed. Most adenomas contained areas of mild or moderate dysplasia but 10% (31) were severely dysplastic. Six Dukes' A adenocarcinomas were identified together with 25 more advanced adenocarcinomas. The likelihood of Dukes' A cancer or severe dysplasia increased from 4% (3/70) in small flat lesions, to 6% (9/154) in small polyps, 16% (8/50) in larger polyps, 29% (14/49) in large flat lesions, and 75% (3/4) in depressed lesions. 54% (20/37) lesions containing severe dysplasia or Dukes' A carcinoma were flat or depressed. Interpretation The polyp-carcinoma hypothesis prompts colonoscopists to search only for polypoid lesions when screening for cancer, and many early colorectal neoplasms may therefore be missed. Colonoscopists require training in the recognition of flat and depressed lesions to detect colorectal tumours in the early stages.	Gen Infirm, Ctr Digest Dis, Leeds LS1 3EX, W Yorkshire, England; Natl Canc Ctr, Tokyo 104, Japan	Leeds General Infirmary; University of Leeds; National Cancer Center - Japan	Rembacken, BJ (corresponding author), Gen Infirm, Ctr Digest Dis, Leeds LS1 3EX, W Yorkshire, England.	BJR@firstnet.co.uk						ADACHI M, 1988, DIS COLON RECTUM, V31, P236, DOI 10.1007/BF02552553; BEDENNE L, 1992, CANCER, V69, P883, DOI 10.1002/1097-0142(19920215)69:4<883::AID-CNCR2820690408>3.0.CO;2-B; Cairns A, 1999, GUT, V44, pA142; CRAWFORD BE, 1983, CANCER, V51, P1760, DOI 10.1002/1097-0142(19830501)51:9<1760::AID-CNCR2820510933>3.0.CO;2-N; FLEISCHER DE, 1989, JAMA-J AM MED ASSOC, V261, P580, DOI 10.1001/jama.261.4.580; Fujii T, 1998, ENDOSCOPY, V30, P437, DOI 10.1055/s-2007-1001304; HACHISU T, 1991, SURG ENDOSC-ULTRAS, V5, P70, DOI 10.1007/BF00316840; Hachisu T, 1988, Surg Endosc, V2, P13, DOI 10.1007/BF00591392; *JAP RES SOC CANC, 1983, GEN RUL CLIN PATH ST; JARAMILLO E, 1994, GASTROINTEST ENDOSC, V40, P369, DOI 10.1016/S0016-5107(94)70077-X; Jass JR, 1989, WHO INT HISTOLOGICAL, V2nd; KASUMI A, 1995, SURG ENDOSC-ULTRAS, V9, P690; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; KUDO S, 1995, EUR J CANCER, V31A, P1118, DOI 10.1016/0959-8049(95)00251-D; KUDO S, 1986, GASTROINTEST ENDOSC, V28, P2811; KUDO S, 1989, GASTROENTEROL ENDOSC, V31, P2845; KURAMOTO S, 1989, CANCER, V64, P950, DOI 10.1002/1097-0142(19890815)64:4<950::AID-CNCR2820640430>3.0.CO;2-O; LANSPA SJ, 1992, DIS COLON RECTUM, V35, P543, DOI 10.1007/BF02050533; LYNCH HT, 1992, DIS COLON RECTUM, V35, P411, DOI 10.1007/BF02049396; MORSON B, 1974, P ROY SOC MED, V67, P451, DOI 10.1177/00359157740676P115; MORSON BC, 1968, BRIT J SURG, V55, P725, DOI 10.1002/bjs.1800551003; MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002; MUTO T, 1991, DIS COLON RECTUM, V34, P696, DOI 10.1007/BF02050353; MUTO T, 1985, DIS COLON RECTUM, V28, P847, DOI 10.1007/BF02555490; SAWADA T, 1989, BAILLIERE CLIN GASTR, V3, P627, DOI 10.1016/0950-3528(89)90021-3; SHIMODA T, 1989, CANCER, V64, P1138, DOI 10.1002/1097-0142(19890901)64:5<1138::AID-CNCR2820640529>3.0.CO;2-A; SPRATT JS, 1962, JAMA-J AM MED ASSOC, V179, P337, DOI 10.1001/jama.1962.03050050027005; STOLTE M, 1995, ENDOSCOPY, V27, P286, DOI 10.1055/s-2007-1005694; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; WOLBER RA, 1991, HUM PATHOL, V34, P981	30	522	538	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 8	2000	355	9211					1211	1214		10.1016/S0140-6736(00)02086-9	http://dx.doi.org/10.1016/S0140-6736(00)02086-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770302				2022-12-24	WOS:000086448000009
J	Morita, YS; Paul, KS; Englund, PT				Morita, YS; Paul, KS; Englund, PT			Specialized fatty acid synthesis in African trypanosomes: Myristate for GPI anchors	SCIENCE			English	Article							VARIANT SURFACE GLYCOPROTEIN; BIOLOGICAL PROPERTIES; CULTURE FORMS; BRUCEI; BIOSYNTHESIS; BLOOD; THIOLACTOMYCIN; RHODESIENSE; METABOLISM; LEWISI	African trypanosomes, the cause of sleeping sickness, need massive amounts of myristate to remodel glycosyl phosphatidylinositol (GPI) anchors on their surface glycoproteins. However, it has been believed that the parasite is unable to synthesize any fatty acids, and myristate is not abundant in the hosts' bloodstreams. Thus, it has been unclear how trypanosomes meet their myristate requirement. Here we found that they could indeed synthesize fatty acids. The synthetic pathway was unique in that the major product, myristate, was preferentially incorporated into GPIs and not into other lipids. The antibiotic thiolactomycin inhibited myristate synthesis and killed the parasite, making this pathway a potential chemotherapeutic target.	Johns Hopkins Med Sch, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Englund, PT (corresponding author), Johns Hopkins Med Sch, Dept Biol Chem, Baltimore, MD 21205 USA.	penglund@jhmi.edu	Paul, Kimberly/AAO-4275-2020	Morita, Yasu/0000-0002-4514-9242	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI021334] Funding Source: NIH RePORTER; NIAID NIH HHS [AI21334] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; DIXON H, 1970, COMP BIOCHEM PHYSIOL, V33, P111, DOI 10.1016/0010-406X(70)90487-1; DIXON H, 1971, COMP BIOCHEM PHYSIOL, V39, P247, DOI 10.1016/0305-0491(71)90168-4; DOERING TL, 1994, BIOCHEM J, V299, P741, DOI 10.1042/bj2990741; DOERING TL, 1993, J BIOL CHEM, V268, P9215; DOERING TL, 1991, SCIENCE, V252, P1851, DOI 10.1126/science.1829548; Edelstein C., 1986, BIOCH BIOL PLASMA LI, P495; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; FOSBROOKE AS, 1968, CLIN CHIM ACTA, V20, P517, DOI 10.1016/0009-8981(68)90311-2; GUTHER MLS, 1995, EMBO J, V14, P3080, DOI 10.1002/j.1460-2075.1995.tb07311.x; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Ilgoutz SC, 1999, EMBO J, V18, P3643, DOI 10.1093/emboj/18.13.3643; KAMP F, 1993, BIOCHEMISTRY-US, V32, P11074, DOI 10.1021/bi00092a017; KLEIN RA, 1976, BIOCHEM SOC T, V4, P48, DOI 10.1042/bst0040048; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MASTERSON WJ, 1990, CELL, V62, P73, DOI 10.1016/0092-8674(90)90241-6; MIYAKAWA S, 1982, J ANTIBIOT, V35, P411, DOI 10.7164/antibiotics.35.411; OISHI H, 1982, J ANTIBIOT, V35, P391, DOI 10.7164/antibiotics.35.391; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; Werbovetz KA, 1997, MOL BIOCHEM PARASIT, V85, P1, DOI 10.1016/S0166-6851(96)02820-4	21	100	104	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2000	288	5463					140	143		10.1126/science.288.5463.140	http://dx.doi.org/10.1126/science.288.5463.140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753118				2022-12-24	WOS:000086387700052
J	Vukusic, P; Sambles, JR; Lawrence, CR				Vukusic, P; Sambles, JR; Lawrence, CR			Structural colour - Colour mixing in wing scales of a butterfly	NATURE			English	Article									Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England; DERA, Mech Sci Sector, Farnborough GU14 0LX, Hants, England	University of Exeter	Vukusic, P (corresponding author), Univ Exeter, Sch Phys, Exeter EX4 4QL, Devon, England.	P.Vukusic@ex.ac.uk	Sambles, John Roy/X-8675-2019	SAMBLES, John/0000-0003-2721-0692				BURNHAM RW, 1963, COLOR; Fox DL, 1976, ANIMAL BIOCHROMES ST, V2d; Ghiradella H, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P257; HUXLEY J, 1975, J ENTOMOL SER A, V50, P9; Kelber A, 1999, NATURE, V402, P251, DOI 10.1038/46204; SCHULTZ TD, 1989, NATURE, V337, P72, DOI 10.1038/337072a0; Vukusic P, 1999, P ROY SOC B-BIOL SCI, V266, P1403, DOI 10.1098/rspb.1999.0794	7	320	342	12	230	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 30	2000	404	6777					457	457		10.1038/35006561	http://dx.doi.org/10.1038/35006561			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761905				2022-12-24	WOS:000086257700036
J	Gould, DC; Petty, R; Jacobs, HS				Gould, DC; Petty, R; Jacobs, HS			For and against - The male menopause - does it exist?	BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPOGONADAL MEN; BIOAVAILABLE TESTOSTERONE; ANDROGEN LEVELS; AGING MALE; LONG-TERM; OLDER MEN; ADULT MEN; PLASMA; REPLACEMENT; AGE		WellMan Clin, London W1N 3FA, England		Gould, DC (corresponding author), Goldcross Med Serv, 20 Harley St, London W1N 1AL, England.							Barrett-Connor E, 1999, J CLIN ENDOCR METAB, V84, P573, DOI 10.1210/jc.84.2.573; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; BROWN WA, 1978, ARCH SEX BEHAV, V7, P97, DOI 10.1007/BF01542059; BURRIS AS, 1992, J ANDROL, V13, P297; DAVIDSON JM, 1983, J CLIN ENDOCR METAB, V57, P71, DOI 10.1210/jcem-57-1-71; DESLYPERE JP, 1984, J CLIN ENDOCR METAB, V59, P955, DOI 10.1210/jcem-59-5-955; FELDMAN JM, 1976, ARCH INTERN MED, V136, P606, DOI 10.1001/archinte.136.5.606; FINKELSTEIN JS, 1998, TESTOSTERONE ACTION, P187; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; GOUCHIE C, 1991, PSYCHONEUROENDOCRINO, V16, P323, DOI 10.1016/0306-4530(91)90018-O; GRAY A, 1991, J CLIN EPIDEMIOL, V44, P671, DOI 10.1016/0895-4356(91)90028-8; Greendale GA, 1997, J BONE MINER RES, V12, P1833, DOI 10.1359/jbmr.1997.12.11.1833; Heller CG, 1944, J AMER MED ASSOC, V126, P472, DOI 10.1001/jama.1944.02850430006003; IDA Y, 1992, DRUG ALCOHOL DEPEN, V31, P57, DOI 10.1016/0376-8716(92)90009-2; JACKSON JA, 1992, AM J MED SCI, V304, P4, DOI 10.1097/00000441-199207000-00003; JANOWSKY JS, 1994, BEHAV NEUROSCI, V108, P325, DOI 10.1037/0735-7044.108.2.325; Katznelson L, 1996, J CLIN ENDOCR METAB, V81, P4358, DOI 10.1210/jc.81.12.4358; KAUFMAN JM, 1998, TESTOSTERONE ACTION, P437; KLEY HK, 1974, HORM METAB RES, V6, P213, DOI 10.1055/s-0028-1093855; KORENMAN SG, 1990, J CLIN ENDOCR METAB, V71, P963, DOI 10.1210/jcem-71-4-963; MANTZOROS CS, 1995, BRIT MED J, V310, P1289, DOI 10.1136/bmj.310.6990.1289; MEIKLE AW, 1988, J CLIN ENDOCR METAB, V67, P104, DOI 10.1210/jcem-67-1-104; MORLEY JE, 1986, AM J MED, V80, P897, DOI 10.1016/0002-9343(86)90635-2; NAHOUL K, 1990, J STEROID BIOCHEM, V35, P293, DOI 10.1016/0022-4731(90)90287-3; NANKIN HR, 1986, J CLIN ENDOCR METAB, V63, P1418, DOI 10.1210/jcem-63-6-1418; NIESCHLAG E, 1978, CIBA F SYMP, V62, P182; NILSSON PM, 1995, J INTERN MED, V237, P479, DOI 10.1111/j.1365-2796.1995.tb00873.x; PHILLIPS GB, 1994, ARTERIOSCLER THROMB, V14, P701, DOI 10.1161/01.ATV.14.5.701; SIMON D, 1992, AM J EPIDEMIOL, V135, P783, DOI 10.1093/oxfordjournals.aje.a116365; STEPAN JJ, 1989, J CLIN ENDOCR METAB, V69, P523; Tenover JL, 1997, J ANDROL, V18, P103; THEORELL T, 1990, J INTERN MED, V227, P31, DOI 10.1111/j.1365-2796.1990.tb00115.x; VERMEULEN A, 1985, MATURITAS, V7, P273, DOI 10.1016/0378-5122(85)90050-7; Vermeulen A, 1996, J CLIN ENDOCR METAB, V81, P1821, DOI 10.1210/jc.81.5.1821; VERMEULEN A, 1992, J CLIN ENDOCR METAB, V74, P939, DOI 10.1210/jc.74.4.939; Wang C, 1996, J CLIN ENDOCR METAB, V81, P3578, DOI 10.1210/jc.81.10.3578; Werner AA, 1939, J AMER MED ASSOC, V112, P1441, DOI 10.1001/jama.1939.02800150013004; *WORLD HLTH ORG, 1992, GUID US ANDR MEN	38	31	32	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					858	860		10.1136/bmj.320.7238.858	http://dx.doi.org/10.1136/bmj.320.7238.858			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731186	Green Published			2022-12-24	WOS:000086180300031
J	Feany, MB; Bender, WW				Feany, MB; Bender, WW			A Drosophila model of Parkinson's disease	NATURE			English	Article							CATECHOLAMINE-CONTAINING NEURONS; ALPHA-SYNUCLEIN; LEWY BODIES; CELL-DEATH; MELANOGASTER; MUTANT; DEGENERATION; EXPRESSION; INCLUSIONS; PATHOLOGY	Parkinson's disease is a common neurodegenerative syndrome characterized by loss of dopaminergic neurons in the substantia nigra, formation of filamentous intraneuronal inclusions (Lewy bodies) and an extrapyramidal movement disorder. Mutations in the alpha-synuclein gene are linked to familial Parkinson's disease(1,2) and alpha-synuclein accumulates in Lewy bodies and Lewy neurites(3-5). Here we express normal and mutant forms of alpha-synuclein in Drosophila and produce adult-onset loss of dopaminergic neurons, filamentous intraneuronal inclusions containing alpha-synuclein and locomotor dysfunction. Our Drosophila model thus recapitulates the essential features of the human disorder, and makes possible a powerful genetic approach to Parkinson's disease.	Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Feany, MB (corresponding author), Brigham & Womens Hosp, Dept Pathol, Div Neuropathol, 75 Francis St, Boston, MA 02115 USA.			Feany, Mel/0000-0003-0315-7970				Baba M, 1998, AM J PATHOL, V152, P879; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUCHANAN RL, 1993, NEURON, V10, P839, DOI 10.1016/0896-6273(93)90200-B; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; BUDNIK V, 1986, J NEUROSCI, V6, P3682; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; COOMBE PE, 1986, J NEUROGENET, V3, P135, DOI 10.3109/01677068609106845; DICKSON DW, 1989, ACTA NEUROPATHOL, V78, P572, DOI 10.1007/BF00691284; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; ELLIS MC, 1993, DEVELOPMENT, V119, P855; Franceschini N., 1972, INFORMATION PROCESSI, P75; GANETZKY B, 1978, EXP GERONTOL, V13, P189, DOI 10.1016/0531-5565(78)90012-8; GIBB WRG, 1991, J NEUROL NEUROSUR PS, V54, P388, DOI 10.1136/jnnp.54.5.388; Hong L, 1998, NEUROREPORT, V9, P1239, DOI 10.1097/00001756-199804200-00051; JELLINGER KA, 1991, MOL CHEM NEUROPATHOL, V14, P153, DOI 10.1007/BF03159935; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; LEBOURG E, 1992, GERONTOLOGY, V38, P59; LI H, IN PRESS CURR BIOL; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; POLLANEN MS, 1993, J NEUROPATH EXP NEUR, V52, P183, DOI 10.1097/00005072-199305000-00001; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Warrick JM, 1998, CELL, V93, P939, DOI 10.1016/S0092-8674(00)81200-3	30	1572	1659	7	171	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					394	398		10.1038/35006074	http://dx.doi.org/10.1038/35006074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746727				2022-12-24	WOS:000086119000052
J	Castner, SA; Williams, GV; Goldman-Rakic, PS				Castner, SA; Williams, GV; Goldman-Rakic, PS			Reversal of antipsychotic-induced working memory deficits by short-term doper D1 receptor stimulation	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; POSITRON EMISSION TOMOGRAPHY; PRIMATE CEREBRAL-CORTEX; AGE-RELATED-CHANGES; DOPAMINE-RECEPTORS; PREFRONTAL CORTEX; BEHAVIORAL SUPERSENSITIVITY; HALOPERIDOL TREATMENT; AMPHETAMINE; SENSITIZATION	Chronic blockade of dopamine D2 receptors, a common mechanism of action for antipsychotic drugs, down-regulates D1 receptors in the prefrontal cortex and, as shown here, produces severe impairments in working memory. These deficits were reversed in monkeys by short-term coadministration of a D1 agonist, ABT 431, and this improvement was sustained for more than a year after cessation of D1 treatment. These findings indicate that pharmacological modulation of the D1 signaling pathway can produce long-lasting changes in functional circuits underlying working memory. Resetting this pathway by brief exposure to the agonist may provide a valuable strategy for therapeutic intervention in schizophrenia and other dopamine dysfunctional states.	Yale Univ, Sch Med, Neurobiol Sect, New Haven, CT 06510 USA	Yale University	Goldman-Rakic, PS (corresponding author), Yale Univ, Sch Med, Neurobiol Sect, 333 Cedar St, New Haven, CT 06510 USA.				NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH044866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010160] Funding Source: NIH RePORTER; NIDA NIH HHS [P01DA10160] Funding Source: Medline; NIMH NIH HHS [P50MH44866] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arnsten AFT, 1998, ARCH GEN PSYCHIAT, V55, P362, DOI 10.1001/archpsyc.55.4.362; ARNSTEN AFT, 1994, PSYCHOPHARMACOLOGY, V116, P143, DOI 10.1007/BF02245056; BACHEVALIER J, 1984, BEHAV NEUROSCI, V98, P770, DOI 10.1037/0735-7044.98.5.770; Bjijou Y, 1996, J PHARMACOL EXP THER, V277, P1177; BUCKLAND PR, 1993, NEUROSCI LETT, V150, P25, DOI 10.1016/0304-3940(93)90099-7; CAI JX, 1997, J PHARMACOL EXP THER, V282, P1; CASTNER SA, UNPUB; CIVELLI O, 1993, ANN REV PHARM TOXICO, V32, P281; Crawford CA, 1997, NEUROREPORT, V8, P2523, DOI 10.1097/00001756-199707280-00021; CRISWELL H, 1989, J NEUROSCI, V9, P125; DAVIDSON M, 1990, ARCH GEN PSYCHIAT, V47, P190; DEKEYSER J, 1990, BRAIN RES, V528, P308, DOI 10.1016/0006-8993(90)91672-4; Florijn WJ, 1997, J PHARMACOL EXP THER, V280, P561; GOLDMANRAKIC PS, 1992, J NEURAL TRANSM-GEN, P163; GOSS JR, 1991, LIFE SCI, V48, P1015, DOI 10.1016/0024-3205(91)90367-K; KALIVAS PW, 1991, BRAIN RES REV, V16, P223, DOI 10.1016/0165-0173(91)90007-U; Kelley JJ, 1997, EXP NEUROL, V146, P471, DOI 10.1006/exnr.1997.6552; LEZCANO, 2000, SCIENCE, V287, P1660; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Lidow MS, 1997, J PHARMACOL EXP THER, V281, P597; LIDOW MS, 1994, P NATL ACAD SCI USA, V91, P4353, DOI 10.1073/pnas.91.10.4353; Lidow MS, 1998, TRENDS PHARMACOL SCI, V19, P136, DOI 10.1016/S0165-6147(98)01186-9; MARIN C, 1993, EUR J PHARMACOL, V231, P191, DOI 10.1016/0014-2999(93)90448-Q; Meltzer HY, 1999, SCHIZOPHRENIA BULL, V25, P233, DOI 10.1093/oxfordjournals.schbul.a033376; Okubo Y, 1997, MOL PSYCHIATR, V2, P291, DOI 10.1038/sj.mp.4000281; Okubo Y, 1997, NATURE, V385, P634, DOI 10.1038/385634a0; RINNE JO, 1990, BRAIN RES, V508, P349, DOI 10.1016/0006-8993(90)90423-9; Robinson TE, 1997, J NEUROSCI, V17, P8491; ROBINSON TE, 1986, BRAIN RES REV, V11, P157, DOI 10.1016/0165-0173(86)90002-0; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SCHNEIDER JS, 1994, BRAIN RES, V663, P140, DOI 10.1016/0006-8993(94)90471-5; SEDVALL G, 1995, LANCET, V346, P743, DOI 10.1016/S0140-6736(95)91508-7; SEEMAN P, 1987, SYNAPSE, V1, P133, DOI 10.1002/syn.890010203; STEWART J, 1989, BRAIN RES, V495, P401, DOI 10.1016/0006-8993(89)90236-9; SUHARA T, 1992, PSYCHOPHARMACOLOGY, V106, P14, DOI 10.1007/BF02253582; SUHARA T, 1991, PSYCHOPHARMACOLOGY, V103, P41, DOI 10.1007/BF02244071; Vezina P, 1996, J NEUROSCI, V16, P2411; VINCENT SL, 1991, NEUROPSYCHOPHARMACOL, V5, P147; WENK GL, 1989, NEUROBIOL AGING, V10, P11, DOI 10.1016/S0197-4580(89)80005-3; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0	40	295	310	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2020	2022		10.1126/science.287.5460.2020	http://dx.doi.org/10.1126/science.287.5460.2020			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720329				2022-12-24	WOS:000085902800063
J	Fliss, MS; Usadel, H; Cabellero, OL; Wu, L; Buta, MR; Eleff, SM; Jen, J; Sidransky, D				Fliss, MS; Usadel, H; Cabellero, OL; Wu, L; Buta, MR; Eleff, SM; Jen, J; Sidransky, D			Facile detection of mitochondrial DNA mutations in tumors and bodily fluids	SCIENCE			English	Article							OXIDATIVE DAMAGE; NUCLEAR	Examination of human bladder, head and neck, and lung primary tumors revealed a high frequency of mitochondrial DNA (mtDNA) mutations. The majority of these somatic mutations were homoplasmic in nature, indicating that the mutant mtDNA became dominant in tumor cells. The mutated mtDNA was readily detectable in paired bodily fluids from each type of cancer and was 19 to 220 times as abundant as mutated nuclear p53 DNA. By virtue of their clonal nature and high copy number, mitochondrial mutations may provide a powerful molecular marker for noninvasive detection of cancer.	Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Head & Neck Canc Res Div, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Sidransky, D (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Head & Neck Canc Res Div, Baltimore, MD 21205 USA.				NATIONAL CANCER INSTITUTE [P50CA058184, P01CA077664] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE012488] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA 58184, R01 CA77664] Funding Source: Medline; NIDCR NIH HHS [R01 DE 012488] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahrendt SA, 1999, JNCI-J NATL CANCER I, V91, P332, DOI 10.1093/jnci/91.4.332; Ahrendt SA, 1999, P NATL ACAD SCI USA, V96, P7382, DOI 10.1073/pnas.96.13.7382; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Cadet J, 1997, Rev Physiol Biochem Pharmacol, V131, P1; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Croteau DL, 1997, J BIOL CHEM, V272, P25409, DOI 10.1074/jbc.272.41.25409; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; JEN J, 1994, CANCER RES, V54, P5523; Khrapko K, 1999, NUCLEIC ACIDS RES, V27, P2434, DOI 10.1093/nar/27.11.2434; Lightowlers RN, 1997, TRENDS GENET, V13, P450, DOI 10.1016/S0168-9525(97)01266-3; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; RICHTER C, 1988, P NATL ACAD SCI USA, V85, P6465, DOI 10.1073/pnas.85.17.6465; SHAY JW, 1987, MUTAT RES, V186, P149, DOI 10.1016/0165-1110(87)90028-5; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; WALLACE DC, 1994, P NATL ACAD SCI USA, V91, P8746; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	17	649	710	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2017	2019		10.1126/science.287.5460.2017	http://dx.doi.org/10.1126/science.287.5460.2017			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720328				2022-12-24	WOS:000085902800062
J	Aldhous, P				Aldhous, P			Protests force primate farm to close	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2000	404	6775					215	215		10.1038/35005241	http://dx.doi.org/10.1038/35005241			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10766598	Bronze			2022-12-24	WOS:000086022200007
J	Wadman, M				Wadman, M			Republican candidates clash on fetal tissue in research	NATURE			English	News Item																			0	0	0	0	1	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2000	403	6771					694	694		10.1038/35001743	http://dx.doi.org/10.1038/35001743			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286BE	10733383	Bronze			2022-12-24	WOS:000085423100013
J	Cobey, J; Ayotte, B				Cobey, J; Ayotte, B			Tools to measure landmine incidents and injuries	LANCET			English	Editorial Material									Physicians Human Rights, Boston, MA 02116 USA		Cobey, J (corresponding author), Physicians Human Rights, 100 Boylston St,Suite 702, Boston, MA 02116 USA.								0	6	6	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 29	2000	355	9214					1549	1550		10.1016/S0140-6736(05)74597-9	http://dx.doi.org/10.1016/S0140-6736(05)74597-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LR	10801190				2022-12-24	WOS:000086830100044
J	Blazquez, MA; Weigel, D				Blazquez, MA; Weigel, D			Integration of floral inductive signals in Arabidopsis	NATURE			English	Article							FLOWERING-TIME GENES; INFLORESCENCE DEVELOPMENT; PLANT TRANSFORMATION; SHOOT DEVELOPMENT; BINARY VECTORS; EMF GENES; LEAFY; THALIANA; EXPRESSION; INITIATION	Flowering of Arabidopsis is regulated by a daylength-dependent pathway that accelerates flowering in long days and a daylength-independent pathway that ensures flowering in the absence of inductive conditions(1-3). These pathways are genetically separable, as there are mutations that delay flowering in long but not short days(4). Conversely, mutations that block synthesis of the hormone gibberellin abolish flowering in short days, but have on their own only a minor effect in long days(5). A third pathway, the autonomous pathway, probably acts by modulating the other two pathways(3). Understanding where and how these pathways are integrated is a prerequisite for understanding why similar environmental or endogenous cues can elicit opposite flowering responses in different plants(6,7). In Arabidopsis, floral induction leads ultimately to the upregulation of floral meristem-identity genes such as LEAFY(8-13), indicating that floral inductive signals are integrated upstream of LEAFY. Here we show that gibberellins activate the LEAFY promoter through cis elements that are different from those that are sufficient for the daylength response, demonstrating that the LEAFY promoter integrates environmental and endogenous signals controlling flowering time.	Salk Inst Biol Studies, La Jolla, CA 92037 USA	Salk Institute	Weigel, D (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.		Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/AAR-3312-2021; Weigel, Detlef/C-1418-2008; Blazquez, Miguel A/B-1495-2008	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Blazquez, Miguel A/0000-0001-5743-0448				Bechtold N, 1998, METH MOL B, V82, P259; BERNIER G, 1988, ANNU REV PLANT PHYS, V39, P175, DOI 10.1146/annurev.arplant.39.1.175; Bernier G., 1981, PHYSL FLOWERING; Blazquez MA, 1998, PLANT CELL, V10, P791, DOI 10.1105/tpc.10.5.791; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Chen LJ, 1997, PLANT CELL, V9, P2011, DOI 10.1105/tpc.9.11.2011; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hempel FD, 1997, DEVELOPMENT, V124, P3845; HUALA E, 1992, PLANT CELL, V4, P901, DOI 10.1105/tpc.4.8.901; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, ANNU REV PLANT PHYS, V49, P345, DOI 10.1146/annurev.arplant.49.1.345; Liljegren SJ, 1999, PLANT CELL, V11, P1007, DOI 10.1105/tpc.11.6.1007; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; MCBRIDE KE, 1990, PLANT MOL BIOL, V14, P269, DOI 10.1007/BF00018567; Nilsson O, 1998, GENETICS, V150, P403; Pineiro M, 1998, PLANT PHYSIOL, V117, P1, DOI 10.1104/pp.117.1.1; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; RuizGarcia L, 1997, PLANT CELL, V9, P1921, DOI 10.1105/tpc.9.11.1921; SCHULTZ EA, 1991, PLANT CELL, V3, P771, DOI 10.1105/tpc.3.8.771; Simon R, 1996, NATURE, V384, P59, DOI 10.1038/384059a0; Simpson GG, 1999, ANNU REV CELL DEV BI, V15, P519, DOI 10.1146/annurev.cellbio.15.1.519; SUNG ZR, 1992, SCIENCE, V258, P1645, DOI 10.1126/science.258.5088.1645; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; Wang ZY, 1997, PLANT CELL, V9, P491, DOI 10.1105/tpc.9.4.491; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; YANG CH, 1995, DEV BIOL, V169, P421, DOI 10.1006/dbio.1995.1158; YANOFSKY MF, 1995, ANNU REV PLANT PHYS, V46, P167, DOI 10.1146/annurev.pp.46.060195.001123	30	354	405	4	79	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					889	892		10.1038/35009125	http://dx.doi.org/10.1038/35009125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786797				2022-12-24	WOS:000086625000049
J	Beekman, M; Calis, JNM; Boot, WJ				Beekman, M; Calis, JNM; Boot, WJ			Insect behaviour - Parasitic honeybees get royal treatment	NATURE			English	Article							APIS-MELLIFERA-CAPENSIS; CASTE DIFFERENTIATION; EVOLUTION; LARVAE		Wageningen Univ Agr, Entomol Lab, NL-6700 EH Wageningen, Netherlands	Wageningen University & Research	Beekman, M (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England.		Beekman, Madeleine/A-3983-2011; Beekman, Madeleine/AAF-8574-2019	Beekman, Madeleine/0000-0002-9040-3756; Beekman, Madeleine/0000-0002-9040-3756				Allsopp M, 1992, S AFR BEE J, V64, P52; BROUWERS EVM, 1984, J APICULT RES, V23, P94, DOI 10.1080/00218839.1984.11100616; CREWE RM, 1980, NATURWISSENSCHAFTEN, V67, P467, DOI 10.1007/BF00405650; Greeff JM, 1997, S AFR J SCI, V93, P306; HEPBURN HR, 1994, S AFR J SCI, V90, P247; Moritz RFA, 1996, NATURE, V384, P31, DOI 10.1038/384031a0; NONACS P, 1992, EVOLUTION, V46, P1605, DOI 10.1111/j.1558-5646.1992.tb01157.x; RUTTNER F, 1977, APIDOLOGIE, V8, P281, DOI 10.1051/apido:19770305; VANHANDE.E, 1967, ANAL BIOCHEM, V19, P193, DOI 10.1016/0003-2697(67)90152-2; WIRTZ P, 1972, ENTOMOL EXP APPL, V15, P517, DOI 10.1007/BF00293616	10	53	55	0	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					723	723		10.1038/35008148	http://dx.doi.org/10.1038/35008148			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783876	Bronze			2022-12-24	WOS:000086523600039
J	Nishikawa, T; Edelstein, D; Du, XL; Yamagishi, S; Matsumura, T; Kaneda, Y; Yorek, MA; Beebe, D; Oates, PJ; Hammes, HP; Giardino, I; Brownlee, M				Nishikawa, T; Edelstein, D; Du, XL; Yamagishi, S; Matsumura, T; Kaneda, Y; Yorek, MA; Beebe, D; Oates, PJ; Hammes, HP; Giardino, I; Brownlee, M			Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage	NATURE			English	Article							ADVANCED GLYCATION ENDPRODUCTS; BOVINE ENDOTHELIAL-CELLS; ALDOSE REDUCTASE; IN-VITRO; KAPPA-B; ACTIVATION; OVEREXPRESSION; EXPRESSION; PROTEIN; RAT	Diabetic hyperglycaemia causes a variety of pathological changes in small vessels, arteries and peripheral nerves(1). Vascular endothelial cells are an important target of hyperglycaemic damage, but the mechanisms underlying this damage are not fully understood. Three seemingly independent biochemical pathways are involved in the pathogenesis: glucose-induced activation of protein kinase C isoforms(2); increased formation of glucose-derived advanced glycation end-products(3); and increased glucose flux through the aldose reductase pathway(4). The relevance of each of these pathways is supported by animal studies in which pathway-specific inhibitors prevent various hyperglycaemia-induced abnormalities(3,5-7). Hyperglycaemia increases the production of reactive oxygen species inside cultured bovine aortic endothelial cells(8). Here we show that this increase in reactive oxygen species is prevented by an inhibitor of electron transport chain complex II, by an uncoupler of oxidative phosphorylation, by uncoupling protein-1 and by manganese superoxide dismutase. Normalizing levels of mitochondrial reactive oxygen species with each of these agents prevents glucose-induced activation of protein kinase C, formation of advanced glycation end-products, sorbitol accumulation and NF kappa B activation.	Albert Einstein Coll Med, Diabet Res Ctr, Bronx, NY 10461 USA; Osaka Univ, Sch Med, Div Gene Therapy Sci, Suita, Osaka 5650871, Japan; Univ Iowa, Dept Internal Med, Iowa City, IA 52246 USA; Pfizer Inc, Div Cent Res, Dept Metab Dis, Groton, CT 06340 USA; Univ Giessen, Dept Med 3, D-35385 Giessen, Germany	Yeshiva University; Albert Einstein College of Medicine; Osaka University; University of Iowa; Pfizer; Justus Liebig University Giessen	Brownlee, M (corresponding author), Albert Einstein Coll Med, Diabet Res Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.		Yorek, Mark/AAC-3136-2021; Hammes, Hans-Peter/S-3719-2019	Yorek, Mark/0000-0001-7737-5554; 				BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; CASTEILLA L, 1990, P NATL ACAD SCI USA, V87, P5124, DOI 10.1073/pnas.87.13.5124; Chandra A, 1997, BBA-PROTEIN STRUCT M, V1341, P217, DOI 10.1016/S0167-4838(97)00084-8; Giardino I, 1996, J CLIN INVEST, V97, P1422, DOI 10.1172/JCI118563; Ishihara H, 1996, DIABETES, V45, P1238, DOI 10.2337/diabetes.45.9.1238; Ishii H, 1996, SCIENCE, V272, P728, DOI 10.1126/science.272.5262.728; Knight RJ, 1996, CARDIOVASC RES, V32, P1016, DOI 10.1016/S0008-6363(96)00137-X; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; Koya D, 1998, DIABETES, V47, P859, DOI 10.2337/diabetes.47.6.859; Kurose I, 1997, J CLIN INVEST, V99, P867, DOI 10.1172/JCI119251; Kwong LK, 1998, ARCH BIOCHEM BIOPHYS, V350, P118, DOI 10.1006/abbi.1997.0489; LEE AYW, 1995, P NATL ACAD SCI USA, V92, P2780, DOI 10.1073/pnas.92.7.2780; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; *NAT DIAB DAT GROU, 1994, DIAB AM; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Pieper GM, 1997, J CARDIOVASC PHARM, V30, P528, DOI 10.1097/00005344-199710000-00019; Pieper GM, 1997, CARDIOVASC RES, V34, P145, DOI 10.1016/S0008-6363(96)00237-4; Saeki Y, 1998, GENE THER, V5, P1031, DOI 10.1038/sj.gt.3300711; Saeki Y, 1997, HUM GENE THER, V8, P2133, DOI 10.1089/hum.1997.8.17-2133; Shinohara M, 1998, J CLIN INVEST, V101, P1142, DOI 10.1172/JCI119885; SIMA AAF, 1990, J CLIN INVEST, V85, P1410, DOI 10.1172/JCI114585; TRUMPOWER BL, 1990, J BIOL CHEM, V265, P11409; WALLACE DC, 1992, ANNU REV BIOCHEM, V61, P1175, DOI 10.1146/annurev.bi.61.070192.005523; Yorek MA, 1999, KIDNEY INT, V55, P215, DOI 10.1046/j.1523-1755.1999.00235.x	24	3260	3460	7	254	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					787	790		10.1038/35008121	http://dx.doi.org/10.1038/35008121			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783895				2022-12-24	WOS:000086523600058
J	Beach, R				Beach, R			Minimally invasive approach to management of irritable hip in children	LANCET			English	Editorial Material							HOSPITAL ADMISSION; ULTRASOUND		Norfolk & Norwich Hlth Care NHS Trust, Dept Paediat, Norwich NR1 3SR, Norfolk, England	Norfolk & Norwich University Hospitals NHS Foundation Trust	Beach, R (corresponding author), Norfolk & Norwich Hlth Care NHS Trust, Dept Paediat, Norwich NR1 3SR, Norfolk, England.							BENNETT OM, 1992, CLIN ORTHOP RELAT R, P123; Eich GF, 1999, EUR J PEDIATR, V158, P923, DOI 10.1007/s004310051243; FINK AM, 1995, ARCH DIS CHILD, V72, P110, DOI 10.1136/adc.72.2.110; Fischer SU, 1999, J BONE JOINT SURG BR, V81B, P1029, DOI 10.1302/0301-620X.81B6.9607; GOPAKUMAR TS, 1992, EUR J RADIOL, V15, P113, DOI 10.1016/0720-048X(92)90134-U; Loder RT, 1996, CLIN ORTHOP RELAT R, P8; MAH ET, 1994, PEDIATR RADIOL, V24, P484, DOI 10.1007/BF02015005; Mattick A, 1999, J ACCID EMERG MED, V16, P345; TAYLOR GR, 1994, ARCH DIS CHILD, V71, P59, DOI 10.1136/adc.71.1.59	9	11	12	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1202	1203		10.1016/S0140-6736(00)02082-1	http://dx.doi.org/10.1016/S0140-6736(00)02082-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303VX	10770298				2022-12-24	WOS:000086448000005
J	Arico, M; Valsecchi, MG; Camitta, B; Schrappe, M; Chessells, J; Baruchel, A; Gaynon, P; Silverman, L; Janka-Schaub, G; Kamps, W; Pui, CH; Masera, G				Arico, M; Valsecchi, MG; Camitta, B; Schrappe, M; Chessells, J; Baruchel, A; Gaynon, P; Silverman, L; Janka-Schaub, G; Kamps, W; Pui, CH; Masera, G			Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; PEDIATRIC-ONCOLOGY-GROUP; CLINICAL-SIGNIFICANCE; POOR-PROGNOSIS; PROSPECTIVE METAANALYSIS; INTENSIVE CHEMOTHERAPY; INTERIM ANALYSIS; CANCER GROUP; CHILDHOOD; THERAPY	Background: Children with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-positive ALL) have a poor prognosis, and there is no consensus on the optimal treatment for this variant of ALL. Methods: We reviewed the medical records of patients with Ph-positive ALL who were treated with intensive chemotherapy, with or without bone marrow transplantation, by 10 study groups or large single institutions from 1986 to 1996. Data on 326 children and young adults, who ranged in age from 0.4 to 19.9 years (median, 8.1), were analyzed to determine the rate of complete remission and the probability of event-free, disease-free, and overall survival according to standard prognostic factors and type of treatment. Results: The 267 patients who had a complete remission after induction chemotherapy (82 percent) were stratified into three subgroups according to the age and leukocyte count at the time of diagnosis: those with the best prognosis (a leukocyte count of less than 50,000 per cubic millimeter and an age of less than 10 years; 95 patients); those with an intermediate prognosis (intermediate-risk features; 92 patients); and those with the worst prognosis (a leukocyte count of more than 100,000 per cubic millimeter; 80 patients). The estimates of disease-free survival at five years (+/-SE) were 49+/-5 percent (for patients with the best prognosis), 30+/-5 percent (for those with an intermediate prognosis), and 20+/-5 percent (for those with the worst prognosis) (P<0.001 for the overall comparison). We also found that transplantation of bone marrow from an HLA-matched related donor offered significantly greater benefit than intensive chemotherapy alone in terms of protecting patients from relapse or other adverse events (relative risk, 0.3; 95 percent confidence interval, 0.2 to 0.5; P<0.001). This finding was consistent in all three subgroups. Conclusions: Unlike the usual type of ALL, Ph-positive ALL is associated with a poor prognosis. Nevertheless, in some patients with favorable prognostic features, the disease can be controlled by intensive chemotherapy. Transplantation of bone marrow from an HLA-matched related donor is superior to other types of transplantation and to intensive chemotherapy alone in prolonging initial complete remissions. (N Engl J Med 2000;342:998-1006.) (C) 2000, Massachusetts Medical Society.	Policlin San Matteo, IRCCS, Pediat Clin, Dept Pediat, I-27100 Pavia, Italy; Univ Verona, Dept Publ Hlth, I-37100 Verona, Italy; Med Coll Wisconsin, Midw Childrens Canc Ctr, Dept Pediat, Milwaukee, WI 53226 USA; Med Hsch Hannover, Dept Pediat Hematol Oncol, Hannover, Germany; Inst Child Hlth, Leukemia Res Fund, London, England; Hop St Louis, Serv Pediat Hematol, Paris, France; Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; Univ So Calif, Los Angeles, CA USA; Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA; Univ Hamburg, Dept Pediat Hematol & Oncol, Hamburg, Germany; Beatrix Children Hosp, Dept Pediat Oncol, Groningen, Netherlands; St Jude Childrens Res Hosp, Memphis, TN 38105 USA; Univ Tennessee, Coll Med, Memphis, TN USA; Univ Milan, Dept Pediat, Monza, Italy; Osped San Gerardo, Monza, Italy	IRCCS Fondazione San Matteo; University of Pavia; University of Verona; Medical College of Wisconsin; Hannover Medical School; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Children's Hospital Los Angeles; University of Southern California; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Hamburg; University of Groningen; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Milan; San Gerardo Hospital	Arico, M (corresponding author), Policlin San Matteo, IRCCS, Pediat Clin, Dept Pediat, I-27100 Pavia, Italy.		Schrappe, Martin/A-8109-2010; Pui, Ching-Hon/N-8076-2018; Arico, Maurizio/S-3039-2019; Valsecchi, Maria Grazia/K-8891-2016; SESM, SESM/C-1440-2008; Schrappe, Martin/ABA-6144-2020	Pui, Ching-Hon/0000-0003-0303-5658; Arico, Maurizio/0000-0002-1908-6671; Valsecchi, Maria Grazia/0000-0001-5574-3504; 	NATIONAL CANCER INSTITUTE [R37CA036401, R29CA051001, R01CA036401, R01CA051001, P30CA021765] Funding Source: NIH RePORTER; NCI NIH HHS [CA21765, CA 51001, CA 36401] Funding Source: Medline; Telethon [E.0755] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Telethon(Fondazione Telethon)		BARRETT AJ, 1992, BLOOD, V79, P3067; Bassan R, 1999, ADV EXP MED BIOL, V457, P489; CASPER J, 1992, BLOOD S, V80, pA65; CHESSELLS JM, 1995, LANCET, V345, P143, DOI 10.1016/S0140-6736(95)90164-7; Conter V, 1998, HAEMATOLOGICA, V83, P791; CONTER V, 1995, J CLIN ONCOL, V13, P2497, DOI 10.1200/JCO.1995.13.10.2497; CRIST W, 1990, BLOOD, V76, P489; FLETCHER JA, 1991, BLOOD, V77, P435; GAJJAR A, 1995, BLOOD, V86, P1292, DOI 10.1182/blood.V86.4.1292.bloodjournal8641292; GAYNON PS, 1990, MED PEDIATR ONCOL, V18, P273, DOI 10.1002/mpo.2950180403; Harbott J, 1993, Recent Results Cancer Res, V131, P123; JankaSchaub GE, 1996, EUR J PEDIATR, V155, P640; KANTARJIAN HM, 1991, BLOOD, V78, P2411, DOI 10.1182/blood.V78.9.2411.bloodjournal7892411; Marks DI, 1998, J CLIN ONCOL, V16, P931, DOI 10.1200/JCO.1998.16.3.931; MARUBINI E, 1995, ANAL SURVIVAL DATA C, P171; MASTRANGELO R, 1986, MED PEDIATR ONCOL, V14, P191, DOI 10.1002/mpo.2950140317; MAURER J, 1991, LANCET, V337, P1055, DOI 10.1016/0140-6736(91)91706-Z; Nachman JB, 1998, NEW ENGL J MED, V338, P1663, DOI 10.1056/NEJM199806043382304; PUI CH, 1990, BLOOD, V76, P1449; PUI CH, 1994, J PEDIATR-US, V124, P491, DOI 10.1016/S0022-3476(05)83125-7; Pui CH, 1998, NEW ENGL J MED, V339, P605, DOI 10.1056/NEJM199808273390907; RAIMONDI SC, 1999, CHILDHOOD LEUKEMIAS, P168; REITER A, 1994, BLOOD, V84, P3122, DOI 10.1182/blood.V84.9.3122.3122; RIBEIRO RC, 1987, BLOOD, V70, P948; Ribeiro RC, 1997, LEUKEMIA, V11, P1493, DOI 10.1038/sj.leu.2400749; RIEHM H, 1987, KLIN PADIATR, V199, P151, DOI 10.1055/s-2008-1026781; ROBERTS WM, 1994, LANCET, V343, P331, DOI 10.1016/S0140-6736(94)91166-5; RUSSO C, 1991, BLOOD, V77, P1050; Schlieben S, 1996, LEUKEMIA, V10, P957; Schrappe M, 1998, BLOOD, V92, P2730; SCHRAPPE M, 1994, KLIN PADIATR, V206, P208, DOI 10.1055/s-2008-1046607; Shuster JJ, 1996, ANN ONCOL, V7, P1009; Silverman LB, 1999, CANCER-AM CANCER SOC, V85, P1395, DOI 10.1002/(SICI)1097-0142(19990315)85:6<1395::AID-CNCR25>3.0.CO;2-2; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Smith M, 1996, J CLIN ONCOL, V14, P680, DOI 10.1200/JCO.1996.14.2.680; Steinherz PG, 1996, J CLIN ONCOL, V14, P389, DOI 10.1200/JCO.1996.14.2.389; Stram DO, 1996, BIOMETRICS, V52, P1079, DOI 10.2307/2533069; SURYANARAYAN K, 1991, BLOOD, V77, P324; Thomas X, 1998, HEMATOL CELL THER, V40, P119; Uckun FM, 1998, CANCER-AM CANCER SOC, V83, P2030, DOI 10.1002/(SICI)1097-0142(19981101)83:9<2030::AID-CNCR21>3.0.CO;2-Q; Uderzo C, 1997, BRIT J HAEMATOL, V96, P387, DOI 10.1046/j.1365-2141.1997.d01-2033.x; Valsecchi MG, 1996, ANN ONCOL, V7, P1005	42	415	442	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2000	342	14					998	1006		10.1056/NEJM200004063421402	http://dx.doi.org/10.1056/NEJM200004063421402			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300JB	10749961	Bronze			2022-12-24	WOS:000086248900002
J	DiTullio, GR; Grebmeier, JM; Arrigo, KR; Lizotte, MP; Robinson, DH; Leventer, A; Barry, JB; VanWoert, ML; Dunbar, RB				DiTullio, GR; Grebmeier, JM; Arrigo, KR; Lizotte, MP; Robinson, DH; Leventer, A; Barry, JB; VanWoert, ML; Dunbar, RB			Rapid and early export of Phaeocystis antarctica blooms in the Ross Sea, Antarctica	NATURE			English	Article							PHYTOPLANKTON; CARBON; DIMETHYLSULFIDE; POUCHETII; PRYMNESIOPHYCEAE; POLYNYA; OCEAN; CYCLE	The Southern Ocean is very important for the potential sequestration of carbon dioxide in the oceans(1) and is expected to be vulnerable to changes in carbon export forced by anthropogenic climate warming(2). Annual phytoplankton blooms in seasonal ice zones are highly productive and are thought to contribute significantly to pCO(2) drawdown in the Southern Ocean. Diatoms are assumed to be the most important phytoplankton class with respect to export production in the Southern Ocean; however, the colonial prymnesiophyte Phaeocystis antarctica regularly forms huge blooms in seasonal ice zones and coastal Antarctic waters(3). There is little evidence regarding the fate of carbon produced by P. antarctica in the Southern Ocean, although remineralization in the upper water column has been proposed to be the main pathway in polar waters(4,5). Here we present evidence for early and rapid carbon export from P. antarctica blooms to deep water and sediments in the Ross Sea. Carbon sequestration from P. antarctica blooms may influence the carbon cycle in the Southern Ocean, especially if projected climatic changes lead to an alteration in the structure of the phytoplankton community(6,7).	Univ Charleston, Grice Marine Lab, Charleston, SC 29412 USA; Univ Tennessee, Knoxville, TN 37996 USA; Stanford Univ, Dept Geophys, Stanford, CA 94305 USA; Univ Wisconsin, Dept Biol & Microbiol, Oshkosh, WI 54901 USA; San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA 94920 USA; Colgate Univ, Dept Geol, Hamilton, NY 13346 USA; Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; NOAA, NESDIS, Off Res & Applicat, Camp Springs, MD 20746 USA; Natl Ice Ctr, Washington, DC 20395 USA; Stanford Univ, Stanford, CA 94305 USA	College of Charleston; University of Tennessee System; University of Tennessee Knoxville; Stanford University; University of Wisconsin System; California State University System; San Francisco State University; Colgate University; Monterey Bay Aquarium Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA; Stanford University	DiTullio, GR (corresponding author), Univ Charleston, Grice Marine Lab, 205 Ft Johnson, Charleston, SC 29412 USA.	ditullioj@cofc.edu	Grebmeier, Jacqueline/L-9805-2013	Grebmeier, Jacqueline/0000-0001-7624-3568; Leventer, Amy/0000-0001-9401-0987; Arrigo, Kevin/0000-0002-7364-876X; Dunbar, Robert/0000-0002-9728-5609				Accornero A, 1999, OCEANOGRAPHY OF THE ROSS SEA, P177; Arrigo KR, 1999, SCIENCE, V283, P365, DOI 10.1126/science.283.5400.365; ARRIGO KR, IN PRESS J GEOPHYS R; Asper VL, 1999, J GEOPHYS RES-OCEANS, V104, P5345, DOI 10.1029/1998JC900067; CANTONI GL, 1956, J BIOL CHEM, V222, P171; Carlson CA, 1998, LIMNOL OCEANOGR, V43, P375, DOI 10.4319/lo.1998.43.3.0375; DACEY JWH, 1986, SCIENCE, V233, P1314, DOI 10.1126/science.233.4770.1314; De La Rocha CL, 1998, NATURE, V395, P680, DOI 10.1038/27174; DITULLIO GR, 1995, DEEP-SEA RES PT I, V42, P873, DOI 10.1016/0967-0637(95)00051-7; Dunbar R., 1985, ANTARCT RES SER, P291, DOI [DOI 10.1029/AR043P0291), 10.1029/AR043p0291, DOI 10.1029/AR043P0291]; ELSAYED SZ, 1983, DEEP-SEA RES, V30, P871, DOI 10.1016/0198-0149(83)90005-5; HANSEN FC, 1991, MAR ECOL PROG SER, V78, P123, DOI 10.3354/meps078123; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; LEGRAND M, 1991, NATURE, V350, P144, DOI 10.1038/350144a0; MARTIN JH, 1992, ENVIR SCI R, V43, P123; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; MATRAI PA, 1995, MAR BIOL, V124, P157, DOI 10.1007/BF00349157; MOORE JK, IN PRESS GLOB BIOGEO; PASSOW U, 1994, MAR ECOL PROG SER, V104, P153, DOI 10.3354/meps104153; Sarmiento JL, 1996, SCIENCE, V274, P1346, DOI 10.1126/science.274.5291.1346; Sarmiento JL, 1998, NATURE, V393, P245, DOI 10.1038/30455; SEDWICK PN, IN PRESS J GEOPHYS R; Smith WO, 1997, GEOPHYS RES LETT, V24, P233, DOI 10.1029/96GL03926; Stefels J, 1996, BIOLOGICAL AND ENVIRONMENTAL CHEMISTRY OF DMSP AND RELATED SULFONIUM COMPOUNDS, P305; Stefels J, 1998, J PHYCOL, V34, P486, DOI 10.1046/j.1529-8817.1998.340486.x; SWEENEY C, IN PRESS DEEP SEA RE; VERITY PG, 1989, MAR BIOL, V100, P161, DOI 10.1007/BF00391955; WASSMANN P, 1990, MAR ECOL PROG SER, V66, P183, DOI 10.3354/meps066183	28	237	245	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					595	598		10.1038/35007061	http://dx.doi.org/10.1038/35007061			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766240				2022-12-24	WOS:000086400100051
J	Loder, N				Loder, N			Giant tortoises come home	NATURE			English	News Item																			0	0	0	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					426	426		10.1038/35006716	http://dx.doi.org/10.1038/35006716			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10787341	Bronze			2022-12-24	WOS:000086257700009
J	Smith, GD; Harding, S; Rosato, M				Smith, GD; Harding, S; Rosato, M			Relation between infants' birth weight and mothers' mortality: prospective observational study	BRITISH MEDICAL JOURNAL			English	Article									Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Off Natl Stat, London SW1V 2QQ, England	University of Bristol	Smith, GD (corresponding author), Univ Bristol, Dept Social Med, Canynge Hall, Bristol BS8 2PR, Avon, England.		Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314				Barker D. J. P., 1994, MOTHERS BABIES DIS L; Frankel S, 1996, PUBLIC HEALTH, V110, P139, DOI 10.1016/S0033-3506(96)80066-7; Goldblatt P, 1990, LONGITUDINAL STUDY M; KRAMER MS, 1987, B WORLD HEALTH ORGAN, V65, P663; Smith GD, 1997, BRIT MED J, V315, P1189, DOI 10.1136/bmj.315.7117.1189	5	108	108	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					839	840		10.1136/bmj.320.7238.839	http://dx.doi.org/10.1136/bmj.320.7238.839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731177	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000086180300025
J	Stevens, B; Fields, RD				Stevens, B; Fields, RD			Response of Schwann cells to action potentials in development	SCIENCE			English	Article							INCREASES INTRACELLULAR CALCIUM; PERIPHERAL NERVOUS-SYSTEM; DIFFERENTIAL REGULATION; NEUROMUSCULAR-JUNCTION; DEPENDENT REGULATION; MYELINATION; PATTERNS; L1; MECHANISMS; ACTIVATION	Sensory axons become functional late in development when Schwann cells (SC) stop proliferating and differentiate into distinct phenotypes, We report that impulse activity in premyelinated axons can inhibit proliferation and differentiation of SCs. This neuron-glial signaling is mediated by adenosine triphosphate acting through PZ receptors on SCs and intracellular signaling pathways involving Ca(2+), Ca(2+)/calmodulin kinase, mitogen-activated protein kinase, cyclic adenosine 3',5'-monophosphate response element binding protein, and expression of c-fos and Krox-24. Adenosine triphosphate arrests maturation of SCs in an immature morphological stage and prevents expression of O4, myelin basic protein, and the formation of myelin. Through;this mechanism, functional activity in the developing nervous system could delay terminal differentiation of SCs until exposure to appropriate axon-derived signals.	NICHHD, Dev Neurobiol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Fields, RD (corresponding author), NICHHD, Dev Neurobiol Lab, NIH, Bldg 49,Room 5A38,49 Convent Dr, Bethesda, MD 20892 USA.	fields@helix.nih.gov	Messier, Claude/A-2322-2008	Messier, Claude/0000-0002-4791-1763				Ansselin AD, 1997, NEUROSCIENCE, V76, P947, DOI 10.1016/S0306-4522(96)00370-3; COLELLO RJ, 1995, J NEUROSCI, V15, P7665; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Fields RD, 1997, J NEUROSCI, V17, P7252; FITZGERALD M, 1987, NATURE, V326, P603, DOI 10.1038/326603a0; GOODMAN CS, 1993, CELL, V72, P77, DOI 10.1016/S0092-8674(05)80030-3; Green AC, 1997, NEUROSCIENCE, V80, P635, DOI 10.1016/S0306-4522(97)00117-6; Guthrie PB, 1999, J NEUROSCI, V19, P520, DOI 10.1523/jneurosci.19-02-00520.1999; Itoh K, 1997, J NEUROBIOL, V33, P735, DOI 10.1002/(SICI)1097-4695(19971120)33:6<735::AID-NEU3>3.0.CO;2-A; ITOH K, 1995, SCIENCE, V270, P1369, DOI 10.1126/science.270.5240.1369; JAHROMI BS, 1992, NEURON, V8, P1069, DOI 10.1016/0896-6273(92)90128-Z; JESSEN KR, 1991, GLIA, V4, P185, DOI 10.1002/glia.440040210; LEVRAM V, 1995, J NEUROSCI, V15, P2628; LYONS SA, 1995, GLIA, V13, P27, DOI 10.1002/glia.440130104; Mayer C, 1998, GLIA, V23, P374, DOI 10.1002/(SICI)1098-1136(199808)23:4<374::AID-GLIA9>3.0.CO;2-2; MINXU I, 1996, J NEUROPHYSIOL, V76, P2595; Mirsky R, 1999, BRAIN PATHOL, V9, P293; REIST NE, 1992, P NATL ACAD SCI USA, V89, P7625, DOI 10.1073/pnas.89.16.7625; ROBITAILLE R, 1995, J NEUROSCI, V15, P7121; Scherer SS, 1997, CURR OPIN NEUROL, V10, P386, DOI 10.1097/00019052-199710000-00006; SEILHEIMER B, 1988, J CELL BIOL, V107, P341, DOI 10.1083/jcb.107.1.341; SHENG HZ, 1993, J NEUROSCI RES, V35, P459, DOI 10.1002/jnr.490350502; SHENG HZ, 1994, ANAL BIOCHEM, V222, P123, DOI 10.1006/abio.1994.1463; SHENG M, 1990, NEURON, V4, P571, DOI 10.1016/0896-6273(90)90115-V; Stevens B, 1998, J NEUROSCI, V18, P9303; STEVENS B, UNPUB; STEWART HJS, 1993, EUR J NEUROSCI, V5, P1136, DOI 10.1111/j.1460-9568.1993.tb00968.x; Topilko P, 1997, J NEUROSCI RES, V50, P702, DOI 10.1002/(SICI)1097-4547(19971201)50:5<702::AID-JNR7>3.0.CO;2-L; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; WOOD P, 1990, ANN NY ACAD SCI, V605, P1, DOI 10.1111/j.1749-6632.1990.tb42376.x; WOOD PM, 1990, J NEUROSCI, V10, P3635; Zorick TS, 1999, DEVELOPMENT, V126, P1397	32	202	206	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2267	2271		10.1126/science.287.5461.2267	http://dx.doi.org/10.1126/science.287.5461.2267			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731149				2022-12-24	WOS:000086049100052
J	Gaba, DM				Gaba, DM			Anaesthesiology as a model for patient safety in health care	BRITISH MEDICAL JOURNAL			English	Article							ANESTHESIA; ERRORS; ENVIRONMENT; INCIDENTS; MORTALITY; MISHAPS; SYSTEM		VA Palo Alto Hlth Care Syst, Patient Safety Ctr Inquiry, Palo Alto, CA 94304 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Gaba, DM (corresponding author), VA Palo Alto Hlth Care Syst, Patient Safety Ctr Inquiry, 112PSCI,3801 Miranda Ave, Palo Alto, CA 94304 USA.		Gaba, David M/D-5229-2009	Gaba, David M/0000-0002-0657-5396				ARENS J, 1999, ASA NEWSLETTER, V63, P26; Beckmann U, 1996, ANAESTH INTENS CARE, V24, P314, DOI 10.1177/0310057X9602400303; Bhasale AL, 1998, MED J AUSTRALIA, V169, P73, DOI 10.5694/j.1326-5377.1998.tb140186.x; Cheney FW, 1999, ANESTHESIOLOGY, V91, P552, DOI 10.1097/00000542-199908000-00030; COOPER JB, 1984, ANESTHESIOLOGY, V60, P34, DOI 10.1097/00000542-198401000-00008; COOPER JB, 1978, ANESTHESIOLOGY, V49, P399, DOI 10.1097/00000542-197812000-00004; DEANDA A, 1991, ANESTH ANALG, V72, P308; DERRINGTON MC, 1987, BRIT J ANAESTH, V59, P815, DOI 10.1093/bja/59.7.815; DRUI AB, 1973, ANESTH ANALG, V52, P584; EAGLE CJ, 1992, CAN J ANAESTH, V39, P118, DOI 10.1007/BF03008640; EICHHORN JH, 1986, JAMA-J AM MED ASSOC, V256, P1017; GABA D, 1999, ANESTHESIA; GABA DM, 1987, ANESTHESIOLOGY, V66, P670, DOI 10.1097/00000542-198705000-00013; GABA DM, 1988, ANESTHESIOLOGY, V69, P387, DOI 10.1097/00000542-198809000-00017; GABA DM, 1991, PROBLEMS ANESTHESIA, V5, P329; GALLETLY DC, 1991, ANAESTH INTENS CARE, V19, P66, DOI 10.1177/0310057X9101900112; GOOD ML, 1989, INT ANESTHESIOL CLIN, V27, P161, DOI 10.1097/00004311-198902730-00005; KURREK M, 1998 M SOC TECHN AN; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LUNN JN, 1986, EPIDEMIOLOGY ANAESTH; MACKENZIE CF, 1994, ANESTHESIOLOGY, V81, P763, DOI 10.1097/00000542-199409000-00030; MARSCH S, 1998, SIMULATORS ANESTHESI; *NAT PAT SAF FDN, 1997, PROSP NPSF IMP LEAD; ORKIN FK, 1993, ANESTHESIOLOGY, V78, P417; PETTY C, 1987, ANESTHESIA MACH; RAEMER D, 1998 M SOC TECHN AN; RUNCIMAN WB, 1993, ANAESTH INTENS CARE, V21, P506, DOI 10.1177/0310057X9302100506; SCHWID HA, 1987, COMPUT BIOMED RES, V20, P64, DOI 10.1016/0010-4809(87)90019-X; Small SD, 1999, ACAD EMERG MED, V6, P312, DOI 10.1111/j.1553-2712.1999.tb00395.x; WARDEN JC, 1994, MED J AUSTRALIA, V161, P585, DOI 10.5694/j.1326-5377.1994.tb127636.x; WEBB RK, 1993, ANAESTH INTENS CARE, V21, P520, DOI 10.1177/0310057X9302100507; Weinger MB, 1997, ANESTHESIOLOGY, V87, P144, DOI 10.1097/00000542-199707000-00019; XIAO Y, 1992, PROCEEDINGS OF THE HUMAN FACTORS SOCIETY, 36TH ANNUAL MEETING, VOLS 1 AND 2, P1279	33	306	316	0	14	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	2000	320	7237					785	788		10.1136/bmj.320.7237.785	http://dx.doi.org/10.1136/bmj.320.7237.785			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720368	Green Published			2022-12-24	WOS:000086054700033
J	Schimel, D; Melillo, J; Tian, HQ; McGuire, AD; Kicklighter, D; Kittel, T; Rosenbloom, N; Running, S; Thornton, P; Ojima, D; Parton, W; Kelly, R; Sykes, M; Neilson, R; Rizzo, B				Schimel, D; Melillo, J; Tian, HQ; McGuire, AD; Kicklighter, D; Kittel, T; Rosenbloom, N; Running, S; Thornton, P; Ojima, D; Parton, W; Kelly, R; Sykes, M; Neilson, R; Rizzo, B			Contribution of increasing CO2 and climate to carbon storage by ecosystems in the United States	SCIENCE			English	Article							TERRESTRIAL ECOSYSTEMS; VARIABILITY; DATABASE; PRECIPITATION; DIOXIDE; CYCLE; SINK	The effects of increasing carbon dioxide (CO2) and climate on net carbon storage in terrestrial ecosystems of the conterminous United States for the period 1895-1993 were modeled with new, detailed historical climate information. For the period 1980-1993, results from an ensemble of three models agree within 25%, simulating a land carbon sink from CO2 and climate effects of 0.08 gigaton of carbon per year. The best estimates of the total sink from inventory data are about three times larger, suggesting that processes such as regrowth on abandoned agricultural land or in forests harvested before 1980 have effects as large as or larger than the direct effects of CO2 and climate. The modeled sink varies by about 100% from year to year as a result of climate variability.	Max Planck Inst Biogeochem, D-07701 Jena, Germany; Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; Univ Alaska, US Geol Survey, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK 99775 USA; Natl Ctr Atmospher Res, Boulder, CO 80307 USA; Univ Montana, Missoula, MT 59812 USA; Colorado State Univ, NREL, Ft Collins, CO 80523 USA; Univ Lund, Ekol Huset, S-22362 Lund, Sweden; Oregon State Univ, Forest Sci Lab, USDA, US Forest Serv, Corvallis, OR 97333 USA; Univ Virginia, Dept Environm Sci, Charlottesville, VA 22903 USA	Max Planck Society; Marine Biological Laboratory - Woods Hole; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; National Center Atmospheric Research (NCAR) - USA; University of Montana System; University of Montana; Colorado State University; Lund University; Oregon State University; United States Department of Agriculture (USDA); United States Forest Service; University of Virginia	Schimel, D (corresponding author), Max Planck Inst Biogeochem, Postfach 10 01 64, D-07701 Jena, Germany.		Noojipady, Praveen/B-2511-2010; Thornton, Peter E/B-9145-2012; Gutierrez, Emilia/O-7568-2014; Kittel, Timothy G. F./F-2792-2011; Tian, Hanqin/A-6484-2012; Ojima, Dennis/C-5272-2016	Thornton, Peter E/0000-0002-4759-5158; Gutierrez, Emilia/0000-0002-6085-5700; Kittel, Timothy G. F./0000-0002-4153-1006; Tian, Hanqin/0000-0002-1806-4091; 				BIRDSEY RA, 1995, PRODUCTIVITY AM FORE, P56; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; Brown SL, 1999, ECOL APPL, V9, P968, DOI 10.1890/1051-0761(1999)009[0968:SPOAPA]2.0.CO;2; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; CIAS P, 1995, SCIENCE, V269, P1098; DAI A, 1993, GLOBAL BIOGEOCHEM CY, V7, P599, DOI 10.1029/93GB01165; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; ENTING IG, 1994, CSIRO DIV ATMOS RES, V31, P1; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Goulden ML, 1996, SCIENCE, V271, P1576, DOI 10.1126/science.271.5255.1576; Holland EA, 1997, J GEOPHYS RES-ATMOS, V102, P15849, DOI 10.1029/96JD03164; Houghton RA, 1999, SCIENCE, V285, P574, DOI 10.1126/science.285.5427.574; Karl TR, 1998, B AM METEOROL SOC, V79, P231, DOI 10.1175/1520-0477(1998)079<0231:STOPAF>2.0.CO;2; Kittel TGF, 1995, J BIOGEOGR, V22, P857, DOI 10.2307/2845986; KITTEL TGF, 1997, P 10 C APPL CLIM BOS, P222; LOVELAND TR, 1991, PHOTOGRAMM ENG REM S, V57, P1453; MELILLO JM, 1995, GLOBAL BIOGEOCHEM CY, V9, P407; Parton W.J., 1994, SSSA SPECIAL PUBLICA, V39, P147, DOI DOI 10.2136/SSSASPECPUB39.C9; Peterson TC, 1997, B AM METEOROL SOC, V78, P2837, DOI 10.1175/1520-0477(1997)078<2837:AOOTGH>2.0.CO;2; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; Running S.W., 1993, SCALING PHYSL PROCES, P141, DOI DOI 10.1016/B978-0-12-233440-5.50014-2; SAMIENTO JL, 1999, US CARBON CYCLE SCI; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Stallard RF, 1998, GLOBAL BIOGEOCHEM CY, V12, P231, DOI 10.1029/98GB00741; Steffen W, 1998, SCIENCE, V280, P1393; Tian H, 1999, TELLUS B, V51, P414, DOI 10.1034/j.1600-0889.1999.00021.x	26	434	534	10	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2004	2006		10.1126/science.287.5460.2004	http://dx.doi.org/10.1126/science.287.5460.2004			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720324				2022-12-24	WOS:000085902800058
J	Mendez, R; Hake, LE; Andresson, T; Littlepage, LE; Ruderman, JV; Richter, JD				Mendez, R; Hake, LE; Andresson, T; Littlepage, LE; Ruderman, JV; Richter, JD			Phosphorylation of CPE binding factor by Eg2 regulates translation of c-mos mRNA	NATURE			English	Article							XENOPUS OOCYTE MATURATION; CYTOPLASMIC POLYADENYLATION; RNA-BINDING; KINASE; PATHWAY; PROTEIN; SPECIFICITY; ACTIVATION; SEPARATION; ELEMENTS	Full-grown Xenopus oocytes arrest at the G2/M border of meiosis. I. Progesterone breaks this arrest, leading to the resumption of the meiotic cell cycles and maturation of the oocyte into a fertilizable egg. In these oocytes, progesterone interacts with an unidentified surface-associated receptor, which induces a non-transcriptional signalling pathway that stimulates the translation of dormant c-mos messenger RNA. Mos, a mitogen-activated protein (MAP) kinase kinase kinase, indirectly activates MAP kinase, which in turn leads to oocyte maturation. The translational recruitment of c-mos and several other mRNAs is regulated by cytoplasmic polyadenylation, a process that requires two 3' untranslated regions, the cytoplasmic polyadenylation element (CPE) and the polyadenylation hexanucleotide AAUAAA(1-4). Although the signalling events that trigger c-mos mRNA polyadenylation and translation are unclear, they probably involve the activation of CPEB, the CPE binding factor(5,6), Here we show that an early site-specific phosphorylation of CPEB is essential for the polyadenylation of c-mos mRNA and its subsequent translation, and for oocyte maturation. In addition, we show that this selective, early phosphorylation of CPEB is catalysed by Eg2, a member of the Aurora family of serine/threonine protein kinases.	Univ Massachusetts, Med Ctr, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA; Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	Richter, JD (corresponding author), Univ Massachusetts, Med Ctr, Dept Mol Genet & Microbiol, Worcester, MA 01655 USA.	joel.richter@umassmed.edu		Mendez, Raul/0000-0002-1952-6905				Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; Ballantyne S, 1997, MOL BIOL CELL, V8, P1633, DOI 10.1091/mbc.8.8.1633; BILGER A, 1994, GENE DEV, V8, P1106, DOI 10.1101/gad.8.9.1106; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; deMoor CH, 1997, MOL CELL BIOL, V17, P6419, DOI 10.1128/MCB.17.11.6419; Dickson KS, 1999, MOL CELL BIOL, V19, P5707; FOX CA, 1992, EMBO J, V11, P5021, DOI 10.1002/j.1460-2075.1992.tb05609.x; FRANCISCO L, 1994, MOL CELL BIOL, V14, P4731, DOI 10.1128/MCB.14.7.4731; Giet R, 1999, J BIOL CHEM, V274, P15005, DOI 10.1074/jbc.274.21.15005; GLOVER DM, 1995, CELL, V81, P95, DOI 10.1016/0092-8674(95)90374-7; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; Hake LE, 1997, BBA-REV CANCER, V1332, pM31, DOI 10.1016/S0304-419X(96)00039-X; Hake LE, 1998, MOL CELL BIOL, V18, P685, DOI 10.1128/MCB.18.2.685; Katsu Y, 1999, DEV BIOL, V209, P186, DOI 10.1006/dbio.1999.9247; MCGREW LL, 1989, GENE DEV, V3, P803, DOI 10.1101/gad.3.6.803; MCGREW LL, 1990, EMBO J, V9, P3743, DOI 10.1002/j.1460-2075.1990.tb07587.x; PARIS J, 1991, GENE DEV, V5, P1697, DOI 10.1101/gad.5.9.1697; Sen S, 1997, ONCOGENE, V14, P2195, DOI 10.1038/sj.onc.1201065; Stebbins-Boaz B, 1999, MOL CELL, V4, P1017, DOI 10.1016/S1097-2765(00)80230-0; StebbinsBoaz B, 1996, EMBO J, V15, P2582, DOI 10.1002/j.1460-2075.1996.tb00616.x; Tatsuka M, 1998, CANCER RES, V58, P4811; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496	24	284	290	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					302	307		10.1038/35005126	http://dx.doi.org/10.1038/35005126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749216				2022-12-24	WOS:000086022200054
J	Hall, AC; Lucas, FR; Salinas, PC				Hall, AC; Lucas, FR; Salinas, PC			Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling	CELL			English	Article							SYNAPSIN-I; GRANULE CELLS; NEURONS; LOCALIZATION; EXPRESSION; TARGET; MOUSE; CLONING; MOSSY; MECHANISMS	Synapse formation requires changes in cell morphology and the upregulation and localization of synaptic proteins. In the cerebellum, mossy fibers undergo extensive remodeling as they contact several granule cells and form complex, multisynaptic glomerular rosettes. Here we show that granule cells secrete factors that induce axon and growth cone remodeling in mossy fibers. This effect is blocked by the WNT antagonist, sFRP-1, and mimicked by WNT-7a, which is expressed by granule cells. WNT-7a also induces synapsin I clustering at remodeled areas of mossy fibers, a: preliminary step in synaptogenesis. Wnt-7a mutant mice show a delay in the morphological maturation of glomerular rosettes and in the accumulation of synapsin I. We propose that WNT-7a can function as a synaptogenic factor.	Kings Coll London, Randall Inst, Dev Biol Res Ctr, London WC2B 5RL, England	University of London; King's College London	Salinas, PC (corresponding author), Kings Coll London, Randall Inst, Dev Biol Res Ctr, 26-29 Drury Lane, London WC2B 5RL, England.	patricia.salinas@kcl.ac.uk						ALTMAN J, 1997, DEV CEREBELLAR SYSTE, P470; ATACK JR, 1995, TRENDS NEUROSCI, V18, P343, DOI 10.1016/0166-2236(95)93926-O; BAIRD DH, 1992, J NEUROSCI, V12, P619; BOWIE JE, 1977, ACTA CYTOL, V21, P455; BRAY D, 1978, P NATL ACAD SCI USA, V75, P5226, DOI 10.1073/pnas.75.10.5226; Burden SJ, 1998, GENE DEV, V12, P133, DOI 10.1101/gad.12.2.133; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; CHIN LS, 1995, P NATL ACAD SCI USA, V92, P9230, DOI 10.1073/pnas.92.20.9230; EISENMAN LM, 1991, BRAIN RES, V558, P149, DOI 10.1016/0006-8993(91)90733-C; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; HAMORI J, 1983, J COMP NEUROL, V220, P365, DOI 10.1002/cne.902200402; HANGER DP, 1992, NEUROSCI LETT, V147, P58, DOI 10.1016/0304-3940(92)90774-2; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Katoh M, 1996, ONCOGENE, V13, P873; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; KUHSE J, 1995, CURR OPIN NEUROBIOL, V5, P318, DOI 10.1016/0959-4388(95)80044-1; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lucas FR, 1998, J CELL SCI, V111, P1351; Martin CS, 1998, NEUROSCIENCE, V87, P861, DOI 10.1016/S0306-4522(98)00195-X; MASON CA, 1984, J NEUROSCI, V4, P1715; Mueller BK, 1999, ANNU REV NEUROSCI, V22, P351, DOI 10.1146/annurev.neuro.22.1.351; O'Brien RJ, 1998, CURR OPIN NEUROBIOL, V8, P364, DOI 10.1016/S0959-4388(98)80062-7; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0; SALINAS PC, 1994, DEVELOPMENT, V120, P1277; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schlesinger A, 1999, GENE DEV, V13, P2028, DOI 10.1101/gad.13.15.2028; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; SOTELO C, 1975, BRAIN RES, V94, P19, DOI 10.1016/0006-8993(75)90874-4; Strutt DI, 1997, NATURE, V387, P292, DOI 10.1038/387292a0; TAKAHASHI M, 1994, J NEUROCHEM, V63, P245; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Wang JW, 1996, ONCOGENE, V13, P1537; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3; Zhang Q, 1998, DEV BIOL, V195, P75, DOI 10.1006/dbio.1997.8837	41	559	578	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 3	2000	100	5					525	535		10.1016/S0092-8674(00)80689-3	http://dx.doi.org/10.1016/S0092-8674(00)80689-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	290WC	10721990	Bronze			2022-12-24	WOS:000085700000006
J	Patel, DD; Gooding, ME; Parrott, RE; Curtis, KM; Haynes, BF; Buckley, RH				Patel, DD; Gooding, ME; Parrott, RE; Curtis, KM; Haynes, BF; Buckley, RH			Thymic function after hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE-MARROW TRANSPLANTATION; T-CELLS; V(D)J RECOMBINATION; RECONSTITUTION; REGENERATION; EXPRESSION; IMMUNITY; PRODUCTS; INFANTS; CD4(+)	Background: Immune function can be restored in infants with severe combined immunodeficiency by transplantation of unfractionated bone marrow from HLA-identical donors or T-cell-depleted marrow stem cells from haploidentical donors, with whom there is a single haplotype mismatch, without the need for chemotherapy before transplantation or prophylaxis against graft-versus-host disease. The role of the thymus in this process is unknown. Methods: We analyzed the phenotypes of circulating T cells and the proliferative responses of peripheral-blood mononuclear cells to phytohemagglutinin in 83 patients with severe combined immunodeficiency who received allogeneic marrow transplants without T-cell ablation from related donors over an 18-year period. We also tested for the presence of episomes of T-cell antigen receptors (extrachromosomal DNA circles formed during intrathymic T-cell development) to assess thymus-dependent T-cell reconstitution. Results: Before and early after transplantation, the numbers of circulating T cells were low, with a predominance of mature CD45RO+ T cells (primarily resulting from the transplacental transfer of maternal cells); T-cell antigen-receptor episomes were undetectable in peripheral-blood mononuclear cells. In 73 of the infants, thymus-derived T cells expressing CD45RA and T-cell antigen-receptor episomes were detected within three to six weeks after transplantation. The mean (+/-SD) value for thymus-dependent T-cell antigen-receptor episomes peaked (at 7311+/-8652 per microgram of peripheral-blood mononuclear-cell DNA) 1 to 2 years after transplantation and declined to low levels (less than 100 episomes per microgram of DNA) within 14 years, as compared with a gradual decline from birth to the age of about 80 years in normal subjects. Conclusions: The vestigial thymus in infants with severe combined immunodeficiency is functional and can produce enough T cells after bone marrow transplantation to provide normal immune function. (N Engl J Med 2000;342:1325-32.) (C) 2000, Massachusetts Medical Society.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University; Duke University	Patel, DD (corresponding author), Duke Univ, Med Ctr, Dept Med, Box 3258, Durham, NC 27710 USA.	pate1003@mc.duke.edu	Buckley, Rebecca/AAB-1578-2019		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI018613, R01AI047604, R01AI047605] Funding Source: NIH RePORTER; NIAID NIH HHS [5R37AI18613, R01 AI47604, R01 AI47605] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARRETT MJ, 1988, CLIN EXP IMMUNOL, V72, P118; Bell EB, 1998, IMMUNOL TODAY, V19, P60, DOI 10.1016/S0167-5699(97)01211-5; Bogue M, 1996, CURR OPIN IMMUNOL, V8, P175, DOI 10.1016/S0952-7915(96)80055-0; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Buckley RH, 1997, J PEDIATR-US, V130, P378, DOI 10.1016/S0022-3476(97)70199-9; BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; Cossarizza A, 1996, MECH AGEING DEV, V86, P173, DOI 10.1016/0047-6374(95)01691-0; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; FRIEDMAN NJ, 1991, PEDIAT ALLERG IMMUNO, V2, P111; HAYNE SBF, 1999, J CLIN INVEST, V103, P921; Haynes BF, 1999, J CLIN INVEST, V103, P453, DOI 10.1172/JCI5201; Heitger A, 1997, BLOOD, V90, P850, DOI 10.1182/blood.V90.2.850.850_850_857; HOLLANDER GA, 1994, TRANSPLANTATION, V58, P1037, DOI 10.1097/00007890-199411150-00011; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; HONG R, 1987, BONE MARROW TRANSPL, V1, P405; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Livak F, 1996, MOL CELL BIOL, V16, P609; Mackall CL, 1997, IMMUNOL REV, V157, P61, DOI 10.1111/j.1600-065X.1997.tb00974.x; MACKALL CL, 1993, BLOOD, V82, P2585; Markert ML, 1999, NEW ENGL J MED, V341, P1180, DOI 10.1056/NEJM199910143411603; NEUHAUS T J, 1986, Pediatric Pathology, V5, P251; NEZELOF C, 1992, HISTOPATHOLOGY, V21, P499, DOI 10.1111/j.1365-2559.1992.tb00437.x; REISNER Y, 1983, BLOOD, V61, P341; RITTER MA, 1993, IMMUNOL TODAY, V14, P462, DOI 10.1016/0167-5699(93)90250-O; ROBERTS JL, 1989, J IMMUNOL, V143, P1575; SCHIFF SE, 1987, J IMMUNOL, V138, P2088; SCHIFF SE, 1987, CLIN EXP IMMUNOL, V68, P685; TAKESHITA S, 1989, EMBO J, V8, P3261, DOI 10.1002/j.1460-2075.1989.tb08486.x; TJONNFJORD GE, 1994, BLOOD, V84, P3584	29	156	160	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 4	2000	342	18					1325	1332		10.1056/NEJM200005043421804	http://dx.doi.org/10.1056/NEJM200005043421804			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	309RE	10793165				2022-12-24	WOS:000086782400004
J	Ku, CC; Murakami, M; Sakamato, A; Kappler, J; Marrack, P				Ku, CC; Murakami, M; Sakamato, A; Kappler, J; Marrack, P			Control of homeostasis of CD8(+) memory T cells by opposing cytokines	SCIENCE			English	Article							MURINE IL-2 RECEPTOR; MONOCLONAL-ANTIBODY; IN-VIVO; MICE; EXPRESSION; INDUCTION; ANTIGEN; INTERLEUKIN-7; ACTIVATION; SUBSETS	Memory T cells maintain their numbers for long periods after antigen exposure, Here we show that CD8(+) T cells of memory phenotype divide slowly in animals. This division requires interleukin-15 and is markedly increased by inhibition of interleukin-2 (IL-2), Therefore, the numbers of CD8(+) memory T cells in animals are controlled by a balance between IL-15 and IL-2.	Univ Colorado, Hlth Sci Ctr, Natl Jewish Med Ctr, Howard Hughes Med Inst,Dept Med, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Biochem & Mol Biol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Pharmacol, Denver, CO 80206 USA; Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80206 USA	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Marrack, P (corresponding author), Univ Colorado, Hlth Sci Ctr, Natl Jewish Med Ctr, Howard Hughes Med Inst,Dept Med, 4200 E 9th Ave, Denver, CO 80206 USA.	marrackp@njc.org	Marrack, Philippa/AHE-6316-2022	KU, CHIA-CHI/0000-0002-5740-1505; Marrack, Philippa/0000-0003-1883-3687	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI018785, R56AI017134, R01AI017134, P01AI022295, R01AI018785, R37AI017134, R37AI018785] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-17134, AI-18785, AI-22295] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bamford RN, 1998, J IMMUNOL, V160, P4418; BARRAT F, 1995, RES IMMUNOL, V146, P23, DOI 10.1016/0923-2494(96)80237-9; Bruno L, 1996, EUR J IMMUNOL, V26, P3179, DOI 10.1002/eji.1830261251; BRUNO L, 1995, IMMUNITY, V2, P37, DOI 10.1016/1074-7613(95)90077-2; CARAYON P, 1992, J IMMUNOL METHODS, V147, P225, DOI 10.1016/S0022-1759(12)80012-3; Cho BK, 1999, P NATL ACAD SCI USA, V96, P2976, DOI 10.1073/pnas.96.6.2976; Doherty TM, 1996, J IMMUNOL, V156, P735; Ehrhardt RO, 1997, J IMMUNOL, V158, P566; GRABSTEIN KH, 1993, J EXP MED, V178, P257, DOI 10.1084/jem.178.1.257; GRAY D, 1991, J EXP MED, V174, P969, DOI 10.1084/jem.174.5.969; GRIFFIN JP, 1994, INFECT IMMUN, V62, P1683, DOI 10.1128/IAI.62.5.1683-1690.1994; HEUFLER C, 1993, J EXP MED, V178, P1109, DOI 10.1084/jem.178.3.1109; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Jonuleit H, 1997, J IMMUNOL, V158, P2610; Ke Y, 1998, J EXP MED, V187, P49, DOI 10.1084/jem.187.1.49; KRAMER S, 1994, EUR J IMMUNOL, V24, P2317, DOI 10.1002/eji.1830241009; KU CC, UNPUB; Kung JT, 1998, CELL IMMUNOL, V185, P158, DOI 10.1006/cimm.1998.1282; LAU LL, 1994, NATURE, V369, P648, DOI 10.1038/369648a0; Lodolce JP, 1998, IMMUNITY, V9, P669, DOI 10.1016/S1074-7613(00)80664-0; MALEK TR, 1984, J IMMUNOL, V133, P1976; MALEK TR, 1993, P NATL ACAD SCI USA, V90, P9125; Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521; Miller RA, 1997, FASEB J, V11, P775, DOI 10.1096/fasebj.11.10.9271362; Moore TA, 1996, J IMMUNOL, V157, P2366; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; MULLBACHER A, 1994, J EXP MED, V179, P317, DOI 10.1084/jem.179.1.317; Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377; Nelson BH, 1998, ADV IMMUNOL, V70, P1, DOI 10.1016/S0065-2776(08)60386-7; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; PICKER LJ, 1990, J IMMUNOL, V145, P3247; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Selin LK, 1996, J EXP MED, V183, P2489, DOI 10.1084/jem.183.6.2489; SIMPSON SJ, 1995, EUR J IMMUNOL, V25, P2618, DOI 10.1002/eji.1830250932; SUDO T, 1989, J EXP MED, V170, P333, DOI 10.1084/jem.170.1.333; Swain S L, 1992, Semin Immunol, V4, P59; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tagaya Y, 1997, P NATL ACAD SCI USA, V94, P14444, DOI 10.1073/pnas.94.26.14444; TANAKA T, 1991, J IMMUNOL, V147, P2222; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Wrenshall LE, 1999, J IMMUNOL, V163, P3793; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6; Zheng LX, 1998, J IMMUNOL, V160, P763	45	690	721	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2000	288	5466					675	678		10.1126/science.288.5466.675	http://dx.doi.org/10.1126/science.288.5466.675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308RR	10784451				2022-12-24	WOS:000086727100045
J	Goh, KJ; Tan, CT; Chew, NK; Tan, PSK; Kamarulzaman, A; Sarji, SA; Wong, KT; Abdullah, BJJ; Chua, KB; Lam, SK				Goh, KJ; Tan, CT; Chew, NK; Tan, PSK; Kamarulzaman, A; Sarji, SA; Wong, KT; Abdullah, BJJ; Chua, KB; Lam, SK			Clinical features of nipah virus encephalitis among pig farmers in Malaysia.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HORSES	Background: Between September 1998 and June 1999, there was an outbreak of severe viral encephalitis due to Nipah virus, a newly discovered paramyxovirus, in Malaysia. Methods: We studied the clinical features of the patients with Nipah virus encephalitis who were admitted to a medical center in Kuala Lumpur. The case definition was based on epidemiologic, clinical, cerebrospinal fluid, and neuroimaging findings. Results: Ninety-four patients with Nipah virus infection were seen from February to June 1999 (mean age, 37 years; ratio of male patients to female patients, 4.5 to 1). Ninety-three percent had had direct contact with pigs, usually in the two weeks before the onset of illness, suggesting that there was direct viral transmission from pigs to humans and a short incubation period. The main presenting features were fever, headache, dizziness, and vomiting. Fifty-two patients (55 percent) had a reduced level of consciousness and prominent brain-stem dysfunction. Distinctive clinical signs included segmental myoclonus, areflexia and hypotonia, hypertension, and tachycardia and thus suggest the involvement of the brain stem and the upper cervical spinal cord. The initial cerebrospinal fluid findings were abnormal in 75 percent of patients. Antibodies against Hendra virus were detected in serum or cerebrospinal fluid in 76 percent of 83 patients tested. Thirty patients (32 percent) died after rapid deterioration in their condition. An abnormal doll's-eye reflex and tachycardia were factors associated with a poor prognosis. Death was probably due to severe brain-stem involvement. Neurologic relapse occurred after initially mild disease in three patients. Fifty patients (53 percent) recovered fully, and 14 (15 percent) had persistent neurologic deficits. Conclusions: Nipah virus causes a severe, rapidly progressive encephalitis with a high mortality rate and features that suggest involvement of the brain stem. The infection is associated with recent contact with pigs. (N Engl J Med 2000;342:1229-35.) (C) 2000, Massachusetts Medical Society.	Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur 59100, Malaysia; Univ Malaya, Dept Med, Div Infect Dis, Kuala Lumpur 59100, Malaysia; Univ Malaya, Dept Anaesthesiol & Intens Care, Kuala Lumpur 59100, Malaysia; Univ Malaya, Dept Radiol, Kuala Lumpur 59100, Malaysia; Univ Malaya, Dept Pathol, Kuala Lumpur 59100, Malaysia; Univ Malaya, Dept Med Microbiol, Kuala Lumpur 59100, Malaysia	Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya; Universiti Malaya	Tan, PSK (corresponding author), Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur 59100, Malaysia.		Wong, Kum Thong/B-2788-2010; Goh, Khean Jin/D-1990-2010; LAM, SAI KIT/B-5231-2010; KAMARULZAMAN, ADEEBA/B-5216-2010	Goh, Khean Jin/0000-0001-5416-9627; 				[Anonymous], 1999, MMWR-MORBID MORTAL W, V48, P335; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Lee KE, 1999, ANN NEUROL, V46, P428, DOI 10.1002/1531-8249(199909)46:3<428::AID-ANA23>3.3.CO;2-9; OSullivan JD, 1997, LANCET, V349, P93, DOI 10.1016/S0140-6736(96)06162-4; Paton NI, 1999, LANCET, V354, P1253, DOI 10.1016/S0140-6736(99)04379-2; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; THONGCHAROEN P, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P559; 1999, MMWR MORB MORTAL WKL, V48, P339; 1999, MMWR MORB MORTAL WKL, V48, P265	9	311	332	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 27	2000	342	17					1229	1235		10.1056/NEJM200004273421701	http://dx.doi.org/10.1056/NEJM200004273421701			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307NZ	10781618	Green Submitted, Green Published			2022-12-24	WOS:000086660600001
J	Caterina, MJ; Leffler, A; Malmberg, AB; Martin, WJ; Trafton, J; Petersen-Zeitz, KR; Koltzenburg, M; Basbaum, AI; Julius, D				Caterina, MJ; Leffler, A; Malmberg, AB; Martin, WJ; Trafton, J; Petersen-Zeitz, KR; Koltzenburg, M; Basbaum, AI; Julius, D			Impaired nociception and pain sensation in mice lacking the capsaicin receptor	SCIENCE			English	Article							RAT SENSORY NEURONS; CATION CHANNEL; ION-CHANNEL; RESPONSES; PROTONS; SENSITIZATION; SENSITIVITY; INVITRO; SKIN	The capsaicin (vanilloid) receptor VR1 is a cation channel expressed by primary sensory neurons of the "pain" pathway. Heterologously expressed VR1 can be activated by vanilloid compounds, protons, or heat (>43 degrees C), but whether this channel contributes to chemical or thermal sensitivity in vivo is not known. Here, we demonstrate that sensory neurons from mice lacking VR1 are severely deficient in their responses to each of these noxious stimuli. VR1(-/-) mice showed normal responses to noxious mechanical stimuli but exhibited no vanilloid-evoked pain behavior, were impaired in the detection of painful heat, and showed little thermal hypersensitivity in the setting of inflammation. Thus, VR1 is essential for selective modalities of pain sensation and for tissue injury-induced thermal hyperalgesia.	Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; Univ Calif San Francisco, WM Keck Ctr Neurosci, San Francisco, CA 94143 USA; Univ Wurzburg, Dept Neurol, D-97080 Wurzburg, Germany	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wurzburg	Julius, D (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94143 USA.	julius@socrates.ucsf.edu	Koltzenburg, Martin/C-1349-2008; Leffler, Andreas/K-1191-2012; Leffler, Andreas/C-6552-2009; Martin, William J/L-9033-2017	Koltzenburg, Martin/0000-0001-9181-5966; Leffler, Andreas/0000-0003-1121-6387; Martin, William J/0000-0002-2749-3365	NINDS NIH HHS [NS07265] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benson CJ, 1999, CIRC RES, V84, P921; BEVAN S, 1994, TRENDS NEUROSCI, V17, P509, DOI 10.1016/0166-2236(94)90149-X; Cao YQ, 1998, NATURE, V392, P390, DOI 10.1038/32897; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Chen CC, 1998, P NATL ACAD SCI USA, V95, P10240, DOI 10.1073/pnas.95.17.10240; de Castro F, 1998, EUR J NEUROSCI, V10, P146, DOI 10.1046/j.1460-9568.1998.00037.x; DOUCETTE R, 1987, J COMP NEUROL, V261, P583, DOI 10.1002/cne.902610409; DUBNER R, 1977, PAIN TRIGEMINAL REGI, P57; FEIGIN AM, 1995, NEUROREPORT, V6, P2134, DOI 10.1097/00001756-199511000-00009; Fields H. L., 1987, PAIN; GARCIAHIRSCHFELD J, 1995, NEUROSCIENCE, V67, P235, DOI 10.1016/0306-4522(95)00055-N; Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x; HANDWERKER HO, 1991, PAIN RES CL, V4, P59; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Helliwell RJA, 1998, NEUROSCI LETT, V250, P177, DOI 10.1016/S0304-3940(98)00475-3; HOLZER P, 1991, PHARMACOL REV, V43, P143; JANCSOGABOR A, 1970, J PHYSIOL-LONDON, V206, P495, DOI 10.1113/jphysiol.1970.sp009027; JANIG W, 1986, PROG BRAIN RES, V67, P87; Kirschstein T, 1999, J NEUROPHYSIOL, V82, P2853, DOI 10.1152/jn.1999.82.6.2853; Koltzenburg M, 1997, J NEUROPHYSIOL, V78, P1841, DOI 10.1152/jn.1997.78.4.1841; KRESS M, 1992, J NEUROPHYSIOL, V68, P581, DOI 10.1152/jn.1992.68.2.581; Kress M, 1999, TRENDS PHARMACOL SCI, V20, P112, DOI 10.1016/S0165-6147(99)01294-8; Levine J.D., 1994, TXB PAIN, P45; Malmberg AB, 1997, SCIENCE, V278, P279, DOI 10.1126/science.278.5336.279; MARTENSON ME, 1994, BRAIN RES, V651, P143, DOI 10.1016/0006-8993(94)90690-4; MARTIN WJ, UNPUB; McCleskey EW, 1999, ANNU REV PHYSIOL, V61, P835, DOI 10.1146/annurev.physiol.61.1.835; Nagy I, 1999, J NEUROSCI, V19, P10647, DOI 10.1523/JNEUROSCI.19-24-10647.1999; Nagy I, 1999, NEUROSCIENCE, V88, P995, DOI 10.1016/S0306-4522(98)00535-1; Petersen M, 1996, NEUROSCIENCE, V75, P495, DOI 10.1016/0306-4522(96)00259-X; QIU MS, 1995, GENE DEV, V9, P2523, DOI 10.1101/gad.9.20.2523; RAJA SN, 1999, TXB PAIN, P00011; Reichling DB, 1997, P NATL ACAD SCI USA, V94, P7006, DOI 10.1073/pnas.94.13.7006; STEEN KH, 1992, J NEUROSCI, V12, P86; SZALLASI A, 1990, BRAIN RES, V524, P106, DOI 10.1016/0006-8993(90)90498-Z; Szallasi A, 1999, PHARMACOL REV, V51, P159; SZOLCSANYI J, 1975, ARZNEIMITTEL-FORSCH, V25, P1877; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Waldmann R, 1997, J BIOL CHEM, V272, P20975, DOI 10.1074/jbc.272.34.20975; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Yeomans DC, 1996, PAIN, V68, P133, DOI 10.1016/S0304-3959(96)03176-4; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	44	2646	2800	15	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 14	2000	288	5464					306	313		10.1126/science.288.5464.306	http://dx.doi.org/10.1126/science.288.5464.306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764638				2022-12-24	WOS:000086454300029
J	Kivimaki, M; Vahtera, J; Pentti, J; Ferrie, JE				Kivimaki, M; Vahtera, J; Pentti, J; Ferrie, JE			Factors underlying the effect of organisational downsizing on health of employees: longitudinal cohort study	BRITISH MEDICAL JOURNAL			English	Article							PSYCHOSOCIAL WORK-ENVIRONMENT; SICKNESS ABSENCE; WHITEHALL-II; MORTALITY; DISEASE; ALCOHOL; MEN	Objective To explore the underlying mechanisms between organisational downsizing and deterioration of health of employees. Design Longitudinal cohort study. Data were assembled from before downsizing (time 1); during major downsizing affecting some job categories (time 2); and after downsizing (time 3), Contributions of changes in work, support, and health related behaviours between time 1 and rime 2 to the relation between downsizing and sickness absence at time 3 were assessed by multilevel modelling. Mean length of follow up was 4.9 years. Setting Raisio, a town in Finland. Subjects 764 municipal employees who remained in employment after downsizing. Main outcome measures Records of absences from work from all causes with medical certificate. Results Downsizing was associated with negative changes in work, impaired support from spouse, and increased prevalence of smoking. Sickness absence rate from all causes was 2.17 (95% confidence inter-val 1.54 to 3.07) times higher after major downsizing than after minor downsizing. Adjustment for changes in work (for instance, physical demands,job control, and job insecurity) diminished the relation between downsizing and sickness absence by 49%. Adjustments for impaired social support or increased smoking did not alter. the relation between downsizing and sickness absence. The findings were unaffected by sex and income. Conclusions The exploration of potential mediating factors provides new information about the possible of Applied causal pathways linking organisational do downsizing Psychology, and health. Downsizing results in changes in work, social relationships, and health related behaviours. The observed increase in certificated sickness absence was partially explained by concomitant increases in physical demands and job insecurity and a reduction in job control, A considerable proportion of the increase, however, remained unexplained by the factors measured.	Univ Helsinki, Dept Psychol, Div Appl Psychol, FIN-00014 Helsinki, Finland; Finnish Inst Occupat Hlth, FIN-20500 Turku, Finland; UCL, Sch Med, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	University of Helsinki; Finnish Institute of Occupational Health; University of London; University College London; UCL Medical School	Kivimaki, M (corresponding author), Univ Helsinki, Dept Psychol, Div Appl Psychol, POB 13, FIN-00014 Helsinki, Finland.	mika.kivimaki@occuphealth.fi	Ferrie, Jane/AAZ-2009-2020; Vahtera, Jussi/J-3271-2013; Kivimaki, Mika/B-3607-2012	Kivimaki, Mika/0000-0002-4699-5627				BEALE N, 1988, BRIT MED J, V296, P1508, DOI 10.1136/bmj.296.6635.1508; Bosma H, 1997, BRIT MED J, V314, P558, DOI 10.1136/bmj.314.7080.558; Cobb S, 1977, TERMINATION CONSEQUE; Cohen J., 2013, APPL MULTIPLE REGRES; Diez-Roux AV, 1998, AM J PUBLIC HEALTH, V88, P216, DOI 10.2105/AJPH.88.2.216; Ferrie JE, 1998, AM J PUBLIC HEALTH, V88, P1030, DOI 10.2105/AJPH.88.7.1030; Hurrell JJ, 1998, AM J PUBLIC HEALTH, V88, P1012, DOI 10.2105/AJPH.88.7.1012; Johnson JV, 1996, AM J PUBLIC HEALTH, V86, P324, DOI 10.2105/AJPH.86.3.324; KAPRIO J, 1987, ALCOHOL CLIN EXP RES, V11, P349, DOI 10.1111/j.1530-0277.1987.tb01324.x; Kivimaki M, 1997, J APPL PSYCHOL, V82, P858, DOI 10.1037/0021-9010.82.6.858; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; LITTELL RC, 1998, SAS SYSTEM MIXED MOD; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; MARMOT MG, 1993, ADDICTION, V88, P369, DOI 10.1111/j.1360-0443.1993.tb00824.x; MCCULLAGH P., 1991, GEN LINEAR MODELS; North FM, 1996, AM J PUBLIC HEALTH, V86, P332, DOI 10.2105/AJPH.86.3.332; Parker S K, 1997, J Occup Health Psychol, V2, P289, DOI 10.1037/1076-8998.2.4.289; RAEL EGS, 1995, J EPIDEMIOL COMMUN H, V49, P474, DOI 10.1136/jech.49.5.474; *SAS I, 1993, P243 SAS I; SCHNALL PL, 1994, ANNU REV PUBL HEALTH, V15, P381, DOI 10.1146/annurev.pu.15.050194.002121; *STAT FINL, 1998, STAT YB FINL; Vahtera J, 1997, LANCET, V350, P1124, DOI 10.1016/S0140-6736(97)03216-9; Vahtera J, 1996, WORK STRESS, V10, P286, DOI 10.1080/02678379608256809; VAHTERA J, 1999, EMPLOYEES STORM EC D	24	276	280	0	28	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	APR 8	2000	320	7240					971	975		10.1136/bmj.320.7240.971	http://dx.doi.org/10.1136/bmj.320.7240.971			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303XP	10753148	Green Submitted, Green Published, Bronze			2022-12-24	WOS:000086453100021
J	Nishitani, H; Lygerou, Z; Nishimoto, T; Nurse, P				Nishitani, H; Lygerou, Z; Nishimoto, T; Nurse, P			The Cdt1 protein is required to license DNA for replication in fission yeast	NATURE			English	Article							ORIGIN RECOGNITION COMPLEX; S-PHASE; CELL-CYCLE; SCHIZOSACCHAROMYCES-POMBE; MCM PROTEINS; SACCHAROMYCES-CEREVISIAE; INITIATION; COMPONENT; XENOPUS; MITOSIS	To maintain genome stability in eukaryotic cells, DNA is licensed for replication only after the cell has completed mitosis, ensuring that DNA synthesis (S phase) occurs once every cell cycle(1). This licensing control is thought to require the protein Cdc6 (Cdc18 in fission yeast) as a mediator for association of minichromosome maintenance (MCM) proteins with chromatin(2-10). The control is overridden in fission yeast by overexpressing Cdc18 (ref. 11) which leads to continued DNA synthesis in the absence of mitosis(12). Other factors acting in this control have been postulated(13) and we have used a re-replication assay to identify Cdt1 (ref. 14) as one such factor. Cdt1 cooperates with Cdc18 to promote DNA replication, interacts with Cdc18, is located in the nucleus, and its concentration peaks as cells finish mitosis and proceed to S phase. Both Cdc18 and Cdt1 are required to load the MCM protein Cdc21 onto chromatin at the end of mitosis and this is necessary to initiate DNA replication. Genes related to Cdt1 have been found in Metazoa and plants (A. Whitaker, I. Roysman and T. Orr-Weaver, personal communication), suggesting that the cooperation of Cdc6/Cdc18 with Cdt1 to load MCM proteins onto chromatin may be a generally conserved feature of DNA licensing in eukaryotes.	Imperial Canc Res Fund, London WC2A 3PX, England; Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan	Cancer Research UK; Kyushu University	Lygerou, Z (corresponding author), Imperial Canc Res Fund, 44 Lincolns Inn Fields, London WC2A 3PX, England.	z_lygerou@yahoo.com		Nishitani, Hideo/0000-0001-5907-9380				Alfa C, 1993, EXPT FISSION YEAST L; Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; BLOW JJ, 1988, NATURE, V332, P546, DOI 10.1038/332546a0; CHONG JPJ, 1995, NATURE, V375, P418, DOI 10.1038/375418a0; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; Grallert B, 1996, GENE DEV, V10, P2644, DOI 10.1101/gad.10.20.2644; Greenwood E, 1998, J CELL SCI, V111, P3101; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; KELLY TJ, 1993, CELL, V74, P371, DOI 10.1016/0092-8674(93)90427-R; KUBOTA Y, 1995, CELL, V81, P601, DOI 10.1016/0092-8674(95)90081-0; Liang C, 1997, GENE DEV, V11, P3375, DOI 10.1101/gad.11.24.3375; Lygerou Z, 1999, J CELL SCI, V112, P3703; MADINE MA, 1995, NATURE, V375, P421, DOI 10.1038/375421a0; Maiorano D, 1996, EMBO J, V15, P861, DOI 10.1002/j.1460-2075.1996.tb00421.x; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MuziFalconi M, 1995, P NATL ACAD SCI USA, V92, P12475, DOI 10.1073/pnas.92.26.12475; MuziFalconi M, 1996, P NATL ACAD SCI USA, V93, P1566, DOI 10.1073/pnas.93.4.1566; NISHITANI H, 1995, CELL, V83, P397, DOI 10.1016/0092-8674(95)90117-5; Rowles A, 1996, CELL, V87, P287, DOI 10.1016/S0092-8674(00)81346-X; SARABIA MJF, 1993, MOL GEN GENET, V238, P241, DOI 10.1007/BF00279553; Tada S, 1999, CURR BIOL, V9, P211, DOI 10.1016/S0960-9822(99)80092-X; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7	25	365	369	2	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					625	+		10.1038/35007110	http://dx.doi.org/10.1038/35007110			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766248				2022-12-24	WOS:000086400100059
J	Phair, RD; Misteli, T				Phair, RD; Misteli, T			High mobility of proteins in the mammalian cell nucleus	NATURE			English	Article							RNA SPLICING FACTORS; LIVING CELLS; LOCALIZATION; DIFFUSION	The mammalian cell nucleus contains numerous sub-compartments, which have been implicated in essential processes such as transcription and splicing(1,2). The mechanisms by which nuclear compartments are formed and maintained are unclear. More fundamentally, it is not known how proteins move within the cell nucleus. We have measured the kinetic properties of proteins in the nucleus of living cells using photobleaching techniques. Here we show that proteins involved in diverse nuclear processes move rapidly throughout the entire nucleus. Protein movement is independent of energy, which indicates that proteins may use a passive mechanism of movement. Proteins rapidly associate and dissociate with nuclear compartments. Using kinetic modelling, we determined residence times and steady-state fluxes of molecules in two main nuclear compartments. These data show that many nuclear proteins roam the cell nucleus in vivo and that nuclear compartments are the reflection of the steady-state association/dissociation of its 'residents' with the nucleoplasmic space. Our observations have conceptual implications for understanding nuclear architecture and how nuclear processes are organized in vivo.	NCI, NIH, Bethesda, MD 20892 USA; BioInformat Serv, Rockville, MD 20854 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov			NATIONAL CANCER INSTITUTE [Z01BC010309] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bell BM, 1996, COMPUT STAT DATA AN, V22, P119, DOI 10.1016/0167-9473(95)00043-7; Boudonck K, 1999, MOL BIOL CELL, V10, P2297, DOI 10.1091/mbc.10.7.2297; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Caceres JF, 1997, J CELL BIOL, V138, P225, DOI 10.1083/jcb.138.2.225; Daneholt B, 1999, CURR BIOL, V9, pR412, DOI 10.1016/S0960-9822(99)80256-5; DINGWALL C, 1987, EMBO J, V6, P69, DOI 10.1002/j.1460-2075.1987.tb04720.x; FOSTER DM, 1994, P SIM HLTH SCI C SOC, P87; GE H, 1990, CELL, V62, P25, DOI 10.1016/0092-8674(90)90236-8; Hanamura A, 1998, RNA, V4, P430; Hock R, 1998, EMBO J, V17, P6992, DOI 10.1093/emboj/17.23.6992; Houtsmuller AB, 1999, SCIENCE, V284, P958, DOI 10.1126/science.284.5416.958; Jolly C, 1999, P NATL ACAD SCI USA, V96, P6769, DOI 10.1073/pnas.96.12.6769; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Matera AG, 1999, TRENDS CELL BIOL, V9, P302, DOI 10.1016/S0962-8924(99)01606-2; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Misteli T, 1998, CURR OPIN CELL BIOL, V10, P323, DOI 10.1016/S0955-0674(98)80007-0; Misteli T, 1997, NATURE, V387, P523, DOI 10.1038/387523a0; OCHS RL, 1985, BIOL CELL, V54, P123, DOI 10.1111/j.1768-322X.1985.tb00387.x; OLSON MOJ, IN PRESS TRENDS CELL; Politz JC, 1998, P NATL ACAD SCI USA, V95, P6043, DOI 10.1073/pnas.95.11.6043; Politz JC, 1999, CURR BIOL, V9, P285, DOI 10.1016/S0960-9822(99)80136-5; Scheer U, 1999, CURR OPIN CELL BIOL, V11, P385, DOI 10.1016/S0955-0674(99)80054-4; Seksek O, 1997, J CELL BIOL, V138, P131, DOI 10.1083/jcb.138.1.131; Singh OP, 1999, EXP CELL RES, V251, P135, DOI 10.1006/excr.1999.4490; Sleeman J, 1998, EXP CELL RES, V243, P290, DOI 10.1006/excr.1998.4135; White J, 1999, TRENDS CELL BIOL, V9, P61, DOI 10.1016/S0962-8924(98)01433-0; Yokoe E, 1996, NAT BIOTECHNOL, V14, P1252, DOI 10.1038/nbt1096-1252	30	936	960	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					604	+		10.1038/35007077	http://dx.doi.org/10.1038/35007077			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766243				2022-12-24	WOS:000086400100054
J	Dennis, MS; Eigenbrot, C; Skelton, NJ; Ultsch, MH; Santell, L; Dwyer, MA; O'Connell, MP; Lazarus, RA				Dennis, MS; Eigenbrot, C; Skelton, NJ; Ultsch, MH; Santell, L; Dwyer, MA; O'Connell, MP; Lazarus, RA			Peptide exosite inhibitors of factor VIIa as anticoagulants	NATURE			English	Article							TISSUE FACTOR PATHWAY; COAGULATION-FACTOR VIIA; SERINE PROTEASES; ALPHA-THROMBIN; PROTEINASES; LIBRARIES; DISCOVERY; COMPLEX; DISPLAY; DOMAIN	Potent anticoagulants have been derived by targeting the tissue factor-factor VIIa complex with naive peptide libraries displayed on M13 phage, The peptides specifically block the activation of factor X with a median inhibitory concentration of 1 nM and selectively inhibit tissue-factor-dependent clotting, The peptides do not bind to the active site of factor VIIa; rather, they work by binding to an exosite on the factor VIIa protease domain, and non-competitively inhibit activation of factor X and amidolytic activity. One such peptide (E-76) has a well defined structure in solution determined by NMR spectroscopy that is similar to the X-ray crystal structure when complexed with factor VIIa, These structural and functional studies indicate an allosteric 'switch' mechanism of inhibition involving an activation loop of factor VIIa and represent a new framework for developing inhibitors of serine proteases.	Genentech Inc, Dept Prot Engn, S San Francisco, CA 94080 USA	Roche Holding; Genentech	Lazarus, RA (corresponding author), Genentech Inc, Dept Prot Engn, 1 DNA Way, S San Francisco, CA 94080 USA.							Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; Bode W, 1997, THROMB HAEMOSTASIS, V78, P501; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; BODE W, 1986, MOL CELLULAR BASIS D, P213; BROZE GJ, 1993, BLOOD, V82, P1679; BROZE GJ, 1990, BIOCHEMISTRY-US, V29, P7539, DOI 10.1021/bi00485a001; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DENNIS MS, 1994, J BIOL CHEM, V269, P22129; FuentesPrior P, 1997, P NATL ACAD SCI USA, V94, P11845, DOI 10.1073/pnas.94.22.11845; GALLOP MA, 1994, J MED CHEM, V37, P1233, DOI 10.1021/jm00035a001; Higashi S, 1998, INT J HEMATOL, V67, P229; HIRSH J, 1991, NEW ENGL J MED, V324, P1565; Hirsh J, 1999, LANCET, V353, P1431, DOI 10.1016/S0140-6736(98)09233-2; HIRSH J, 1994, HEMOSTASIS THROMBOSI, P1567; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Johnson K, 1998, CORONARY ARTERY DIS, V9, P83, DOI 10.1097/00019501-199809020-00004; Kelley RF, 1997, BLOOD, V89, P3219, DOI 10.1182/blood.V89.9.3219; Kemball-Cook G, 1999, J STRUCT BIOL, V127, P213, DOI 10.1006/jsbi.1999.4158; Kirchhofer D, 1997, TRENDS CARDIOVAS MED, V7, P316, DOI 10.1016/S1050-1738(97)00094-7; KRAUT J, 1977, ANNU REV BIOCHEM, V46, P331, DOI 10.1146/annurev.bi.46.070177.001555; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Lowman HB, 1998, BIOCHEMISTRY-US, V37, P8870, DOI 10.1021/bi980426e; Lowman HB, 1997, ANNU REV BIOPH BIOM, V26, P401, DOI 10.1146/annurev.biophys.26.1.401; MANN KG, 1993, BLOOD, V82, P1680; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; NASKI MC, 1990, J BIOL CHEM, V265, P13484; NEMERSON Y, 1988, BLOOD, V71, P1; NEUENSCHWANDER PF, 1993, THROMB HAEMOSTASIS, V70, P970; Pike ACW, 1999, P NATL ACAD SCI USA, V96, P8925, DOI 10.1073/pnas.96.16.8925; POLGAR L, 1989, MECHANISMS PROTEASE, P87; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; Ruf W, 1998, TRENDS CARDIOVAS MED, V8, P350, DOI 10.1016/S1050-1738(98)00031-0; Sanderson PEJ, 1999, MED RES REV, V19, P179, DOI 10.1002/(SICI)1098-1128(199903)19:2<179::AID-MED4>3.0.CO;2-5; Segel I.H., 1975, ENZYME KINETICS BEHA, Vsecond, P100; Shobe J, 1999, BIOCHEMISTRY-US, V38, P2745, DOI 10.1021/bi981951g; SKELTON NJ, 1994, BIOCHEMISTRY-US, V33, P13581, DOI 10.1021/bi00250a010; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; STEITZ TA, 1982, ANNU REV BIOPHYS BIO, V11, P419, DOI 10.1146/annurev.bb.11.060182.002223; STUBBS MT, 1994, CURR OPIN STRUC BIOL, V4, P823, DOI 10.1016/0959-440X(94)90263-1; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; TOOMEY JR, 1991, J BIOL CHEM, V266, P19198; Vlasuk GP, 1998, ARCH PATHOL LAB MED, V122, P812; Weitz JI, 1997, NEW ENGL J MED, V337, P688, DOI 10.1056/NEJM199709043371007; Zhang E, 1999, J MOL BIOL, V285, P2089, DOI 10.1006/jmbi.1998.2452	45	192	217	1	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					465	470		10.1038/35006574	http://dx.doi.org/10.1038/35006574			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761907				2022-12-24	WOS:000086257700038
J	Lee, L; Tirnauer, JS; Li, JJ; Schuyler, SC; Liu, JY; Pellman, D				Lee, L; Tirnauer, JS; Li, JJ; Schuyler, SC; Liu, JY; Pellman, D			Positioning of the mitotic spindle by a cortical-microtubule capture mechanism	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; NUCLEAR MIGRATION; BINDING PROTEIN; YEAST; ORIENTATION; DYNEIN; SITES; BNI1P; EB1	Correct positioning of the mitotic spindle is critical for cell division and development. Spindle positioning involves a search-and-capture mechanism whereby dynamic microtubules find and then interact with specific sites on the submembrane cortex. Genetic, biochemical, and imaging experiments suggest a mechanism for cortical-microtubule capture. Bim1p, Located at microtubule distal ends, bound Kar9p, a protein associated with the daughter cell cortex. Bim1p is the yeast ortholog of human EB1, a binding partner for the adenomatous polyposis coli tumor suppressor. EB1 family proteins may have a general role in linking the microtubule cytoskeleton to cortical polarity determinants.	Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Oncol, Boston, MA 02115 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Hematol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Princeton University; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School	Pellman, D (corresponding author), Harvard Univ, Childrens Hosp, Sch Med, Dana Farber Canc Inst,Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	daivd_pellman@dfci.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK002578] Funding Source: NIH RePORTER; NIDDK NIH HHS [KO8 DK02578] Funding Source: Medline; NIGMS NIH HHS [GM55772] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Berrueta L, 1998, P NATL ACAD SCI USA, V95, P10596, DOI 10.1073/pnas.95.18.10596; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; Chant J, 1991, CURR OPIN GENET DEV, V1, P342, DOI 10.1016/S0959-437X(05)80298-9; Cottingham FR, 1997, J CELL BIOL, V138, P1041, DOI 10.1083/jcb.138.5.1041; DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023; Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118; Fuchs E, 1999, CELL, V98, P547, DOI 10.1016/S0092-8674(00)80041-0; Gavin RH, 1997, INT REV CYTOL, V173, P207; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gundersen GG, 1999, CURR OPIN CELL BIOL, V11, P81, DOI 10.1016/S0955-0674(99)80010-6; Heil-Chapdelaine RA, 1999, J CELL BIOL, V144, P809, DOI 10.1083/jcb.144.5.809; Hunt AJ, 1998, MOL BIOL CELL, V9, P2857, DOI 10.1091/mbc.9.10.2857; HYMAN AA, 1989, J CELL BIOL, V109, P1185, DOI 10.1083/jcb.109.3.1185; Imamura H, 1997, EMBO J, V16, P2745, DOI 10.1093/emboj/16.10.2745; Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z; Korinek WS, 2000, SCIENCE, V287, P2257, DOI 10.1126/science.287.5461.2257; Lee L, 1999, J CELL BIOL, V144, P947, DOI 10.1083/jcb.144.5.947; LEE L, UNPUB; Miller R, UNPUB; Miller RK, 1998, J CELL BIOL, V140, P377, DOI 10.1083/jcb.140.2.377; Miller RK, 1998, MOL BIOL CELL, V9, P2051, DOI 10.1091/mbc.9.8.2051; Miller RK, 1999, J CELL BIOL, V144, P963, DOI 10.1083/jcb.144.5.963; MITCHISON TJ, 1985, J CELL BIOL, V101, P766, DOI 10.1083/jcb.101.3.766; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Muhua L, 1998, NATURE, V393, P487, DOI 10.1038/31014; RHYU MS, 1995, CELL, V82, P523, DOI 10.1016/0092-8674(95)90022-5; Schwartz K, 1997, MOL BIOL CELL, V8, P2677, DOI 10.1091/mbc.8.12.2677; Shaw SL, 1998, MOL BIOL CELL, V9, P1627, DOI 10.1091/mbc.9.7.1627; SIEGEL LM, 1966, BIOCHIM BIOPHYS ACTA, V112, P346, DOI 10.1016/0926-6585(66)90333-5; SNYDER M, 1991, J CELL BIOL, V114, P515, DOI 10.1083/jcb.114.3.515; SU LK, 1995, CANCER RES, V55, P2972; Tirnauer JS, 1999, J CELL BIOL, V145, P993, DOI 10.1083/jcb.145.5.993; XIANG X, 1995, P NATL ACAD SCI USA, V92, P9890, DOI 10.1073/pnas.92.21.9890	34	237	239	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2260	2262		10.1126/science.287.5461.2260	http://dx.doi.org/10.1126/science.287.5461.2260			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731147				2022-12-24	WOS:000086049100050
J	Hill, EW; Jobling, MA; Bradley, DG				Hill, EW; Jobling, MA; Bradley, DG			Y-chromosome variation and Irish origins	NATURE			English	Article									Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	Trinity College Dublin; University of Leicester	Hill, EW (corresponding author), Trinity Coll, Dept Genet, Dublin 2, Ireland.		Bradley, Daniel G/A-3240-2012	Jobling, Mark/0000-0002-8061-1308; Hill, Emmeline/0000-0002-1805-2250; Bradley, Daniel G/0000-0001-7335-7092	Wellcome Trust [057559] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Hurles ME, 1999, AM J HUM GENET, V65, P1437, DOI 10.1086/302617; Hurles ME, 1998, AM J HUM GENET, V63, P1793, DOI 10.1086/302147; JOBLING MA, 1995, TRENDS GENET, V11, P449, DOI 10.1016/S0168-9525(00)89144-1; MacLYSAGHT EDWARD, 1997, SURNAMES IRELAND; SEIELSTAD MT, 1994, HUM MOL GENET, V3, P2159; WHITFIELD LS, 1995, NATURE, V378, P379, DOI 10.1038/378379a0	6	96	97	0	10	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					351	352		10.1038/35006158	http://dx.doi.org/10.1038/35006158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746711				2022-12-24	WOS:000086119000036
J	Nielsen, LK; Bjornholm, T; Mouritsen, OG				Nielsen, LK; Bjornholm, T; Mouritsen, OG			Critical phenomena - Fluctuations caught in the act	NATURE			English	Article							MEMBRANES		Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark; Univ Copenhagen, Dept Chem, DK-2100 Copenhagen, Denmark	Technical University of Denmark; University of Copenhagen	Nielsen, LK (corresponding author), Tech Univ Denmark, Dept Chem, DK-2800 Lyngby, Denmark.	ogm@kemi.dtu.dk		Bjornholm, Thomas/0000-0002-2981-8290; Mouritsen, Ole G./0000-0002-4258-8960				ALBRECHT O, 1978, J PHYS-PARIS, V39, P301, DOI 10.1051/jphys:01978003903030100; Andrews T, 1869, PHILOS T R SOC LOND, V159, P575, DOI [10.1098/rstl.1869.0021, DOI 10.1098/RSTL.1869.0021]; Edidin M, 1997, CURR OPIN STRUC BIOL, V7, P528, DOI 10.1016/S0959-440X(97)80117-0; Honger T, 1996, BIOCHEMISTRY-US, V35, P9003, DOI 10.1021/bi960866a; Knobler CM, 1999, CURR OPIN COLLOID IN, V4, P46, DOI 10.1016/S1359-0294(99)00002-3; Korlach J, 1999, P NATL ACAD SCI USA, V96, P8461, DOI 10.1073/pnas.96.15.8461; MONRITSEN OG, 1997, CURR OPIN STRUC BIOL, V7, P518; Mouritsen O. G., 1998, BIOL SKR DAN VID SEL, V49, P1; MUSTONEN P, 1987, BIOCHEMISTRY-US, V26, P2991, DOI 10.1021/bi00385a006; Nielsen LK, 2000, J PHYS-CONDENS MAT, V12, pA309, DOI 10.1088/0953-8984/12/8A/340; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stanley HE, 1999, REV MOD PHYS, V71, pS358, DOI 10.1103/RevModPhys.71.S358	12	79	80	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					352	352		10.1038/35006162	http://dx.doi.org/10.1038/35006162			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746712				2022-12-24	WOS:000086119000037
J	Caplan, AL; Snyder, L; Faber-Langendoen, K				Caplan, AL; Snyder, L; Faber-Langendoen, K		Univ Pennsylvania	The role of guidelines in the practice of physician-assisted suicide	ANNALS OF INTERNAL MEDICINE			English	Article							DEATH; NETHERLANDS; EUTHANASIA; MODEL; CARE	Oregon has legalized and implemented physician-assisted suicide, while observers argue about the moral import of attempting to formulate guidelines; the utility any set of guidelines can have for physician practice, health care providers, patients, or families; and whether guidelines can really protect against harm or abuse. What were once theoretical questions have taken on new urgency. The debate over the value and power of guidelines includes the following questions: What has been the experience of efforts to implement physician-assisted suicide using consensus guidelines? What goals are guidelines intended to serve? Who should formulate guidelines? What features should be reflected in any proposed guidelines to make them practical and to permit achievement of their goals? Are there any fundamental obstacles to the creation or implementation of guidelines', Is dying a process that is amenable to direction under guidelines, be they issued by physicians, departments of health, blue ribbon panels, or other regulatory bodies? This paper explores these questions as physician-assisted suicide becomes legal.	Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; SUNY Hlth Sci Ctr, Syracuse, NY 13210 USA	University of Pennsylvania; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Snyder, L (corresponding author), Univ Penn, Ctr Bioeth, 3401 Market St,Suite 320, Philadelphia, PA 19104 USA.	lsnyder@mail.acponline.org						Albom M., 1997, TUESDAYS MORRIE OLD; Anderson P, 1996, ALL US AM TALK MEANI; Baron CH, 1996, HARVARD J LEGIS, V33, P1; Battin Margaret, 1994, LEAST WORST DEATH ES; Block SD, 2000, ANN INTERN MED, V132, P209, DOI 10.7326/0003-4819-132-3-200002010-00007; Byock I., 1997, DYING WELL; Callahan Daniel, 1996, Univ Richmond Law Rev, V30, P1; Chin AE, 1999, NEW ENGL J MED, V340, P577, DOI 10.1056/NEJM199902183400724; Coleman CH, 1996, J LAW MED ETHICS, V24, P217, DOI 10.1111/j.1748-720X.1996.tb01855.x; *COMM STUD MED PRA, 1991, MED DEC END LIF; Drickamer MA, 1997, ANN INTERN MED, V126, P146, DOI 10.7326/0003-4819-126-2-199701150-00009; *DUTCH SOC ADV PHA, 1994, ADM PREP EUTH; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Faber-Langendoen K, 2000, ANN INTERN MED, V132, P482, DOI 10.7326/0003-4819-132-6-200003210-00010; Field MJ, 1997, APPROACHING DEATH IM; Fins, 1996, Cancer Control, V3, P272; Gomez Carlos F., 1991, REGULATING DEATH EUT; Heilig S, 1997, WESTERN J MED, V166, P370; Hendin H., 1998, SEDUCED DEATH DOCTOR; Humphrey D., 1991, FINAL EXIT PRACTICAL; HUMPHREY D, 1993, LAWFUL EXIT LIMITS F; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Kubler-Ross Elisabeth, 1997, WHEEL LIFE MEMOIR LI; LARUE GA, 1996, PLAYING GOD 50 RELIG; MCNEES P, 1998, DYING BOOK COMFORT; MILLER FG, 1994, NEW ENGL J MED, V331, P119, DOI 10.1056/NEJM199407143310211; Miller FG, 1997, CAMB Q HEALTHC ETHIC, V6, P78, DOI 10.1017/S0963180100007635; *NEW YORK STAT TAS, 1994, DEATH IS SOUGHT ASS; Nuland S.B., 1994, WE DIE REFLECTIONS L; PECK MS, 1997, DENIAL SOUL; PIJNENBORG P, 1995, END LIFE DECISIONS D; Quill T, 1996, MIDWIFE DYING PROCES; QUILL TE, 1992, NEW ENGL J MED, V327, P1380, DOI 10.1056/NEJM199211053271911; Rabe David, 1998, QUESTION MERCY; ROLLIN B, 1985, LAST WISH; SHAVELSON L, 1995, CHOSEN DEATH DYING C; SIMONS M, 1995, NY TIMES        0909; Smith W.J., 1997, FORCED EXIT SLIPPERY; SNEIDERMAN B, 1992, HUM MED, V8, P104; Snyder L, 1996, Pa Med, V99, P10; TILDEN VP, 1997, J FAMILY NURSING, V3, P120; Tolle SW, 1998, ANN INTERN MED, V128, P567, DOI 10.7326/0003-4819-128-7-199804010-00009; van der Maas PJ, 1996, NEW ENGL J MED, V335, P1699, DOI 10.1056/NEJM199611283352227; vanderWal G, 1996, NEW ENGL J MED, V335, P1706; VITEZ M, 1998, FINAL CHOICES SEEKIN; Webb M, 1997, GOOD DEATH NEW AM SE; Young EWD, 1997, WESTERN J MED, V166, P381	47	24	24	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					476	481		10.7326/0003-4819-132-6-200003210-00009	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00009			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	293CV	10733448				2022-12-24	WOS:000085834700008
J	Russell, CT; Kivelson, MG				Russell, CT; Kivelson, MG			Detection of SO in lo's exosphere	SCIENCE			English	Article							ION-CYCLOTRON WAVES; PLASMA TORUS; GALILEO; ENCOUNTER	The Galileo orbiter's close pass by Io in 1995 produced evidence for extensive mass Loading of the plasma torus through the ionization of SO2. On 11 October 1999, Galileo passed even closer to Io, this time across the upstream side relative to the flow of magnetospheric plasma that corotates with Jupiter. On the first flyby, ion cyclotron waves gave direct evidence for the production of SO2+ ions. On the second flyby, ion cyclotron waves associated with SO+ were stronger and more persistent. Moreover, SO+ emissions were seen closer to lo than SO2+ emissions, suggesting that the exosphere was spatially inhomogeneous. The location of the waves suggests a fan-shaped region of ion pickup extending in the anti-Jupiter direction. Because the wave spectra were different even where the 1995 and 1999 trajectories crossed, we infer that lo's exosphere is temporally variable.	Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Russell, CT (corresponding author), Univ Calif Los Angeles, Inst Geophys & Planetary Phys, 3845 Slichter Hall, Los Angeles, CA 90095 USA.		Russell, Christopher T/E-7745-2012; Kivelson, Margaret G/I-9019-2012	Russell, Christopher T/0000-0003-1639-8298; Kivelson, Margaret G/0000-0003-3859-8581				BALCHER JW, 1983, PHYSICS JOVIAN MAGNE, P68; Frank LA, 1996, SCIENCE, V274, P394, DOI 10.1126/science.274.5286.394; Gurnett DA, 1996, SCIENCE, V274, P391, DOI 10.1126/science.274.5286.391; Huddleston DE, 1997, GEOPHYS RES LETT, V24, P2143, DOI 10.1029/97GL01203; Kivelson MG, 1996, SCIENCE, V274, P396, DOI 10.1126/science.274.5286.396; Lellouch E, 1996, ICARUS, V124, P1, DOI 10.1006/icar.1996.0186; Lopes-Gautier R, 1999, ICARUS, V140, P243, DOI 10.1006/icar.1999.6129; McEwen AS, 1998, ICARUS, V135, P181, DOI 10.1006/icar.1998.5972; Russell CT, 1999, J GEOPHYS RES-SPACE, V104, P17471, DOI 10.1029/1999JA900202; Warnecke J, 1997, GEOPHYS RES LETT, V24, P2139, DOI 10.1029/97GL01129; Williams DJ, 1996, SCIENCE, V274, P401, DOI 10.1126/science.274.5286.401; Zolotov MY, 1998, ICARUS, V132, P431, DOI 10.1006/icar.1998.5906	12	46	46	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1998	1999		10.1126/science.287.5460.1998	http://dx.doi.org/10.1126/science.287.5460.1998			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720321				2022-12-24	WOS:000085902800055
J	Williams, RJ; Martinez, ND				Williams, RJ; Martinez, ND			Simple rules yield complex food webs	NATURE			English	Article							TROPHIC INTERACTIONS; PATTERNS; SCALE; ECOSYSTEM; PREY	Several of the most ambitious theories in ecology(1-14) describe food webs that document the structure of strong and weak trophic links(9) that is responsible for ecological dynamics among diverse assemblages of species(4,11-13). Early mechanism-based theory asserted that food webs have little omnivory and several properties that are independent of species richness(1-4,6). This theory was overturned by empirical studies that found food webs to be much more complex(5,7-9,14-18), but these studies did not provide mechanistic explanations for the complexity(9). Here we show that a remarkably simple model. fills this scientific void by successfully predicting key structural properties of the most complex and comprehensive food webs in the primary literature. These properties include the fractions of species at top, intermediate and basal trophic levels, the means and variabilities of generality, vulnerability and food-chain length, and the degrees of cannibalism, omnivory, looping and trophic similarity. Using only two empirical parameters, species number and connectance, our 'niche model' extends the existing 'cascade model'(3,19) and improves its fit ten-fold by constraining species to consume a contiguous sequence of prey in a one-dimensional trophic niche(20).	San Francisco State Univ, Dept Biol, Romberg Tiburon Ctr, Tiburon, CA 94920 USA	California State University System; San Francisco State University	Martinez, ND (corresponding author), San Francisco State Univ, Dept Biol, Romberg Tiburon Ctr, POB 855, Tiburon, CA 94920 USA.		Williams, Richard J/B-8344-2011; Martinez, Neo/A-5312-2008	Williams, Richard J/0000-0001-8847-3213; Martinez, Neo/0000-0002-1130-5550				BAIRD D, 1989, ECOL MONOGR, V59, P329, DOI 10.2307/1943071; Begon M., 1996, ECOLOGY INDIVIDUALS; Berlow EL, 1999, NATURE, V398, P330, DOI 10.1038/18672; Cohen J. E., 1990, BIOMATHEMATICS, V20; COHEN JE, 1993, J ANIM ECOL, V62, P67, DOI 10.2307/5483; Cohen JE, 1978, FOOD WEBS NICHE SPAC; DERUITER PC, 1995, SCIENCE, V269, P1257, DOI 10.1126/science.269.5228.1257; GOLDWASSER L, 1993, ECOLOGY, V74, P1216, DOI 10.2307/1940492; HALL SJ, 1991, J ANIM ECOL, V60, P823, DOI 10.2307/5416; HAVENS K, 1992, SCIENCE, V257, P1107, DOI 10.1126/science.257.5073.1107; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; HUXMAN M, 1995, J ANIM ECOL, V64, P168; Lawton J.H., 1989, P43; LAWTON JH, 1995, OIKOS, V72, P305, DOI 10.2307/3546114; Marcogliese DJ, 1997, TRENDS ECOL EVOL, V12, P320, DOI 10.1016/S0169-5347(97)01080-X; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; MARTINEZ ND, 1994, AM NAT, V144, P935, DOI 10.1086/285719; MARTINEZ ND, 1993, SCIENCE, V260, P242, DOI 10.1126/science.260.5105.242; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; McCann K, 1998, NATURE, V395, P794, DOI 10.1038/27427; Murtaugh PA, 1997, ECOLOGY, V78, P1382; PIMM SL, 1991, NATURE, V350, P669, DOI 10.1038/350669a0; Polis G.A., 1996, FOOD WEBS INTEGRATIO; POLIS GA, 1991, AM NAT, V138, P123, DOI 10.1086/285208; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Solow AR, 1998, ECOLOGY, V79, P2013, DOI 10.2307/176705; Symstad AJ, 1998, OIKOS, V81, P389, DOI 10.2307/3547058; WARREN PH, 1989, OIKOS, V55, P299, DOI 10.2307/3565588; WARREN PH, 1987, OECOLOGIA, V74, P231, DOI 10.1007/BF00379364; Warren Philip H., 1996, P142	30	948	987	10	333	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					180	183		10.1038/35004572	http://dx.doi.org/10.1038/35004572			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724169				2022-12-24	WOS:000085870900050
J	Spechler, SJ; Fischbach, L; Feldman, M				Spechler, SJ; Fischbach, L; Feldman, M			Clinical aspects of genetic variability in Helicobacter pylori	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DUODENAL-ULCER DISEASE; GASTRIC-CANCER; REFLUX ESOPHAGITIS; INCREASED RISK; CAGA GENE; CYTOTOXIN ACTIVITY; INFECTION; STRAINS; ANTIGENS; STOMACH		Dept Vet Affairs Med Ctr, Dallas, TX USA; Univ Texas, SW Med Ctr, Houston, TX USA; Univ Texas, Sch Publ Hlth, Houston, TX USA; Univ Texas, Hlth Sci Ctr, Houston, TX USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; University of Texas System; University of Texas Health Science Center Houston	Spechler, SJ (corresponding author), Dallas VA Med Ctr, Div Gastroenterol 111B1, 4500 S Lancaster Rd, Dallas, TX 75216 USA.							Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Atherton JC, 1998, BRIT MED BULL, V54, P105; Atherton JC, 1999, GUT, V44, P307, DOI 10.1136/gut.44.3.307; Blaser MJ, 1998, GUT, V43, P721, DOI 10.1136/gut.43.5.721; Blaser MJ, 1997, LANCET, V349, P1020, DOI 10.1016/S0140-6736(96)09133-7; Blaser MJ, 1996, ALIMENT PHARM THER, V10, P73, DOI 10.1046/j.1365-2036.1996.22164008.x; BLASER MJ, 1995, CANCER RES, V55, P2111; Ching CK, 1996, AM J GASTROENTEROL, V91, P949; Cover TL, 1999, GASTROENTEROLOGY, V117, P257, DOI 10.1016/S0016-5085(99)70575-5; COVER TL, 1992, J BIOL CHEM, V267, P10570; COVER TL, 1990, INFECT IMMUN, V58, P603, DOI 10.1128/IAI.58.3.603-610.1990; FORMAN D, 1993, GUT, V34, P1672, DOI 10.1136/gut.34.12.1672; Go M F, 1996, Helicobacter, V1, P107, DOI 10.1111/j.1523-5378.1996.tb00019.x; Graham DY, 1998, HELICOBACTER, V3, P145, DOI 10.1046/j.1523-5378.1998.08031.x; Hamlet A, 1999, GASTROENTEROLOGY, V116, P259, DOI 10.1016/S0016-5085(99)70121-6; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Holtmann G, 1998, AM J GASTROENTEROL, V93, P1222, DOI 10.1111/j.1572-0241.1998.00399.x; Kidd M, 1999, GUT, V45, P499, DOI 10.1136/gut.45.4.499; Kikuchi S, 1999, AM J GASTROENTEROL, V94, P3455, DOI 10.1111/j.1572-0241.1999.01607.x; Klaamas K, 1996, INT J CANCER, V67, P1, DOI 10.1002/(SICI)1097-0215(19960703)67:1<1::AID-IJC1>3.0.CO;2-0; Labenz J, 1997, GASTROENTEROLOGY, V112, P1442, DOI 10.1016/S0016-5085(97)70024-6; Miehlke S, 1996, AM J GASTROENTEROL, V91, P1322; Mitchell HM, 1996, AM J GASTROENTEROL, V91, P1785; Park SM, 1998, SCAND J GASTROENTERO, V33, P923, DOI 10.1080/003655298750026921; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; PEEK RM, 1995, LAB INVEST, V71, P760; Rudi J, 1997, DIGEST DIS SCI, V42, P1652, DOI 10.1023/A:1018849112533; Scheiman JM, 1999, AM J MED, V106, P222, DOI 10.1016/S0002-9343(98)00393-3; Shyu RY, 1998, J CLIN GASTROENTEROL, V27, P54, DOI 10.1097/00004836-199807000-00011; TUMMURU MKR, 1994, INFECT IMMUN, V62, P2609, DOI 10.1128/IAI.62.6.2609-2613.1994; van Doorn LJ, 1998, GASTROENTEROLOGY, V115, P58, DOI 10.1016/S0016-5085(98)70365-8; Vicari JJ, 1998, GASTROENTEROLOGY, V115, P50, DOI 10.1016/S0016-5085(98)70364-6; Vorobjova T, 1998, EUR J GASTROEN HEPAT, V10, P41, DOI 10.1097/00042737-199801000-00008; Werdmuller BFM, 1997, DIGEST DIS SCI, V42, P103, DOI 10.1023/A:1018841222856; Wong BCY, 1999, ALIMENT PHARM THER, V13, P1295; Yamaoka Y, 1999, J CLIN PATHOL, V52, P215, DOI 10.1136/jcp.52.3.215	36	11	11	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 8	2000	283	10					1264	1266		10.1001/jama.283.10.1264	http://dx.doi.org/10.1001/jama.283.10.1264			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	289ND	10714712				2022-12-24	WOS:000085628100001
J	Willis, KJ; Whittaker, RJ				Willis, KJ; Whittaker, RJ			Paleoecology - The refugial debate	SCIENCE			English	Editorial Material							PHYLOGEOGRAPHY; SPECIATION; FOREST; EUROPE		Univ Oxford, Sch Geog, Oxford OX1 3TB, England	University of Oxford	Willis, KJ (corresponding author), Univ Oxford, Sch Geog, Mansfield Rd, Oxford OX1 3TB, England.		Whittaker, Robert J/H-1548-2015	Whittaker, Robert J/0000-0001-7775-3383; Willis, Katherine/0000-0002-6763-2489				Aide TM, 1998, J BIOGEOGR, V25, P695, DOI 10.1046/j.1365-2699.1998.2540695.x; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Colinvaux PA, 2000, QUATERNARY SCI REV, V19, P141, DOI 10.1016/S0277-3791(99)00059-1; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Demesure B, 1996, EVOLUTION, V50, P2515, DOI 10.1111/j.1558-5646.1996.tb03638.x; Haberle SG, 1999, QUATERNARY RES, V51, P27, DOI 10.1006/qres.1998.2020; HAFFER J, 1969, SCIENCE, V165, P131, DOI 10.1126/science.165.3889.131; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Nores M, 1999, J BIOGEOGR, V26, P475, DOI 10.1046/j.1365-2699.1999.t01-1-00311.x; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028	12	180	187	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2000	287	5457					1406	1407		10.1126/science.287.5457.1406	http://dx.doi.org/10.1126/science.287.5457.1406			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	287WZ	10722388				2022-12-24	WOS:000085531600024
J	Han, J; Craighead, HG				Han, J; Craighead, HG			Separation of long DNA molecules in a microfabricated entropic trap array	SCIENCE			English	Article							CAPILLARY ELECTROPHORESIS; MICROLITHOGRAPHIC ARRAYS; NUCLEIC-ACIDS; DEVICE	A nanofluidic channel device, consisting of many entropic traps, was designed and fabricated for the separation of Long DNA molecules. The channel comprises narrow constrictions and wider regions that cause size-dependent trapping of DNA at the onset of a constriction. This process creates electrophoretic mobility differences, thus enabling efficient separation without the use of a gel matrix or pulsed electric fields. Samples of Long DNA molecules (5000 to similar to 160,000 base pairs) were efficiently separated into bands in 15-millimeter-long channels. Multiple-channel devices operating in parallel were demonstrated. The efficiency, compactness, and ease of fabrication of the device suggest the possibility of more practical integrated DNA analysis systems.	Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA	Cornell University	Craighead, HG (corresponding author), Cornell Univ, Sch Appl & Engn Phys, Ithaca, NY 14853 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R44HG001597, R43HG001597] Funding Source: NIH RePORTER; NHGRI NIH HHS [HG01597] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Burke DT, 1997, GENOME RES, V7, P189, DOI 10.1101/gr.7.3.189; Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; Chou CF, 1999, P NATL ACAD SCI USA, V96, P13762, DOI 10.1073/pnas.96.24.13762; Chou HP, 1999, P NATL ACAD SCI USA, V96, P11, DOI 10.1073/pnas.96.1.11; Duke TAJ, 1996, ELECTROPHORESIS, V17, P1075, DOI 10.1002/elps.1150170616; GIDDINGS JC, 1991, UNIFIED SEPARATION S, P96; Han J, 1999, J VAC SCI TECHNOL A, V17, P2142, DOI 10.1116/1.581740; Han J, 1999, PHYS REV LETT, V83, P1688, DOI 10.1103/PhysRevLett.83.1688; KIM Y, 1994, ANAL CHEM, V66, P3081, DOI 10.1021/ac00091a015; KIM YS, 1995, ANAL CHEM, V67, P784, DOI 10.1021/ac00101a002; Madabhushi RS, 1997, ELECTROPHORESIS, V18, P104, DOI 10.1002/elps.1150180120; MITNIK L, 1995, SCIENCE, V267, P219, DOI 10.1126/science.7809626; SUDOR J, 1994, ANAL CHEM, V66, P2446, DOI 10.1021/ac00087a007; Turner SW, 1998, J VAC SCI TECHNOL B, V16, P3835, DOI 10.1116/1.590419; VOLKMUTH WD, 1992, NATURE, V358, P600, DOI 10.1038/358600a0; VOLKMUTH WD, 1994, PHYS REV LETT, V72, P2117, DOI 10.1103/PhysRevLett.72.2117	16	855	937	6	154	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2000	288	5468					1026	1029		10.1126/science.288.5468.1026	http://dx.doi.org/10.1126/science.288.5468.1026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10807568				2022-12-24	WOS:000086988400030
J	Oda, E; Ohki, R; Murasawa, H; Nemoto, J; Shibue, T; Yamashita, T; Tokino, T; Taniguchi, T; Tanaka, N				Oda, E; Ohki, R; Murasawa, H; Nemoto, J; Shibue, T; Yamashita, T; Tokino, T; Taniguchi, T; Tanaka, N			Nora, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis	SCIENCE			English	Article							TRANSCRIPTION FACTOR IRF-1; P53-DEPENDENT APOPTOSIS; CYTOCHROME-C; CELL-DEATH; DEPENDENT ACTIVATION; THYMOCYTE APOPTOSIS; DNA-DAMAGE; P53; BAX; PROTEIN	A critical function of tumor suppressor p53 is the induction of apoptosis in cells exposed to noxious stresses. We report a previously unidentified pro-apoptotic gene, Nora. Expression of Nora induction in primary mouse cells exposed to x-ray irradiation was dependent on p53, Nora encodes a Bcl-2 homology 3 (BH3)-only member of the Bcl-2 family of proteins; this member contains the BH3 region but not other BH domains. When ectopically expressed, Nora underwent BH3 motif-dependent Localization to mitochondria and interacted with anti-apoptotic Bcl-2 family members, resulting in the activation of caspase-9. We also demonstrate that blocking the endogenous Nora induction results in the suppression of apoptosis. Nora may thus represent a mediator of p53-dependent apoptosis.	Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Sapporo Med Univ, Sch Med, Canc Res Inst, Dept Mol Biol,Chuo Ku, Sapporo, Hokkaido 0608543, Japan	University of Tokyo; University of Tokyo; Sapporo Medical University	Taniguchi, T (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		MURASAWA, Hideki/AAP-9514-2021; Tokino, Takashi/AAI-9887-2021	MURASAWA, Hideki/0000-0003-4897-1239; Tanaka, Nobuyuki/0000-0002-6373-2220				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Brady HJM, 1996, EMBO J, V15, P1221, DOI 10.1002/j.1460-2075.1996.tb00463.x; Burns TF, 1999, J CELL PHYSIOL, V181, P231, DOI 10.1002/(SICI)1097-4652(199911)181:2<231::AID-JCP5>3.0.CO;2-L; CANMAN CE, 1995, GENE DEV, V9, P600, DOI 10.1101/gad.9.5.600; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Gottlieb TM, 1998, SEMIN CANCER BIOL, V8, P359, DOI 10.1006/scbi.1998.0098; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Gross A, 1998, EMBO J, V17, P3878, DOI 10.1093/emboj/17.14.3878; Hakem A, 1999, J EXP MED, V189, P957, DOI 10.1084/jem.189.6.957; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; HIJIKATA M, 1990, J VIROL, V64, P4632, DOI 10.1128/JVI.64.10.4632-4639.1990; Kelekar A, 1998, TRENDS CELL BIOL, V8, P324, DOI 10.1016/S0962-8924(98)01321-X; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Lowe Scott W., 1995, Current Opinion in Oncology, V7, P547, DOI 10.1097/00001622-199511000-00013; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Marcellus RC, 1996, CELL GROWTH DIFFER, V7, P1643; McCurrach ME, 1997, P NATL ACAD SCI USA, V94, P2345, DOI 10.1073/pnas.94.6.2345; MIYASHITA T, 1995, CELL, V80, P293; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Nechushtan A, 1999, EMBO J, V18, P2330, DOI 10.1093/emboj/18.9.2330; NEMOTO J, UNPUB; Nozawa H, 1999, GENE DEV, V13, P1240, DOI 10.1101/gad.13.10.1240; ODA E, UNPUB; Quelle FW, 1998, GENE DEV, V12, P1099, DOI 10.1101/gad.12.8.1099; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Sugrue MM, 1999, BIOCHEM BIOPH RES CO, V261, P123, DOI 10.1006/bbrc.1999.0984; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Tanaka N, 1996, NATURE, V382, P816, DOI 10.1038/382816a0; TANAKA N, 1994, CELL, V77, P829, DOI 10.1016/0092-8674(94)90132-5; Ulloa L, 1999, NATURE, V397, P710, DOI 10.1038/17826; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Yamano S, 1999, J VIROL, V73, P10095, DOI 10.1128/JVI.73.12.10095-10103.1999; Zha JP, 1997, J BIOL CHEM, V272, P24101, DOI 10.1074/jbc.272.39.24101; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	43	1588	1679	1	87	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2000	288	5468					1053	1058		10.1126/science.288.5468.1053	http://dx.doi.org/10.1126/science.288.5468.1053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10807576				2022-12-24	WOS:000086988400038
J	Ramanan, N; Wang, Y				Ramanan, N; Wang, Y			A high-affinity iron permease essential for Candida albicans virulence	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSPORT; GENE; ACQUISITION; EXPRESSION; INFECTION; CLONING; PROTEIN; GROWTH; YEAST	Microbial pathogens must compete with the iron-withholding defense systems of their host to acquire this essential nutrient. Here, two high-affinity iron permease genes, CaFTR1 and CaFTR2, were isolated. CaFTR1 expression was induced under iron-limited conditions and repressed when iron supply was sufficient, whereas the expression of CaFTR2 was regulated in a reversed manner. Mutants Lacking CaFTR1 but not CaFTR2 exhibited a severe growth defect in iron-deficient medium and were unable to establish systemic infection in mice. Thus, CaFTR1-mediated iron-uptake mechanism constitutes a virulence factor of Candida albicans and may be a target for the development of anti-Candida therapies.	Inst Mol & Cell Biol, Microbial Collect & Screening Lab, Singapore 117609, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Wang, Y (corresponding author), Inst Mol & Cell Biol, Microbial Collect & Screening Lab, 30 Med Dr, Singapore 117609, Singapore.		Wang, Yue/AGN-6053-2022; Wang, Yue/H-2107-2011	Wang, Yue/0000-0002-1211-2822				Askwith C, 1998, TRENDS BIOCHEM SCI, V23, P135, DOI 10.1016/S0968-0004(98)01192-X; Askwith C, 1997, J BIOL CHEM, V272, P401; Cormack BP, 1997, MICROBIOL-UK, V143, P303, DOI 10.1099/00221287-143-2-303; Cornelissen CN, 1998, MOL MICROBIOL, V27, P611, DOI 10.1046/j.1365-2958.1998.00710.x; DeSilva DM, 1996, PHYSIOL REV, V76, P31, DOI 10.1152/physrev.1996.76.1.31; Eck R, 1999, MICROBIOL-UK, V145, P2415, DOI 10.1099/00221287-145-9-2415; EIDE D, 1992, J GEN MICROBIOL, V138, P347, DOI 10.1099/00221287-138-2-347; EIDE D, 1992, J BIOL CHEM, V267, P20774; Fonzi WA, 1999, J BACTERIOL, V181, P7070, DOI 10.1128/JB.181.22.7070-7079.1999; Gale CA, 1998, SCIENCE, V279, P1355, DOI 10.1126/science.279.5355.1355; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; Howard DH, 1999, CLIN MICROBIOL REV, V12, P394, DOI 10.1128/CMR.12.3.394; Kohler JR, 1996, P NATL ACAD SCI USA, V93, P13223, DOI 10.1073/pnas.93.23.13223; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; NICHOLAS DJD, 1965, METHOD ENZYMOL, V3, P1035; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Sanglard D, 1997, INFECT IMMUN, V65, P3539, DOI 10.1128/IAI.65.9.3539-3546.1997; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; Stevens MK, 1996, INFECT IMMUN, V64, P1724, DOI 10.1128/IAI.64.5.1724-1735.1996; VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D	22	248	260	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2000	288	5468					1062	1064		10.1126/science.288.5468.1062	http://dx.doi.org/10.1126/science.288.5468.1062			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10807578				2022-12-24	WOS:000086988400040
J	Peppard, PE; Young, T; Palta, M; Skatrud, J				Peppard, PE; Young, T; Palta, M; Skatrud, J			Prospective study of the association between sleep-disordered breathing and hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CARDIOVASCULAR RISK-FACTORS; BLOOD-PRESSURE; SYSTEMIC HYPERTENSION; LONGITUDINAL DATA; APNEA SYNDROME; POPULATION; PREVALENCE; MEN; COMMUNITY; HYPOXIA	Background: Sleep-disordered breathing is prevalent in the general population and has been linked to chronically elevated blood pressure in cross-sectional epidemiologic studies. We performed a prospective, population-based study of the association between objectively measured sleep-disordered breathing and hypertension (defined as a laboratory-measured blood pressure of at least 140/90 mm Hg or the use of antihypertensive medications). Methods: We analyzed data on sleep-disordered breathing, blood pressure, habitus, and health history at base line and after four years of follow-up in 709 participants of the Wisconsin Sleep Cohort Study (and after eight years of follow-up in the case of 184 of these participants). Participants were assessed overnight by 18-channel polysomnography for sleep-disordered breathing, as defined by the apnea-hypopnea index (the number of episodes of apnea and hypopnea per hour of sleep). The odds ratios for the presence of hypertension at the four-year follow-up study according to the apnea-hypopnea index at base line were estimated after adjustment for base-line hypertension status, body-mass index, neck and waist circumference, age, sex, and weekly use of alcohol and cigarettes. Results: Relative to the reference category of an apnea-hypopnea index of 0 events per hour at base line, the odds ratios for the presence of hypertension at follow-up were 1.42 (95 percent confidence interval, 1.13 to 1.78) with an apnea-hypopnea index of 0.1 to 4.9 events per hour at base line as compared with none, 2.03 (95 percent confidence interval, 1.29 to 3.17) with an apnea-hypopnea index of 5.0 to 14.9 events per hour, and 2.89 (95 percent confidence interval, 1.46 to 5.64) with an apnea-hypopnea index of 15.0 or more events per hour. Conclusions: We found a dose-response association between sleep-disordered breathing at base line and the presence of hypertension four years later that was independent of known confounding factors. The findings suggest that sleep-disordered breathing is likely to be a risk factor for hypertension and consequent cardiovascular morbidity in the general population. (N Engl J Med 2000;342:1378-84.) (C)2000, Massachusetts Medical Society.	Univ Wisconsin, Sch Med, Dept Prevent Med, Madison, WI 53705 USA; Univ Wisconsin, Sch Med, Dept Biostat & Med Informat, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Peppard, PE (corresponding author), Univ Wisconsin, Sch Med, Dept Prevent Med, 502 N Walnut St, Madison, WI 53705 USA.	ppeppard@facstaff.wisc.edu	Lavu, Madhav/A-9409-2013		NCRR NIH HHS [RR03186] Funding Source: Medline; NHLBI NIH HHS [P01HL42242, R01HL62252] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL042242, R01HL062252] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1992, AM J HYPERTENS, V5, P207; [Anonymous], 1997, ARCH INTERN MED, V157, P2413; Arabi Y, 1999, J APPL PHYSIOL, V87, P689, DOI 10.1152/jappl.1999.87.2.689; BEARPARK H, 1995, AM J RESP CRIT CARE, V151, P1459, DOI 10.1164/ajrccm.151.5.7735600; Black HR, 1998, ARCH INTERN MED, V158, P573; CARLSON JT, 1994, AM J RESP CRIT CARE, V150, P72, DOI 10.1164/ajrccm.150.1.8025776; DAVIES RJO, 1994, CLIN SCI, V86, P417, DOI 10.1042/cs0860417; ESCOURROU P, 1990, CHEST, V98, P1362, DOI 10.1378/chest.98.6.1362; FERINISTRAMBI L, 1994, CHEST, V105, P1759, DOI 10.1378/chest.105.6.1759; FLETCHER EC, 1995, AM J MED, V98, P118, DOI 10.1016/S0002-9343(99)80395-7; GARPESTAD E, 1992, J APPL PHYSIOL, V73, P1743, DOI 10.1152/jappl.1992.73.5.1743; *GENMOD PROC, 1996, SAS STAT SOFTW CHANG; GISLASON T, 1987, ACTA MED SCAND, V222, P415; GISLASON T, 1993, CHEST, V103, P1147, DOI 10.1378/chest.103.4.1147; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; GUILLEMINAULT C, 1986, CHEST, V89, P331, DOI 10.1378/chest.89.3.331; Hedner J, 1994, SLEEP BREATH, P823; HEITJAN DF, 1994, J AM STAT ASSOC, V89, P750, DOI 10.2307/2290900; HOFFSTEIN V, 1992, CHEST, V101, P379, DOI 10.1378/chest.101.2.379; Hu FB, 1999, AM J EPIDEMIOL, V150, P806; JENNUM P, 1992, CHEST, V102, P1371, DOI 10.1378/chest.102.5.1371; JENNUM P, 1993, INT J EPIDEMIOL, V22, P439, DOI 10.1093/ije/22.3.439; KOSKENVUO M, 1985, LANCET, V1, P893; Kripke DF, 1997, SLEEP, V20, P65, DOI 10.1093/sleep/20.1.65; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.2307/2336267; LOHMAN TG, 1988, ANTHROPOMETRIC STAND, P1; MILLMAN RP, 1991, CHEST, V99, P861, DOI 10.1378/chest.99.4.861; Morgan BJ, 1998, SLEEP, V21, P737, DOI 10.1093/sleep/21.7.737; Nieto FJ, 2000, JAMA-J AM MED ASSOC, V283, P1829, DOI 10.1001/jama.283.14.1829; OKABE S, 1995, THORAX, V50, P28, DOI 10.1136/thx.50.1.28; OLSON LG, 1995, AM J RESP CRIT CARE, V152, P711, DOI 10.1164/ajrccm.152.2.7633731; OLSON LG, 1995, AM J RESP CRIT CARE, V152, P717, DOI 10.1164/ajrccm.152.2.7633732; Pankow W, 1997, CHEST, V112, P1253, DOI 10.1378/chest.112.5.1253; RAUSCHER H, 1992, CHEST, V102, P367, DOI 10.1378/chest.102.2.367; Rechtschaffen A, 1968, NIH PUBLICATION, V204; Rothman K., 1998, MODERN EPIDEMIOLOGY; SCHMIDTNOWARA WW, 1990, ARCH INTERN MED, V150, P597, DOI 10.1001/archinte.150.3.597; SCHMIDTNOWARA WW, 1990, PROG CLIN BIOL RES, V345, P377; STRADLING JR, 1990, BRIT MED J, V300, P75, DOI 10.1136/bmj.300.6717.75; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; STROHL KP, 1994, SLEEP, V17, P614, DOI 10.1093/sleep/17.7.614; Wilcox I, 1998, THORAX, V53, pS25; Wright J, 1997, BRIT MED J, V314, P851; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; YOUNG T, 2000, SLEEP APNEA IMPLICAT, P261; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	47	3335	3531	6	138	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2000	342	19					1378	1384		10.1056/NEJM200005113421901	http://dx.doi.org/10.1056/NEJM200005113421901			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	312JR	10805822	Bronze			2022-12-24	WOS:000086940600001
J	Grissom, CK; Radwin, MI; Harmston, CH; Hirshberg, EL; Crowley, TJ				Grissom, CK; Radwin, MI; Harmston, CH; Hirshberg, EL; Crowley, TJ			Respiration during snow burial using an artificial air pocket	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AVALANCHE	Context Asphyxia is the most common cause of death after avalanche burial. A device that allows a person to breathe air contained in snow by diverting expired carbon dioxide (CO2) away from a 500-cm(3) artificial inspiratory air pocket may improve chances of survival in avalanche burial. Objective To determine the duration of adequate oxygenation and ventilation during burial in dense snow while breathing with vs without the artificial air pocket device. Design Field study of physiologic respiratory measures during snow burial with and without the device from December 1998 to March 1999. Study burials were terminated at the subject's request, when oxygen saturation as measured by pulse oximetry (SpO(2)) dropped to less than 84%, or after 60 minutes elapsed. Setting Mountainous outdoor site at 2385 m elevation, with an average barometric pressure of 573 mm Hg. Participants Six male and 2 female volunteers (mean age, 34.6 years; range, 28-39 years). Main Outcome Measures Burial time, SpO(2), partial pressure of end-tidal CO2 (ETCO2), partial pressure of inspiratory CO2 (PICO2), respiratory rate, and heart rate at baseline (in open atmosphere) and during snow burial while breathing with the device and without the device but with a 500-cm(3) air pocket in the snow. Results Mean burial time was 58 minutes (range, 45-60 minutes) with the device and 10 minutes (range, 5-14 minutes) without it (P=.001). A mean baseline SpO(2) of 96% (range, 90%-99%) decreased to 90% (range, 77%-96%) in those buried with the device (P=.01) and to 84% (range, 79%-92%) in the control burials (P=.02). Only 1 subject buried with the device, but 6 central subjects buried without the device, decreased SpO(2) to less than 88% (P=.005). A mean baseline ETCO2 of 32 mm Hg (range, 27-38 mm Hg) increased to 45 mm Hg (range, 32-53 mm Hg) in the burials with the device (P=.02) and to 54 mm Hg (range, 44-63 mm Hg) in the control burials (P=.02). A mean baseline Pico, of 2 mm Hg (range, 0-3 mm Hg) increased to 32 mm Hg (range, 20-44 mm Hg) in the burials with the device (P=.01) and to 44 mm Hg (range, 37-50 mm Hg) in the control burials (P=.02). Respiratory and heart rates did not change in burials with the device but significantly increased in control burials. Conclusions In our study, although hypercapnia developed, breathing with the device during snow burial considerably extended duration of adequate oxygenation compared with breathing with an air pocket in the snow. Further study will be needed to determine whether the device improves survival during avalanche burial.	Univ Utah, Latter Day St Hosp, Div Pulm, Salt Lake City, UT 84143 USA; Black Diamond Equipment Ltd, Salt Lake City, UT USA; TJ Crowley Corp, Aurora, CO USA	Utah System of Higher Education; University of Utah	Grissom, CK (corresponding author), Univ Utah, Latter Day St Hosp, Div Pulm, 8th Ave & C St, Salt Lake City, UT 84143 USA.			Radwin, Martin/0000-0002-4455-414X				ATKINS D, 1999, COLORADO AVALANCHE I; BERGER AJ, 1988, TXB RESP MED, P199; De Vito EL, 1998, AM J RESP CRIT CARE, V158, P107, DOI 10.1164/ajrccm.158.1.9709098; FALK M, 1994, NATURE, V368, P21, DOI 10.1038/368021a0; GROSSMAN MD, 1989, J TRAUMA, V29, P1705, DOI 10.1097/00005373-198912000-00021; LOCHER T, 1991, SCHWEIZ MED WSCHR, V121, P1020; MARGID J, 1998, P 1998 INT SNOW SCI; MCCLUNG D, 1993, AVALANCHE HDB, P115; NUNN JF, 1987, APPL RESP PHYSL, P226; Page CE, 1999, WILD ENVIRON MED, V10, P146, DOI 10.1580/1080-6032(1999)010[0146:ADITUS]2.3.CO;2; RADWIN MI, 1998, P 1998 INT SNOW SCI; STALSBERG H, 1989, VIRCHOWS ARCH A, V414, P415, DOI 10.1007/BF00718625; WILLIAMS K, 1995, WILDERNESS MED MANAG, P616	13	53	53	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2000	283	17					2266	2271		10.1001/jama.283.17.2266	http://dx.doi.org/10.1001/jama.283.17.2266			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307UB	10807386				2022-12-24	WOS:000086671600034
J	Scarlatis, G				Scarlatis, G			Optical prosthesis: Visions of the future	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									Northwestern Univ, Sch Med, Chicago, IL 60611 USA	Northwestern University	Scarlatis, G (corresponding author), Northwestern Univ, Sch Med, Chicago, IL 60611 USA.							BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; DEJUAN E, 1999, OPHTHALMOLOGY CLIN N, V12, P539; Majji AB, 1999, INVEST OPHTH VIS SCI, V40, P2073; Normann RA, 1999, VISION RES, V39, P2577, DOI 10.1016/S0042-6989(99)00040-1; Peachey NS, 1999, J REHABIL RES DEV, V36, P371; Peyman G, 1998, OPHTHALMIC SURG LAS, V29, P234; Walter P, 1999, RETINA-J RET VIT DIS, V19, P546, DOI 10.1097/00006982-199911000-00012; Zrenner E, 1999, VISION RES, V39, P2555, DOI 10.1016/S0042-6989(98)00312-5	8	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2000	283	17					2297	+		10.1001/jama.283.17.2297	http://dx.doi.org/10.1001/jama.283.17.2297			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307UB	10807393	hybrid			2022-12-24	WOS:000086671600041
J	Gallopin, T; Fort, P; Eggermann, E; Cauli, B; Luppi, PH; Rossier, J; Audinat, E; Muhlethaler, M; Serafin, M				Gallopin, T; Fort, P; Eggermann, E; Cauli, B; Luppi, PH; Rossier, J; Audinat, E; Muhlethaler, M; Serafin, M			Identification of sleep-promoting neurons in vitro	NATURE			English	Article							CEREBELLAR SLICES; BASAL FOREBRAIN; IN-VITRO; RAT; INVITRO; CELLS; NUCLEUS; AROUSAL	The neurons responsible for the onset of sleep are thought to be located in the preoptic area(1-3) and more specifically, in the ventrolateral preoptic nucleus (VLPO)(4-6). Here we identify sleep-promoting neurons in vitro and show that they represent an homogeneous population of cells that must be inhibited by systems of arousal during the waking state. We rnd that two-thirds of the VLPO neurons are multipolar triangular cells that show a low-threshold spike. This proportion matches that of cells active during sleep in the same region(6). We then show, using single-cell reverse transcriptase followed by polymerase chain reaction, that these neurons probably contain g-aminobutyric acid (GABA). We also show that these neurons are inhibited by noradrenaline and acetylcholine, both of which are transmitters of wakefulness(3,7,8). As most of these cells are also inhibited by serotonin but unaffected by histamine, their overall inhibition by transmitters of wakefulness is in agreement with their relative inactivity during waking with respect to sleep(6). We propose that the reciprocal inhibitory interaction of such VLPO neurons with the noradrenergic, serotoninergic and cholinergic waking systems to which they project(5,9,10) is a key factor for promoting sleep.	Ctr Med Univ Geneva, Dept Physiol, CH-1211 Geneva 4, Switzerland; Neurobiol Etats Sommeil & Eveil, F-69373 Lyon, France; ESPCI, CNRS, UMR 7637, Lab Neurobiol & Divers Cellulaire, F-75005 Paris, France	University of Geneva; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)	Muhlethaler, M (corresponding author), Ctr Med Univ Geneva, Dept Physiol, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.		Audinat, Etienne/F-4789-2019; Luppi, Pierre-Hervé/C-4333-2014; FORT, Patrice/G-6851-2017	Audinat, Etienne/0000-0002-6389-422X; Luppi, Pierre-Hervé/0000-0002-0503-423X; FORT, Patrice/0000-0003-1211-8631; Cauli, Bruno/0000-0003-1471-4621; Gallopin, Thierry/0000-0002-9741-3738				Audinat E, 1996, NEUROCHEM INT, V28, P119, DOI 10.1016/0197-0186(95)00075-5; Cauli B, 1997, J NEUROSCI, V17, P3894; DODT HU, 1994, TRENDS NEUROSCI, V17, P453, DOI 10.1016/0166-2236(94)90130-9; Fort P, 1998, NEUROREPORT, V9, P61, DOI 10.1097/00001756-199801050-00013; FORT P, 1998, NEUR ABSTR, V24; GAUS SE, 1998, NEUR ABSTR, V24; Gorelova N, 1996, J NEUROPHYSIOL, V75, P695, DOI 10.1152/jn.1996.75.2.695; GRIFFITH WH, 1988, J NEUROPHYSIOL, V59, P1590, DOI 10.1152/jn.1988.59.5.1590; JONES BE, 1994, PRINCIPLES PRACTICE, P145; Kondo S, 1998, J PHYSIOL-LONDON, V509, P221, DOI 10.1111/j.1469-7793.1998.221bo.x; LAMBOLEZ B, 1992, NEURON, V9, P247, DOI 10.1016/0896-6273(92)90164-9; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P171, DOI 10.1113/jphysiol.1980.sp013357; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P549, DOI 10.1113/jphysiol.1981.sp013763; Lu J, 1999, NEUROSCIENCE, V93, P209, DOI 10.1016/S0306-4522(99)00094-9; Luppi PH, 1999, RAPID EYE MOVEMENT SLEEP, P107; McCormick DA, 1997, ANNU REV NEUROSCI, V20, P185, DOI 10.1146/annurev.neuro.20.1.185; OSAKA T, 1995, NEUROSCI RES, V21, P323, DOI 10.1016/0168-0102(94)00871-C; OSAKA T, 1994, NEUROSCI RES, V19, P39, DOI 10.1016/0168-0102(94)90006-X; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Porter JT, 1998, EUR J NEUROSCI, V10, P3617, DOI 10.1046/j.1460-9568.1998.00367.x; Porter JT, 1999, J NEUROSCI, V19, P5228; Sherin JE, 1998, J NEUROSCI, V18, P4705; Sherin JE, 1996, SCIENCE, V271, P216, DOI 10.1126/science.271.5246.216; SHIROMANI PJ, 1999, HDB BEHAV STATE CONT, P311; Steriade M., 1990, BRAINSTEM CONTROL WA; SZYMUSIAK R, 1995, SLEEP, V18, P478, DOI 10.1093/sleep/18.6.478; Szymusiak R, 1998, BRAIN RES, V803, P178, DOI 10.1016/S0006-8993(98)00631-3	27	334	347	4	42	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2000	404	6781					992	995		10.1038/35010109	http://dx.doi.org/10.1038/35010109			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801127				2022-12-24	WOS:000086762000055
J	Wong, CA; Walsh, LJ; Smith, CJP; Wisniewski, AF; Lewis, SA; Hubbard, R; Cawte, S; Green, DJ; Pringle, M; Tattersfield, AE				Wong, CA; Walsh, LJ; Smith, CJP; Wisniewski, AF; Lewis, SA; Hubbard, R; Cawte, S; Green, DJ; Pringle, M; Tattersfield, AE			Inhaled corticosteroid use and bone-mineral density in patients with asthma	LANCET			English	Article							BECLOMETHASONE DIPROPIONATE; REFERENCE RANGES; STEROID-THERAPY; WOMEN; RISK; BUDESONIDE; GLUCOCORTICOIDS; FLUTICASONE; METABOLISM; FRACTURE	Background Inhaled corticosteroids are absorbed into the systemic circulation, but the extent to which they have adverse effects on bone is uncertain. The question is important since 3% of the European population take an inhaled corticosteroid regularly and may do so for many years. Methods We studied the dose-response relation between cumulative inhaled corticosteroid dose and bone-mineral density at the lumbar spine and proximal femur in 196 adults (119 women) with asthma aged 20-40 years. Patients had taken an inhaled corticosteroid regularly for at least 6 months, and had had limited exposure to systemic steroids. Cumulative dose of inhaled corticosteroid was calculated from questionnaires and computerised and written general-practice records, and its effect on bone-mineral density was estimated by multiple regression analysis. Findings Median duration of inhaled corticosteroid treatment was 6 years (range 0.5-24), and median cumulative dose was 876 mg (87-4380), There was a negative association between cumulative dose of inhaled corticosteroid and bone-mineral density at the lumbar spine (L2-L4), femoral neck, Ward's triangle, and trochanter, both before and after adjustment for the effects of age and sex. A doubling in dose of inhaled corticosteroid was associated with a decrease in bone-mineral density at the lumbar spine of 0.16 SD (95% CI 0.04-0.28). Similar decreases were found at the femoral neck, Ward's triangle, and trochanter, Adjustment for potential confounding factors including physical activity and past oral, nasal, dermal, and parenteral corticosteroids did not weaken the associations. Interpretation This study provides evidence of a negative relation between total cumulative dose of inhaled corticosteroid and bone-mineral density in patients with asthma.	City Hosp, Div Resp Med, Nottingham NG5 1PB, England; City Hosp, Dept Radiol, Nottingham NG5 1PB, England; Queens Med Ctr, Dept Gen Practice, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham	Wong, CA (corresponding author), City Hosp, Div Resp Med, Nottingham NG5 1PB, England.							BALFOURLYNN L, 1987, PAEDIATRICIAN, V24, P237; BARNES PJ, 1993, AM REV RESPIR DIS, V148, pS1, DOI 10.1164/ajrccm/148.4_Pt_2.S1; Bisgaard H, 1996, EUR RESPIR J, V9, pS28; BOULET LP, 1994, J ALLERGY CLIN IMMUN, V94, P796, DOI 10.1016/0091-6749(94)90145-7; Cumming RG, 1997, NEW ENGL J MED, V337, P8, DOI 10.1056/NEJM199707033370102; EASTELL R, 1991, J BONE MINER RES, V6, P207; Ebeling PR, 1998, J BONE MINER RES, V13, P1283, DOI 10.1359/jbmr.1998.13.8.1283; Egan JJ, 1999, EUR RESPIR J, V13, P1267, DOI 10.1183/09031936.99.13612769; Garbe E, 1997, JAMA-J AM MED ASSOC, V277, P722, DOI 10.1001/jama.277.9.722; HANANIA NA, 1995, J ALLERGY CLIN IMMUN, V96, P571, DOI 10.1016/S0091-6749(95)70254-7; HERRALA J, 1994, BONE, V15, P621, DOI 10.1016/8756-3282(94)90309-3; Hughes JA, 1999, THORAX, V54, P223, DOI 10.1136/thx.54.3.223; IP M, 1994, CHEST, V105, P1722, DOI 10.1378/chest.105.6.1722; JAGLAL SB, 1993, AM J EPIDEMIOL, V138, P107, DOI 10.1093/oxfordjournals.aje.a116833; Lau EMC, 1998, CLIN EXP ALLERGY, V28, P1066; Luengo M, 1997, EUR RESPIR J, V10, P2110, DOI 10.1183/09031936.97.10092110; Marystone JF, 1995, AM J PUBLIC HEALTH, V85, P1693, DOI 10.2105/AJPH.85.12.1693; Mazess RB, 1997, BRIT J RADIOL, V70, P109, DOI 10.1259/bjr.70.829.9059309; Packe GE, 1996, J ROY COLL PHYS LOND, V30, P128; PACKE GE, 1992, THORAX, V47, P414, DOI 10.1136/thx.47.6.414; Pauwels RA, 1999, NEW ENGL J MED, V340, P1948, DOI 10.1056/NEJM199906243402503; Petley GW, 1996, BRIT J RADIOL, V69, P655, DOI 10.1259/0007-1285-69-823-655; RUSELL G, 1993, ARCH DIS CHILD, V69, P694; SAMBROOK P, 1990, J BONE MINER RES, V5, P1211; TOOGOOD JH, 1995, J ALLERGY CLIN IMMUN, V96, P157, DOI 10.1016/S0091-6749(95)70003-X; Truscott JG, 1997, BRIT J RADIOL, V70, P1245, DOI 10.1259/bjr.70.840.9505843; Walsh LJ, 1999, THORAX, V54, P296, DOI 10.1136/thx.54.4.296; WASNICH R, 1993, AM J MED, V95, pS6, DOI 10.1016/0002-9343(93)90374-X; Wisniewski AF, 1997, THORAX, V52, P853, DOI 10.1136/thx.52.10.853; WOLFF AH, 1991, ANN ALLERGY, V67, P117	30	247	258	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 22	2000	355	9213					1399	1403		10.1016/S0140-6736(00)02138-3	http://dx.doi.org/10.1016/S0140-6736(00)02138-3			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LN	10791523				2022-12-24	WOS:000086829800010
J	Smith, O				Smith, O			Physiology - Contortions of the heart	SCIENCE			English	Editorial Material																		Kilner PJ, 2000, NATURE, V404, P759, DOI 10.1038/35008075	1	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2000	288	5465					453	453		10.1126/science.288.5465.453	http://dx.doi.org/10.1126/science.288.5465.453			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10798983				2022-12-24	WOS:000086626000027
J	Dear, P; Newell, S				Dear, P; Newell, S			Establishing probable cause in cerebral palsy - How much certainty is enough?	BRITISH MEDICAL JOURNAL			English	Letter									St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England	Saint James's University Hospital	Dear, P (corresponding author), St James Univ Hosp, Leeds LS9 7TF, W Yorkshire, England.							Little WJ., 1861, T OBSTET SOC LOND, P293; MacLennan A, 1999, BMJ-BRIT MED J, V319, P1054, DOI 10.1136/bmj.319.7216.1054	2	10	10	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 15	2000	320	7241					1075	1076						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307VW	10764378				2022-12-24	WOS:000086675700044
J	Williams, TM; Davis, RW; Fuiman, LA; Francis, J; Le Boeuf, BL; Horning, M; Calambokidis, J; Croll, DA				Williams, TM; Davis, RW; Fuiman, LA; Francis, J; Le Boeuf, BL; Horning, M; Calambokidis, J; Croll, DA			Sink or swim: Strategies for cost-efficient diving by marine mammals	SCIENCE			English	Article							CONFLICTING METABOLIC DEMANDS; NORTHERN ELEPHANT SEALS; DOLPHINS; KINEMATICS; EXERCISE; ENERGY; BIRDS	Locomotor activity by diving marine mammals is accomplished while breath-holding and often exceeds predicted aerobic capacities. Video sequences of freely diving seals and whales wearing submersible cameras reveal a behavioral strategy that improves energetic efficiency in these animals. Prolonged gliding (greater than 78% descent duration) occurred during dives exceeding 80 meters in depth. Gliding was attributed to buoyancy changes with Lung compression at depth. By modifying locomotor patterns to take advantage of these physical changes, Weddell seals realized a 9.2 to 59.6% reduction in diving energetic costs. This energy-conserving strategy allows marine mammals to increase aerobic dive duration and achieve remarkable depths despite Limited,oxygen availability when submerged.	Univ Calif Santa Cruz, Dept Biol, Santa Cruz, CA 95064 USA; Texas A&M Univ, Dept Marine Biol, Galveston, TX 77553 USA; Univ Texas, Dept Marine Sci, Port Aransas, TX 78373 USA; Natl Geog Soc, Comm Res & Explorat, Washington, DC 20036 USA; Cascadia Res, Olympia, WA USA; Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Texas A&M University System; University of Texas System; National Geographic Society; University of California System; University of California Santa Cruz	Williams, TM (corresponding author), Univ Calif Santa Cruz, Dept Biol, EMS-A316, Santa Cruz, CA 95064 USA.		Horning, Markus/I-3019-2015; Fuiman, Lee A/L-9514-2017	Horning, Markus/0000-0001-6178-4935; Fuiman, Lee A/0000-0003-2667-2684				AU D, 1980, NATURE, V284, P548, DOI 10.1038/284548a0; Butler PJ, 1997, PHYSIOL REV, V77, P837, DOI 10.1152/physrev.1997.77.3.837; CASTELLINI MA, 1992, J EXP BIOL, V165, P181; CASTELLINI MA, 1985, J APPL PHYSIOL, V58, P392, DOI 10.1152/jappl.1985.58.2.392; Crocker DE, 1997, CAN J ZOOL, V75, P27, DOI 10.1139/z97-004; Davis RW, 1999, SCIENCE, V283, P993, DOI 10.1126/science.283.5404.993; DAVIS RW, 1985, PHYSIOL ZOOL, V58, P590, DOI 10.1086/physzool.58.5.30158585; Fish FE, 1998, J EXP BIOL, V201, P2867; FISH FE, 1988, J EXP BIOL, V137, P157; HADRICH Y, 1997, NATURE, V388, P64; HOCHACHKA PW, 1986, FASEB J, V45, P2948; KOOYMAN GL, 1970, SCIENCE, V169, P82, DOI 10.1126/science.169.3940.82; Kooyman GL, 1998, ANNU REV PHYSIOL, V60, P19, DOI 10.1146/annurev.physiol.60.1.19; Lovvorn JR, 1999, J EXP BIOL, V202, P1741; Marshall GJ, 1998, MAR TECHNOL SOC J, V32, P11; PONGANIS PJ, 1990, CAN J ZOOL, V68, P2105, DOI 10.1139/z90-293; RIDGWAY SH, 1969, SCIENCE, V166, P1651, DOI 10.1126/science.166.3913.1651; RIDGWAY SH, 1979, SCIENCE, V206, P1182, DOI 10.1126/science.505001; SCHMIDTNIELSEN K, 1972, SCIENCE, V177, P222, DOI 10.1126/science.177.4045.222; Skrovan RC, 1999, J EXP BIOL, V202, P2749; STEPHENSON R, 1994, J EXP BIOL, V190, P155; Thompson D., 1993, Symposia of the Zoological Society of London, V66, P349; VIDELER J, 1985, J EXP BIOL, V119, P265; Webb PM, 1998, J EXP BIOL, V201, P2349; WEBB PW, 1999, THESIS U CALIFORNIA; WEIHS D, 1974, J THEOR BIOL, V48, P215, DOI 10.1016/0022-5193(74)90192-1; Williams T.M., 1993, Symposia of the Zoological Society of London, V66, P383; Williams TM, 1999, J EXP BIOL, V202, P2739; WILLIAMS TM, 1992, NATURE, V355, P821, DOI 10.1038/355821a0; Williams TM, 1999, PHILOS T R SOC B, V354, P193, DOI 10.1098/rstb.1999.0371	30	311	319	2	170	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					133	136		10.1126/science.288.5463.133	http://dx.doi.org/10.1126/science.288.5463.133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753116				2022-12-24	WOS:000086387700050
J	Butler, D; Pockley, P				Butler, D; Pockley, P			Cereal gene bank accepts need for patents ... as Monsanto makes rice genome public	NATURE			English	News Item																		1999, NATURE, V401, P102	1	3	4	0	2	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					534	534		10.1038/35007230	http://dx.doi.org/10.1038/35007230			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10787345	hybrid			2022-12-24	WOS:000086400100013
J	Zeki, S				Zeki, S			Abstraction and idealism - From Plato to Einstein: how do we acquire knowledge?	NATURE			English	Editorial Material									UCL, Wellcome Dept Cognit Neurol, London WC1E 6BT, England	University of London; University College London	Zeki, S (corresponding author), UCL, Wellcome Dept Cognit Neurol, Gower St, London WC1E 6BT, England.								0	6	7	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					547	547		10.1038/35007158	http://dx.doi.org/10.1038/35007158			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	303BC	10766218	Bronze			2022-12-24	WOS:000086400100027
J	Brinsden, PR; Appleton, TC; Murray, E; Hussein, M; Akagbosu, F; Marcus, SF				Brinsden, PR; Appleton, TC; Murray, E; Hussein, M; Akagbosu, F; Marcus, SF			Treatment by in vitro fertilisation with surrogacy: experience of one British centre	BRITISH MEDICAL JOURNAL			English	Article							INVITRO FERTILIZATION		Bourn Hall Clin, Cambridge CB3 7TR, England		Brinsden, PR (corresponding author), Bourn Hall Clin, Cambridge CB3 7TR, England.							*AM COLL OBST GYN, 1990, ETH ISS SURR MOTH; [Anonymous], GENESIS; [Anonymous], GENESIS, V21; [Anonymous], GENESIS; Blyth E., 1994, J REPROD INFANT PSYC, V12, P189, DOI DOI 10.1080/02646839408408885; BRAZIER M, 1998, SURROGACY REV UK HLT; Brinsden PR, 1999, TXB IN VITRO FERTILI, P361; *BRIT MED ASS, 1985, BMJ S, V291; *BRIT MED ASS, 1987, SURR MOTH REP BOARD; *BRIT MED ASS, 1985, BMJ S, V295; British Medical Association, 1996, CHANG CONC MOTH PRAC; British Medical Association, 1990, SURR ETH CONS REP WO; *DEP HLTH, 1997, SURR REV UK HLTH MIN; *ETH COMM AM FERT, 1986, FERTIL STERIL S1, V46, P62; *ETH COMM BOURN HA, GUID TREATM IN VITRO; FISHER S, 1991, PSYCHIATRY, V54, P13; MACNAMEE MC, 1999, TXB IN VITRO FERTILI, P91; MARCUS SF, 1993, HUM REPROD, V8, P238, DOI 10.1093/oxfordjournals.humrep.a138030; MARRS RP, 1993, AM J OBSTET GYNECOL, V168, P1858, DOI 10.1016/0002-9378(93)90702-K; SATHANANDAN M, 1991, HUM REPROD, V5, P1025; UTIAN WH, 1989, FERTIL STERIL, V52, P633	21	16	17	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 1	2000	320	7239					924	928		10.1136/bmj.320.7239.924	http://dx.doi.org/10.1136/bmj.320.7239.924			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	301YA	10742007	Green Published			2022-12-24	WOS:000086337100033
J	Smith, H; Pickering, RM; Struthers, A; Simpson, I; Mant, D				Smith, H; Pickering, RM; Struthers, A; Simpson, I; Mant, D			Biochemical diagnosis of ventricular dysfunction in elderly patients in general practice: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NATRIURETIC PEPTIDE; HEART-FAILURE; CARE	Objective To investigate die usefulness of measuring plasma concentrations of B type natriuretic peptide in the diagnosis of left ventricular systolic dysfunction ill an unselected group of elderly people. Design Observational study. Setting General practice with four centres in Poole, Dorset Participants 155 elderly patients aged 70 to 84 years. Main outcome measures Diagnostic characteristics of plasma B type natriuretic peptide measured by radioimmunoassay as a test for left ventricular systolic dysfunction assessed by echocardiograph): Results The median plasma concentration of B type natriuretic peptide was 39.3 pmol/l in patients with left ventricular systolic dysfunction and 15.8 pmol/l in those with normal function. The proportional area under the receiver operator curve was 0.85. At a cut-off point of 18.7 pmol/l the test sensitivity. was 92% and the predictive value 18%. Conclusions Plasma concentration of B type natriuretic peptide could be used effectively as an initial test in a community screening programme and, possibly, using a low cut-off point, as a means of ruling out left ventricular systolic dysfunction. It is, however, not a good test to "rule in" the diagnosis, and access to echocardiography remains essential for general practitioners to diagnose heart failure early.	Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; Univ Southampton, Southampton Gen Hosp, Southampton SO16 6YD, Hants, England; Univ Dundee, Ninewells Hosp & Med Sch, Dept Clin Pharmacol, Dundee DD1 9SY, Scotland; Southampton Gen Hosp, Wessex Cardiothorac Ctr, Dept Cardiol, Southampton, Hants, England; Univ Oxford, Div Publ Hlth & Primary Hlth Care, Inst Hlth Sci, Oxford OX3 7LF, England	University of Southampton; University of Southampton; University of Dundee; University of Southampton; University of Oxford	Smith, H (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	hes@soton.ac.uk	Mant, David CA/C-7763-2009; Smith, Helen E/M-2449-2016	Smith, Helen E/0000-0003-1883-6124; Struthers, Allan/0000-0002-2926-2528				Cowie MR, 1997, LANCET, V350, P1349, DOI 10.1016/S0140-6736(97)06031-5; DAVIDSON NC, 1995, CIRCULATION, V91, P1276; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; Morgan S, 1999, BRIT MED J, V318, P368, DOI 10.1136/bmj.318.7180.368; Omland T, 1998, LANCET, V351, P1063, DOI 10.1016/S0140-6736(05)79035-8; REMES J, 1991, EUR HEART J, V12, P315, DOI 10.1093/oxfordjournals.eurheartj.a059896; STRUTHERS AD, 1994, BMJ-BRIT MED J, V308, P1615, DOI 10.1136/bmj.308.6944.1615; SUDOH T, 1988, NATURE, V332, P78, DOI 10.1038/332078a0	8	75	82	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2000	320	7239					906	908		10.1136/bmj.320.7239.906	http://dx.doi.org/10.1136/bmj.320.7239.906			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	301YA	10741999	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000086337100024
J	Emery, P; Stanewsky, R; Hall, JC; Rosbash, M				Emery, P; Stanewsky, R; Hall, JC; Rosbash, M			Drosophila cryptochromes - A unique circadian-rhythm photoreceptor	NATURE			English	Article							CLOCK; PHOTOSENSITIVITY		Brandeis Univ, NSF Ctr Biol Timing, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; Univ Regensburg, Inst Zool, D-93040 Regensburg, Germany	Brandeis University; National Science Foundation (NSF); Brandeis University; Howard Hughes Medical Institute; University of Regensburg	Emery, P (corresponding author), Brandeis Univ, NSF Ctr Biol Timing, Dept Biol, Waltham, MA 02454 USA.		Stanewsky, Ralf/ABB-9193-2021	Stanewsky, Ralf/0000-0001-8238-6864				ASCHOFF J, 1979, Z TIERPSYCHOL, V49, P225; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; EWER J, 1992, J NEUROSCI, V12, P3321; KONOPKA RJ, 1989, J NEUROGENET, V6, P1, DOI 10.3109/01677068909107096; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; OHATA K, 1999, BIOL CLOCKS MECHANIS, P167; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114	10	197	204	6	39	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					456	457		10.1038/35006558	http://dx.doi.org/10.1038/35006558			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761904				2022-12-24	WOS:000086257700035
J	Benos, PV; Gatt, MK; Ashburner, M; Murphy, L; Harris, D; Barrell, B; Ferraz, C; Vidal, S; Brun, C; Demailles, J; Cadieu, E; Dreano, S; Gloux, S; Lelaure, V; Mottier, S; Galibert, F; Borkova, D; Minana, B; Kafatos, FC; Louis, C; Siden-Kiamos, I; Bolshakov, S; Papagiannakis, G; Spanos, L; Cox, S; Madueno, E; de Pablos, B; Modolell, J; Peter, A; Schottler, P; Werner, M; Mourkioti, F; Beinert, N; Dowe, G; Schafer, U; Jackle, H; Bucheton, A; Callister, DM; Campbell, LA; Darlamitsou, A; Henderson, NS; McMillan, PJ; Salles, C; Tait, EA; Valenti, P; Saunders, RDC; Glover, DM				Benos, PV; Gatt, MK; Ashburner, M; Murphy, L; Harris, D; Barrell, B; Ferraz, C; Vidal, S; Brun, C; Demailles, J; Cadieu, E; Dreano, S; Gloux, S; Lelaure, V; Mottier, S; Galibert, F; Borkova, D; Minana, B; Kafatos, FC; Louis, C; Siden-Kiamos, I; Bolshakov, S; Papagiannakis, G; Spanos, L; Cox, S; Madueno, E; de Pablos, B; Modolell, J; Peter, A; Schottler, P; Werner, M; Mourkioti, F; Beinert, N; Dowe, G; Schafer, U; Jackle, H; Bucheton, A; Callister, DM; Campbell, LA; Darlamitsou, A; Henderson, NS; McMillan, PJ; Salles, C; Tait, EA; Valenti, P; Saunders, RDC; Glover, DM			From sequence to chromosome: The tip of the X chromosome of D. melanogaster	SCIENCE			English	Editorial Material							DROSOPHILA-MELANOGASTER; TRANSPOSABLE ELEMENTS; PHYSICAL MAP; DNA; POPULATION; NUMBER; GENE	One of the rewards of having a Drosophila melanogaster whole-genome sequence will be the potential to understand the molecular bases for structural features of chromosomes that have been a Long-standing puzzle. Analysis of 2.6 megabases of sequence from the tip of the X chromosome of Drosophila identifies 273 genes. Cloned DNAs from the characteristic bulbous structure at the tip of the X chromosome in the region of the broad complex display an unusual pattern of in situ hybridization. Sequence analysis revealed that this region comprises 154 kilobases of DNA flanked by 1.2-kilobases of inverted repeats, each composed of a 350-base pair satellite related element. Thus, some aspects of chromosome structure appear to be revealed directly within the DNA sequence itself.	European Bioinformat Inst, Cambridge CB10 1SD, England; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Sanger Ctr, Cambridge CB10 1SA, England; Univ Montpellier, Sch Med, IGH, CNRS, F-34396 Montpellier 5, France; Fac Med, CNRS, Unite Propre Rech 41, F-35043 Rennes, France; European Mol Biol Lab, Heidelberg, Germany; Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Heraklion, Greece; Univ Crete, Dept Biol, Heraklion, Greece; Univ Autonoma Madrid, E-28049 Madrid, Spain; CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain; Max Planck Inst Biophys Chem, Dept Mol Dev Biol, D-37070 Gottingen, Germany; Univ Dundee, Dept Anat & Physiol, Canc Res Campaign, Cell Cycle Genet Grp, Dundee DD1 4HN, Scotland; Open Univ, Dept Biol Sci, Milton Keynes MK7 6AA, Bucks, England	European Molecular Biology Laboratory (EMBL); University of Cambridge; Wellcome Trust Sanger Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); Foundation for Research & Technology - Hellas (FORTH); University of Crete; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Max Planck Society; University of Dundee; Open University - UK	Benos, PV (corresponding author), European Bioinformat Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SD, England.		Louis, Christos/F-2527-2012; minana, belen/K-5530-2015; McMillan, Paul James/P-6441-2019; McMillan, Paul/B-5081-2008	minana, belen/0000-0001-7676-5788; McMillan, Paul James/0000-0001-5629-1175; Glover, David/0000-0003-0956-0103; Murphy, Lee/0000-0001-6467-7449; Benos, Panayiotis/0000-0003-3172-3132; Mourkioti, Foteini/0000-0002-7119-6640				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Ashburner M, 1999, GENETICS, V153, P179; Ashburner M., 1989, DROSOPHILA LAB HDB; BECKER HJ, 1959, CHROMOSOMA, V10, P654, DOI 10.1007/BF00396591; BRIDGES C. B., 1937, Cytologia, P745, DOI 10.1508/cytologia.FujiiJubilaei.745; Bridges CB, 1938, J HERED, V29, P11, DOI 10.1093/oxfordjournals.jhered.a104399; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Carson Hampton L., 1992, P441; CHARLESWORTH B, 1989, GENET RES, V54, P113, DOI 10.1017/S0016672300028482; DIBARTOLOMEIS SM, 1992, NUCLEIC ACIDS RES, V20, P1113, DOI 10.1093/nar/20.5.1113; GUBB D, 1990, GENETICS, V126, P167; Hoogland C, 1996, GENETICS, V144, P197; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; KASTRITSIS CD, 1986, CHROMOSOMA, V93, P381, DOI 10.1007/BF00327598; LANGLEY CH, 1988, GENET RES, V52, P223, DOI 10.1017/S0016672300027695; MADUENO E, 1995, GENETICS, V139, P1631; Morgan TH, 1910, SCIENCE, V32, P120, DOI 10.1126/science.32.812.120; OFFERMANN CA, 1936, J GENET, V32, P102; Parsons JD, 1995, COMPUT APPL BIOSCI, V11, P615; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SAUNDERS RDC, 1989, NUCLEIC ACIDS RES, V17, P9027, DOI 10.1093/nar/17.22.9027; SIDENKIAMOS I, 1990, NUCLEIC ACIDS RES, V18, P6261, DOI 10.1093/nar/18.21.6261; SNIEGOWSKI PD, 1994, GENETICS, V137, P815; Sonnhammer ELL, 1995, GENE, V167, pGC1, DOI 10.1016/0378-1119(95)00714-8; SORSA V, 1988, CHROMOSOME MAPS DROS, V1; STALKER HD, 1972, GENETICS, V70, P457; Sturtevant AH, 1913, J EXP ZOOL, V14, P43, DOI 10.1002/jez.1400140104; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4573; Tzolovsky G, 1999, GENETICS, V153, P1371; WARING GL, 1987, P NATL ACAD SCI USA, V84, P2843, DOI 10.1073/pnas.84.9.2843; ZHIMULEV IF, 1995, EUR J ENTOMOL, V92, P263; [No title captured]	32	22	153	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2220	2222		10.1126/science.287.5461.2220	http://dx.doi.org/10.1126/science.287.5461.2220			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731137				2022-12-24	WOS:000086049100038
J	Sun, ZM; Arendt, CW; Ellmeier, W; Schaeffer, EM; Sunshine, MJ; Gandhi, L; Annes, J; Petrzilka, D; Kupfer, A; Schwartzberg, PL; Littman, DR				Sun, ZM; Arendt, CW; Ellmeier, W; Schaeffer, EM; Sunshine, MJ; Gandhi, L; Annes, J; Petrzilka, D; Kupfer, A; Schwartzberg, PL; Littman, DR			PKC-theta is required for TCR-induced NF-kappa B activation in mature but not immature T lymphocytes	NATURE			English	Article							PROTEIN-KINASE-C; CELL ACTIVATION; SIGNAL-TRANSDUCTION; TRANSGENIC MICE; IL-2 PROMOTER; RECEPTOR; INTERLEUKIN-2; VAV; THYMOCYTES; EPSILON	Productive interaction of a T lymphocyte with an antigen-presenting cell results in the clustering of the T-cell antigen receptor (TCR) and the recruitment of a large signalling complex to the site of cell-cell contact(1,2). Subsequent signal transduction resulting in cytokine gene expression requires the activation of one or more of the multiple isoenzymes of serine/threonine-specific protein kinase C (PKC)(3). Among the several PKC isoenzymes expressed in T cells, PKC-theta is unique in being rapidly recruited to the site of TCR clustering(4). Here we show that PKC-theta is essential for TCR-mediated T-cell activation, but is dispensable during TCR-dependent thymocyte development. TCR-initiated NF-kappa B activation was absent from PKC-theta(-/-) mature T lymphocytes, but was intact in thymocytes. Activation of NF-kappa B by tumour-necrosis factor alpha and interleukin-1 was unaffected in the mutant mice. Although studies in T-cell lines had suggested that PKC-B regulates activation of the JNK signalling pathway(5,6), induction of JNK was normal in T cells from mutant mice. These results indicate that PKC-theta functions in a unique pathway that links the TCR signalling, complex to the activation of NF-kappa B in mature T lymphocytes.	NYU, Sch Med, Mol Pathogenesis Program, Sjirball Inst Biomol Med, New York, NY 10016 USA; NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; Natl Human Genome Res Inst, NIH, Bethesda, MD 20892 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Natl Jewish Med & Res Ctr, Dept Pediat, Div Basic Sci, Denver, CO 80262 USA	New York University; Howard Hughes Medical Institute; New York University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Chicago; National Jewish Health	Littman, DR (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Sjirball Inst Biomol Med, New York, NY 10016 USA.			Ellmeier, Wilfried/0000-0001-8192-8481; Sunshine, Mary Jean/0000-0002-2188-7881; Annes, Justin/0000-0001-8431-3589; Gandhi, Leena/0000-0002-2398-9179				Boothby MR, 1997, J EXP MED, V185, P1897, DOI 10.1084/jem.185.11.1897; Edwards AS, 1999, J BIOL CHEM, V274, P6461, DOI 10.1074/jbc.274.10.6461; Esslinger CW, 1998, MOL IMMUNOL, V35, P847, DOI 10.1016/S0161-5890(98)00071-6; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; GENOT EM, 1995, J BIOL CHEM, V270, P9833, DOI 10.1074/jbc.270.17.9833; Ghaffari-Tabrizi N, 1999, EUR J IMMUNOL, V29, P132; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hettmann T, 1999, J EXP MED, V189, P145, DOI 10.1084/jem.189.1.145; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JAIN J, 1992, J EXP MED, V175, P853, DOI 10.1084/jem.175.3.853; JAMIESON C, 1991, J IMMUNOL, V147, P416; KAWAKAMI Y, 1995, J IMMUNOL, V155, P3556; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Meller N, 1998, STEM CELLS, V16, P178, DOI 10.1002/stem.160178; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Monks CRF, 1997, NATURE, V385, P83, DOI 10.1038/385083a0; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NORTHROP JP, 1994, NATURE, V369, P497, DOI 10.1038/369497a0; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1; SMITH KA, 1989, ANNU REV CELL BIOL, V5, P397; VALGE VE, 1988, CELL, V55, P101, DOI 10.1016/0092-8674(88)90013-X; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Weiss L, 2000, J EXP MED, V191, P139, DOI 10.1084/jem.191.1.139; Werlen G, 1998, EMBO J, V17, P3101, DOI 10.1093/emboj/17.11.3101; Zandi E, 1999, MOL CELL BIOL, V19, P4547	28	762	802	0	23	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					402	407		10.1038/35006090	http://dx.doi.org/10.1038/35006090			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746729				2022-12-24	WOS:000086119000054
J	Gebo, DL; Dagosto, M; Beard, KC; Qi, T; Wang, JW				Gebo, DL; Dagosto, M; Beard, KC; Qi, T; Wang, JW			The oldest known anthropoid postcranial fossils and the early evolution of higher primates	NATURE			English	Article							EOCENE FISSURE-FILLINGS; MIDDLE EOCENE; ORIGINS; CHINA; FOOT; MORPHOLOGY; PROVINCE; SKULLS	The middle Eocene primate family Eosimiidae, which is known from sites in central and eastern China(1,2) and Myanmar(3), is central to efforts to reconstruct the origin and early evolution of anthropoid or 'higher' primates (monkeys, apes and humans)(1-6). Previous knowledge of eosimiid anatomy has been restricted to the dentition(3-3,7) and an isolated petrosal bone(5), and this limited anatomical information has led to conflicting interpretations of early anthropoid phylogeny(1-6,8,9). Here we describe foot bones of Eosimias from the same middle Eocene sites in China that yield abundant dental remains of this primate. Tarsals of Eosimias show derived anatomical traits that are otherwise restricted to living and fossil anthropoids. These new fossils substantiate the anthropoid status of Eosimias and clarify the phylogenetic position of anthropoids with respect to other major primate clades. Early anthropoids possessed a mosaic of primitive and derived traits in their postcranial skeletons, reflecting their derivation from haplorhine ancestors that retained marry prosimian-like features.	No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA; Northwestern Univ, Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; Carnegie Museum Nat Hist, Sect Vertebrate Paleontol, Pittsburgh, PA 15213 USA; Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Beijing 100044, Peoples R China	Northern Illinois University; Northwestern University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Gebo, DL (corresponding author), No Illinois Univ, Dept Anthropol, De Kalb, IL 60115 USA.		Beard, K. Christopher/AAQ-4438-2021	Beard, K. Christopher/0000-0002-6279-9837				Beard K. Christopher, 1994, P55; Beard KC, 1996, SCIENCE, V272, P82, DOI 10.1126/science.272.5258.82; BEARD KC, 1988, NATURE, V331, P712, DOI 10.1038/331712a0; BEARD KC, 1991, NATURE, V349, P64, DOI 10.1038/349064a0; BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Cartmill M., 1980, P243; Cartmill M., 1978, RECENT ADV PRIMATOL, P205; DAGOSTO M, 1992, INT J PRIMATOL, V13, P307, DOI 10.1007/BF02547818; DAGOSTO M, 1988, J HUM EVOL, V17, P35, DOI 10.1016/0047-2484(88)90048-6; Dagosto Marian, 1994, P567; Decker R.L., 1974, P261; FLEAGIE JG, 1999, PRIMATE ADAPTATION E; GEBO DL, 1986, J HUM EVOL, V15, P421, DOI 10.1016/S0047-2484(86)80025-2; GEBO DL, 1988, FOLIA PRIMATOL, V50, P3, DOI 10.1159/000156332; Gingerich P.D., 1980, P123; Godinot Marc, 1994, P235; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; LEWIS OJ, 1980, J ANAT, V131, P275; MacPhee RDE, 1995, J HUM EVOL, V29, P501, DOI 10.1006/jhev.1995.1073; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Rasmussen D. Tab, 1994, P335; RASMUSSEN DT, 1990, INT J PRIMATOL, V11, P439, DOI 10.1007/BF02196131; Rosenberger A.L., 1980, P139; Ross C, 1998, J HUM EVOL, V35, P221, DOI 10.1006/jhev.1998.0254; Ross Callum, 1994, P469; SIMONS EL, 1989, AM J PHYS ANTHROPOL, V79, P1, DOI 10.1002/ajpa.1330790103; SIMONS EL, 1995, SCIENCE, V268, P1885, DOI 10.1126/science.7604261; Swofford DL, 1998, PHYLOGENETIC ANAL US; TONG Y, 1997, PALEONTOLOGIA SINICA, V26, P1	30	54	57	2	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2000	404	6775					276	278		10.1038/35005066	http://dx.doi.org/10.1038/35005066			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	296JX	10749208				2022-12-24	WOS:000086022200046
J	Grigsby, PW; Siegel, BA; Baker, S; Eichling, JO				Grigsby, PW; Siegel, BA; Baker, S; Eichling, JO			Radiation exposure from outpatient radioactive iodine (I-131) therapy for thyroid carcinoma	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Context In May 1997, the US Nuclear Regulatory Commission (NRC) revised its patient release regulations, allowing for outpatient administration of larger activities of sodium iodide I-131 than previously permitted. Objective To measure the radiation exposure to household members from patients receiving outpatient I-131 therapy for thyroid carcinoma in accordance with the new regulations, Design Consecutive case series from October 1998 to June 1999. Setting and Patients Thirty patients who received outpatient I-131 therapy following thyroidectomy for differentiated thyroid carcinoma were enrolled, along with their 65 household members and 17 household pets. Main Outcome Measure Radiation exposure to household members and 4 rooms in each home, as monitored with dosimeters for 10 days following I-131 administration. Results The patients received I-131 doses ranging from 2.8 to 5.6 GBq (mean, 4.3 GBq). The radiation dose to 65 household members ranged from 0.01 mSv to 1.09 mSv (mean, 0.24 mSv). The dose to 17 household pets ranged from 0.02 mSv to 1.11 mSv (mean, 0.37 mSv). The mean dose to the 4 rooms ranged from 0.17 mSv (kitchen) to 0.58 mSv (bedroom). Conclusion In our study, I-131 doses to household members of patients receiving outpatient I-131 therapy were well below the limit (5.0 mSv) mandated by current NRC regulations.	Washington Univ, Sch Med, Edward Mallinckrodt Inst Radiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Grigsby, PW (corresponding author), Radiat Oncol Ctr, Box 8224,4939 Childrens Pl,Suite 5500, St Louis, MO 63110 USA.							CULVER CM, 1991, J NUCL MED, V32, P169; HARBERT JC, 1974, J NUCL MED, V15, P887; IBIS E, 1992, J NUCL MED, V33, P2110; JACOBSON AP, 1978, AM J PUBLIC HEALTH, V68, P225, DOI 10.2105/AJPH.68.3.225; *US NUCL REG COMM, 2000, REL PAT ADM RAD MAT; 1997, FED REG, V62, P4120	6	78	82	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2000	283	17					2272	2274		10.1001/jama.283.17.2272	http://dx.doi.org/10.1001/jama.283.17.2272			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307UB	10807387	Bronze			2022-12-24	WOS:000086671600035
J	Kant, AK; Schatzkin, A; Graubard, BI; Schairer, C				Kant, AK; Schatzkin, A; Graubard, BI; Schairer, C			A prospective study of diet quality and mortality in women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-HEALTH; RISK; QUESTIONNAIRE; MEN; DIVERSITY	Context Most studies of diet and health care have focused on the role of single nutrients, foods, or food groups in disease prevention or promotion. Few studies have addressed the health effects of dietary patterns, which include complex mixtures of foods containing multiple nutrients and nonnutrients. Objective To examine the association of mortality with a multifactorial diet quality index. Design and Setting Data from phase 2 (1987-1989) of a prospective cohort study of breast cancer screening, the Breast Cancer Detection Demonstration Project, with a median follow-up of 5.6 years. Participants A total of 42 254 women (mean age, 61.1 years) who completed the food frequency questionnaire portion of the survey. Main Outcome Measure All-cause mortality by quartile of Recommended Food Score (RFS; the sum of the number of foods recommended by current dietary guidelines [fruits, vegetables, whole grains, low-fat dairy, and lean meats and poultry] that were reported on the questionnaire to be consumed at least once a week, for a maximum score of 23). Results There were 2065 deaths due to all causes in the cohort. The RFS was inversely associated with all-cause mortality. Compared with those in the lowest quartile, subjects in the upper quartiles of the RFS had relative risks for all-cause mortality of 0.82 (95% confidence interval [CI], 0.73-0.92) for quartile 2, 0.71 (95% CI, 0.62-0.81) for quartile 3, and 0.69 (95% CI, 0.61-0.78) for quartile 4 adjusted for education, ethnicity, age, body mass index, smoking status, alcohol use, level of physical activity, menopausal hormone use, and history of disease (chi(1)(2) for trend = 35.64, P<.001 for trend). Conclusions These data suggest that a dietary pattern characterized by consumption of foods recommended in current dietary guidelines is associated with decreased risk of mortality in women.	NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; CUNY Queens Coll, Dept Family Nutr & Exercise Sci, Flushing, NY 11367 USA; NCI, Biostat Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; NCI, Environm Epidemiol Branch, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); City University of New York (CUNY) System; Queens College NY (CUNY); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Schatzkin, A (corresponding author), NCI, Nutr Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, 6120 Execut Blvd,EPS 7032, Bethesda, MD 20892 USA.			Kant, Ashima/0000-0003-4141-2063	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [Z01CP010118] Funding Source: NIH RePORTER	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)		Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; BINGHAM SA, 1994, AM J CLIN NUTR, V59, p227S, DOI 10.1093/ajcn/59.1.227S; BLACK AE, 1993, J AM DIET ASSOC, V93, P572, DOI 10.1016/0002-8223(93)91820-G; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; DURRLEMAN S, 1989, STAT MED, V8, P551, DOI 10.1002/sim.4780080504; Huijbregts P, 1997, BRIT MED J, V315, P13, DOI 10.1136/bmj.315.7099.13; KANT AK, 1993, AM J CLIN NUTR, V57, P434, DOI 10.1093/ajcn/57.3.434; Kant AK, 1996, J AM DIET ASSOC, V96, P785, DOI 10.1016/S0002-8223(96)00217-9; KANT AK, 1995, J AM COLL NUTR, V14, P233; Kant AK, 1997, NUTR RES, V17, P1443, DOI 10.1016/S0271-5317(97)00135-8; Kipnis V, 1999, AM J EPIDEMIOL, V150, P642, DOI 10.1093/oxfordjournals.aje.a010063; MARESPERLMAN JA, 1993, J NUTR, V123, P489, DOI 10.1093/jn/123.3.489; McCullough M, 1999, FASEB J, V13, pA932; MERTZ W, 1984, J AM DIET ASSOC, V84, P769; NUBE M, 1987, J AM DIET ASSOC, V87, P171; SEMPOS CT, 1992, AM J EPIDEMIOL, V135, P1127, DOI 10.1093/oxfordjournals.aje.a116212; SMUCKER R, 1989, AM J EPIDEMIOL, V129, P445, DOI 10.1093/oxfordjournals.aje.a115149; Yong LC, 1996, AM J EPIDEMIOL, V143, P985, DOI 10.1093/oxfordjournals.aje.a008681; [No title captured]; [No title captured]	20	401	419	0	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2000	283	16					2109	2115		10.1001/jama.283.16.2109	http://dx.doi.org/10.1001/jama.283.16.2109			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	305MA	10791502	Bronze			2022-12-24	WOS:000086542800026
J	Fritz, J; Baller, MK; Lang, HP; Rothuizen, H; Vettiger, P; Meyer, E; Guntherodt, HJ; Gerber, C; Gimzewski, JK				Fritz, J; Baller, MK; Lang, HP; Rothuizen, H; Vettiger, P; Meyer, E; Guntherodt, HJ; Gerber, C; Gimzewski, JK			Translating biomolecular recognition into nanomechanics	SCIENCE			English	Article							ATOMIC-FORCE MICROSCOPY; INDUCED SURFACE STRESS; DNA; OLIGONUCLEOTIDES; MOLECULES; GOLD	We report the specific transduction, via surface stress changes, of DNA hybridization and receptor-ligand binding into a direct nanomechanical response of microfabricated cantilevers. Cantilevers in an array were functionalized with a selection of biomolecules. The differential deflection of the cantilevers was found to provide a true molecular recognition signal despite Large nonspecific responses of individual cantilevers. Hybridization of complementary oligonucleotides shows that a single base mismatch between two 12-mer oligonucleotides is clearly detectable. Similar experiments on protein A-immunoglobulin interactions demonstrate the wide-ranging applicability of nanomechanical transduction to detect biomolecular recognition.	IBM Res, Zurich Res Lab, CH-8803 Ruschlikon, Switzerland; Univ Basel, Inst Phys, CH-4056 Basel, Switzerland	International Business Machines (IBM); University of Basel	Gerber, C (corresponding author), IBM Res, Zurich Res Lab, Saumerstr 4, CH-8803 Ruschlikon, Switzerland.		Gerber, Christoph E/G-4851-2011; Meyer, Ernst/L-3873-2016; Lang, Hans Peter/G-3884-2011	Meyer, Ernst/0000-0001-6385-3412; Lang, Hans Peter/0000-0002-0012-2564; gimzewski, james/0000-0003-4333-6957				Abel AP, 1996, ANAL CHEM, V68, P2905, DOI 10.1021/ac960071+; Baller MK, 2000, ULTRAMICROSCOPY, V82, P1, DOI 10.1016/S0304-3991(99)00123-0; Berger R, 1997, SCIENCE, V276, P2021, DOI 10.1126/science.276.5321.2021; Butt HJ, 1996, J COLLOID INTERF SCI, V180, P251, DOI 10.1006/jcis.1996.0297; CHEN GY, 1995, J APPL PHYS, V77, P3618, DOI 10.1063/1.359562; FLORIN EL, 1994, SCIENCE, V264, P415, DOI 10.1126/science.8153628; Fritz J, 1998, P NATL ACAD SCI USA, V95, P12283, DOI 10.1073/pnas.95.21.12283; IBACH H, 1994, J VAC SCI TECHNOL A, V12, P2240, DOI 10.1116/1.579122; KUO SC, 1993, SCIENCE, V260, P232, DOI 10.1126/science.8469975; LEE GU, 1994, SCIENCE, V266, P771, DOI 10.1126/science.7973628; Lundbaek JA, 1997, BIOCHEMISTRY-US, V36, P5695, DOI 10.1021/bi9619841; Miyatani T, 1997, J APPL PHYS, V81, P7099, DOI 10.1063/1.365306; Moulin AM, 1999, LANGMUIR, V15, P8776, DOI 10.1021/la990416u; Okahata Y, 1998, ANAL CHEM, V70, P1288, DOI 10.1021/ac970584w; Rekesh D, 1996, BIOPHYS J, V71, P1079, DOI 10.1016/S0006-3495(96)79308-6; RICHMAN DD, 1982, J IMMUNOL, V128, P2300; Safran SA, 1999, ADV PHYS, V48, P395, DOI 10.1080/000187399243428; SMITH SB, 1992, SCIENCE, V258, P1122, DOI 10.1126/science.1439819; Vettiger P, 1999, MICROELECTRON ENG, V46, P11, DOI 10.1016/S0167-9317(99)00006-4; Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039	20	1396	1504	4	269	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					316	318		10.1126/science.288.5464.316	http://dx.doi.org/10.1126/science.288.5464.316			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764640				2022-12-24	WOS:000086454300031
J	Lebestky, T; Chang, T; Hartenstein, V; Banerjee, U				Lebestky, T; Chang, T; Hartenstein, V; Banerjee, U			Specification of Drosophila hematopoietic lineage by conserved transcription factors	SCIENCE			English	Article							CHROMOSOMAL TRANSLOCATIONS; CELL LINEAGE; DIFFERENTIATION; LEUKEMIA; LOZENGE; SWITCH; BLOOD; AML1; EYE	Two major classes of cells observed within the Drosophila hematopoietic repertoire are plasmatocytes/macrophages and crystal cells. The transcription factor Lz (Lozenge), which resembles human AML1 (acute myeloid leukemia-1) protein, is necessary for the development of crystal cells during embryonic and larval hematopoiesis. Another transcription factor, Gcm (glial cells missing), has previously been shown to be required for plasmatocyte development. Misexpression of Gcm causes crystal cells to be transformed into plasmatocytes. The Drosophila GATA protein Srp (Serpent) is required for both Lz and Gcm expression and is necessary for the development of both classes of hemocytes, whereas Lz and Gcm are required in a lineage-specific manner. Given the similarities of Srp and Lz to; mammalian GATA and AML1 proteins, observations in Drosophila are Likely to have broad implications for understanding mammalian hematopoiesis and leukemias.	Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Lebestky, T (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu			NEI NIH HHS [R01EY08152] Funding Source: Medline; NIGMS NIH HHS [GM07185] Funding Source: Medline; NINDS NIH HHS [NS29367] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY008152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS029367, R56NS029367] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Bae SC, 1999, HISTOL HISTOPATHOL, V14, P1213, DOI 10.14670/HH-14.1213; Bernardoni R, 1997, DEV BIOL, V191, P118; Daga A, 1996, GENE DEV, V10, P1194, DOI 10.1101/gad.10.10.1194; Dearolf CR, 1998, BBA-REV CANCER, V1377, pM13, DOI 10.1016/S0304-419X(97)00031-0; Flores GV, 1998, DEVELOPMENT, V125, P3681; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kanemura Y, 1999, FEBS LETT, V442, P151, DOI 10.1016/S0014-5793(98)01650-0; Kim JS, 1998, P NATL ACAD SCI USA, V95, P12364, DOI 10.1073/pnas.95.21.12364; Mathey-Prevot B, 1998, CELL, V92, P697, DOI 10.1016/S0092-8674(00)81396-3; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Orkin SH, 1998, INT J DEV BIOL, V42, P927; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rehorn KP, 1996, DEVELOPMENT, V122, P4023; Riechmann V, 1998, DEVELOPMENT, V125, P713; RIZKI T M, 1981, Genetics, V97, pS90; RIZKI TM, 1980, ROUX ARCH DEV BIOL, V188, P91, DOI 10.1007/BF00848799; RIZKI TM, 1978, GENETICS BIOL DROS B, V2, P398; RUGENDORFF A, 1994, ROUX ARCH DEV BIOL, V203, P266, DOI 10.1007/BF00360522; SHRESTHA R, 1982, DEV GROWTH DIFFER, V24, P65; Sieweke MH, 1998, CURR OPIN GENET DEV, V8, P545, DOI 10.1016/S0959-437X(98)80009-9; Speck NA, 1999, CANCER RES, V59, p1789S; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444	29	361	376	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 7	2000	288	5463					146	149		10.1126/science.288.5463.146	http://dx.doi.org/10.1126/science.288.5463.146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753120				2022-12-24	WOS:000086387700054
J	Murtagh, GJ; Dyer, PS; Crittenden, PD				Murtagh, GJ; Dyer, PS; Crittenden, PD			Reproductive systems - Sex and the single lichen	NATURE			English	Article							EVOLUTION; ISLAND; PLANTS		Univ Nottingham, Sch Biol Sci, Nottingham NG7 2RD, England	University of Nottingham	Murtagh, GJ (corresponding author), Univ Nottingham, Sch Biol Sci, Univ Pk, Nottingham NG7 2RD, England.			Dyer, Paul/0000-0003-0237-026X				BURNETT JH, 1975, MYCOGENETICS INTRO G; FAHSELT D, 1989, LICHENOLOGIST, V21, P343, DOI 10.1017/S0024282989000587; HESTMARK G, 1992, OECOLOGIA, V92, P305, DOI 10.1007/BF00317455; JAHNS H. M., 1997, BIBLIOTHECA LICHENOL, V67, P49; JAIN SK, 1976, ANNU REV ECOL SYST, V7, P469, DOI 10.1146/annurev.es.07.110176.002345; JARNE P, 1993, ANNU REV ECOL SYST, V24, P441, DOI 10.1146/annurev.es.24.110193.002301; Kershaw K.A., 1985, PHYSL ECOLOGY LICHEN, DOI 10.2307/3243300; Maynard Smith J., 1978, EVOLUTION SEX; Murtagh GJ, 1999, LICHENOLOGIST, V31, P257; Purvis O.W., 1992, LICHEN FLORA GREAT B; Richards A.J, 1997, PLANT BREEDING SYSTE; SANCHO LG, 1993, POLAR BIOL, V13, P227; WEISING K, 1995, FINGERPRINTING PLANT	13	83	86	1	25	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					564	564		10.1038/35007142	http://dx.doi.org/10.1038/35007142			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766229				2022-12-24	WOS:000086400100040
J	Davenport, RJ; Wuite, GJL; Landick, R; Bustamante, C				Davenport, RJ; Wuite, GJL; Landick, R; Bustamante, C			Single-molecule study of transcriptional pausing and arrest by E-coli RNA polymerase	SCIENCE			English	Article							DNA; FORCE; BACTERIOPHAGE-T7; TERMINATION; MICROSCOPY; REGION	Using an optical-trap/flow-control video microscopy technique, we followed transcription by single molecules of Escherichia coli RNA polymerase in real time over long template distances. These studies reveal that RNA polymerase molecules possess different intrinsic transcription rates and different propensities to pause and stop. The data also show that reversible pausing is a kinetic intermediate between normal elongation and the arrested state. The conformational metastability of RNA polymerase revealed by this single-molecule study of transcription has direct implications for the mechanisms of gene regulation in both bacteria and eukaryotes.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Wisconsin System; University of Wisconsin Madison; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Bustamante, C (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	carlos@alice.berkeley.edu		Bustamante, Carlos/0000-0002-2970-0073; wuite, gijs/0000-0002-5706-043X	NIGMS NIH HHS [GM-32543, GM-38660] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038660, R01GM032543, R01GM038660, R37GM032543, R29GM038660] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0; KABATA H, 1993, SCIENCE, V262, P1561, DOI 10.1126/science.8248804; Kasas S, 1997, BIOCHEMISTRY-US, V36, P461, DOI 10.1021/bi9624402; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; KORNISSAROVA N, 1997, J BIOL CHEM, V272, P15329; Landick R, 1997, CELL, V88, P741, DOI 10.1016/S0092-8674(00)81919-4; Landick R, 1999, SCIENCE, V284, P598, DOI 10.1126/science.284.5414.598; LEE DN, 1992, J MOL BIOL, V228, P759, DOI 10.1016/0022-2836(92)90862-E; LEVIN JR, 1987, J MOL BIOL, V196, P61, DOI 10.1016/0022-2836(87)90511-0; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Palangat M, 1998, MOL CELL, V1, P1033, DOI 10.1016/S1097-2765(00)80103-3; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Wuite GJL, 2000, NATURE, V404, P103, DOI 10.1038/35003614; XUE QF, 1995, NATURE, V373, P681, DOI 10.1038/373681a0; YAGER TD, 1987, CELLULAR MOL BIOL, P1241; YIN H, 1995, SCIENCE, V270, P1653, DOI 10.1126/science.270.5242.1653; Yin H, 1999, P NATL ACAD SCI USA, V96, P13124, DOI 10.1073/pnas.96.23.13124; YIN H, 1994, BIOPHYS J, V67, P2468, DOI 10.1016/S0006-3495(94)80735-0	22	266	279	0	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 31	2000	287	5462					2497	2500		10.1126/science.287.5462.2497	http://dx.doi.org/10.1126/science.287.5462.2497			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741971				2022-12-24	WOS:000086202200048
J	Abbott, A				Abbott, A			German researchers seek legal backing for stem cell work	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					424	424		10.1038/35006702	http://dx.doi.org/10.1038/35006702			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10787340	Bronze			2022-12-24	WOS:000086257700004
J	Goldman, JM				Goldman, JM			Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia	LANCET			English	Editorial Material							ABL-POSITIVE CELLS; LEUKEMIA; GROWTH		Hammersmith Hosp, Imperial Coll, Sch Med, Dept Haematol, London W12 0NN, England	Imperial College London	Goldman, JM (corresponding author), Hammersmith Hosp, Imperial Coll, Sch Med, Dept Haematol, London W12 0NN, England.							Buchdunger E, 1996, CANCER RES, V56, P100; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Deininger MWN, 1997, BLOOD, V90, P3691, DOI 10.1182/blood.V90.9.3691; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; le Coutre P, 1999, J NATL CANCER I, V91, P163, DOI 10.1093/jnci/91.2.163; Melo JV, 1996, LEUKEMIA, V10, P751; NOWELL PC, 1960, SCIENCE, V132, P1497; ROWLEY D, 1973, NATURE, V43, P290	8	42	46	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1031	1032		10.1016/S0140-6736(00)02029-8	http://dx.doi.org/10.1016/S0140-6736(00)02029-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744084				2022-12-24	WOS:000086380800005
J	Myers, EW; Sutton, GG; Delcher, AL; Dew, IM; Fasulo, DP; Flanigan, MJ; Kravitz, SA; Mobarry, CM; Reinert, KHJ; Remington, KA; Anson, EL; Bolanos, RA; Chou, HH; Jordan, CM; Halpern, AL; Lonardi, S; Beasley, EM; Brandon, RC; Chen, L; Dunn, PJ; Lai, ZW; Liang, Y; Nusskern, DR; Zhan, M; Zhang, Q; Zheng, XQ; Rubin, GM; Adams, MD; Venter, JC				Myers, EW; Sutton, GG; Delcher, AL; Dew, IM; Fasulo, DP; Flanigan, MJ; Kravitz, SA; Mobarry, CM; Reinert, KHJ; Remington, KA; Anson, EL; Bolanos, RA; Chou, HH; Jordan, CM; Halpern, AL; Lonardi, S; Beasley, EM; Brandon, RC; Chen, L; Dunn, PJ; Lai, ZW; Liang, Y; Nusskern, DR; Zhan, M; Zhang, Q; Zheng, XQ; Rubin, GM; Adams, MD; Venter, JC			A whole-genome assembly of Drosophila	SCIENCE			English	Review							SHOTGUN	We report on the quality of a whole-genome assembly of Drosophila melanogaster and the nature of the computer algorithms that accomplished it. Three independent external data sources essentially agree with and support the assembly's sequence and ordering of contigs across the euchromatic portion of the genome. In addition, there are isolated contigs that we believe represent nonrepetitive pockets within the heterochromatin of the centromeres. Comparison with a previously sequenced 2.9-megabase region indicates that sequencing accuracy within nonrepetitive segments is greater than 99.99% without manual curation. As such, this initial reconstruction of the Drosophila sequence should be of substantial value to the scientific community.	Celera Genom Inc, Rockville, MD 20850 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Myers, EW (corresponding author), Celera Genom Inc, 45 W Gude Dr, Rockville, MD 20850 USA.	Myers@celera.com	Reinert, Knut/V-3327-2019; Lonardi, Stefano/AAO-8070-2020	Reinert, Knut/0000-0003-3078-8129; Lonardi, Stefano/0000-0002-2696-7274; Rubin, Gerald/0000-0001-8762-8703				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Ashburner M, 1999, GENETICS, V153, P179; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; CHURCHILL G, 1982, GENOMICS, V14, P89; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Green P, 1997, GENOME RES, V7, P410, DOI 10.1101/gr.7.5.410; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; Mewes HW, 1997, NATURE, V387, P7, DOI 10.1038/387s007; MYERS EW, 1995, J COMP BIOL, V2, P2; MYERS EW, 1999, P 7 INT C INT SYST M; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SANGER F, 1982, J MOL BIOL, V162, P4; SANGER F, 1977, P NATL ACAD SCI USA, V74, P12; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401	20	1083	1146	5	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2196	2204		10.1126/science.287.5461.2196	http://dx.doi.org/10.1126/science.287.5461.2196			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731133				2022-12-24	WOS:000086049100034
J	Adams, MM; Elam-Evans, LD; Wilson, HG; Gilbertz, DA				Adams, MM; Elam-Evans, LD; Wilson, HG; Gilbertz, DA			Rates of and factors associated with recurrence of preterm delivery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LINKING VITAL RECORDS; GESTATIONAL-AGE; REPRODUCTIVE HISTORIES; BIRTH; OUTCOMES; RISK; PREGNANCIES; PREDICTION; COHORT	Context Information about risk of recurrent preterm delivery is useful to clinicians, researchers, and policy makers for counseling, generating etiologic leads, and measuring the related public health burden. Objectives To identify the rate of recurrence of preterm delivery in second pregnancies, factors associated with recurrence, and the percentage of preterm deliveries in women with a history of preterm delivery. Design and Setting Population-based cohort study of data from birth and fetal death certificates from the state of Georgia between 1980 and 1995. Subjects A total of 122 722 white and 56 174 black women with first and second singleton deliveries at 20 to 44 weeks' gestation. Main Outcome Measure Length of gestation (categorized as 20-31, 32-36, or greater than or equal to 37 weeks) at second delivery compared with length of gestation at first delivery, by age and race. Results Most women whose first delivery was preterm subsequently had term deliveries. Of 1023 white women whose first delivery occurred at 20 to 31 weeks, 8.2% (95% confidence interval [CI], 6.6%-10.1%) delivered their second birth at 20 to 31 weeks and 20.1% (95 % CI, 17.7%-22.8%) at 32 to 36 weeks. Of 1084 comparable black women, 13.4% (95% CI, 11.4%-15.6%) delivered at 20 to 31 weeks and 23.4% (95% CI, 20.9%-26.1%) delivered at 32 to 36 weeks. Among women whose first delivery occurred at 32 to 36 weeks, all corresponding rates were lower than those whose first birth was at 20 to 31 weeks; the rates of second birth at 20 to 31 weeks were substantially lower (for white women, 1.9% [95% CI, 1.7%-2.2%]; for black women, 3.8% [95% CI, 3.4%-4.2%]). Compared with women aged 20 to 49 years at their second delivery, women younger than 18 years had twice the risk of recurrence of delivery at 20 to 31 weeks. Of all second deliveries at 20 to 31 weeks, 29.4% for white women and 37.8% for black women were preceded by a preterm delivery. Conclusions Our data suggest that recurrence of preterm delivery contributes a notable portion of all preterm deliveries, especially at the shortest gestations.	Ctr Dis Control & Prevent, Div Reprod Hlth, WHO, Collaborating Ctr Perinatal Care & Hlth Serv Res, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA; World Health Organization	Adams, MM (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, WHO, Collaborating Ctr Perinatal Care & Hlth Serv Res, MS E 52,1600 Clifton Rd, Atlanta, GA 30333 USA.	mma1@cdc.gov		Elam-Evans, Laurie/0000-0003-1313-5484				Adams MM, 1997, AM J EPIDEMIOL, V145, P339; ADAMS MM, 1991, INT J EPIDEMIOL, V20, P950, DOI 10.1093/ije/20.4.950; Adams MM, 1997, PAEDIATR PERINAT EP, V11, P78, DOI 10.1111/j.1365-3016.1997.tb00799.x; Adams MM, 1997, PAEDIATR PERINAT EP, V11, P1; ALEXANDER GR, 1995, PUBLIC HEALTH REP, V110, P395; Baker RK, 1997, MEDIA STUD J, V11, P1; BAKKETEIG LS, 1979, AM J OBSTET GYNECOL, V135, P1086, DOI 10.1016/0002-9378(79)90742-7; BLANKSON ML, 1993, JAMA-J AM MED ASSOC, V269, P1401, DOI 10.1001/jama.269.11.1401; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P185; Cnattingius S, 1999, NEW ENGL J MED, V341, P943, DOI 10.1056/NEJM199909233411303; Emery ES, 1997, PAEDIATR PERINAT EP, V11, P313; Goldenberg RL, 1998, NEW ENGL J MED, V339, P313, DOI 10.1056/NEJM199807303390506; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; IAMS JD, 1995, AM J OBSTET GYNECOL, V172, P1097, DOI 10.1016/0002-9378(95)91469-2; Iams JD, 1998, AM J OBSTET GYNECOL, V178, P1035, DOI 10.1016/S0002-9378(98)70544-7; Kramer MS, 1998, JAMA-J AM MED ASSOC, V280, P1849, DOI 10.1001/jama.280.21.1849; KRISTENSEN J, 1995, OBSTET GYNECOL, V86, P800, DOI 10.1016/0029-7844(95)00275-V; Mercer B., 1995, American Journal of Obstetrics and Gynecology, V172, P404; Schieve LA, 1996, OBSTET GYNECOL, V88, P356, DOI 10.1016/0029-7844(96)00203-7; Ventura S J, 1999, Natl Vital Stat Rep, V47, P1; Winkvist A, 1998, INT J EPIDEMIOL, V27, P248, DOI 10.1093/ije/27.2.248; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	22	210	212	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2000	283	12					1591	1596		10.1001/jama.283.12.1591	http://dx.doi.org/10.1001/jama.283.12.1591			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MV	10735396	Bronze			2022-12-24	WOS:000085857300036
J	Edwards, KJ; Bond, PL; Gihring, TM; Banfield, JF				Edwards, KJ; Bond, PL; Gihring, TM; Banfield, JF			An archaeal iron-oxidizing extreme acidophile important in acid mine drainage	SCIENCE			English	Article							AQUEOUS PYRITE OXIDATION; FAM-NOV; GEN-NOV; ENVIRONMENT; DIVERSITY	A new species of Archaea grows at pH similar to 0.5 and similar to 40 degrees C in slime streamers and attached to pyrite surfaces at a sulfide ore body, Iron Mountain, California. This iron-oxidizing Archaeon is capable of growth at pH 0. This species represents a dominant prokaryote in the environment studied (slimes and sediments) and constituted up to 85% of the microbial community when solution concentrations were high (conductivity of 100 to 160 millisiemens per centimeter). The presence of this and other closely related Thermoplasmales suggests that these acidophiles are important contributors to acid mine drainage and may substantially impact iron and sulfur cycles.	Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA; Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	Woods Hole Oceanographic Institution; University of Wisconsin System; University of Wisconsin Madison	Edwards, KJ (corresponding author), Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA.		Bond, Philip/C-6046-2009; Bond, Philip/N-6649-2017	Bond, Philip/0000-0002-9025-4797; Banfield, Jill/0000-0001-8203-8771				Barker WW, 1998, AM MINERAL, V83, P1551, DOI 10.2138/am-1998-11-1243; BARNS SM, 1994, P NATL ACAD SCI USA, V91, P1609, DOI 10.1073/pnas.91.5.1609; Benson DA, 1998, NUCLEIC ACIDS RES, V26, P1, DOI 10.1093/nar/26.1.1; BOND P, UNPUB; Brimblecombe P, 1989, EVOLUTION GLOBAL BIO, P77; Edwards KJ, 1998, AM MINERAL, V83, P1444, DOI 10.2138/am-1998-11-1233; Edwards KJ, 1999, APPL ENVIRON MICROB, V65, P3627; EDWARDS KJ, 1999, THESIS WISCONSIN MAD; GOLYSHINA OV, IN PRESS INT J SYST; Hugenholtz P, 1998, J BACTERIOL, V180, P4765, DOI 10.1128/JB.180.18.4765-4774.1998; KAPUSCINSKI J, 1995, BIOTECH HISTOCHEM, V70, P220, DOI 10.3109/10520299509108199; LATHE R, 1985, J MOL BIOL, V183, P1, DOI 10.1016/0022-2836(85)90276-1; LUTHER GW, 1987, GEOCHIM COSMOCHIM AC, V51, P3193, DOI 10.1016/0016-7037(87)90127-X; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; MOSES CO, 1987, GEOCHIM COSMOCHIM AC, V51, P1561, DOI 10.1016/0016-7037(87)90337-1; Nordstrom DK, 2000, ENVIRON SCI TECHNOL, V34, P254, DOI 10.1021/es990646v; Nordstrom DK, 1999, P NATL ACAD SCI USA, V96, P3455, DOI 10.1073/pnas.96.7.3455; Nordstrom DK, 1997, REV MINERAL, V35, P361; Schleper C, 1996, INT J SYST BACTERIOL, V46, P814, DOI 10.1099/00207713-46-3-814; SCHLEPER C, 1995, J BACTERIOL, V177, P7050, DOI 10.1128/jb.177.24.7050-7059.1995; Schrenk MO, 1998, SCIENCE, V279, P1519, DOI 10.1126/science.279.5356.1519; SILVERMAN M. P., 1964, Advances in Applied Microbiology, V6, P153, DOI 10.1016/S0065-2164(08)70626-9; Staley JT, 1999, ASM NEWS, V65, P681; van de Vossenberg JLCM, 1998, EXTREMOPHILES, V2, P163, DOI 10.1007/s007920050056; Vasquez M, 1999, FEMS MICROBIOL LETT, V173, P183, DOI 10.1111/j.1574-6968.1999.tb13500.x; WILLIAMSON MA, 1994, GEOCHIM COSMOCHIM AC, V58, P5443, DOI 10.1016/0016-7037(94)90241-0	26	390	423	6	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1796	1799		10.1126/science.287.5459.1796	http://dx.doi.org/10.1126/science.287.5459.1796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710303				2022-12-24	WOS:000085775300035
J	Thomas, PC; Malin, MC; Edgett, KS; Carr, MH; Hartmann, WK; Ingersoll, AP; James, PB; Soderblom, LA; Veverka, J; Sullivan, R				Thomas, PC; Malin, MC; Edgett, KS; Carr, MH; Hartmann, WK; Ingersoll, AP; James, PB; Soderblom, LA; Veverka, J; Sullivan, R			North-south geological differences between the residual polar caps on Mars	NATURE			English	Article							VIKING; REGION; DEPOSITS	Polar processes can be sensitive indicators of global climate, and the geological features associated with polar ice caps can therefore indicate evolution of climate with time. The polar regions on Mars have distinctive morphologic and climatologic features: thick layered deposits, seasonal CO2 frost caps extending to mid latitudes, and near-polar residual frost deposits that survive the summer(1,2). The relationship of the seasonal and residual frost caps to the layered deposits has been poorly constrained(3,4), mainly by the limited spatial resolution of the available data. In particular, it has not been known if the residual caps represent simple thin frost cover or substantial geologic features. Here we show that the residual cap on the south pole is a distinct geologic unit with striking collapse and erosional topography; this is very different from the residual cap on the north pole, which grades into the underlying layered materials. These findings indicate that the differences between the caps are substantial (rather than reflecting short-lived differences in frost cover), and so support the idea of long-term asymmetry in the polar climates of Mars.	Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA; Malin Space Sci Syst, San Diego, CA 92191 USA; US Geol Survey, Menlo Park, CA 94025 USA; CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; Planetary Sci Inst, Tucson, AZ 85719 USA; Univ Toledo, Dept Phys & Astron, Toledo, OH 43606 USA; US Geol Survey, Flagstaff, AZ 86001 USA	Cornell University; United States Department of the Interior; United States Geological Survey; California Institute of Technology; University System of Ohio; University of Toledo; United States Department of the Interior; United States Geological Survey	Thomas, PC (corresponding author), Cornell Univ, Ctr Radiophys & Space Res, Ithaca, NY 14853 USA.			Edgett, Kenneth/0000-0001-7197-5751				CUTTS JA, 1982, ICARUS, V50, P216, DOI 10.1016/0019-1035(82)90124-5; FARMER CB, 1976, SCIENCE, V194, P1339, DOI 10.1126/science.194.4271.1339; HERKENHOFF KE, IN PRESS ICARUS; HOWARD AD, 1982, ICARUS, V50, P161, DOI 10.1016/0019-1035(82)90123-3; Jakosky B. M., 1992, MARS, P969; JAMES PB, 1979, J GEOPHYS RES, V84, P2889, DOI 10.1029/JB084iB06p02889; JAMES PB, 1992, MARS, P934; Kieffer H. H., 1992, MARS, P1180; KIEFFER HH, 1979, J GEOPHYS RES, V84, P8263, DOI 10.1029/JB084iB14p08263; KIEFFER HH, UNPUB J GEOPHYS RES; Malin MC, 1998, SCIENCE, V279, P1681, DOI 10.1126/science.279.5357.1681; MALIN MC, 2000, LUNAR PLANET SCI, V34; Mellon MT, 1997, J GEOPHYS RES-PLANET, V102, P25617, DOI 10.1029/97JE02582; Mellon MT, 1996, ICARUS, V124, P268, DOI 10.1006/icar.1996.0203; MUHLEMAN DO, 1995, ANNU REV EARTH PL SC, V23, P337, DOI 10.1146/annurev.earth.23.1.337; PAIGE DA, 1994, J GEOPHYS RES-PLANET, V99, P25993, DOI 10.1029/93JE03429; PLAUT JJ, 1988, ICARUS, V76, P357, DOI 10.1016/0019-1035(88)90076-0; POLLACK JB, 1979, J GEOPHYS RES, V84, P2929, DOI 10.1029/JB084iB06p02929; SCHENK PM, INPRESS J GEOPHYS RE; Smith DE, 1999, SCIENCE, V284, P1495, DOI 10.1126/science.284.5419.1495; Thomas P., 1992, MARS, P767; TOON OB, 1980, ICARUS, V44, P552, DOI 10.1016/0019-1035(80)90130-X; Ward W. R., 1992, MARS, P298; Zuber MT, 1998, SCIENCE, V282, P2053, DOI 10.1126/science.282.5396.2053	24	88	88	1	14	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					161	164		10.1038/35004528	http://dx.doi.org/10.1038/35004528			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724162				2022-12-24	WOS:000085870900043
J	Winker, K				Winker, K			Evolution - Migration and speciation	NATURE			English	Article									Univ Alaska Museum, Fairbanks, AK 99775 USA	University of Alaska System; University of Alaska Fairbanks	Winker, K (corresponding author), Univ Alaska Museum, 907 Yukon Dr, Fairbanks, AK 99775 USA.		Winker, Kevin/M-2042-2014	Winker, Kevin/0000-0002-8985-8104				Bohning-Gaese K, 1998, EVOL ECOL, V12, P767, DOI 10.1023/A:1006538414645; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; Darwin C., 1859, ORIGIN SPECIES FACSI; Dieckmann U, 1999, NATURE, V400, P354, DOI 10.1038/22521; DILGER W. C., 1956, AUK, V73, P313; Grinnell J., 1922, Auk Lancaster Pa, V39, P373; Groth JG, 1993, U CALIFORNIA PUBLICA, V127, P1; Helbig AJ, 1996, IBIS, V138, P650, DOI 10.1111/j.1474-919X.1996.tb04767.x; Kondrashov AS, 1999, NATURE, V400, P351, DOI 10.1038/22514; Mayr E., 1963, ANIMAL SPECIES EVOLU; Mengel R. M., 1964, LIVING BIRD, V3, P9; Montgomery Jr T. H, 1896, AM NAT, P458; RICHMAN AD, 1996, EVOLUTION, V50, P767	13	51	52	0	19	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					36	36		10.1038/35003651	http://dx.doi.org/10.1038/35003651			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716433	Bronze			2022-12-24	WOS:000085775100035
J	Spillman, BC; Lubitz, J				Spillman, BC; Lubitz, J			The effect of longevity on spending for acute and long-term care.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NURSING-HOME CARE; EXPENDITURES; PERSPECTIVE; TRENDS; AGE	Background: The proportion of the population made up of elderly persons in the United States is projected to increase from 13 percent of the population in 2000 to 20 percent by 2030. The implications for health care expenditures may be profound, because elderly persons use health care services at a greater rate than younger persons. We estimated total expenditures for acute and long-term care from the age of 65 years until death and in the last two years of life. Methods: We combined data from Medicare, the National Mortality Followback Survey, and the National Medical Expenditure Survey to estimate total national expenditures for health care according to the age at death. We also simulated expenditures with the use of projected demographic characteristics of two cohorts: people turning 65 in 2000 and those turning 65 in 2015. Results: Total expenditures (in 1996 dollars) from the age of 65 years until death increase substantially with longevity, from $31,181 for persons who die at the age of 65 years to more than $200,000 for those who die at the age of 90, in part because of steep increases in nursing home expenditures for very old persons. Spending in the last two years of life also increases with longevity, but a reduction in Medicare expenditures ($37,000 for persons who die at the age of 75 years and $21,000 for those who die at the age of 95) moderates the effect of the increase in nursing home expenditures ($6,000 for those who die at the age of 75 years and $32,000 for those who die at the age of 95). Health care spending for women is consistently higher than that for men, after adjustment for the increased longevity of women. Simulations show that increased longevity after the age of 65 years has a relatively small effect on the anticipated increase in spending, especially for services covered by Medicare, from 2000 to 2015. The effects of the larger number of people born in 1950 than in 1935 and the larger number of people surviving to the age of 65 years are much more important. Conclusions: In the United States, the effect of longevity on expenditures for acute care differs from its effect on expenditures for long-term care. Acute care expenditures, principally for hospital care and physicians' services, increase at a reduced rate as the age at death increases, whereas expenditures for long-term care increase at an accelerated rate. Increases in longevity after the age of 65 years may result in greater spending for long-term care, but the increase in the number of elderly persons has a more important effect on total spending. (N Engl J Med 2000;342:1409-15.) (C)2000, Massachusetts Medical Society.	Urban Inst, Ctr Hlth Policy, Washington, DC 20037 USA; Natl Ctr Hlth Stat, Off Anal Epidemiol & Hlth Promot, Hyattsville, MD USA; US Hlth Care Financing Adm, Off Strateg Planning, Baltimore, MD 21207 USA	Urban Institute; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Spillman, BC (corresponding author), Urban Inst, Ctr Hlth Policy, 2100 M St NW, Washington, DC 20037 USA.							Braden BR, 1998, HEALTH CARE FINANC R, V20, P83; *C BUDG OFF, 1997, LONG TERM BUDG PRESS; CARLSON BL, 1995, J ECON SOC MEAS, V21, P187; *CTR COST FIN STUD, 1998, DATA NAT MED EXP SUR; Freedman VA, 1998, AM J PUBLIC HEALTH, V88, P1457, DOI 10.2105/AJPH.88.10.1457; GORNICK M, 1993, HEALTH AFFAIR, V12, P140, DOI 10.1377/hlthaff.12.2.140; Gruenberg L, 1996, HEALTH CARE FINANC R, V17, P59; Guralnik J M, 1997, J Am Med Womens Assoc (1972), V52, P113; HELDING C, 1992, HLTH CARE FINANCE S, P23; KEMPER P, 1991, NEW ENGL J MED, V324, P595, DOI 10.1056/NEJM199102283240905; KEMPER P, 1991, INQUIRY-J HEALTH CAR, V28, P333; LUBITZ J, 1995, NEW ENGL J MED, V332, P999, DOI 10.1056/NEJM199504133321506; Manton KG, 1997, P NATL ACAD SCI USA, V94, P2593, DOI 10.1073/pnas.94.6.2593; *OFF ACT, 1999, US LIF TABL FUNCT AC; *OFF ACT, 1999, SOC SEC AR POP 1999; Riley G F, 1989, Health Care Financ Rev, V11, P1; ROOS NP, 1987, MILBANK Q, V65, P231, DOI 10.2307/3350021; SCITOVSKY AA, 1994, MILBANK Q, V72, P561, DOI 10.2307/3350356; SCITOVSKY AA, 1988, MILBANK Q, V66, P640, DOI 10.2307/3349934; *SOC SEC ADM, 2000, 2000 ANN REP BOARD T; TEMKINGREENER H, 1992, MILBANK Q, V70, P679, DOI 10.2307/3350216; VERBRUGGE LM, 1990, WOMEN HLTH MED AM HI, P41; WAIDMANN TA, 1998, INTER EVIDENCE TREND; Waldo D R, 1989, Health Care Financ Rev, V10, P111; WEISSERT WG, 1994, J AM GERIATR SOC, V42, P348, DOI 10.1111/j.1532-5415.1994.tb01763.x	25	253	257	0	30	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAY 11	2000	342	19					1409	1415		10.1056/NEJM200005113421906	http://dx.doi.org/10.1056/NEJM200005113421906			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	312JR	10805827				2022-12-24	WOS:000086940600006
J	Levine, JM				Levine, JM			Species diversity and biological invasions: Relating local process to community pattern	SCIENCE			English	Article							BIODIVERSITY; ECOSYSTEM; INVASIBILITY; RESISTANCE; GRASSLANDS; STABILITY	In a California riparian system, the most diverse natural assemblages are the most invaded by exotic plants. A direct in situ manipulation of local diversity and a seed addition experiment showed that these patterns emerge despite the intrinsic negative effects of diversity on invasions. The results suggest that species loss at small scales may reduce invasion resistance. At community-wide scales, the overwhelming effects of ecological factors spatially covarying with diversity, such as propagule supply, make the most diverse communities most likely to be invaded.	Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Levine, JM (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.		Levine, Jonathan/A-7167-2014	Levine, Jonathan/0000-0003-2857-7904				CASE TJ, 1990, P NATL ACAD SCI USA, V87, P9610, DOI 10.1073/pnas.87.24.9610; Chapin FS, 1998, BIOSCIENCE, V48, P45, DOI 10.2307/1313227; DRAKE JA, 1990, J THEOR BIOL, V147, P213, DOI 10.1016/S0022-5193(05)80053-0; DUKES JS, 1999, THESIS STANFORD U; Elton C. S., 1958, ECOLOGY INVASIONS; Enserink M, 1999, SCIENCE, V285, P1834, DOI 10.1126/science.285.5435.1834; GOLDBERG DE, 1990, ECOLOGY, V71, P213, DOI 10.2307/1940261; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Knops JMH, 1999, ECOL LETT, V2, P286, DOI 10.1046/j.1461-0248.1999.00083.x; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Levine JM, 1999, ECOLOGY, V80, P1762, DOI 10.2307/176566; LEVINE JM, IN PRESS ECOLOGY; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; NAEEM S, IN PRESS OIKOS; NILSSON C, 1991, CAN J BOT, V69, P2631, DOI 10.1139/b91-328; PlantyTabacchi AM, 1996, CONSERV BIOL, V10, P598, DOI 10.1046/j.1523-1739.1996.10020598.x; POST WM, 1983, MATH BIOSCI, V64, P169, DOI 10.1016/0025-5564(83)90002-0; ROBINSON GR, 1995, ECOLOGY, V76, P786, DOI 10.2307/1939344; ROBINSON JV, 1979, J THEOR BIOL, V81, P91, DOI 10.1016/0022-5193(79)90083-3; Stachowicz JJ, 1999, SCIENCE, V286, P1577, DOI 10.1126/science.286.5444.1577; Stohlgren TJ, 1999, ECOL MONOGR, V69, P25, DOI 10.1890/0012-9615(1999)069[0025:EPSIHS]2.0.CO;2; Symstad AJ, 2000, ECOLOGY, V81, P99, DOI 10.1890/0012-9658(2000)081[0099:ATOTEO]2.0.CO;2; Tilman D, 1999, SCIENCE, V286, P1099, DOI 10.1126/science.286.5442.1099; Tilman D, 1996, NATURE, V379, P718, DOI 10.1038/379718a0; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; WASER NM, 1982, EVOLUTION, V36, P753, DOI 10.1111/j.1558-5646.1982.tb05441.x; Williamson M, 1996, BIOL INVASIONS; Wiser SK, 1998, ECOLOGY, V79, P2071, DOI 10.1890/0012-9658(1998)079[2071:CSAFIB]2.0.CO;2	30	756	822	11	395	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2000	288	5467					852	854		10.1126/science.288.5467.852	http://dx.doi.org/10.1126/science.288.5467.852			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797006				2022-12-24	WOS:000086869600036
J	Nakamagoe, K; Iwamoto, Y; Yoshida, K				Nakamagoe, K; Iwamoto, Y; Yoshida, K			Evidence for brainstem structures participating in oculomotor integration	SCIENCE			English	Article							MOVEMENT-RELATED NEURONS; EYE-MOVEMENT; CEREBELLAR FLOCCULUS; INTERSTITIAL NUCLEUS; VESTIBULAR NEURONS; PARAMEDIAN TRACTS; CELL GROUPS; CAT; PREPOSITUS; SYSTEM	The cerebellar flocculus has been implicated in vestibulo-oculomotor control. One major central input to this structure originates from brainstem cells in the paramedian tract (PMT), whose function is unknown. Here it is reported that PMT cells in the pens carry vestibular and eye movement signals and their pharmacological inactivation produces a leaky integrator combined with vestibular imbalance. The results suggest that PMT cells provide the cerebellum with sensory and motor signals that are essential for velocity-to-position integration, a common premotor process that is required in all motor systems.	Univ Tsukuba, Inst Basic Med Sci, Dept Physiol, Tsukuba, Ibaraki 3058575, Japan; Univ Tsukuba, Inst Clin Med, Dept Neurol, Tsukuba, Ibaraki 3058575, Japan	University of Tsukuba; University of Tsukuba	Yoshida, K (corresponding author), Univ Tsukuba, Inst Basic Med Sci, Dept Physiol, Tsukuba, Ibaraki 3058575, Japan.			Nakamagoe, Kiyotaka/0000-0003-4025-5780				ButtnerEnnever JA, 1996, ANN NY ACAD SCI, V781, P532, DOI 10.1111/j.1749-6632.1996.tb15726.x; BUTTNERENNEVER JA, 1989, REV NEUROL-FRANCE, V145, P533; CANNON SC, 1987, J NEUROPHYSIOL, V57, P1383, DOI 10.1152/jn.1987.57.5.1383; CHERON G, 1995, J NEUROPHYSIOL, V74, P1367, DOI 10.1152/jn.1995.74.3.1367; Chimoto S, 1999, J NEUROPHYSIOL, V81, P1199, DOI 10.1152/jn.1999.81.3.1199; CRAWFORD JD, 1991, SCIENCE, V252, P1551, DOI 10.1126/science.2047862; FUCHS AF, 1966, J APPL PHYSIOL, V21, P1068, DOI 10.1152/jappl.1966.21.3.1068; GODAUX E, 1993, J PHYSIOL-LONDON, V472, P459, DOI 10.1113/jphysiol.1993.sp019956; GRAF W, 1986, EXP BRAIN RES, V63, P35; KAMATH BY, 1976, MATH BIOSCI, V30, P341, DOI 10.1016/0025-5564(76)90073-0; MCCREA RA, 1987, J COMP NEUROL, V264, P571, DOI 10.1002/cne.902640409; METTENS P, 1994, J NEUROPHYSIOL, V72, P785, DOI 10.1152/jn.1994.72.2.785; NAKAO S, 1980, BRAIN RES, V183, P291, DOI 10.1016/0006-8993(80)90465-5; ROBINSON DA, 1974, BRAIN RES, V71, P195, DOI 10.1016/0006-8993(74)90961-5; Robinson DA, 1975, BASIC MECH OCULAR MO, P337; SATO Y, 1990, J NEUROPHYSIOL, V64, P551, DOI 10.1152/jn.1990.64.2.551; ZEE DS, 1980, ANN NEUROL, V7, P37, DOI 10.1002/ana.410070108; ZEE DS, 1981, J NEUROPHYSIOL, V46, P878, DOI 10.1152/jn.1981.46.4.878	18	70	72	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2000	288	5467					857	859		10.1126/science.288.5467.857	http://dx.doi.org/10.1126/science.288.5467.857			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797008				2022-12-24	WOS:000086869600038
J	Ayus, JC; Varon, J; Arieff, AI				Ayus, JC; Varon, J; Arieff, AI			Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners	ANNALS OF INTERNAL MEDICINE			English	Article; Proceedings Paper	32nd Annual Meeting of the American-Society-of-Nephrology	NOV 01-08, 1999	MIAMI, FL	Amer Soc Nephrol			SYMPTOMATIC HYPONATREMIA; WATER-INTOXICATION; EXERCISE; ENCEPHALOPATHY; WOMEN	Background: Noncardiogenic pulmonary edema is often associated with increased intracranial pressure and can be the initial manifestation of hyponatremic encephalopathy. Marathon runners tend to develop conditions that lead to hyponatremia. Objective: To describe the development and treatment of noncardiogenic pulmonary edema in marathon runners that was associated with hyponatremic encephalopathy. Case series. One university hospital and two community Design: Case series. Setting: One university hospital and two community hospitals. Patients: Seven healthy marathon runners who had a history of nonsteroidal anti-inflammatory drug use. The runners collapsed after competing in a marathon and were hospitalized with pulmonary edema. Measurements: Plasma sodium levels, chest radiograph, electrocardiogram, cardiac enzyme levels, and magnetic resonance imaging or computed tomographic scans of the brain. Results: Patients had nausea, emesis, and obtundation. The mean (+/-SD) plasma sodium level was 121 +/- 3 mmol/L, and oxygen saturation was less than 70%. Electrocardiograms and echocardiograms were normal. Chest radiographs showed pulmonary edema with a normal heart. Creatine phosphokinase-MB bands, troponin levels, and pulmonary wedge pressure were not elevated. Scanning of the brain showed cerebral edema. All patients were intubated and mechanically ventilated. Treatment with intravenous NaCl, 514 mmol/L, increased plasma sodium levers by 10 mmol/L in 22 hours. Pulmonary and cerebral edema resolved as the sodium level increased. One patient had unsuspected hyponatremic encephalopathy and died of cardiopulmonary arrest ca used by brainstem herniation. All six treated patients recovered and were well after 1 year of follow-up. Conclusions: In healthy marathon runners, noncardiogenic pulmonary edema can be associated with hyponatremic encephalopathy. The condition may be fatal if undiagnosed and can be successfully treated with hypertonic NaCl.	Baylor Coll Med, Houston, TX 77024 USA; Univ Calif San Francisco, Sch Med, San Francisco, CA USA	Baylor College of Medicine; University of California System; University of California San Francisco	Ayus, JC (corresponding author), Baylor Coll Med, 4 Brompton Court, Houston, TX 77024 USA.		Varon, Joseph/T-9481-2019; Varon, Joseph/R-5198-2019	Varon, Joseph/0000-0002-7622-9974				ARMSTRONG LE, 1993, MED SCI SPORT EXER, V25, P543; AYUS JC, 1987, NEW ENGL J MED, V317, P1190, DOI 10.1056/NEJM198711053171905; AYUS JC, 1995, CHEST, V107, P517, DOI 10.1378/chest.107.2.517; AYUS JC, 1992, ANN INTERN MED, V117, P891, DOI 10.7326/0003-4819-117-11-891; Ayus JC, 1999, JAMA-J AM MED ASSOC, V281, P2299, DOI 10.1001/jama.281.24.2299; Ayus JC, 2000, TXB CRITICAL CARE, P853; Garigan TP, 1999, MIL MED, V164, P234, DOI 10.1093/milmed/164.3.234; GILBERT S, 1999, NY TIMES        1102, pF8; HOLTZHAUSEN LM, 1994, MED SCI SPORT EXER, V26, P1095; IRVING RA, 1991, J APPL PHYSIOL, V70, P342, DOI 10.1152/jappl.1991.70.1.342; MCKECHNIE JK, 1979, S AFR MED J, V56, P261; NOAKES TD, 1990, MED SCI SPORT EXER, V22, P165; NOAKES TD, 1985, MED SCI SPORT EXER, V17, P370; Speedy DB, 1999, MED SCI SPORT EXER, V31, P809, DOI 10.1097/00005768-199906000-00008; YOUNG M, 1987, AM REV RESPIR DIS, V136, P737, DOI 10.1164/ajrccm/136.3.737; Zelingher J, 1996, AM J MED SCI, V311, P86, DOI 10.1097/00000441-199602000-00007	16	229	233	1	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2000	132	9					711	714		10.7326/0003-4819-132-9-200005020-00005	http://dx.doi.org/10.7326/0003-4819-132-9-200005020-00005			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	308VT	10787364				2022-12-24	WOS:000086734100004
J	Rhee, I; Jair, KW; Yen, RWC; Lengauer, C; Herman, JG; Kinzler, KW; Vogelstein, B; Baylin, SB; Schuebel, KE				Rhee, I; Jair, KW; Yen, RWC; Lengauer, C; Herman, JG; Kinzler, KW; Vogelstein, B; Baylin, SB; Schuebel, KE			CpG methylation is maintained in human cancer cells lacking DNMT1	NATURE			English	Article							DNA-CYTOSINE METHYLTRANSFERASE; DE-NOVO METHYLATION; GENETIC INSTABILITY; NEOPLASIA	Hypermethylation is associated with the silencing of tumour susceptibility genes in several forms of cancer(1,2); however, the mechanisms responsible for this aberrant methylation are poorly understood(3,4). The prototypic DNA methyltransferase, DNMT1, has been widely assumed to be responsible for most of the methylation of the human genome, including the abnormal methylation found in cancers(5,6). To test this hypothesis, we disrupted the DNMT1 gene through homologous recombination in human colorectal carcinoma cells. Here we show that cells lacking DNMT1 exhibited markedly decreased cellular DNA methyltransferase activity, but there was only a 20% decrease in overall genomic methylation. Although juxtacentromeric satellites became significantly demethylated, most of the loci that we analysed, including the tumour suppressor gene p16(INK4a), remained fully methylated and silenced. These results indicate that DNMT1 has an unsuspected degree of regional specificity in human cells and that methylating activities other than DNMT1 can maintain the methylation of most of the genome.	Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21231 USA; Johns Hopkins Univ, Sch Med, Program Human Genet, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University	Schuebel, KE (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, 1650 Orleans St, Baltimore, MD 21231 USA.							Bachman KE, 1999, CANCER RES, V59, P798; Baylin SB, 1998, ADV CANCER RES, V72, P141; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Eads CA, 1999, CANCER RES, V59, P2302; FEINBERG AP, 1988, CANCER RES, V48, P1159; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Graff JR, 1997, J BIOL CHEM, V272, P22322, DOI 10.1074/jbc.272.35.22322; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hsu DW, 1999, P NATL ACAD SCI USA, V96, P9751, DOI 10.1073/pnas.96.17.9751; JEANPIERRE M, 1994, ANN GENET-PARIS, V37, P163; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; KUO KC, 1980, NUCLEIC ACIDS RES, V8, P4763, DOI 10.1093/nar/8.20.4763; Lei H, 1996, DEVELOPMENT, V122, P3195; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Lengauer C, 1997, P NATL ACAD SCI USA, V94, P2545, DOI 10.1073/pnas.94.6.2545; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Myohanen SK, 1998, CANCER RES, V58, P591; OKAMOTO A, 1994, P NATL ACAD SCI USA, V91, P11045, DOI 10.1073/pnas.91.23.11045; Okano M, 1998, NAT GENET, V19, P219, DOI 10.1038/890; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; SANTI DV, 1983, CELL, V33, P9, DOI 10.1016/0092-8674(83)90327-6; Schmutte C, 1996, CANCER RES, V56, P2375; Toyota M, 1999, CANCER RES, V59, P2307; Vertino PM, 1996, MOL CELL BIOL, V16, P4555, DOI 10.1128/mcb.16.8.4555; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	30	349	366	1	21	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2000	404	6781					1003	1007		10.1038/35010000	http://dx.doi.org/10.1038/35010000			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801130				2022-12-24	WOS:000086762000058
J	Wong, W; Barlow, H				Wong, W; Barlow, H			Pattern recognition - Tunes and templates	NATURE			English	Article									Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Physiol Lab, Cambridge CB2 3EG, England	University of Cambridge; University of Cambridge	Wong, W (corresponding author), Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England.	hbb10@cam.ac.uk						Neri P, 1998, NATURE, V395, P894, DOI 10.1038/27661; Swets J. A., 1964, SIGNAL DETECT RECOG, P3; Tripathy SP, 1999, VISION RES, V39, P4161, DOI 10.1016/S0042-6989(99)00125-X; Warren RM, 2008, AUDITORY PERCEPTION: AN ANALYSIS AND SYNTHESIS, 3RD EDITION, P126, DOI 10.1017/CBO9780511754777.006	4	6	6	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2000	404	6781					952	953		10.1038/35010196	http://dx.doi.org/10.1038/35010196			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801115				2022-12-24	WOS:000086762000043
J	Lendvai, B; Stern, EA; Chen, B; Svoboda, K				Lendvai, B; Stern, EA; Chen, B; Svoboda, K			Experience-dependent plasticity of dendritic spines in the developing rat barrel cortex in vivo	NATURE			English	Article							CORTICAL PLASTICITY; PYRAMIDAL NEURONS; VISUAL-CORTEX; FIELD CORTEX; SYNAPTOGENESIS; ORGANIZATION; FILOPODIA; SYNAPSES; DYNAMICS; CLOSURE	Do changes in neuronal structure underlie cortical plasticity(1,2)? Here we used time-lapse two-photon microscopy(3,4) of pyramidal neurons in layer 2/3 of developing rat barrel cortex(5) to image the structural dynamics of dendritic spines and filopodia. We found that these protrusions were highly motile: spines and filopodia appeared, disappeared or changed shape over tens of minutes. To test whether sensory experience drives this motility we trimmed whiskers one to three days before imaging. Sensory deprivation markedly (similar to 40%) reduced protrusive motility in deprived regions of the barrel cortex during a critical period around postnatal days (P)11-13, but had no effect in younger (P8-10) or older (P14-16) animals. Unexpectedly, whisker trimming did not change the density, length or shape of spines and filopodia. However, sensory deprivation during the critical period degraded the tuning of layer 2/3 receptive fields. Thus sensory experience drives structural plasticity in dendrites, which may underlie the reorganization of neural circuits.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Svoboda, K (corresponding author), Hungarian Acad Sci, Inst Expt Med, Szigony U43, H-1083 Budapest, Hungary.							BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Chapin J., 1990, CEREBRAL CORTEX RAT, P341; Dailey ME, 1996, J NEUROSCI, V16, P2983; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Fox K, 1996, J PHYSIOLOGY-PARIS, V90, P263, DOI 10.1016/S0928-4257(97)81436-2; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Horch HW, 1999, NEURON, V23, P353; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; MALINOW R, 1999, IMAGING LIVING CELLS; Micheva KD, 1996, J COMP NEUROL, V373, P340, DOI 10.1002/(SICI)1096-9861(19960923)373:3<340::AID-CNE3>3.0.CO;2-2; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Moore CI, 1998, J NEUROPHYSIOL, V80, P2882, DOI 10.1152/jn.1998.80.6.2882; MOVSHON JA, 1977, J NEUROPHYSIOL, V40, P1255, DOI 10.1152/jn.1977.40.6.1255; PURPURA DP, 1975, ADV NEUROL, P91; SCHLAGGAR BL, 1993, NATURE, V364, P623, DOI 10.1038/364623a0; SIMONS DJ, 1987, NATURE, V326, P694, DOI 10.1038/326694a0; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Vees AM, 1998, J COMP NEUROL, V400, P110; Welker W. I., 1964, Behaviour, V22, P223, DOI 10.1163/156853964X00030; WINFIELD DA, 1981, BRAIN RES, V206, P166, DOI 10.1016/0006-8993(81)90110-4; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Zhu JJ, 1999, J NEUROPHYSIOL, V81, P1171, DOI 10.1152/jn.1999.81.3.1171; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	30	597	617	0	39	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					876	881		10.1038/35009107	http://dx.doi.org/10.1038/35009107			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786794				2022-12-24	WOS:000086625000046
J	Rudolph, RE; Vaughan, TL; Storer, BE; Haggitt, RC; Rabinovitch, PS; Levine, DS; Reid, BJ				Rudolph, RE; Vaughan, TL; Storer, BE; Haggitt, RC; Rabinovitch, PS; Levine, DS; Reid, BJ			Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus	ANNALS OF INTERNAL MEDICINE			English	Article						aneuploidy; Barrett esophagus; adenocarcinoma; esophageal neoplasms; endoscopy	COLUMNAR-LINED ESOPHAGUS; HIGH-GRADE DYSPLASIA; INTESTINAL METAPLASIA; ESOPHAGOGASTRIC JUNCTION; GASTROESOPHAGEAL JUNCTION; ENDOSCOPIC SURVEILLANCE; FOLLOW-UP; ADENOCARCINOMA; PREVALENCE; MANAGEMENT	Background: The increased risk for esophageal adenocarcinoma associated with long-segment (greater than or equal to 3 cm) Barrett esophagus is well recognized. Recent studies suggest that short-segment (<3 cm) Barrett esophagus is substantially more common; however, the risk for neoplastic progression in patients with this disorder is largely unknown. Objective: To examine the relation between segment length and risk for aneuploidy and esophageal adenocarcinoma in patients with Barrett esophagus. Design: Prospective cohort study. Setting: University medical center in Seattle, Washington. Patients: 309 patients with Barrett esophagus. Measurements: Patients were monitored for progression to aneuploidy and adenocarcinoma by repeated endoscopy with biopsy for an average of 3.8 years. Cox proportional hazards analysis was used to calculate adjusted relative risks and 95% Cls. Results: After adjustment for histologic diagnosis at study entry, segment length was not related to risk for cancer in the full cohort (P > 0.2 for trend). When patients with high-grade dysplasia at baseline were excluded, however, a nonsignificant trend was observed; based on a linear model, a 5-cm difference in segment length was associated with a 1.7-fold (95% CI, 0.8-fold to 3.8-fold) increase in cancer risk. Among all eligible patients, a 5-cm difference in segment length was associated with a small increase in the risk for aneuploidy (relative risk, 1.4 [CI, 1.0 to 2.1]; P = 0.06 far trend). A similar trend was observed among patients without high-grade dysplasia at baseline. Conclusions: The risk for esophageal adenocarcinoma in patients with short-segment Barrett esophagus was not substantially lower than that in patients with longer segments. Although our results suggest a small increase in risk for neoplastic progression with increasing segment length, additional follow-up is needed to determine whether the patterns of risk occurred by chance or represent true differences. Until more data are available, the frequency of endoscopic surveillance should be selected without regard to segment length.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Rudolph, RE (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,MP-474,Box 19024, Seattle, WA 98109 USA.		Reid, Brian John/AFT-8587-2022	Reid, Brian John/0000-0002-9613-979X	NATIONAL CANCER INSTITUTE [R01CA061202, R25CA057734] Funding Source: NIH RePORTER; NCI NIH HHS [R25 CA57734, R01 CA61202] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACHKAR E, 1988, AM J GASTROENTEROL, V83, P291; AMES BN, 1990, SCIENCE, V249, P970, DOI 10.1126/science.2136249; BANERJEE B, 1994, GASTROENTEROLOGY, V106, pA45; Beck I T, 1997, Can J Gastroenterol, V11 Suppl B, p7B; CAMERON AJ, 1995, GASTROENTEROLOGY, V109, P1541, DOI 10.1016/0016-5085(95)90642-8; Cameron AJ, 1998, MAYO CLIN PROC, V73, P457; Chalasani N, 1997, DIGEST DIS SCI, V42, P603, DOI 10.1023/A:1018863529777; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Farrow DC, 1996, CANCER CAUSE CONTROL, V7, P322, DOI 10.1007/BF00052937; Fitzgerald RC, 1998, DIGEST DIS, V16, P63, DOI 10.1159/000016850; HAMEETEMAN W, 1989, GASTROENTEROLOGY, V96, P1249, DOI 10.1016/S0016-5085(89)80011-3; HAMILTON SR, 1988, HUM PATHOL, V19, P942, DOI 10.1016/S0046-8177(88)80010-8; HARLE IA, 1985, ANN THORAC SURG, V40, P330, DOI 10.1016/S0003-4975(10)60062-8; Hirota WK, 1999, GASTROENTEROLOGY, V116, P277, DOI 10.1016/S0016-5085(99)70123-X; HONG MK, 1995, CANCER, V75, P423, DOI 10.1002/1097-0142(19950115)75:2<423::AID-CNCR2820750202>3.0.CO;2-5; IFTIKHAR SY, 1992, GUT, V33, P1155, DOI 10.1136/gut.33.9.1155; Johnston MH, 1996, AM J GASTROENTEROL, V91, P1507; KIM SL, 1994, GASTROENTEROLOGY, V107, P945, DOI 10.1016/0016-5085(94)90217-8; KINGSNORTH AN, 1983, CANCER RES, V43, P2545; LERUT T, 1994, J THORAC CARDIOV SUR, V107, P1059, DOI 10.1016/S0022-5223(94)70381-7; LEVINE DS, 1993, GASTROENTEROLOGY, V105, P40, DOI 10.1016/0016-5085(93)90008-Z; LEVINE DS, 1991, GASTROINTEST ENDOSC, V37, P332, DOI 10.1016/S0016-5107(91)70726-8; MENKEPLUYMERS MBE, 1994, GUT, V35, P1348, DOI 10.1136/gut.35.10.1348; MENKEPLUYMERS MBE, 1993, CANCER, V72, P1155, DOI 10.1002/1097-0142(19930815)72:4<1155::AID-CNCR2820720404>3.0.CO;2-C; MIROS M, 1991, GUT, V32, P1441, DOI 10.1136/gut.32.12.1441; Morales TG, 1997, AM J GASTROENTEROL, V92, P414; PROVENZALE D, 1994, AM J GASTROENTEROL, V89, P670; RANSOM JM, 1982, ANN THORAC SURG, V33, P19, DOI 10.1016/S0003-4975(10)63192-X; REID BJ, 1988, HUM PATHOL, V19, P166, DOI 10.1016/S0046-8177(88)80344-7; REID BJ, 1993, GASTROENTEROLOGY, V105, P119, DOI 10.1016/0016-5085(93)90017-7; Reid BJ, 1996, EUR J CANCER PREV, V5, P57, DOI 10.1097/00008469-199612002-00009; REID BJ, 1992, GASTROENTEROLOGY, V102, P1212; REID BJ, 1987, GASTROENTEROLOGY, V93, P1; Riddell RH, 1996, AM J GASTROENTEROL, V91, P853; RUSCH VW, 1994, CANCER, V74, P1225, DOI 10.1002/1097-0142(19940815)74:4<1225::AID-CNCR2820740408>3.0.CO;2-Q; Sampliner RE, 1998, AM J GASTROENTEROL, V93, P1028; SCHNELL TG, 1992, DIGEST DIS SCI, V37, P137, DOI 10.1007/BF01308357; Sharma P, 1997, AM J GASTROENTEROL, V92, P2012; Spechler SJ, 1996, GASTROENTEROLOGY, V110, P614, DOI 10.1053/gast.1996.v110.agast960614; SPECHLER SJ, 1994, LANCET, V344, P1533, DOI 10.1016/S0140-6736(94)90349-2; *STAT CORP, 1997, STAT STAT SOFTW REL; STREITZ JM, 1993, J THORAC CARDIOV SUR, V105, P383; STREITZ JM, 1991, ANN SURG, V213, P122, DOI 10.1097/00000658-199102000-00005; TERPSTRA OT, 1981, GASTROENTEROLOGY, V81, P475; vanderBurgh A, 1996, GUT, V39, P5, DOI 10.1136/gut.39.1.5; Weston AP, 1996, AM J GASTROENTEROL, V91, P981; Weston AP, 1997, AM J GASTROENTEROL, V92, P407; WILLIAMSON WA, 1991, ARCH INTERN MED, V151, P2212, DOI 10.1001/archinte.151.11.2212	48	201	204	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2000	132	8					612	+		10.7326/0003-4819-132-8-200004180-00003	http://dx.doi.org/10.7326/0003-4819-132-8-200004180-00003			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304RG	10766679				2022-12-24	WOS:000086497500002
J	Anderson, RT; Lovley, DR				Anderson, RT; Lovley, DR			Biogeochemistry - Hexadecane decay by methanogenesis	NATURE			English	Article									Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst	Anderson, RT (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.							Anderson RT, 1998, ENVIRON SCI TECHNOL, V32, P1222, DOI 10.1021/es9704949; LOVLEY DR, 1995, REV GEOPHYS, V33, P365, DOI 10.1029/95RG01305; Parkes J, 1999, NATURE, V401, P217, DOI 10.1038/45686; WARD DM, 1978, GEOMICROBIOL J, V1, P1, DOI 10.1080/01490457809377720; WARD DM, 1980, AMBIO, V9, P277; Zengler K, 1999, NATURE, V401, P266, DOI 10.1038/45777	6	116	140	5	36	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					722	723		10.1038/35008145	http://dx.doi.org/10.1038/35008145			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783875				2022-12-24	WOS:000086523600038
J	Velicer, GJ; Kroos, L; Lenski, RE				Velicer, GJ; Kroos, L; Lenski, RE			Developmental cheating in the social bacterium Myxococcus xanthus	NATURE			English	Article							CELL; EVOLUTION; DICTYOSTELIUM; MUTANTS; LOCUS; GENES	Cheating is a potential problem in any social system that depends on cooperation and in which actions that benefit a group are costly to individuals that perform them(1-5). Genetic mutants that fail to perform a group-beneficial function but that reap the benefits of belonging to the group should have a within-group selective advantage, provided that the mutants are not too common. Here we show that social cheating exists even among prokaryotes. The bacterium Myxococcus xanthus exhibits several social behaviours, including aggregation of cells into spore-producing fruiting bodies during starvation. We examined a number of M. xanthus genotypes that were defective for fruiting-body development, including several lines that evolved for 1,000 generations under asocial conditions(6) and others carrying defined mutations in developmental pathways(7-10), to determine whether they behaved as cheaters when mixed with their developmentally proficient progenitor. Clones from several evolved lines and two defined mutants exhibited cheating during development, being overrepresented among resulting spores relative to their initial frequency in the mixture. The ease of finding anti-social behaviours suggests that cheaters may be common in natural populations of M. xanthus.	Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA; Michigan State Univ, Ctr Microbial Ecol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Velicer, GJ (corresponding author), Michigan State Univ, Dept Biochem, E Lansing, MI 48824 USA.	velicerg@pilot.msu.edu		Lenski, Richard/0000-0002-1064-8375				Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BONNER JT, 1967, CELLULAR SLIME MOLDS; BUSS LW, 1982, P NATL ACAD SCI-BIOL, V79, P5337, DOI 10.1073/pnas.79.17.5337; Buss LW, 1999, P NATL ACAD SCI USA, V96, P8801, DOI 10.1073/pnas.96.16.8801; DOWNARD J, 1993, J BACTERIOL, V175, P7762, DOI 10.1128/JB.175.24.7762-7770.1993; DWORKIN M, 1993, MYCOBACTERIA, V2; Frank S. A., 1998, FDN SOCIAL EVOLUTION, DOI DOI 10.1515/9780691206820; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Garza AG, 2000, MOL MICROBIOL, V35, P812, DOI 10.1046/j.1365-2958.2000.01753.x; Grosberg RK, 1998, TRENDS ECOL EVOL, V13, P112, DOI 10.1016/S0169-5347(97)01313-X; HAGEN DC, 1978, DEV BIOL, V64, P284, DOI 10.1016/0012-1606(78)90079-9; HODGKIN J, 1977, P NATL ACAD SCI USA, V74, P2938, DOI 10.1073/pnas.74.7.2938; KAISER D, 1979, P NATL ACAD SCI USA, V76, P5952, DOI 10.1073/pnas.76.11.5952; KAISER D, 1986, ANNU REV GENET, V20, P539; KROOS L, 1986, DEV BIOL, V117, P252, DOI 10.1016/0012-1606(86)90368-4; KUSPA A, 1989, J BACTERIOL, V171, P2762, DOI 10.1128/jb.171.5.2762-2772.1989; KUSPA A, 1986, DEV BIOL, V117, P267, DOI 10.1016/0012-1606(86)90369-6; LAUE BE, 1995, J BACTERIOL, V177, P4089, DOI 10.1128/jb.177.14.4089-4096.1995; Matapurkar AK, 1997, AM NAT, V150, P790, DOI 10.1086/286094; Maynard Smith J., 1982, pi; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; Reichenbach H, 1993, MYXOBACTERIA, P13; Rosenberg E, 1984, MYXOBACTERIA DEV CEL, P109; SHIMKETS LJ, 1988, MOL GEN GENET, V211, P63, DOI 10.1007/BF00338394; Smith J. M., 1995, MAJOR TRANSITIONS EV; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Velicer GJ, 1998, P NATL ACAD SCI USA, V95, P12376, DOI 10.1073/pnas.95.21.12376; Wall D, 1999, J BACTERIOL, V181, P24, DOI 10.1128/JB.181.1.24-33.1999	30	234	238	1	47	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					598	+		10.1038/35007066	http://dx.doi.org/10.1038/35007066			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766241				2022-12-24	WOS:000086400100052
J	Emsley, J; Knight, CG; Farndale, RW; Barnes, MJ; Liddington, RC				Emsley, J; Knight, CG; Farndale, RW; Barnes, MJ; Liddington, RC			Structural basis of collagen recognition by integrin alpha 2 beta 1	CELL			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; FUNCTION-ASSOCIATED ANTIGEN-1; CATION-INDEPENDENT ADHESION; I-DOMAIN; DIVALENT-CATION; LIGAND-BINDING; PLATELET-ADHESION; CRYSTAL-STRUCTURE; A-DOMAIN; ALPHA(2)BETA(1) INTEGRIN	We have determined the crystal structure of a complex between the I domain of integrin alpha 2 beta 1 and a triple helical collagen peptide containing a critical GFOGER motif. Three loops on the upper surface of the I domain that coordinate a metal ion also engage the collagen, with a collagen glutamate completing the coordination sphere of the metal. Comparison with the unliganded I domain reveals a change in metal coordination linked to a reorganization of the upper surface that together create a complementary surface for binding collagen. Conformational changes propagate from the upper surface to the opposite pole of the domain, suggesting both a basis for affinity regulation and a pathway for signal transduction. The structural features observed here may represent a general mechanism for integrin-ligand recognition.	Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; Burnham Inst, La Jolla, CA 92037 USA	University of Leicester; University of Cambridge; Sanford Burnham Prebys Medical Discovery Institute	Liddington, RC (corresponding author), Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England.		emsley, jonas/A-8509-2016	emsley, jonas/0000-0002-8949-8030				BACON D, 1988, J MOL GRAPHICS, V6, P219, DOI 10.1016/S0263-7855(98)80030-1; Baldwin ET, 1998, STRUCTURE, V6, P923, DOI 10.1016/S0969-2126(98)00093-8; Bella J, 1998, P NATL ACAD SCI USA, V95, P4140, DOI 10.1073/pnas.95.8.4140; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BILSLAND CAG, 1994, J LEUKOCYTE BIOL, V55, P501, DOI 10.1002/jlb.55.4.501; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; DEMBO M, 1988, PROC R SOC SER B-BIO, V234, P55, DOI 10.1098/rspb.1988.0038; Dickeson SK, 1998, BIOCHEMISTRY-US, V37, P11280, DOI 10.1021/bi9727848; Dickeson SK, 1997, J BIOL CHEM, V272, P7661, DOI 10.1074/jbc.272.12.7661; EDWARDS CP, 1995, J BIOL CHEM, V270, P12635, DOI 10.1074/jbc.270.21.12635; Edwards CP, 1998, J BIOL CHEM, V273, P28937, DOI 10.1074/jbc.273.44.28937; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley J, 1997, J BIOL CHEM, V272, P28512, DOI 10.1074/jbc.272.45.28512; Erb EM, 1997, BIOCHEMISTRY-US, V36, P7395, DOI 10.1021/bi9702187; Hantgan RR, 1999, BIOCHEMISTRY-US, V38, P14461, DOI 10.1021/bi9907680; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Huang CC, 1997, P NATL ACAD SCI USA, V94, P3156, DOI 10.1073/pnas.94.7.3156; Huang CC, 1997, P NATL ACAD SCI USA, V94, P3162, DOI 10.1073/pnas.94.7.3162; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jung SM, 1998, J BIOL CHEM, V273, P14827, DOI 10.1074/jbc.273.24.14827; Kadler KE, 1996, BIOCHEM J, V316, P1; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Kamata T, 1999, J BIOL CHEM, V274, P32108, DOI 10.1074/jbc.274.45.32108; KAMATA T, 1994, J BIOL CHEM, V269, P26006; KAMATA T, 1994, J BIOL CHEM, V269, P9659; Kashiwagi H, 1997, J CELL BIOL, V137, P1433, DOI 10.1083/jcb.137.6.1433; KERN A, 1994, J BIOL CHEM, V269, P22811; Knight CG, 2000, J BIOL CHEM, V275, P35, DOI 10.1074/jbc.275.1.35; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Lee JO, 1995, STRUCTURE, V3, P1333, DOI 10.1016/S0969-2126(01)00271-4; Li R, 1998, J CELL BIOL, V143, P1523, DOI 10.1083/jcb.143.6.1523; Liddington R, 1998, STRUCT FOLD DES, V6, P937, DOI 10.1016/S0969-2126(98)00094-X; Loftus JC, 1997, J CLIN INVEST, V99, P2302, DOI 10.1172/JCI119408; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; MICHISHITA M, 1993, CELL, V72, P857, DOI 10.1016/0092-8674(93)90575-B; MORTON LF, 1994, BIOCHEM J, V299, P791, DOI 10.1042/bj2990791; Mould AP, 1997, J BIOL CHEM, V272, P17283, DOI 10.1074/jbc.272.28.17283; Nakamura T, 1998, J BIOL CHEM, V273, P4338, DOI 10.1074/jbc.273.8.4338; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Nicholls A., 1992, GRASP GRAPHICAL REPR; Nolte M, 1999, FEBS LETT, V452, P379, DOI 10.1016/S0014-5793(99)00666-3; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; OTWINOWSKI Z, 1993, DATA COLLECTION PROC, P59; Oxvig C, 1999, P NATL ACAD SCI USA, V96, P2215, DOI 10.1073/pnas.96.5.2215; Qu AD, 1996, STRUCTURE, V4, P931, DOI 10.1016/S0969-2126(96)00100-1; Rich RL, 1999, J BIOL CHEM, V274, P24906, DOI 10.1074/jbc.274.35.24906; SADLER JE, 1995, THROMB HAEMOSTASIS, V74, P161; Sixma JJ, 1997, THROMB HAEMOSTASIS, V78, P434; Smith C, 2000, J BIOL CHEM, V275, P4205, DOI 10.1074/jbc.275.6.4205; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; TUCKWELL D, 1995, J CELL SCI, V108, P1629; Zhang L, 1999, BIOCHEMISTRY-US, V38, P8064, DOI 10.1021/bi990141h; Zhang L, 1996, J BIOL CHEM, V271, P29953, DOI 10.1074/jbc.271.47.29953; Zhang L, 1997, J BIOL CHEM, V272, P17558, DOI 10.1074/jbc.272.28.17558; ZIJENAH LS, 1990, BIOCHEM J, V268, P481, DOI 10.1042/bj2680481	61	809	834	5	80	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 31	2000	101	1					47	56		10.1016/S0092-8674(00)80622-4	http://dx.doi.org/10.1016/S0092-8674(00)80622-4			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	300JM	10778855	Bronze			2022-12-24	WOS:000086249900007
J	Keck, JL; Roche, DD; Lynch, AS; Berger, JM				Keck, JL; Roche, DD; Lynch, AS; Berger, JM			Structure of the RNA polymerase domain of E-coli primase	SCIENCE			English	Article							SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; REPLICATION FORK; PROTEIN MODELS; HELICASE; BACTERIOPHAGE-T7; TOPOISOMERASES; RECOGNITION; REFINEMENT; EVOLUTION	All cellular organisms use specialized RNA polymerases called "primases" to synthesize RNA primers for the initiation of DNA replication. The high-resolution crystal structure of a primase, comprising the catalytic core of the Escherichia coli DnaG protein, was determined. The core structure contains an active-site architecture that is unrelated to other DNA or RNA polymerase palm folds, but is instead related to the "toprim" fold. On the basis of the structure, it is Likely that DnaG binds nucleic acid in a groove clustered with invariant residues and that DnaG is positioned within the replisome to accept single-stranded DNA directly from the replicative helicase.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Tularik, S San Francisco, CA 94080 USA	University of California System; University of California Berkeley	Lynch, AS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall,No 3206, Berkeley, CA 94720 USA.			Keck, James/0000-0002-5961-0220				Aravind L, 1998, NUCLEIC ACIDS RES, V26, P4205, DOI 10.1093/nar/26.18.4205; BENNER SA, 1994, PROTEIN ENG, V7, P1323, DOI 10.1093/protein/7.11.1323; Berger JM, 1998, P NATL ACAD SCI USA, V95, P7876, DOI 10.1073/pnas.95.14.7876; BRUTLAG D, 1971, P NATL ACAD SCI USA, V68, P2826, DOI 10.1073/pnas.68.11.2826; CARSON M, 1991, J APPL CRYSTALLOGR, V24, P958, DOI 10.1107/S0021889891007240; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; HOLTON J, UNPUB; ILYINA TV, 1992, J MOL EVOL, V34, P351, DOI 10.1007/BF00160243; Jezewska MJ, 1998, J BIOL CHEM, V273, P10515, DOI 10.1074/jbc.273.17.10515; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABASCH W, 1988, J APPL CRYSTALLOGR, V21, P916; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KECK J, UNPUB; KITANI T, 1985, J MOL BIOL, V184, P45, DOI 10.1016/0022-2836(85)90042-7; Kornberg A., 1992, DNA REPLICATION; Kusakabe T, 1998, EMBO J, V17, P1542, DOI 10.1093/emboj/17.5.1542; LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886; Leslie A, 1992, NEWSLETTER PROTEIN C; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; MARIANS KJ, 1992, ANNU REV BIOCHEM, V61, P673, DOI 10.1146/annurev.bi.61.070192.003325; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR D, V50, P1507; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Nichols MD, 1999, EMBO J, V18, P6177, DOI 10.1093/emboj/18.21.6177; OLLIS DL, 1985, NATURE, V313, P762, DOI 10.1038/313762a0; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Sun WL, 1999, J BACTERIOL, V181, P3761, DOI 10.1128/JB.181.12.3761-3767.1999; SUN WL, 1994, P NATL ACAD SCI USA, V91, P11462, DOI 10.1073/pnas.91.24.11462; Terwilliger TC, 1996, ACTA CRYSTALLOGR D, V52, P749, DOI 10.1107/S0907444996000832; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tougu K, 1996, J BIOL CHEM, V271, P21398, DOI 10.1074/jbc.271.35.21398; TOUGU K, 1994, J BIOL CHEM, V269, P4675; VERSALOVIC J, 1993, GENE, V136, P281, DOI 10.1016/0378-1119(93)90480-Q; Yu X, 1996, NAT STRUCT BIOL, V3, P740, DOI 10.1038/nsb0996-740; Yuzhakov A, 1999, CELL, V96, P153, DOI 10.1016/S0092-8674(00)80968-X; ZECHNER EL, 1992, J BIOL CHEM, V267, P4054; ZIEGELIN G, 1995, J BACTERIOL, V177, P4333, DOI 10.1128/jb.177.15.4333-4341.1995	40	124	126	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2482	2486		10.1126/science.287.5462.2482	http://dx.doi.org/10.1126/science.287.5462.2482			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741967				2022-12-24	WOS:000086202200044
J	Difilippantonio, MJ; Zhu, J; Chen, HT; Meffre, E; Nussenzweig, MC; Max, EE; Ried, T; Nussenzweig, A				Difilippantonio, MJ; Zhu, J; Chen, HT; Meffre, E; Nussenzweig, MC; Max, EE; Ried, T; Nussenzweig, A			DNA repair protein Ku80 suppresses chromosomal aberrations and malignant transformation	NATURE			English	Article							V(D)J RECOMBINATION; MICE; P53; TRANSPOSITION; GROWTH; RAG1; GENE	Cancer susceptibility genes have been classified into two groups: gatekeepers and caretakers(1). Gatekeepers are genes that control cell proliferation and death, whereas caretakers are DNA repair genes whose inactivation leads to genetic instability. Abrogation of both caretaker and gatekeeper function markedly increases cancer susceptibility. Although the importance of Ku80 in DNA double-strand break repair is well established, neither Ku80 nor other components of the non-homologous end-joining pathway are known to have a caretaker role in maintaining genomic stability. Here we show that mouse cells deficient for Ku80 display a marked increase in chromosomal aberrations, including breakage, translocations and aneuploidy. Despite the observed chromosome instabilities, Ku80(-/-) mice have only a slightly earlier onset of cancer(2,3). Loss of p53 synergizes with Ku80 to promote tumorigenesis such that all Ku80(-/-) p53(-/-) mice succumb to disseminated pro-B-cell lymphoma before three months of age. Tumours result from a specific set of chromosomal translocations and gene amplications involving IgH and c-Myc, reminiscent of Burkitt's lymphoma. We conclude that Ku80 is a caretaker gene that maintains the integrity of the genome by a mechanism involving the suppression of chromosomal rearrangements.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA; NCI, Dept Genet, NIH, Bethesda, MD 20892 USA; Rockefeller Inst, Lab Mol Immunol, New York, NY 10021 USA; Rockefeller Inst, Howard Hughes Med Inst, New York, NY 10021 USA; US FDA, Lab Cell Regulat, Ctr Biol Evaluat & Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; US Food & Drug Administration (FDA)	Nussenzweig, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.		Difilippantonio, Michael/AAF-2839-2021; Nussenzweig, Michel/AAE-7292-2019	Difilippantonio, Michael/0000-0002-4676-7034; 	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; DIVISION OF CLINICAL SCIENCES - NCI [Z01SC010298, Z01SC010299] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF CLINICAL SCIENCES - NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9; Chen C, 1998, MOL CELL, V2, P9, DOI 10.1016/S1097-2765(00)80109-4; CHU CC, 1992, P NATL ACAD SCI USA, V89, P6978, DOI 10.1073/pnas.89.15.6978; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gao YJ, 1998, IMMUNITY, V9, P367, DOI 10.1016/S1074-7613(00)80619-6; Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6; Ghadimi BM, 2000, GENE CHROMOSOME CANC, V27, P183, DOI 10.1002/(SICI)1098-2264(200002)27:2<183::AID-GCC10>3.0.CO;2-P; GU Y, 1997, IMMUNITY, V7, P367; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liyanage M, 1996, NAT GENET, V14, P312, DOI 10.1038/ng1196-312; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Nussenzweig A, 1996, NATURE, V382, P551, DOI 10.1038/382551a0; Ouyang H, 1997, J EXP MED, V186, P921, DOI 10.1084/jem.186.6.921; Ramsden DA, 1998, EMBO J, V17, P609, DOI 10.1093/emboj/17.2.609; Smith GCM, 1999, GENE DEV, V13, P916, DOI 10.1101/gad.13.8.916; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; TIMME TL, 1994, BIOTECHNIQUES, V17, P462; Vanasse GJ, 1999, J CLIN INVEST, V103, P1669, DOI 10.1172/JCI6658; Vogel H, 1999, P NATL ACAD SCI USA, V96, P10770, DOI 10.1073/pnas.96.19.10770; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Zhu CM, 1996, CELL, V86, P379, DOI 10.1016/S0092-8674(00)80111-7	30	440	451	0	15	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					510	514		10.1038/35006670	http://dx.doi.org/10.1038/35006670			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761921	Green Accepted			2022-12-24	WOS:000086257700052
J	Emanuel, EJ; Fairclough, DL; Slutsman, J; Emanuel, LL				Emanuel, EJ; Fairclough, DL; Slutsman, J; Emanuel, LL			Understanding economic and other burdens of terminal illness: The experience of patients and their caregivers	ANNALS OF INTERNAL MEDICINE			English	Article						terminally ill; terminal care; cost of illness; caregivers; physician role	PHYSICIAN-ASSISTED SUICIDE; MENTAL-HEALTH; UNITED-STATES; CARE; EUTHANASIA; CANCER; ATTITUDES; FAMILIES; ADULTS; NEEDS	Background: Terminal illness imposes substantial burdens-economic and otherwise-on patients and caregivers. The cause of these burdens is not understood. Objective: To determine the mechanism for economic and noneconomic burdens of terminal illness and to identify potential ameliorating interventions. Design: In-person interviews of terminally ill patients and their caregivers. Setting: Six randomly selected U.S. sites: Worcester, Massachusetts; St. Louis, Missouri; Tucson, Arizona; Birmingham, Alabama; Brooklyn, New York; and Mesa County, Colorado. Participants: 988 terminally ill patients and 893 caregivers. Measurements: Needs for transportation, nursing care, homemaking, and personal care; subjective perception of economic burden; expenditure of more than 10% of household income on health care costs; caregiver depression and sense of interference with his or her life; and patient consideration of euthanasia or physician-assisted suicide. Results: Of all patients, 34.7% had substantial care needs. Patients who had substantial care needs were more likely to report that they had a subjective sense of economic burden (44.9% compared with 35.3%; difference, 9.6 percentage points [95% CI, 3.1 to 16.1]; P = 0.005); that 10% of their household income was spent on health care (28.0% compared with 17.0%; difference, 11.0 percentage points [CI, 4.8 to 17.1]; P less than or equal to 0.001); and that they or their families had to take out a loan or mortgage, spend their savings, or obtain an additional job (16.3% compared with 10.2%; difference, 6.1 percentage points [CI, 1.4 to 10.6]; P = 0.004). Patients with substantial care needs were more likely to consider euthanasia or physician-assisted suicide (P = 0.001). Caregivers of these patients were more likely to have depressive symptoms (31.4% compared with 24.8%; difference, 6.6 percentage points [CI, 0.4 to 12.8]; P = 0.01) and to report that caring for the patients interfered with their lives (35.6% compared with 24.3%; difference, 11.3 percentage points [CI, 5.0 to 17.7]; P = 0.001). Caregivers of patients whose physicians listened to patients' and caregivers' needs had fewer burdens. Conclusions: Substantial care needs are an important cause of the economic and other burdens imposed by terminal illness. Through empathy, physicians may be able to ameliorate some of these burdens.	NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bethesda, MD 20892 USA; AMC Canc Res Ctr, Denver, CO USA; Johns Hopkins Univ, Baltimore, MD USA; Amer Med Assoc, Inst Eth, Chicago, IL 60610 USA	National Institutes of Health (NIH) - USA; AMC Cancer Research Center; Johns Hopkins University; American Medical Association	Emanuel, EJ (corresponding author), NIH, Dept Clin Bioeth, Warren G Magnuson Clin Ctr, Bldg 10,Room 1C118, Bethesda, MD 20892 USA.							BERKMAN BJ, 1993, CANCER-AM CANCER SOC, V72, P2846, DOI 10.1002/1097-0142(19931101)72:9+<2846::AID-CNCR2820721515>3.0.CO;2-3; BERWICK DM, 1991, MED CARE, V29, P169, DOI 10.1097/00005650-199102000-00008; *BUR CENS, 1998, STAT ABSTR US 1998; CANTOR MH, 1983, GERONTOLOGIST, V23, P597, DOI 10.1093/geront/23.6.597; COVINSKY KE, 1994, JAMA-J AM MED ASSOC, V272, P1839, DOI 10.1001/jama.272.23.1839; DAUT RL, 1983, PAIN, V17, P197, DOI 10.1016/0304-3959(83)90143-4; Emanuel EJ, 1999, NEW ENGL J MED, V341, P956, DOI 10.1056/NEJM199909233411306; Emanuel EJ, 1998, LANCET, V351, P21, DOI 10.1016/S0140-6736(98)90329-4; Emanuel EJ, 1996, LANCET, V347, P1805, DOI 10.1016/S0140-6736(96)91621-9; EPSTEIN AM, 1995, INQUIRY-J HEALTH CAR, V32, P211; Field MJ, 1997, APPROACHING DEATH IM; Ganzini L, 1998, NEW ENGL J MED, V339, P967, DOI 10.1056/NEJM199810013391406; GEORGE LK, 1986, GERONTOLOGIST, V26, P253, DOI 10.1093/geront/26.3.253; GREER DS, 1986, J CHRON DIS, V39, P9, DOI 10.1016/0021-9681(86)90103-7; *GROUP HLTH ASS AM, 1992, NAT DIR HMOS; HOUTS PS, 1988, CANCER, V62, P627, DOI 10.1002/1097-0142(19880801)62:3<627::AID-CNCR2820620331>3.0.CO;2-1; KISSANE DW, 1994, PSYCHO-ONCOLOGY, V3, P47, DOI DOI 10.1002/P0N.2960030109; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; KNAUS WA, 1995, ANN INTERN MED, V122, P191, DOI 10.7326/0003-4819-122-3-199502010-00007; Meier DE, 1998, NEW ENGL J MED, V338, P1193, DOI 10.1056/NEJM199804233381706; MOR V, 1987, Journal of Psychosocial Oncology, V5, P1, DOI 10.1300/J077v05n01_01; *OFF PROT RES RISK, 1993, PROT HUM RES SUBJ I; PATRICK C, 1992, GEN HOSP PSYCHIAT, V14, P219, DOI 10.1016/0163-8343(92)90091-N; PRUCHNO RA, 1989, J AM GERIATR SOC, V37, P697, DOI 10.1111/j.1532-5415.1989.tb02230.x; RICE DP, 1993, HEALTH AFFAIR, V12, P164, DOI 10.1377/hlthaff.12.2.164; SHERBOURNE CD, 1991, SOC SCI MED, V32, P705, DOI 10.1016/0277-9536(91)90150-B; SIEGEL K, 1991, CANCER, V68, P1131, DOI 10.1002/1097-0142(19910901)68:5<1131::AID-CNCR2820680541>3.0.CO;2-N; van der Maas PJ, 1991, LANCET, V338, P669, DOI 10.1016/0140-6736(91)91241-L; Ware J., 1993, SF 36 HLTH SURVEY MA; Zubrod C.G., 1960, J CHRON DIS, V11, P7	30	294	299	0	46	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					451	+		10.7326/0003-4819-132-6-200003210-00005	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	293CV	10733444				2022-12-24	WOS:000085834700004
J	Ling, LH; Oh, JK; Breen, JF; Schaff, HV; Danielson, GK; Mahoney, DW; Seward, JB; Tajik, AJ				Ling, LH; Oh, JK; Breen, JF; Schaff, HV; Danielson, GK; Mahoney, DW; Seward, JB; Tajik, AJ			Calcific constrictive pericarditis: Is it still with us?	ANNALS OF INTERNAL MEDICINE			English	Article						pericarditis, constrictive; calcinosis; heart failure, congestive; dyspnea	TUBERCULOUS PERICARDITIS; ETIOLOGY	Background: The presence of pericardial calcification on a plain radiograph strongly suggests constrictive pericarditis in patients with heart failure. However, calcific constrictive pericarditis is considered rare in the United States since tuberculosis incidence has decreased, and doubt has therefore been raised about the importance of this radiologic finding in modern cardiovascular practice. Objective: To determine the clinical and prognostic significance of pericardial calcification on radiography in patients with constrictive pericarditis. Design: Retrospective cohort study. Setting: Tertiary referral center. Patients: A consecutive series of 135 patients (mean age +/- SD, 56 +/- 16 years) who from 1985 through 1995 had constrictive pericarditis confirmed surgically (n = 133) or by autopsy (n = 2). Patients were divided into two groups: those with pericardial calcification on chest radiography (group I) and those without (group II). Measurements: Clinical and diagnostic findings were compared in both groups, and outcome was compared in 132 patients who had pericardiectomy. Results: Pericardial calcification was seen in 36 patients (27%). The cause of constrictive pericardial disease was indeterminate in 67% of patients in group I and in 21% of patients in group II(P < 0.001). Patients in group I had had symptoms for a longer period and were more likely to have pericardial knock, larger atrial size, and atrial arrhythmia. Significantly more perioperative deaths were seen in group I, but incidence of late survival and incidence of noncalcific disease were similar in both groups. Conclusions: Pericardial calcification is a common finding in patients with constrictive pericarditis. It is often associated with idiopathic disease and other markers of disease chronicity and is an independent predictor of increased perioperative mortality rates.	Mayo Clin & Mayo Fdn, Rochester, MN 55905 USA	Mayo Clinic	Oh, JK (corresponding author), Mayo Clin & Mayo Fdn, 200 1st St SW, Rochester, MN 55905 USA.			Schaff, Hartzell/0000-0003-0994-027X; Ling, Lieng H./0000-0001-6063-8530				AAGAARD MT, 1984, THORAC CARDIOV SURG, V32, P311, DOI 10.1055/s-2007-1023411; BASHI VV, 1988, THORAX, V43, P637, DOI 10.1136/thx.43.8.637; BLAKE S, 1983, BRIT HEART J, V50, P273; CAMERON J, 1987, AM HEART J, V113, P354, DOI 10.1016/0002-8703(87)90278-X; CHAMBLISS JR, 1951, CIRCULATION, V4, P816, DOI 10.1161/01.CIR.4.6.816; CIMINO JJ, 1989, AM HEART J, V118, P1292, DOI 10.1016/0002-8703(89)90021-5; DALTON JC, 1956, ANN INTERN MED, V45, P445, DOI 10.7326/0003-4819-45-3-445; DCRUZ IA, 1978, RADIOLOGY, V127, P755, DOI 10.1148/127.3.755; DINES DE, 1958, P STAFF M MAYO CLIN, V33, P93; FEIRING AJ, 1985, CIRCULATION, V72, P1355, DOI 10.1161/01.CIR.72.6.1355; FOWLER NO, 1991, JAMA-J AM MED ASSOC, V266, P99, DOI 10.1001/jama.266.1.99; GIMLETTE TMD, 1959, BRIT HEART J, V21, P9; HAGEMAN JH, 1964, NEW ENGL J MED, V270, P327, DOI 10.1056/NEJM196402132700702; HARVEY RM, 1953, CIRCULATION, V8, P695, DOI 10.1161/01.CIR.8.5.695; HEINZ R, 1957, RADIOLOGY, V69, P54, DOI 10.1148/69.1.54; HOLMAN E, 1955, JAMA-J AM MED ASSOC, V157, P789, DOI 10.1001/jama.1955.02950270007003; LEVINE HD, 1973, CIRCULATION, V48, P1268, DOI 10.1161/01.CIR.48.6.1268; Ling LH, 1999, CIRCULATION, V100, P1380, DOI 10.1161/01.CIR.100.13.1380; MACGREGOR JH, 1987, AM J ROENTGENOL, V148, P675, DOI 10.2214/ajr.148.4.675; Matsubara H, 1995, J Cardiol, V25, P89; MCCAUGHAN BC, 1985, J THORAC CARDIOV SUR, V89, P340; NI Y, 1990, ANN THORAC SURG, V49, P445, DOI 10.1016/0003-4975(90)90252-2; PAUL O, 1948, AM J MED SCI, V216, P361, DOI 10.1097/00000441-194810000-00001; Potwar S A, 1989, Indian Heart J, V41, P30; RIENMULLER R, 1993, J THORAC IMAG, V8, P108; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; SCHIAVONE WA, 1989, AM J CARDIOL, V63, P145, DOI 10.1016/0002-9149(89)91106-5; SCHIAVONE WA, 1986, AM J CARDIOL, V58, P373, DOI 10.1016/0002-9149(86)90087-1; SCHOENFELD MH, 1987, CIRCULATION, V75, P1012, DOI 10.1161/01.CIR.75.5.1012; STEINBERG I, 1961, AM J CARDIOL, V7, P33, DOI 10.1016/0002-9149(61)90421-0; SUWAN PK, 1995, BRIT HEART J, V73, P187; TIRILOMIS T, 1994, EUR J CARDIO-THORAC, V8, P487, DOI 10.1016/1010-7940(94)90020-5; Wise D E, 1976, Cardiovasc Clin, V7, P197; WOOD P, 1961, AM J CARDIOL, V7, P48, DOI 10.1016/0002-9149(61)90422-2; WYCHULIS AR, 1971, J THORAC CARDIOV SUR, V62, P608, DOI 10.1016/S0022-5223(19)42030-8	35	102	112	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 21	2000	132	6					444	+		10.7326/0003-4819-132-6-200003210-00004	http://dx.doi.org/10.7326/0003-4819-132-6-200003210-00004			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293CV	10733443				2022-12-24	WOS:000085834700003
J	Bell, S; Kamm, MA				Bell, S; Kamm, MA			Antibodies to tumour necrosis factor alpha as treatment for Crohn's disease	LANCET			English	Editorial Material							INFLAMMATORY BOWEL-DISEASE; AZATHIOPRINE; TERM; CA2		St Marks Hosp, Dept Gastroenterol, Harrow HA1 3UJ, Middx, England	Imperial College London	Bell, S (corresponding author), St Marks Hosp, Dept Gastroenterol, Harrow HA1 3UJ, Middx, England.							Baert FJ, 1999, INT J COLORECTAL DIS, V14, P47, DOI 10.1007/s003840050182; Bickston SJ, 1999, GASTROENTEROLOGY, V117, P1433, DOI 10.1016/S0016-5085(99)70294-5; CONNELL WR, 1994, GUT, V35, P347, DOI 10.1136/gut.35.3.347; CONNELL WR, 1994, LANCET, V343, P1249, DOI 10.1016/S0140-6736(94)92150-4; CONNELL WR, 1993, GUT, V34, P1081, DOI 10.1136/gut.34.8.1081; D'Haens G, 1999, GASTROENTEROLOGY, V116, P1029, DOI 10.1016/S0016-5085(99)70005-3; Dalum I, 1999, NAT BIOTECHNOL, V17, P666, DOI 10.1038/10878; GREENSTEIN AJ, 1992, CANCER-AM CANCER SOC, V69, P1119; Hanauer SB, 1999, GASTROENTEROLOGY, V116, pA731; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Rutgeerts P, 1999, GASTROENTEROLOGY, V117, P761, DOI 10.1016/S0016-5085(99)70332-X; SANDBORN WJ, 1999, GUT, V45, pA133; SCALLON BJ, 1995, CYTOKINE, V7, P251, DOI 10.1006/cyto.1995.0029; Stack WA, 1997, LANCET, V349, P521, DOI 10.1016/S0140-6736(97)80083-9; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502	15	79	81	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					858	860		10.1016/S0140-6736(99)00442-0	http://dx.doi.org/10.1016/S0140-6736(99)00442-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752696				2022-12-24	WOS:000085896000002
J	Russ, AP; Wattler, S; Colledge, WH; Aparicio, SAJR; Carlton, MBL; Pearce, JJ; Barton, SC; Surani, MA; Ryan, K; Nehls, MC; Wilson, V; Evans, MJ				Russ, AP; Wattler, S; Colledge, WH; Aparicio, SAJR; Carlton, MBL; Pearce, JJ; Barton, SC; Surani, MA; Ryan, K; Nehls, MC; Wilson, V; Evans, MJ			Eomesodermin is required for mouse trophoblast development and mesoderm formation	NATURE			English	Article							CHIMERIC ANALYSIS; T-GENE; EMBRYO; GASTRULATION; EXPRESSION; FAMILY	The earliest cell fate decision in the mammalian embryo separates the extra-embryonic trophoblast lineage, which forms the fetal portion of the placenta, from the embryonic cell lineages. The body plan of the embryo proper is established only later at gastrulation, when the pluripotent epiblast gives rise to the germ layers ectoderm, mesoderm and endoderm. Here we show that the T-box gene Eomesodermin(1) performs essential functions in both trophoblast development and gastrulation, Mouse embryos lacking Eomesodermin arrest at the blastocyst stage. Mutant trophoectoderm does not differentiate into trophoblast, indicating that Eomesodermin may be required for the development of trophoblast stem cells(2), In the embryo proper, Eomesodermin is essential for mesoderm formation. Although the specification of the anterior-posterior axis and the initial response to mesoderm-inducing signals is intact in mutant epiblasts, the prospective mesodermal cells are not recruited into the primitive streak. Our results indicate that Eomesodermin defines a conserved molecular pathway controlling the morphogenetic movements of germ layer formation and has acquired a new function in mammals in the differentiation of trophoblast.	Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge CB2 1QR, England; Univ Cambridge, Dept Physiol, Cambridge CB2 3EG, England; Paradigm Therapeut Ltd, Cambridge CB2 3EG, England; Niedersachs Inst Peptidforsch, D-30625 Hannover, Germany; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Oncol, Cambridge CB2 2XY, England; Univ Edinburgh, Ctr Genome Res, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh	Russ, AP (corresponding author), Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Tennis Court Rd, Cambridge CB2 1QR, England.		Wilson, Valerie A/H-5427-2011; Colledge, William/X-4976-2019	Colledge, William/0000-0002-9603-4429; Aparicio, Samuel/0000-0002-0487-9599				Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Beddington RSP, 1998, TRENDS GENET, V14, P277, DOI 10.1016/S0168-9525(98)01499-1; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Casey ES, 1999, DEVELOPMENT, V126, P4193; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; Ciruna BG, 1999, MECH DEVELOP, V81, P199, DOI 10.1016/S0925-4773(98)00243-3; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; Hancock SN, 1999, MECH DEVELOP, V81, P205, DOI 10.1016/S0925-4773(98)00244-5; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Hogan B, 1994, MANIPULATING MOUSE E; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Papaioannou VE, 1998, BIOESSAYS, V20, P9, DOI 10.1002/(SICI)1521-1878(199801)20:1<9::AID-BIES4>3.0.CO;2-Q; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Rossant J, 1998, TRENDS GENET, V14, P358, DOI 10.1016/S0168-9525(98)01552-2; ROSSANT J, 1981, J EMBRYOL EXP MORPH, V62, P217; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Smith J, 1999, TRENDS GENET, V15, P154, DOI 10.1016/S0168-9525(99)01693-5; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; SUTHERLAND AE, 1988, J CELL BIOL, V106, P1331, DOI 10.1083/jcb.106.4.1331; SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175; Tada M, 1998, DEVELOPMENT, V125, P3997; Tam PPL, 1997, MECH DEVELOP, V68, P3, DOI 10.1016/S0925-4773(97)00123-8; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Wattler S, 1998, GENOMICS, V48, P24, DOI 10.1006/geno.1997.5150; WILSON V, 1993, DEVELOPMENT, V117, P1321; WILSON V, 1995, DEVELOPMENT, V121, P877	29	466	474	0	40	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 2	2000	404	6773					95	99		10.1038/35003601	http://dx.doi.org/10.1038/35003601			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BW	10716450				2022-12-24	WOS:000085775100053
J	Ellis, M; Manandhar, N; Manandhar, DS; Costello, AMDL				Ellis, M; Manandhar, N; Manandhar, DS; Costello, AMDL			Risk factors for neonatal encephalopathy in Kathmandu, Nepal, a developing country: unmatched case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; AUSTRALIAN CASE-CONTROL; FULL-TERM INFANTS; NEWBORN ENCEPHALOPATHY; BIRTH ASPHYXIA; INDUCTION; LABOR; MECONIUM; PREGNANCY; MAGNESIUM	Objective To determine the risk factors for neonatal encephalopathy among term infants in a developing country. Design Unmatched case-control study. Setting Principal maternity hospital of Kathmandu, Nepal. Subjects All 131 infants with neonatal encephalopathy from a population of 21 609 infants born over an 18 month period, and 635 unmatched infants systematically recruited over 12 months. Main outcome measures Adjusted odds ratio estimates for antepartum and intrapartum risk factors. Results The prevalence of neonatal encephalopathy was 6.1 per 1000 live births of which 63% were infants with moderate or severe encephalopathy. The risk of death from neonatal encephalopathy was 31%. The risk of neonatal encephalopathy increased with increasing maternal age and decreasing maternal height. Antepartum risk factors included primiparity (odds ratio 2.0) and non-attendance for antenatal care (2.1). Multiple births were at greatly increased risk (22). Intrapartum risk factors included non-cephalic presentation (3.4), prolonged rupture of membranes (3.8), and various other complications. Particulate meconium was strongly associated with encephalopathy (18). Induction of labour with oxytocin was associated with encephalopathy in 12 of 41 deliveries (5.7), Overall, 78 affected infants (60%) compared with 36 controls (6%) either had evidence of intrapartum compromise or were born after an intrapartum difficulty likely to result ill fetal compromise. A concentration of maternal haemoglobin of less than 8.0 g/dl in the puerperium was significantly associated with encephalopathy (2.5) as was a maternal thyroid stimulating hormone concentration greater than 5 mIU/l (2.1). Conclusions Intrapartum risk factors remain important for neonatal encephalopathy in developing countries. There is some evidence of a protective effect from antenatal care. The use of oxytocin in low income countries where intrapartum monitoring is suboptimal presents a major risk to the fetus. More work is required to explore the association between maternal deficiency states and neonatal encephalopathy.	UCL, Inst Child Hlth, Ctr Int Child Hlth, London WC1N 1EH, England; Maternal & Infant Res Act, Kathmandu, Nepal	University of London; University College London	Ellis, M (corresponding author), Royal Hosp Sick Children, Inst Child Hlth, Bristol BS2 8BJ, Avon, England.	M.Ellis@bristol.ac.uk			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ADAMSON SJ, 1995, BRIT MED J, V311, P598, DOI 10.1136/bmj.311.7005.598; Amiel-Tison C., 1995, P83; AMIELTISON C, 1986, DEV MED CHILD NEUROL, V28, P671; Badawi N, 1998, BMJ-BRIT MED J, V317, P1549, DOI 10.1136/bmj.317.7172.1549; Badawi N, 1998, BMJ-BRIT MED J, V317, P1554, DOI 10.1136/bmj.317.7172.1554; Badawi N, 1999, BRIT MED J, V318, P1415; Bhutta ZA, 2000, IMPROVING NEWBORN INFANT HEALTH IN DEVELOPING COUNTRIES, P289, DOI 10.1142/9781848160705_0016; BOLAM A, 1997, J NEPAL MED ASS, V35, P122; *CENTR BUR STAT, 1993, AN 1991 POP CENS; CONNELL J, 1989, ARCH DIS CHILD-FETAL, V64, P452, DOI 10.1136/adc.64.4_Spec_No.452; DAGA AS, 1990, J TROP PEDIATRICS, V36, P34, DOI 10.1093/tropej/36.1.34; DIJXHOORN MJ, 1986, BRIT J OBSTET GYNAEC, V93, P217, DOI 10.1111/j.1471-0528.1986.tb07896.x; Edwards AD, 1998, BMJ-BRIT MED J, V317, P1537, DOI 10.1136/bmj.317.7172.1537; Ellis M, 2000, PAEDIATR PERINAT EP, V14, P39; Ellis M, 1999, DEV MED CHILD NEUROL, V41, P689, DOI 10.1017/S0012162299001413; ELLIS M, 1988, INDIAN PEDIATR, V35, P415; ELLIS ME, 1999, THESIS U COLLEGE LON; ESCOFFERY C, 1994, PAEDIATR PERINAT EP, V8, P119, DOI 10.1111/j.1365-3016.1994.tb00496.x; FENICHEL GM, 1983, ARCH NEUROL-CHICAGO, V40, P261, DOI 10.1001/archneur.1983.04050050029002; GAFFNEY G, 1994, BRIT MED J, V308, P743, DOI 10.1136/bmj.308.6931.743; HANNAH ME, 1992, NEW ENGL J MED, V326, P1587, DOI 10.1056/NEJM199206113262402; Harrison V, 1997, EARLY HUM DEV, V47, P287, DOI 10.1016/S0378-3782(96)01787-2; HOFMEYER GJ, 2000, COCHRANE LIBRARY; Ilves P, 1996, ACTA PAEDIATR, V85, P1348, DOI 10.1111/j.1651-2227.1996.tb13923.x; Jackson M, 1997, CLIN OBSTET GYNECOL, V40, P496, DOI 10.1097/00003081-199709000-00007; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Laube DW, 1997, CLIN OBSTET GYNECOL, V40, P485, DOI 10.1097/00003081-199709000-00006; LEVENE ML, 1985, EARLY HUM DEV, V11, P21, DOI 10.1016/0378-3782(85)90115-X; LEVENE RJ, 1995, FETAL NEONATAL NEURO, P427; LEVITON A, 1992, PEDIATR NEUROL, V8, P85, DOI 10.1016/0887-8994(92)90026-U; LOW JA, 1985, AM J OBSTET GYNECOL, V152, P256, DOI 10.1016/S0002-9378(85)80205-2; Mahomed K, 1998, BRIT J OBSTET GYNAEC, V105, P309, DOI 10.1111/j.1471-0528.1998.tb10092.x; MAHOMED K, 1998, COCHRANE LIBRARY; MAHOMED K, 1997, COCHRANE LIBRARY; MAKAREM A, 1974, CLIN CHEM, P1125; MINCHOM P, 1987, BRIT J OBSTET GYNAEC, V94, P431, DOI 10.1111/j.1471-0528.1987.tb03121.x; PARKIN JM, 1976, ARCH DIS CHILD, V51, P259, DOI 10.1136/adc.51.4.259; Reddy V., 1992, NUTR INDIA; REDLINE RW, 1995, CURR OPIN OBSTET GYN, V7, P10; WISWELL TE, 1993, PEDIATR CLIN N AM, V40, P955; *WORLD BANK, 1996, WORLD DEV REP; World Health Organization, 1996, WHOFRHMSM967; YUDKIN P, 1979, BRIT J OBSTET GYNAEC, V86, P257, DOI 10.1111/j.1471-0528.1979.tb11252.x	44	92	95	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAY 6	2000	320	7244					1229	1236		10.1136/bmj.320.7244.1229	http://dx.doi.org/10.1136/bmj.320.7244.1229			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CF	10797030	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000086981400015
J	Rector, TS				Rector, TS			Exhaustion of drug benefits and disenrollment of medicare beneficiaries from managed care organizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK	Context Many Medicare beneficiaries enroll in managed care health plans to obtain outpatient drug benefits. Increasing pharmaceutical utilization and costs and decreasing drug benefits increase the likelihood that medication use by such enrollees will exceed drug benefits, which may lead to health plan disenrollment. Objective To test the hypothesis that exhaustion of managed care drug benefits by Medicare beneficiaries is associated with disenrollment from the health plan. Design Retrospective cohort study followed up for 1 year (1998) using an enrollment/claims database. Setting Four geographically diverse network-model health plans that had annual drug benefits of $300, $500, $600, or $1000. Participants A total of 61 412 elderly Medicare beneficiaries. Main Outcome Measure Voluntary disenrollment from health plans by members who did or did not exhaust their drug benefits. Results The likelihood of exhausting 1998 drug benefits ranged from 17% to 25% across health plans (P<.001). The relative hazards of disenrollment from the 4 plans when drug benefits had been exhausted were 2.5 (95% confidence interval [CI], 2.3-2.8), 1.9 (95% CI, 1.7-2.1), 2.7 (95% CI, 2.0-3.6), and 2.1 (95% CI, 1.9-2.4). Statistical adjustments for age, sex, prior enrollment, hospital admissions, physician visits, and county of residence did not alter these estimates. Conclusions Exhaustion of drug benefits was associated with a significant increase in the likelihood of disenrollment of Medicare beneficiaries, this finding arouses concern that Medicare beneficiaries must change plans to have financial access to medications, which can lead to discontinuity in care and diversion of resources from care to administrative matters. Policymakers should strive to avoid fragmented systems of providing drug benefits.	Unitedhlth Grp, Ctr Hlth Care Policy & Evaluat, Minneapolis, MN 55440 USA		Rector, TS (corresponding author), Unitedhlth Grp, Ctr Hlth Care Policy & Evaluat, POB 1459, Minneapolis, MN 55440 USA.							ALLISON PD, 1995, SURVIVAL ANAL USING, P111; Davis M, 1999, HEALTH AFFAIR, V18, P231, DOI 10.1377/hlthaff.18.1.231; Greenwald LM, 1998, INQUIRY-J HEALTH CAR, V35, P193; HARRINGTON C, 1993, INQUIRY-J HEALTH CAR, V30, P429; JERNIGAN CL, 1999, J MANAGED CARE PHARM, V5, P44; Mueller C, 1997, AM J PUBLIC HEALTH, V87, P1626, DOI 10.2105/AJPH.87.10.1626; Newcomer R, 1996, INQUIRY-J HEALTH CAR, V33, P144; PORELL FW, 1992, FACTORS ASS DISENROL; Riley GF, 1997, HEALTH AFFAIR, V16, P117, DOI 10.1377/hlthaff.16.5.117; Schlesinger M, 1999, HEALTH SERV RES, V34, P547; Soumerai SB, 1999, NEW ENGL J MED, V340, P722, DOI 10.1056/NEJM199903043400909; Wilson J, 1998, CLIN THER, V20, P1263, DOI 10.1016/S0149-2918(98)80121-5	12	34	34	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 26	2000	283	16					2163	2167		10.1001/jama.283.16.2163	http://dx.doi.org/10.1001/jama.283.16.2163			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	305MA	10791512				2022-12-24	WOS:000086542800036
J	Molinari, M; Helenius, A				Molinari, M; Helenius, A			Chaperone selection during glycoprotein translocation into the endoplasmic reticulum	SCIENCE			English	Article							INFLUENZA-VIRUS HEMAGGLUTININ; CHAIN BINDING-PROTEIN; SEQUENTIAL INTERACTION; BIP; ASSOCIATION; CALNEXIN; TRANSPORT; SECRETION; GLYCOSYLATION; MATURATION	A variety of molecular chaperones and folding enzymes assist the folding of newly synthesized proteins in the endoplasmic reticulum. Here we investigated why some glycoproteins interact with the molecular chaperone sip, and others with the calnexin/calreticulin pathway. The folding of Semliki forest virus glycoproteins and influenza hemagglutinin was studied in Living cells. The initial choice of chaperone depended on the Location of N-linked glycans in the growing nascent chain. Direct interaction with calnexin and calreticulin without prior interaction with BiP occurred if glycans were present within about 50 residues of the protein's NH2-terminus.	ETH Zurich, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Helenius, A (corresponding author), ETH Zurich, Univ Str 16, CH-8092 Zurich, Switzerland.		Molinari, Maurizio/N-2587-2019	Molinari, Maurizio/0000-0002-7636-5829				BRAAKMAN I, 1991, J CELL BIOL, V114, P401, DOI 10.1083/jcb.114.3.401; CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229; COPELAND CS, 1988, CELL, V53, P197, DOI 10.1016/0092-8674(88)90381-9; DORNER AJ, 1987, J CELL BIOL, V105, P2665, DOI 10.1083/jcb.105.6.2665; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAMMOND C, 1994, SCIENCE, V266, P456, DOI 10.1126/science.7939687; HEBERT DN, 1995, CELL, V81, P425, DOI 10.1016/0092-8674(95)90395-X; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; HURTLEY SM, 1989, J CELL BIOL, V108, P2117, DOI 10.1083/jcb.108.6.2117; KIM PS, 1995, J CELL BIOL, V128, P29, DOI 10.1083/jcb.128.1.29; Knarr G, 1999, J BIOL CHEM, V274, P29850, DOI 10.1074/jbc.274.42.29850; MELNICK J, 1994, NATURE, V370, P373, DOI 10.1038/370373a0; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; MULVEY M, 1995, J VIROL, V69, P1621, DOI 10.1128/JVI.69.3.1621-1627.1995; NG DTW, 1989, J CELL BIOL, V109, P3273, DOI 10.1083/jcb.109.6.3273; PITTMAN DD, 1994, J BIOL CHEM, V269, P17329; SU K, 1993, J BIOL CHEM, V268, P14301; Xu AM, 1998, J VIROL, V72, P9865, DOI 10.1128/JVI.72.12.9865-9872.1998; Yang YN, 1998, J BIOL CHEM, V273, P25552, DOI 10.1074/jbc.273.40.25552; ZHANG Y, 1993, BIOCHEM J, V295, P841, DOI 10.1042/bj2950841	21	273	282	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					331	333		10.1126/science.288.5464.331	http://dx.doi.org/10.1126/science.288.5464.331			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764645				2022-12-24	WOS:000086454300036
J	Ohno, M; Segref, A; Bachi, A; Wilm, M; Mattaj, IW				Ohno, M; Segref, A; Bachi, A; Wilm, M; Mattaj, IW			PHAX, a mediator of U snRNA nuclear export whose activity is regulated by phosphorylation	CELL			English	Article							CAP-BINDING PROTEIN; MESSENGER-RNA; IMPORTIN-BETA; NUCLEOCYTOPLASMIC TRANSPORT; SACCHAROMYCES-CEREVISIAE; RECEPTOR; COMPLEX; IDENTIFICATION; REV; RAN	In metazoa, assembly of spliceosomal U snRNPs requires nuclear export of U snRNA precursors. Export depends upon the RNA cap structure, nuclear cap-binding complex (CBC), the export receptor CRM1/Xpo1, and RanGTP. These components are however insufficient to support U snRNA export. We identify PHAX (phosphorylated adaptor for RNA export) as the additional factor required for U snRNA export complex assembly in vitro. In vivo, PHAX is required for U snRNA export but not for CRM1-mediated export in general. PHAX is phosphorylated in the nucleus and then exported with RNA to the cytoplasm, where it is dephosphorylated. PHAX phosphorylation is essential for export complex assembly while its dephosphorylation causes export complex disassembly. The compartmentalized PHAX phosphorylation cycle can contribute to the directionality of export.	European Mol Biol Lab, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Mattaj, IW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.		bachi, angela/B-3527-2015; Segref, Alexandra/C-8325-2011	bachi, angela/0000-0003-4842-6556; Wilm, Matthias/0000-0002-5461-6834; Segref, Alexandra/0000-0001-8095-4469; Mattaj, Iain/0000-0002-5537-8284				Arts GJ, 1998, CURR BIOL, V8, P305, DOI 10.1016/S0960-9822(98)70130-7; Askjaer P, 1999, MOL CELL BIOL, V19, P6276; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; Cole CN, 1998, CURR BIOL, V8, pR368, DOI 10.1016/S0960-9822(98)70239-8; Dahlberg JE, 1998, CURR OPIN CELL BIOL, V10, P400, DOI 10.1016/S0955-0674(98)80017-3; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Floer M, 1997, J BIOL CHEM, V272, P19538, DOI 10.1074/jbc.272.31.19538; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Gorlich D, 1996, CELL, V87, P21, DOI 10.1016/S0092-8674(00)81319-7; Gorlich D, 1998, EMBO J, V17, P2721, DOI 10.1093/emboj/17.10.2721; HAMM J, 1990, CELL, V63, P109, DOI 10.1016/0092-8674(90)90292-M; Hellmuth K, 1998, MOL CELL BIOL, V18, P6374, DOI 10.1128/MCB.18.11.6374; Hood JK, 1999, CURR OPIN CELL BIOL, V11, P241, DOI 10.1016/S0955-0674(99)80032-5; Huber J, 1998, EMBO J, V17, P4114, DOI 10.1093/emboj/17.14.4114; Izaurralde E, 1995, COLD SPRING HARB SYM, V60, P669, DOI 10.1101/SQB.1995.060.01.072; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Izaurralde E, 1998, RNA, V4, P351; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; JARMOLOWSKI A, 1994, J CELL BIOL, V124, P627, DOI 10.1083/jcb.124.5.627; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; KATAOKA N, 1994, NUCLEIC ACIDS RES, V22, P3861, DOI 10.1093/nar/22.19.3861; KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Kohler M, 1999, MOL CELL BIOL, V19, P7782; Kutay U, 1998, MOL CELL, V1, P359, DOI 10.1016/S1097-2765(00)80036-2; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; LUHRMANN R, 1990, BIOCHIM BIOPHYS ACTA, V1087, P265, DOI 10.1016/0167-4781(90)90001-I; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; MATTAJ IW, 1988, STRUCTURE FUNCTION M, P100; Neville M, 1999, EMBO J, V18, P3746, DOI 10.1093/emboj/18.13.3746; NINKINA NN, 1994, MOL BRAIN RES, V22, P39, DOI 10.1016/0169-328X(94)90030-2; Ohno M, 1998, CELL, V92, P327, DOI 10.1016/S0092-8674(00)80926-5; Palacios I, 1997, EMBO J, V16, P6783, DOI 10.1093/emboj/16.22.6783; Paraskeva E, 1999, J CELL BIOL, V145, P255, DOI 10.1083/jcb.145.2.255; Pasquinelli AE, 1997, EMBO J, V16, P7500, DOI 10.1093/emboj/16.24.7500; Sarkar S, 1998, MOL BIOL CELL, V9, P3041, DOI 10.1091/mbc.9.11.3041; Senger B, 1998, EMBO J, V17, P2196, DOI 10.1093/emboj/17.8.2196; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; SONTHEIMER EJ, 1994, MOL BIOL REP, V20, P35, DOI 10.1007/BF00999853; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Takizawa CG, 1999, P NATL ACAD SCI USA, V96, P7938, DOI 10.1073/pnas.96.14.7938; Truant R, 1999, MOL CELL BIOL, V19, P1210; Visa N, 1996, J CELL BIOL, V133, P5, DOI 10.1083/jcb.133.1.5; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X	51	261	272	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	APR 14	2000	101	2					187	198		10.1016/S0092-8674(00)80829-6	http://dx.doi.org/10.1016/S0092-8674(00)80829-6			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	305DP	10786834	Bronze			2022-12-24	WOS:000086524400005
J	Purvis, A; Agapow, PM; Gittleman, JL; Mace, GM				Purvis, A; Agapow, PM; Gittleman, JL; Mace, GM			Nonrandom extinction and the loss of evolutionary history	SCIENCE			English	Article							DIVERSITY; PHYLOGENY; FUTURE	The hierarchical nature of phylogenies means that random extinction of species affects a smaller fraction of higher taxa, and so the total amount of evolutionary history lost may be comparatively slight. However, current extinction risk is not phylogenetically random. We show the potentially severe implications of the clumped nature of threat for the loss of biodiversity. An additional 120 avian and mammalian genera are at risk compared with the number predicted under random extinction. We estimate that the prospective extra Loss of mammalian evolutionary history alone would be equivalent to Losing a monotypic phylum.	Univ London Imperial Coll Sci Technol & Med, Dept Biol, Ascot SL5 7PY, Berks, England; Univ Virginia, Dept Biol, Charlottesville, VA 22903 USA; Zool Soc London, Inst Zool, London NW1 4RY, England	Imperial College London; University of Virginia; Zoological Society of London	Purvis, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Biol, Silwood Pk, Ascot SL5 7PY, Berks, England.		Mace, Georgina M/I-3072-2016; Purvis, Andy/A-7529-2008	Mace, Georgina M/0000-0001-8965-5211; Purvis, Andy/0000-0002-8609-6204				[Anonymous], 1995, GLOBAL BIODIVERSITY; AVISE JC, 1982, EVOL BIOL, V15, P151; Bennett PM, 1997, P ROY SOC B-BIOL SCI, V264, P401, DOI 10.1098/rspb.1997.0057; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Crozier RH, 1997, ANNU REV ECOL SYST, V28, P243, DOI 10.1146/annurev.ecolsys.28.1.243; Faith Daniel P., 1994, V50, P251; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gaston KJ, 1997, EVOL ECOL, V11, P557, DOI 10.1007/s10682-997-1511-4; Heard SB, 2000, P ROY SOC B-BIOL SCI, V267, P613, DOI 10.1098/rspb.2000.1046; IUCN, 2021, THE IUCN RED LIST TH, DOI [10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.en, DOI 10.2305/IUCN.UK.2015-2.RLTS.T2446A22156678.EN]; IUCN (International Union for Conservation of Nature), 1994, IUCN RED LIST CAT; MACE GM, 1999, FUTURE PRIORITIES CO; MacPhee R.D.E., 1999, P333; MAY RM, 1990, NATURE, V347, P129, DOI 10.1038/347129a0; May Robert M., 1995, P1; Morony JJ, 1975, REFERENCE LIST BIRDS; Nee S, 1997, SCIENCE, V278, P692, DOI 10.1126/science.278.5338.692; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Russell GJ, 1998, CONSERV BIOL, V12, P1365, DOI 10.1046/j.1523-1739.1998.96332.x; Rylands Anthony B., 1995, Neotropical Primates, V3, P113; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Williams Paul H., 1996, P261; Williams Paul H., 1996, P54; Wilson DE, 1993, MAMMAL SPECIES WORLD	25	396	403	3	124	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 14	2000	288	5464					328	330		10.1126/science.288.5464.328	http://dx.doi.org/10.1126/science.288.5464.328			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303YA	10764644				2022-12-24	WOS:000086454300035
J	Yusuf, HR; Akhter, HH; Rahman, MH; Chowdhury, MEEK; Rochat, RW				Yusuf, HR; Akhter, HH; Rahman, MH; Chowdhury, MEEK; Rochat, RW			Injury-related deaths among women aged 10-50 years in Bangladesh, 1996-97	LANCET			English	Article							RURAL BANGLADESH; EPIDEMIOLOGY; DELHI; INDIA	Background Few studies have examined injury-related deaths among women in Bangladesh. We did a case-finding study to identify causes and the impact of intentional and unintentional injury-related deaths among women aged 10-50 years in Bangladesh. Methods Between 1996 and 1997, health care and other service providers at 4751 health facilities throughout Bangladesh were interviewed about their knowledge of deaths among women aged 10-50 years. In addition, at all public facilities providing inpatient service. medical records of women who died during the study period were reviewed. The reported circumstances surrounding each death were carefully reviewed to attribute the most likely cause of death. Findings 28 998 deaths among women aged 10-50 years were identified in our study, and, of these, 6610 (23%) were thought to be caused by intentional or unintentional injuries. About half (3317) of the injury deaths were attributable to suicide, 352 (5%) to homicide, 1100 (17%) to accidental injuries, and the intent was unknown for 1841 (28%) deaths. The unadjusted rate of suicides were higher in the Khulna administrative division (27.0 per 100 000) than the other four administrative divisions of Bangladesh (range 3.5-11.3 per 100 000). Poisoning (n=3971) was the commonest cause of injury-related death-60% of all injury deaths (6610) and 14% of all deaths (28 998). Other common causes of injury deaths in order of frequency were hanging or suffocation, road traffic accidents, bums, drowning, physical assault, firearm or sharp instrument injury, and snake or animal bite. Interpretation Intentional and unintentional injuries are a major cause of death among women aged 10-50 years in Bangladesh. Strategies to reduce injury-related deaths among women need to be devised.	Ctr Dis Control & Prevent, Immunisat Serv Div, Hlth Serv Res & Evaluat Branch, Atlanta, GA 30333 USA; Bangladesh Inst Res & Promot Essential & Reprod H, Dhaka, Bangladesh; Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Div Reprod Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Yusuf, HR (corresponding author), Ctr Dis Control & Prevent, Immunisat Serv Div, Hlth Serv Res & Evaluat Branch, Atlanta, GA 30333 USA.		Rochat, Roger/J-9802-2012					Adityanjee D R, 1986, Int J Soc Psychiatry, V32, P64, DOI 10.1177/002076408603200208; *BANGL BUR STAT, 1994, HDSPUB004 BANGL BUR; *BANGL BUR STAT, 1994, BANGL POP CENS 1991, V1, P98; Bhattacharjee JB, 1996, MED SCI LAW, V36, P194, DOI 10.1177/002580249603600303; FAUVEAU V, 1989, INT J EPIDEMIOL, V18, P139, DOI 10.1093/ije/18.1.139; FAUVEAU V, 1988, B WORLD HEALTH ORGAN, V66, P643; ISLAM S, 1985, WOMEN VICTIMS VIOLEN; KUMAR P, 1994, BURNS, V20, P236, DOI 10.1016/0305-4179(94)90189-9; Latha KS, 1996, ACTA PSYCHIAT SCAND, V94, P26, DOI 10.1111/j.1600-0447.1996.tb09820.x; MAHLER H, 1987, LANCET, V1, P668; MURRAY CJL, 1996, GLOBAL BURDEN DIS, V1, P117; NAGPAUL H, 1985, INT J OFFENDER THER, V29, P147, DOI 10.1177/0306624X8502900207; PANDEY R, 1985, INDIAN J SOC WORK, V45, P429; PANDEY R, 1986, SOCIAL DEFENSE, V21, P5; PRASAD BD, 1994, J COMP FAM STUD, V25, P71, DOI 10.3138/jcfs.25.1.71; ROCHAT R W, 1981, International Journal of Gynecology and Obstetrics, V19, P155, DOI 10.1016/0020-7292(81)90056-4; SAHDEV P, 1994, ACCIDENT ANAL PREV, V26, P377, DOI 10.1016/0001-4575(94)90011-6; SHIQING Z, 1994, CRISIS, V15, P44; SMITH GS, 1991, EPIDEMIOL REV, V13, P228, DOI 10.1093/oxfordjournals.epirev.a036070; STEIN S, 1986, INT J EPIDEMIOL, V15, P303; *WHO, 1978, LAY REP HLTH INF; *WHO, 1993, WHO2 REG OFF SE AS	22	41	42	0	1	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 8	2000	355	9211					1220	1224		10.1016/S0140-6736(00)02088-2	http://dx.doi.org/10.1016/S0140-6736(00)02088-2			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303VX	10770304				2022-12-24	WOS:000086448000011
J	Chong, L; Culotta, E; Sugden, A				Chong, L; Culotta, E; Sugden, A			On the move	SCIENCE			English	Editorial Material																			0	15	16	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					79	79		10.1126/science.288.5463.79	http://dx.doi.org/10.1126/science.288.5463.79			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10766639				2022-12-24	WOS:000086387700033
J	Cotton, K				Cotton, K			Surrogacy should pay	BRITISH MEDICAL JOURNAL			English	Article									Childlessness Overcome Through Surrogacy, Sutherland IV27 4EF, Scotland		Cotton, K (corresponding author), Childlessness Overcome Through Surrogacy, Loandhu Cottage, Sutherland IV27 4EF, Scotland.								0	2	2	1	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 1	2000	320	7239					928	929						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	301YA	10787254				2022-12-24	WOS:000086337100034
J	Lloyd, BW; Brodie, K				Lloyd, BW; Brodie, K			Recognition of television images as a developmental milestone in young children: observational study	BRITISH MEDICAL JOURNAL			English	Article								Objectives To determine the age at which children with apparently normal development can recognise the television image of a cat, dog, or baby. Design Observational study. Setting District general hospital in north London. Subjects 797 children with apparently normal development aged between 8 and 23 months and 26 children with Down's syndrome aged 18 months. Outcome measures Whether or not the child recognised the television image of a cat, dog, or baby by naming, imitating, or pointing at the image. Results by 18 months of age 96% (95% confidence interval 94% to 98%) of normal children recognised the television image of a cat, dog, or baby compared with 5 of 26 (19%) children with Down's syndrome. Conclusion Recognition of the television image of a cat, dog, or baby is a simple milestone, which may help in the developmental assessment of young children.	N Middlesex Hosp, Childrens Dept, London N18 1QX, England		Lloyd, BW (corresponding author), Royal Free Hosp, Pond St, London NW3 2QG, England.							Baron-Cohen Simon, 1996, British Journal of Psychiatry, V168, P158, DOI 10.1192/bjp.168.2.158; Bayley N., 1993, BAYLEY SCALES INFANT; FRANKENBURG WK, 1992, PEDIATRICS, V89, P91; HUNTLEY M, 1996, GRIFFITHMS MENTAL DE; REYNELL J, 1980, LANGUAGE DEV ASSESSM; Sheridan M., 1997, BIRTH 5 YEARS CHILDR	6	2	2	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					836	838		10.1136/bmj.320.7238.836	http://dx.doi.org/10.1136/bmj.320.7238.836			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	299DJ	10731175	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000086180300023
J	Power, C; Li, L				Power, C; Li, L			Cohort study of birthweight, mortality, and disability	BRITISH MEDICAL JOURNAL			English	Article							LOW-BIRTH-WEIGHT; INFANTS		Inst Child Hlth, Dept Epidemiol & Publ Hlth, London WC1N 1EH, England	University of London; University College London	Power, C (corresponding author), Inst Child Hlth, Dept Epidemiol & Publ Hlth, 30 Guilford St, London WC1N 1EH, England.							FERRI E, 1993, LIFE 33 5 FOLLOW UP; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; PHAROAH POD, 1994, ARCH DIS CHILD, V70, P264, DOI 10.1136/adc.70.4.264; STEWART AL, 1981, LANCET, V1, P1038; WEIR W, 1992, ARCH DIS CHILD, V67, P675	5	24	24	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					840	841		10.1136/bmj.320.7238.840	http://dx.doi.org/10.1136/bmj.320.7238.840			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731178	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000086180300026
J	Rubin, GM; Hong, L; Brokstein, P; Evans-Holm, M; Frise, E; Stapleton, M; Harvey, DA				Rubin, GM; Hong, L; Brokstein, P; Evans-Holm, M; Frise, E; Stapleton, M; Harvey, DA			A Drosophila complementary DNA resource	SCIENCE			English	Editorial Material							EXPRESSED SEQUENCE TAGS	Collections of nonredundant, full-length complementary DNA (cDNA) clones for each of the model organisms and humans will be important resources for studies of gene structure and function. We describe a general strategy for producing such collections and its implementation, which so far has generated a set of cDNAs corresponding to over 40% of the genes in the fruit fly Drosophila melanogaster.	Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA; Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Rubin, GM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley Drosophila Genome Project, Berkeley, CA 94720 USA.			Rubin, Gerald/0000-0001-8762-8703				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873; Bonaldo MDF, 1996, GENOME RES, V6, P791, DOI 10.1101/gr.6.9.791; Hillier L, 1996, GENOME RES, V6, P807, DOI 10.1101/gr.6.9.807; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; MUNROE DJ, 1995, P NATL ACAD SCI USA, V92, P2209, DOI 10.1073/pnas.92.6.2209; Strausberg RL, 1999, SCIENCE, V286, P455, DOI 10.1126/science.286.5439.455	7	289	361	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2222	2224		10.1126/science.287.5461.2222	http://dx.doi.org/10.1126/science.287.5461.2222			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731138				2022-12-24	WOS:000086049100039
J	El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS				El-Omar, EM; Carrington, M; Chow, WH; McColl, KEL; Bream, JH; Young, HA; Herrera, J; Lissowska, J; Yuan, CC; Rothman, N; Lanyon, G; Martin, M; Fraumeni, JF; Rabkin, CS			Interleukin-1 polymorphisms associated with increased risk of gastric cancer	NATURE			English	Article							HELICOBACTER-PYLORI INFECTION; NECROSIS-FACTOR-ALPHA; DUODENAL-ULCER DISEASE; ACID-SECRETION; RECEPTOR; CELLS; PATHWAYS	Helicobacter pylori infection is associated with a variety of clinical outcomes including gastric cancer and duodenal ulcer disease(1). The reasons for this variation are not clear, but the gastric physiological response is influenced by the severity and anatomical distribution of gastritis induced by H. pylori. Thus, individuals with gastritis predominantly localized to the antrum retain normal (or even high) acid secretion(2), whereas individuals with extensive corpus gastritis develop hypochlorhydria and gastric atrophy(3), which are presumptive precursors of gastric cancer(4). Here we report that interleukin-1 gene cluster polymorphisms suspected of enhancing production of interleukin-1-beta are associated with an increased risk of both hypochlorhydria induced by H. pylori and gastric cancer. Two of these polymorphism are hi near-complete linkage disequilibrium and one is a TATA-box polymorphism that markedly affects DNA-protein interactions in vitro. The association with disease may be explained by the biological properties of interleukin-1-beta, which is an important pro-inflammatory cytokine(5) and a powerful inhibitor of gastric acid secretion(6,7). Host genetic factors that affect interleukin-1-beta may determine why some individuals infected with H. pylori develop gastric cancer while others do not.	NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; Univ Aberdeen, Dept Med & Therapeut, Aberdeen, Scotland; NCI, Intramural Res Support Program, Sci Applicat Int Corp Frederick, Frederick Canc Res & Dev Ctr, Bethesda, MD 20892 USA; Univ Glasgow, Western Infirm, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland; NCI, Div Basic Sci, Frederick Canc Res & Dev Ctr, Bethesda, MD 20892 USA; M Sklodowska Curie Inst Oncol, Warsaw, Poland; Ctr Canc, Div Canc Epidemiol & Prevent, Warsaw, Poland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Aberdeen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Glasgow; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Maria Sklodowska-Curie National Research Institute of Oncology	El-Omar, EM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	elomare@mail.nih.gov	Garza-González, Elvira/B-7569-2009; El-Omar, Emad/AAT-7780-2021; Lissowska, Jolanta/AAH-3252-2020; Young, Howard/A-6350-2008	Lissowska, Jolanta/0000-0003-2695-5799; Bream, Jay/0000-0002-9149-7643; El-Omar, Emad/0000-0002-0011-3924; Young, Howard/0000-0002-3118-5111	NATIONAL CANCER INSTITUTE [Z01CP010136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andus T, 1997, GUT, V41, P651, DOI 10.1136/gut.41.5.651; Basso D, 1996, INT J CLIN LAB RES, V26, P207, DOI 10.1007/BF02592984; Beales ILP, 1998, GUT, V42, P227, DOI 10.1136/gut.42.2.227; BIDWELL JL, CYTOKINE GENE POLYM; Blaser MJ, 1998, BRIT MED J, V316, P1507, DOI 10.1136/bmj.316.7143.1507; CARRINGTON M, 1992, HUM IMMUNOL, V33, P208, DOI 10.1016/0198-8859(92)90073-V; Chow WH, 1999, INT J CANCER, V81, P871, DOI 10.1002/(SICI)1097-0215(19990611)81:6&lt;871::AID-IJC6&gt;3.0.CO;2-#; CORREA P, 1992, CANCER RES, V52, P6735; Cox A, 1998, AM J HUM GENET, V62, P1180, DOI 10.1086/301817; DANIS VA, 1995, CLIN EXP IMMUNOL, V99, P303; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; El-Omar EM, 2000, GASTROENTEROLOGY, V118, P22, DOI 10.1016/S0016-5085(00)70410-0; ElOmar EM, 1997, GASTROENTEROLOGY, V113, P15, DOI 10.1016/S0016-5085(97)70075-1; ELOMAR EM, 1995, GASTROENTEROLOGY, V109, P681, DOI 10.1016/0016-5085(95)90374-7; Hansson LE, 1996, NEW ENGL J MED, V335, P242, DOI 10.1056/NEJM199607253350404; Jung HC, 1997, J GASTROEN HEPATOL, V12, P473, DOI 10.1111/j.1440-1746.1997.tb00469.x; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; NOACH LA, 1994, SCAND J GASTROENTERO, V29, P425, DOI 10.3109/00365529409096833; Parkin DM, 1999, INT J CANCER, V80, P827, DOI 10.1002/(SICI)1097-0215(19990315)80:6&lt;827::AID-IJC6&gt;3.0.CO;2-P; POCIOT F, 1992, EUR J CLIN INVEST, V22, P396, DOI 10.1111/j.1365-2362.1992.tb01480.x; ROYALL RM, 1986, INT STAT REV, V54, P221, DOI 10.2307/1403146; RUIZ B, 1994, AM J GASTROENTEROL, V89, P533; SANTODONATO J, 1981, J ENVIRON PATHOL TOX, V5, P1; SIPPONEN P, 1994, SCAND J GASTROENTERO, V29, P24, DOI 10.3109/00365529409105356; STOCKBRUEGGER RW, 1984, SCAND J GASTROENTERO, V19, P355, DOI 10.1080/00365521.1984.12005735; Tountas NA, 1999, GASTROENTEROLOGY, V117, P806, DOI 10.1016/S0016-5085(99)70338-0; WALLACE JL, 1991, AM J PHYSIOL, V261, pG559, DOI 10.1152/ajpgi.1991.261.4.G559; Wolfe M M, 1992, Gastroenterology, V102, P2177; Yamaoka Y, 1999, J CLIN MICROBIOL, V37, P2274, DOI 10.1128/JCM.37.7.2274-2279.1999; Yu CR, 1996, J IMMUNOL, V157, P126	30	1801	1914	2	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					398	402		10.1038/35006081	http://dx.doi.org/10.1038/35006081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746728	Green Published, Green Accepted			2022-12-24	WOS:000086119000053
J	Gu, L; Tseng, S; Horner, RM; Tam, C; Loda, M; Rollins, BJ				Gu, L; Tseng, S; Horner, RM; Tam, C; Loda, M; Rollins, BJ			Control of T(H)2 polarization by the chemokine monocyte chemoattractant protein-1	NATURE			English	Article							T-LYMPHOCYTES; CHEMOTACTIC RESPONSIVENESS; TRANSGENIC MICE; CELL-LINE; EXPRESSION; RECEPTOR; INDUCTION; CLONING; PURIFICATION; RECRUITMENT	Activated T lymphocytes differentiate into effector cells tailored to meet disparate challenges to host integrity(1). For example, type 1 and type 2 helper (T(H)1 and T(H)2) cells secrete cytokines that enhance cell-mediated and humoral immunity, respectively. The chemokine monocyte chemoattractant protein-1 (MCP-1) can stimulate interleukin-4 production(2) and its overexpression is associated with defects in cell-mediated immunity(3), indicating that it might be involved in T(H)2 polarization. Here we show that MCP-1-deficient mice are unable to mount T(H)2 responses. Lymph node cells from immunized MCP-1(-/-) mice synthesize extremely low levels of interleukin-4, interleukin-5 and interleukin-10, but normal amounts of interferon-gamma and interleukin-2. Consequently, these mice do not accomplish the immunoglobulin subclass switch that is characteristic of T(H)2 responses and are resistant to Leishmania major. These effects are direct rather than due to abnormal cell migration, because the trafficking of naive T cells is undisturbed in MCP-1(-/-) mice despite the presence of MCP-1-expressing cells in secondary lymphoid organs of wild-type mice. Thus, MCP-1 influences both innate immunity, through effects on monocytes, and adaptive immunity, through control of T helper cell polarization.	Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Rollins, BJ (corresponding author), Brigham & Womens Hosp, Dana Farber Canc Inst, Dept Adult Oncol, 44 Binney St, Boston, MA 02115 USA.			Tam-Amersdorfer, Carmen/0000-0003-3123-6342				Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; ALLAVENA P, 1994, EUR J IMMUNOL, V24, P3233, DOI 10.1002/eji.1830241249; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; CHENSUE SW, 1995, AM J PATHOL, V146, P130; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; FUENTES ME, 1995, J IMMUNOL, V155, P5769; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Gunn MD, 1998, P NATL ACAD SCI USA, V95, P258, DOI 10.1073/pnas.95.1.258; Gunn MD, 1997, J IMMUNOL, V158, P376; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Karpus WJ, 1997, J IMMUNOL, V158, P4129; Karpus WJ, 1998, J EXP MED, V187, P733, DOI 10.1084/jem.187.5.733; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Loetscher P, 1996, J EXP MED, V184, P569, DOI 10.1084/jem.184.2.569; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; MAGHAZACHI AA, 1994, J IMMUNOL, V153, P4969; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; NAKAMURA K, 1995, J INVEST DERMATOL, V105, P635, DOI 10.1111/1523-1747.ep12324061; Nibbs RJB, 1997, J BIOL CHEM, V272, P12495, DOI 10.1074/jbc.272.19.12495; POWER CA, 1995, J BIOL CHEM, V270, P19495, DOI 10.1074/jbc.270.33.19495; ROLLINS BJ, 1988, P NATL ACAD SCI USA, V85, P3738, DOI 10.1073/pnas.85.11.3738; RUTLEDGE BJ, 1995, J IMMUNOL, V155, P4838; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Schecter AD, 1997, J BIOL CHEM, V272, P28568, DOI 10.1074/jbc.272.45.28568; Warmington KS, 1999, AM J PATHOL, V154, P1407, DOI 10.1016/S0002-9440(10)65394-1; YOSHIMURA T, 1989, J EXP MED, V169, P1449, DOI 10.1084/jem.169.4.1449	30	691	719	0	16	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					407	411		10.1038/35006097	http://dx.doi.org/10.1038/35006097			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746730				2022-12-24	WOS:000086119000055
J	Nolan, TW				Nolan, TW			System changes to improve patient safety	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; TASK COMPLEXITY; MEDICINE		Associates Proc Improvement, Silver Spring, MD 20910 USA		Nolan, TW (corresponding author), Associates Proc Improvement, 1110 Bonifant St, Silver Spring, MD 20910 USA.	TNolan@apiweb.org						BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Cook RI, 1994, HUMAN ERROR MED, P255; Fraass BA, 1998, INT J RADIAT ONCOL, V42, P651, DOI 10.1016/S0360-3016(98)00244-2; HINCKLEY CM, 1995, J QUAL TECHNOL, V27, P242, DOI 10.1080/00224065.1995.11979596; LEAPE LL, 1994, JAMA-J AM MED ASSOC, V272, P1851, DOI 10.1001/jama.272.23.1851; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEVENSON MD, 1993, SOLID STATE TECHNOL, V36, P18; LEVESON NG, 1993, SAFEWARE SYSTEMS SAF; MAYLOR EA, 1992, Q J EXP PSYCHOL-A, V44, P119, DOI 10.1080/14640749208401286; Murray SA, 1996, HUM FACTORS, V38, P323, DOI 10.1518/001872096779048011; Norman D., 1988, PSYCHOL EVERYDAY THI; Norman D. A., 1993, THINGS MAKE US SMART; Park K, 1997, HDB HUMAN FACTORS ER, P150; Reason J., 1991, HUMAN ERROR, DOI 10.1017/cbo9781139062367; Salvendy G., 2021, HDB HUMAN FACTORS ER, DOI [10.1002/9781119636113, DOI 10.1002/9781119636113]; SARTER NB, 1992, INT J AVIAT PSYCHOL, V4, P1; Strong MJ, 1999, NEUROLOGY, V53, pS31; Ushakov IA, 1994, HDB RELIABILITY ENG; Vincent C, 1998, BRIT MED J, V316, P1154, DOI 10.1136/bmj.316.7138.1154; WICHMAN H, 1983, HUM FACTORS, V25, P583, DOI 10.1177/001872088302500512	22	202	217	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2000	320	7237					771	773		10.1136/bmj.320.7237.771	http://dx.doi.org/10.1136/bmj.320.7237.771			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296YQ	10720364	Green Published			2022-12-24	WOS:000086054700029
J	Abdurashidova, G; Deganuto, M; Klima, R; Riva, S; Biamonti, G; Giacca, M; Falaschi, A				Abdurashidova, G; Deganuto, M; Klima, R; Riva, S; Biamonti, G; Giacca, M; Falaschi, A			Start sites of bidirectional DNA synthesis at the human lamin B2 origin	SCIENCE			English	Article							REPLICATION ORIGIN; RECOGNITION COMPLEX; IN-VIVO; IDENTIFICATION; PROTEINS; MEMBER	The initiation sites of bidirectional synthesis at the DNA replication origin located at the 3' end of the human lamin B2 gene were investigated. RNA-primed nascent DNA molecules were subjected to second-strand synthesis with appropriate primers, amplified by ligation-mediated polymerase chain reaction, and size fractionated. Evidence for precise start sites was obtained. Exploration of close to 1 kilobase, coupled to inhibition of Okazaki fragment synthesis, demonstrates that the leading strands initiate at precise nucleotides on either helix, overlapping by three base pairs, within the area bound to a protein complex possibly analogous to the prereplicative complex of yeast.	Int Ctr Genet Engn & Biotechnol, Mol Biol Unit, I-34012 Trieste, Italy; Int Ctr Genet Engn & Biotechnol, Mol Med Unit, I-34012 Trieste, Italy; CNR, Ist Genet Biochim & Evoluzionist, I-27100 Pavia, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB); Consiglio Nazionale delle Ricerche (CNR)	Falaschi, A (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Biol Unit, Padriciano 99, I-34012 Trieste, Italy.		Giacca, Mauro/J-9287-2016	Giacca, Mauro/0000-0003-2927-7225; BIAMONTI, GIUSEPPE/0000-0001-6804-4315				Abdurashidova G, 1998, EMBO J, V17, P2961, DOI 10.1093/emboj/17.10.2961; BIAMONTI G, 1992, CHROMOSOMA, V102, pS24, DOI 10.1007/BF02451782; Bielinsky AK, 1999, MOL CELL, V3, P477, DOI 10.1016/S1097-2765(00)80475-X; Bielinsky AK, 1998, SCIENCE, V279, P95, DOI 10.1126/science.279.5347.95; BURHANS WC, 1991, EMBO J, V10, P4351, DOI 10.1002/j.1460-2075.1991.tb05013.x; DIFFLEY JFX, 1994, CELL, V78, P303, DOI 10.1016/0092-8674(94)90299-2; Dimitrova DS, 1996, P NATL ACAD SCI USA, V93, P1498, DOI 10.1073/pnas.93.4.1498; Donaldson AD, 1999, CURR OPIN GENET DEV, V9, P62, DOI 10.1016/S0959-437X(99)80009-4; GAVIN KA, 1995, SCIENCE, V270, P1667, DOI 10.1126/science.270.5242.1667; Giacca M, 1997, METHODS, V13, P301, DOI 10.1006/meth.1997.0529; GIACCA M, 1994, P NATL ACAD SCI USA, V91, P7119, DOI 10.1073/pnas.91.15.7119; HAY RT, 1982, CELL, V28, P767, DOI 10.1016/0092-8674(82)90056-3; Kearsey SE, 1998, BBA-GENE STRUCT EXPR, V1398, P113, DOI 10.1016/S0167-4781(98)00033-5; Kumar S, 1996, NUCLEIC ACIDS RES, V24, P3289, DOI 10.1093/nar/24.17.3289; MARAHRENS Y, 1994, EMBO J, V13, P3395, DOI 10.1002/j.1460-2075.1994.tb06642.x; Quintana DG, 1997, J BIOL CHEM, V272, P28247, DOI 10.1074/jbc.272.45.28247; Quintana DG, 1998, J BIOL CHEM, V273, P27137, DOI 10.1074/jbc.273.42.27137; QUIVY JP, 1993, NUCLEIC ACIDS RES, V21, P2779, DOI 10.1093/nar/21.11.2779; Tugal T, 1998, J BIOL CHEM, V273, P32421, DOI 10.1074/jbc.273.49.32421	19	148	152	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2023	2026		10.1126/science.287.5460.2023	http://dx.doi.org/10.1126/science.287.5460.2023			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720330				2022-12-24	WOS:000085902800064
J	Akashi, K; Traver, D; Miyamoto, T; Weissman, IL				Akashi, K; Traver, D; Miyamoto, T; Weissman, IL			A clonogenic common myeloid progenitor that gives rise to all myeloid lineages	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR GATA-1; MICE; GENE; DIFFERENTIATION; LEUKEMIA; SYSTEM; LYMPHOPOIESIS; COMMITMENT; LACKING	Haematopoietic stem cells give rise to progeny that progressively lose self-renewal capacity and become restricted to one lineage(1,2). The points at which haematopoietic stem cell-derived progenitors commit to each of the various lineages remain mostly unknown. We have identified a clonogenic common lymphoid progenitor that can differentiate into T, B and natural killer cells but not myeloid cells(3). Here we report the prospective identification, purification and characterization, using cell-surface markers and flow cytometry, of a complementary clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Common myeloid progenitors give rise to either megakaryocyte/erythrocyte or granulocyte/macrophage progenitors. Purified progenitors were used to provide a first-pass expression profile of various haematopoiesis-related genes. We propose that the common lymphoid progenitor and common myeloid progenitor populations reflect the earliest branch points between the lymphoid and myeloid lineages, and that the commitment of common myeloid progenitors to either the megakaryocyte/erythrocyte or the granulocyte/macrophage lineages are mutually exclusive events.	Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Akashi, K (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	akashi@leland.stanford.edu						Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; ANDREWS NC, 1993, NATURE, V362, P722, DOI 10.1038/362722a0; DEXTER TM, 1990, CANCER SURV, V9, P1; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Enver T, 1998, CELL, V94, P9, DOI 10.1016/S0092-8674(00)81215-5; Fujiwara Y, 1996, P NATL ACAD SCI USA, V93, P12355, DOI 10.1073/pnas.93.22.12355; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; KELLER G, 1993, MOL CELL BIOL, V13, P473, DOI 10.1128/MCB.13.1.473; KO LJ, 1991, MOL CELL BIOL, V11, P2778, DOI 10.1128/MCB.11.5.2778; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lacaud G, 1998, IMMUNITY, V9, P827, DOI 10.1016/S1074-7613(00)80648-2; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; METCALF D, 1979, J CELL PHYSIOL, V98, P401, DOI 10.1002/jcp.1040980216; Metcalf D, 1999, ANN NY ACAD SCI, V872, P289, DOI 10.1111/j.1749-6632.1999.tb08473.x; Miyamoto T, 1996, BLOOD, V87, P4789, DOI 10.1182/blood.V87.11.4789.bloodjournal87114789; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nutt SL, 1997, GENE DEV, V11, P476, DOI 10.1101/gad.11.4.476; OGAWA M, 1993, BLOOD, V81, P2844; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; UCHIDA N, 1994, BLOOD, V83, P3758; WEISS TG, 1994, ETHICS INT AFF, V8, P1	30	1834	1894	5	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 9	2000	404	6774					193	197		10.1038/35004599	http://dx.doi.org/10.1038/35004599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724173				2022-12-24	WOS:000085870900054
J	Osterhaus, ADME; Rimmelzwaan, GF; Martina, BEE; Bestebroer, TM; Fouchier, RAM				Osterhaus, ADME; Rimmelzwaan, GF; Martina, BEE; Bestebroer, TM; Fouchier, RAM			Influenza B virus in seals	SCIENCE			English	Article							MASS MORTALITY; A VIRUS; ECOLOGY	Influenza B virus is a human pathogen whose origin and possible reservoir in nature are not known. An influenza B virus was isolated from a naturally infected harbor seal (Phoca vitulina) and was found to be infectious to seal kidney cells in vitro. Sequence analyses and serology indicated that influenza virus B/Seal/Netherlands/1/99 is closely related to strains that circulated in humans 4 to 5 years earlier. Retrospective analyses of sera collected from 971 seals showed a prevalence of antibodies to influenza B virus in 2% of the animals after 1995 and in none before 1995. This animal reservoir, harboring influenza B viruses that have circulated in the past, may pose a direct threat to humans.	Erasmus Univ, Dept Virol, Natl Influenza Ctr, NL-3015 GE Rotterdam, Netherlands; Seal Rehabil & Res Ctr, NL-9968 AG Pieterburen, Netherlands	Erasmus University Rotterdam	Osterhaus, ADME (corresponding author), Erasmus Univ, Dept Virol, Natl Influenza Ctr, Doctor Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.		Fouchier, Ron A/A-1911-2014	Fouchier, Ron A/0000-0001-8095-2869	NICHD NIH HHS [HD 15527] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD015527] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		CALLAN RJ, 1995, J GEN VIROL, V76, P199, DOI 10.1099/0022-1317-76-1-199; CHANG C P, 1976, International Journal of Zoonoses, V3, P61; FRANK AL, 1981, J INFECT DIS, V144, P443; GERACI JR, 1982, SCIENCE, V215, P1129; HALL CB, 1979, J INFECT DIS, V140, P610, DOI 10.1093/infdis/140.4.610; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; HINSHAW VS, 1984, J VIROL, V51, P863, DOI 10.1128/JVI.51.3.863-865.1984; MURPHY BR, 1990, VIROLOGY; Osterhaus A, 1997, NATURE, V388, P838, DOI 10.1038/42163; OSTERHAUS ADM, UNPUB; OSTERHAUS ADME, 1988, NATURE, V335, P20, DOI 10.1038/335020a0; OSTERHAUS ADME, 1989, NATURE, V337, P21, DOI 10.1038/337021a0; OSTERHAUS ADME, 1985, ARCH VIROL, V86, P239, DOI 10.1007/BF01309828; PRATO CM, 1974, NATURE, V249, P255, DOI 10.1038/249255a0; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Roitt I.M, 1977, ESSENTIAL IMMUNOLOGY, V3rd; Shope RE, 1943, J EXP MED, V77, P111, DOI 10.1084/jem.77.2.111; SMITH AW, 1979, J AM VET MED ASSOC, V175, P918; TAKATSY G, 1967, ACTA MICROBIOL HUNG, V14, P309; Voeten JTM, 1998, J CLIN MICROBIOL, V36, P3527, DOI 10.1128/JCM.36.12.3527-3531.1998; WALLACE GW, 1977, J INFECT DIS, V135, P490, DOI 10.1093/infdis/135.3.490; WEBSTER RG, 1981, VIROLOGY, V113, P712, DOI 10.1016/0042-6822(81)90200-2; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992	23	240	275	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 12	2000	288	5468					1051	1053		10.1126/science.288.5468.1051	http://dx.doi.org/10.1126/science.288.5468.1051			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	313EY	10807575				2022-12-24	WOS:000086988400037
J	Gladwin, MT; Rodgers, GP				Gladwin, MT; Rodgers, GP			Pathogenesis and treatment of acute chest syndrome of sickle-cell anaemia	LANCET			English	Editorial Material							INHALED NITRIC-OXIDE; RISK-FACTORS; DISEASE; HYDROXYUREA; ANEMIA; TRANSFUSION; HEMOGLOBIN; BLOOD		NIDDK, Dept Crit Care Med, NIH, Bethesda, MD 20892 USA; NIDDK, Crit Hematol Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Rodgers, GP (corresponding author), NIDDK, Dept Crit Care Med, NIH, Bethesda, MD 20892 USA.							Atz AM, 1997, ANESTHESIOLOGY, V87, P988, DOI 10.1097/00000542-199710000-00037; BELLET PS, 1995, NEW ENGL J MED, V333, P699, DOI 10.1056/NEJM199509143331104; CASTRO O, 1994, BLOOD, V84, P643, DOI 10.1182/blood.V84.2.643.643; EMRE U, 1995, J PEDIATR-US, V127, P901, DOI 10.1016/S0022-3476(95)70025-0; Gladwin MT, 1999, J CLIN INVEST, V104, P937, DOI 10.1172/JCI7637; Glover RE, 1999, MOL PHARMACOL, V55, P1006, DOI 10.1124/mol.55.6.1006; Pacelli R, 1996, LANCET, V347, P900, DOI 10.1016/S0140-6736(96)91378-1; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Saleh AW, 1999, ACTA HAEMATOL-BASEL, V102, P31, DOI 10.1159/000040964; Setty BNY, 1996, BLOOD, V88, P2311, DOI 10.1182/blood.V88.6.2311.bloodjournal8862311; Stuart MJ, 1999, BLOOD, V94, P1555, DOI 10.1182/blood.V94.5.1555.417k36_1555_1560; Styles LA, 1996, BLOOD, V87, P2573, DOI 10.1182/blood.V87.6.2573.bloodjournal8762573; Styles LA, 1997, BLOOD, V89, P2554, DOI 10.1182/blood.V89.7.2554; Sullivan KJ, 1999, CRIT CARE MED, V27, P2563, DOI 10.1097/00003246-199911000-00039; VICHINSKY E, 1994, BLOOD, V83, P3107; Vichinsky EP, 1997, BLOOD, V89, P1787, DOI 10.1182/blood.V89.5.1787.1787_1787_1792; WAYNE AS, 1993, BLOOD, V81, P1109	17	40	44	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 29	2000	355	9214					1476	1478		10.1016/S0140-6736(00)02157-7	http://dx.doi.org/10.1016/S0140-6736(00)02157-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LR	10801164				2022-12-24	WOS:000086830100004
J	Gross, JA; Johnston, J; Mudri, S; Enselman, R; Dillon, SR; Madden, K; Xu, WF; Parrish-Novak, J; Foster, D; Lofton-Day, C; Moore, M; Littau, A; Grossman, A; Haugen, H; Foley, K; Blumberg, H; Harrison, K; Kindsvogel, W; Clegg, CH				Gross, JA; Johnston, J; Mudri, S; Enselman, R; Dillon, SR; Madden, K; Xu, WF; Parrish-Novak, J; Foster, D; Lofton-Day, C; Moore, M; Littau, A; Grossman, A; Haugen, H; Foley, K; Blumberg, H; Harrison, K; Kindsvogel, W; Clegg, CH			TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease	NATURE			English	Article							GENE; EXPRESSION	B cells are important in the development of autoimmune disorders by mechanisms involving disregulated polyclonal B-cell activation, production of pathogenic antibodies, and co-stimulation of autoreactive T cells. zTNF4 (BLyS, BAFF, TALL-1, THANK)(1-5) is a member of the tumour necrosis factor (TNF) ligand family that is a potent co-activator of B cells in vitro and in vivo(1,2,5). Here we identify two receptors for zTNF4 and demonstrate a relationship between zTNF4 and autoimmune disease. Transgenic animals overexpressing zTNF4 in lymphoid cells develop symptoms characteristic of systemic lupus erythaematosus (SLE) and expand a rare population of splenic B-1a lymphocytes. In addition, circulating zTNF4 is more abundant in NZBWF1 and MRL-lpr/lpr mice during the onset and progression of SLE. We have identified two TNF receptor family members, TACI(6) and BCMA(7,8), that bind zTNF4. Treatment of NZBWF1 mice with soluble TACI-Ig fusion protein inhibits the development of proteinuria and prolongs survival of the animals. These findings demonstrate the involvement of zTNF4 and its receptors in the development of SLE and identify TACI-Ig as a promising treatment of autoimmune disease in humans.	Zymogenet Inc, Dept Immunol, Seattle, WA 98102 USA; Zymogenet Inc, Dept Funct Cloning, Seattle, WA 98102 USA; Zymogenet Inc, Dept In Vivo Biol, Seattle, WA 98102 USA; Zymogenet Inc, Dept Genet, Seattle, WA 98102 USA	Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.; Zymogenet Inc.	Gross, JA (corresponding author), Zymogenet Inc, Dept Immunol, 1201 Eastlake Ave E, Seattle, WA 98102 USA.	grossj@zgi.com	Foley, Kevin/ABC-1041-2020					BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; Foster MH, 1999, SEMIN NEPHROL, V19, P12; GRAS MP, 1995, INT IMMUNOL, V7, P1093, DOI 10.1093/intimm/7.7.1093; HARDY RR, 1994, IMMUNOL REV, V137, P91, DOI 10.1111/j.1600-065X.1994.tb00660.x; HU J, 1993, J EXP MED, V177, P1681, DOI 10.1084/jem.177.6.1681; Kotzin BL, 1996, CELL, V85, P303, DOI 10.1016/S0092-8674(00)81108-3; LAABI Y, 1992, EMBO J, V11, P3897, DOI 10.1002/j.1460-2075.1992.tb05482.x; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; MALDRY C, 1998, INT IMMUNOL, V10, P1693; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Mukhopadhyay A, 1999, J BIOL CHEM, V274, P15978, DOI 10.1074/jbc.274.23.15978; Raymond CK, 1998, YEAST, V14, P11, DOI 10.1002/(SICI)1097-0061(19980115)14:1<11::AID-YEA196>3.0.CO;2-S; SCHEIDER P, 1999, J EXP MED, V189, P1747; SEEBURG PH, 1982, DNA-J MOLEC CELL BIO, V1, P239, DOI 10.1089/dna.1.1982.1.239; Shu HB, 1999, J LEUKOCYTE BIOL, V65, P680, DOI 10.1002/jlb.65.5.680; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; WOFSY D, 1985, J EXP MED, V161, P378, DOI 10.1084/jem.161.2.378	21	935	1084	0	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 27	2000	404	6781					995	999		10.1038/35010115	http://dx.doi.org/10.1038/35010115			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801128				2022-12-24	WOS:000086762000056
J	Aqvist, J; Luzhkov, V				Aqvist, J; Luzhkov, V			Ion permeation mechanism of the potassium channel	NATURE			English	Article							RANGE ELECTROSTATIC INTERACTIONS; MOLECULAR-DYNAMICS; SIMULATIONS; SELECTIVITY; CONDUCTION	Ion-selective channels enable the specific permeation of ions through cell membranes and provide the basis of several important biological functions; for example, electric signalling in the nervous system(1). Although a large amount of electrophysiological data is available(1,2), the molecular mechanisms by which these channels can mediate ion transport remain a significant unsolved problem. With the recently determined crystal structure of the representative K+ channel (KcsA) from Streptomyces lividans(3), it becomes possible to examine ion conduction pathways on a microscopic level. K+ channels utilize multi-ion conduction mechanisms(1,2,4-6), and the three-dimensional structure also shows several ions present in the channel. Here we report results from molecular dynamics free energy perturbation calculations that both establish the nature of the multiple ion conduction mechanism and yield the correct ion selectivity of the channel. By evaluating the energetics of all relevant occupancy states of the selectivity filter, we rnd that the favoured conduction pathway involves transitions only between two main states with a free difference of about 5 kcal mol(-1). Other putative permeation pathways can be excluded because they would involve states that are too high in energy.	Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, SE-75124 Uppsala, Sweden; Russian Acad Sci, Inst Chem Phys Problems, Chernogolovka 142432, Moscow Region, Russia	Uppsala University; Russian Academy of Sciences; Institute of Problems of Chemical Physics of the Russian Academy of Sciences	Aqvist, J (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Box 596, SE-75124 Uppsala, Sweden.		Luzhkov, Victor/AAE-1857-2019	Luzhkov, Victor/0000-0003-2528-4567				AQVIST J, 1990, J PHYS CHEM-US, V94, P8021, DOI 10.1021/j100384a009; Aqvist J, 1996, J COMPUT CHEM, V17, P1587, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1587::AID-JCC1>3.0.CO;2-H; BAMBERG E, 1974, BIOCHIM BIOPHYS ACTA, V367, P127, DOI 10.1016/0005-2736(74)90037-6; BEGENISICH T, 1980, J GEN PHYSIOL, V76, P83, DOI 10.1085/jgp.76.1.83; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; HILLE B, 1978, J GEN PHYSIOL, V72, P409, DOI 10.1085/jgp.72.4.409; Hille B., 1992, IONIC CHANNELS EXCIT; HLADKY SB, 1972, BIOCHIM BIOPHYS ACTA, V274, P294, DOI 10.1016/0005-2736(72)90178-2; HODGKIN AL, 1955, J PHYSIOL-LONDON, V128, P61, DOI 10.1113/jphysiol.1955.sp005291; KARPLUS M, 1990, NATURE, V347, P631, DOI 10.1038/347631a0; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; LATORRE R, 1983, J MEMBRANE BIOL, V71, P11, DOI 10.1007/BF01870671; LEE FS, 1992, J CHEM PHYS, V97, P3100, DOI 10.1063/1.462997; Marelius J, 1998, J MOL GRAPH MODEL, V16, P213, DOI 10.1016/S1093-3263(99)00012-1; MCCLESKEY EW, J GEN PHYSL, V13, P765; Miller C, 1999, J GEN PHYSIOL, V113, P783, DOI 10.1085/jgp.113.6.783; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; ROUX B, 1991, J PHYS CHEM-US, V95, P4856, DOI 10.1021/j100165a049; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; van Gunsteren W. F., 1987, GRONINGEN MOL SIMULA; VANGUNSTEREN WF, 1990, ANGEW CHEM INT EDIT, V29, P992, DOI 10.1002/anie.199009921	23	378	383	2	66	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					881	884		10.1038/35009114	http://dx.doi.org/10.1038/35009114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786795				2022-12-24	WOS:000086625000047
J	Moody, DB; Ulrichs, T; Muhlecker, W; Young, DC; Gurcha, SS; Grant, E; Rosat, JP; Brenner, MB; Costello, CE; Besra, GS; Porcelli, SA				Moody, DB; Ulrichs, T; Muhlecker, W; Young, DC; Gurcha, SS; Grant, E; Rosat, JP; Brenner, MB; Costello, CE; Besra, GS; Porcelli, SA			CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection	NATURE			English	Article							LIPOGLYCAN ANTIGENS; BIOSYNTHESIS; DOLICHOL; CD1; LIPOARABINOMANNAN; IDENTIFICATION; REQUIREMENTS; LYMPHOCYTES; METABOLISM; RESTRICTS	The discovery of the CD1 antigen presentation pathway has expanded the spectrum of T-cell antigens to include lipids(1-4), but the range of natural lipid antigens and functions of CD1-restricted T cells in vivo remain poorly understood. Here we show that the T-cell antigen receptor and the CD1c protein mediate recognition of an evolutionarily conserved family of isoprenoid glycolipids whose members include essential components of protein glycosylation and cell-wall synthesis pathways. A CD1c-restricted, mycobacteria-specific T-cell line recognized two previously unknown mycobacterial hexosyl-1-phosphoisoprenoids and structurally related mannosyl-beta 1-phosphodolichols. Responses to mannosyl-b1-phosphodolichols were common among CD1c-restricted T-cell lines and peripheral blood T lymphocytes of human subjects recently infected with M. tuberculosis, but were not seen in naive control subjects. These results define a new class of broadly distributed lipid antigens presented by the CD1 system during infection in vivo and suggest an immune mechanism for recognition of senescent or transformed cells that are known to have altered dolichol lipids.	Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Univ Newcastle Upon Tyne, Sch Med, Dept Microbiol & Immunol, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; Newcastle University - UK	Moody, DB (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.			Costello, Catherine/0000-0003-1594-5122; Besra, Gurdyal/0000-0002-5605-0395				Beckman EM, 1996, J IMMUNOL, V157, P2795; BEEKMAN EM, 1994, NATURE, V372, P691, DOI 10.1038/372691a0; BENDELAC A, 1995, SCIENCE, V268, P863, DOI 10.1126/science.7538697; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; BESRA GS, 1994, P NATL ACAD SCI USA, V91, P12735, DOI 10.1073/pnas.91.26.12735; Besra GS, 1997, BIOCHEM SOC T, V25, P845, DOI 10.1042/bst0250845; CALABI F, 1986, NATURE, V323, P540, DOI 10.1038/323540a0; CRICK DC, 1994, J BIOL CHEM, V269, P10559; DEROSA M, 1986, MICROBIOL REV, V50, P70, DOI 10.1128/MMBR.50.1.70-80.1986; EDLUND C, 1992, BIOCHEM CELL BIOL, V70, P422, DOI 10.1139/o92-065; Ernst WA, 1998, IMMUNITY, V8, P331, DOI 10.1016/S1074-7613(00)80538-5; Exley M, 1997, J EXP MED, V186, P109, DOI 10.1084/jem.186.1.109; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; HENRY A, 1991, BIOCHEM J, V278, P741, DOI 10.1042/bj2780741; Joyce S, 1998, SCIENCE, V279, P1541, DOI 10.1126/science.279.5356.1541; Kawano T, 1997, SCIENCE, V278, P1626, DOI 10.1126/science.278.5343.1626; LOW P, 1991, J BIOL CHEM, V266, P19250; Moody DB, 1999, IMMUNOL REV, V172, P285, DOI 10.1111/j.1600-065X.1999.tb01373.x; Moody DB, 1997, SCIENCE, V278, P283, DOI 10.1126/science.278.5336.283; PARODI AJ, 1993, GLYCOBIOLOGY, V3, P193, DOI 10.1093/glycob/3.3.193; PENNOCK JF, 1960, NATURE, V186, P470, DOI 10.1038/186470b0; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6; Rosat JP, 1999, J IMMUNOL, V162, P366; Schofield L, 1999, SCIENCE, V283, P225, DOI 10.1126/science.283.5399.225; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; SIELING PA, 1995, SCIENCE, V269, P227, DOI 10.1126/science.7542404; TAKAYAMA K, 1973, BIOCHIM BIOPHYS ACTA, V316, P212, DOI 10.1016/0005-2760(73)90011-8; Wolucka BA, 1998, ANAL BIOCHEM, V255, P244, DOI 10.1006/abio.1997.2421; Zeng ZH, 1997, SCIENCE, V277, P339, DOI 10.1126/science.277.5324.339	30	368	378	0	11	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					884	888		10.1038/35009119	http://dx.doi.org/10.1038/35009119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786796				2022-12-24	WOS:000086625000048
J	Ryan, KM; Ernst, MK; Rice, NR; Vousden, KH				Ryan, KM; Ernst, MK; Rice, NR; Vousden, KH			Role of NF-kappa B in p53-mediated programmed cell death	NATURE			English	Article							RIBOSOMAL S6 KINASE; P53-DEPENDENT APOPTOSIS; DNA-DAMAGE; P53; ALPHA; INDUCTION; DEGRADATION; MUTANTS	The tumour suppressor p53 inhibits cell growth through activation of cell-cycle arrest and apoptosis(1), and most cancers have either mutation within the p53 gene or defects in the ability to induce p53. Activation or re-introduction of p53 induces apoptosis in many tumour cells and may provide effective cancer therapy 2. One of the key proteins that modulates the apoptotic response is NF-kappa B, a transcription factor that can protect or contribute to apoptosis(3). Here we show that induction of p53 causes an activation of NF-kappa B that correlates with the ability of p53 to induce apoptosis. Inhibition or loss of NF-kappa B activity abrogated p53-induced apoptosis, indicating that NF-kappa B is essential in p53-mediated cell death. Activation of NF-kappa B by p53 was distinct from that mediated by tumour-necrosis factor-alpha and involved MEK1 and the activation of pp90(rsk). Inhibition of MEK1 blocked activation of NF-kappa B by p53 and completely abrogated p53-induced cell death. We conclude that inhibition of NF-kappa B in tumours that retain wild-type p53 may diminish, rather than augment, a therapeutic response.	NCI, Frederick Canc Res & Dev Ctr, Regulat Cell Growth Lab, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Vousden, KH (corresponding author), NCI, Frederick Canc Res & Dev Ctr, Regulat Cell Growth Lab, Bldg 560,Room 22-96,W 7th St, Frederick, MD 21702 USA.			Ryan, Kevin M./0000-0002-1059-9681				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; BROWN K, 1995, SCIENCE, V267, P1485, DOI 10.1126/science.7878466; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; CHIOU SK, 1994, MOL CELL BIOL, V14, P2556, DOI 10.1128/MCB.14.4.2556; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; ERNST MK, 1995, MOL CELL BIOL, V15, P872; Foo SY, 1999, TRENDS GENET, V15, P229; Ghoda L, 1997, J BIOL CHEM, V272, P21281, DOI 10.1074/jbc.272.34.21281; Hickman ES, 1997, J VIROL, V71, P3710, DOI 10.1128/JVI.71.5.3710-3718.1997; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Lane DP, 1999, BRIT J CANCER, V80, P1; LOWE SW, 1993, CELL, V74, P957, DOI 10.1016/0092-8674(93)90719-7; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Phillips AC, 1999, MOL CELL, V4, P771, DOI 10.1016/S1097-2765(00)80387-1; Phillips AC, 1997, GENE DEV, V11, P1853, DOI 10.1101/gad.11.14.1853; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Samuelson AV, 1997, P NATL ACAD SCI USA, V94, P12094, DOI 10.1073/pnas.94.22.12094; Schouten GJ, 1997, EMBO J, V16, P3133, DOI 10.1093/emboj/16.11.3133; Shao RP, 1999, J BIOL CHEM, V274, P21495, DOI 10.1074/jbc.274.31.21495; Sionov RV, 1999, ONCOGENE, V18, P6145, DOI 10.1038/sj.onc.1203130; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Waddick KG, 1999, BIOCHEM PHARMACOL, V57, P9, DOI 10.1016/S0006-2952(98)00224-X; Webster GA, 1999, MOL CELL BIOL, V19, P3485; WHITESIDE ST, 1995, MOL CELL BIOL, V15, P5339; WU HY, 1994, J BIOL CHEM, V269, P20067; Zhou Q, 1998, BIOCHEMISTRY-US, V37, P10757, DOI 10.1021/bi980893w	30	641	675	2	27	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					892	897		10.1038/35009130	http://dx.doi.org/10.1038/35009130			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786798				2022-12-24	WOS:000086625000050
J	Kilner, PJ; Yang, GZ; Wilkes, AJ; Mohiaddin, RH; Firmin, DN; Yacoub, MH				Kilner, PJ; Yang, GZ; Wilkes, AJ; Mohiaddin, RH; Firmin, DN; Yacoub, MH			Asymmetric redirection of flow through the heart	NATURE			English	Article							PATTERNS	Through cardiac looping during embryonic development(1), paths of flow through the mature heart have direction changes and asymmetries whose topology and functional significance remain relatively unexplored. Here we show, using magnetic resonance velocity mapping(2-5), the asymmetric redirection of streaming blood in atrial and ventricular cavities of the adult human heart, with sinuous, chirally asymmetric paths of flow through the whole. On the basis of mapped flow fields and drawings that illustrate spatial relations between flow paths, we propose that asymmetries and curvatures of the looped heart have potential fluidic and dynamic advantages. Patterns of atrial filling seem to be asymmetric in a manner that allows the momentum of inflowing streams to be redirected towards atrio-ventricular valves, and the change in direction at ventricular level is such that recoil away from ejected blood is in a direction that can enhance rather than inhibit ventriculo-atrial coupling(6). Chiral asymmetry might help to minimize dissipative interaction between entering, recirculating and outflowing streams(7). These factors might combine to allow a reciprocating, sling-like, 'morphodynamic' mode of action to come into effect when heart rate and output increase during exercise(6).	Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, London SW3 6NP, England; Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Dept Comp, Visual Informat Proc Grp, London SW3 6NP, England; Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Dept Cardiothorac Surg, London SW3 6NP, England; Emerson Coll, Flow Design Res Grp, Forest Row RH18 5JX, E Sussex, England	Imperial College London; Royal Brompton Hospital; Imperial College London; Royal Brompton Hospital; Imperial College London; Royal Brompton Hospital	Kilner, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Royal Brompton Hosp, Cardiovasc Magnet Resonance Unit, Sydney St, London SW3 6NP, England.	p.kilner@rbh.nthames.nhs.uk	tay, wee beng/B-1095-2010	Firmin, David/0000-0003-3894-7489				BELLHOUSE BJ, 1969, NATURE, V224, P615, DOI 10.1038/224615a0; Caro CG, 1996, P ROY SOC A-MATH PHY, V452, P185, DOI 10.1098/rspa.1996.0011; DiBello V, 1996, MED SCI SPORT EXER, V28, P190, DOI 10.1097/00005768-199602000-00006; FIRMIN DN, 1990, MAGN RESON MED, V14, P230, DOI 10.1002/mrm.1910140209; FIRMIN DN, 1987, J COMPUT ASSIST TOMO, V11, P751, DOI 10.1097/00004728-198709000-00001; FRIEDMAN MH, 1993, ATHEROSCLEROSIS, V98, P193, DOI 10.1016/0021-9150(93)90128-H; Icardo JM, 1996, J EXP ZOOL, V275, P144, DOI 10.1002/(SICI)1097-010X(19960601/15)275:2/3<144::AID-JEZ7>3.3.CO;2-2; Kilner PJ, 1997, HEART VESSELS, V12, P103, DOI 10.1007/BF02767127; KILNER PJ, 1993, CIRCULATION, V88, P2235, DOI 10.1161/01.CIR.88.5.2235; KILNER PJ, 1998, THESIS U LONDON; KIM WY, 1995, J AM COLL CARDIOL, V26, P224, DOI 10.1016/0735-1097(95)00141-L; Landesberg A, 1997, ADV EXP MED BIOL, V430, P75; Liang YL, 1999, CLIN EXP PHARMACOL P, V26, P342, DOI 10.1046/j.1440-1681.1999.03039.x; Logan M, 1998, CELL, V94, P307, DOI 10.1016/S0092-8674(00)81474-9; NOBLE MIM, 1978, CLIN SCI MOL MED, V54, P1; Peskin C.S., 1996, CASE STUDIES MATH MO, P309; Ryan AK, 1998, NATURE, V394, P545, DOI 10.1038/29004; Shapiro Leonard M., 1997, Cardiology Clinics, V15, P373, DOI 10.1016/S0733-8651(05)70346-5; TAYLOR DEM, 1973, CARDIOVASC RES, V7, P14, DOI 10.1093/cvr/7.1.14; TAYLOR TW, 1995, BIORHEOLOGY, V32, P61; Yacoub MH, 1999, ANN THORAC SURG, V68, pS37, DOI 10.1016/S0003-4975(99)00745-6; YANG GZ, IN PRESS INT J CARDI	22	523	551	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 13	2000	404	6779					759	761		10.1038/35008075	http://dx.doi.org/10.1038/35008075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783888				2022-12-24	WOS:000086523600051
J	Vella, K; Goldfrad, C; Rowan, K; Bion, J; Black, N				Vella, K; Goldfrad, C; Rowan, K; Bion, J; Black, N			Use of consensus development to establish national research priorities in critical care	BRITISH MEDICAL JOURNAL			English	Article							DELPHI	Objectives To test the Feasibility of using a nominal group technique to establish clinical and health services research priorities in critical care and to test the representativeness of the group's views. Design Generation of topics by means of a national survey a nominal group technique to establish the level of consensus: a survey to test the representativeness of the results. Setting United Kingdom and Republic of Ireland. Subjects Nominal group composed of 10 doctors (8 consultants, 2 trainees) and 2 nurses. Main outcome measure Level of support (median) and level of agreement (mean absolute deviation from the median) derived from a 9 point Likert scale. Results Of the 325 intensive care units approached. 187 (58%) responded, providing about 1000 suggestions for research Of the 106 most frequently suggested topics considered by the nominal group. 37 attracted strong support. 48 moderate support and 21 weak support. There was more agreement after the group had met-overall mean of the mean absolute deviations from the median fell from 1.41 to 1.26. The group's views represented the views of the wider community of critical care staff (r = 0.73, P < 0.01). There was no significant difference in the views of staff from teaching or from non-teaching hospitals. Of the 37 topics that attracted the strongest support, 24 were concerned with organisational aspects of critical care and only 13 with technology assessment or clinical research. Conclusions A nominal group technique is feasible and reliable for determining research priorities among clinicians. This approach is more democratic and transparent than the traditional methods used by research funding bodies. The results suggest that clinicians perceive research into the best ways of delivering and organising services as a high priority.	London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; Intens Care & Natl Audit & Res Ctr, London WC1H 9HR, England; Univ Birmingham, Dept Anaesthesia & Intens Care, Birmingham B15 2TH, W Midlands, England	University of London; London School of Hygiene & Tropical Medicine; Intensive Care National Audit & Research Centre; University of Birmingham	Black, N (corresponding author), London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.			Bion, Julian/0000-0003-0344-5403				Ayanian JZ, 1998, NEW ENGL J MED, V338, P1896, DOI 10.1056/NEJM199806253382608; Black N, 1999, J Health Serv Res Policy, V4, P236; BOND S, 1982, J ADV NURS, V7, P565, DOI 10.1111/j.1365-2648.1982.tb00277.x; Brittenham GM, 1998, ANN INTERN MED, V129, P993, DOI 10.7326/0003-4819-129-11_Part_2-199812011-00011; Harrington JM, 1996, OCCUP ENVIRON MED, V53, P642, DOI 10.1136/oem.53.9.642; LINDEMAN CA, 1975, NURS RES, V24, P434, DOI 10.1097/00006199-197511000-00006; Mootz RD, 1997, J MANIP PHYSIOL THER, V20, P201; Rudy S F, 1996, ORL Head Neck Nurs, V14, P16; Schmidt K, 1997, J Pediatr Nurs, V12, P201, DOI 10.1016/S0882-5963(97)80002-4; Sedlak C, 1998, Orthop Nurs, V17, P51; THOMAS B, 1983, J NURS EDUC, V22, P335; vanderBeek AJ, 1997, OCCUP ENVIRON MED, V54, P504, DOI 10.1136/oem.54.7.504	12	123	124	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 8	2000	320	7240					976	980		10.1136/bmj.320.7240.976	http://dx.doi.org/10.1136/bmj.320.7240.976			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	303XP	10753149	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000086453100022
J	Kim, S; Wadsworth, WG				Kim, S; Wadsworth, WG			Positioning of longitudinal nerves in C-elegans by nidogen	SCIENCE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; GLR-1 GLUTAMATE-RECEPTOR; EPITHELIAL MORPHOGENESIS; BASEMENT-MEMBRANES; AXON GUIDANCE; IN-VITRO; LAMININ; COLLAGEN; BINDING; MIGRATIONS	Basement membranes can help determine pathways of migrating axons. Although members of the nidogen (entactin) protein family are structural components of basement membranes, we find that nidogen is not required for basement membrane assembly in the nematode Caenorhabditis elegans. Nidogen is Localized to body wall basement membranes and is required to direct longitudinal nerves dorsoventrally and to direct axons at the midlines. By examining migration of a single axon in vivo, we show that nidogen is required for the axon to switch from circumferential to Longitudinal migration. Specialized basement membranes may thus regulate nerve position.	Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Wadsworth, WG (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pathol, Piscataway, NJ 08854 USA.		Wadsworth, William G/N-7866-2014	Wadsworth, William G/0000-0003-3824-2948				Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; EKBLOM P, 1994, DEVELOPMENT, V120, P2003; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FOX JW, 1991, EMBO J, V10, P3137, DOI 10.1002/j.1460-2075.1991.tb04875.x; GARRIGA G, 1993, DEVELOPMENT, V117, P1071; Graham PL, 1997, J CELL BIOL, V137, P1171, DOI 10.1083/jcb.137.5.1171; HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0; HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K; Hopf M, 1999, EUR J BIOCHEM, V259, P917, DOI 10.1046/j.1432-1327.1999.00127.x; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Kadoya Y, 1997, DEVELOPMENT, V124, P683; Kim S, 1999, DEVELOPMENT, V126, P3881; KRAMER JM, 1990, MOL CELL BIOL, V10, P2081, DOI 10.1128/MCB.10.5.2081; MARICQ AV, 1995, NATURE, V378, P78, DOI 10.1038/378078a0; Mayer U, 1998, ANN NY ACAD SCI, V857, P130, DOI 10.1111/j.1749-6632.1998.tb10113.x; Mello C, 1995, METHOD CELL BIOL, V48, P451; Moerman DG, 1996, DEV BIOL, V173, P228, DOI 10.1006/dbio.1996.0019; NICOSIA RF, 1994, DEV BIOL, V164, P197, DOI 10.1006/dbio.1994.1191; Ren XC, 1999, J NEUROBIOL, V39, P107, DOI 10.1002/(SICI)1097-4695(199904)39:1&lt;107::AID-NEU9&gt;3.0.CO;2-7; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; Seydoux G, 1995, METHOD CELL BIOL, V48, P323; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208; TROEMEL ER, 1995, CELL, V83, P207, DOI 10.1016/0092-8674(95)90162-0; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; YELIAN FD, 1993, J CELL BIOL, V121, P923, DOI 10.1083/jcb.121.4.923; [No title captured]	30	84	95	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					150	154		10.1126/science.288.5463.150	http://dx.doi.org/10.1126/science.288.5463.150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753123				2022-12-24	WOS:000086387700055
J	Porter, EA; Wang, XF; Lee, HS; Weisblum, B; Gellman, SH				Porter, EA; Wang, XF; Lee, HS; Weisblum, B; Gellman, SH			Antibiotics - Non-haemolytic beta-amino-acid oligomers	NATURE			English	Article							PEPTIDES		Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; Univ Wisconsin, Dept Pharmacol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Porter, EA (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.		Lee, Hee-Seung/C-1627-2011					Appella DH, 1997, NATURE, V387, P381, DOI 10.1038/387381a0; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; CHEN HC, 1988, FEBS LETT, V236, P462, DOI 10.1016/0014-5793(88)80077-2; DeGrado WF, 1999, J PEPT RES, V54, P206, DOI 10.1034/j.1399-3011.1999.00131.x; Gellman SH, 1998, ACCOUNTS CHEM RES, V31, P173, DOI 10.1021/ar960298r; HABERMAN.E, 1972, SCIENCE, V177, P314, DOI 10.1126/science.177.4046.314; Hamuro Y, 1999, J AM CHEM SOC, V121, P12200, DOI 10.1021/ja992728p; Hintermann T, 1997, CHIMIA, V51, P244; Oren Z, 1998, BIOPOLYMERS, V47, P451; SABERWAL G, 1994, BBA-REV BIOMEMBRANES, V1197, P109, DOI 10.1016/0304-4157(94)90002-7; SEEBACH D, 1997, J CHEM SOC CHEM COMM, P2015, DOI DOI 10.1039/A704933A; Werder M, 1999, HELV CHIM ACTA, V82, P1774; Wu MH, 1999, BIOCHEMISTRY-US, V38, P7235, DOI 10.1021/bi9826299; ZASLOFF M, 1987, P NATL ACAD SCI USA, V84, P5449, DOI 10.1073/pnas.84.15.5449	14	621	642	1	90	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					565	565		10.1038/35007145	http://dx.doi.org/10.1038/35007145			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766230	Bronze			2022-12-24	WOS:000086400100041
J	Hippisley-Cox, J; Allen, J; Pringle, M; Ebdon, D; McPhearson, M; Churchill, D; Bradley, S				Hippisley-Cox, J; Allen, J; Pringle, M; Ebdon, D; McPhearson, M; Churchill, D; Bradley, S			Association between teenage pregnancy rates and the age and sex of general practitioners: cross sectional survey in Trent 1994-7	BRITISH MEDICAL JOURNAL			English	Article							FAMILY-PLANNING-SERVICES; WOMENS HEALTH; PHYSICIANS; PREFERENCE; CARE; CONSULTATION; PREVENTION; PATTERNS; MEN	Objective To examine variations in teenage pregnancy rates in Trent region and to determine possible associations with local general practice characteristics such as the age and sex of the doctors. Design Cross sectional survey. Setting All 526 general practices in Trent region in existence between 1994 and 1997. Subjects All pregnancies of teenagers aged 13 to 19 between 1994 and 1997 that resulted in an admission to an NHS hospital. Main outcome measures Pregnancy rates for teenagers aged 13 to 19 and general practice characteristics: presence of a female or young doctor (under 36 years old), number of whole time equivalent practice nurses, Townsend score, vocational training status, list size per whole time equivalent doctor, fundholding status, and partnership size. Results On multivariate analysis, lower teenage pregnancy rates were associated with the presence of a female or young doctor and more nurse time. Practices in deprived areas had higher teenage pregnancy rates. Conclusion General practices with female doctors, young doctors, or more nurse time had lower teenage pregnancy rates. The findings may have implications for the mix of health professionals within primary care.	Queens Med Ctr, Sch Med, Div Gen Practice, Nottingham NG7 2UH, England; Queens Med Ctr, Dept Obstet & Gynaecol, Nottingham NG7 2UH, England; Queens Med Ctr, Sch Nursing, Nottingham NG7 2UH, England; Univ Nottingham, Dept Geog, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham; University of Nottingham; University of Nottingham	Hippisley-Cox, J (corresponding author), Queens Med Ctr, Sch Med, Div Gen Practice, Nottingham NG7 2UH, England.		Hippisley-Cox, Julia/AAY-2788-2020	Hippisley-Cox, Julia/0000-0002-2479-7283; Churchill, Richard/0000-0003-0049-8200; Bethea, Jane/0000-0003-0297-0468				Adler MW, 1997, BRIT MED J, V314, P1743, DOI 10.1136/bmj.314.7096.1743; BABB P, 1993, POPULATION TRENDS, V74, P12; BAKER D, 1991, BRIT MED J, V303, P225, DOI 10.1136/bmj.303.6796.225; Britt H, 1996, MED CARE, V34, P403, DOI 10.1097/00005650-199605000-00003; Carstairs V, 1991, DEPRIVATION HLTH; Craft N, 1997, BRIT MED J, V315, P1301, DOI 10.1136/bmj.315.7118.1301; CURTIS HA, 1988, ARCH DIS CHILD, V63, P373, DOI 10.1136/adc.63.4.373; Frank E, 1996, ARCH FAM MED, V5, P215, DOI 10.1001/archfami.5.4.215; GARLICK R, 1993, PUBLIC HEALTH, V107, P135, DOI 10.1016/S0033-3506(05)80411-1; Glatstein IZ, 1997, FERTIL STERIL, V67, P443, DOI 10.1016/S0015-0282(97)80067-2; JACOBSON LD, 1995, FAM PRACT, V12, P232, DOI 10.1093/fampra/12.2.232; JEFFREYS LA, 1995, BRIT J GEN PRACT, V45, P415; Kerssens JJ, 1997, SOC SCI MED, V44, P1531, DOI 10.1016/S0277-9536(96)00272-9; Langille DB, 1997, CAN FAM PHYSICIAN, V43, P1563; LAW SAT, 1995, BRIT J GEN PRACT, V45, P520; Maheux B, 1997, CAN FAM PHYSICIAN, V43, P1089; McKee M, 1993, Qual Health Care, V2, P104, DOI 10.1136/qshc.2.2.104; MELLANBY AR, 1995, BRIT MED J, V311, P414, DOI 10.1136/bmj.311.7002.414; MOORE AT, 1989, BRIT MED J, V298, P500, DOI 10.1136/bmj.298.6672.500; NHS Centre for Reviews and Dissemination University of York, 1997, EFFECTIVE HLTH CARE, V3, P1; *OFF NAT STAT, 1996, MONITOR POPUL HLTH, V96, P1; PEARSON VAH, 1995, BRIT J FAM PLAN, V21, P45; PHILLIPS DR, 1995, ATTITUDES FAMILY PLA, P403; Reid I, 1998, BRIT MED J, V317, P1051; ROWLANDS S, 1991, BRIT J GEN PRACT, V41, P138; Seamark CJ, 1997, BRIT J GEN PRACT, V47, P175; Secretary of State for Health, 1992, HLTH NAT STRAT HLTH; SMITH R, 1997, BRIT MED J, V314, P695; SMITH T, 1993, BRIT MED J, V306, P1232, DOI 10.1136/bmj.306.6887.1232; van den Brink-Muinen A, 1998, MED CARE, V36, P100, DOI 10.1097/00005650-199801000-00012; WEYRAUCH KF, 1990, J FAM PRACTICE, V30, P559; WILSON SH, 1992, J PUBLIC HEALTH MED, V14, P17	32	33	33	0	3	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					842	845		10.1136/bmj.320.7238.842	http://dx.doi.org/10.1136/bmj.320.7238.842			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	299DJ	10731180	Green Submitted, Bronze, Green Published			2022-12-24	WOS:000086180300027
J	Jasny, BR				Jasny, BR			The universe of Drosophila genes	SCIENCE			English	Editorial Material																			0	13	13	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 24	2000	287	5461					2181	2181		10.1126/science.287.5461.2181	http://dx.doi.org/10.1126/science.287.5461.2181			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10744541				2022-12-24	WOS:000086049100030
J	Ritchie, KB; Nagelkerken, I; James, S; Smith, GW				Ritchie, KB; Nagelkerken, I; James, S; Smith, GW			Environmental microbiology - A tetrodotoxin-producing marine pathogen	NATURE			English	Article							MASS		Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Carmabi Fdn, Curacao, Neth Antilles; Clemson Univ, Dept Microbiol & Mol Med, Clemson, SC 29634 USA; Univ S Carolina, Dept Biol, Aiken, SC 29801 USA	University of North Carolina; University of North Carolina Chapel Hill; Clemson University; University of South Carolina	Ritchie, KB (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	Smithres@aiken.ac.edu	Nagelkerken, Ivan/E-1093-2011	Nagelkerken, Ivan/0000-0003-4499-3940				BOCHNER BR, 1989, NATURE, V339, P157, DOI 10.1038/339157a0; Brigmon RL, 1998, APPL ENVIRON MICROB, V64, P3491; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; LESSIOS HA, 1984, SCIENCE, V226, P335, DOI 10.1126/science.226.4672.335; LESSIOS HA, 1988, ANNU REV ECOL SYST, V19, P371, DOI 10.1146/annurev.es.19.110188.002103; MARTINEZMURCIA AJ, 1992, INT J SYST BACTERIOL, V42, P412, DOI 10.1099/00207713-42-3-412; Nagelkerken I, 1999, DIS AQUAT ORGAN, V38, P71, DOI 10.3354/dao038071; NOGUCHI T, 1987, MAR BIOL, V94, P625, DOI 10.1007/BF00431409; PETERS EC, 1993, ADV FISH SC, P393; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; SIMIDU U, 1987, APPL ENVIRON MICROB, V53, P1714, DOI 10.1128/AEM.53.7.1714-1715.1987; YOTSU M, 1987, TOXICON, V25, P225, DOI 10.1016/0041-0101(87)90245-5	12	40	42	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 23	2000	404	6776					354	354		10.1038/35006168	http://dx.doi.org/10.1038/35006168			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746714	Bronze			2022-12-24	WOS:000086119000039
J	Cook, RI; Render, M; Woods, DD				Cook, RI; Render, M; Woods, DD			Gaps in the continuity of care and progress on patient safety	BRITISH MEDICAL JOURNAL			English	Article									Univ Chicago, VA Patient Safety Ctr Inquiry GAPS, Chicago, IL 60637 USA; Cincinnati VAMC, VA Patient Safety Ctr Inquiry GAPS, Cincinnati, OH 45220 USA; Ohio State Univ, VA Patient Safety Ctr Inquiry GAPS, Columbus, OH 43210 USA	University of Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; University System of Ohio; Ohio State University	Cook, RI (corresponding author), Univ Chicago, VA Patient Safety Ctr Inquiry GAPS, 5841 S Maryland Ave,MC 4028, Chicago, IL 60637 USA.							BARLEY SR, 1997, CRAFT SCI TECHNICAL, P16; Cook R., 1998, TALE 2 STORIES CONTR; Cook RI, 1994, HUMAN ERROR MED, P255; COOK RI, 1999, ENHANCING PATIENT SA, P61; Klein G. A, 1999, SOURCES POWER PEOPLE; Kohn LTCJ., BUILDING SAFER HLTH; *NAT PAT SAF FDN, 1999, AG RES DEV PAT SAF; RASMUSSEN J, 1994, COGNITIVE SYSTEMS EN, P135; SENDERS JW, 1999, ENHANCING PATIENT SA, P65; Woods D.D., 1988, TASKS ERRORS MENTAL, P128; WOODS DD, 1999, HDB APPL COGNITION, P141	11	323	327	0	25	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	2000	320	7237					791	794		10.1136/bmj.320.7237.791	http://dx.doi.org/10.1136/bmj.320.7237.791			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720370	Green Published			2022-12-24	WOS:000086054700035
J	Doncaster, CP; Pound, GE; Cox, SJ				Doncaster, CP; Pound, GE; Cox, SJ			The ecological cost of sex	NATURE			English	Article							COEXISTENCE; COEVOLUTION; DIVERSITY; SELECTION; CLONES; MODEL	Why sex prevails in nature remains one of the great puzzles of evolution(1,2). Sexual reproduction has an immediate cost relative to asexual reproduction, as males only express their contribution to population growth through females. With no males to sustain, an asexual mutant can double its relative representation in the population in successive generations. This is the widely accepted 'twofold cost of males'(1-3). Many studies(4-7) have attempted to explain how sex can recoup this cost from fitness benefits associated with the recombination of parental genotypes, but these require complex biological environments that cycle over evolutionary timescales. In contrast, we have considered the ecological dynamics that govern asexual invasion. Here we show the existence of a threshold growth rate for the sexual population, above which the invasion is halted by intraspecific competition. The asexual population then exerts a weaker inhibitory effect on the carrying capacity of the sexual population than on its own carrying capacity. The stable outcome of this is coexistence on a depleted resource base. Under these ecological circumstances, longer-term benefits of sex may eventually drive out the asexual competitor.	Univ Southampton, Sch Biol Sci, Div Biodivers & Ecol, Southampton SO16 7PX, Hants, England; Univ Southampton, Dept Elect & Comp Sci, Southampton SO17 1BJ, Hants, England	University of Southampton; University of Southampton	Doncaster, CP (corresponding author), Univ Southampton, Sch Biol Sci, Div Biodivers & Ecol, Bassett Crescent E, Southampton SO16 7PX, Hants, England.	cpd@soton.ac.uk	Doncaster, C. Patrick/AAT-7621-2020	Doncaster, C. Patrick/0000-0001-9406-0693				Begon M., 1996, ECOLOGY; Bell G., 1982, MASTERPIECE NATURE; BOLGER DT, 1994, OECOLOGIA, V100, P397, DOI 10.1007/BF00317861; BROWNE RA, 1990, EVOLUTION, V44, P1035, DOI 10.1111/j.1558-5646.1990.tb03824.x; BULEMR M, 1994, THEORETICAL EVOLUTIO; CASE TJ, 1986, EVOLUTION, V40, P366, DOI 10.1111/j.1558-5646.1986.tb00478.x; CASE TJ, 1990, OECOLOGIA, V83, P220, DOI 10.1007/BF00317756; Connolly SR, 1999, ECOL MONOGR, V69, P277, DOI 10.1890/0012-9615(1999)069[0277:TOMCCP]2.0.CO;2; Doebeli M, 1996, ECOLOGY, V77, P510, DOI 10.2307/2265626; Futuyama D.J., 1998, EVOLUTIONARY BIOL; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hurst Laurence D., 1996, Trends in Ecology and Evolution, V11, P46, DOI 10.1016/0169-5347(96)81041-X; Jokela J, 1997, EVOLUTION, V51, P1120, DOI 10.1111/j.1558-5646.1997.tb03959.x; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; KONDRASHOV AS, 1993, J HERED, V84, P372, DOI 10.1093/oxfordjournals.jhered.a111358; Levins R., 1970, SOME MATH PROBLEMS B, P75; Lively CM, 1996, BIOSCIENCE, V46, P107, DOI 10.2307/1312813; LOTKA ALFRED J., 1932, JOUR WASHINGTON ACAD SCI, V22, P461; Maynard Smith, 1998, EVOL GENET; Maynard Smith J., 1978, EVOLUTION SEX; Ridley M., 1996, EVOLUTION; Semlitsch RD, 1997, EVOLUTION, V51, P1249, DOI 10.1111/j.1558-5646.1997.tb03972.x; Skelton P., 1993, EVOLUTION BIOL PALAE; Stearns S.C., 2000, EVOLUTION INTRO; VJIJENHOEK RC, 1997, EVOLUTION, V51, P1593; Volterra V, 1931, ANIMAL ECOLOGY, P409; VRIJENHOEK RC, 1979, AM ZOOL, V19, P787; Weeks AR, 1998, EVOLUTION, V52, P1325, DOI [10.2307/2411302, 10.1111/j.1558-5646.1998.tb02014.x]; Williams G.C., 1975, Journal Cell Biol, VNo. 8, pi	29	111	114	0	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					281	285		10.1038/35005078	http://dx.doi.org/10.1038/35005078			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749210				2022-12-24	WOS:000086022200048
J	Yudkin, JS				Yudkin, JS			Insulin for the world's poorest countries	LANCET			English	Article							AFRICA	In the industrialised world, type 1 diabetes rarely results in death from ketoacidosis. The same is not true in many countries in the developing world where insulin availability is intermittent, and insulin may not even be included on national formularies of essential drugs. The life expectancy for a newly diagnosed patient with type 1 diabetes in some parts of Africa may be as short as 1 year. The World Bank has identified 40 highly indebted poor countries (HIPCs) whose national debt substantially exceeds any possibility of repayment without heavy impact on health and social programmes. Incidence and prognosis of type 1 diabetes in HIPCs are lower than in most industrialised countries, and 0.48% of the world's current use of insulin is estimated to be sufficient to treat all type 1 diabetic patients in these countries. A proposal is made for the major insulin manufacturers to donate insulin, at an estimated cost of US$3-5 million per year, as part of a distribution and education initiative for type 1 diabetic patients in the HIPCs. No type 1 diabetic patient in the world's poorest countries need then die because they, or their government, cannot afford insulin.	Royal Free & UCL Sch Med, Whittington Hosp, London N19 3UA, England	University of London; University College London	Yudkin, JS (corresponding author), Royal Free & UCL Sch Med, Whittington Hosp, London N19 3UA, England.	j.yudkin@ucl.ac.uk	Yudkin, John S/C-1988-2008					Abbasi K, 1999, BMJ-BRIT MED J, V318, P1003, DOI 10.1136/bmj.318.7189.1003; Abbasi K, 1999, BRIT MED J, V318, P865, DOI 10.1136/bmj.318.7187.865; Abbasi K, 1999, BMJ-BRIT MED J, V318, P1568, DOI 10.1136/bmj.318.7198.1568; ALBERTI KGM, 1994, WORLD HEALTH FORUM, V15, P6; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; CASTLE WM, 1980, DIABETOLOGIA, V18, P121, DOI 10.1007/BF00290487; CHALE SS, 1992, BRIT MED J, V304, P1215, DOI 10.1136/bmj.304.6836.1215; CHANTELAU E, 1993, LANCET, V342, P620, DOI 10.1016/0140-6736(93)91447-T; Decosas J, 1999, LANCET, V353, P143, DOI 10.1016/S0140-6736(98)11454-X; DEEB LC, 1994, DIABETES CARE, V17, P220, DOI 10.2337/diacare.17.3.220; Gill G. V., 1997, DIABETES AFRICA, P65; MAKAME MH, 1992, DIABETIC MED, V9, P571, DOI 10.1111/j.1464-5491.1992.tb01841.x; McLarty D. G., 1994, International Diabetes Digest, V5, P15; RAAB R, 1999, PRACT DIABETES INT, V16, P58; SAVAGE A, 1994, INT DIABETES DIGEST, V5, P19; United Nations Development Programme, 1997, HUM DEV REP; World Bank, 1993, WORLD DEV REP 1993 I; Yudkin JS, 1999, LANCET, V353, P1519, DOI 10.1016/S0140-6736(98)09440-9; Zaffran M, 1996, DEV BIOL STAND, V87, P9; 1996, JUBILEE 2000 DEBT CU; 1999, LYMPHATIC FILARIASIS	21	45	46	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 11	2000	355	9207					919	+		10.1016/S0140-6736(99)09225-9	http://dx.doi.org/10.1016/S0140-6736(99)09225-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752719				2022-12-24	WOS:000085896000042
J	Tierney, S; Fennessy, F; Hayes, DB				Tierney, S; Fennessy, F; Hayes, DB			ABC of arterial and vascular disease - Secondary prevention of peripheral vascular disease	BRITISH MEDICAL JOURNAL			English	Review									Beaumont Hosp, Dublin 9, Ireland		Tierney, S (corresponding author), Beaumont Hosp, Dublin 9, Ireland.		Tierney, Sean/I-7740-2013	Tierney, Sean/0000-0002-1886-7214				*AM HEART ASS WRIT, 1994, OPT RISK FACT MAN PA; BAINTON D, 1994, BRIT HEART J, V72, P128; *COTT INT GUID NET, 1999, SIGN, P40; *DEP HLTH, 1997, STAND MED ADV STAT U; LENG GC, 1999, COCHRANE LIBRARY; O'Brien E, 1998, LANCET, V352, P1700, DOI 10.1016/S0140-6736(97)09026-0; Tribble DL, 1999, CIRCULATION, V99, P591, DOI 10.1161/01.CIR.99.4.591	7	35	37	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAY 6	2000	320	7244					1262	1265		10.1136/bmj.320.7244.1262	http://dx.doi.org/10.1136/bmj.320.7244.1262			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	313CF	10797042	Green Published			2022-12-24	WOS:000086981400026
J	Sharples, JM; Meharg, AA; Chambers, SM; Cairney, JWG				Sharples, JM; Meharg, AA; Chambers, SM; Cairney, JWG			Evolution - Symbiotic solution to arsenic contamination	NATURE			English	Article							PHOSPHATE-UPTAKE SYSTEM; RESISTANCE; TOLERANCE; PLANTS		Univ Western Sydney, Sch Sci, Mycorrhiza Res Grp, Kingswood, NSW 2747, Australia; Inst Terr Ecol, Huntingdon PE17 2LS, England	Western Sydney University; UK Centre for Ecology & Hydrology (UKCEH)	Sharples, JM (corresponding author), Univ Western Sydney, Sch Sci, Mycorrhiza Res Grp, POB 10, Kingswood, NSW 2747, Australia.		Meharg, Andrew Alexander/F-8182-2014	Meharg, Andrew Alexander/0000-0003-2019-0449				BRADLEY R, 1981, NATURE, V292, P335, DOI 10.1038/292335a0; Cairney JWG, 1999, ENVIRON POLLUT, V106, P169, DOI 10.1016/S0269-7491(99)00081-0; LEE RB, 1982, ANN BOT-LONDON, V50, P429, DOI 10.1093/oxfordjournals.aob.a086383; MACNAIR MR, 1993, NEW PHYTOL, V124, P541, DOI 10.1111/j.1469-8137.1993.tb03846.x; MEHARG AA, 1992, J EXP BOT, V43, P519, DOI 10.1093/jxb/43.4.519; Silver S, 1996, ANNU REV MICROBIOL, V50, P753, DOI 10.1146/annurev.micro.50.1.753; Smith SE., 1996, MYCORRHIZAL SYMBIOSI; STRAKER CJ, 1987, NEW PHYTOL, V106, P129, DOI 10.1111/j.1469-8137.1987.tb04796.x	8	104	128	4	50	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2000	404	6781					951	952		10.1038/35010193	http://dx.doi.org/10.1038/35010193			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801114				2022-12-24	WOS:000086762000042
J	Costedoat-Chalumeau, N; Amoura, Z; Aymard, G; Sevin, O; Wechsler, B; Cacoub, P; Du, LTH; Diquet, B; Ankri, A; Piette, JC				Costedoat-Chalumeau, N; Amoura, Z; Aymard, G; Sevin, O; Wechsler, B; Cacoub, P; Du, LTH; Diquet, B; Ankri, A; Piette, JC			Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone	ANNALS OF INTERNAL MEDICINE			English	Article							WARFARIN; ANTICOAGULATION; FLUINDIONE; POPULATION; AUDIT	Background: Oral anticoagulants and pulse high-dose intravenous methylprednisolone are often administered concomitantly, but no data on potential interactions are available. Objective: To assess possible potentiation of oral anticoagulation by high-dose intravenous methylprednisolone. Design: Prospective cohort study. Setting: University hospital in Paris, France. Patients: 10 consecutive patients concomitantly receiving methylprednisolone and oral anticoagulants (fluindione and acenocoumarol) and 5 consecutive controls receiving methylprednisolone alone. Measurements: Serial determinations of the international normalized ratio (INR) and clotting factors during administration of pulse methylprednisolone. The total plasma fluindione concentration was determined in 3 patients. Results: The mean INR was 2.75 (range, 2.02 to 3.81) at baseline and increased to 8.04 (range, 5.32 to 20.0) after methylprednisolone administration. Plasma fluindione concentrations and the INR increased after methylprednisolone administration. Methylprednisolone alone did not increase prothrombin time. Conclusions: The action of oral anticoagulants is potentiated by intravenous high-dose methylprednisolone. The INR should be monitored daily during concomitant administration of these medications.	Grp Hosp Univ Pitie Salpetriere, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Costedoat-Chalumeau, N (corresponding author), Hop La Pitie Salpetriere, Serv Med Interne, 47-83 Blvd Hop, F-75013 Paris, France.		AMOURA, Zahir/P-5324-2017; Amoura, Zahir/P-5325-2017	AMOURA, Zahir/0000-0003-0292-9043; , nathalie/0000-0002-1555-9021; Cacoub, Patrice/0000-0002-6727-4992				Aymard G, 1998, J CHROMATOGR B, V707, P169, DOI 10.1016/S0378-4347(97)00587-2; Brigden ML, 1998, AM J HEMATOL, V59, P22, DOI 10.1002/(SICI)1096-8652(199809)59:1<22::AID-AJH5>3.3.CO;2-J; BROZOVIC M, 1973, BRIT J HAEMATOL, V24, P579, DOI 10.1111/j.1365-2141.1973.tb01684.x; CHATTERJEA JB, 1954, BRIT MED J, V2, P790, DOI 10.1136/bmj.2.4891.790; COSGRIFF SW, 1950, AM J MED, V9, P752, DOI 10.1016/0002-9343(50)90290-7; GOODMAN BW, 1979, AM J MED, V67, P839, DOI 10.1016/0002-9343(79)90744-7; Hirsh J, 1998, CHEST, V114, p445S, DOI 10.1378/chest.114.5_Supplement.445S; Hylek EM, 1998, JAMA-J AM MED ASSOC, V279, P657, DOI 10.1001/jama.279.9.657; Kaminsky LS, 1997, PHARMACOL THERAPEUT, V73, P67, DOI 10.1016/S0163-7258(96)00140-4; Kaufman M, 1997, MULT SCLER, V3, P248, DOI 10.1177/135245859700300406; KHAMASHTA MA, 1995, NEW ENGL J MED, V332, P993, DOI 10.1056/NEJM199504133321504; Mentre F, 1998, CLIN PHARMACOL THER, V63, P64, DOI 10.1016/S0009-9236(98)90122-9; Murphy PT, 1998, CLIN LAB HAEMATOL, V20, P253, DOI 10.1046/j.1365-2257.1998.00142.x; PATEL PM, 1993, HEMATOL ONCOL, V11, P89, DOI 10.1002/hon.2900110206; PICHARD L, 1990, DRUG METAB DISPOS, V18, P595; Roujeau JC, 1996, ARCH DERMATOL, V132, P1499, DOI 10.1001/archderm.132.12.1499; Wechsler B, 1992, Eur J Med, V1, P387	17	36	39	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 18	2000	132	8					631	635		10.7326/0003-4819-132-8-200004180-00005	http://dx.doi.org/10.7326/0003-4819-132-8-200004180-00005			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	304RG	10766681				2022-12-24	WOS:000086497500004
J	Canto, JG; Allison, JJ; Kiefe, CI; Fincher, C; Farmer, R; Sekar, P; Person, S; Weissman, NW				Canto, JG; Allison, JJ; Kiefe, CI; Fincher, C; Farmer, R; Sekar, P; Person, S; Weissman, NW			Relation of race and sex to the use of reperfusion therapy in medicare beneficiaries with acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THROMBOLYTIC THERAPY; NATIONAL REGISTRY; UNITED-STATES; IMMEDIATE ANGIOPLASTY; GENDER DIFFERENCES; MANAGEMENT; WOMEN; PERSPECTIVE; GUIDELINES; MORTALITY	Background: There are few reports describing the combined influence of the race and sex of a patient on the use of reperfusion therapy for acute myocardial infarction. Methods: To determine the relation of race and sex to the receipt of reperfusion therapy for myocardial infarction in the United States, we reviewed the medical records of 234,769 Medicare patients with myocardial infarction. From these records we identified 26,575 white or black patients who met strict eligibility criteria for reperfusion therapy. We then performed bivariate and multivariate analyses of prevalence ratios to determine predictors of the use of reperfusion therapy in four subgroups of patients categorized according to race and sex: white men, white women, black men, and black women. Results: Among eligible patients, white men received reperfusion therapy with the highest frequency (59 percent), followed by white women (56 percent), black men (50 percent), and black women (44 percent). After adjustment for differences in demographic and clinical characteristics, white women were as likely as white men to receive reperfusion therapy (prevalence ratio, 1.00; 95 percent confidence interval, 0.98 to 1.03). Likewise, black women were as likely as black men to receive reperfusion therapy (prevalence ratio, 1.00; 95 percent confidence interval, 0.89 to 1.13). However, black women were significantly less likely to receive reperfusion therapy than white men (prevalence ratio, 0.90; 95 percent confidence interval, 0.82 to 0.98), as were black men (prevalence ratio, 0.85; 95 percent confidence interval, 0.78 to 0.93). Conclusions: After adjustment for differences in clinical and demographic characteristics and clinical presentation, differences according to sex in the use of reperfusion therapy are minimal. However, blacks, regardless of sex, are significantly less likely than whites to receive this potentially lifesaving therapy. (N Engl J Med 2000;342:1094-100.) (C) 2000, Massachusetts Medical Society.	Univ Alabama, Ctr Outcomes & Effect Res & Educ, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Canto, JG (corresponding author), Univ Alabama, Ctr Outcomes & Effect Res & Educ, 363 BDB,1808 7th Ave S, Birmingham, AL 35294 USA.			Allison, Jeroan/0000-0003-4472-2112	AHRQ HHS [HS08843, HS09446] Funding Source: Medline; NCRR NIH HHS [RR00032] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS009446, R01HS008843] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Allison JJ, 1996, J GEN INTERN MED, V11, P736, DOI 10.1007/BF02598987; Barron HV, 1998, CIRCULATION, V97, P1150, DOI 10.1161/01.CIR.97.12.1150; BEHAR S, 1994, AM J CARDIOL, V73, P438, DOI 10.1016/0002-9149(94)90672-6; Borzak S, 1999, AM HEART J, V137, P338, DOI 10.1053/hj.1999.v137.92523; *CDCP, 1993, CARD DIS SURV ISCH H; Chandra NC, 1998, ARCH INTERN MED, V158, P981, DOI 10.1001/archinte.158.9.981; Chen J, 1999, NEW ENGL J MED, V340, P286, DOI 10.1056/NEJM199901283400407; Dellborg M, 1993, Qual Assur Health Care, V5, P261; GIBBONS RJ, 1993, NEW ENGL J MED, V328, P685, DOI 10.1056/NEJM199303113281003; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; GRINES CL, 1993, NEW ENGL J MED, V328, P673, DOI 10.1056/NEJM199303113281001; Gurwitz JH, 1996, ANN INTERN MED, V124, P283, DOI 10.7326/0003-4819-124-3-199602010-00001; *ICD, 1980, ICD9CM; JOHNSON N, 1988, ENCY STAT, P646; Krumholz HM, 1997, JAMA-J AM MED ASSOC, V277, P1683, DOI 10.1001/jama.277.21.1683; Lauderdale DS, 1996, AM J PUBLIC HEALTH, V86, P712, DOI 10.2105/AJPH.86.5.712; MAYNARD C, 1991, AM J CARDIOL, V68, P529, DOI 10.1016/0002-9149(91)90791-I; McLaughlin TJ, 1996, ARCH INTERN MED, V156, P799, DOI 10.1001/archinte.156.7.799; MCLAUGHLIN TJ, 1996, ARCH INTERN MED, V156, P1920; *NAT CTR HLTH STAT, 1998, HLTH US 1998 SOC STA; PAGLEY PR, 1993, ARCH INTERN MED, V153, P625, DOI 10.1001/archinte.153.5.625; Pan CX, 1999, J AM GERIATR SOC, V47, P730, DOI 10.1111/j.1532-5415.1999.tb01599.x; ROGERS WJ, 1994, CIRCULATION, V90, P2103, DOI 10.1161/01.CIR.90.4.2103; Ryan TJ, 1996, J AM COLL CARDIOL, V28, P1328; SCHULMAN K, 1918, NEW ENGL J MED, V340, P1130; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Taylor HA, 1998, AM J CARDIOL, V82, P1019, DOI 10.1016/S0002-9149(98)00547-5; WEAVER WD, 1991, J AM COLL CARDIOL, V18, P657, DOI 10.1016/0735-1097(91)90784-7; Yarzebski J, 1996, AM HEART J, V131, P43, DOI 10.1016/S0002-8703(96)90049-6; ZIJLSTRA F, 1993, NEW ENGL J MED, V328, P680, DOI 10.1056/NEJM199303113281002; Zocchetti C, 1997, INT J EPIDEMIOL, V26, P220, DOI 10.1093/ije/26.1.220	32	175	177	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 13	2000	342	15					1094	1100		10.1056/NEJM200004133421505	http://dx.doi.org/10.1056/NEJM200004133421505			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303DZ	10760310	Bronze			2022-12-24	WOS:000086406700005
J	Anbar, AD; Roe, JE; Barling, J; Nealson, KH				Anbar, AD; Roe, JE; Barling, J; Nealson, KH			Nonbiological fractionation of iron isotopes	SCIENCE			English	Article							CHLORIDE SOLUTIONS; COMPLEXES	Laboratory experiments demonstrate that iron isotopes can be chemically fractionated in the absence of biology. Isotopic variations comparable to those seen during microbially mediated reduction of ferrihydrite are observed. Fractionation may occur in aqueous solution during equilibration between inorganic iron complexes. These findings provide insight into the mechanisms of iron isotope fractionation and suggest that nonbiological processes may contribute to iron isotope variations observed in sediments.	Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA; Univ Rochester, Dept Chem, Rochester, NY 14627 USA; CALTECH, Jet Prop Lab, Pasadena, CA 91106 USA	University of Rochester; University of Rochester; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Anbar, AD (corresponding author), Univ Rochester, Dept Earth & Environm Sci, Rochester, NY 14627 USA.		Barling, Jane/F-9443-2015	Barling, Jane/0000-0001-8535-5262				ANBAR AD, 1998, MINERAL MAG A, V62, P53; APTED MJ, 1985, GEOCHIM COSMOCHIM AC, V49, P2081, DOI 10.1016/0016-7037(85)90065-1; Beard BL, 1999, SCIENCE, V285, P1889, DOI 10.1126/science.285.5435.1889; Beard BL, 1999, GEOCHIM COSMOCHIM AC, V63, P1653, DOI 10.1016/S0016-7037(99)00089-7; BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; BJERRUM J, 1986, ACTA CHEM SCAND A, V40, P31, DOI 10.3891/acta.chem.scand.40a-0031; Bullen T.D., 1998, MINERAL MAG A, V62, P255; BULLEN TD, 1999, EOS, V80, P479; Criss R. E., 1999, PRINCIPLES STABLE IS; GLUECKAUF E, 1958, T FARADAY SOC, V54, P1203, DOI 10.1039/tf9585401203; HALLIDAY AN, 1995, INT J MASS SPECTROM, V146, P21, DOI 10.1016/0168-1176(95)04200-5; MAGINI M, 1979, J CHEM PHYS, V71, P4255, DOI 10.1063/1.438233; Mandernack KW, 1999, SCIENCE, V285, P1892, DOI 10.1126/science.285.5435.1892; Marechal CN, 1999, CHEM GEOL, V156, P251, DOI 10.1016/S0009-2541(98)00191-0; MOORE GE, 1959, J AM CHEM SOC, V72, P5792; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Polyakov VB, 2000, GEOCHIM COSMOCHIM AC, V64, P849, DOI 10.1016/S0016-7037(99)00329-4; RUSSELL WA, 1978, ANAL CHEM, V50, P1151, DOI 10.1021/ac50030a036; SKOOG DA, 1998, INSTRUMENTAL ANAL, P675; Taylor TI, 1938, J CHEM PHYS, V6, P429, DOI 10.1063/1.1750288; UREY HC, 1947, J CHEM SOC, P562, DOI 10.1039/jr9470000562; VANDERWALT TN, 1985, SOLVENT EXTR ION EXC, V3, P723, DOI 10.1080/07366298508918536; Zhu XK, 2000, CHEM GEOL, V163, P139, DOI 10.1016/S0009-2541(99)00076-5	23	224	248	1	116	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					126	128		10.1126/science.288.5463.126	http://dx.doi.org/10.1126/science.288.5463.126			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10753114				2022-12-24	WOS:000086387700048
J	Smith, O				Smith, O			Nota bene: Development - Awakening aurora	SCIENCE			English	Editorial Material																		Andresson T, 1998, EMBO J, V17, P5627, DOI 10.1093/emboj/17.19.5627; Mendez R, 2000, NATURE, V404, P302, DOI 10.1038/35005126	2	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					69	69		10.1126/science.288.5463.69	http://dx.doi.org/10.1126/science.288.5463.69			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10766638				2022-12-24	WOS:000086387700032
J	Battle, M; Bender, ML; Tans, PP; White, JWC; Ellis, JT; Conway, T; Francey, RJ				Battle, M; Bender, ML; Tans, PP; White, JWC; Ellis, JT; Conway, T; Francey, RJ			Global carbon sinks and their variability inferred from atmospheric O-2 and delta C-13	SCIENCE			English	Article							CO2; CYCLE; AIR; DIOXIDE; OXYGEN; RATIO	Recent time-series measurements of atmospheric O-2 show that the land biosphere and world oceans annually sequestered 1.4 +/- 0.8 and 2.0 +/- 0.6 gigatons of carbon, respectively between mid-1991 and mid-1997. The rapid storage of carbon by the Land biosphere from 1991 to 1997 contrasts with the 1980s, when the land biosphere was approximately neutral. Comparison with measurements of delta(13)CO(2) implies an isotopic flux of 89 +/- 21 gigatons of carbon per mil per year, in agreement with model- and inventory-based estimates of this flux. Both the delta(13)C and the O-2 data show significant interannual variability in carbon storage over the period of record. The general agreement of the independent estimates from O-2 and delta(13)C is a robust signal of variable carbon uptake by both the Land biosphere and the oceans.	Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; NOAA, Climate Monitoring & Diagnost Lab, Boulder, CO 80303 USA; Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; Univ Rhode Isl, Grad Sch Oceanog, Narragansett, RI 02882 USA; CSIRO, Div Atmospher Res, Mordialloc, Vic 3195, Australia	Princeton University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Rhode Island; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Battle, M (corresponding author), Bowdoin Coll, Dept Phys & Astron, 8800 Coll Stn, Brunswick, ME 04011 USA.		Tans, Pieter/AAG-8273-2019; White, James W.C./A-7845-2009; Francey, Roger J/A-2345-2012	Tans, Pieter/0000-0002-9883-0787; White, James W.C./0000-0001-6041-4684; 				ANDRES R, COMMUNICATION; Battle M, 1996, NATURE, V383, P231, DOI 10.1038/383231a0; Bender M, 1996, GLOBAL BIOGEOCHEM CY, V10, P9, DOI 10.1029/95GB03295; BENDER ML, 1994, GEOCHIM COSMOCHIM AC, V58, P4751, DOI 10.1016/0016-7037(94)90205-4; CIAIS P, 1995, J GEOPHYS RES-ATMOS, V100, P5051, DOI 10.1029/94JD02847; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; CONWAY TJ, 1994, J GEOPHYS RES-ATMOS, V99, P22831, DOI 10.1029/94JD01951; FRANCEY R, 1994, 22 NOAA; FRANCEY RJ, 1995, NATURE, V373, P326, DOI 10.1038/373326a0; Heimann M, 1996, GLOBAL BIOGEOCHEM CY, V10, P89, DOI 10.1029/95GB03191; KEELING CD, 1995, NATURE, V375, P666, DOI 10.1038/375666a0; KEELING CD, 1989, GEOPHYS MONOGR SER, V55, P305, DOI DOI 10.1029/GM055P0305; Keeling RF, 1996, NATURE, V381, P218, DOI 10.1038/381218a0; KEELING RF, 1992, NATURE, V358, P723, DOI 10.1038/358723a0; KEELING RF, 1993, GLOBAL BIOGEOCHEM CY, V7, P37, DOI 10.1029/92GB02733; KEELING RF, 1988, THESIS HARVARD U; Langenfelds RL, 1999, GEOPHYS RES LETT, V26, P1897, DOI 10.1029/1999GL900446; MACHTA L, 1970, SCIENCE, V168, P199; MARLAND G, 1997, 5 INT CARB DIOX C CA, P4; MASARIE K, UNPUB; Rayner PJ, 1999, TELLUS B, V51, P213, DOI 10.1034/j.1600-0889.1999.t01-1-00008.x; SARMIENTO JL, 1992, NATURE, V356, P589, DOI 10.1038/356589a0; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Severinghaus J.P., 1995, THESIS COLUMBIA U; Siegenthaler U., 1981, CARBON CYCLE MODEL, P249; TANS PP, 1993, GLOBAL BIOGEOCHEM CY, V7, P353, DOI 10.1029/93GB00053; THONING KW, 1989, J GEOPHYS RES-ATMOS, V94, P8549, DOI 10.1029/JD094iD06p08549; Trolier M, 1996, J GEOPHYS RES-ATMOS, V101, P25897, DOI 10.1029/96JD02363; WANNINKHOF R, 1985, TELLUS B, V37, P128, DOI 10.1111/j.1600-0889.1985.tb00061.x	29	373	421	4	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2467	2470		10.1126/science.287.5462.2467	http://dx.doi.org/10.1126/science.287.5462.2467			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741962				2022-12-24	WOS:000086202200039
J	Neal, KR; Nguyen-Van-Tam, JS; Jeffrey, N; Slack, RCB; Madeley, RJ; Ait-Tahar, K; Job, K; Wale, MCJ; Ala'Aldeen, DAA				Neal, KR; Nguyen-Van-Tam, JS; Jeffrey, N; Slack, RCB; Madeley, RJ; Ait-Tahar, K; Job, K; Wale, MCJ; Ala'Aldeen, DAA			Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study	BRITISH MEDICAL JOURNAL			English	Article							C MENINGOCOCCAL DISEASE; COAGGLUTINATION; OUTBREAK; ELISA	Objective To determine the rates of, and risk factors for, meningococcal carriage and acquisition among university students. Design Repeated cross sectional study. Participants 2507 students in their first year at university. Main outcome measures Prevalence of carriage of meningococci and risk factors for carriage and acquisition of meningococci. Results Carriage rates for meningoccoci increased rapidly in the first week of term from 6.9% on day 1, to 11.2% on day 2, to 19.0% on day 3, and to 23.1% on day 4. The average carriage rate during the first week of term in October among students living in catered halls was 13.9%. By November this had risen to 31.0% and in December it had reached 34.2%. Independent associations for acquisition of meningococci in the autumn term were frequency of visits to a hall bar (5-7 visits: odds ratio 2.7, 95% confidence interval 1.5 to 4.8), active smoking (1.6, 1.0 to 2.6), being male (1.6, 1.2 to 2.2), visits to night clubs (1.3, 1.0 to 1.6), and intimate kissing (1.4, 1.0 to 1.8). Lower rates of acquisition were found in female only halls (0.5, 0.3 to 0.9). The most commonly acquired meningococcal strain was C2a P1.5 (P1.2), which has been implicated in clusters of invasive meningococcal disease at other UK universities. Conclusions Carriage rates of meningococci among university students increase rapidly in the first week of term, with further increases during the term. The rapid rate of acquisition may explain the increased risk of invasive meningococcal disease and the timing of cases and outbreaks in university students.	Univ Nottingham, Queens Med Ctr, Dept Epidemiol & Publ Hlth Med, Nottingham NG7 2UH, England; Queens Med Ctr, Div Microbiol, Meningococcal Res Grp, Nottingham, England; Queens Med Ctr, Ctr Communicable Dis Surveillance, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham	Neal, KR (corresponding author), Univ Nottingham, Queens Med Ctr, Dept Epidemiol & Publ Hlth Med, Nottingham NG7 2UH, England.		Nguyen-Van-Tam, Jonathan/I-2162-2019	Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655				ABDILLAHI H, 1988, MICROB PATHOGENESIS, V4, P27, DOI 10.1016/0882-4010(88)90045-9; Andersen J, 1998, EPIDEMIOL INFECT, V121, P85, DOI 10.1017/S0950268898008930; DEVINE LF, 1970, AM J EPIDEMIOL, V92, P25, DOI 10.1093/oxfordjournals.aje.a121176; ELDRIDGE J, 1978, MED LAB SCI, V35, P63; FRASCH CE, 1985, REV INFECT DIS, V7, P504; Hubert B, 1997, Euro Surveill, V2, P69; Imrey PB, 1996, AM J EPIDEMIOL, V143, P624, DOI 10.1093/oxfordjournals.aje.a008792; JACKSON LA, 1995, JAMA-J AM MED ASSOC, V273, P383, DOI 10.1001/jama.273.5.383; JACKSON LA, 1995, AM J PUBLIC HEALTH, V85, P843, DOI 10.2105/AJPH.85.6.843; Jelfs J, 1998, EPIDEMIOL INFECT, V120, P263, DOI 10.1017/S0950268898008681; Le Saux N, 1992, Can J Infect Dis, V3, P60; MELTON LJ, 1977, AM J EPIDEMIOL, V106, P215, DOI 10.1093/oxfordjournals.aje.a112456; Neal KR, 1999, EPIDEMIOL INFECT, V122, P351, DOI 10.1017/S0950268899002368; Neal KR, 1998, EPIDEMIOL INFECT, V121, P487, DOI 10.1017/S0950268898001502; RONNE T, 1993, SCAND J INFECT DIS, V25, P331, DOI 10.3109/00365549309008507; STUART JM, 1989, LANCET, V2, P723, DOI 10.1016/S0140-6736(89)90781-2; WEDEGE E, 1990, J MED MICROBIOL, V31, P195, DOI 10.1099/00222615-31-3-195; WHALEN CM, 1995, JAMA-J AM MED ASSOC, V273, P390, DOI 10.1001/jama.273.5.390; 1999, FORMIC INTEGRATED QU; 1997, COMMUN DIS REP, V7, P393; 1996, COMMUN DIS REP, V6, P425	21	94	101	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					846	849		10.1136/bmj.320.7238.846	http://dx.doi.org/10.1136/bmj.320.7238.846			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731181	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000086180300028
J	Scully, RE				Scully, RE			Influence of origin of ovarian cancer on efficacy of screening	LANCET			English	Editorial Material									Harvard Univ, Massachusetts Gen Hosp, Sch Med, James Homer Wright Pathol Labs, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Scully, RE (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, James Homer Wright Pathol Labs, Boston, MA 02114 USA.							BELL DA, 1994, CANCER, V73, P1859, DOI 10.1002/1097-0142(19940401)73:7<1859::AID-CNCR2820730714>3.0.CO;2-L; BELL DA, IN PRESS PATHOLOGY I; BHAN V, 1989, BRIT J OBSTET GYNAEC, V96, P1384, DOI 10.1111/j.1471-0528.1989.tb06299.x; Caduff RF, 1999, AM J SURG PATHOL, V23, P323, DOI 10.1097/00000478-199903000-00012; Deligdisch L, 1997, INT J GYNECOL CANCER, V7, P89, DOI 10.1046/j.1525-1438.1997.00379.x; PECORELLI S, 1998, J EPIDEMIOL BIOSTAT, V3, P1; PULS LE, 1992, GYNECOL ONCOL, V47, P53, DOI 10.1016/0090-8258(92)90075-T; Rosenthal A, 1998, SEMIN ONCOL, V25, P315; RUSSELL P, 1997, SURG PATHOLOGY OVARI; SCULLY R, 1995, OVARIAN CANC, V3, P139; Scully RE, 1998, ATLAS TUMOUR PATHOL	11	29	29	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 25	2000	355	9209					1028	1029		10.1016/S0140-6736(00)02026-2	http://dx.doi.org/10.1016/S0140-6736(00)02026-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744081				2022-12-24	WOS:000086380800002
J	Pfister, GC; Puffer, JC; Maron, BJ				Pfister, GC; Puffer, JC; Maron, BJ			Preparticipation cardiovascular screening for US collegiate student-athletes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							AMERICAN-HEART-ASSOCIATION; SUDDEN CARDIAC DEATH; HYPERTROPHIC CARDIOMYOPATHY; CLINICAL CARDIOLOGY; YOUNG-ADULTS; DISEASE; PROFESSIONALS; STATEMENT	Context Sudden death in young competitive athletes due to unsuspected cardiovascular disease has heightened interest in preparticipation screening. Objective To assess screening practices for detecting potentially lethal cardiovascular diseases in college-aged student-athletes. Design, Setting, and Participants A total of 1110 National Collegiate Athletic Association member colleges and universities were surveyed between 1995 and 1997, with 879 (79%) responding to the questionnaire, Main Outcome Measures Information on the administration and scope of the preparticipation screening process was obtained from the team physician or athletic director; preparticipation screening forms were evaluated for content and compared with 12 items recommended by the 1996 American Heart Association (AHA) consensus panel screening guidelines. Results Preparticipation screening was a requirement at 855 (97%) of 879 schools, was performed on campus at 713 schools (81%), and was required annually by 446 schools (51%), Team physicians were responsible for examinations at 603 (85%) of 713 schools with on-campus screening, although 135 of these schools (19%) also approved nurse practitioners and 244 schools (34%) allowed athletic trainers to perform examinations. Of the history and physical examination screening forms analyzed from 625 institutions, only 163 schools (26%) had forms that contained at least 9 of the recommended 12 AHA screening guidelines and were judged to be adequate, whereas 150 (24%) contained 4 or fewer of these parameters and were considered to be inadequate. Smaller Division III schools were more likely than larger Division I schools to have inadequate screening forms (30% vs 14%, P<.001). Relevant items that were omitted from more than 40% of the screening forms included history of exertional chest pain, dyspnea, or fatigue; familial heart disease or premature sudden death; and physical stigmata or family history of Marfan syndrome. Conclusion The preparticipation screening process used by many US colleges and universities may have limited potential to detect (or raise the suspicion of) cardiovascular abnormalities capable of causing sudden death in competitive student-athletes.	Minneapolis Heart Inst Fdn, Cardiovasc Res Div, Minneapolis, MN 55407 USA; Univ Calif Los Angeles, Sch Med, Dept Family Med, Div Sports Med, Los Angeles, CA USA	Minneapolis Heart Institute Foundation; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Maron, BJ (corresponding author), Minneapolis Heart Inst Fdn, Cardiovasc Res Div, 920 E 28th St,Suite 40, Minneapolis, MN 55407 USA.							BURKE AP, 1991, AM HEART J, V121, P568, DOI 10.1016/0002-8703(91)90727-Y; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Glover DW, 1998, JAMA-J AM MED ASSOC, V279, P1817, DOI 10.1001/jama.279.22.1817; KAPLAN NM, 1994, J AM COLL CARDIOL, V24, P885, DOI 10.1016/0735-1097(94)90845-1; Liberthson RR, 1996, NEW ENGL J MED, V334, P1039, DOI 10.1056/NEJM199604183341607; Maron BJ, 1998, CIRCULATION, V98, P1460, DOI 10.1161/01.CIR.98.14.1460; Maron BJ, 1998, NEW ENGL J MED, V339, P1632, DOI 10.1056/NEJM199811263392211; Maron BJ, 1998, J AM COLL CARDIOL, V32, P1881, DOI 10.1016/S0735-1097(98)00491-4; Maron BJ, 1998, ANN INTERN MED, V129, P379, DOI 10.7326/0003-4819-129-5-199809010-00006; MARON BJ, 1993, NEW ENGL J MED, V329, P55, DOI 10.1056/NEJM199307013290113; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Maron BJ, 1994, J AM COLL CARDIOL, V24, P845; *NAT COLL ATHL ASS, 1996, 1996 97 NCAA DIR; SMITH DM, 1996, PREPARTICIPATION PHY, P1; Smith J, 1998, MAYO CLIN PROC, V73, P419; THIENE G, 1988, NEW ENGL J MED, V318, P129, DOI 10.1056/NEJM198801213180301; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641	19	89	89	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2000	283	12					1597	+		10.1001/jama.283.12.1597	http://dx.doi.org/10.1001/jama.283.12.1597			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MV	10735397	Bronze			2022-12-24	WOS:000085857300037
J	Thomson, R; Parkin, D; Eccles, M; Sudlow, M; Robinson, A				Thomson, R; Parkin, D; Eccles, M; Sudlow, M; Robinson, A			Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation	LANCET			English	Article							COST-EFFECTIVENESS; MEDICAL LITERATURE; USERS GUIDES; WARFARIN; ASPIRIN; COMMUNITY; COMPLICATIONS; PROPHYLAXIS; POPULATION; PREVALENCE	Background Clinical guidelines are needed on whether or not to use anticoagulant therapy to prevent stroke in patients with non-valvular atrial fibrillation. We did a Markov decision analysis to model decision-making with regard to warfarin treatment in patients with atrial fibrillation, and used the model to develop evaluative guidelines. Methods The decision analysis involved a systematic literature review supplemented by patients' estimates of the quality of life associated with different states of health, secondary analysis of stroke-registry data, and estimation of service costs; it also incorporated a sensitivity analysis. The derived guidelines were subsequently applied to a cohort of patients with atrial fibrillation, Findings We constructed decision tables for 12 age and sex groups. For most risk combinations, warfarin treatment would have decreased healthcare costs and increased quality-of-life years, although the clinical decision was sensitive to patients' preferences and to the estimate of warfarin's effectiveness. 97% of women with atrial fibrillation older than 75 years, and 69% aged 65-74 would have been recommended for treatment; for men, the corresponding figures would have been 75% and 53%, With the upper quartile for the loss of quality of life associated with being on warfarin treatment (1.00), all but two of the 116 patients without contraindications would have been treated, whereas with the lower quartile (0.92), only 27 of 116 would have been treated. Interpretation Decision analysis is useful in the incorporation of complex probabilistic data into informed decision-making, the identification of factors influencing such decisions, and the subsequent development of evaluative guidelines.	Med Sch Newcastle Upon Tyne, Sch Hlth Sci, Dept Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Med Sch Newcastle Upon Tyne, Sch Hlth Sci, Ctr Hlth Serv Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Thomson, R (corresponding author), Med Sch Newcastle Upon Tyne, Sch Hlth Sci, Dept Epidemiol & Publ Hlth, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	richard.thomson@ncl.ac.uk	Eccles, Martin P/AAD-4029-2020					[Anonymous], 1997, ARCH INTERN MED, V157, P1237; *ATR FIBR INV, 1994, ARCH INTERN MED, V15, P1449; BERTAKIS KD, 1977, J FAM PRACTICE, V5, P217; *COCHR COLL, 1997, COCHR STROK GROUP SE; CONNOLLY SJ, 1991, J AM COLL CARDIOL, V18, P349, DOI 10.1016/0735-1097(91)90585-W; *CTR REV DISS, 1996, MAK COST EFF INF ACC; Eccles M, 1996, BMJ-BRIT MED J, V312, P760; ECKMAN MH, 1995, CHEST, V108, pS457, DOI 10.1378/chest.108.4_Supplement.457S; EZEKOWITZ MD, 1992, NEW ENGL J MED, V327, P1406, DOI 10.1056/NEJM199211123272002; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; FORBES JF, 1995, COSTS HLTH OUTCOMES; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; Gage BF, 1998, STROKE, V29, P1083, DOI 10.1161/01.STR.29.6.1083; Gage BF, 1996, ARCH INTERN MED, V156, P1829, DOI 10.1001/archinte.156.16.1829; GLASZIOU PP, 1995, BMJ-BRIT MED J, V311, P1356, DOI 10.1136/bmj.311.7016.1356; GUYATT GH, 1993, JAMA-J AM MED ASSOC, V270, P2598, DOI 10.1001/jama.270.21.2598; Hart RG, 1999, STROKE, V30, P1223, DOI 10.1161/01.STR.30.6.1223; Hart RG, 1999, ANN INTERN MED, V131, P492, DOI 10.7326/0003-4819-131-7-199910050-00003; HAYNES RB, 1994, J AM MED INFORM ASSN, V1, P447, DOI 10.1136/jamia.1994.95153434; HUTCHINSON A, 1995, DEV IMPLEMENTATION C; ISARD PA, 1992, CEREBROVASC DIS, V2, P47, DOI 10.1159/000108988; KING D, 1995, BRIT J CLIN PRACT, V49, P123; KISTLER JP, 1990, NEW ENGL J MED, V323, P1505; KOUDSTAAL PJ, 1993, LANCET, V342, P1255; LAKE FR, 1989, AUST NZ J MED, V19, P321, DOI 10.1111/j.1445-5994.1989.tb00271.x; LAUPACIS A, 1994, JAMA-J AM MED ASSOC, V272, P234, DOI 10.1001/jama.272.3.234; Lilford R, 1998, J Health Serv Res Policy, V3, P159; MCBRIDE R, 1991, CIRCULATION, V84, P527, DOI 10.1161/01.CIR.84.2.527; MCCRORY DC, 1995, ARCH INTERN MED, V155, P277, DOI 10.1001/archinte.155.3.277; O'Connor AM, 1999, BRIT MED J, V319, P731, DOI 10.1136/bmj.319.7212.731; *OFF NAT STAT, 1997, ANN ABSTR STAT; Palareti G, 1996, LANCET, V348, P423, DOI 10.1016/S0140-6736(96)01109-9; PETERSEN P, 1989, LANCET, V1, P175; Rodgers H, 1997, BRIT J GEN PRACT, V47, P309; Roter DL, 1998, MED CARE, V36, P1138, DOI 10.1097/00005650-199808000-00004; SANDERCOCK P, 1992, BRIT MED J, V305, P1460, DOI 10.1136/bmj.305.6867.1460; Sudlow M, 1998, LANCET, V352, P1167, DOI 10.1016/S0140-6736(98)01401-9; Sudlow M, 1997, BRIT MED J, V314, P1529, DOI 10.1136/bmj.314.7093.1529; SWEENEY KG, 1995, BRIT J GEN PRACT, V45, P153; Thomson R, 1998, BRIT MED J, V316, P509, DOI 10.1136/bmj.316.7130.509; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Ubel PA, 1997, SOC SCI MED, V44, P647, DOI 10.1016/S0277-9536(96)00217-1; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOOLF SH, 1992, ARCH INTERN MED, V152, P946, DOI 10.1001/archinte.152.5.946; 1994, EFFECTIVE HLTH CARE	45	142	143	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2000	355	9208					956	962		10.1016/S0140-6736(00)90012-6	http://dx.doi.org/10.1016/S0140-6736(00)90012-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	296YH	10768433				2022-12-24	WOS:000086054000009
J	Koster, JC; Marshall, BA; Ensor, N; Corbett, JA; Nichols, CG				Koster, JC; Marshall, BA; Ensor, N; Corbett, JA; Nichols, CG			Targeted overactivity of beta cell K-ATP channels induces profound neonatal diabetes	CELL			English	Article							PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA; SENSITIVE POTASSIUM CHANNELS; DEFECTIVE INSULIN-SECRETION; SULFONYLUREA RECEPTOR GENE; PORE-FORMING SUBUNIT; TRANSGENIC MICE; GLUCOKINASE GENE; FAMILIAL HYPERINSULINISM; NONSENSE MUTATION; KIR6.2	A paradigm for control of insulin secretion is that glucose metabolism elevates cytoplasmic [ATP]/[ADP] in beta cells, closing K-ATP channels and causing depolarization, Ca2+ entry, and insulin release. Decreased responsiveness of K-ATP channels to elevated [ATP]/[ADP] should therefore lead to decreased insulin secretion and diabetes. To test this critical prediction, we generated transgenic mice expressing beta cell K-ATP channels with reduced ATP sensitivity. Animals develop severe hyperglycemia, hypoinsulinemia, and ketoacidosis within 2 days and typically die within 5. Nevertheless, islet morphology, insulin localization, and alpha and beta cell distributions were normal (before day 3), pointing to reduced insulin secretion as causal. The data indicate that normal K-ATP channel activity is critical for maintenance of euglycemia and that overactivity can cause diabetes by inhibiting insulin secretion.	Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; St Louis Childrens Hosp, Dept Pediat, St Louis, MO 63110 USA; St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); Saint Louis University	Nichols, CG (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.		Nichols, Colin/D-6336-2012		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, R01DK055282, K08DK002339] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK55282, DK20579, DK02339] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; Aizawa T, 1998, TRENDS PHARMACOL SCI, V19, P496, DOI 10.1016/S0165-6147(98)01273-5; ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; ASHCROFT FM, 1990, BIOCHEM SOC T, V18, P109, DOI 10.1042/bst0180109; ASHCROFT FM, 1988, ANNU REV NEUROSCI, V11, P97, DOI 10.1146/annurev.neuro.11.1.97; AYNSLEYGREEN A, 1981, ARCH DIS CHILD, V56, P496, DOI 10.1136/adc.56.7.496; Babenko AP, 1999, BIOCHEM BIOPH RES CO, V255, P231, DOI 10.1006/bbrc.1999.0172; BAETENS D, 1978, DIABETES, V27, P1, DOI 10.2337/diabetes.27.1.1; Baukrowitz T, 1998, SCIENCE, V282, P1141, DOI 10.1126/science.282.5391.1141; BONNERWEIR S, 1983, J CLIN INVEST, V71, P44; Bosch F, 1998, ANNU REV NUTR, V18, P207, DOI 10.1146/annurev.nutr.18.1.207; Branstrom R, 1997, J BIOL CHEM, V272, P17390, DOI 10.1074/jbc.272.28.17390; Branstrom R, 1998, J BIOL CHEM, V273, P31395, DOI 10.1074/jbc.273.47.31395; CESAR LA, 1994, VIRCHOWS ARCH, V425, P73; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; COOK DL, 1988, DIABETES, V37, P495, DOI 10.2337/diabetes.37.5.495; DANDOYDRON F, 1991, NUCLEIC ACIDS RES, V19, P4925, DOI 10.1093/nar/19.18.4925; Dobie KW, 1996, P NATL ACAD SCI USA, V93, P6659, DOI 10.1073/pnas.93.13.6659; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; Dunne MJ, 1997, NEW ENGL J MED, V336, P703, DOI 10.1056/NEJM199703063361005; ENGLER P, 1991, CELL, V65, P939, DOI 10.1016/0092-8674(91)90546-B; EPSTEIN PN, 1989, CELL, V58, P1067, DOI 10.1016/0092-8674(89)90505-9; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; FROGUEL P, 1993, NEW ENGL J MED, V328, P697, DOI 10.1056/NEJM199303113281005; Gribble FM, 1998, J BIOL CHEM, V273, P26383, DOI 10.1074/jbc.273.41.26383; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Hani EH, 1998, DIABETOLOGIA, V41, P1511, DOI 10.1007/s001250051098; Harvey J, 1997, J PHYSIOL-LONDON, V504, P527, DOI 10.1111/j.1469-7793.1997.527bd.x; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; Hogan B, 1994, MANIPULATING MOUSE E; HUMASON GL, 1997, HUMASONS ANIMAL TISS, P361; Inagaki N, 1997, FEBS LETT, V409, P232, DOI 10.1016/S0014-5793(97)00488-2; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; Kane C, 1996, NAT MED, V2, P1344, DOI 10.1038/nm1296-1344; Kellerer M, 1997, DIABETOLOGIA, V40, P1358, DOI 10.1007/s001250050832; Kieffer TJ, 1997, DIABETES, V46, P1087, DOI 10.2337/diabetes.46.6.1087; Koster JC, 1999, J GEN PHYSIOL, V114, P203, DOI 10.1085/jgp.114.2.203; Koster JC, 1999, J PHYSIOL-LONDON, V515, P19, DOI 10.1111/j.1469-7793.1999.019ad.x; Lalli MJ, 1998, PFLUG ARCH EUR J PHY, V436, P957, DOI 10.1007/s004240050729; MARSHALL BA, 1993, J BIOL CHEM, V268, P18442; MARSHALL BA, 1994, AM J PHYSIOL-ENDOC M, V267, pE738, DOI 10.1152/ajpendo.1994.267.5.E738; Miki T, 1997, P NATL ACAD SCI USA, V94, P11969, DOI 10.1073/pnas.94.22.11969; MISLER S, 1992, DIABETES, V41, P1211; Nestorowicz A, 1996, HUM MOL GENET, V5, P1813, DOI 10.1093/hmg/5.11.1813; Nestorowicz A, 1997, DIABETES, V46, P1743, DOI 10.2337/diabetes.46.11.1743; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; OVERBEEK P, 1994, TRANSGENIC ANIMAL TE, P96; PHILIPSON LH, 1994, J BIOL CHEM, V269, P27787; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; PRAVTCHEVA DD, 1991, DEVELOPMENT, V111, P1109; Proks P, 1999, J PHYSIOL-LONDON, V514, P19, DOI 10.1111/j.1469-7793.1999.019af.x; RAHIER J, 1983, DIABETOLOGIA, V24, P366; Reimann F, 1999, J PHYSIOL-LONDON, V518, P325, DOI 10.1111/j.1469-7793.1999.0325p.x; Sakura H, 1998, DIABETOLOGIA, V41, P654, DOI 10.1007/s001250050964; Schwanstecher M, 1998, EMBO J, V17, P5529, DOI 10.1093/emboj/17.19.5529; Shyng SL, 1997, J GEN PHYSIOL, V110, P141, DOI 10.1085/jgp.110.2.141; Shyng SL, 1998, DIABETES, V47, P1145, DOI 10.2337/diabetes.47.7.1145; Shyng SL, 1997, J GEN PHYSIOL, V110, P655, DOI 10.1085/jgp.110.6.655; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Shyng SL, 1998, SCIENCE, V282, P1138, DOI 10.1126/science.282.5391.1138; Tanabe K, 1999, J BIOL CHEM, V274, P3931, DOI 10.1074/jbc.274.7.3931; Terauchi Y, 1995, J BIOL CHEM, V270, P30253, DOI 10.1074/jbc.270.51.30253; THOMAS PM, 1995, SCIENCE, V268, P426, DOI 10.1126/science.7716548; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; ZHOU YP, 1995, ENDOCRINOLOGY, V136, P3546, DOI 10.1210/en.136.8.3546	72	233	243	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 17	2000	100	6					645	654		10.1016/S0092-8674(00)80701-1	http://dx.doi.org/10.1016/S0092-8674(00)80701-1			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761930	Bronze			2022-12-24	WOS:000085983800007
J	Hammond, SM; Bernstein, E; Beach, D; Hannon, GJ				Hammond, SM; Bernstein, E; Beach, D; Hannon, GJ			An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells	NATURE			English	Article							MESSENGER-RNA; EXPRESSION; PLANTS; VIRUS	In a diverse group of organisms that includes Caenorhabditis elegans, Drosophila, planaria, hydra, trypanosomes, fungi and plants, the introduction of double-stranded RNAs inhibits gene expression in a sequence-specific manner(1-7). These responses, called RNA interference or post-transcriptional gene silencing, may provide anti-viral defence, modulate transposition or regulate gene expression(1,6,8-10). We have taken a biochemical approach towards elucidating the mechanisms underlying this genetic phenomenon. Here we show that 'loss-of-function' phenotypes can be created in cultured Drosophila cells by transfection with specific double-stranded RNAs. This coincides with a marked reduction in the level of cognate cellular messenger RNAs. Extracts of transfected cells contain a nuclease activity that specifically degrades exogenous transcripts homologous to transfected double-stranded RNA. This enzyme contains an essential RNA component. After partial purification, the sequence-specific nuclease co-fractionates with a discrete, similar to 25-nucleotide RNA species which may confer specificity to the enzyme through homology to the substrate mRNAs.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Genet Inc, Cold Spring Harbor, NY 11724 USA; SUNY Stony Brook, Grad Program Genet, Stony Brook, NY 11794 USA; UCL, Wolfson Inst Biol Sci, London WC1E 6BT, England	Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of London; University College London	Hannon, GJ (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	hannon@cshl.org	Hannon, Gregory/AAB-3568-2019					Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Bosher JM, 1999, GENETICS, V153, P1245; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; DINOCERA PP, 1983, P NATL ACAD SCI-BIOL, V80, P7095; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; Jones L, 1999, PLANT CELL, V11, P2291, DOI 10.1105/tpc.11.12.2291; Kalejta RF, 1999, EXP CELL RES, V248, P322, DOI 10.1006/excr.1999.4427; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kramer ER, 1998, CURR BIOL, V8, P1207, DOI 10.1016/S0960-9822(07)00510-6; Lohmann JU, 1999, DEV BIOL, V214, P211, DOI 10.1006/dbio.1999.9407; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; SHUTTLEWORTH J, 1988, EMBO J, V7, P427, DOI 10.1002/j.1460-2075.1988.tb02830.x; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 1998, SCIENCE, V282, P430, DOI 10.1126/science.282.5388.430; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wolf DA, 1998, CURR BIOL, V8, pR636, DOI 10.1016/S0960-9822(07)00410-1	23	2183	2688	10	224	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					293	296		10.1038/35005107	http://dx.doi.org/10.1038/35005107			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749213				2022-12-24	WOS:000086022200051
J	Newby, LK; Eisenstein, EL; Califf, RM; Thompson, TD; Nelson, CL; Peterson, ED; Armstrong, PW; Van de Werf, F; White, HD; Topol, EJ; Mark, DB				Newby, LK; Eisenstein, EL; Califf, RM; Thompson, TD; Nelson, CL; Peterson, ED; Armstrong, PW; Van de Werf, F; White, HD; Topol, EJ; Mark, DB			Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COOPERATIVE CARDIOVASCULAR PROJECT; HOSPITAL DISCHARGE; MEDICARE PATIENTS; TRIAL; ANGIOPLASTY; QUALITY; CARE; ERA	Background: Reducing the length of hospitalizations can reduce short-term costs, but there are few data on the long-term clinical and economic consequences of early discharge after uncomplicated myocardial infarction. Methods: Using data from the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-1) trial, we identified 22,361 patients with acute myocardial infarction who had an uncomplicated course for 72 hours after thrombolysis. Then, using a decision-analytic model, we examined the cost effectiveness of an additional day of hospitalization in this group. We defined incremental survival attributable to another day of monitored hospitalization, on the basis of the rate of resuscitation after cardiac arrest between 72 and 96 hours. Lifetime survival curves for each group in the decision-analytic model were estimated from one-year survival data from GUSTO-1. Results: Of the patients with an uncomplicated course within 72 hours after thrombolysis, 16 had ventricular arrhythmias during the next 24 hours; 13 of these patients (81 percent) survived for at least 24 hours. On average, another 0.006 year of life per patient could be saved by keeping patients with an uncomplicated course in the hospital another day. At a cost of $624 for hospital and physicians' services, extending the hospital stay by another day would cost $105,629 per year of life saved. In sensitivity analyses, it was found that a fourth day of hospitalization would be economically attractive only if its cost could be reduced by more than 50 percent or if a high-risk subgroup could be identified in which the estimated survival benefit would be doubled. Conclusions: Hospitalization of patients with uncomplicated myocardial infarction beyond three days after thrombolysis is economically unattractive by conventional standards. (N Engl J Med 2000;342:749-55.) (C)2000, Massachusetts Medical Society.	Duke Clin Res Inst, Durham, NC 27715 USA; Univ Ziekenhuizen Leuven, Louvain, Belgium; Univ Alberta, Edmonton, AB, Canada; Green Lane Hosp, Auckland 3, New Zealand; Cleveland Clin Fdn, Cleveland, OH 44195 USA	Duke University; KU Leuven; University Hospital Leuven; University of Alberta; Cleveland Clinic Foundation	Newby, LK (corresponding author), Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	newby001@mc.duke.edu	Peterson, Eric David/ABF-5033-2021	Armstrong, Paul/0000-0002-0460-3445; Mark, Daniel/0000-0001-6340-8087; Topol, Eric/0000-0002-1478-4729				EISENBERG MS, 1991, AM J EMERG MED, V9, P544, DOI 10.1016/0735-6757(91)90108-V; ELLERBECK EF, 1995, JAMA-J AM MED ASSOC, V273, P1509, DOI 10.1001/jama.273.19.1509; Gold MR, 1996, COST EFFECTIVENESS H; Grines CL, 1998, J AM COLL CARDIOL, V31, P967, DOI 10.1016/S0735-1097(98)00031-X; JAIN A, 1993, J AM COLL CARDIOL, V22, P1816, DOI 10.1016/0735-1097(93)90763-Q; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Krumholz HM, 1997, AM J CARDIOL, V79, P581, DOI 10.1016/S0002-9149(96)00819-3; Krumholz HM, 1999, JAMA-J AM MED ASSOC, V281, P37; Krumholz HM, 1998, JAMA-J AM MED ASSOC, V280, P623, DOI 10.1001/jama.280.7.623; MADSEN EB, 1983, CIRCULATION, V68, P9, DOI 10.1161/01.CIR.68.1.9; Marciniak TA, 1998, JAMA-J AM MED ASSOC, V279, P1351, DOI 10.1001/jama.279.17.1351; MARK DB, 1991, CIRCULATION, V83, P1186, DOI 10.1161/01.CIR.83.4.1186; Mark DB, 2000, CIRCULATION, V101, P366, DOI 10.1161/01.CIR.101.4.366; Mark DB, 1998, CIRCULATION, V97, P1702, DOI 10.1161/01.CIR.97.17.1702; MARK DB, 1995, NEW ENGL J MED, V333, P267; MARK DB, 1997, TXB CARDIOVASCULAR M, P1033; MCNEER JF, 1978, NEW ENGL J MED, V298, P229, DOI 10.1056/NEJM197802022980501; Newby LK, 1996, J AM COLL CARDIOL, V27, P625; Pierard LA, 1999, AM HEART J, V137, P500, DOI 10.1016/S0002-8703(99)70499-0; SANZ G, 1993, J AM COLL CARDIOL, V22, P1795, DOI 10.1016/0735-1097(93)90759-T; Stratmann HG, 1998, AM HEART J, V136, P87, DOI 10.1016/S0002-8703(98)70186-3; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; TOPOL EJ, 1988, NEW ENGL J MED, V318, P1083, DOI 10.1056/NEJM198804283181702; TOPOL EJ, 1987, AM J CARDIOL, V60, P958, DOI 10.1016/0002-9149(87)90332-8; *TREEAG SOFTW, 1996, DATA 3 0 US MAN	27	98	99	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 16	2000	342	11					749	755		10.1056/NEJM200003163421101	http://dx.doi.org/10.1056/NEJM200003163421101			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293HW	10717009				2022-12-24	WOS:000085846900001
J	Blanchoin, L; Amann, KJ; Higgs, HN; Marchand, JB; Kaiser, DA; Pollard, TD				Blanchoin, L; Amann, KJ; Higgs, HN; Marchand, JB; Kaiser, DA; Pollard, TD			Direct observation of dendritic actin filament networks nucleated by Arp2/3 complex and WASP/Scar proteins	NATURE			English	Article							CAPPING PROTEIN; ACANTHAMOEBA-CASTELLANII; F-ACTIN; POLYMERIZATION; PROFILIN; PURIFICATION; PHOSPHATE; MECHANISM; DYNAMICS; AGAROSE	Most nucleated cells crawl about by extending a pseudopod that is driven by the polymerization of actin filaments in the cytoplasm behind the leading edge of the plasma membrane(1,2). These actin filaments are linked into a network by Y-branches, with the pointed end of each filament attached to the side of another filament and the rapidly growing barbed end facing forward(3). Because Arp2/3 complex nucleates actin polymerization and links the pointed end to the side of another filament in vitro, a dendritic nucleation model has been proposed 4 in which Arp2/3 complex initiates filaments from the sides of older filaments. Here we report, by using a light microscopy assay, many new features of the mechanism. Branching occurs during, rather than after, nucleation by Arp2/3 complex activated by the Wiskott-Aldrich syndrome protein (WASP) or Scar protein; capping protein and profilin act synergistically with Arp2/3 complex to favour branched nucleation; phosphate release from aged actin filaments favours dissociation of Arp2/3 complex from the pointed ends of filaments; and branches created by Arp2/3 complex are relatively rigid. These properties result in the automatic assembly of the branched actin network after activation by proteins of the WASP/ Scar family and favour the selective disassembly of proximal regions of the network.	Salk Inst Biol Studies, Struct Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Pollard, TD (corresponding author), Salk Inst Biol Studies, Struct Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.			Higgs, Henry/0000-0002-2917-9644				ALMO SC, 1994, J MOL BIOL, V236, P950, DOI 10.1006/jmbi.1994.1200; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; CALDWELL JE, 1989, BIOCHEMISTRY-US, V28, P8506, DOI 10.1021/bi00447a036; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; COMBEAU C, 1989, J BIOL CHEM, V264, P19017; COOPER JA, 1984, J CELL BIOL, V99, P217, DOI 10.1083/jcb.99.1.217; COOPER JA, 1985, BIOCHEMISTRY-US, V24, P793, DOI 10.1021/bi00324a039; DANCKER P, 1990, BIOCHIM BIOPHYS ACTA, V1035, P197, DOI 10.1016/0304-4165(90)90116-E; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; KAISER DA, 1989, CELL MOTIL CYTOSKEL, V14, P251, DOI 10.1002/cm.970140211; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Loisel TP, 1999, NATURE, V401, P613, DOI 10.1038/44183; Machesky LM, 1999, P NATL ACAD SCI USA, V96, P3739, DOI 10.1073/pnas.96.7.3739; MACHESKY LM, 1994, J CELL BIOL, V127, P107, DOI 10.1083/jcb.127.1.107; MACIVER SK, 1991, J CELL BIOL, V115, P1611, DOI 10.1083/jcb.115.6.1611; MOGILNER A, 1996, BIOPHYS J, V71, P303; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; POLLARD TD, 1984, BIOCHEMISTRY-US, V23, P6631, DOI 10.1021/bi00321a054; POLLARD TD, 1999, GUIDEBOOK CYTOSKELET, P3; Schafer DA, 1996, J CELL BIOL, V135, P169, DOI 10.1083/jcb.135.1.169; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; WANG YL, 1985, J CELL BIOL, V101, P597, DOI 10.1083/jcb.101.2.597; Xu JY, 1999, CELL MOTIL CYTOSKEL, V42, P73, DOI 10.1002/(SICI)1097-0169(1999)42:1<73::AID-CM7>3.0.CO;2-Z	28	409	421	4	37	MACMILLAN PUBLISHERS LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 27	2000	404	6781					1007	1011		10.1038/35010008	http://dx.doi.org/10.1038/35010008			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	309HG	10801131				2022-12-24	WOS:000086762000059
J	Corper, AL; Stratmann, T; Apostolopoulos, V; Scott, CA; Garcia, KC; Kang, AS; Wilson, IA; Teyton, L				Corper, AL; Stratmann, T; Apostolopoulos, V; Scott, CA; Garcia, KC; Kang, AS; Wilson, IA; Teyton, L			A structural framework for deciphering the link between I-A(g7) and autoimmune diabetes	SCIENCE			English	Article							BIOZZI AB/H MICE; A BETA-CHAIN; CRYSTAL-STRUCTURE; PEPTIDE; PROTEIN; COMPLEX; MELLITUS; MOLECULES; EPITOPE; DRA-ASTERISK-0101	Susceptibility to murine and human insulin-dependent diabetes mellitus correlates strongly with major histocompatibility complex (MHC) class II I-A or HLA-DQ alleles that lack an aspartic acid at position beta 57. I-A(g7) lacks this aspartate and is the only class II allele expressed by the nonobese diabetic mouse. The crystal structure of I-A(g7) was determined at 2.6 angstrom resolution as a complex with a high-affinity peptide from the autoantigen glutamic acid decarboxylase (CAD) 65. I-A(g7) has a substantially wider peptide-binding groove around beta 57, which accounts for distinct peptide preferences compared with other MHC class II alleles. Loss of Asp(beta 57) Leads to an oxyanion hole in I-A(g7) that can be filled by peptide carboxyl residues or, perhaps, through interaction with the T cell receptor.	Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; Scripps Res Inst, Skaggs Inst Chem Biol, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu; lteyton@scripps.edu	Apostolopoulos, Vasso/Q-4525-2019	Stratmann, Thomas/0000-0001-6196-1487; Apostolopoulos, Vasso/0000-0001-6788-2771; Kang, Angray/0000-0002-4672-4114	NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055037] Funding Source: NIH RePORTER; NCI NIH HHS [CA58896] Funding Source: Medline; NIDDK NIH HHS [DK55037] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; AMOR S, 1993, J IMMUNOL, V150, P5666; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartnes K, 1997, INT IMMUNOL, V9, P1185, DOI 10.1093/intimm/9.8.1185; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrasco-Marin E, 1999, P NATL ACAD SCI USA, V96, P8621, DOI 10.1073/pnas.96.15.8621; CarrascoMarin E, 1996, J IMMUNOL, V156, P450; Chao CC, 1997, IMMUNOGENETICS, V46, P29, DOI 10.1007/s002510050238; Chao CC, 1999, P NATL ACAD SCI USA, V96, P9299, DOI 10.1073/pnas.96.16.9299; CORPER A, UNPUB; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; ELIAS D, 1991, P NATL ACAD SCI USA, V88, P3088, DOI 10.1073/pnas.88.8.3088; Fremont DH, 1998, IMMUNITY, V8, P305, DOI 10.1016/S1074-7613(00)80536-1; Harrison LC, 1997, J EXP MED, V185, P1013, DOI 10.1084/jem.185.6.1013; Hausmann DHF, 1999, J EXP MED, V189, P1723, DOI 10.1084/jem.189.11.1723; HURTENBACH U, 1993, J EXP MED, V177, P1499, DOI 10.1084/jem.177.5.1499; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIU GY, 1993, IMMUNOGENETICS, V37, P296, DOI 10.1007/BF00187458; LUND T, 1990, NATURE, V345, P727, DOI 10.1038/345727a0; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; NALEFSKI EA, 1995, J BIOL CHEM, V270, P22351, DOI 10.1074/jbc.270.38.22351; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; QUARTEYPAPAFIO R, 1995, J IMMUNOL, V154, P5567; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; Read RJ, 1997, METHOD ENZYMOL, V277, P110, DOI 10.1016/S0076-6879(97)77009-5; REICH EP, 1994, J IMMUNOL, V152, P2279; Reizis B, 1997, INT IMMUNOL, V9, P43, DOI 10.1093/intimm/9.1.43; Ridgway WM, 1999, CURR OPIN IMMUNOL, V11, P638, DOI 10.1016/S0952-7915(99)00030-8; Scott CA, 1996, J EXP MED, V183, P2087, DOI 10.1084/jem.183.5.2087; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; SINGER SM, 1993, P NATL ACAD SCI USA, V90, P9566, DOI 10.1073/pnas.90.20.9566; SMILEK DE, 1990, IMMUNOL REV, V118, P37, DOI 10.1111/j.1600-065X.1990.tb00813.x; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; STIFFEL C, 1987, IMMUNOL LETT, V16, P205, DOI 10.1016/0165-2478(87)90149-0; STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D; Tisch R, 1996, CELL, V85, P291, DOI 10.1016/S0092-8674(00)81106-X; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Yoon JW, 1999, SCIENCE, V284, P1183, DOI 10.1126/science.284.5417.1183	47	221	233	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 21	2000	288	5465					505	511		10.1126/science.288.5465.505	http://dx.doi.org/10.1126/science.288.5465.505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10775108				2022-12-24	WOS:000086626000043
J	Giardina, CP; Ryan, MG				Giardina, CP; Ryan, MG			Evidence that decomposition rates of organic carbon in mineral soil do not vary with temperature	NATURE			English	Article							NATURAL C-13 ABUNDANCE; 5 HAWAIIAN SOILS; MATTER DYNAMICS; MICROBIAL RESPIRATION; FOREST; TURNOVER; STORAGE; FLUXES; CO2; SENSITIVITY	It has been suggested that increases in temperature can accelerate the decomposition of organic carbon contained in forest mineral soil (C-s), and, therefore, that global warming should increase the release of soil organic carbon to the atmosphere(1-6). These predictions assume, however, that decay constants can be accurately derived from short-term laboratory incubations of soil or that in situ incubations of fresh litter accurately represent the temperature sensitivity of C-s decomposition. But our limited understanding of the biophysical factors that control C-s decomposition rates, and observations of only minor increases in C-s decomposition rate with temperature in longer-term forest soil heating experiments(7-12) and in latitudinal comparisons of C-s decomposition rates(13-15) bring these predictions into question. Here we have compiled C-s decomposition data from 82 sites on five continents. We found that C-s decomposition rates were remarkably constant across a global-scale gradient in mean annual temperature. These data suggest that C-s decomposition rates for forest soils are not controlled by temperature limitations to microbial activity, and that increased temperature alone will not stimulate the decomposition of forest-derived carbon in mineral soil.	Univ Hawaii Manoa, Dept Nat Resources & Environm Management, Honolulu, HI 96822 USA; US Forest Serv, USDA, Rocky Mt Res Stn, Ft Collins, CO 80526 USA; Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO 80523 USA	University of Hawaii System; University of Hawaii Manoa; United States Department of Agriculture (USDA); United States Forest Service; Colorado State University	Giardina, CP (corresponding author), Univ Hawaii Manoa, Dept Nat Resources & Environm Management, 1910 East West Rd, Honolulu, HI 96822 USA.		Ryan, Michael G/A-9805-2008; Giardina, Christian P/C-3120-2011	Ryan, Michael G/0000-0002-2500-6738; Giardina, Christian P/0000-0002-3431-5073				[Anonymous], 1996, SOIL MICROBIOLOGY BI; BALESDENT J, 1987, SOIL BIOL BIOCHEM, V19, P25, DOI 10.1016/0038-0717(87)90120-9; Bashkin MA, 1998, ECOLOGY, V79, P828, DOI 10.1890/0012-9658(1998)079[0828:CISCFA]2.0.CO;2; Binkley D, 1999, SOIL SCI SOC AM J, V63, P222, DOI 10.2136/sssaj1999.03615995006300010032x; BONDE TA, 1992, SOIL BIOL BIOCHEM, V24, P275, DOI 10.1016/0038-0717(92)90230-U; Cao MK, 1998, NATURE, V393, P249, DOI 10.1038/30460; Cheng WX, 1996, SOIL BIOL BIOCHEM, V28, P1283, DOI 10.1016/S0038-0717(96)00138-1; Feller C, 1997, GEODERMA, V79, P69, DOI 10.1016/S0016-7061(97)00039-6; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; GREGORICH EG, 1995, CAN J SOIL SCI, V75, P161, DOI 10.4141/cjss95-023; HART SC, 1994, ECOLOGY, V75, P880, DOI 10.2307/1939413; HOLLAND EA, 1995, GLOB CHANGE BIOL, V1, P115, DOI 10.1111/j.1365-2486.1995.tb00011.x; JENKINSON DS, 1991, NATURE, V351, P304, DOI 10.1038/351304a0; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Liski J, 1999, AMBIO, V28, P171; Mahieu N, 1999, SOIL SCI SOC AM J, V63, P307, DOI 10.2136/sssaj1999.03615995006300020008x; MELILLO JM, 1995, GLOBAL BIOGEOCHEM CY, V9, P407; MOTAVALLI PP, 1994, SOIL BIOL BIOCHEM, V26, P935, DOI 10.1016/0038-0717(94)90106-6; NADELHOFFER KJ, 1991, ECOLOGY, V72, P242, DOI 10.2307/1938918; PETERJOHN WT, 1993, OECOLOGIA, V93, P18, DOI 10.1007/BF00321185; POST WM, 1982, NATURE, V298, P156, DOI 10.1038/298156a0; SCHIMEL DS, 1994, GLOBAL BIOGEOCHEM CY, V8, P279, DOI 10.1029/94GB00993; SORENSEN L H, 1981, Soil Biology and Biochemistry, V13, P313, DOI 10.1016/0038-0717(81)90068-7; Townsend AR, 1997, BIOGEOCHEMISTRY, V38, P1, DOI 10.1023/A:1017942918708; TOWNSEND AR, 1995, ECOLOGY, V76, P721, DOI 10.2307/1939339; Trumbore SE, 1996, SCIENCE, V272, P393, DOI 10.1126/science.272.5260.393; TRUMBORE SE, 1995, GLOBAL BIOGEOCHEM CY, V9, P515, DOI 10.1029/95GB02148; UPDEGRAFF K, 1995, ECOL APPL, V5, P151, DOI 10.2307/1942060; VELDKAMP E, 1994, SOIL SCI SOC AM J, V58, P175, DOI 10.2136/sssaj1994.03615995005800010025x; Winkler JP, 1996, SOIL BIOL BIOCHEM, V28, P1067, DOI 10.1016/0038-0717(96)00076-4	30	709	834	16	387	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 20	2000	404	6780					858	861		10.1038/35009076	http://dx.doi.org/10.1038/35009076			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786789				2022-12-24	WOS:000086625000041
J	Slovis, BS; Plitman, JD; Haas, DW				Slovis, BS; Plitman, JD; Haas, DW			The case against anergy testing as a routine adjunct to tuberculin skin testing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; DELAYED-TYPE HYPERSENSITIVITY; CELL-MEDIATED-IMMUNITY; INTRAVENOUS-DRUG-USERS; PULMONARY TUBERCULOSIS; ACTIVE TUBERCULOSIS; NURSING-HOME; MILIARY TUBERCULOSIS; HIGH-RISK; MULTITEST	Although anergy testing is commonly used to help interpret negative tuberculin skin test results, the validity of this approach haj not been demonstrated. Specific issues include lack of a standardized protocol for antigen selection, number needed to reliably evaluate inability to respond, and uniform criteria for defining cutaneous reactivity, as well as regional variation in skin test reactivity. Tuberculin skin testing is used to screen for latent infection and to evaluate the need for isoniazid prophylaxis. The presence or absence of reactivity to control antigens does not affect this decision. The results of anergy testing also do not predict the risk for progression to active disease in either HIV-negative or HIV-positive patients. In HIV-negative patients with active tuberculosis, 10% to 20% have negative tuberculin test results, and 5% to 10% have a negative tuberculin result but have a positive reaction to another antigen. A negative tuberculin skin test result does not exclude either latent infection or active disease, even in the presence of a reaction to other antigens, Neither anergy testing nor tuberculin testing obviates the need for microbiologic evaluation when there is suspicion for active tuberculosis infection. Therefore, anergy testing is not useful in screening for asymptomatic tuberculous infection or for diagnosing active tuberculosis.	Vanderbilt Univ, Med Ctr, Div Infect Dis, Dept Med, Nashville, TN 37221 USA; High Point Gastroenterol Associates, High Point, NC USA	Vanderbilt University	Haas, DW (corresponding author), Vanderbilt Univ, Med Ctr, Div Infect Dis, Dept Med, 1211 21st Ave S,Suite 539, Nashville, TN 37221 USA.	david.haas@mcmail.vanderbilt.edu			NHLBI NIH HHS [HL 07123] Funding Source: Medline; NIAID NIH HHS [U01-92-AI-14] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ABOUYA YL, 1992, AM REV RESPIR DIS, V145, P617, DOI 10.1164/ajrccm/145.3.617; ALLEN S, 1992, AM REV RESPIR DIS, V146, P1439, DOI 10.1164/ajrccm/146.6.1439; ALVAREZ S, 1984, MEDICINE, V63, P25, DOI 10.1097/00005792-198401000-00003; [Anonymous], 1997, MMWR Recomm Rep, V46, P1; BASS JB, 1985, AM REV RESPIR DIS, V132, P379; BATES SE, 1979, CANCER, V43, P2306, DOI 10.1002/1097-0142(197906)43:6<2306::AID-CNCR2820430621>3.0.CO;2-K; BEER DJ, 1987, CRC CR REV IMMUNOL, V7, P55; BROCKMEYER NH, 1988, CLIN IMMUNOL IMMUNOP, V48, P50, DOI 10.1016/0090-1229(88)90156-0; Buckley C E 3rd, 1977, Monogr Allergy, V11, P97; CAINZOS M, 1993, JPEN-PARENTER ENTER, V17, P454, DOI 10.1177/0148607193017005454; CHAISSON RE, 1987, AM REV RESPIR DIS, V136, P570, DOI 10.1164/ajrccm/136.3.570; Chin DP, 1998, AM J RESP CRIT CARE, V158, P1797, DOI 10.1164/ajrccm.158.6.9804029; COHN JR, 1983, J AM GERIATR SOC, V31, P261, DOI 10.1111/j.1532-5415.1983.tb04867.x; CREDITOR MC, 1988, J GERONTOL, V43, pM97, DOI 10.1093/geronj/43.4.M97; DANIEL TM, 1981, AM REV RESPIR DIS, V123, P556; DELAFUENTE JC, 1988, J AM GERIATR SOC, V36, P733, DOI 10.1111/j.1532-5415.1988.tb07176.x; DORKEN E, 1987, CHEST, V92, P237, DOI 10.1378/chest.92.2.237; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; ELLNER JJ, 1978, ANN INTERN MED, V89, P932, DOI 10.7326/0003-4819-89-6-932; ELLNER JJ, 1978, J IMMUNOL, V121, P2573; Ellner JJ, 1996, INFECT AGENT DIS, V5, P62; FAIST E, 1990, J TRAUMA, V30, P8, DOI 10.1097/00005373-199001000-00002; FRAZER IH, 1985, CLIN IMMUNOL IMMUNOP, V35, P182, DOI 10.1016/0090-1229(85)90064-9; Furcolow Michael L., 1942, AMER REV TUBERC, V45, P504; GANTZ NM, 1986, HOSP PRACT, V21, P25; GOLDBERG N M, 1968, Rocky Mountain Medical Journal, V65, P66; Gordin FM, 1997, NEW ENGL J MED, V337, P315, DOI 10.1056/NEJM199707313370505; GRAHAM NMH, 1992, JAMA-J AM MED ASSOC, V267, P369, DOI 10.1001/jama.267.3.369; GUELAR A, 1993, AIDS, V7, P1345, DOI 10.1097/00002030-199310000-00007; HARRISON BD, 1975, LANCET, V1, P421; HOLDEN M, 1971, NEW ENGL J MED, V285, P1506, DOI 10.1056/NEJM197112302852704; HUEBNER RE, 1994, CLIN INFECT DIS, V19, P26, DOI 10.1093/clinids/19.1.26; HYDE L, 1972, AM REV RESPIR DIS, V105, P453; JENSEN B, 1977, CLIN EXP IMMUNOL, V27, P303; Kendig EL, 1998, CHEST, V113, P1175, DOI 10.1378/chest.113.5.1175; KENT DC, 1967, AM J MED SCI, V254, P866, DOI 10.1097/00000441-196712000-00016; KHAN MA, 1977, AM J MED, V62, P31, DOI 10.1016/0002-9343(77)90346-1; KIM JH, 1990, REV INFECT DIS, V12, P583; KLEINHENZ ME, 1981, J CLIN INVEST, V68, P153, DOI 10.1172/JCI110231; KNIKER WT, 1984, ANN ALLERGY, V52, P75; Koch R., 1890, DEUT MED WOCHENSCHR, V16, P1029, DOI [10.1055/s-0029-1207546, DOI 10.1055/S-0029-1207546]; MAARTENS G, 1990, AM J MED, V89, P291, DOI 10.1016/0002-9343(90)90340-J; MARKOWITZ N, 1993, ANN INTERN MED, V119, P185, DOI 10.7326/0003-4819-119-3-199308010-00002; Markowitz N, 1997, ANN INTERN MED, V126, P123, DOI 10.7326/0003-4819-126-2-199701150-00005; MARRIE TJ, 1988, J ALLERGY CLIN IMMUN, V81, P836, DOI 10.1016/0091-6749(88)90939-6; MCFADDEN J, 1992, J INVEST DERMATOL, V99, P784, DOI 10.1111/1523-1747.ep12614744; MCMURRAY DN, 1978, AM REV RESPIR DIS, V118, P827; MORENO S, 1993, ANN INTERN MED, V119, P194, DOI 10.7326/0003-4819-119-3-199308010-00003; Murray J F, 1991, Bull Int Union Tuberc Lung Dis, V66, P21; NASH DR, 1980, CHEST, V77, P32, DOI 10.1378/chest.77.1.32; Pouchot J, 1997, ANN INTERN MED, V126, P210, DOI 10.7326/0003-4819-126-3-199702010-00005; Reichman LB, 1998, CHEST, V113, P1153, DOI 10.1378/chest.113.5.1153; REUBEN JM, 1984, ANN ALLERGY, V53, P390; ROOK GAW, 1976, CLIN EXP IMMUNOL, V26, P129; ROONEY JJ, 1976, AM J MED, V60, P517, DOI 10.1016/0002-9343(76)90718-X; SELWYN PA, 1989, NEW ENGL J MED, V320, P545, DOI 10.1056/NEJM198903023200901; SELWYN PA, 1992, JAMA-J AM MED ASSOC, V268, P504, DOI 10.1001/jama.268.4.504; SMALL PM, 1991, NEW ENGL J MED, V324, P289, DOI 10.1056/NEJM199101313240503; STIMPSON PG, 1976, SOUTHERN MED J, V69, P424, DOI 10.1097/00007611-197604000-00013; SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362; WADEE AA, 1980, J IMMUNOL, V125, P1380; WEBSTER CT, 1995, AM J RESP CRIT CARE, V151, P805, DOI 10.1164/ajrccm/151.3_Pt_1.805; WIECZOREK Z, 1977, ARCH IMMUNOL THER EX, V25, P63; WINKELSTEIN W, 1992, EPIDEMIOL REV, V14, P1; 1991, MMWR MORB MORTAL WKL, V40, P27; 1993, MMWR MORB MORTAL WKL, V42, P961; [No title captured]; 1997, MMWR MORB MORTAL WKL, V46, P880; 1999, WKLY EPIDEMIOL REC, V74, P401	69	35	35	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 19	2000	283	15					2003	2007		10.1001/jama.283.15.2003	http://dx.doi.org/10.1001/jama.283.15.2003			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303RC	10789669				2022-12-24	WOS:000086436600036
J	Medema, RH; Kops, GJPL; Bos, JL; Burgering, BMT				Medema, RH; Kops, GJPL; Bos, JL; Burgering, BMT			AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27(kip1)	NATURE			English	Article							CAENORHABDITIS-ELEGANS; RETINOBLASTOMA PROTEIN; KINASE; DAF-16; SIGNALS	The Forkhead transcription factors AFX, FKHR and FKHR-L1 are orthologues of DAF-16, a Forkhead factor that regulates longevity in Caenorhabditis elegans(1-3). Here we show that overexpression of these Forkhead transcription factors causes growth suppression in a variety of cell lines, including a Ras-transformed cell line and a cell line lacking the tumour suppressor PTEN. Expression of AFX blocks cell-cycle progression at phase G(1), independent of functional retinoblastoma protein (pRb) but dependent on the cell-cycle inhibitor p27(kip1). Indeed, AFX transcriptionally activates p27(kip1), resulting in increased protein levels. We conclude that AFX-like proteins are involved in cell-cycle regulation and that inactivation of these proteins is an important step in oncogenic transformation.	Univ Utrecht, Med Ctr, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; Univ Utrecht, Med Ctr, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Hematol, Jordan Lab G03647, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University	Burgering, BMT (corresponding author), Univ Utrecht, Med Ctr, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands.			Kops, Geert/0000-0003-3555-5295; Medema, Rene/0000-0002-6754-0381				Boonen GJJC, 1999, J BIOL CHEM, V274, P34676, DOI 10.1074/jbc.274.49.34676; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; BURGERING BMT, 1991, EMBO J, V10, P1103, DOI 10.1002/j.1460-2075.1991.tb08050.x; BURGERING BMT, 1995, NATURE, V376, P599, DOI 10.1038/376599a0; Furnari FB, 1998, CANCER RES, V58, P5002; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Haas-Kogan D, 1998, CURR BIOL, V8, P1195, DOI 10.1016/S0960-9822(07)00493-9; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Kwon TK, 1996, GENE, V180, P113, DOI 10.1016/S0378-1119(96)00416-7; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lissy NA, 1998, IMMUNITY, V8, P57, DOI 10.1016/S1074-7613(00)80458-6; MEDEMA RH, 1995, P NATL ACAD SCI USA, V92, P6289, DOI 10.1073/pnas.92.14.6289; Medema RH, 1998, ONCOGENE, V16, P431, DOI 10.1038/sj.onc.1201558; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; OHTSUBO M, 1995, MOL CELL BIOL, V15, P2612; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Peeper DS, 1997, NATURE, V386, P177, DOI 10.1038/386177a0; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; ROCHE S, 1994, P NATL ACAD SCI USA, V91, P9185, DOI 10.1073/pnas.91.19.9185; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741	22	1188	1223	0	30	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					782	787		10.1038/35008115	http://dx.doi.org/10.1038/35008115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783894				2022-12-24	WOS:000086523600057
J	Morrison, RS; Wallenstein, S; Natale, DK; Senzel, RS; Huang, LL				Morrison, RS; Wallenstein, S; Natale, DK; Senzel, RS; Huang, LL			"We don't carry that" - Failure of pharmacies in predominantly nonwhite neighborhoods to stock opioid analgesics	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COOPERATIVE-ONCOLOGY-GROUP; CANCER PAIN; SURGERY; MANAGEMENT; MEDICATION; ATTITUDES; RELIEF	Background: We have observed that many black and Hispanic patients receiving palliative care at a major urban teaching hospital are unable to obtain prescribed opioids from their neighborhood pharmacies. In this study, we investigated the availability of commonly prescribed opioids in New York City pharmacies. Methods: We surveyed a randomly selected sample of 30 percent of New York City pharmacies to obtain information about their stock of opioids. For each pharmacy, U.S. Census estimates for 1997 were used to determine the racial and ethnic composition of the neighborhood (defined as the area within a 0.4-km [0.25-mile] radius of the pharmacy) and the proportion of residents who were more than 65 years old. Data on robberies, burglaries, and arrests involving illicit drugs in 1997 were obtained for the precinct in which each pharmacy was located. We used a generalized linear model to examine the relation between the racial or ethnic composition of neighborhoods and the opioid supplies of pharmacies, while controlling for the proportion of elderly persons at the census-block level and for crime rates at the precinct level. Results: Pharmacists representing 347 of 431 eligible pharmacies (81 percent) responded to the survey. A total of 176 pharmacies (51 percent) did not have sufficient supplies of opioids to treat patients with severe pain. Only 25 percent of pharmacies in predominantly nonwhite neighborhoods (those in which less than 40 percent of residents were white) had opioid supplies that were sufficient to treat patients in severe pain, as compared with 72 percent of pharmacies in predominantly white neighborhoods (those in which at least 80 percent of residents were white) (P<0.001). Conclusions: Pharmacies in predominantly nonwhite neighborhoods of New York City do not stock sufficient medications to treat patients with severe pain adequately. (N Engl J Med 2000;342:1023-6.) (C) 2000, Massachusetts Medical Society.	Mt Sinai Sch Med, Dept Geriatr & Adult Dev, Hertzberg Palliat Care Inst, New York, NY USA; Mt Sinai Sch Med, Dept Biomath Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Morrison, RS (corresponding author), CUNY Mt Sinai Sch Med, Dept Geriatr, Box 1070,1 Gustave L Levy Pl, New York, NY 10029 USA.			Natale, Dana/0000-0003-4976-0310	NIA NIH HHS [K08AG00833-01] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG000833] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bernabei R, 1998, JAMA-J AM MED ASSOC, V279, P1877, DOI 10.1001/jama.279.23.1877; Breitbart W, 1996, PAIN, V68, P315, DOI 10.1016/S0304-3959(96)03215-0; Cleeland CS, 1997, ANN INTERN MED, V127, P813, DOI 10.7326/0003-4819-127-9-199711010-00006; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; CLOSS SJ, 1990, J ADV NURS, V15, P42, DOI 10.1111/j.1365-2648.1990.tb01671.x; COHEN FL, 1980, PAIN, V9, P265, DOI 10.1016/0304-3959(80)90013-5; FAHERTY BS, 1984, NURS RES, V33, P369, DOI 10.1097/00006199-198411000-00013; JACOX A, 1994, CLIN PRACTICE GUIDEL, V9, P257; KANNER RM, 1986, J PAIN SYMPTOM MANAG, V1, P187; KELSEN DP, 1995, J CLIN ONCOL, V13, P748, DOI 10.1200/JCO.1995.13.3.748; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; LARUE F, 1995, BRIT MED J, V310, P1034, DOI 10.1136/bmj.310.6986.1034; Lynch EP, 1997, ANESTH ANALG, V85, P117, DOI 10.1097/00000539-199707000-00021; MCDONALD DD, 1994, RES NURS HEALTH, V17, P45, DOI 10.1002/nur.4770170107; *MED EC, 1998, PHYS DESK REF; Meier DE, 1997, ANN INTERN MED, V127, P225, DOI 10.7326/0003-4819-127-3-199708010-00008; MORRISON RS, IN PRESS J PAIN SYMP; *NYNEX INF RES, 1998, NYNEX YELL PAG; OATES JDL, 1994, ANAESTHESIA, V49, P755; *SUPPORT PRINC INV, 1996, JAMA-J AM MED ASSOC, V275, P1232, DOI DOI 10.1001/JAMA.1995.03530200027032; Tay W. K. J., 1994, Annals Academy of Medicine Singapore, V23, P191; TODD KH, 1993, JAMA-J AM MED ASSOC, V269, P1537, DOI 10.1001/jama.269.12.1537; TWYCROSS RG, 1982, PAIN, V14, P303, DOI 10.1016/0304-3959(82)90137-3; VONROENN JH, 1993, ANN INTERN MED, V119, P121, DOI 10.7326/0003-4819-119-2-199307150-00005; ZENZ M, 1995, J PAIN SYMPTOM MANAG, V10, P187, DOI 10.1016/0885-3924(94)00122-2	25	281	283	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 6	2000	342	14					1023	1026		10.1056/NEJM200004063421406	http://dx.doi.org/10.1056/NEJM200004063421406			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	300JB	10749965	Bronze			2022-12-24	WOS:000086248900006
J	Joranson, DE; Ryan, KM; Gilson, AM; Dahl, JL				Joranson, DE; Ryan, KM; Gilson, AM; Dahl, JL			Trends in medical use and abuse of opioid analgesics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PAIN MANAGEMENT; ADDICTION; BARRIERS; SYSTEM	Context Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available about the health consequences of the abuse of these drugs. Objective To evaluate the proportion of drug abuse related to opioid analgesics and the trends in medical use and abuse of 5 opioid analgesics used to treat severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone. Design and Setting Retrospective survey of medical records from 1990 to 1996 stored in the databases of the Drug Abuse Warning Network (source of abuse data)and the Automation of Reports and Consolidated Orders System (source of medical use data). Patients Nationally representative sample of hospital emergency department admissions resulting from drug abuse. Main Outcome Measures Medical use in grams and grams per 100 000 population and mentions of drug abuse by number and percentage of the population. Results From 1990 to 1996, there were increases in medical use of morphine (59%; 2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41 371 g), oxycodone (23%; 1.6 to 2.0 million g), and hydromorphone (19%; 118 455 to 141 325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During the same period, the total number of drug abuse mentions per year due to opioid analgesics increased from 32 430 to 34 563 (6.6%), although the proportion of mentions for opioid abuse relative to total drug abuse mentions decreased from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone (15%; 718 to 609), and increased for morphine (3%; 838 to 865). Conclusions The trend of increasing medical use of opioid analgesics to treat pain does not appear to contribute to increases in the health consequences of opioid analgesic abuse.	Univ Wisconsin, Sch Med, Pain & Policy Studies Grp, Ctr Comprehens Canc, Madison, WI 53705 USA; Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Joranson, DE (corresponding author), Univ Wisconsin, Sch Med, Pain & Policy Studies Grp, Ctr Comprehens Canc, 1900 Univ Ave, Madison, WI 53705 USA.							*AC PAIN MAN GUID, 1992, CLIN PRACT GUID; ADAMS EH, 1991, NEW YORK STATE J MED, V91, pS32; *ALC DRUG AB MENT, 1990, DAT DRUG AB WARN NET; American Academy of Pain Medicine and American Pain Society, 1997, US OP TREATM CHRON P; [Anonymous], [No title captured]; Doyle D, 1993, OXFORD TXB PALLIATIV; *DRUG ENF ADM, 1997, ARCOS DAT SEL OP AN; *DRUG ENF ADM, 1984, ARCOS DADS STATE LOC; Federation of State Medical Boards of the United States, 1998, MOD GUID US CONTR SU; Field MJ, 1997, APPROACHING DEATH IM; HILL CS, 1993, SEMIN ONCOL, V20, P1; Jacox A, 1994, CLIN PRACTICE GUIDEL; Joranson D E, 1998, Semin Oncol Nurs, V14, P158, DOI 10.1016/S0749-2081(98)80022-3; JORANSON DE, 1993, MONOGRAPH NATL I DRU, V131, P18; KAIKO RF, 1983, ANN NEUROL, V13, P180, DOI 10.1002/ana.410130213; KNAUS WA, 1995, JAMA-J AM MED ASSOC, V274, P1591, DOI 10.1001/jama.1995.03530200027032; Lebovits AH, 1997, CLIN J PAIN, V13, P237, DOI 10.1097/00002508-199709000-00009; Litovitz TL, 1998, AM J EMERG MED, V16, P443, DOI 10.1016/S0735-6757(98)90000-6; MCCAFFERY M, 1995, AM J NURS, V95, P61; *OFF INSP GEN US D, 1991, AUD REP DRUG ENF ADM; Paice JA, 1998, J PAIN SYMPTOM MANAG, V16, P1, DOI 10.1016/S0885-3924(98)00025-6; *SUBST AB MENT HLT, 1996, DAT DRUG AB WARN NET; *SUBST AB MENT HLT, 1997, NATL HOUSEHOLD SURVE; *UN, 1977, SINGL CONV NARC DRUG; Ward SE, 1996, RES NURS HEALTH, V19, P205, DOI 10.1002/(SICI)1098-240X(199606)19:3<205::AID-NUR4>3.0.CO;2-O; WEISSMAN DE, 1993, SEMIN ONCOL, V20, P53; World Health Organization, 1996, CANC PAIN REL GUID O	27	354	370	0	25	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 5	2000	283	13					1710	1714		10.1001/jama.283.13.1710	http://dx.doi.org/10.1001/jama.283.13.1710			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	298BK	10755497				2022-12-24	WOS:000086119300031
J	Brodsky, MH; Nordstrom, W; Tsang, G; Kwan, E; Rubin, GM; Abrams, JM				Brodsky, MH; Nordstrom, W; Tsang, G; Kwan, E; Rubin, GM; Abrams, JM			Drosophila p53 binds a damage response element at the reaper locus	CELL			English	Article							PROGRAMMED CELL-DEATH; TUMOR-SUPPRESSOR; CRYSTAL-STRUCTURE; GENE-EXPRESSION; WILD-TYPE; PROTEIN; DOMAIN; MUTATIONS; APOPTOSIS; OLIGOMERIZATION	The tumor suppressor gene p53 regulates multiple cellular responses to DNA damage, but the transcriptional targets that specify these responses are incompletely understood. We describe a Drosophila p53 homolog and demonstrate that it can activate transcription from a promoter containing binding sites for human p53. Dominant-negative forms of Drosophila p53 inhibit both transactivation in cultured cells and radiation-induced apoptosis in developing tissues. The cis-regulatory region of the proapoptotic gene reaper contains a radiation-inducible enhancer that includes a consensus p53 binding site. Drosophila p53 can activate transcription from this site in yeast and a multimer of this site is sufficient for radiation induction in vivo. These results indicate that reaper is a direct transcriptional target of Drosophila p53 following DNA damage.	Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; Univ Texas, SW Med Ctr, Dept Cell Biol, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Rubin, GM (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.			Rubin, Gerald/0000-0001-8762-8703	NATIONAL INSTITUTE ON AGING [R01AG012466] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG12466] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Abrams JM, 1999, TRENDS CELL BIOL, V9, P435, DOI 10.1016/S0962-8924(99)01646-3; ABRAMS JM, 1996, APOPTOSIS NORMAL DEV, P171; Ashburner M., 2004, DROSOPHILA LAB MANUA, V2nd; BARGONETTI J, 1991, CELL, V65, P1083, DOI 10.1016/0092-8674(91)90560-L; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; Bowman T, 1996, GENE DEV, V10, P826, DOI 10.1101/gad.10.7.826; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brodsky MH, 2000, GENE DEV, V14, P666; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; Friedberg E.C., 2016, DNA REPAIR MUTAGENES, V33, P35; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; HOLLSTEIN M, 1994, NUCLEIC ACIDS RES, V22, P3551; IWABUCHI K, 1993, ONCOGENE, V8, P1693; James P, 1996, GENETICS, V144, P1425; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Kanuka H, 1999, MOL CELL, V4, P757, DOI 10.1016/S1097-2765(00)80386-X; KERN SE, 1991, SCIENCE, V252, P1708, DOI 10.1126/science.2047879; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Kitazono A, 1998, BIOESSAYS, V20, P391, DOI 10.1002/(SICI)1521-1878(199805)20:5<391::AID-BIES6>3.0.CO;2-R; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; KRAISS S, 1988, J VIROL, V62, P4737, DOI 10.1128/JVI.62.12.4737-4744.1988; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Luo Y, 1996, BIOTECHNIQUES, V20, P564; May P, 1999, ONCOGENE, V18, P7621, DOI 10.1038/sj.onc.1203285; McCall K, 1997, TRENDS GENET, V13, P222, DOI 10.1016/S0168-9525(97)01126-8; Meier P, 2000, EMBO J, V19, P598, DOI 10.1093/emboj/19.4.598; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; MIYASHITA T, 1995, CELL, V80, P293; Munsch D, 2000, J BIOL CHEM, V275, P3867, DOI 10.1074/jbc.275.6.3867; Nordstrom W, 1996, DEV BIOL, V180, P213, DOI 10.1006/dbio.1996.0296; Ollmann M, 2000, CELL, V101, P91, DOI 10.1016/S0092-8674(00)80626-1; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; PAVLETICH NP, 1993, GENE DEV, V7, P2556, DOI 10.1101/gad.7.12b.2556; Rodriguez A, 1999, NAT CELL BIOL, V1, P272, DOI 10.1038/12984; Soussi T, 1996, J MOL BIOL, V260, P623, DOI 10.1006/jmbi.1996.0425; TEPASS U, 1990, ROUX ARCH DEV BIOL, V199, P189, DOI 10.1007/BF01682078; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Thanos CD, 1999, PROTEIN SCI, V8, P1708, DOI 10.1110/ps.8.8.1708; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; Weinert T, 1998, CELL, V94, P555, DOI 10.1016/S0092-8674(00)81597-4; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yamaguchi M, 1999, ONCOGENE, V18, P6767, DOI 10.1038/sj.onc.1203113; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yu J, 1999, P NATL ACAD SCI USA, V96, P14517, DOI 10.1073/pnas.96.25.14517; Zhou L, 1999, MOL CELL, V4, P745, DOI 10.1016/S1097-2765(00)80385-8	63	381	388	1	15	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 31	2000	101	1					103	113		10.1016/S0092-8674(00)80627-3	http://dx.doi.org/10.1016/S0092-8674(00)80627-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	300JM	10778860	Bronze			2022-12-24	WOS:000086249900012
J	Thomas, DD; Donnelly, CA; Wood, RJ; Alphey, LS				Thomas, DD; Donnelly, CA; Wood, RJ; Alphey, LS			Insect population control using a dominant, repressible, lethal genetic system	SCIENCE			English	Article							DROSOPHILA-MELANOGASTER; EXPRESSION	A major modification to the sterile insect technique is described, in which transgenic insects homozygous for a dominant, repressible, female-specific lethal gene system are used. We demonstrate two methods that give the required genetic characteristics in an otherwise wild-type genetic background. The first system uses a sex-specific promoter or enhancer to drive the expression of a repressible transcription factor, which in turn controls the expression of a toxic gene product. The second system uses non-sex-specific expression of the repressible transcription factor to regulate a selectively Lethal gene product. Both methods work efficiently in Drosophila melanogaster, and we expect these principles to be widely applicable to more economically important organisms.	Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, Oxford OX1 3PS, England; Univ Manchester, Sch Biol Sci, Manchester M13 9PT, Lancs, England	University of Oxford; University of Manchester	Alphey, LS (corresponding author), Univ Oxford, Dept Zool, Wellcome Trust Ctr Epidemiol Infect Dis, S Parks Rd, Oxford OX1 3PS, England.			Alphey, Luke/0000-0002-2916-3802; Donnelly, Christl/0000-0002-0195-2463				Bello B, 1998, DEVELOPMENT, V125, P2193; FORTINI ME, 1992, NATURE, V355, P559, DOI 10.1038/355559a0; FOSTER GG, 1988, THEOR APPL GENET, V76, P870, DOI 10.1007/BF00273675; Gebauer F, 1998, RNA, V4, P142; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HENDRICHS J, 1995, J APPL ENTOMOL, V119, P371, DOI 10.1111/j.1439-0418.1995.tb01303.x; KELLEY RL, 1995, CELL, V81, P867, DOI 10.1016/0092-8674(95)90007-1; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Krafsur ES, 1998, J AGR ENTOMOL, V15, P303; LIDDELL S, 1991, MOL GEN GENET, V230, P219, DOI 10.1007/BF00290671; Matsuo T, 1997, DEVELOPMENT, V124, P2671; ROBINSON A, IN PRESS TRENDS ENTO; ROGERS DJ, 1984, INSECT SCI APPL, V5, P419, DOI 10.1017/S1742758400008766; RONALDSON E, 1995, GENET RES, V66, P9, DOI 10.1017/S0016672300034340; SEAWRIGHT JA, 1978, SCIENCE, V200, P1303, DOI 10.1126/science.663614; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; THOMAS D, UNPUB	18	406	448	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 31	2000	287	5462					2474	2476		10.1126/science.287.5462.2474	http://dx.doi.org/10.1126/science.287.5462.2474			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	299MK	10741964				2022-12-24	WOS:000086202200041
J	Zamore, PD; Tuschl, T; Sharp, PA; Bartel, DP				Zamore, PD; Tuschl, T; Sharp, PA; Bartel, DP			RNAi: Double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals	CELL			English	Article							CAENORHABDITIS-ELEGANS; TOMATO LEAVES; GENE; INTERFERENCE; NEUROSPORA; POLYMERASE	Double-stranded RNA (dsRNA) directs the sequence-specific degradation of mRNA through a process known as RNA interference (RNAi). Using a recently developed Drosophila in vitro system, we examined the molecular mechanism underlying RNAi. We find that RNAi is ATP dependent yet uncoupled from mRNA translation. During the RNAi reaction, both strands of the dsRNA are processed to RNA segments 21-23 nucleotides in length. Processing of the dsRNA to the small RNA fragments does not require the targeted mRNA. The mRNA is cleaved only within the region of identity with the dsRNA. Cleavage occurs at sites 21-23 nucleotides apart, the same interval observed for the dsRNA itself, suggesting that the 21-23 nucleotide fragments from the dsRNA are guiding mRNA cleavage.	Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01655 USA; Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; MIT, Ctr Canc Res, Cambridge, MA 02139 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of Massachusetts System; University of Massachusetts Worcester; Max Planck Society; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Zamore, PD (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Biol, Worcester, MA 01655 USA.	phillip.zamore@umassmed.edu; ttuschl@mpibpc.gwdg.de	Zamore, Phillip D/A-8941-2013	Zamore, Phillip/0000-0002-4505-9618				Alvarado AS, 1999, P NATL ACAD SCI USA, V96, P5049, DOI 10.1073/pnas.96.9.5049; Auxilien S, 1996, J MOL BIOL, V262, P437, DOI 10.1006/jmbi.1996.0527; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; BASS BL, 1997, TRENDS BIOCHEM SCI, V22, P278; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Cogoni C, 1996, EMBO J, V15, P3153, DOI 10.1002/j.1460-2075.1996.tb00678.x; Cundliffe E., 1981, MOL BASIS ANTIBIOTIC, V2nd, P402; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gebauer F, 1999, EMBO J, V18, P6146, DOI 10.1093/emboj/18.21.6146; Grant SR, 1999, CELL, V96, P303, DOI 10.1016/S0092-8674(00)80541-3; GRISHOK A, 2000, IN PRESS SCIENCE; GUO S, 1995, CELL, V81, P611, DOI 10.1016/0092-8674(95)90082-9; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hunter CP, 2000, CURR BIOL, V10, pR137, DOI 10.1016/S0960-9822(00)00325-0; Hunter CP, 1999, CURR BIOL, V9, pR440, DOI 10.1016/S0960-9822(99)80276-0; Kennerdell JR, 1998, CELL, V95, P1017, DOI 10.1016/S0092-8674(00)81725-0; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; Lohmann JU, 1999, DEV BIOL, V214, P211, DOI 10.1006/dbio.1999.9407; Merrick WC., 1996, TRANSLATION CONTROL, P31; Misquitta L, 1999, P NATL ACAD SCI USA, V96, P1451, DOI 10.1073/pnas.96.4.1451; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Montgomery MK, 1998, TRENDS GENET, V14, P255, DOI 10.1016/S0168-9525(98)01510-8; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Page AW, 1997, DEV BIOL, V183, P195, DOI 10.1006/dbio.1997.8506; QIAO L, 1995, GENETICS, V141, P551; Ratcliff FG, 1999, PLANT CELL, V11, P1207, DOI 10.1105/tpc.11.7.1207; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sharp PA, 1999, GENE DEV, V13, P139, DOI 10.1101/gad.13.2.139; Silberklang M, 1979, Methods Enzymol, V59, P58; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vaucheret H, 1998, PLANT J, V16, P651, DOI 10.1046/j.1365-313x.1998.00337.x; Wagner RW, 1998, NATURE, V391, P744, DOI 10.1038/35750; Wargelius A, 1999, BIOCHEM BIOPH RES CO, V263, P156, DOI 10.1006/bbrc.1999.1343; Waterhouse PM, 1999, TRENDS PLANT SCI, V4, P452, DOI 10.1016/S1360-1385(99)01493-4; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016	46	1972	2604	11	341	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 31	2000	101	1					25	33		10.1016/S0092-8674(00)80620-0	http://dx.doi.org/10.1016/S0092-8674(00)80620-0			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	300JM	10778853	Bronze			2022-12-24	WOS:000086249900005
J	Spurgeon, P; Barwell, F; Kerr, D				Spurgeon, P; Barwell, F; Kerr, D			Waiting times for cancer patients in England after general practitioners' referrals: retrospective national survey	BRITISH MEDICAL JOURNAL			English	Article									Univ Birmingham, Sch Publ Policy, Hlth Serv Management Ctr, Birmingham B15 2RT, W Midlands, England; Univ Birmingham, Sch Med, CRC, Inst Canc Studies, Birmingham B15 2TJ, W Midlands, England	University of Birmingham; University of Birmingham	Spurgeon, P (corresponding author), Univ Birmingham, Sch Publ Policy, Hlth Serv Management Ctr, Pk House, Birmingham B15 2RT, W Midlands, England.							Berrino F, 1999, IARC SCI PUBLICATION, V151; Coleman MP., 1999, CANC SURVIVAL TRENDS; National Cancer Institute, 1998, SEER STAT CANC INC P	3	53	53	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 25	2000	320	7238					838	839		10.1136/bmj.320.7238.838	http://dx.doi.org/10.1136/bmj.320.7238.838			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	299DJ	10731176	Bronze			2022-12-24	WOS:000086180300024
J	Thum, T; Borlak, J				Thum, T; Borlak, J			Gene expression in distinct regions of the heart	LANCET			English	Article							CONVERTING ENZYME-INHIBITORS; CYTOCHROME-P450; ACID; LIVER	Background Cytochrome P450 mono-oxygenases bring about metabolism of marry drugs, including verapamil, but no information is available on the metabolism of such drugs in the human heart. Methods We investigated the gene expression of major human cytochrome P450 monooxygenases in the various regions of explanted hearts from six patients with dilated cardiomyopathy and one with transposition of the arterial trunk. For comparison we also studied samples of liver and lung from three patients and two samples of normal heart. The biological significance of tissue-specific cytochrome monooxygenase gene expression was further investigated by study of the microsomal metabolism of verapamil in ventricular tissue. Findings mRNA for the cytochromes 1A1, 2B6/7, 2C8-19, 2D6, and 4B1 was predominantly expressed in the right ventricle, the unilateral expression of the 2D6 gene in right-venticular tissue is important because of its key role in the metabolism of beta-blockers. A strong correlation between tissue-specific gene expression and enzyme activity was found; microsomal metabolism of verapamil was confined to the right ventricle. By contrast, cytochrome P450 3A genes (which are the major drug-metabolising enzymes in the liver and the lung) were not expressed in any of the human heart tissues, and mRNA transcripts for epoxide hydrolase, cytochrome P450 2E1, and flavin-containing monooxygenases 2 and 5 were detected in all regions of the human heart and the great vessels. Interpretation These findings show that expression of genes for cytochrome P450 monooxygenases and verapamil metabolism are found predominantly in the right side of the heart. This finding may explain lack of efficacy of certain cardioselective drugs.	Fraunhofer Inst Toxicol & Aerosol Res, Dept Mol Toxicol & Pharmacokinet, D-30659 Hannover, Germany	Fraunhofer Gesellschaft	Borlak, J (corresponding author), Fraunhofer Inst Toxicol & Aerosol Res, Dept Mol Toxicol & Pharmacokinet, Nicolal Fuchs Str 1, D-30659 Hannover, Germany.			Thum, Thomas/0000-0003-4360-1511				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARISTIZABAL D, 1994, AM J CARDIOL, V73, P483, DOI 10.1016/0002-9149(94)90679-3; BORLAK JT, 1994, BIOCHEM PHARMACOL, V48, P1717, DOI 10.1016/0006-2952(94)90456-1; Cheng YF, 1998, J CHROMATOGR A, V828, P273, DOI 10.1016/S0021-9673(98)00823-1; Clarke SE, 1998, XENOBIOTICA, V28, P1167, DOI 10.1080/004982598238877; HAKKOLA J, 1994, BIOCHEM PHARMACOL, V48, P59, DOI 10.1016/0006-2952(94)90223-2; JURIMAROMET M, 1993, BIOCHEM PHARMACOL, V46, P2163, DOI 10.1016/0006-2952(93)90605-V; Kivisto KT, 1996, N-S ARCH PHARMACOL, V353, P207; MCCALLUM GP, 1993, CAN J PHYSIOL PHARM, V71, P151, DOI 10.1139/y93-021; Oldham HG, 1997, DRUG METAB DISPOS, V25, P970; PRICE T, 1992, J CLIN ENDOCR METAB, V74, P879, DOI 10.1210/jc.74.4.879; RAUNIO H, 1995, ADV DRUG METABOLISM, P233; Smith DA, 1998, XENOBIOTICA, V28, P1095, DOI 10.1080/004982598238859; Smith G, 1998, XENOBIOTICA, V28, P1129, DOI 10.1080/004982598238868; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STEARNS RA, 1995, DRUG METAB DISPOS, V23, P207; Tracy TS, 1999, BRIT J CLIN PHARMACO, V47, P545, DOI 10.1046/j.1365-2125.1999.00923.x; Wu S, 1996, J BIOL CHEM, V271, P3460; Xiao YF, 1998, J PHYSIOL-LONDON, V508, P777, DOI 10.1111/j.1469-7793.1998.777bp.x; ZIERHUT W, 1990, J CARDIOVASC PHARM, V16, P480, DOI 10.1097/00005344-199009000-00019	20	159	167	0	7	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 18	2000	355	9208					979	983		10.1016/S0140-6736(00)99016-0	http://dx.doi.org/10.1016/S0140-6736(00)99016-0			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YH	10768437				2022-12-24	WOS:000086054000013
J	Szabo, SJ; Kim, ST; Costa, GL; Zhang, XK; Fathman, CG; Glimcher, LH				Szabo, SJ; Kim, ST; Costa, GL; Zhang, XK; Fathman, CG; Glimcher, LH			A novel transcription factor, T-bet, directs Th1 lineage commitment	CELL			English	Article							INTERFERON-GAMMA PROMOTER; CYTOKINE GENE-EXPRESSION; HELPER CELL SUBSETS; NATURAL-KILLER; IFN-GAMMA; IMMUNE-RESPONSES; TRANSGENIC MICE; FACTOR GATA-3; DNA-BINDING; T-HELPER-1	Naive T helper cells differentiate into two subsets, Th1 and Th2, each with distinct functions and cytokine profiles. Here, we report the isolation of T-bet, a Th1-specific T box transcription factor that controls the expression of the hallmark Th1 cytokine, IFN gamma. T-bet expression correlates with IFN gamma expression in Th1 and NK cells. Ectopic expression of T-bet both transactivates the IFN gamma gene and induces endogenous IFN gamma production. Remarkably, retroviral gene transduction of T-bet into polarized Th2 and Tc2 primary T cells redirects them into Th1 and Tc1 cells, respectively, as evidenced by the simultaneous induction of IFN gamma and repression of IL-4 and IL-5. Thus, T-bet initiates Th1 lineage development from naive Thp cells both by activating Th1 genetic programs and by repressing the opposing Th2 programs.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Stanford Univ, Sch Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA; Med Univ S Carolina, Div Rheumatol & Immunol, Charleston, SC 29425 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Stanford University; Medical University of South Carolina	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI037833, P01AI039646, P01AI036535] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 36535, AI/AG 37833, AI 39646] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Bamshad M, 1997, NAT GENET, V16, P311, DOI 10.1038/ng0797-311; Basson CT, 1997, NAT GENET, V15, P30, DOI 10.1038/ng0197-30; Borges E, 1997, J EXP MED, V185, P573, DOI 10.1084/jem.185.3.573; BROMBACHER F, 1994, INT IMMUNOL, V6, P189, DOI 10.1093/intimm/6.2.189; Carter LL, 1999, J EXP MED, V189, P1355, DOI 10.1084/jem.189.8.1355; Coccia EM, 1999, J BIOL CHEM, V274, P6698, DOI 10.1074/jbc.274.10.6698; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; CROFT M, 1994, J EXP MED, V180, P1715, DOI 10.1084/jem.180.5.1715; Ferber IA, 1999, CLIN IMMUNOL, V91, P134, DOI 10.1006/clim.1999.4718; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Fisher AL, 1998, GENE DEV, V12, P1931, DOI 10.1101/gad.12.13.1931; GAJEWSKI TF, 1989, J IMMUNOL, V143, P15; Gately MK, 1998, ANNU REV IMMUNOL, V16, P495, DOI 10.1146/annurev.immunol.16.1.495; GOUILLEUX F, 1994, EMBO J, V13, P4361, DOI 10.1002/j.1460-2075.1994.tb06756.x; GRAY PW, 1982, NATURE, V298, P859, DOI 10.1038/298859a0; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Hodge MR, 1996, SCIENCE, V274, P1903, DOI 10.1126/science.274.5294.1903; Hofmann A, 1996, P NATL ACAD SCI USA, V93, P5185, DOI 10.1073/pnas.93.11.5185; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; Huang H, 1997, J IMMUNOL, V159, P3731; HUANG S, 1993, SCIENCE, V259, P1742, DOI 10.1126/science.8456301; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; KORNBLUTH J, 1982, J IMMUNOL, V129, P2831; LAFAILLE JJ, 1994, CELL, V78, P399, DOI 10.1016/0092-8674(94)90419-7; LEDERER JA, 1994, J IMMUNOL, V152, P77; Lohoff M, 1997, IMMUNITY, V6, P681, DOI 10.1016/S1074-7613(00)80444-6; Ma XJ, 1996, J EXP MED, V183, P147, DOI 10.1084/jem.183.1.147; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Muller CW, 1997, NATURE, V389, P884, DOI 10.1038/39929; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Nakamura T, 1997, J IMMUNOL, V158, P1085; Nelms K, 1999, ANNU REV IMMUNOL, V17, P701, DOI 10.1146/annurev.immunol.17.1.701; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Ouyang W, 1999, P NATL ACAD SCI USA, V96, P3888, DOI 10.1073/pnas.96.7.3888; Papaioannou VE, 1997, TRENDS GENET, V13, P212, DOI 10.1016/S0168-9525(97)01144-X; PAUL WE, 1994, CELL, V76, P241, DOI 10.1016/0092-8674(94)90332-8; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Rolink A, 1996, J EXP MED, V183, P187, DOI 10.1084/jem.183.1.187; ROMAGNANI S, 1994, ANNU REV IMMUNOL, V12, P227, DOI 10.1146/annurev.iy.12.040194.001303; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Sica A, 1997, J BIOL CHEM, V272, P30412, DOI 10.1074/jbc.272.48.30412; Smith J, 1997, CURR OPIN GENET DEV, V7, P474, DOI 10.1016/S0959-437X(97)80073-1; Sweetser MT, 1998, J BIOL CHEM, V273, P34775, DOI 10.1074/jbc.273.52.34775; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; SZABO SJ, 1993, MOL CELL BIOL, V13, P4793, DOI 10.1128/MCB.13.8.4793; Takeuchi JK, 1999, NATURE, V398, P810, DOI 10.1038/19762; Taki S, 1997, IMMUNITY, V6, P673, DOI 10.1016/S1074-7613(00)80443-4; Thierfelder WE, 1996, NATURE, V382, P171, DOI 10.1038/382171a0; TONY Y, 1995, CURR BIOL, V5, P1; Xu XA, 1996, SCIENCE, V273, P794, DOI 10.1126/science.273.5276.794; Yasui DH, 1998, J IMMUNOL, V160, P4433; YODOI J, 1985, J IMMUNOL, V134, P1623; Yoshimoto T, 1997, P NATL ACAD SCI USA, V94, P3948, DOI 10.1073/pnas.94.8.3948; YOUNG HA, 1994, J IMMUNOL, V153, P3603; Zhang DH, 1999, IMMUNITY, V11, P473, DOI 10.1016/S1074-7613(00)80122-3; Zhang DH, 1997, J BIOL CHEM, V272, P21597, DOI 10.1074/jbc.272.34.21597; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	64	2605	2839	1	98	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 17	2000	100	6					655	669		10.1016/S0092-8674(00)80702-3	http://dx.doi.org/10.1016/S0092-8674(00)80702-3			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	295TK	10761931	Bronze			2022-12-24	WOS:000085983800008
J	Trachtenberg, JT; Trepel, C; Stryker, MP				Trachtenberg, JT; Trepel, C; Stryker, MP			Rapid extragranular plasticity in the absence of thalamocortical plasticity in the developing primary visual cortex	SCIENCE			English	Article							MONOCULAR DEPRIVATION; HORIZONTAL CONNECTIONS; OCULAR DOMINANCE; CORTICAL PLASTICITY; BRIEF PERIODS; KITTENS; MAPS; CATS	Monocular deprivation during early postnatal development remodels the circuitry of the primary visual cortex so that most neurons respond poorly to stimuli presented to the deprived eye. This rapid physiological change is ultimately accompanied by a matching anatomical loss of input from the deprived eye. This remodeling is thought to be initiated at the thalamocortical synapse. Ocular dominance plasticity after brief (24 hours) monocular deprivation was analyzed by intrinsic signal optical imaging and by targeted extracellular unit recordings. Deprived-eye responsiveness was lost in the extragranular Layers, whereas normal binocularity in layer IV was preserved. This finding supports the hypothesis that thalamocortical organization is guided by earlier changes at higher stages.	Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Stryker, MP (corresponding author), Univ Calif San Francisco, WM Keck Fdn Ctr Integrat Neurosci, San Francisco, CA 94143 USA.			Stryker, Michael/0000-0003-1546-5831	NEI NIH HHS [R37 EY002874-21, F32 EY006824, EY06824, R37-EY02874, R37 EY002874] Funding Source: Medline; NATIONAL EYE INSTITUTE [R37EY002874, U10EY006824] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; DAW NW, 1992, J NEUROPHYSIOL, V67, P197, DOI 10.1152/jn.1992.67.1.197; DIAMOND ME, 1994, SCIENCE, V265, P1885, DOI 10.1126/science.8091215; FREEMAN RD, 1982, J NEUROPHYSIOL, V47, P139, DOI 10.1152/jn.1982.47.2.139; GILBERT CD, 1979, NATURE, V280, P120, DOI 10.1038/280120a0; Gilbert CD, 1998, PHYSIOL REV, V78, P467, DOI 10.1152/physrev.1998.78.2.467; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hess G, 1996, J NEUROPHYSIOL, V75, P1765, DOI 10.1152/jn.1996.75.5.1765; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; LOWEL S, 1992, SCIENCE, V255, P209, DOI 10.1126/science.1372754; MALONEK D, 1990, 20 ANN M SOC NEUR ST; MILLER KD, 1989, SCIENCE, V245, P605, DOI 10.1126/science.2762813; MITCHELL DE, 1991, PHILOS T R SOC B, V333, P51, DOI 10.1098/rstb.1991.0060; MOVSHON JA, 1977, J NEUROPHYSIOL, V40, P1255, DOI 10.1152/jn.1977.40.6.1255; OLSON CR, 1975, J NEUROPHYSIOL, V38, P26, DOI 10.1152/jn.1975.38.1.26; REITER H, 1986, P NATL ACAD SCI USA, V85, P3623; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Ruthazer ES, 1996, J NEUROSCI, V16, P7253; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267, DOI 10.1113/jphysiol.1978.sp012421; Stryker Michael P., 1999, Journal of Physiology (Cambridge), V515P, p25S	23	183	194	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2029	2032		10.1126/science.287.5460.2029	http://dx.doi.org/10.1126/science.287.5460.2029			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720332	Green Accepted			2022-12-24	WOS:000085902800066
J	Ostermann, A; Waschipky, R; Parak, FG; Nienhaus, GU				Ostermann, A; Waschipky, R; Parak, FG; Nienhaus, GU			Ligand binding and conformational motions in myoglobin	NATURE			English	Article							SPERM WHALE MYOGLOBIN; CARBONMONOXY-MYOGLOBIN; MOLECULAR-DYNAMICS; HEME-PROTEINS; MONOXIDE; CRYSTALLOGRAPHY; SPECTROSCOPY; TRANSITION; SCATTERING; PHOTOLYSIS	Myoglobin, a small globular haem protein that binds gaseous ligands such as O-2, CO and NO reversibly at the haem iron, serves as a model for studying structural and dynamic aspects of protein reactions. Time-resolved spectroscopic measurements after photodissociation of the ligand revealed a complex ligand-binding reaction with multiple kinetic intermediates, resulting from protein relaxation and movements of the ligand within the protein(1-3). To observe the structural changes induced by ligand dissociation, we have carried out X-ray crystallographic investigations of carbon monoxy-myoglobin (MbCO mutant L29W) crystals illuminated below and above 180 K, complemented by time-resolved infrared spectroscopy of CO rebinding. Here we show that below 180 K photodissociated ligands migrate to specific sites within an internal cavity-the distal haem pocket-of an essentially immobilized, frozen protein, from where they subsequently rebind by thermally activated barrier crossing. Upon photodissociation above 180 K. Ligands escape from the distal pocket, aided by protein fluctuations that transiently open exit channels. We recover most of the ligands in a cavity on the opposite side of the haem group.	Univ Ulm, Dept Biophys, D-89069 Ulm, Germany; Tech Univ Munich, Fak Phys E17, D-85747 Garching, Germany; Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Ulm University; Technical University of Munich; University of Illinois System; University of Illinois Urbana-Champaign	Nienhaus, GU (corresponding author), Univ Ulm, Dept Biophys, D-89069 Ulm, Germany.		Nienhaus, Gerd Ulrich/G-8698-2012	Nienhaus, Gerd Ulrich/0000-0002-5027-3192; Ostermann, Andreas/0000-0002-1477-5590				ALBEN JO, 1982, P NATL ACAD SCI-BIOL, V79, P3744, DOI 10.1073/pnas.79.12.3744; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BRUNGER AT, 1992, X PLOR VERSION 3 1; DOSTER W, 1989, NATURE, V337, P754, DOI 10.1038/337754a0; ELBER R, 1990, J AM CHEM SOC, V112, P9161, DOI 10.1021/ja00181a020; FRAUENFELDER H, 1988, ANNU REV BIOPHYS BIO, V17, P451; Hartmann H, 1996, P NATL ACAD SCI USA, V93, P7013, DOI 10.1073/pnas.93.14.7013; HENRY ER, 1983, J MOL BIOL, V166, P443, DOI 10.1016/S0022-2836(83)80094-1; Hirota S, 1996, J AM CHEM SOC, V118, P7845, DOI 10.1021/ja9608297; HUANG XH, 1994, NAT STRUCT BIOL, V1, P226, DOI 10.1038/nsb0494-226; Lim MH, 1997, NAT STRUCT BIOL, V4, P209, DOI 10.1038/nsb0397-209; Nienhaus G. U., 1996, ENCY APPL PHYSICS, V15, P163; NIENHAUS GU, 1989, NATURE, V338, P665, DOI 10.1038/338665a0; NIENHAUS GU, 1992, P NATL ACAD SCI USA, V89, P2902, DOI 10.1073/pnas.89.7.2902; NIENHAUS GU, 1994, BIOCHEMISTRY-US, V33, P13413, DOI 10.1021/bi00249a030; Olson JS, 1996, J BIOL CHEM, V271, P17593, DOI 10.1074/jbc.271.30.17593; PARAK F, 1982, J MOL BIOL, V161, P177, DOI 10.1016/0022-2836(82)90285-6; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SCHLICHTING I, 1994, NATURE, V371, P808, DOI 10.1038/371808a0; SCHOENBORN BP, 1965, NATURE, V207, P28, DOI 10.1038/207028a0; Scott EE, 1997, BIOCHEMISTRY-US, V36, P11909, DOI 10.1021/bi970719s; SPRINGER BA, 1987, P NATL ACAD SCI USA, V84, P8961, DOI 10.1073/pnas.84.24.8961; SPRINGER BA, 1994, CHEM REV, V94, P699, DOI 10.1021/cr00027a007; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; STEINBACH PJ, 1991, BIOCHEMISTRY-US, V30, P3988, DOI 10.1021/bi00230a026; TENG TY, 1994, NAT STRUCT BIOL, V1, P701, DOI 10.1038/nsb1094-701; TILTON RF, 1984, BIOCHEMISTRY-US, V23, P2849, DOI 10.1021/bi00308a002; Vitkup D, 1997, NAT STRUCT BIOL, V4, P202, DOI 10.1038/nsb0397-202	31	359	361	2	54	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 9	2000	404	6774					205	208		10.1038/35004622	http://dx.doi.org/10.1038/35004622			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	293UC	10724176				2022-12-24	WOS:000085870900057
J	Walter, P; Keenan, R; Schmitz, U				Walter, P; Keenan, R; Schmitz, U			Structural biology - SRP - Where the RNA and membrane worlds meet	SCIENCE			English	Editorial Material							SIGNAL RECOGNITION PARTICLE; SEQUENCE; SUBUNIT		Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Maxygen, Redwood City, CA 94063 USA; Genelab Technol, Redwood City, CA 94063 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Walter, P (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.			Keenan, Robert/0000-0003-1466-0889				Batey RT, 2000, SCIENCE, V287, P1232, DOI 10.1126/science.287.5456.1232; BERNSTEIN HD, 1989, NATURE, V340, P482, DOI 10.1038/340482a0; BUTLER S, 1904, NOT SAD STYGIAN SHOR; GEWIRTH DT, 1995, NAT STRUCT BIOL, V2, P386, DOI 10.1038/nsb0595-386; Keenan RJ, 1998, CELL, V94, P181, DOI 10.1016/S0092-8674(00)81418-X; Khvorova A, 1999, P NATL ACAD SCI USA, V96, P10649, DOI 10.1073/pnas.96.19.10649; PORITZ MA, 1988, CELL, V55, P4, DOI 10.1016/0092-8674(88)90003-7; Royer WE, 1996, P NATL ACAD SCI USA, V93, P14526, DOI 10.1073/pnas.93.25.14526; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; SCHIRMER T, 1990, NATURE, V343, P140, DOI 10.1038/343140a0; Schmitz U, 1999, NAT STRUCT BIOL, V6, P634, DOI 10.1038/10683; Schmitz U, 1999, RNA, V5, P1419, DOI 10.1017/S1355838299991458	12	24	25	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2000	287	5456					1212	1213		10.1126/science.287.5456.1212	http://dx.doi.org/10.1126/science.287.5456.1212			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	286KG	10712156				2022-12-24	WOS:000085444700033
J	Holmes, MC; Tjian, R				Holmes, MC; Tjian, R			Promoter-selective properties of the TBP-Related factor TRF1	SCIENCE			English	Article							TATA-BINDING PROTEIN; TRANSCRIPTION; DROSOPHILA; COMPLEX; ACTIVATION; DOMAINS; DNA	The TATA-binding protein (TBP)-related factor 1 (TRF1) is expressed in a tissue-restricted fashion during Drosophila embryogenesis and may serve as a promoter-specific recognition factor that can replace TBP in regulating transcription. However, bona fide target promoters that would preferentially respond to TRF1 have remained elusive. Polytene chromosome staining, chromatin immunoprecipitation, direct messenger RNA analysis, and transient cotransfection assays identified the Drosophila gene tudor as containing a TRF1-responsive promoter. Reconstituted in vitro transcription reactions and deoxyribonuclease I footprinting assays confirmed the ability of TRF1 to bind preferentially and direct transcription of the tudor gene from an alternate promoter. Thug, metazoans appear to have evolved gene-selective and tissue-specific components of the core transcription machinery to regulate gene expression.	Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Tjian, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Howard Hughes Med Inst, 229 Stanley Hall, Berkeley, CA 94720 USA.				NATIONAL CANCER INSTITUTE [R01CA025417, R37CA025417] Funding Source: NIH RePORTER; NCI NIH HHS [CA25417] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BUNCH TA, 1988, NUCLEIC ACIDS RES, V16, P1043, DOI 10.1093/nar/16.3.1043; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; CROWLEY TE, 1993, NATURE, V361, P557, DOI 10.1038/361557a0; Dikstein R, 1996, CELL, V87, P137, DOI 10.1016/S0092-8674(00)81330-6; ENGLAND BP, 1990, J BIOL CHEM, V265, P5086; HANSEN SK, 1995, CELL, V82, P565, DOI 10.1016/0092-8674(95)90029-2; Hansen SK, 1997, CELL, V91, P71, DOI 10.1016/S0092-8674(01)80010-6; HEBERLEIN U, 1988, NATURE, V331, P410, DOI 10.1038/331410a0; HILL CS, 1995, CELL, V80, P199, DOI 10.1016/0092-8674(95)90403-4; Holmes M. J., UNPUB; Maldonado E, 1999, J BIOL CHEM, V274, P12963, DOI 10.1074/jbc.274.19.12963; Mannervik M, 1999, SCIENCE, V284, P606, DOI 10.1126/science.284.5414.606; Margolis P, 1991, CURR OPIN GENET DEV, V1, P330, DOI 10.1016/S0959-437X(05)80296-5; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; Ohbayashi T, 1999, NUCLEIC ACIDS RES, V27, P750, DOI 10.1093/nar/27.3.750; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; PUGH BF, 1991, GENE DEV, V5, P1935, DOI 10.1101/gad.5.11.1935; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; SADOVSKY Y, 1995, MOL CELL BIOL, V15, P1554; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; TAKADA S, UNPUB; Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283; YOKOMORI K, 1994, GENE DEV, V8, P2313, DOI 10.1101/gad.8.19.2313	23	87	89	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAY 5	2000	288	5467					867	870		10.1126/science.288.5467.867	http://dx.doi.org/10.1126/science.288.5467.867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	311DN	10797011				2022-12-24	WOS:000086869600041
J	Greene, WL; Concato, J; Feinstein, AR				Greene, WL; Concato, J; Feinstein, AR			Claims of equivalence in medical research: Are they supported by the evidence?	ANNALS OF INTERNAL MEDICINE			English	Article							SAMPLE-SIZE; GENERAL-PRACTICE; BRAND-NAME; THERAPY; TRIAL; BIOAVAILABILITY; BIOEQUIVALENCY; EXPERIENCE; EFFICACY; POTENCY	Background: Most clinical studies are done to show comparative superiority, but many reports now claim equivalence between the investigated entities. These assertions may not always be supported by the methods used and the results obtained. Purpose: To assess the justification and support for claims of clinical or therapeutic equivalence in medical journals. Data Sources: A search of MEDLINE for articles published from 1992 through 1996. Study Selection: From 1209 citations that contained the word equivalence in the title or abstract or contained the Medical Subject Heading therapeutic equivalency, we excluded 1121 studies reporting nonoriginal research, purely laboratory or other nonhuman research, and studies in which equivalence was not the main claim. The remaining 88 eligible papers were evaluated for five methodologic attributes. Data Synthesis: Only 45 (51%) of the 88 reports were specifically aimed at studying equivalence; the others either tried to show superiority or did not state a research aim. The quantitative distinctions regarded as "equivalent" ranged from 0% to 21% for direct increments and from 0% to 76% for proportionate differences. An equivalence boundary was set and confirmed with an appropriate statistical test in only 23% of reports. In 67% of reports, equivalence was declared after a failed test for comparative superiority, and in 10%, the claim of equivalence was not statistically evaluated. The sample size needed to confirm results had been calculated in advance for only 33% of reports. Sample size was 20 patients per group or fewer in 25% of reports. Conclusions: Many studies of clinical equivalence do not set boundaries for equivalence. Claims of "difference" or "similarity" are often made not by thoughtful examination of the data but by tests of statistical significance that are often misapplied or accompanied by inadequate sample sizes. These methodologic flaws can lead to false claims, inconsistencies, and harm to patients.	Yale Univ, Sch Med, New Haven, CT USA; Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Greene, WL (corresponding author), Genentech Inc, Med Affairs Dept, Mailstop 84,1 DNA Way, San Francisco, CA 94080 USA.	wgreene@gene.com						ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; [Anonymous], 1995, Lancet, V346, P329; Babul N, 1998, J CLIN PHARMACOL, V38, P74, DOI 10.1002/j.1552-4604.1998.tb04380.x; BARCKOW D, 1993, J ANTIMICROB CHEMOTH, V32, P187, DOI 10.1093/jac/32.suppl_B.187; BOISSEL JP, 1995, J HYPERTENS, V13, P1059, DOI 10.1097/00004872-199509000-00018; Cohen J., 1988, STAT POWER ANAL BEHA; DIMUNNO O, 1995, J RHEUMATOL, V22, P1492; Dong BJ, 1997, JAMA-J AM MED ASSOC, V277, P1205, DOI 10.1001/jama.277.15.1205; DUNNETT CW, 1977, BIOMETRICS, V33, P593, DOI 10.2307/2529457; EDGAR PP, 1992, MOL PHARMACOL, V41, P1124; Feinstein AR, 1998, J CLIN EPIDEMIOL, V51, P527; FEINSTEIN AR, 1975, CLIN PHARMACOL THER, V18, P491; FREIMAN JA, 1978, NEW ENGL J MED, V299, P690, DOI 10.1056/NEJM197809282991304; FULLER RW, 1995, RESP MED, V89, P525, DOI 10.1016/0954-6111(95)90152-3; GROOTHUIS JR, 1995, ANTIMICROB AGENTS CH, V39, P668, DOI 10.1128/AAC.39.3.668; Harenberg J, 1996, HAEMOSTASIS, V26, P127; Hatala R, 1996, ANN INTERN MED, V124, P717, DOI 10.7326/0003-4819-124-8-199604150-00003; Jones E, 1996, BMJ-BRIT MED J, V313, P36, DOI 10.1136/bmj.313.7048.36; JURGENS RW, 1992, AM J OBSTET GYNECOL, V167, P459, DOI 10.1016/S0002-9378(11)91429-X; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; KRAGHSORENSEN P, 1995, J CLIN PSYCHOPHARM, V15, pS24, DOI 10.1097/00004714-199508001-00005; KRON IL, 1992, ANN THORAC SURG, V54, P617, DOI 10.1016/0003-4975(92)91003-R; LECOUTRE B, 1995, STAT MED, V14, P1057, DOI 10.1002/sim.4780140924; Lefebvre JL, 1996, J NATL CANCER I, V88, P890, DOI 10.1093/jnci/88.13.890; MAKUCH R, 1978, CANCER TREAT REP, V62, P1037; MASON KA, 1994, INT J RADIAT ONCOL, V28, P667, DOI 10.1016/0360-3016(94)90192-9; *NAT LIB MED, 1997, ABR IND MED, V28; OBERLIN O, 1992, J CLIN ONCOL, V10, P1602, DOI 10.1200/JCO.1992.10.10.1602; OLES KS, 1992, NEUROLOGY, V42, P1147, DOI 10.1212/WNL.42.6.1147; OQUIGLEY J, 1988, STATISTICIAN, V37, P51, DOI 10.2307/2348378; PALAZZINI E, 1992, INT J CLIN PHARM RES, V12, P179; RAMMELOO RHU, 1992, RESPIRATION, V59, P322; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; SPRIET A, 1979, BRIT J CLIN PHARMACO, V7, P623, DOI 10.1111/j.1365-2125.1979.tb04653.x; STOCK AJ, 1994, AM J HOSP PHARM, V51, P2279, DOI 10.1093/ajhp/51.18.2279; TAGGART SCO, 1995, BRIT MED J, V310, P1639, DOI 10.1136/bmj.310.6995.1639a; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; VandeWerf F, 1997, NEW ENGL J MED, V337, P1124; Verster GC, 1998, S AFR MED J, V88, P260; Ware JH, 1997, NEW ENGL J MED, V337, P1159, DOI 10.1056/NEJM199710163371610; 1999, N ENGL J MED, V354, P716	41	123	125	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 2	2000	132	9					715	722		10.7326/0003-4819-132-9-200005020-00006	http://dx.doi.org/10.7326/0003-4819-132-9-200005020-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	308VT	10787365				2022-12-24	WOS:000086734100005
J	Nicholl, J				Nicholl, J			The ethics of research ethics committees	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Sheffield, Med Care Res Unit, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Nicholl, J (corresponding author), Univ Sheffield, Med Care Res Unit, Sheffield S10 2TN, S Yorkshire, England.		Nicholl, Jon/B-8257-2008						0	24	24	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 29	2000	320	7243					1217	1217		10.1136/bmj.320.7243.1217	http://dx.doi.org/10.1136/bmj.320.7243.1217			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310MW	10784570	Green Published			2022-12-24	WOS:000086832800051
J	Lanza, RP; Cibelli, JB; Blackwell, C; Cristofalo, VJ; Francis, MK; Baerlocher, GM; Mak, J; Schertzer, M; Chavez, EA; Sawyer, N; Lansdorp, PM; West, MD				Lanza, RP; Cibelli, JB; Blackwell, C; Cristofalo, VJ; Francis, MK; Baerlocher, GM; Mak, J; Schertzer, M; Chavez, EA; Sawyer, N; Lansdorp, PM; West, MD			Extension of cell life-span and telomere length in animals cloned from senescent somatic cells	SCIENCE			English	Article							HUMAN DIPLOID CELLS; HUMAN FIBROBLASTS; REPLICATIVE SENESCENCE; G(0) STATE; CULTURE; ARREST; FETAL; ADULT	The potential of cloning depends in part on whether the procedure can reverse cellular aging and restore somatic cells to a phenotypically youthful state. Here, we report the birth of six healthy cloned calves derived from populations of senescent donor somatic cells. Nuclear transfer extended the replicative lifespan of senescent cells (zero to four population doublings remaining) to greater than 90 population doublings. Early population doubling level complementary DNA-1 (EPC-1, an age-dependent gene) expression in cells from the cloned animals was 3.5- to 5-fold higher than that in cells from age-matched (5 to 10 months old) controls. Southern blot and flow cytometric analyses indicated that the telomeres were also extended beyond those of newborn (<2 weeks old) and age-matched control animals. The ability to regenerate animals and cells may have important implications for medicine and the study of mammalian aging.	Adv Cell Technol, Worcester, MA 01605 USA; Lankenau Inst Med Res, Wynnewood, PA 19096 USA; Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19104 USA; British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; Univ British Columbia, Dept Med, Vancouver, BC V6T 2B5, Canada	Lankenau Medical Center; Lankenau Institute for Medical Research; Jefferson University; British Columbia Cancer Agency; University of British Columbia	Lanza, RP (corresponding author), Adv Cell Technol, 1 Innovat Dr, Worcester, MA 01605 USA.	rlanza@advancedcell.com		West, Michael/0000-0002-4842-5468; Lansdorp, Peter/0000-0001-7435-1071; Cibelli, Jose/0000-0002-2176-3854	NIAID NIH HHS [AI29524] Funding Source: Medline; NIA NIH HHS [AG00378] Funding Source: Medline; NIGMS NIH HHS [GM56162] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI029524, R01AI029524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056162] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Baguisi A, 1999, NAT BIOTECHNOL, V17, P456, DOI 10.1038/8632; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Cibelli JB, 1998, SCIENCE, V280, P1256, DOI 10.1126/science.280.5367.1256; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; CRISTOFALO VJ, 1973, EXP CELL RES, V76, P419, DOI 10.1016/0014-4827(73)90394-7; Cristofalo VJ, 1996, EXP GERONTOL, V31, P111, DOI 10.1016/0531-5565(95)02018-7; CRISTOFALO VJ, 1992, ANN NY ACAD SCI, V663, P187, DOI 10.1111/j.1749-6632.1992.tb38662.x; de Lange T, 1999, SCIENCE, V283, P947, DOI 10.1126/science.283.5404.947; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Galli C, 1999, Cloning, V1, P161, DOI 10.1089/15204559950019924; GORMAN SD, 1986, EXP CELL RES, V167, P87, DOI 10.1016/0014-4827(86)90206-5; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Hill JR, 1999, THERIOGENOLOGY, V51, P1451, DOI 10.1016/S0093-691X(99)00089-8; Kato Y, 1998, SCIENCE, V282, P2095, DOI 10.1126/science.282.5396.2095; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Kubota C, 2000, P NATL ACAD SCI USA, V97, P990, DOI 10.1073/pnas.97.3.990; Lanza RP, 1999, NAT BIOTECHNOL, V17, P1171, DOI 10.1038/70709; Lanza RP, 1999, NAT MED, V5, P975, DOI 10.1038/12404; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; LIPETZ J, 1972, J ULTRA MOL STRUCT R, V39, P43, DOI 10.1016/S0022-5320(72)80005-4; Meng L, 1997, BIOL REPROD, V57, P454, DOI 10.1095/biolreprod57.2.454; PHINNEY DG, 1994, ONCOGENE, V9, P2353; Pignolo RJ, 1998, EXP GERONTOL, V33, P67, DOI 10.1016/S0531-5565(97)00090-9; PIGNOLO RJ, 1993, J BIOL CHEM, V268, P8949; Renard JP, 1999, LANCET, V353, P1489, DOI 10.1016/S0140-6736(98)12173-6; Rufer N, 1998, NAT BIOTECHNOL, V16, P743, DOI 10.1038/nbt0898-743; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Smogorzewska A, 2000, MOL CELL BIOL, V20, P1659, DOI 10.1128/MCB.20.5.1659-1668.2000; Vaziri H, 1997, EMBO J, V16, P6018, DOI 10.1093/emboj/16.19.6018; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; WEST MD, 1994, ARCH DERMATOL, V130, P87, DOI 10.1001/archderm.130.1.87; West MD, 1996, EXP GERONTOL, V31, P175, DOI 10.1016/0531-5565(95)02013-6; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	41	325	374	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2000	288	5466					665	669		10.1126/science.288.5466.665	http://dx.doi.org/10.1126/science.288.5466.665			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308RR	10784448				2022-12-24	WOS:000086727100042
J	Zars, T; Fischer, M; Schulz, R; Heisenberg, M				Zars, T; Fischer, M; Schulz, R; Heisenberg, M			Localization of a short-term memory in Drosophila	SCIENCE			English	Article							I ADENYLYL-CYCLASE; MUSHROOM BODIES; SYNAPTIC PLASTICITY; BEHAVIORAL SENSITIZATION; PREFERENTIAL EXPRESSION; NERVOUS-SYSTEM; SPATIAL MEMORY; MUTANT MICE; CYCLIC-AMP; MELANOGASTER	Memories are thought to be due to lasting synaptic modifications in the brain. The search for memory traces has relied predominantly on determining regions that are necessary for the process. However, a more informative approach is to define the smallest sufficient set of brain structures. The rutabaga adenylyl cyclase, an enzyme that is ubiquitously expressed in the Drosophila brain and that mediates synaptic plasticity, is needed exclusively in the Kenyon cells of the mushroom bodies for a component of olfactory short-term memory. This demonstrates that synaptic plasticity in a small brain region can be sufficient for memory formation.	Theodor Boveri Inst Biowissensch, Lehrstuhl Genet, Biozentrum, D-97074 Wurzburg, Germany; Univ Texas, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Wurzburg; University of Texas System; UTMD Anderson Cancer Center	Zars, T (corresponding author), Theodor Boveri Inst Biowissensch, Lehrstuhl Genet, Biozentrum, D-97074 Wurzburg, Germany.	zars@biozentrum.uni-wuerzburg.de		Zars, Troy/0000-0003-4114-9322				ACEVESPINA EO, 1983, COLD SPRING HARB SYM, V48, P831, DOI 10.1101/SQB.1983.048.01.086; Armstrong JD, 1998, LEARN MEMORY, V5, P102; BALLING A, 1987, J NEUROGENET, V4, P65, DOI 10.3109/01677068709102334; BRAND AH, 1993, DEVELOPMENT, V118, P401; BRUNELLI M, 1976, SCIENCE, V194, P1178, DOI 10.1126/science.186870; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104; Crittenden JR, 1998, LEARN MEMORY, V5, P38; DEBELLE JS, 1994, SCIENCE, V263, P692, DOI 10.1126/science.8303280; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Faber T, 1999, NAT NEUROSCI, V2, P74, DOI 10.1038/4576; FOLKERS E, 1982, J INSECT PHYSIOL, V28, P535, DOI 10.1016/0022-1910(82)90034-8; GAILEY DA, 1984, GENETICS, V106, P613; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; Hammer M, 1998, LEARN MEMORY, V5, P146; Han KA, 1998, J NEUROSCI, V18, P3650; Han KA, 1996, NEURON, V16, P1127, DOI 10.1016/S0896-6273(00)80139-7; HAN PL, 1992, NEURON, V9, P619, DOI 10.1016/0896-6273(92)90026-A; HANSE E, 1992, EUR J NEUROSCI, V4, P1191, DOI 10.1111/j.1460-9568.1992.tb00144.x; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Ito K, 1998, LEARN MEMORY, V5, P52; Ito K, 1997, CELL TISSUE RES, V290, P1, DOI 10.1007/s004410050901; Joiner MLA, 1999, LEARN MEMORY, V6, P177; KLEIN M, 1980, P NATL ACAD SCI-BIOL, V77, P6912, DOI 10.1073/pnas.77.11.6912; Lashley KS., 1929, BRAIN MECH INTELLIGE; Lechner HA, 1998, NEURON, V20, P355, DOI 10.1016/S0896-6273(00)80977-0; Lee T, 1999, DEVELOPMENT, V126, P4065; Liu L, 1999, NATURE, V400, P753, DOI 10.1038/23456; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Martin JR, 1998, LEARN MEMORY, V5, P179; MCCORMICK DA, 1984, SCIENCE, V223, P296, DOI 10.1126/science.6701513; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; ODELL KMC, 1995, NEURON, V15, P55, DOI 10.1016/0896-6273(95)90064-0; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; SCHACHER S, 1993, NEURON, V10, P1079, DOI 10.1016/0896-6273(93)90056-W; Schulz RA, 1996, ONCOGENE, V12, P1827; Strausfeld NJ., 1976, ATLAS INSECT BRAIN, DOI 10.1007/978-3-642-66179-2; TECHNAU G, 1982, NATURE, V295, P405, DOI 10.1038/295405a0; Tettamanti M, 1997, DEV GENES EVOL, V207, P242, DOI 10.1007/s004270050112; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Villacres EC, 1998, J NEUROSCI, V18, P3186; WAYMAN GA, 1994, J BIOL CHEM, V269, P25400; Wolf R, 1998, LEARN MEMORY, V5, P166; WU ZL, 1995, P NATL ACAD SCI USA, V92, P220, DOI 10.1073/pnas.92.1.220; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Wustmann G, 1997, LEARN MEMORY, V4, P328, DOI 10.1101/lm.4.4.328; YANG MY, 1995, NEURON, V15, P45; YAO KM, 1994, J NEUROCHEM, V63, P41; Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18; ZARS T, UNPUB; ZHONG Y, 1991, SCIENCE, V251, P198, DOI 10.1126/science.1670967	55	412	416	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 28	2000	288	5466					672	675		10.1126/science.288.5466.672	http://dx.doi.org/10.1126/science.288.5466.672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308RR	10784450				2022-12-24	WOS:000086727100044
J	Nieto, FJ; Young, TB; Lind, BK; Shahar, E; Samet, JM; Redline, S; D'Agostino, RB; Newman, AB; Lebowitz, MD; Pickering, TG				Nieto, FJ; Young, TB; Lind, BK; Shahar, E; Samet, JM; Redline, S; D'Agostino, RB; Newman, AB; Lebowitz, MD; Pickering, TG		Sleep Heart Hlth Study	Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE AIRWAY PRESSURE; BLOOD-PRESSURE; SYSTEMIC HYPERTENSION; RISK-FACTORS; RELATIVE RISK; PREVALENCE; POPULATION; MORTALITY; HEALTH; MEN	Context Sleep-disordered breathing (SDB) and sleep apnea have been linked to hypertension in previous studies, but most of these studies used surrogate information to define SDB (eg, snoring) and were based on small clinic populations, or both. Objective To assess the association between SDB and hypertension in a large cohort of middle-aged and older persons. Design and Setting Cross-sectional analyses of participants in the Sleep Heart Health Study, a community-based multicenter study conducted between November 1995 and January 1998. Participants A total of 6132 subjects recruited from ongoing population-based studies (aged greater than or equal to 40 years; 52.8% female). Main Outcome Measures Apnea-hypopnea index (AHI, the average number of apneas plus hypopneas per hour of sleep, with hypopnea defined as a greater than or equal to 30% reduction in airflow or thoracoabdominal excursion accompanied by a greater than or equal to 4% drop in oxyhemoglobin saturation), obtained by unattended home polysomnography. Other measures include arousal index; percentage of sleep time below 90% oxygen saturation; history of snoring; and presence of hypertension, defined as resting blood pressure of at least 140/90 mm Hg or use of antihypertensive medication. Results Mean systolic and diastolic blood pressure and prevalence of hypertension increased significantly with increasing SDB measures, although some of this association was explained by body mass index (BMI). After adjusting for demographics and anthropometric variables (including BMI, neck circumference, and waist-to-hip ratio), as well as for alcohol intake and smoking, the odds ratio for hypertension, comparing the highest category of AHI (greater than or equal to 30 per hour) with the lowest category (<1.5 per hour), was 1.37 (95% confidence interval [CI], 1.03-1.83; P for trend=.005). The corresponding estimate comparing the highest and lowest categories of percentage of sleep time below 90% oxygen saturation (greater than or equal to 12% vs <0.05%) was 1.46 (95% CI, 1.12-1.88; P for trend <.001). In stratified analyses, associations of hypertension with either measure of SDB were seen in both sexes, older and younger ages, all ethnic groups, and among normal-weight and overweight individuals. Weaker and nonsignificant associations were observed for the arousal index or self-reported history of habitual snoring. Conclusion Our findings from the largest cross-sectional study to date indicate that SDB is associated with systemic hypertension in middle-aged and older individuals of different sexes and ethnic backgrounds.	Johns Hopkins Univ, Johns Hopkins Sch Hyg & Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Univ Wisconsin, Madison, WI USA; Univ Minnesota, Minneapolis, MN USA; Univ Hosp Cleveland, Rainbow Babies & Childrens Hosp, Div Clin Epidemiol, Cleveland, OH 44106 USA; Boston Univ, Dept Math, Boston, MA 02215 USA; Univ Pittsburgh, Sch Med, Div Geriatr Med, Pittsburgh, PA USA; Univ Arizona, Coll Med, Resp Sci Ctr, Tucson, AZ USA; Cornell Univ, New York Cornell Med Ctr, Ctr Cardiovasc, New York, NY USA	Johns Hopkins University; University of Wisconsin System; University of Wisconsin Madison; University of Minnesota System; University of Minnesota Twin Cities; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Boston University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Arizona; Cornell University	Nieto, FJ (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Hyg & Publ Hlth, Dept Epidemiol, 615 N Wolfe St,Room W6009, Baltimore, MD 21205 USA.		Newman, Anne B./C-6408-2013	Newman, Anne B./0000-0002-0106-1150	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL053940, U01HL053938, U01HL053931] Funding Source: NIH RePORTER; NHLBI NIH HHS [U01HL53940, U01HL53931, U01HL53938] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ASKENASY JJM, 1995, ISRAEL J MED SCI, V31, P561; Bartel PR, 1995, AM J HYPERTENS, V8, P1200, DOI 10.1016/0895-7061(95)00387-8; BLIWISE DL, 1988, AM J PUBLIC HEALTH, V78, P544, DOI 10.2105/AJPH.78.5.544; BONNET MH, 1992, SLEEP, V15, P526; BONSIGNORE MR, 1994, EUR RESPIR J, V7, P786, DOI 10.1183/09031936.94.07040786; CARLSON JT, 1994, AM J RESP CRIT CARE, V150, P72, DOI 10.1164/ajrccm.150.1.8025776; Donato KA, 1998, ARCH INTERN MED, V158, P1855, DOI 10.1001/archinte.158.17.1855; FLETCHER EC, 1985, ANN INTERN MED, V103, P190, DOI 10.7326/0003-4819-103-2-190; FREEMAN J, 1980, AM J EPIDEMIOL, V112, P707, DOI 10.1093/oxfordjournals.aje.a113043; GISLASON T, 1987, ACTA MED SCAND, V222, P415; GISLASON T, 1993, CHEST, V103, P1147, DOI 10.1378/chest.103.4.1147; GRUNSTEIN R, 1993, INT J OBESITY, V17, P533; Hastie TJ., 1990, GEN ADDITIVE MODELS; HE J, 1988, CHEST, V94, P9, DOI 10.1378/chest.94.1.9; HLA KM, 1994, ANN INTERN MED, V120, P382, DOI 10.7326/0003-4819-120-5-199403010-00005; HOFFSTEIN V, 1991, AM J MED, V91, P190, DOI 10.1016/0002-9343(91)90014-O; Hu FB, 1999, AM J EPIDEMIOL, V150, P806; JENNUM P, 1993, INT J EPIDEMIOL, V22, P439, DOI 10.1093/ije/22.3.439; KALES A, 1984, LANCET, V2, P1005; LAVIE P, 1993, CHEST, V103, P717, DOI 10.1378/chest.103.3.717; LAVIE P, 1984, ARCH INTERN MED, V144, P2025, DOI 10.1001/archinte.144.10.2025; LEVINSON PD, 1991, ARCH INTERN MED, V151, P455, DOI 10.1001/archinte.151.3.455; Lindberg E, 1998, EUR RESPIR J, V11, P884, DOI 10.1183/09031936.98.11040884; Martorell R., 1988, ANTHROPOMETRIC STAND, P41; *MATHS INC, 1993, S PLUS 2000 GUID STA, V1; MILLMAN RP, 1991, CHEST, V99, P861, DOI 10.1378/chest.99.4.861; *NAT HIGH BLOOD PR, 1993, NAT I HLTH PUBL; NORTON PG, 1985, BRIT MED J, V291, P630, DOI 10.1136/bmj.291.6496.630; PARTINEN M, 1988, CHEST, V94, P1200, DOI 10.1378/chest.94.6.1200; Pickering T, 1996, AM J HYPERTENS, V9, P1, DOI 10.1016/0895-7061(95)00341-X; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; Quan SF, 1997, SLEEP, V20, P1077; Redline S, 1997, SLEEP, V20, P1209, DOI 10.1093/sleep/20.12.1209; Redline S, 1998, SLEEP, V21, P759; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SCHMIDTNOWARA WW, 1990, ARCH INTERN MED, V150, P597, DOI 10.1001/archinte.150.3.597; *SHHS RES GROP, 1996, SLEEP HEART HLTH STU; SILVERBERG DS, 1995, ISRAEL J MED SCI, V31, P527; Stradling J, 1997, SLEEP, V20, P789, DOI 10.1093/sleep/20.9.789a; STRADLING JR, 1990, BRIT MED J, V300, P75, DOI 10.1136/bmj.300.6717.75; STRADLING JR, 1991, THORAX, V46, P85, DOI 10.1136/thx.46.2.85; SUZUKI M, 1993, SLEEP, V16, P545, DOI 10.1093/sleep/16.6.545; Szklo M, 2014, EPIDEMIOLOGY BASICS; WALLER PC, 1989, LANCET, V1, P143; Whitney CW, 1998, SLEEP, V21, P749, DOI 10.1093/sleep/21.7.749; WIGGINS CL, 1990, SLEEP, V13, P245, DOI 10.1093/sleep/13.3.245; WILCOX I, 1993, SLEEP, V16, P539, DOI 10.1093/sleep/16.6.539; WILLIAMS AJ, 1985, AM J CARDIOL, V55, P1019, DOI 10.1016/0002-9149(85)90738-6; Worsnop CJ, 1998, AM J RESP CRIT CARE, V157, P111, DOI 10.1164/ajrccm.157.1.9609063; Wright J, 1997, BRIT MED J, V314, P851; Young T, 1997, ARCH INTERN MED, V157, P1746, DOI 10.1001/archinte.157.15.1746; Young T, 1996, SLEEP, V19, pS202, DOI 10.1093/sleep/19.suppl_10.S202; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhao LP, 1996, AM J EPIDEMIOL, V144, P598	54	2247	2371	2	107	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 12	2000	283	14					1829	1836		10.1001/jama.283.14.1829	http://dx.doi.org/10.1001/jama.283.14.1829			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	300HY	10770144	Bronze			2022-12-24	WOS:000086248600028
J	Landray, MJ; Lehman, R; Arnold, I				Landray, MJ; Lehman, R; Arnold, I			Measuring brain natriuretic peptide in suspected left ventricular systolic dysfunction in general practice: cross-sectional study	BRITISH MEDICAL JOURNAL			English	Article									Hightown Surg, Banbury OX18 9DB, Oxon, England; Univ Birmingham, Div Med Sci, Birmingham B15 2TH, W Midlands, England; Oxford Radcliffe Hosp NHS Trust, Horton Hosp, Dept Med, Banbury OX16 9AL, Oxon, England	University of Birmingham; Oxford University Hospitals NHS Foundation Trust	Lehman, R (corresponding author), Hightown Surg, Banbury OX18 9DB, Oxon, England.			Landray, Martin/0000-0001-6646-827X				Hoes A. W., 1998, European Heart Journal, V19, pL2; McDonagh TA, 1998, LANCET, V351, P9, DOI 10.1016/S0140-6736(97)03034-1; Struthers AD, 1999, EUR HEART J, V20, P712; WHEELDON NM, 1993, Q J MED, V86, P17	4	63	64	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 8	2000	320	7240					985	986		10.1136/bmj.320.7240.985	http://dx.doi.org/10.1136/bmj.320.7240.985			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	303XP	10753153	Bronze, Green Submitted, Green Published			2022-12-24	WOS:000086453100028
J	Gavaghan, H				Gavaghan, H			Companies of all sizes are prospecting for proteins	NATURE			English	Editorial Material																		Abbott A, 1999, NATURE, V402, P715, DOI 10.1038/45350; Blackstock WP, 1999, TRENDS BIOTECHNOL, V17, P121, DOI 10.1016/S0167-7799(98)01245-1; Brent R, 2000, CELL, V100, P169, DOI 10.1016/S0092-8674(00)81693-1; Kell DB, 2000, TRENDS BIOTECHNOL, V18, P93, DOI 10.1016/S0167-7799(99)01407-9; 2000, NATURE, V403, P815; 1999, NATURE, V402, P715	6	3	3	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 6	2000	404	6778					684	+		10.1038/35007267	http://dx.doi.org/10.1038/35007267			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766256				2022-12-24	WOS:000086400100069
J	Bath, PHW; Lees, KR				Bath, PHW; Lees, KR			ABC of arterial and venous disease - Acute stroke	BMJ-BRITISH MEDICAL JOURNAL			English	Review									Univ Nottingham, Nottingham NG7 2RD, England; Univ Glasgow, Western Infirm, Dept Med & Therapeut, Glasgow G11 6NT, Lanark, Scotland	University of Nottingham; University of Glasgow	Bath, PHW (corresponding author), Univ Nottingham, Nottingham NG7 2RD, England.							Asplund K, 1997, BMJ-BRIT MED J, V314, P1151; Bath PMW, 1997, INT J CLIN PRACT, V51, P504; LEES KR, 1998, LANCET S3, V352, P28; *ROYAL COLL PHYS, 1994, STROK AUD PACK	4	34	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	APR 1	2000	320	7239					920	923		10.1136/bmj.320.7239.920	http://dx.doi.org/10.1136/bmj.320.7239.920			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	301YA	10742005	Green Published			2022-12-24	WOS:000086337100032
J	McGlynn, P; Lloyd, RG				McGlynn, P; Lloyd, RG			Modulation of RNA polymerase by (p)ppGpp reveals a RecG-dependent mechanism for replication fork progression	CELL			English	Article							ESCHERICHIA-COLI K-12; HOLLIDAY JUNCTION RESOLVASE; DOUBLE-STRAND BREAKS; MEIOTIC RECOMBINATION; DNA-REPLICATION; HOMOLOGOUS RECOMBINATION; PROTEIN PRIA; TRANSCRIPTION; MUTANTS; REPAIR	We have discovered a correlation between the ability of Escherichia coli cells to survive damage to DNA and their ability to modulate RNA polymerase via the stringent response regulators, (p)ppGpp. Elevation of (p)ppGpp, or certain mutations in the beta subunit of RNA polymerase, dramatically improve survival of UV-irradiated strains lacking the RuvABC Holliday junction resolvase. Increased survival depends on excision and recombination proteins and relies on the ability of RecG helicase to form Holliday junctions from replication forks stalled at lesions in the DNA and of PriA to initiate replication restart. The role of RecG provides novel insights into the interplay between transcription, replication, and recombination, and suggests a general model in which recombination underpins genome duplication in the face of frequent obstacles to replication fork progression.	Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England	University of Nottingham	Lloyd, RG (corresponding author), Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2UH, England.			McGlynn, Peter/0000-0001-8629-4713				AlDeib AA, 1996, J BACTERIOL, V178, P6782, DOI 10.1128/jb.178.23.6782-6789.1996; Anderson DG, 1997, CELL, V90, P77, DOI 10.1016/S0092-8674(00)80315-3; BACHMANN BJ, 1996, ESCHERICHIA COLI SAL, P2460; Bartlett MS, 1998, J MOL BIOL, V279, P331, DOI 10.1006/jmbi.1998.1779; Baudat F, 1997, P NATL ACAD SCI USA, V94, P5213, DOI 10.1073/pnas.94.10.5213; Bolt EL, 1999, J MOL BIOL, V286, P403, DOI 10.1006/jmbi.1998.2499; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chakraverty RK, 1999, BIOESSAYS, V21, P286; Chan SN, 1998, NUCLEIC ACIDS RES, V26, P1560, DOI 10.1093/nar/26.7.1560; Chatterji D, 1998, GENES CELLS, V3, P279, DOI 10.1046/j.1365-2443.1998.00190.x; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; DUNDERDALE HJ, 1994, J BIOL CHEM, V269, P5187; Gentry DR, 1996, MOL MICROBIOL, V19, P1373, DOI 10.1111/j.1365-2958.1996.tb02480.x; Gerber JK, 1997, CELL, V90, P559, DOI 10.1016/S0092-8674(00)80515-2; Johnson RE, 1999, P NATL ACAD SCI USA, V96, P12224, DOI 10.1073/pnas.96.22.12224; Jones JM, 1999, J MOL BIOL, V289, P503, DOI 10.1006/jmbi.1999.2783; Kogoma T, 1997, MICROBIOL MOL BIOL R, V61, P212, DOI 10.1128/.61.2.212-238.1997; KOWALCZYKOWSKI SC, 1994, MICROBIOL REV, V58, P401, DOI 10.1128/MMBR.58.3.401-465.1994; Krasilnikova MM, 1998, EMBO J, V17, P5095, DOI 10.1093/emboj/17.17.5095; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LAFFLER T, 1974, CELL, V1, P27, DOI 10.1016/0092-8674(74)90151-2; Lindahl T, 1996, PHILOS T ROY SOC B, V351, P1529, DOI 10.1098/rstb.1996.0139; LLOYD RG, 1991, J BACTERIOL, V173, P5414, DOI 10.1128/jb.173.17.5414-5418.1991; Mahdi AA, 1996, J MOL BIOL, V257, P561, DOI 10.1006/jmbi.1996.0185; MANDAL TN, 1993, J BACTERIOL, V175, P4325, DOI 10.1128/JB.175.14.4325-4334.1993; McGlynn P, 1997, J MOL BIOL, V270, P212, DOI 10.1006/jmbi.1997.1120; McGlynn P, 1999, NUCLEIC ACIDS RES, V27, P3049, DOI 10.1093/nar/27.15.3049; Nicolas A, 1998, P NATL ACAD SCI USA, V95, P87, DOI 10.1073/pnas.95.1.87; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Prado F, 1997, EMBO J, V16, P2826, DOI 10.1093/emboj/16.10.2826; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Sandler SJ, 1996, GENETICS, V143, P5; Schwacha A, 1997, CELL, V90, P1123, DOI 10.1016/S0092-8674(00)80378-5; Seigneur M, 1998, CELL, V95, P419, DOI 10.1016/S0092-8674(00)81772-9; SELBY CP, 1994, MICROBIOL REV, V58, P317, DOI 10.1128/MMBR.58.3.317-329.1994; TSANEVA IR, 1992, MOL GEN GENET, V235, P1, DOI 10.1007/BF00286175; WEST SC, 1981, NATURE, V294, P659, DOI 10.1038/294659a0; West SC, 1997, ANNU REV GENET, V31, P213, DOI 10.1146/annurev.genet.31.1.213; XIAO H, 1991, J BIOL CHEM, V266, P5980; Xu F, 1996, GENETICS, V143, P1115; XU LH, 1995, EMBO J, V14, P5115, DOI 10.1002/j.1460-2075.1995.tb00194.x; ZAVITZ KH, 1992, J BIOL CHEM, V267, P6933; Zerbib D, 1998, J MOL BIOL, V281, P621, DOI 10.1006/jmbi.1998.1959; Zerbib D, 1997, J MOL BIOL, V270, P663, DOI 10.1006/jmbi.1997.1157; Zhang GY, 1999, CELL, V98, P811, DOI 10.1016/S0092-8674(00)81515-9; Zhou YN, 1998, P NATL ACAD SCI USA, V95, P2908, DOI 10.1073/pnas.95.6.2908; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	48	232	235	1	8	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	0092-8674			CELL	Cell	MAR 31	2000	101	1					35	45		10.1016/S0092-8674(00)80621-2	http://dx.doi.org/10.1016/S0092-8674(00)80621-2			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	300JM	10778854	Bronze			2022-12-24	WOS:000086249900006
J	Williams, TJ; Pepitone, ME; Christensen, SE; Cooke, BM; Huberman, AD; Breedlove, NJ; Breedlove, TJ; Jordan, CL; Breedlove, SM				Williams, TJ; Pepitone, ME; Christensen, SE; Cooke, BM; Huberman, AD; Breedlove, NJ; Breedlove, TJ; Jordan, CL; Breedlove, SM			Finger-length ratios and sexual orientation	NATURE			English	Article									Univ Calif Berkeley, Dept Psychol, Berkeley, CA 94720 USA; Univ Calif Berkeley, Grad Grp Neurosci Endocrinol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Williams, TJ (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall,MC 1650, Berkeley, CA 94720 USA.		; Cooke, Bradley/E-4568-2013	Breedlove, S. Marc/0000-0003-4359-4315; Cooke, Bradley/0000-0003-0989-9684				BAILEY JM, 1991, ARCH GEN PSYCHIAT, V48, P1089; Blanchard R, 1997, Annu Rev Sex Res, V8, P27; Bogaert AF, 1999, ARCH SEX BEHAV, V28, P213, DOI 10.1023/A:1018780108597; Bogaert AF, 1997, BEHAV NEUROSCI, V111, P1395, DOI 10.1037/0735-7044.111.6.1395; Breedlove SM, 1999, BRAIN BEHAV EVOLUT, V54, P8, DOI 10.1159/000006607; BRODIE HK, 1974, AM J PSYCHIAT, V131, P82, DOI 10.1176/ajp.131.1.82; GORMAN MR, 1994, PERSPECT BIOL MED, V38, P61; HAMER DH, 1993, SCIENCE, V261, P321, DOI 10.1126/science.8332896; JAMES WH, 1987, HUM BIOL, V59, P721; Manning JT, 1999, NATURE, V399, P214, DOI 10.1038/20341; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; MAYERBAHLBURG HFL, 1984, PROGR BRAIN RES, V61, P375; McFadden D, 1998, P NATL ACAD SCI USA, V95, P2709, DOI 10.1073/pnas.95.5.2709; MCFADDEN D, IN PRESS J ASS RES O	14	314	336	6	84	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					455	456		10.1038/35006555	http://dx.doi.org/10.1038/35006555			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761903				2022-12-24	WOS:000086257700034
J	Yasutomo, K; Doyle, C; Miele, L; Germain, RN				Yasutomo, K; Doyle, C; Miele, L; Germain, RN			The duration of antigen receptor signalling determines CD4(+) versus CD8(+) T-cell lineage fate	NATURE			English	Article							CLASS-II INTERACTION; TRANSGENIC MICE; TYROSINE KINASE; THYMOCYTES; COMMITMENT; DIFFERENTIATION; SPECIFICITY; EXPRESSION; ACTIVATION; MECHANISM	Signals elicited by binding of the T-cell antigen receptor and the CD4/CD8 co-receptor to major histocompatibility complex (MHC) molecules control the generation of CD4(+) (helper) or CD8(+) (cytotoxic) T cells from thymic precursors that initially express both co-receptor proteins'. These precursors have unique, clonally distributed T-cell receptors with unpredictable specificity for the self-MHC molecules involved in this differentiation process', However, the mature T cells that emerge express only the CD4 (MHC class II-binding) or CD8 (MHC class I-binding) co-receptor that complements the MHC class-specificity of the T-cell receptor. How this matching of co-receptor-defined lineage and T-cell-receptor specificity is achieved remains unknown(1,3,4), as does whether signalling by the T-cell receptors, co-receptors and/ or general cell-fate regulators such as Notch-1 (refs 5, 6) contributes to initial lineage choice, to subsequent differentiation processes or to both. Here we show that the CD4 versus CD8 lineage fate of immature thymocytes is controlled by the co-receptor-influenced duration of initial T-cell receptor-dependent signalling. Notch-1 does not appear to be essential for this fate determination, but it is selectively required for CD8(+) T-cell maturation after commitment directed by T-cell receptors, This indicates that the signals constraining CD4 versus CD8 lineage decisions are distinct from those that support subsequent differentiation events such as silencing of co-receptor loci.	NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Canc Immunol Program, Maywood, IL 60153 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Duke University; Loyola University Chicago	Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Immunol Lab, NIH, Bethesda, MD 20892 USA.		Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020	Yasutomo, Koji/0000-0003-0411-2037; Miele, Lucio/0000-0002-5853-7287	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000757] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Basson MA, 1998, J EXP MED, V187, P1249; Beatus P, 1999, DEVELOPMENT, V126, P3925; Bommhardt U, 1999, J IMMUNOL, V163, P715; CHAN TYK, 1995, PHARMACOEPIDEM DR S, V4, P165; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deftos ML, 1998, IMMUNITY, V9, P777, DOI 10.1016/S1074-7613(00)80643-3; Felli MP, 1999, INT IMMUNOL, V11, P1017, DOI 10.1093/intimm/11.7.1017; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; HOGQUIST KA, 1995, IMMUNITY, V3, P79, DOI 10.1016/1074-7613(95)90160-4; INABA M, 1991, J EXP MED, V173, P549, DOI 10.1084/jem.173.3.549; Iwata M, 1996, EUR J IMMUNOL, V26, P2081, DOI 10.1002/eji.1830260918; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KONIG R, 1992, NATURE, V356, P796, DOI 10.1038/356796a0; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Riberdy JM, 1998, P NATL ACAD SCI USA, V95, P4493, DOI 10.1073/pnas.95.8.4493; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; Sharp LL, 1997, IMMUNITY, V7, P609, DOI 10.1016/S1074-7613(00)80382-9; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VEILLETTE A, 1989, J EXP MED, V170, P1671, DOI 10.1084/jem.170.5.1671; vonBoehmer H, 1996, J EXP MED, V183, P713, DOI 10.1084/jem.183.3.713; WIEST DL, 1993, J EXP MED, V178, P1701, DOI 10.1084/jem.178.5.1701	30	198	206	0	4	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					506	510		10.1038/35006664	http://dx.doi.org/10.1038/35006664			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761920				2022-12-24	WOS:000086257700051
J	Adams, MD; Celniker, SE; Holt, RA; Evans, CA; Gocayne, JD; Amanatides, PG; Scherer, SE; Li, PW; Hoskins, RA; Galle, RF; George, RA; Lewis, SE; Richards, S; Ashburner, M; Henderson, SN; Sutton, GG; Wortman, JR; Yandell, MD; Zhang, Q; Chen, LX; Brandon, RC; Rogers, YHC; Blazej, RG; Champe, M; Pfeiffer, BD; Wan, KH; Doyle, C; Baxter, EG; Helt, G; Nelson, CR; Miklos, GLG; Abril, JF; Agbayani, A; An, HJ; Andrews-Pfannkoch, C; Baldwin, D; Ballew, RM; Basu, A; Baxendale, J; Bayraktaroglu, L; Beasley, EM; Beeson, KY; Benos, PV; Berman, BP; Bhandari, D; Bolshakov, S; Borkova, D; Botchan, MR; Bouck, J; Brokstein, P; Brottier, P; Burtis, KC; Busam, DA; Butler, H; Cadieu, E; Center, A; Chandra, I; Cherry, JM; Cawley, S; Dahlke, C; Davenport, LB; Davies, A; de Pablos, B; Delcher, A; Deng, ZM; Mays, AD; Dew, I; Dietz, SM; Dodson, K; Doup, LE; Downes, M; Dugan-Rocha, S; Dunkov, BC; Dunn, P; Durbin, KJ; Evangelista, CC; Ferraz, C; Ferriera, S; Fleischmann, W; Fosler, C; Gabrielian, AE; Garg, NS; Gelbart, WM; Glasser, K; Glodek, A; Gong, FC; Gorrell, JH; Gu, ZP; Guan, P; Harris, M; Harris, NL; Harvey, D; Heiman, TJ; Hernandez, JR; Houck, J; Hostin, D; Houston, DA; Howland, TJ; Wei, MH; Ibegwam, C; Jalali, M; Kalush, F; Karpen, GH; Ke, ZX; Kennison, JA; Ketchum, KA; Kimmel, BE; Kodira, CD; Kraft, C; Kravitz, S; Kulp, D; Lai, ZW; Lasko, P; Lei, YD; Levitsky, AA; Li, JY; Li, ZY; Liang, Y; Lin, XY; Liu, XJ; Mattei, B; McIntosh, TC; McLeod, MP; McPherson, D; Merkulov, G; Milshina, NV; Mobarry, C; Morris, J; Moshrefi, A; Mount, SM; Moy, M; Murphy, B; Murphy, L; Muzny, DM; Nelson, DL; Nelson, DR; Nelson, KA; Nixon, K; Nusskern, DR; Pacleb, JM; Palazzolo, M; Pittman, GS; Pan, S; Pollard, J; Puri, V; Reese, MG; Reinert, K; Remington, K; Saunders, RDC; Scheeler, F; Shen, H; Shue, BC; Siden-Kiamos, I; Simpson, M; Skupski, MP; Smith, T; Spier, E; Spradling, AC; Stapleton, M; Strong, R; Sun, E; Svirskas, R; Tector, C; Turner, R; Venter, E; Wang, AHH; Wang, X; Wang, ZY; Wassarman, DA; Weinstock, GM; Weissenbach, J; Williams, SM; Woodage, T; Worley, KC; Wu, D; Yang, S; Yao, QA; Ye, J; Yeh, RF; Zaveri, JS; Zhan, M; Zhang, GG; Zhao, Q; Zheng, LS; Zheng, XQH; Zhong, FN; Zhong, WY; Zhou, XJ; Zhu, SP; Zhu, XH; Smith, HO; Gibbs, RA; Myers, EW; Rubin, GM; Venter, JC				Adams, MD; Celniker, SE; Holt, RA; Evans, CA; Gocayne, JD; Amanatides, PG; Scherer, SE; Li, PW; Hoskins, RA; Galle, RF; George, RA; Lewis, SE; Richards, S; Ashburner, M; Henderson, SN; Sutton, GG; Wortman, JR; Yandell, MD; Zhang, Q; Chen, LX; Brandon, RC; Rogers, YHC; Blazej, RG; Champe, M; Pfeiffer, BD; Wan, KH; Doyle, C; Baxter, EG; Helt, G; Nelson, CR; Miklos, GLG; Abril, JF; Agbayani, A; An, HJ; Andrews-Pfannkoch, C; Baldwin, D; Ballew, RM; Basu, A; Baxendale, J; Bayraktaroglu, L; Beasley, EM; Beeson, KY; Benos, PV; Berman, BP; Bhandari, D; Bolshakov, S; Borkova, D; Botchan, MR; Bouck, J; Brokstein, P; Brottier, P; Burtis, KC; Busam, DA; Butler, H; Cadieu, E; Center, A; Chandra, I; Cherry, JM; Cawley, S; Dahlke, C; Davenport, LB; Davies, A; de Pablos, B; Delcher, A; Deng, ZM; Mays, AD; Dew, I; Dietz, SM; Dodson, K; Doup, LE; Downes, M; Dugan-Rocha, S; Dunkov, BC; Dunn, P; Durbin, KJ; Evangelista, CC; Ferraz, C; Ferriera, S; Fleischmann, W; Fosler, C; Gabrielian, AE; Garg, NS; Gelbart, WM; Glasser, K; Glodek, A; Gong, FC; Gorrell, JH; Gu, ZP; Guan, P; Harris, M; Harris, NL; Harvey, D; Heiman, TJ; Hernandez, JR; Houck, J; Hostin, D; Houston, DA; Howland, TJ; Wei, MH; Ibegwam, C; Jalali, M; Kalush, F; Karpen, GH; Ke, ZX; Kennison, JA; Ketchum, KA; Kimmel, BE; Kodira, CD; Kraft, C; Kravitz, S; Kulp, D; Lai, ZW; Lasko, P; Lei, YD; Levitsky, AA; Li, JY; Li, ZY; Liang, Y; Lin, XY; Liu, XJ; Mattei, B; McIntosh, TC; McLeod, MP; McPherson, D; Merkulov, G; Milshina, NV; Mobarry, C; Morris, J; Moshrefi, A; Mount, SM; Moy, M; Murphy, B; Murphy, L; Muzny, DM; Nelson, DL; Nelson, DR; Nelson, KA; Nixon, K; Nusskern, DR; Pacleb, JM; Palazzolo, M; Pittman, GS; Pan, S; Pollard, J; Puri, V; Reese, MG; Reinert, K; Remington, K; Saunders, RDC; Scheeler, F; Shen, H; Shue, BC; Siden-Kiamos, I; Simpson, M; Skupski, MP; Smith, T; Spier, E; Spradling, AC; Stapleton, M; Strong, R; Sun, E; Svirskas, R; Tector, C; Turner, R; Venter, E; Wang, AHH; Wang, X; Wang, ZY; Wassarman, DA; Weinstock, GM; Weissenbach, J; Williams, SM; Woodage, T; Worley, KC; Wu, D; Yang, S; Yao, QA; Ye, J; Yeh, RF; Zaveri, JS; Zhan, M; Zhang, GG; Zhao, Q; Zheng, LS; Zheng, XQH; Zhong, FN; Zhong, WY; Zhou, XJ; Zhu, SP; Zhu, XH; Smith, HO; Gibbs, RA; Myers, EW; Rubin, GM; Venter, JC			The genome sequence of Drosophila melanogaster	SCIENCE			English	Review							DNA-REPLICATION; CHROMOSOME DYNAMICS; GENE-EXPRESSION; HETEROCHROMATIN; PROTEINS; FAMILY; PREDICTION; CHROMATIN	The fly Drosophila melanogaster is one of the most intensively studied organisms in biology and serves as a model system for the investigation of many developmental and cellular processes common to higher eukaryotes, including humans. We have determined the nucleotide sequence of nearly all of the similar to 120-megabase euchromatic portion of the Drosophila genome using a whole-genome shotgun sequencing strategy supported by extensive clone-based sequence and a high-quality bacterial artificial chromosome physical map. Efforts are under way to close the remaining gaps; however, the sequence is of sufficient accuracy and Contiguity to be declared substantially complete and to support an initial analysis of genome structure and preliminary gene annotation and interpretation. The genome encodes similar to 13,600 genes, somewhat fewer than the smaller Caenorhabditis elegans genome, but with comparable functional diversity.	Celera Genom, Rockville, MD 20850 USA; Univ Calif Berkeley, Lawrence Berkeley Lab, BDGP, Berkeley, CA 94720 USA; Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; Univ Calif Berkeley, Dept Cell & Mol Biol, BDGP, Berkeley, CA 94720 USA; European Mol Biol Lab, European Bioinformat Inst, Cambridge CB10 1SD, England; Neomorph Inc, Berkeley, CA 94710 USA; Genetixxpress Pty Ltd, Sydney, NSW 2108, Australia; IMIM UPF, Dept Med Informat, Barcelona 08003, Spain; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; FORTH, Inst Mol Biol & Biotechnol, Iraklion, Greece; EMBL, EDGP, Heidelberg, Germany; Univ Calif Berkeley, Dept Cell & Mol Biol, Berkeley, CA 94710 USA; Genoscope, F-91000 Evry, France; Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95618 USA; Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; Univ Rennes 2, Fac Med, Sch Med, EDGP,CNRS,UPR 41, F-35043 Rennes, France; Stanford Univ, Dept Genet, Stanford, CA 94305 USA; Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, EDGP, E-28049 Madrid, Spain; Salk Inst Biol Studies, Mol Biol & Virol Lab, La Jolla, CA 92037 USA; Univ Arizona, Dept Biochem, Tucson, AZ 85721 USA; Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; Univ Montpellier, Sch Med, EDGP, Inst Genet Humaine,CNRS,CRBM, F-34396 Montpellier 5, France; NICHHD, Mol Genet Lab, NIH, Bethesda, MD 20892 USA; McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; Inst Genom Res, Rockville, MD 20850 USA; Sanger Ctr, EDGP, Cambridge CB10 1SA, England; Univ Tennessee, Dept Biochem, Memphis, TN 38163 USA; Univ Dundee, Dept Anat & Physiol, EDGP, Dundee DD1 4HN, Scotland; Open Univ, Dept Biol Sci, Milton Keynes MK7 6AA, Bucks, England; Carnegie Inst Sci, HHM Embryol, Baltimore, MD 21210 USA; Motorola Biochip Syst, Tempe, AZ 85284 USA; NICHHD, Cell Biol & Metab Branch, NIH, Bethesda, MD 20892 USA; Univ Calif Berkeley, Howard Hughes Med Inst, BDGP, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Baylor College of Medicine; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL); Pompeu Fabra University; Harvard University; Washington University (WUSTL); Foundation for Research & Technology - Hellas (FORTH); European Molecular Biology Laboratory (EMBL); University of California System; University of California Berkeley; University of California System; University of California Davis; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite Rennes 2; Stanford University; University of California System; University of California Berkeley; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Salk Institute; University of Arizona; University of Arizona; Centre National de la Recherche Scientifique (CNRS); Universite de Franche-Comte; Universite de Montpellier; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); McGill University; University System of Maryland; University of Maryland College Park; J. Craig Venter Institute; Wellcome Trust Sanger Institute; University of Tennessee System; University of Tennessee Health Science Center; University of Dundee; Open University - UK; Carnegie Institution for Science; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Howard Hughes Medical Institute; University of California System; University of California Berkeley	Adams, MD (corresponding author), Celera Genom, 45 W Gude Dr, Rockville, MD 20850 USA.		Ferrando, Josep F Abril/B-3877-2014; Holt, Robert A/C-3303-2009; Lasko, Paul/C-6761-2014; Reinert, Knut/V-3327-2019; Berman, Benjamin P/D-5942-2014; Weinstock, George M/C-6314-2013; BERMAN, BENJAMIN/AAT-3720-2021	Ferrando, Josep F Abril/0000-0001-7793-589X; Holt, Robert A/0000-0002-7259-1247; Lasko, Paul/0000-0002-4037-3501; Reinert, Knut/0000-0003-3078-8129; Berman, Benjamin P/0000-0002-2099-9005; Weinstock, George M/0000-0002-2997-4592; BERMAN, BENJAMIN/0000-0002-2099-9005; Burtis, Kenneth/0000-0002-9644-3265; Rubin, Gerald/0000-0001-8762-8703; Kulp, David/0000-0001-6540-0222; Worley, Kim/0000-0002-0282-1000; Harris, Michael/0000-0001-8789-0912; Mount, Steve/0000-0003-2748-8205; Wortman, Jennifer/0000-0002-8713-1227; Cherry, J. Michael/0000-0001-9163-5180; Ballew, Richard M/0000-0003-4866-284X; Benos, Panayiotis/0000-0003-3172-3132; Lewis, Suzanna/0000-0002-8343-612X; Murphy, Lee/0000-0001-6467-7449; Svirskas, Robert/0000-0001-8374-6008; Deslattes Mays, Anne/0000-0001-7951-3439	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD001005] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG000750] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [P50-HG00750] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ABRIL JF, IN PRESS BIOINFORMAT; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson B, 1996, BIOTECHNIQUES, V20, P1022; Andersson B, 1996, ANAL BIOCHEM, V236, P107, DOI 10.1006/abio.1996.0138; Ashburner M, 1999, GENETICS, V153, P179; Belotserkovskaya R, 1999, CRIT REV EUKAR GENE, V9, P221, DOI 10.1615/CritRevEukarGeneExpr.v9.i3-4.70; Biessmann H, 1997, CHROMOSOMA, V106, P63, DOI 10.1007/s004120050225; BRIZUELA BJ, 1994, GENETICS, V137, P803; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Burge C. B., 1999, RNA WORLD; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Chesnokov I, 1999, GENE DEV, V13, P1289, DOI 10.1101/gad.13.10.1289; Craig JM, 1999, EXP CELL RES, V246, P249, DOI 10.1006/excr.1998.4278; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; DUBOULE D, 1994, GUIDEBOOK HOMEOBOX G; Dunkov BC, 1999, DNA CELL BIOL, V18, P937, DOI 10.1089/104454999314791; Dutta A, 1997, ANNU REV CELL DEV BI, V13, P293, DOI 10.1146/annurev.cellbio.13.1.293; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Feger G, 1999, GENE, V227, P149, DOI 10.1016/S0378-1119(98)00596-4; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Flores C, 1999, P NATL ACAD SCI USA, V96, P2964, DOI 10.1073/pnas.96.6.2964; FLORESROZAS H, 1994, P NATL ACAD SCI USA, V91, P8655, DOI 10.1073/pnas.91.18.8655; Fraser CM, 1997, ELECTROPHORESIS, V18, P1207, DOI 10.1002/elps.1150180803; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Hampsey M, 1999, CURR OPIN GENET DEV, V9, P132, DOI 10.1016/S0959-437X(99)80020-3; Hampsey M, 1998, MICROBIOL MOL BIOL R, V62, P465, DOI 10.1128/MMBR.62.2.465-503.1998; Hartenstein K, 1997, GENETICS, V147, P1755; HARTL DL, 1992, TRENDS GENET, V8, P70, DOI 10.1016/0168-9525(92)90353-6; Henikoff S., 2000, BIOCHIM BIOPHYS ACTA, V1470, P01; Hirano T, 1998, CURR OPIN CELL BIOL, V10, P317, DOI 10.1016/S0955-0674(98)80006-9; Hoskins RA, 2000, SCIENCE, V287, P2271, DOI 10.1126/science.287.5461.2271; HUANG X, 1995, GENOMICS, V46, P37; Jankowska-Anyszka M, 1998, J BIOL CHEM, V273, P10538, DOI 10.1074/jbc.273.17.10538; Jeanmougin F, 1997, TRENDS BIOCHEM SCI, V22, P151, DOI 10.1016/S0968-0004(97)01042-6; Jessberger R, 1998, CURR OPIN GENET DEV, V8, P254, DOI 10.1016/S0959-437X(98)80149-4; KENNARD ML, 1995, EMBO J, V14, P4178, DOI 10.1002/j.1460-2075.1995.tb00091.x; KOONIN EV, 1995, NUCLEIC ACIDS RES, V23, P4229, DOI 10.1093/nar/23.21.4229; Kusano K, 1999, GENETICS, V151, P1027; Lambert A, 1998, REPROD NUTR DEV, V38, P69, DOI 10.1051/rnd:19980106; Lee TI, 1998, GENE DEV, V12, P1398, DOI 10.1101/gad.12.10.1398; LEVIS RW, 1993, MOL GEN GENET, V236, P440, DOI 10.1007/BF00277145; Lin XY, 1999, NATURE, V402, P761, DOI 10.1038/45471; LOCKE J, UNPUB; LOHE AR, 1993, GENETICS, V134, P1149; Maleszka R, 1997, MICROBIOL-UK, V143, P1781, DOI 10.1099/00221287-143-6-1781; MIKLOS GLG, 1988, P NATL ACAD SCI USA, V85, P2051, DOI 10.1073/pnas.85.7.2051; Miklos GLG, 1996, CELL, V86, P521, DOI 10.1016/S0092-8674(00)80126-9; MOUNT SM, 1992, NUCLEIC ACIDS RES, V20, P4255, DOI 10.1093/nar/20.16.4255; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Pak DTS, 1997, CELL, V91, P311, DOI 10.1016/S0092-8674(00)80415-8; PETER AHG, UNPUB; PIMPINELLI S, 1995, P NATL ACAD SCI USA, V92, P3804, DOI 10.1073/pnas.92.9.3804; Pollard KJ, 1998, BIOESSAYS, V20, P771, DOI 10.1002/(SICI)1521-1878(199809)20:9<771::AID-BIES10>3.0.CO;2-V; Rabenstein MD, 1999, P NATL ACAD SCI USA, V96, P4791, DOI 10.1073/pnas.96.9.4791; Reeder RH, 1999, PROG NUCLEIC ACID RE, V62, P293; REESE MG, IN PRESS GENOME RES; Rohrbough J, 1999, NEURON, V23, P55, DOI 10.1016/S0896-6273(00)80753-9; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222; Rubin GM, 2000, SCIENCE, V287, P2216, DOI 10.1126/science.287.5461.2216; Saffery R, 1999, CHROMOSOME RES, V7, P261, DOI 10.1023/A:1009222729850; Saffery R, 2000, HUM MOL GENET, V9, P175, DOI 10.1093/hmg/9.2.175; Sekelsky JJ, 1999, NUCLEIC ACIDS RES, V27, P3762, DOI 10.1093/nar/27.18.3762; SHAFFER CD, 1994, METHOD CELL BIOL, V44, P185, DOI 10.1016/S0091-679X(08)60913-9; Spradling AC, 1999, GENETICS, V153, P135; Strunnikov AV, 1998, TRENDS CELL BIOL, V8, P454, DOI 10.1016/S0962-8924(98)01370-1; TEARLE RG, 1989, GENETICS, V122, P595; Venter JC, 1998, SCIENCE, V280, P1540, DOI 10.1126/science.280.5369.1540; Venter JC, 1996, NATURE, V381, P364, DOI 10.1038/381364a0; VONHEIJNE G, 1992, J MOL BIOL, V225, P487, DOI 10.1016/0022-2836(92)90934-C; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang Q, 1999, J BIOL CHEM, V274, P10309, DOI 10.1074/jbc.274.15.10309; Weber JL, 1997, GENOME RES, V7, P401, DOI 10.1101/gr.7.5.401; Weiler KS, 1995, ANNU REV GENET, V29, P577, DOI 10.1146/annurev.ge.29.120195.003045; Will CL, 1999, SCIENCE, V284, P2003, DOI 10.1126/science.284.5422.2003; WILLIS IM, 1993, EUR J BIOCHEM, V212, P1, DOI 10.1111/j.1432-1033.1993.tb17626.x; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; YAMAMOTO MT, 1990, GENETICS, V125, P821; Yoshiga T, 1999, EUR J BIOCHEM, V260, P414, DOI 10.1046/j.1432-1327.1999.00173.x	82	4478	8377	15	972	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 24	2000	287	5461					2185	2195		10.1126/science.287.5461.2185	http://dx.doi.org/10.1126/science.287.5461.2185			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296WE	10731132				2022-12-24	WOS:000086049100033
J	Syntichaki, P; Topalidou, I; Thireos, G				Syntichaki, P; Topalidou, I; Thireos, G			The Gcn5 bromodomain co-ordinates nucleosome remodelling	NATURE			English	Article							HISTONE ACETYLTRANSFERASE ACTIVITY; YEAST PHO5 PROMOTER; ADA-COMPLEX; IN-VIVO; CHROMATIN; TRANSCRIPTION; SAGA	The access of transcription factors to eukaryotic promoters often requires modification of their chromatin structure, which is accomplished by the action of two general classes of multiprotein complexes(1). One class contains histone acetyltransferases (HATs), such as Gcn5 in the SAGA complex(2), which acetylate nucleosomal histones. The second dass contains ATPases, such as Swi2 in the Swi/Snf complex(3), which provide the energy for nucleosome remodelling. In several promoters these two complexes cooperate but their functional linkage is unknown(4-8). A protein module that is present in, all, nuclear HATs, the bromodomain, could provide such a link(9). The recently reported in vitro binding of a HAT bromodomain with acetylated lysines within H3 and H4 aminoterminal peptides(10) indicates that this interaction may constitute a targeting step for events that follow histone acetylation. Here we use a suitable promoter to show that bromodomain residues essential for acetyl-lysine binding are not required in vivo for Gcn5-mediated histone acetylation but are fundamental for the subsequent Swi2-dependent nucleosome remodelling and consequent transcriptional activation. We show that the Gcn5 bromodomain stabilizes the Swi/Snf complex on this promoter.	FORTH, Inst Mol Biol & Biotechnol, Heraklion 71110, Crete, Greece; Univ Crete, Dept Biol, Heraklion 71409, Crete, Greece	Foundation for Research & Technology - Hellas (FORTH); University of Crete	Thireos, G (corresponding author), FORTH, Inst Mol Biol & Biotechnol, POB 1527, Heraklion 71110, Crete, Greece.		Topalidou, Irini/ABG-2833-2020; Syntichaki, Popi/ABA-7218-2020	Syntichaki, Popi/0000-0001-9536-8905				ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; Biggar SR, 1999, EMBO J, V18, P2254, DOI 10.1093/emboj/18.8.2254; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; GEORGAKOPOULOS T, 1992, EMBO J, V11, P4145, DOI 10.1002/j.1460-2075.1992.tb05507.x; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Gregory PD, 1999, EMBO J, V18, P6407, DOI 10.1093/emboj/18.22.6407; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Kingston RE, 1999, GENE DEV, V13, P2339, DOI 10.1101/gad.13.18.2339; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kuo MH, 1998, GENE DEV, V12, P627, DOI 10.1101/gad.12.5.627; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Neely KE, 1999, MOL CELL, V4, P649, DOI 10.1016/S1097-2765(00)80216-6; Ornaghi P, 1999, J MOL BIOL, V287, P1, DOI 10.1006/jmbi.1999.2577; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; Pollard KJ, 1997, MOL CELL BIOL, V17, P6212, DOI 10.1128/MCB.17.11.6212; Roberts SM, 1997, GENETICS, V147, P451; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Sudarsanam P, 1999, EMBO J, V18, P3101, DOI 10.1093/emboj/18.11.3101; Svaren J, 1997, TRENDS BIOCHEM SCI, V22, P93, DOI 10.1016/S0968-0004(97)01001-3; Syntichaki P, 1998, J BIOL CHEM, V273, P24414, DOI 10.1074/jbc.273.38.24414; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Wang L, 1998, GENE DEV, V12, P640, DOI 10.1101/gad.12.5.640; Winston F, 1999, NAT STRUCT BIOL, V6, P601, DOI 10.1038/10640	26	163	165	2	13	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					414	417		10.1038/35006136	http://dx.doi.org/10.1038/35006136			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746732				2022-12-24	WOS:000086119000057
J	Triendl, R				Triendl, R			Japan's cloning ban will still allow stem cell experiments	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					321	321		10.1038/35006223	http://dx.doi.org/10.1038/35006223			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10766599	Bronze			2022-12-24	WOS:000086119000006
J	Tropepe, V; Coles, BLK; Chiasson, BJ; Horsford, DJ; Elia, AJ; McInnes, RR; van der Kooy, D				Tropepe, V; Coles, BLK; Chiasson, BJ; Horsford, DJ; Elia, AJ; McInnes, RR; van der Kooy, D			Retinal stem cells in the adult mammalian eye	SCIENCE			English	Article							PIGMENT EPITHELIUM; HOMEOBOX GENE; IN-VITRO; PHOTORECEPTOR DIFFERENTIATION; PROGENITOR PROLIFERATION; NERVOUS-SYSTEM; NEURAL RETINA; RAT RETINA; GROWTH; FOREBRAIN	The mature mammalian retina is thought to lack regenerative capacity. Here, we report the identification of a stem cell in the adult mouse eye, which represents a possible substrate for retinal regeneration. Single pigmented ciliary margin cells clonally proliferate in vitro to form sphere colonies of cells that can differentiate into retinal-specific cell types, including rod photoreceptors, bipolar neurons, and Muller glia. Adult retinal stem cells are localized to the pigmented ciliary margin and not to the central and peripheral retinal pigmented epithelium, indicating that these cells may be homologous to those found in the eye germinal zone of other nonmammalian vertebrates.	Univ Toronto, Dept Anat & Cell Biol, Toronto, ON M5S 1A8, Canada; Hosp Sick Children, Res Inst, Program Dev Biol, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Res Inst, Genet Program, Toronto, ON M5G 1X8, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Pediat, Toronto, ON M5S 1A8, Canada; Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	van der Kooy, D (corresponding author), Univ Toronto, Dept Anat & Cell Biol, Med Sci Bldg 1105,1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.							BASCOM RA, 1992, NEURON, V8, P1171, DOI 10.1016/0896-6273(92)90137-3; BEACH DH, 1979, J COMP NEUROL, V183, P603, DOI 10.1002/cne.901830308; BODENSTEIN L, 1987, DEV BIOL, V121, P192, DOI 10.1016/0012-1606(87)90152-7; Burmeister M, 1996, NAT GENET, V12, P376, DOI 10.1038/ng0496-376; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; COULOMBRE JL, 1965, DEV BIOL, V12, P79, DOI 10.1016/0012-1606(65)90022-9; Craig CG, 1996, J NEUROSCI, V16, P2649; Doetsch F, 1997, J NEUROSCI, V17, P5046; FEIJEN A, 1994, DEVELOPMENT, V120, P3621; Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7; Furukawa T, 1997, CELL, V91, P531, DOI 10.1016/S0092-8674(00)80439-0; HICKS D, 1987, J HISTOCHEM CYTOCHEM, V35, P1317, DOI 10.1177/35.11.3655327; HOCKFIELD S, 1985, J NEUROSCI, V5, P3310; HOLLYFIELD JG, 1972, J COMP NEUROL, V144, P373, DOI 10.1002/cne.901440308; Ilia M, 1996, DEV BRAIN RES, V95, P176; JOHNS PR, 1977, J COMP NEUROL, V176, P343, DOI 10.1002/cne.901760304; KELLEY MW, 1994, DEVELOPMENT, V120, P2091; KONYUKHOV BV, 1975, DEV BIOL, V45, P1, DOI 10.1016/0012-1606(75)90235-3; KONYUKHOV BV, 1966, FOLIA BIOL-PRAGUE, V12, P116; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Levine EM, 1997, J NEUROSCI, V17, P6277; LIU ISC, 1994, NEURON, V13, P377, DOI 10.1016/0896-6273(94)90354-9; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; Morshead C. M., 1998, Society for Neuroscience Abstracts, V24, P1528; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; PARK CM, 1989, DEV BIOL, V134, P201, DOI 10.1016/0012-1606(89)90089-4; Pittack C, 1997, DEVELOPMENT, V124, P805; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; REH TA, 1987, DEV BIOL, V122, P471, DOI 10.1016/0012-1606(87)90311-3; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sakaguchi DS, 1997, DEV DYNAM, V209, P387, DOI 10.1002/(SICI)1097-0177(199708)209:4<387::AID-AJA6>3.0.CO;2-E; STRANZNICKY C, 1971, J EMBRYOL EXP MORPH, V27, P67; Suhonen JO, 1996, NATURE, V383, P624, DOI 10.1038/383624a0; Tropepe V, 1997, J NEUROSCI, V17, P7850; Tropepe V, 1999, DEV BIOL, V208, P166, DOI 10.1006/dbio.1998.9192; TRUSLOVE GM, 1962, J EMBRYOL EXP MORPH, V10, P652; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; WETTS R, 1989, DEV BIOL, V136, P254, DOI 10.1016/0012-1606(89)90146-2; ZHANG DR, 1991, VISUAL NEUROSCI, V6, P429, DOI 10.1017/S0952523800001292; ZHAO SL, 1995, BRAIN RES, V677, P300, DOI 10.1016/0006-8993(95)00163-K	42	821	916	2	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2032	2036		10.1126/science.287.5460.2032	http://dx.doi.org/10.1126/science.287.5460.2032			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720333				2022-12-24	WOS:000085902800067
J	Barnett, HJM; Gunton, RV; Eliasziw, M; Fleming, L; Sharpe, B; Gates, P; Meldrum, H				Barnett, HJM; Gunton, RV; Eliasziw, M; Fleming, L; Sharpe, B; Gates, P; Meldrum, H			Causes and severity of ischemic stroke in patients with internal carotid artery stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LEFT-VENTRICULAR THROMBI; NONVALVULAR ATRIAL-FIBRILLATION; DATA-BANK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; MYOCARDIAL-INFARCTION; CEREBRAL INFARCTION; LACUNAR INFARCTS; NATURAL-HISTORY; CARDIAC SOURCES; CLINICAL RISK	Context Therapeutic trials generally have not distinguished outcomes of stroke according to cause. Objective To determine whether stroke and subsequent disability was of large-artery, lacunar, or cardioembolic origin in patients with different degrees of symptomatic and asymptomatic carotid stenosis. Design Observational study of prospective data collected from the North American Symptomatic Carotid Endarterectomy Trial between 1987 and 1997. Setting and Patients A total of 2885 patients from 106 sites in the United States and abroad (median age, 67 years; 70% male) who had symptomatic internal carotid artery stenosis. Main Outcome Measure Risk of stroke from each of the 3 causes at 5 years by territory and degree of stenosis. Results During an average follow-up of 5 years, 749 patients had 1039 strokes, including 112 of cardioembolic, 211 of lacunar, 698 of large-artery, 17 of primary intracerebral hemorrhage, and 1 of subarachnoid hemorrhage origin. The 5-year risk of first stroke after entry into the trial in any territory was 2.6% of cardioembolic cause, 6.9% of lacunar cause, and 19.7% of large-artery cause. The proportion of cardioembolic strokes in the territory of the symptomatic artery was 12.0% and 6.9% in 60% to 69% and 70% to 99% arterial stenosis, respectively; large-artery strokes predominated (78.4%) at 70% to 99% arterial stenosis. With 70% to 99% arterial stenosis, the proportion of strokes of cardioembolic and lacunar origin was 43.5% and 21.6% in asymptomatic and symptomatic arteries, respectively. A total of 67.6% of cardioembolic, 16.7% of lacunar, and 33.0% of large-artery strokes in the territory of the asymptomatic artery were disabling or fatal. Conclusions Our data suggest that approximately 20% and 45% of strokes in the territory of symptomatic and asymptomatic carotid arteries with 70% to 99% stenosis, respectively, are unrelated to carotid stenosis. The cause of subsequent strokes in similar types of patients should be considered when making treatment decisions involving carotid endarterectomy for patients with asymptomatic carotid stenosis, since lacunar and cardioembolic strokes cannot be prevented by endarterectomy.	John P Robarts Res Inst, London, ON N6A 5K8, Canada; Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada; Univ Western Ontario, Dept Med, London, ON, Canada; Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; Geelong Hosp, Dept Neurosci, Geelong, Vic, Australia; Univ Melbourne, Dept Med, Melbourne, Vic, Australia	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Geelong Hospital; University of Melbourne	Barnett, HJM (corresponding author), John P Robarts Res Inst, POB 5015,100 Perth Dr, London, ON N6A 5K8, Canada.				NINDS NIH HHS [R01-NS-24456] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS024456] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; ANDERSON DC, 1992, ANN INTERN MED, V116, P1, DOI 10.7326/0003-4819-116-1-1; ANDERSON DC, 1992, ANN INTERN MED, V116, P6; Arboix A, 1997, ACTA NEUROL SCAND, V96, P407; ARBOIX A, 1990, STROKE, V21, P842, DOI 10.1161/01.STR.21.6.842; ASINGER RW, 1989, ARCH NEUROL-CHICAGO, V46, P727; BAMFORD J, 1987, STROKE, V18, P545, DOI 10.1161/01.STR.18.3.545; Barnett HJM, 1998, NEW ENGL J MED, V339, P1415, DOI 10.1056/NEJM199811123392002; Biller J, 1998, STROKE, V29, P554, DOI 10.1161/01.STR.29.2.554; BOGOUSSLAVSKY J, 1988, STROKE, V19, P1083, DOI 10.1161/01.STR.19.9.1083; BOGOUSSLAVSKY J, 1991, NEUROLOGY, V41, P855, DOI 10.1212/WNL.41.6.855; Bousser MG, 1997, LANCET, V349, P1564, DOI 10.1016/S0140-6736(97)22022-2; BRICKNER ME, 1994, AM J CARDIOL, V74, P391, DOI 10.1016/0002-9149(94)90409-X; Brickner ME, 1996, AM J MED, V100, P465; CAIRNS JA, 1992, CHEST, V102, pS456, DOI 10.1378/chest.102.4_Supplement.456S; CAPLAN LR, 1988, NEUROLOGY, V38, P791, DOI 10.1212/WNL.38.5.791; CHAN K, 1996, CAN J CARDIOL, V12, pE121; CLAVIER I, 1994, STROKE, V25, P2005, DOI 10.1161/01.STR.25.10.2005; Davis BR, 1998, STROKE, V29, P1333, DOI 10.1161/01.STR.29.7.1333; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; HART RG, 1986, ARCH NEUROL-CHICAGO, V43, P71; HUMPHREY PRD, 1985, POSTGRAD MED J, V61, P1039, DOI 10.1136/pgmj.61.722.1039; Inzitari D, 2000, NEUROLOGY, V54, P660, DOI 10.1212/WNL.54.3.660; KEREN A, 1990, J AM COLL CARDIOL, V15, P790, DOI 10.1016/0735-1097(90)90275-T; KITTNER SJ, 1992, NEUROLOGY, V42, P299, DOI 10.1212/WNL.42.2.299; KITTNER SJ, 1990, NEUROLOGY, V40, P281, DOI 10.1212/WNL.40.2.281; LAUPACIS A, 1994, ARCH INTERN MED, V154, P1449; MADDEN KP, 1995, NEUROLOGY, V45, P1975, DOI 10.1212/WNL.45.11.1975; MAST H, 1994, STROKE, V25, P776, DOI 10.1161/01.STR.25.4.776; QI A, 1996, CAN J CARDIOL, V12, pE98; Rauh G, 1996, STROKE, V27, P691, DOI 10.1161/01.STR.27.4.691; ROSENTHAL MS, 1992, INT J CARDIOL, V37, P277, DOI 10.1016/0167-5273(92)90256-3; ROTHROCK JF, 1993, ARCH INTERN MED, V153, P619, DOI 10.1001/archinte.153.5.619; SANDERCOCK PAG, 1989, BRIT MED J, V298, P75, DOI 10.1136/bmj.298.6666.75; STRATTON JR, 1988, CIRCULATION, V78, P1388, DOI 10.1161/01.CIR.78.6.1388; STRATTON JR, 1987, CIRCULATION, V75, P1004, DOI 10.1161/01.CIR.75.5.1004; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; Yamamoto H, 1998, J NEUROL NEUROSUR PS, V64, P771, DOI 10.1136/jnnp.64.6.771; Yip PK, 1997, STROKE, V28, P2507, DOI 10.1161/01.STR.28.12.2507; Zabalgoitia M, 1998, J AM COLL CARDIOL, V31, P1622, DOI 10.1016/S0735-1097(98)00146-6; ZABALGOITIA M, 1990, CIRCULATION, V82, P109	44	172	184	1	10	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 15	2000	283	11					1429	1436		10.1001/jama.283.11.1429	http://dx.doi.org/10.1001/jama.283.11.1429			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	290UR	10732932				2022-12-24	WOS:000085696700027
J	Sanders, J; Milne, S; Brown, P; Bell, AJ				Sanders, J; Milne, S; Brown, P; Bell, AJ			Assessment of aggression in psychiatric admissions: semistructured interview and case note survey	BRITISH MEDICAL JOURNAL			English	Article							RISK		St Lukes Hosp, Middlesbrough TS4 3AF, Cleveland, England		Milne, S (corresponding author), St Lukes Hosp, Middlesbrough TS4 3AF, Cleveland, England.							APPLEBY L, 1988, MED SCI LAW, V28, P291, DOI 10.1177/002580248802800405; Ferris LE, 1997, CAN J PSYCHIAT, V42, P1051, DOI 10.1177/070674379704201006; Reed J, 1997, BRIT J PSYCHIAT, V170, P4, DOI 10.1192/S0007125000298644; YRNE P, 1998, PSYCHIAT B, V22, P174	4	25	25	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	APR 22	2000	320	7242					1112	1112		10.1136/bmj.320.7242.1112	http://dx.doi.org/10.1136/bmj.320.7242.1112			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	309RJ	10775220	Green Published, Bronze, Green Submitted			2022-12-24	WOS:000086782800017
J	Young, MW				Young, MW			Circadian rhythms - Marking time for a kingdom	SCIENCE			English	Editorial Material							DROSOPHILA CLOCK GENE; MUTATION; HAMSTERS		Rockefeller Univ, Genet Lab, New York, NY 10021 USA; Rockefeller Univ, Natl Sci Fdn, Ctr Biol Timing, New York, NY 10021 USA	Rockefeller University; National Science Foundation (NSF); NSF - Center for Biological Timing; Rockefeller University	Young, MW (corresponding author), Rockefeller Univ, Genet Lab, New York, NY 10021 USA.		, 机智的马小跳和机智的羊不愁/ABC-5169-2020					Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Field MD, 2000, NEURON, V25, P437, DOI 10.1016/S0896-6273(00)80906-X; Keesler GA, 2000, NEUROREPORT, V11, P951, DOI 10.1097/00001756-200004070-00011; Kloss B, 1998, CELL, V94, P97, DOI 10.1016/S0092-8674(00)81225-8; Liu C, 1997, CELL, V91, P855, DOI 10.1016/S0092-8674(00)80473-0; Loudon ASI, 1998, P ROY SOC B-BIOL SCI, V265, P517, DOI 10.1098/rspb.1998.0325; Lowrey PL, 2000, SCIENCE, V288, P483, DOI 10.1126/science.288.5465.483; Okamura H, 1999, SCIENCE, V286, P2531, DOI 10.1126/science.286.5449.2531; Price JL, 1998, CELL, V94, P83, DOI 10.1016/S0092-8674(00)81224-6; RALPH MR, 1988, SCIENCE, V241, P1225, DOI 10.1126/science.3413487; Scully AL, 2000, CELL, V100, P297, DOI 10.1016/S0092-8674(00)80665-0; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Tosini G, 1996, SCIENCE, V272, P419, DOI 10.1126/science.272.5260.419; VIELHABER E, IN PRESS MOL CELL BI; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114	15	25	35	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 21	2000	288	5465					451	453		10.1126/science.288.5465.451	http://dx.doi.org/10.1126/science.288.5465.451			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306YJ	10798982				2022-12-24	WOS:000086626000026
J	Valentini, R; Matteucci, G; Dolman, AJ; Schulze, ED; Rebmann, C; Moors, EJ; Granier, A; Gross, P; Jensen, NO; Pilegaard, K; Lindroth, A; Grelle, A; Bernhofer, C; Grunwald, T; Aubinet, M; Ceulemans, R; Kowalski, AS; Vesala, T; Rannik, U; Berbigier, P; Loustau, D; Guomundsson, J; Thorgeirsson, H; Ibrom, A; Morgenstern, K; Clement, R; Moncrieff, J; Montagnani, L; Minerbi, S; Jarvis, PG				Valentini, R; Matteucci, G; Dolman, AJ; Schulze, ED; Rebmann, C; Moors, EJ; Granier, A; Gross, P; Jensen, NO; Pilegaard, K; Lindroth, A; Grelle, A; Bernhofer, C; Grunwald, T; Aubinet, M; Ceulemans, R; Kowalski, AS; Vesala, T; Rannik, U; Berbigier, P; Loustau, D; Guomundsson, J; Thorgeirsson, H; Ibrom, A; Morgenstern, K; Clement, R; Moncrieff, J; Montagnani, L; Minerbi, S; Jarvis, PG			Respiration as the main determinant of carbon balance in European forests	NATURE			English	Article							LONG-TERM MEASUREMENTS; ATMOSPHERIC CO2; HIGH-LATITUDES; TEMPERATURE; ECOSYSTEMS; DIOXIDE; SINK; SENSITIVITY; FLUXES; WATER	Carbon exchange between the terrestrial biosphere and the atmosphere is one of the key processes that need to be assessed in the context of the Kyoto Protocol(1). Several studies suggest that the terrestrial biosphere is gaining carbon(2-8), but these estimates are obtained primarily by indirect methods, and the factors that control terrestrial carbon exchange, its magnitude and primary locations, are under debate. Here we present data of net ecosystem carbon exchange, collected between 1996 and 1998 from 15 European forests, which confirm that many European forest ecosystems act as carbon sinks. The annual carbon balances range from an uptake of 6.6 tonnes of carbon per hectare per year to a release of nearly 1 t C ha(-1) yr(-1), with a large variability between forests. The data show a significant increase of carbon uptake with decreasing latitude, whereas the gross primary production seems to be largely independent of latitude. Our observations indicate that, in general, ecosystem respiration determines net ecosystem carbon exchange. Also, for an accurate assessment of the carbon balance in a particular forest ecosystem, remote sensing of the normalized difference vegetation index or estimates based on forest inventories may not be sufficient.	Univ Tuscia, Dept Forest Environm & Resources, I-01100 Viterbo, Italy; Alterra, NL-6700 AA Wageningen, Netherlands; Max Planck Inst Biogeochem, D-07745 Jena, Germany; Univ Bayreuth, Lehrstuhl Pflanzenokol, D-95440 Bayreuth, Germany; Ctr Rech Nancy, Unite Ecophysiol Forestiere, Equipe Bioclimatol, F-54280 Champenoux, France; Riso Natl Lab, DK-4000 Roskilde, Denmark; Lund Univ, Dept Phys Geog, SE-22100 Lund, Sweden; SLU, Dept Prod Ecol, Fac Forestry, S-7042 Uppsala, Sweden; Tech Univ Dresden, Inst Hydrol & Meteorol, D-01737 Tharandt, Germany; Fac Univ Sci Agron Gembloux, Unite Phys, B-5030 Gembloux, Belgium; Univ Instelling Antwerp, Dept Biol, B-2610 Antwerp, Belgium; Univ Helsinki, Dept Phys, FIN-00014 Helsinki, Finland; INRA Bordeaux, Unite Bioclimatol, F-33883 Villenave Dornon, France; INRA Bordeaux, Unite Rech Forestieres, F-33611 Gazinet, France; Agr Res Inst, Dept Environm Res, IS-112 Reykjavik, Iceland; Univ Gottingen, Inst Bioklimatol, D-37077 Gottingen, Germany; Univ Edinburgh, Inst Ecol & Resource Management, Edinburgh EH9 3JU, Midlothian, Scotland; Univ Padua, Dept Land & Agroforestry Syst, I-35020 Padua, Italy; Autonomous Prov Bolzano Forest Serv, I-39100 Bolzano, Italy	Tuscia University; Wageningen University & Research; Max Planck Society; University of Bayreuth; Technical University of Denmark; Lund University; Swedish University of Agricultural Sciences; Technische Universitat Dresden; University of Liege; University of Antwerp; University of Helsinki; INRAE; INRAE; University of Gottingen; University of Edinburgh; University of Padua	Valentini, R (corresponding author), Univ Tuscia, Dept Forest Environm & Resources, I-01100 Viterbo, Italy.	rik@unitus.it	Valentini, Riccardo/D-1226-2010; Montagnani, Leonardo/F-1837-2016; Pilegaard, Kim/H-9026-2019; Moors, Eddy/J-5165-2012; Rebmann, Corinna/E-5666-2011; Pilegaard, Kim/I-7137-2013; Gudmundsson, Jon/AAD-1659-2021; Matteucci, Giorgio/AAB-7022-2021; Gudmundsson, Jon/A-7112-2013; Ibrom, Andreas/A-9850-2011; Kowalski, Andrew S./A-7515-2008; Matteucci, Giorgio/N-3526-2015; Vesala, Timo/C-3795-2017; Ceulemans, Reinhart J M/F-2109-2016; Schulze, Ernst-Detlef/K-9627-2014; Lindroth, Anders/N-4697-2014; Rebmann, Corinna/R-2359-2019	Valentini, Riccardo/0000-0002-6756-5634; Montagnani, Leonardo/0000-0003-2957-9071; Pilegaard, Kim/0000-0002-5169-5717; Moors, Eddy/0000-0003-2309-2887; Pilegaard, Kim/0000-0002-5169-5717; Gudmundsson, Jon/0000-0002-1703-8916; Gudmundsson, Jon/0000-0002-1703-8916; Kowalski, Andrew S./0000-0001-9777-9708; Matteucci, Giorgio/0000-0002-4790-9540; Vesala, Timo/0000-0002-4852-7464; Ceulemans, Reinhart J M/0000-0003-4773-9358; Lindroth, Anders/0000-0002-7669-784X; Rebmann, Corinna/0000-0002-8665-0375; Loustau, Denis/0000-0003-3990-400X; Ibrom, Andreas/0000-0002-1341-921X; Dolman, A.J./0000-0003-0099-0457				ANDERSON JM, 1992, ADV ECOL RES, V22, P163, DOI 10.1016/S0065-2504(08)60136-1; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Baldocchi D, 1996, GLOBAL CHANGE BIOL, V2, P159, DOI 10.1111/j.1365-2486.1996.tb00069.x; BALDOCCHI DD, 1988, ECOLOGY, V69, P1331, DOI 10.2307/1941631; Burton AJ, 1998, ECOL APPL, V8, P771, DOI 10.1890/1051-0761(1998)008[0771:DRRRIS]2.0.CO;2; CHAPMAN WL, 1993, B AM METEOROL SOC, V74, P33, DOI 10.1175/1520-0477(1993)074<0033:RVOSIA>2.0.CO;2; Chen WJ, 1999, GLOBAL CHANGE BIOL, V5, P41, DOI 10.1046/j.1365-2486.1998.00201.x; CIAIS P, 1995, SCIENCE, V269, P1098, DOI 10.1126/science.269.5227.1098; DENNING AS, 1995, NATURE, V376, P240, DOI 10.1038/376240a0; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Fan S, 1998, SCIENCE, V282, P442, DOI 10.1126/science.282.5388.442; Goulden ML, 1996, GLOBAL CHANGE BIOL, V2, P169, DOI 10.1111/j.1365-2486.1996.tb00070.x; Goulden ML, 1998, SCIENCE, V279, P214, DOI 10.1126/science.279.5348.214; HANSON PJ, 1993, TREE PHYSIOL, V13, P1, DOI 10.1093/treephys/13.1.1; KAUPPI PE, 1992, SCIENCE, V256, P70, DOI 10.1126/science.256.5053.70; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lindroth A, 1998, GLOBAL CHANGE BIOL, V4, P443, DOI 10.1046/j.1365-2486.1998.00165.x; Moncrieff JB, 1996, GLOB CHANGE BIOL, V2, P231, DOI 10.1111/j.1365-2486.1996.tb00075.x; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Nabuurs GJ, 1997, BIOMASS BIOENERG, V13, P345, DOI 10.1016/S0961-9534(97)00036-6; OECHEL WC, 1993, NATURE, V361, P520, DOI 10.1038/361520a0; Running S. W., 1998, EARTH OBS, V10, P8; SAS, 1989, SAS STATR US GUID VE, V2; SCHLENTNER RE, 1985, CAN J FOREST RES, V15, P97, DOI 10.1139/x85-018; Schlesinger W. H., 1997, BIOGEOCHEMISTRY ANAL, P161; Schulze E.D., 1998, IGBP SERIES, P145; Steffen W, 1998, SCIENCE, V280, P1393; Vogt K., 1995, ADV SOIL SCI SOIL MA, P159	28	1171	1334	19	544	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 20	2000	404	6780					861	865		10.1038/35009084	http://dx.doi.org/10.1038/35009084			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	306XY	10786790				2022-12-24	WOS:000086625000042
J	Naslund, J; Haroutunian, V; Mohs, R; Davis, KL; Davies, P; Greengard, P; Buxbaum, JD				Naslund, J; Haroutunian, V; Mohs, R; Davis, KL; Davies, P; Greengard, P; Buxbaum, JD			Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ALZHEIMERS-DISEASE; SENILE PLAQUES; NEURODEGENERATIVE DISEASES; NEUROFIBRILLARY TANGLES; REGIONAL DISTRIBUTION; DEMENTIA SEVERITY; A-BETA-42(43); MECHANISMS; DEPOSITION; DURATION	Context Alzheimer disease (AD) is characterized neuropathologically by the presence of amyloid beta-peptide (A beta)-containing plaques and neurofibrillary tangles composed of abnormal tau protein. Considerable controversy exists as to whether the extent of accumulation of A beta correlates with dementia and whether A beta alterations precede or follow changes in tau. Objectives To determine whether accumulation of A beta correlates with the earliest signs of cognitive deterioration and to define the relationship between A beta accumulation and early tau changes, Design, Setting, and Patients Postmortem cross-sectional study of 79 nursing home residents with Clinical Dementia Rating (CDR) scale scores of 0.0 to 5.0 who died between 1986 and 1997, comparing the levels of A beta variants in the cortices of the subjects with no (CDR score, 0.0 [n = 16]), questionable (CDR score, 0.5 [n = 11]), mild (CDR score, 1.0 [n = 22]), moderate (CDR score, 2.0 [n = 15]), or severe (CDR score, 4.0 or 5.0 [n = 15]) dementia. Main Outcome Measures Levels of total A beta peptides with intact or truncated amino termini and ending in either amino acid 40 (A beta x-40) or 42 (A beta x-42) in 5 neocortical brain regions as well as levels of tau protein undergoing early conformational changes in frontal cortex, as a function of CDR score. Results The levels of both A beta x-40 and A beta x-42 were elevated even in cases classified as having questionable dementia (CDR score = 0.5), and increases of both peptides correlated with progression of dementia, Levels of the more fibril-prone A beta x-42 peptide were higher than those of A beta x-40 in nondemented cases and remained higher throughout progression of disease in all regions examined. Finally, increases in A beta x-40 and A beta x-42 precede significant tau pathology at least in the frontal cortex, an area chosen for examination because of the absence of neuritic changes in the absence of disease. Conclusions In this study, levels of total A beta x-40 and A beta x-42 were elevated early in dementia and levels of both peptides were strongly correlated with cognitive decline. Of particular interest, in the frontal cortex, A beta was elevated before the occurrence of significant tau pathology, These results support an important role for A beta in mediating initial pathogenic events in AD dementia and suggest that treatment strategies targeting the formation, accumulation, or cytotoxic effects of A beta should be pursued.	CUNY Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Neurobiol, New York, NY 10029 USA; Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA; Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10467 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Rockefeller University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Buxbaum, JD (corresponding author), CUNY Mt Sinai Sch Med, Dept Psychiat, Box 1230,1 Gustave L Levy Pl, New York, NY 10029 USA.		Buxbaum, Joseph D/G-6001-2010	Buxbaum, Joseph/0000-0001-8898-8313	NATIONAL INSTITUTE ON AGING [P01AG002219, R55AG014996, R01AG014996] Funding Source: NIH RePORTER; NIA NIH HHS [AG05138, AG02219, AG14996] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AISEN PS, 1994, AM J PSYCHIAT, V151, P1105; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; BIERER LM, 1995, J NEUROCHEM, V64, P749; Cummings BJ, 1996, NEUROBIOL AGING, V17, P921, DOI 10.1016/S0197-4580(96)00170-4; CUMMINGS BJ, 1995, LANCET, V346, P1524, DOI 10.1016/S0140-6736(95)92053-6; Davis JN, 1997, TRENDS NEUROSCI, V20, P558; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; Desdouits F, 1996, J BIOL CHEM, V271, P24670, DOI 10.1074/jbc.271.40.24670; GIANNAKOPOULOS P, 1995, ARCH NEUROL-CHICAGO, V52, P1150, DOI 10.1001/archneur.1995.00540360028012; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; HEYMAN A, 1987, NEUROLOGY, V37, P980, DOI 10.1212/WNL.37.6.980; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Ikonomovic MD, 1997, J NEUROPATH EXP NEUR, V56, P1018, DOI 10.1097/00005072-199709000-00007; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IWATSUBO T, 1995, ANN NEUROL, V37, P294, DOI 10.1002/ana.410370305; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jicha GA, 1997, J NEUROSCI RES, V48, P128, DOI 10.1002/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E; Kanne SM, 1998, NEUROLOGY, V50, P979, DOI 10.1212/WNL.50.4.979; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MYERS JL, 1973, FUNDAMENTS EXPT DESI; NASLUND J, 1994, P NATL ACAD SCI USA, V91, P8378, DOI 10.1073/pnas.91.18.8378; ROSES AD, 1994, J NEUROPATH EXP NEUR, V53, P429, DOI 10.1097/00005072-199409000-00002; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Tamaoka A, 1998, MOL BRAIN RES, V56, P178, DOI 10.1016/S0169-328X(98)00044-8; Yankner BA, 1996, NEURON, V16, P921, DOI 10.1016/S0896-6273(00)80115-4	29	1027	1085	1	86	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2000	283	12					1571	1577		10.1001/jama.283.12.1571	http://dx.doi.org/10.1001/jama.283.12.1571			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MV	10735393				2022-12-24	WOS:000085857300033
J	Post, JC; Ehrlich, GD				Post, JC; Ehrlich, GD			The impact of the polymerase chain reaction in clinical medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENZYMATIC AMPLIFICATION; OTITIS-MEDIA; DNA; PATHOGENS; SEQUENCES; DIAGNOSIS; EFFUSION; DISEASE; BLOOD; CELLS		Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Pittsburgh, PA 15212 USA; Allegheny Gen Hosp, Dept Surg, Pittsburgh, PA 15212 USA; MCP Hahnemann Univ, Sch Med, Dept Otolaryngol, Pittsburgh, PA USA; MCP Hahnemann Univ, Sch Med, Dept Human Genet, Pittsburgh, PA USA	Allegheny General Hospital; Allegheny General Hospital; Drexel University; Drexel University	Ehrlich, GD (corresponding author), Allegheny Gen Hosp, Ctr Genom Sci, Allegheny Singer Res Inst, Room 1030,320 E North Ave, Pittsburgh, PA 15212 USA.	gehrlich@pgh.auhs.edu		Ehrlich, Garth/0000-0003-1140-6594	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC002398, R01DC002398] Funding Source: NIH RePORTER; NIDCD NIH HHS [DC01248, DC02398] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		ABBOTT MA, 1988, J INFECT DIS, V158, P1158, DOI 10.1093/infdis/158.6.1158; ANDERSON BE, 1991, J CLIN MICROBIOL, V29, P2838, DOI 10.1128/JCM.29.12.2838-2842.1991; BRENNAN JA, 1995, NEW ENGL J MED, V332, P429, DOI 10.1056/NEJM199502163320704; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Ehrlich GD, 1994, PCR BASED DIAGNOSTIC; FOO I, 1992, BIOTECHNIQUES, V12, P811; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Ghossein RA, 1999, CLIN CANCER RES, V5, P1950; HOEFFEL DP, 1999, CLIN ORTHOP RELAT R, V360, P37; KWOK S, 1988, BLOOD, V72, P1117; KWOK S, 1988, J INFECT DIS, V158, P1193, DOI 10.1093/infdis/158.6.1193; KWOK S, 1988, HIV DETECTION GENETI, P243; LUPSKI JR, 1993, JAMA-J AM MED ASSOC, V270, P1363, DOI 10.1001/jama.270.11.1363; POST JC, 1995, JAMA-J AM MED ASSOC, V273, P1598, DOI 10.1001/jama.273.20.1598; Post JC, 1996, AM J OTOLARYNG, V17, P106, DOI 10.1016/S0196-0709(96)90005-8; Rayner MG, 1998, JAMA-J AM MED ASSOC, V279, P296, DOI 10.1001/jama.279.4.296; RELMAN DA, 1990, NEW ENGL J MED, V323, P1573, DOI 10.1056/NEJM199012063232301; ROMERO JR, 1994, PCR BASED DIAGNOSTIC, P341; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sidransky D, 1997, SCIENCE, V278, P1054, DOI 10.1126/science.278.5340.1054; SIMPSON JL, 1993, JAMA-J AM MED ASSOC, V270, P2357, DOI 10.1001/jama.270.19.2357; TRIGGSRAINE BL, 1990, NEW ENGL J MED, V323, P6, DOI 10.1056/NEJM199007053230102; WEGEL JG, 1994, J FORENSIC SCI, V39, P844; WILSON KH, 1991, LANCET, V338, P474, DOI 10.1016/0140-6736(91)90545-Z	25	19	20	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 22	2000	283	12					1544	1546		10.1001/jama.283.12.1544	http://dx.doi.org/10.1001/jama.283.12.1544			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	293MV	10735373				2022-12-24	WOS:000085857300001
J	Bates, DW				Bates, DW			Using information technology to reduce rates of medication errors in hospitals	BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; SYSTEM; PREVENTION		Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Bates, DW (corresponding author), Brigham & Womens Hosp, Div Gen Med & Primary Care, 75 Francis St, Boston, MA 02115 USA.		Bates, David/AAE-7283-2019					Allan E L, 1995, Am Pharm, VNS35, P25; BARKER KN, 1984, AM J HOSP PHARM, V41, P1352, DOI 10.1093/ajhp/41.7.1352; BARKER KN, 1995, AM J HEALTH-SYST PH, V52, P2445, DOI 10.1093/ajhp/52.21.2445; BATES DW, 1993, J GEN INTERN MED, V8, P289, DOI 10.1007/BF02600138; Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Bates DW, 1997, JAMA-J AM MED ASSOC, V277, P307, DOI 10.1001/jama.277.4.307; Bates DW, 1999, J AM MED INFORM ASSN, V6, P313, DOI 10.1136/jamia.1999.00660313; BOREL JM, 1995, AM J HEALTH-SYST PH, V52, P1875, DOI 10.1093/ajhp/52.17.1875; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; CHESTER MIS, 1989, AM J HOSP PHARM, V46, P1380, DOI 10.1093/ajhp/46.7.1380; CLASSEN DC, 1991, JAMA-J AM MED ASSOC, V266, P2847, DOI 10.1001/jama.266.20.2847; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; CULLEN DJ, 1995, JOINT COMM J QUAL IM, V21, P541, DOI 10.1016/S1070-3241(16)30180-8; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; Jha AK, 1998, J AM MED INFORM ASSN, V5, P305, DOI 10.1136/jamia.1998.0050305; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; *MA HOSP ASS B, 1999, MASS HOSP ASS B 0303; Raschke RA, 1998, JAMA-J AM MED ASSOC, V280, P1317, DOI 10.1001/jama.280.15.1317; Sheridan T.B., 2018, HUMAN ERROR MED, P141	21	243	255	0	17	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8138			BRIT MED J	Br. Med. J.	MAR 18	2000	320	7237					788	791		10.1136/bmj.320.7237.788	http://dx.doi.org/10.1136/bmj.320.7237.788			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720369	Green Published			2022-12-24	WOS:000086054700034
J	Ketting, RF; Plasterk, RHA				Ketting, RF; Plasterk, RHA			A genetic link between co-suppression and RNA interference in C-elegans	NATURE			English	Article							CAENORHABDITIS-ELEGANS; TRANSGENIC PLANTS; EXPRESSION; PETUNIA; METHYLATION; GLD-1; VIRUS; DNA	Originally discovered in plants(1,2), the phenomenon of co-suppression by transgenic DNA has since been observed in many organisms from fungi(3) to animals(4-7): introduction of transgenic copies of a gene results in reduced expression of the transgene as well as the endogenous gene. The effect depends on sequence identity between transgene and endogenous gene. Some cases of cosuppression resemble RNA interference (the experimental silencing of genes by the introduction of double-stranded RNA)(8), as RNA seems to be both an important initiator and a target in these processes(9-13). Here we show that co-suppression in Caenorhabditis elegans is also probably mediated by RNA molecules. Both RNA interference(14,15) and co-suppression(16) have been implicated in the silencing of transposons. We now report that mutants of C. elegans that are defective in transposon silencing and RNA interference (mut-2, mut-7, mut-8 and mut-9) are in addition resistant to co-suppression. This indicates that RNA interference and co-suppression in C. elegans may be mediated at least in part by the same molecular machinery, possibly through RNA-guided degradation of messenger RNA molecules.	Netherlands Canc Inst, Div Mol Biol, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Plasterk, RHA (corresponding author), Ctr Biomed Genet, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.know.nl		Ketting, Rene/0000-0001-6161-5621				Ahmed S, 2000, NATURE, V403, P159, DOI 10.1038/35003120; Baulcombe DC, 1996, CURR OPIN BIOTECH, V7, P173, DOI 10.1016/S0958-1669(96)80009-7; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; COLLINS J, 1987, NATURE, V328, P726, DOI 10.1038/328726a0; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; FRANCIS R, 1995, GENETICS, V139, P579; Gaudet J, 1996, MOL BIOL CELL, V7, P1107, DOI 10.1091/mbc.7.7.1107; Grant SR, 1999, CELL, V96, P303, DOI 10.1016/S0092-8674(00)80541-3; INGELBRECHT I, 1994, P NATL ACAD SCI USA, V91, P10502, DOI 10.1073/pnas.91.22.10502; Jensen S, 1999, NAT GENET, V21, P209, DOI 10.1038/5997; Jones AL, 1998, EMBO J, V17, P6385, DOI 10.1093/emboj/17.21.6385; JONES AR, 1995, GENE DEV, V9, P1491, DOI 10.1101/gad.9.12.1491; Jorgensen RA, 1999, TRENDS GENET, V15, P11, DOI 10.1016/S0168-9525(98)01651-5; Jorgensen RA, 1998, SCIENCE, V279, P1486, DOI 10.1126/science.279.5356.1486; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; LINDBO JA, 1993, PLANT CELL, V5, P1749, DOI 10.1105/tpc.5.12.1749; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mette MF, 1999, EMBO J, V18, P241, DOI 10.1093/emboj/18.1.241; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; MORI I, 1988, GENETICS, V120, P397; NAPOLI C, 1990, PLANT CELL, V2, P279, DOI 10.1105/tpc.2.4.279; Pal-Bhadra M, 1999, CELL, V99, P35, DOI 10.1016/S0092-8674(00)80060-4; PalBhadra M, 1997, CELL, V90, P479, DOI 10.1016/S0092-8674(00)80508-5; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Selker EU, 1999, CELL, V97, P157, DOI 10.1016/S0092-8674(00)80725-4; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; VANBLOKLAND R, 1994, PLANT J, V6, P861, DOI 10.1046/j.1365-313X.1994.6060861.x; VANDERKROL AR, 1990, PLANT CELL, V2, P291, DOI 10.1105/tpc.2.4.291; Wolffe AP, 1999, SCIENCE, V286, P481, DOI 10.1126/science.286.5439.481	30	163	199	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					296	298		10.1038/35005113	http://dx.doi.org/10.1038/35005113			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749214				2022-12-24	WOS:000086022200052
J	Frank, C; Mohamed, MK; Strickland, GT; Lavanchy, D; Arthur, RR; Magder, LS; El Khoby, T; Abdel-Wahab, Y; Ohn, EA; Anwar, W; Sallam, I				Frank, C; Mohamed, MK; Strickland, GT; Lavanchy, D; Arthur, RR; Magder, LS; El Khoby, T; Abdel-Wahab, Y; Ohn, EA; Anwar, W; Sallam, I			The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt	LANCET			English	Article							HIGH SEROPREVALENCE; BLOOD-DONORS; B INFECTION; SCHISTOSOMIASIS; PREVALENCE; GENOTYPES; REGIONS	Background The population of Egypt has a heavy burden of liver disease, mostly due to chronic infection with hepatitis C virus (HCV). Overall prevalence of antibody to HCV in the general population is around 15-20%. The risk factor for HCV transmission that specifically sets Egypt apart from other countries is a personal history of parenteral antischistosomal therapy (PAT). A review of the Egyptian PAT mass-treatment campaigns, discontinued only in the 1980s, show a very high potential for transmission of blood-borne pathogens. We examine the relative importance of PAT in the spread of HCV in Egypt. Methods The degree of exposure to PAT by cohort was estimated from 1961-86 Ministry of Health data. A cohort-specific exposure index for PAT was calculated and compared with cohort-specific HCV prevalence rates in four regions. Findings HCV prevalence was calculated for 8499 Egyptians aged 10-50 years. A significant association between seroprevalence of antibodies to HCV and the exposure index (1.31 [95% CI 1.08-1.59]; p=0.007) was identified across four different regions. In all regions cohort-specific HCV prevalence was lowest in children and young adults than in older cohorts. These lower prevalence rates coincided with the gradual and final replacement of PAT with oral antischistosomal drugs at different points in time in the four regions. Interpretation The data suggest that PAT had a major role in the spread of HCV throughout Egypt. This intensive transmission established a large reservoir of chronic HCV infection, responsible for the high prevalence of HCV infection and current high rates of transmission. Egypt's mass campaigns of PAT may represent the world's largest iatrogenic transmission of blood-borne pathogens.	Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA; Ain Shams Univ, Fac Med, Dept Community Environm & Occupat Med, Cairo, Egypt; WHO, Div Communicable Dis Surveillance & Response, CH-1211 Geneva, Switzerland; Egyptian Minist Hlth & Populat, Cairo, Egypt	University System of Maryland; University of Maryland Baltimore; Egyptian Knowledge Bank (EKB); Ain Shams University; World Health Organization; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt	Strickland, GT (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Prevent Med, Baltimore, MD 21201 USA.		mohamed, mostafa/AFE-7371-2022	mohamed, mostafa/0000-0002-1421-2667; Frank, Christina/0000-0001-6776-8450				ABDALLAH A, 1972, SCHISTOWP7241 WHO; ABDELWAHAB MF, 1994, AM J TROP MED HYG, V51, P563, DOI 10.4269/ajtmh.1994.51.563; Arthur R. R., 1997, T R SOC TROP MED HYG, V91, P121; *CENTR AG PUBL MOB, 1993, AR REP EG STAT YB 19; DARWISH MA, 1993, AM J TROP MED HYG, V49, P440, DOI 10.4269/ajtmh.1993.49.440; Darwish MA, 1996, AM J TROP MED HYG, V54, P554, DOI 10.4269/ajtmh.1996.54.554; Davis A., 1993, Human schistosomiasis., P367; DEELDER AM, 1990, LANCET, V335, P724, DOI 10.1016/0140-6736(90)90838-V; DUSHEIKO G, 1994, HEPATOLOGY, V19, P13, DOI 10.1016/0270-9139(94)90046-9; ELGOHARY A, 1995, ACTA TROP, V59, P155, DOI 10.1016/0001-706X(95)00075-P; ELKHOBY T, IN PRESS AM J TROP M; ElSayed HF, 1997, ACTA TROP, V68, P229, DOI 10.1016/S0001-706X(97)00097-1; ElSayed NM, 1996, AM J TROP MED HYG, V55, P179, DOI 10.4269/ajtmh.1996.55.179; FARGHALY AG, 1993, EGYPT PUBL HLTH ASS, V68, P63; GHAFFAR YA, 1991, AM J TROP MED HYG, V45, P743, DOI 10.4269/ajtmh.1991.45.743; HYAMS KC, 1987, J MED VIROL, V23, P109, DOI 10.1002/jmv.1890230203; MADWAR MA, 1989, T ROY SOC TROP MED H, V83, P233, DOI 10.1016/0035-9203(89)90657-3; MAEGRAITH BG, 1964, TREATMENT BILHARZIAS; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; MELLOR J, 1995, J GEN VIROL, V76, P2493, DOI 10.1099/0022-1317-76-10-2493; MOHAMED MK, 1996, EGYPT PUBL HLTH ASS, V71, P79; MOHAMED MK, 1996, EGYPT PUBL HLTH ASS, V71, P113; Quinti I, 1995, ZBL BAKT-INT J MED M, V283, P239; Quinti I, 1997, DIGEST DIS SCI, V42, P2017, DOI 10.1023/A:1018897813268; SHERIF MM, 1985, J MED VIROL, V15, P129, DOI 10.1002/jmv.1890150205; World Health Organization, 1993, WHO TECHN REP SER	26	745	768	0	16	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					887	891		10.1016/S0140-6736(99)06527-7	http://dx.doi.org/10.1016/S0140-6736(99)06527-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	294DM	10752705				2022-12-24	WOS:000085896000011
J	Hicks, D				Hicks, D			Is there a case for school-based screening for sexually transmitted diseases?	LANCET			English	Editorial Material									Royal Hallamshire Hosp, Dept Genitourinary Med, Sheffield S10 2JF, S Yorkshire, England	University of Sheffield	Hicks, D (corresponding author), Royal Hallamshire Hosp, Dept Genitourinary Med, Sheffield S10 2JF, S Yorkshire, England.							Cohen DA, 1999, PEDIATRICS, V104, P1281, DOI 10.1542/peds.104.6.1281; GARLICK R, 1993, PUBLIC HEALTH, V107, P135, DOI 10.1016/S0033-3506(05)80411-1; Lacey CJN, 1997, BRIT MED J, V314, P1715, DOI 10.1136/bmj.314.7096.1715; *OFF NAT STAT, 1999, AB STAT 1998; *SOC EXCL UN, 1999, CN4342 SOC EXCL UN	5	1	1	0	0	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 11	2000	355	9207					864	864		10.1016/S0140-6736(00)90030-8	http://dx.doi.org/10.1016/S0140-6736(00)90030-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	294DM	10752700				2022-12-24	WOS:000085896000006
J	Diehn, M; Alizadeh, AA; Brown, PO				Diehn, M; Alizadeh, AA; Brown, PO			Examining the living genome in health and disease with DNA microarrays	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review									Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Diehn, M (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.		Alizadeh, Ash A/C-5594-2009	Alizadeh, Ash A/0000-0002-5153-5625				Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Hacia JG, 1996, NAT GENET, V14, P441, DOI 10.1038/ng1296-441; Martzen MR, 1999, SCIENCE, V286, P1153, DOI 10.1126/science.286.5442.1153; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Wilson W, 1999, P NATL ACAD SCI USA, V96, P12833, DOI 10.1073/pnas.96.22.12833; Yates JR, 2000, TRENDS GENET, V16, P5, DOI 10.1016/S0168-9525(99)01879-X	11	20	20	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAY 3	2000	283	17					2298	2299		10.1001/jama.283.17.2298	http://dx.doi.org/10.1001/jama.283.17.2298			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	307UB	10807394	hybrid			2022-12-24	WOS:000086671600042
J	Brzustowicz, LM; Hodgkinson, KA; Chow, EWC; Honer, WG; Bassett, AS				Brzustowicz, LM; Hodgkinson, KA; Chow, EWC; Honer, WG; Bassett, AS			Location of a major susceptibility locus for familiar schizophrenia on chromosome 1q21-q22	SCIENCE			English	Article							GENOME-WIDE SEARCH; DUFFY BLOOD-GROUP; LINKAGE ANALYSIS; MILLENNIUM-CONSORTIUM; COMPLEX TRAITS; GENES; SCAN; INHERITANCE; PEDIGREES; SYMPTOMS	Schizophrenia is a complex disorder, and there is substantial evidence supporting a genetic etiology. Despite this, prior attempts to localize susceptibility loci have produced predominantly suggestive findings, A genome-wide scan for schizophrenia susceptibility loci in 22 extended families with high rates of schizophrenia provided highly significant evidence of linkage to chromosome 1 (1q21-q22), with a maximum heterogeneity Logarithm of the likelihood of linkage (lod) score of 6.50. This linkage result should provide sufficient power to allow the positional cloning of the underlying susceptibility gene.	Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Psychiat, Newark, NJ 07103 USA; Univ Toronto, Dept Psychiat, Toronto, ON M6J 1H4, Canada; Univ Toronto, Ctr Addict & Mental Hlth, Schizophrenia Res Program, Genet Sect, Toronto, ON M6J 1H4, Canada; Univ British Columbia, Dept Psychiat, Vancouver, BC V6H 3Z6, Canada	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of British Columbia	Brzustowicz, LM (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.				Canadian Institutes of Health Research [53216] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NIMH NIH HHS [K08 MH01392] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K08MH001392] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abreu PC, 1999, AM J HUM GENET, V65, P847, DOI 10.1086/302536; BASSETT AS, 1993, SCHIZOPHR RES, V11, P9, DOI 10.1016/0920-9964(93)90033-F; BASSETT AS, 1994, AM J HUM GENET, V54, P864; Blouin JL, 1998, NAT GENET, V20, P70, DOI 10.1038/1734; Brzustowicz LM, 1999, AM J HUM GENET, V65, P1096, DOI 10.1086/302579; Brzustowicz LM, 1997, AM J HUM GENET, V61, P1388, DOI 10.1086/301623; Cloninger CR, 1998, AM J MED GENET, V81, P275, DOI 10.1002/(SICI)1096-8628(19980710)81:4<275::AID-AJMG1>3.3.CO;2-U; COON H, 1994, AM J MED GENET, V54, P59, DOI 10.1002/ajmg.1320540111; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Detera-Wadleigh SD, 1999, P NATL ACAD SCI USA, V96, P5604, DOI 10.1073/pnas.96.10.5604; Dror V, 1999, MOL PSYCHIATR, V4, P254, DOI 10.1038/sj.mp.4000508; Durner M, 1999, AM J HUM GENET, V64, P281, DOI 10.1086/302181; Fananas L, 1997, AM J PSYCHIAT, V154, P716; Faraone SV, 1998, AM J MED GENET, V81, P290, DOI 10.1002/(SICI)1096-8628(19980710)81:4<290::AID-AJMG3>3.0.CO;2-Y; Greenberg DA, 1998, AM J HUM GENET, V63, P870, DOI 10.1086/301997; Gurling HMD, 1999, MOL PSYCHIATR, V4, pS4; Hovatta I, 1999, AM J HUM GENET, V65, P1114, DOI 10.1086/302567; Kaufmann CA, 1998, AM J MED GENET, V81, P282, DOI 10.1002/(SICI)1096-8628(19980710)81:4<282::AID-AJMG2>3.0.CO;2-W; KOSOWER NS, 1995, AM J MED GENET, V60, P133, DOI 10.1002/ajmg.1320600209; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Levinson DF, 1998, AM J PSYCHIAT, V155, P741; MCGUFFIN P, 1994, BRIT J PSYCHIAT, V164, P593, DOI 10.1192/bjp.164.5.593; MOISES HW, 1995, NAT GENET, V11, P321, DOI 10.1038/ng1195-321; Morton NE, 1998, AM J HUM GENET, V62, P690, DOI 10.1086/301741; OCONNELL JR, 1995, NAT GENET, V11, P402, DOI 10.1038/ng1295-402; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Ott J., 1999, ANAL HUMAN GENETIC L; Rees MI, 1999, MOL PSYCHIATR, V4, P353, DOI 10.1038/sj.mp.4000521; RISCH N, 1992, HUM HERED, V42, P77, DOI 10.1159/000154047; Risch N, 1996, NAT GENET, V12, P351, DOI 10.1038/ng0496-351; RISCH N, 1990, AM J HUM GENET, V46, P222; SAHA N, 1990, GENET EPIDEMIOL, V7, P303, DOI 10.1002/gepi.1370070408; Shaw SH, 1998, AM J MED GENET, V81, P364, DOI 10.1002/(SICI)1096-8628(19980907)81:5<364::AID-AJMG4>3.0.CO;2-T; Straub RE, 1997, MOL PSYCHIATR, V2, P148, DOI 10.1038/sj.mp.4000258; TERWILLIGER JD, 1993, GENET EPIDEMIOL, V10, P217, DOI 10.1002/gepi.1370100402; VIELAND VJ, 1993, HUM HERED, V43, P329, DOI 10.1159/000154155; WEEKS DE, 1990, AM J HUM GENET S, V47, pA204; Williams NM, 1999, HUM MOL GENET, V8, P1729, DOI 10.1093/hmg/8.9.1729	38	396	429	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 28	2000	288	5466					678	682		10.1126/science.288.5466.678	http://dx.doi.org/10.1126/science.288.5466.678			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	308RR	10784452	Green Accepted			2022-12-24	WOS:000086727100046
J	Maccarrone, M; Valensise, H; Bari, M; Lazzarin, M; Romanini, C; Finazzi-Agro, A				Maccarrone, M; Valensise, H; Bari, M; Lazzarin, M; Romanini, C; Finazzi-Agro, A			Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage	LANCET			English	Article							MOUSE EMBRYO DEVELOPMENT; SPONTANEOUS-ABORTION; CANNABINOID RECEPTORS; EARLY-PREGNANCY; FIRST-TRIMESTER; T-CELLS; BRAIN; UTERUS; IMPLANTATION; DEATH	Background Endocannabinoids such as anandamide are thought to have adverse effects on pregnancy and embryonic development. The activity of the degradative enzyme anandamide hydrolase may therefore be crucial for prevention of excessive concentrations of anandamide in the uterus, and thus prevention of pregnancy failure or female infertility. We tested this hypothesis in a preliminary study, and then used the results to find out whether anandamide hydrolase activity could predict miscarriage in a group of pregnant women. Methods We assessed anandamide hydrolase activity in peripheral lymphocytes from 50 healthy, pregnant women at weeks 6-11 of gestation by a specific radiochromatographic method. The expression of the enzyme at the protein level was measured by ELISA with specific polyclonal antibodies. In a further study, we measured anandamide hydrolase concentration in 120 women who were 7-8 weeks pregnant and compared these findings with subsequent pregnancy outcome. Findings In the first study, seven of the 50 women had a miscarriage. Anandamide hydrolase activity was lower in the seven women who miscarried than in the 43 who did not (60.43 pmol/min per mg protein [SD 29.34] vs 169.60 pmol/min per mg protein [30.20]; difference 109.17 pmol/min per mg protein [95% CI 26.64-191.70]; p<0.0001 by the Mann-Whitney test). Enzyme activity correlated with enzyme concentration, and a threshold concentration represented by an optical density (after ELISA) of 0.15 absorbance units at 450 nm separated the women who had miscarriages from those who did not. In the second study, 15 women had anandamide hydrolase concentrations below the threshold, and 105 had concentrations at or above the threshold. All 15 women in the low anandamide hydrolase group had miscarriages, compared with one of the 105 women with high concentrations [p<0.0001 by Fisher's exact test). Interpretation Decreased anandamide hydrolase activity and expression in peripheral lymphocytes is an early (<8 weeks of gestation) marker of spontaneous abortion, and may prove useful as a diagnostic tool for large-scare, routine monitoring of gestation. Our results also suggest that endocannabinoids might be critical in regulating the lymphocyte-dependent cytokine network associated with human fertility and successful pregnancy.	Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; Univ Roma Tor Vergata, Div Obstet & Gynaecol, I-00133 Rome, Italy; San Giovanni Calibita Hosp, Fatebenefratelli Assoc Res, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Finazzi-Agro, A (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy.		Valensise, Herbert/AAC-1345-2019	Valensise, Herbert/0000-0003-4764-544X				Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Cole LA, 1997, FETAL DIAGN THER, V12, P336, DOI 10.1159/000264500; DAS SK, 1995, P NATL ACAD SCI USA, V92, P4332, DOI 10.1073/pnas.92.10.4332; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 1998, NATURE, V396, P636, DOI 10.1038/25267; Giang DK, 1997, P NATL ACAD SCI USA, V94, P2238, DOI 10.1073/pnas.94.6.2238; GOLDSTEIN SR, 1994, OBSTET GYNECOL, V84, P294; GOLDSTEIN SR, 1994, CLIN OBSTET GYNECOL, V37, P681, DOI 10.1097/00003081-199409000-00020; Kline J.S., 1989, CONCEPTION BIRTH EPI; Kovalevskaya G, 1999, CLIN CHEM, V45, P68; Maccarrone M, 1997, CELL DEATH DIFFER, V4, P396, DOI 10.1038/sj.cdd.4400255; Maccarrone M, 1998, J BIOL CHEM, V273, P32332, DOI 10.1074/jbc.273.48.32332; Molina-Holgado F, 1998, FEBS LETT, V433, P139, DOI 10.1016/S0014-5793(98)00851-5; Ness RB, 1999, NEW ENGL J MED, V340, P333, DOI 10.1056/NEJM199902043400501; Okon MA, 1998, FERTIL STERIL, V69, P682, DOI 10.1016/S0015-0282(98)00007-7; Ouyang YL, 1998, MOL PHARMACOL, V53, P676, DOI 10.1124/mol.53.4.676; Paria BC, 1998, BIOL REPROD, V58, P1490, DOI 10.1095/biolreprod58.6.1490; Paria BC, 1999, BIOL REPROD, V60, P1151, DOI 10.1095/biolreprod60.5.1151; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piccinni MP, 1998, NAT MED, V4, P1020, DOI 10.1038/2006; Redline RW, 1999, HUM PATHOL, V30, P93, DOI 10.1016/S0046-8177(99)90307-6; Schmid PC, 1997, P NATL ACAD SCI USA, V94, P4188, DOI 10.1073/pnas.94.8.4188; Sozio J, 1998, Infect Dis Obstet Gynecol, V6, P8, DOI 10.1155/S1064744998000039; Spandidos DA, 1998, FERTIL STERIL, V70, P892, DOI 10.1016/S0015-0282(98)00279-9; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Stewart CL, 1997, DEV GENET, V21, P91, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;91::AID-DVG11&gt;3.0.CO;2-D; SzekeresBartho J, 1996, J REPROD IMMUNOL, V31, P81, DOI 10.1016/0165-0378(96)00964-3; WALSH RA, 1994, HUM BIOL, V66, P1059; Wang XB, 1998, EPIDEMIOLOGY, V9, P540, DOI 10.1097/00001648-199809000-00012; Yang ZM, 1996, BIOL REPROD, V55, P756, DOI 10.1095/biolreprod55.4.756	30	201	205	0	4	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 15	2000	355	9212					1326	1329		10.1016/S0140-6736(00)02115-2	http://dx.doi.org/10.1016/S0140-6736(00)02115-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	310LJ	10776746				2022-12-24	WOS:000086829400013
J	Harris, J				Harris, J			Essays on science and society - Intimations of immortality	SCIENCE			English	Editorial Material									Univ Manchester, Inst Med Law & Bioeth, Manchester M13 9PL, Lancs, England	University of Manchester	Harris, J (corresponding author), Univ Manchester, Inst Med Law & Bioeth, Manchester M13 9PL, Lancs, England.								0	43	43	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 7	2000	288	5463					59	59		10.1126/science.288.5463.59	http://dx.doi.org/10.1126/science.288.5463.59			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	302VT	10766635				2022-12-24	WOS:000086387700025
J	Lim, DS; Kim, ST; Xu, B; Maser, RS; Lin, JY; Petrini, JHJ; Kastan, MB				Lim, DS; Kim, ST; Xu, B; Maser, RS; Lin, JY; Petrini, JHJ; Kastan, MB			ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway	NATURE			English	Article							NIJMEGEN BREAKAGE SYNDROME; ATAXIA-TELANGIECTASIA; DNA-DAMAGE; IONIZING-RADIATION; PROTEIN-KINASE; REPAIR; P53; LINKAGE	The rare diseases ataxia-telangiectasia (AT), caused by mutations in the ATM gene, and Nijmegen breakage syndrome (NBS), with mutations in the p95/nbs1 gene, share a variety of phenotypic abnormalities such as chromosomal instability, radiation sensitivity and defects in cell-cycle checkpoints in response to ionizing radiation(1-4). The ATM gene encodes a protein kinase that is activated by ionizing radiation or radiomimetic drugs(5,6), whereas p95/nbs1 is part of a protein complex that is involved in responses to DNA double-strand breaks(3,7). Here, because of the similarities between AT and NBS, we evaluated the functional interactions between ATM and p95/nbs1. Activation of the ATM kinase by ionizing radiation and induction of ATM-dependent responses in NBS cells indicated that p95/nbs1 may not be required for signalling to ATM after ionizing radiation. However, p95/nbs1 was phosphorylated on serine 343 in an ATM-dependent manner in vitro and in vivo after ionizing radiation. A p95/nbs1 construct mutated at the ATM phosphorylation site abrogated an S-phase checkpoint induced by ionizing radiation in normal cells and failed to compensate for this functional deficiency in NBS cells. These observations link ATM and p95/nbs1 in a common signalling pathway and provide an explanation for phenotypic similarities in these two diseases.	St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA	St Jude Children's Research Hospital; University of Wisconsin System; University of Wisconsin Madison	Kastan, MB (corresponding author), St Jude Childrens Res Hosp, Dept Hematol Oncol, 332 N Lauderdale, Memphis, TN 38105 USA.	Michael.Kastan@stjude.org	Lim, Dae-Sik/C-1599-2011; Kim, Seong-Tae/A-9917-2013; Maser, Richard/B-2970-2012	Lim, Dae-Sik/0000-0003-2356-7555; 				Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Brown AL, 1999, P NATL ACAD SCI USA, V96, P3745, DOI 10.1073/pnas.96.7.3745; CANMAN CE, 1994, CANCER RES, V54, P5054; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; Cimprich KA, 1996, P NATL ACAD SCI USA, V93, P2850, DOI 10.1073/pnas.93.7.2850; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Featherstone C, 1998, CURR BIOL, V8, pR622, DOI 10.1016/S0960-9822(98)70392-6; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KHANNA KK, 1995, ONCOGENE, V11, P609; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Kim ST, 1999, J BIOL CHEM, V274, P37538, DOI 10.1074/jbc.274.53.37538; Maser RS, 1997, MOL CELL BIOL, V17, P6087, DOI 10.1128/MCB.17.10.6087; MASER RS, 1999, MRE11 RAD50 COMPLEX; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; Morgan SE, 1997, MOL CELL BIOL, V17, P2020, DOI 10.1128/MCB.17.4.2020; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; Paull TT, 1999, GENE DEV, V13, P1276, DOI 10.1101/gad.13.10.1276; Petrini JHJ, 1999, AM J HUM GENET, V64, P1264, DOI 10.1086/302391; Shiloh Y, 1997, ANNU REV GENET, V31, P635, DOI 10.1146/annurev.genet.31.1.635; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5; Wim JM, 1997, MOL CELL BIOL, V17, P5016, DOI 10.1128/MCB.17.9.5016; Yamazaki V, 1998, CANCER RES, V58, P2316; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Ziv Y, 1997, ONCOGENE, V15, P159, DOI 10.1038/sj.onc.1201319	28	644	661	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 6	2000	404	6778					613	+		10.1038/35007091	http://dx.doi.org/10.1038/35007091			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	303BC	10766245				2022-12-24	WOS:000086400100056
J	Goldfrad, C; Rowan, K				Goldfrad, C; Rowan, K			Consequences of discharges from intensive care at night	LANCET			English	Article							HIGH-DEPENDENCY UNIT; SOCIETY APACHE-II; CASE-MIX; SET-UP; BRITAIN; IMPACT; SHORTAGES; ADMISSION; PROVISION; REGISTER	Background It is generally believed that pressure for beds on intensive-care units (ICUs) has increased in the UK. This study used discharge at night as a proxy measure to investigate pressure. Methods Night was defined in two ways: "out of office hours' from 2200 to 0659 h and "the early hours of the morning" from 0000 to 0459 h. The rate of discharge at night was compared for 21 295 adult admissions to 62 ICUs covering the period 1995-98 with 10 806 admissions to 26 ICUs covering the period 1988-90. With data solely from 1995-98, the consequences of discharge at night and premature discharge were investigated. Findings Overall, 2269 (21.0%) admissions did not survive the ICU in 1988-90 compared with 4487 (21.1%) in 1995-98. Of ICU survivors, 2.7% were discharged at night (2200-0659 h) in 1988-90 compared with 6.0% in 1995-98. In 1995-98, night discharges (2200-0659 h) had a higher crude (odds ratio 1.46, 95% CI 1.18-1.80) and case-mix adjusted (1.33, 1.06-1.65) ultimate hospital mortality. Higher odds ratios were observed when the definition of night was 0000-0459 h. Premature discharge was commoner at night, 42.6% vs 5.0% and its importance was apparent when incorporated into the logistic-regression model (premature discharge 1.35, 1.10-1.65; night discharge 1.17, 0.92-1.49). Interpretation Night discharges from ICU are increasing in the UK. This practice is of concern because patients discharged at night fare significantly worse than those discharged during the day. Night discharges are more likely to be "premature" in the view of the clinicians involved. The implication of these results is that many hospitals have insufficient intensive-care beds. In deciding whether or not to invest more resources in intensive care we must, however, consider the cost-utility of this particular service compared with other ways that additional resources could be used.	Intens Care Natl Audit & Res Ctr, London WC1H 9HR, England	Intensive Care National Audit & Research Centre	Rowan, K (corresponding author), Intens Care Natl Audit & Res Ctr, Tavistock House,Tavistock Sq, London WC1H 9HR, England.							BION J, 1995, BMJ-BRIT MED J, V310, P682, DOI 10.1136/bmj.310.6981.682; Black N, 1996, HEART, V76, P1, DOI 10.1136/hrt.76.4_Suppl_4.1; BULL AR, 1995, BRIT MED J, V310, P1010, DOI 10.1136/bmj.310.6985.1010b; CHADDA D, 1995, HLTH SERV J     0720, P4; DYER O, 1995, BRIT MED J, V310, P688, DOI 10.1136/bmj.310.6981.688a; Gunning K, 1999, BRIT MED J, V319, P241, DOI 10.1136/bmj.319.7204.241; KILPATRICK A, 1994, ANAESTHESIA, V49, P666, DOI 10.1111/j.1365-2044.1994.tb04393.x; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; METCALFE A, 1995, STUDY PROVISION INTE; Metcalfe MA, 1997, LANCET, V350, P7, DOI 10.1016/S0140-6736(96)10018-0; MITCHELL I, 1995, LANCET, V345, P652, DOI 10.1016/S0140-6736(95)90554-5; PEACOCK JE, 1995, BRIT MED J, V310, P1413, DOI 10.1136/bmj.310.6991.1413; Rowan K, 1996, BRIT MED J, V313, P1007; ROWAN KM, 1993, BRIT MED J, V307, P977, DOI 10.1136/bmj.307.6910.977; ROWAN KM, 1993, BRIT MED J, V307, P972, DOI 10.1136/bmj.307.6910.972; Rowan KM., 1992, THESIS U OXFORD; RYAN DW, 1995, BRIT MED J, V310, P1010, DOI 10.1136/bmj.310.6985.1010c; Ryan DW, 1997, ANAESTHESIA, V52, P265, DOI 10.1111/j.1365-2044.1997.068-az0055.x; SMITH GB, 1995, BRIT MED J, V310, P1412, DOI 10.1136/bmj.310.6991.1412b; Wallace PGM, 1997, BRIT MED J, V314, P369, DOI 10.1136/bmj.314.7077.369; Warden J, 1996, BRIT MED J, V313, P575; *WORK PART, 1994, REV INT CAR SERV W M; 1995, HLTH SERV J     0126, P6; [No title captured]	24	220	222	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	APR 1	2000	355	9210					1138	1142		10.1016/S0140-6736(00)02062-6	http://dx.doi.org/10.1016/S0140-6736(00)02062-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TC	10791376				2022-12-24	WOS:000086380900011
J	Ovchinnikov, IV; Gotherstrom, A; Romanova, GP; Kharitonov, VM; Liden, K; Goodwin, W				Ovchinnikov, IV; Gotherstrom, A; Romanova, GP; Kharitonov, VM; Liden, K; Goodwin, W			Molecular analysis of Neanderthal DNA from the northern Caucasus	NATURE			English	Article							SEQUENCE; HUMANS	The expansion of premodern humans into western and eastern Europe similar to 40,000 years before the present led to the eventual replacement of the Neanderthals by modern humans similar to 28,000 years ago(1). Here we report the second mitochondrial DNA (mtDNA) analysis of a Neanderthal, and the first such analysis on clearly dated Neanderthal remains. The specimen is from one of the eastern-most Neanderthal populations, recovered from Mezmaiskaya Cave in the northern Caucasus(2). Radiocarbon dating estimated the specimen to be similar to 29,000 years old and therefore from one of the latest living Neanderthals(3). The sequence shows 3.48% divergence from the Feldhofer Neanderthal(4). Phylogenetic analysis places the two Neanderthals from the Caucasus and western Germany together in a clade that is distinct from modern humans, suggesting that their mtDNA types have not contributed to the modern human mtDNA pool. Comparison with modern populations provides no evidence for the multiregional hypothesis of modern human evolution.	Univ Glasgow, Human Identificat Ctr, Glasgow G12 8QQ, Lanark, Scotland; Inst Gerontol, Moscow 129226, Russia; Stockholm Univ, Archaeol Res Lab, S-10691 Stockholm, Sweden; Archaeol Inst, Moscow 117036, Russia; Moscow MV Lomonosov State Univ, Inst Anthropol, Moscow 103009, Russia; Moscow MV Lomonosov State Univ, Museum Anthropol, Moscow 103009, Russia	University of Glasgow; Stockholm University; Lomonosov Moscow State University; Lomonosov Moscow State University	Goodwin, W (corresponding author), Univ Glasgow, Human Identificat Ctr, Glasgow G12 8QQ, Lanark, Scotland.			Gotherstrom, Anders/0000-0001-8579-1304; Liden, Kerstin/0000-0002-5911-9503; Goodwin, William/0000-0002-3632-3552				ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; BROWN TA, 1988, RADIOCARBON, V30, P171, DOI 10.1017/S0033822200044118; Burckhardt F, 1999, NUCLEIC ACIDS RES, V27, P138, DOI 10.1093/nar/27.1.138; Cooper A, 1997, SCIENCE, V277, P1021; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Excoffier L, 1999, MOL BIOL EVOL, V16, P1357, DOI 10.1093/oxfordjournals.molbev.a026046; GABUNIA L, 1995, NATURE, V373, P509, DOI 10.1038/373509a0; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Gamble C, 1998, PREHISTORIC EURPE, P5; Golovanova LV, 1999, CURR ANTHROPOL, V40, P77, DOI 10.1086/515805; Hoss M, 1996, NUCLEIC ACIDS RES, V24, P1304, DOI 10.1093/nar/24.7.1304; Kozlowski JK, 1998, NEANDERTALS AND MODERN HUMANS IN WESTERN ASIA, P461; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krings M, 1999, P NATL ACAD SCI USA, V96, P5581, DOI 10.1073/pnas.96.10.5581; Liden K, 1997, ISKOS, V11, P158; Smith FH, 1999, P NATL ACAD SCI USA, V96, P12281, DOI 10.1073/pnas.96.22.12281; Stringer C., 1996, AFRICAN EXODUS ORIGI; SWOFFORD DL, 1998, PAUP PHYLOGENETIC AN; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023	19	327	351	1	67	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 30	2000	404	6777					490	493		10.1038/35006625	http://dx.doi.org/10.1038/35006625			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	300MX	10761915				2022-12-24	WOS:000086257700046
J	Sharp, D				Sharp, D			Aids to navigation	LANCET			English	Editorial Material									The Lancet, London WC1X 8RR, England		Sharp, D (corresponding author), The Lancet, London WC1X 8RR, England.							Clayton NS, 1998, NEUROPHARMACOLOGY, V37, P441, DOI 10.1016/S0028-3908(98)00037-9; Gron G, 2000, NAT NEUROSCI, V3, P404, DOI 10.1038/73980; MAGUIRE EA, 2000, NAVIGATION RELATED S	3	2	2	0	2	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	MAR 25	2000	355	9209					1034	1034		10.1016/S0140-6736(00)02032-8	http://dx.doi.org/10.1016/S0140-6736(00)02032-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	302TB	10744087				2022-12-24	WOS:000086380800008
J	Gold, JI; Shadlen, MN				Gold, JI; Shadlen, MN			Representation of a perceptual decision in developing oculomotor commands	NATURE			English	Article							SACCADIC EYE-MOVEMENTS; SUPERIOR COLLICULUS; PSYCHOPHYSICAL PERFORMANCE; VISUAL-MOTION; NEURONS; RESPONSES; MONKEY; COMPUTATION; STIMULATION; DISCHARGE	Behaviour often depends on the ability to make categorical judgements about sensory information acquired over time. Such judgements require a comparison of the evidence favouring the alternatives(1-4), but how the brain forms these comparisons is unknown. Here we show that in a visual discrimination task, the accumulating balance of sensory evidence favouring one interpretation over another is evident in the neural circuits that generate the behavioural response. We trained monkeys to make a direction judgement about dynamic random-dot motion(5) and to indicate their judgement with an eye movement to a visual target We interrupted motion viewing with electrical microstimulation of the frontal eye field and analysed the resulting, evoked eye movements for evidence of ongoing activity associated with the oculomotor response(6-10). Evoked eye movements deviated in the direction of the monkey's judgement. The magnitude of the deviation depended on motion strength and viewing time. The oculomotor signals responsible for these deviations reflected the accumulated motion information that informed the monkey's choices on the discrimination task. Thus, for this task, decision formation and motor preparation appear to share a common level of neural organization.	Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; Univ Washington, Reg Primate Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Shadlen, MN (corresponding author), Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA.		Shadlen, Michael Neil/AAL-1870-2020	Shadlen, Michael/0000-0002-2002-2210				BRITTEN KH, 1993, VISUAL NEUROSCI, V10, P1157, DOI 10.1017/S0952523800010269; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; BRUCE CJ, 1985, J NEUROPHYSIOL, V54, P714, DOI 10.1152/jn.1985.54.3.714; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603, DOI 10.1152/jn.1985.53.3.603; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Geisler WS, 1997, VISUAL NEUROSCI, V14, P897, DOI 10.1017/S0952523800011627; Graham N. V. S., 1989, VISUAL PATTERN ANAL; GREEN DM, 1966, SIGNAL DETECTION THE; Horwitz GD, 1999, SCIENCE, V284, P1158, DOI 10.1126/science.284.5417.1158; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Kustov AA, 1996, NATURE, V384, P74, DOI 10.1038/384074a0; LEE CK, 1988, NATURE, V332, P357, DOI 10.1038/332357a0; Leon MI, 1998, NEURON, V21, P669, DOI 10.1016/S0896-6273(00)80584-X; MAYS LE, 1980, J NEUROPHYSIOL, V43, P207, DOI 10.1152/jn.1980.43.1.207; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; ROBINSON DA, 1989, ANNU REV NEUROSCI, V12, P33, DOI 10.1146/annurev.neuro.12.1.33; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Schall JD, 1999, ANNU REV NEUROSCI, V22, P241, DOI 10.1146/annurev.neuro.22.1.241; SCHILLER PH, 1983, EXP BRAIN RES, V49, P381; SCHLAGREY M, 1989, EXP BRAIN RES, V76, P537, DOI 10.1007/BF00248910; Shadlen MN, 1996, P NATL ACAD SCI USA, V93, P628, DOI 10.1073/pnas.93.2.628; Shadlen MN, 1996, J NEUROSCI, V16, P1486; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SPARKS DL, 1990, COLD SH Q B, V55, P805; SPARKS DL, 1987, J NEUROPHYSIOL, V58, P300, DOI 10.1152/jn.1987.58.2.300; SPARKS DL, 1983, J NEUROPHYSIOL, V49, P45, DOI 10.1152/jn.1983.49.1.45; Tehovnik EJ, 1999, EUR J NEUROSCI, V11, P2431, DOI 10.1046/j.1460-9568.1999.00665.x; WURTZ RH, 1972, J NEUROPHYSIOL, V35, P575, DOI 10.1152/jn.1972.35.4.575; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	30	414	452	1	22	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 23	2000	404	6776					390	394		10.1038/35006062	http://dx.doi.org/10.1038/35006062			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	298BG	10746726				2022-12-24	WOS:000086119000051
J	de Man, P; Verhoeven, BAN; Verbrugh, HA; Vos, MC; van den Anker, JN				de Man, P; Verhoeven, BAN; Verbrugh, HA; Vos, MC; van den Anker, JN			An antibiotic policy to prevent emergence of resistant bacilli	LANCET			English	Article							INTENSIVE-CARE-UNIT; ENTEROBACTER-CLOACAE; INFECTION; COLONIZATION; AMPICILLIN; CEFUROXIME; CEFOTAXIME; OUTBREAK; RESTRICTION; IMPACT	Background Fear of infection in neonatal intensive care units (NICUs) often leads to early use of empiric broad-spectrum antibiotics, a strategy that selects for resistant bacteria. We investigated whether the emergence of resistant strains could be halted by modifying the empiric antibiotic regimens to remove the selective pressure that favours resistant bacteria. Methods Two identical NICUs were assigned to different empiric antibiotic regimens. On unit A, penicillin G and tobramycin were used for early-onset septicaemia, flucloxacillin and tobramycin were used for late-onset septicaemia, and no broad-spectrum beta-lactam antibiotics, such as amoxicillin and cefotaxime were used, In unit B, intravenous amoxicillin with cefotaxime was the empiric therapy. After 6 months of the study the units exchanged regimens. Rectal and respiratory cultures were taken on a weekly basis. Findings There were 436 admissions, divided equally between the two regimens (218 in each), Three neonates treated with the penicillin-tobramycin regimen became colonised with bacilli resistant to the empirical therapy used versus 41 neonates on the amoxicillin-cefotaxime regimen (p < 0.001). The relative risk for colonisation with strains resistant to the empirical therapy per 1000 patient days at risk was 18 times higher for the amoxicillin-cefotaxime regimen compared with the penicillin-tobramycin regimen (95% CI 5.6-58.0). Enterobacter cloacae was the predominant bacillus in neonates on the amoxicillin-cefotaxime regimen, whereas Escherichia coli predominated in neonates on the penicillin-tobramycin regimen. These colonisation patterns were also seen when the units exchanged regimens. Interpretation Policies regarding the empiric use of antibiotics do matter in the control of antimicrobial resistance, A regimen avoiding amoxicillin and cefotaxime restricts the resistance problem. of antimicrobial and cefotaxime.	St Franciscus Gasthuis, Dept Med Microbiol & Infect Control, NL-3004 BA Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Control, Rotterdam, Netherlands; Erasmus Univ, Med Ctr, Sophias Childrens Hosp, Dept Paediat, Rotterdam, Netherlands	Franciscus Gasthuis; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	de Man, P (corresponding author), St Franciscus Gasthuis, Dept Med Microbiol & Infect Control, POB 10900, NL-3004 BA Rotterdam, Netherlands.	peter_de_man@franciscus.nl						ACOLET D, 1994, J HOSP INFECT, V28, P273, DOI 10.1016/0195-6701(94)90091-4; ARREDONDO-GARCIA J L, 1992, Revista Latinoamericana de Microbiologia, V34, P11; BERKOWITZ FE, 1995, PEDIATR INFECT DIS J, V14, P97, DOI 10.1097/00006454-199502000-00003; BLAKEY JL, 1982, J MED MICROBIOL, V15, P519, DOI 10.1099/00222615-15-4-519; BRYAN CS, 1985, AM J DIS CHILD, V139, P1086, DOI 10.1001/archpedi.1985.02140130024022; BURMAN LG, 1993, J ANTIMICROB CHEMOTH, V31, P111, DOI 10.1093/jac/31.1.111; Gould IM, 1999, J ANTIMICROB CHEMOTH, V43, P459, DOI 10.1093/jac/43.4.459; HAERTL R, 1993, J HOSP INFECT, V25, P109, DOI 10.1016/0195-6701(93)90101-5; HAMMERSCHLAG MR, 1977, NEW ENGL J MED, V296, P1268, DOI 10.1056/NEJM197706022962206; KALENIC S, 1993, J HOSP INFECT, V23, P35, DOI 10.1016/0195-6701(93)90128-M; KAYYALI MZ, 1972, CLIN PEDIATR, V11, P422; KHADILKAR V, 1995, J PAEDIATR CHILD H, V31, P387, DOI 10.1111/j.1440-1754.1995.tb00843.x; LEDINGHAM IM, 1988, LANCET, V1, P785; MARKOWITZ SM, 1980, J INFECT DIS, V142, P106, DOI 10.1093/infdis/142.1.106; MAYHALL CG, 1980, INFECT CONT HOSP EP, V1, P239, DOI 10.1017/S019594170005308X; MODI N, 1987, ARCH DIS CHILD, V62, P148, DOI 10.1136/adc.62.2.148; NOY JH, 1974, J MED MICROBIOL, V7, P509, DOI 10.1099/00222615-7-4-509; PRICE DJE, 1970, LANCET, V2, P1213; Sanders WE, 1997, CLIN MICROBIOL REV, V10, P220, DOI 10.1128/CMR.10.2.220; Seppala H, 1997, NEW ENGL J MED, V337, P441, DOI 10.1056/NEJM199708143370701; SPRITZER R, 1990, PEDIATR INFECT DIS J, V9, P92, DOI 10.1097/00006454-199002000-00006; Toltzis P, 1998, CRIT CARE MED, V26, P1893, DOI 10.1097/00003246-199811000-00035; TULLUS K, 1989, LANCET, V1, P1405; TULLUS K, 1990, ANTIMICROB AGENTS CH, V34, P361, DOI 10.1128/AAC.34.2.361; VENEZIA RA, 1995, CLIN INFECT DIS, V21, P915, DOI 10.1093/clinids/21.4.915; VERWEIJ PE, 1995, INFECT CONT HOSP EP, V16, P25; White AC, 1997, CLIN INFECT DIS, V25, P230	27	268	274	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 18	2000	355	9208					973	978		10.1016/S0140-6736(00)90015-1	http://dx.doi.org/10.1016/S0140-6736(00)90015-1			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YH	10768436				2022-12-24	WOS:000086054000012
J	Nightingale, PG; Adu, D; Richards, NT; Peters, M				Nightingale, PG; Adu, D; Richards, NT; Peters, M			Implementation of rules based computerised bedside prescribing and administration: intervention study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERSE DRUG EVENTS; DECISION-SUPPORT; MEDICATION ERRORS; PREVENTION; SYSTEMS	Obectives: To Implement and assess a rules based computerised prescribing system with the aim of improving the safety of prescriptions and the administration of drugs. Design: Analysis of performance of computerised system plus questionnaire survey of users. Setting: 64 bed renal unit in a teaching hospital. Intervention: Introduction of the system into routine clinical use. Main outcome measures: Number of attempted prescriptions cancelled by the system; proportion of warning messages overridden; users' comparisons of the system with conventional procedures. Results: Between October 1998 and August 1999 die system cancelled 58 (0.07%) out of 87 789 prescriptions on the grounds of clinical safety. In addition, 427 (57%) attempted prescriptions generating high level warnings and 1257 (8%) generating low level warnings were not completed. In a user survey 82% (31/38) of doctors and nurses considered the system to be an improvement on conventional procedures. Conclusions: The system has contributed to safety and patient care. All prescriptions are complete and legible, and transcription errors have been eliminated. The system assists clinicians when they are writing a prescription by making available information on patients. The system supports clinical decision making and has been well received by doctors, nurses, and pharmacists.	Univ Birmingham, Queen Elizabeth Med Ctr, Dept Med, Wolfson Comp Lab, Birmingham B15 2TH, W Midlands, England; Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp, Dept Nephrol, Renal Serv, Birmingham B15 2TH, W Midlands, England; Univ Hosp Birmingham NHS Trust, Queen Elizabeth Hosp, Dept Nephrol, Urol Serv, Birmingham B15 2TH, W Midlands, England	Birmingham City University; University of Birmingham; University of Birmingham; University of Birmingham	Nightingale, PG (corresponding author), Univ Birmingham, Queen Elizabeth Med Ctr, Dept Med, Wolfson Comp Lab, Birmingham B15 2TH, W Midlands, England.	P.G.Nightingale@bham.ac.uk						Bates DW, 1998, JAMA-J AM MED ASSOC, V280, P1311, DOI 10.1001/jama.280.15.1311; BATES DW, 1995, J GEN INTERN MED, V10, P199, DOI 10.1007/BF02600255; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; EVANS RS, 1994, ARCH INTERN MED, V154, P878, DOI 10.1001/archinte.154.8.878; FERNER RE, 1992, J MED DEFENCE UNION, V8, P60; JOHNSTON ME, 1994, ANN INTERN MED, V120, P135, DOI 10.7326/0003-4819-120-2-199401150-00007; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; LESAR TS, 1990, JAMA-J AM MED ASSOC, V263, P2329, DOI 10.1001/jama.263.17.2329; Lesar TS, 1997, JAMA-J AM MED ASSOC, V277, P312, DOI 10.1001/jama.277.4.312; Pestotnik SL, 1996, ANN INTERN MED, V124, P884, DOI 10.7326/0003-4819-124-10-199605150-00004; Purves IN, 1998, BRIT J GEN PRACT, V48, P1552; Raschke RA, 1998, JAMA-J AM MED ASSOC, V280, P1317, DOI 10.1001/jama.280.15.1317; Schiff GD, 1998, JAMA-J AM MED ASSOC, V279, P1024, DOI 10.1001/jama.279.13.1024; Shojania KG, 1998, J AM MED INFORM ASSN, V5, P554, DOI 10.1136/jamia.1998.0050554; WYATT J, 1995, BRIT MED J, V311, P1181, DOI 10.1136/bmj.311.7014.1181	18	127	128	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 18	2000	320	7237					750	753		10.1136/bmj.320.7237.750	http://dx.doi.org/10.1136/bmj.320.7237.750			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	296YQ	10720357	Green Published, Green Submitted, Bronze			2022-12-24	WOS:000086054700022
J	Cynader, M				Cynader, M			Neuroscience - Strengthening visual connections	SCIENCE			English	Editorial Material							CORTEX		Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 3N9, Canada; Vancouver Hosp, Vancouver, BC V5Z 3N9, Canada	University of British Columbia; University of British Columbia	Cynader, M (corresponding author), Univ British Columbia, Brain Res Ctr, Vancouver, BC V5Z 3N9, Canada.							Bruer J. T., 1999, MYTH 1 3 YEARS; CYNADER M, 1977, NATURE, V270, P177, DOI 10.1038/270177a0; HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; Trachtenberg JT, 2000, SCIENCE, V287, P2029, DOI 10.1126/science.287.5460.2029	5	6	6	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					1943	1944		10.1126/science.287.5460.1943	http://dx.doi.org/10.1126/science.287.5460.1943			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10755946				2022-12-24	WOS:000085902800035
J	Odom, AR; Stahlberg, A; Wente, SR; York, JD				Odom, AR; Stahlberg, A; Wente, SR; York, JD			A role for nuclear inositol 1,4,5-trisphosphate kinase in transcriptional control	SCIENCE			English	Article							PHOSPHOLIPASE-C GENE; SACCHAROMYCES-CEREVISIAE; ARGININE METABOLISM; CELL-CYCLE; S-PHASE; YEAST; EXPRESSION; DNA; PHOSPHORYLATION; TRISPHOSPHATE	Phospholipase C and two inositol polyphosphate (IP) kinases constitute a signaling pathway that regulates nuclear messenger RNA export through production of inositol hexakisphosphate (IP6). The inositol 1,4,5-trisphosphate kinase of this pathway in Saccharomyces cerevisiae, designated Ipk2, was found to be identical to Arg82, a regulator of the transcriptional complex ArgR-Mcm1. Synthesis of inositol 1,4,5,6-tetrakisphosphate, but not IP6, was required for gene regulation through ArgR-Mcm1. Thus, the phospholipase C pathway produces multiple IP messengers that modulate distinct nuclear processes. The results reveal a direct mechanism by which activation of IP signaling may control gene expression.	Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Duke University; Duke University; Washington University (WUSTL)	York, JD (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, DUMC 3813, Durham, NC 27710 USA.		John, Audrey Odom/AAF-1300-2019; Pillay, Nischalan/F-9536-2012	John, Audrey Odom/0000-0001-8395-8537; 				BECHET J, 1970, EUR J BIOCHEM, V12, P31, DOI 10.1111/j.1432-1033.1970.tb00817.x; BERCY J, 1987, GENE, V55, P277, DOI 10.1016/0378-1119(87)90287-3; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BORONENKOV I, 1998, MOL BIOL CELL, P9; CHOI KY, 1990, SCIENCE, V248, P64, DOI 10.1126/science.2157285; COMMUNI D, 1995, CELL SIGNAL, V7, P643, DOI 10.1016/0898-6568(95)00035-N; D'Santos CS, 1998, BBA-MOL CELL BIOL L, V1436, P201, DOI 10.1016/S0005-2760(98)00146-5; DIVECHA N, 1993, CELL, V74, P405, DOI 10.1016/0092-8674(93)80041-C; DUBOIS E, 1987, MOL GEN GENET, V207, P142, DOI 10.1007/BF00331501; DUBOIS E, 1991, MOL CELL BIOL, V11, P2162, DOI 10.1128/MCB.11.4.2162; DUBOIS E, 1994, MOL GEN GENET, V243, P315, DOI 10.1007/BF00301067; ESTEVEZ F, 1994, BIOCHEM J, V302, P709, DOI 10.1042/bj3020709; FLICK JS, 1993, MOL CELL BIOL, V13, P5861, DOI 10.1128/MCB.13.9.5861; Hsu AL, 1998, BIOCHEM BIOPH RES CO, V243, P653, DOI 10.1006/bbrc.1998.8161; IRVINE RF, 1988, PHILOS T ROY SOC B, V320, P281, DOI 10.1098/rstb.1988.0077; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Liu NS, 1996, J BIOL CHEM, V271, P355, DOI 10.1074/jbc.271.1.355; Liu QH, 1998, CURR BIOL, V8, P1300, DOI 10.1016/S0960-9822(07)00560-X; MAHER M, 1995, MOL CELL BIOL, V15, P3129; MAJERUS PW, 1992, ANNU REV BIOCHEM, V61, P225, DOI 10.1146/annurev.bi.61.070192.001301; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; MESSENGUY F, 1993, MOL CELL BIOL, V13, P2586, DOI 10.1128/MCB.13.4.2586; Ongusaha PP, 1998, BIOCHEM J, V335, P671, DOI 10.1042/bj3350671; PAYNE WE, 1993, MOL CELL BIOL, V13, P4351, DOI 10.1128/MCB.13.7.4351; RIJCKE MD, 1992, MOL CELL BIOL, V12, P68; Saiardi A, 1999, CURR BIOL, V9, P1323, DOI 10.1016/S0960-9822(00)80055-X; Shears SB, 1998, BBA-MOL CELL BIOL L, V1436, P49, DOI 10.1016/S0005-2760(98)00131-3; SHORE P, 1995, EUR J BIOCHEM, V229, P1, DOI 10.1111/j.1432-1033.1995.tb20430.x; SMITH CD, 1983, J BIOL CHEM, V258, P9368; Stolz LE, 1998, J BIOL CHEM, V273, P11852, DOI 10.1074/jbc.273.19.11852; VanderKaay J, 1995, BIOCHEM J, V312, P911, DOI 10.1042/bj3120911; Wolberger C, 1999, ANNU REV BIOPH BIOM, V28, P29, DOI 10.1146/annurev.biophys.28.1.29; Yamaga M, 1999, J BIOL CHEM, V274, P28537, DOI 10.1074/jbc.274.40.28537; YOKOO T, 1993, P NATL ACAD SCI USA, V90, P1804, DOI 10.1073/pnas.90.5.1804; YORK JD, 1994, J BIOL CHEM, V269, P19992; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; YORK JD, 1994, J BIOL CHEM, V269, P7847; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5	39	313	329	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 17	2000	287	5460					2026	2029		10.1126/science.287.5460.2026	http://dx.doi.org/10.1126/science.287.5460.2026			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	294GE	10720331				2022-12-24	WOS:000085902800065
J	Catalanotto, C; Azzalin, G; Macino, G; Cogoni, C				Catalanotto, C; Azzalin, G; Macino, G; Cogoni, C			Transcription - Gene silencing in worms and fungi	NATURE			English	Article							PLANTS				Catalanotto, C (corresponding author), Univ Roma La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Sez Genet Mol, Viale Regina Elena 324, I-00161 Rome, Italy.	carlo@bce.med.uniroma1.it		CATALANOTTO, Caterina/0000-0001-6583-5170				Benfey PN, 1999, CURR BIOL, V9, pR171, DOI 10.1016/S0960-9822(99)80105-5; Cogoni C, 1997, TRENDS PLANT SCI, V2, P438, DOI 10.1016/S1360-1385(97)90028-5; Cogoni C, 1997, P NATL ACAD SCI USA, V94, P10233, DOI 10.1073/pnas.94.19.10233; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Fire A, 1999, TRENDS GENET, V15, P358, DOI 10.1016/S0168-9525(99)01818-1; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Montgomery MK, 1998, P NATL ACAD SCI USA, V95, P15502, DOI 10.1073/pnas.95.26.15502; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Wassenegger M, 1998, PLANT MOL BIOL, V37, P349, DOI 10.1023/A:1005946720438; Zou C, 1998, GENE, V211, P187, DOI 10.1016/S0378-1119(98)00107-3	11	191	238	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 16	2000	404	6775					245	245		10.1038/35005169	http://dx.doi.org/10.1038/35005169			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749199	Bronze			2022-12-24	WOS:000086022200037
J	Packer, A; Clay, K				Packer, A; Clay, K			Soil pathogens and spatial patterns of seedling mortality in a temperate tree	NATURE			English	Article							JANZEN-CONNELL MODEL; RAIN-FOREST TREE; MOIST TROPICAL FOREST; NEOTROPICAL FOREST; SPECIES-DIVERSITY; DISTANCE; DENSITY; RECRUITMENT; MAINTENANCE; FEEDBACK	The Janzen-Connell hypothesis(1,2) proposes that host-specific, distance- and/or density-dependent predators and herbivores maintain high tree diversity in tropical forests. Negative feedback between plant and soil communities could be a more effective mechanism promoting species coexistence because soil pathogens can increase rapidly in the presence of their host(3), causing conditions unfavourable for local conspecific recruitment(4-6). Here we show that a soil pathogen leads to patterns of seedling mortality in a temperate tree (Prunus serotina) as predicted by the Janzen-Connell hypothesis. In the field, the mean distance to parent of seedling cohorts shifted away from maternal trees over a period of 3 years. Seedlings were gown in soil collected 0-5 m or 25-30 m from Prunus trees. Sterilization of soil collected beneath trees improved seedling survival relative to unsterilized soil, whereas sterilization of distant soil did not affect survival. Pythium spp., isolated from roots of dying seedlings and used to inoculate healthy seedlings, decreased survival by 65% relative to controls. Our results provide the most complete evidence that native pathogens influence tree distributions, as predicted by the Janzen-Connell hypothesis, and suggest that similar ecological mechanisms operate in tropical and temperate forests.	Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Packer, A (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.		Clay, Keith/C-8730-2012					AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; AUGSPURGER CK, 1983, OIKOS, V40, P189, DOI 10.2307/3544582; Barone JA, 1998, J ANIM ECOL, V67, P400, DOI 10.1046/j.1365-2656.1998.00197.x; BECKER P, 1985, OIKOS, V44, P382, DOI 10.2307/3565778; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; BURDON JJ, 1982, ANNU REV PHYTOPATHOL, V20, P143, DOI 10.1146/annurev.py.20.090182.001043; Burdon JJ., 1987, DIS PLANT POPULATION; BURKEY TV, 1994, OECOLOGIA, V97, P533, DOI 10.1007/BF00325893; CARLISLE MJ, 1994, FUNGI; CHEN W, 1992, PHYTOPATHOLOGY, V82, P1234, DOI 10.1094/Phyto-82-1234; Cintra R, 1997, J TROP ECOL, V13, P641, DOI 10.1017/S0266467400010841; CLARK DA, 1984, AM NAT, V124, P769, DOI 10.1086/284316; CONDIT R, 1992, AM NAT, V140, P261, DOI 10.1086/285412; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; FLORENCE RG, 1965, ECOLOGY, V46, P52, DOI 10.2307/1935257; FOX JF, 1977, AM NAT, V111, P69, DOI 10.1086/283138; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; HUBBELL SP, 1980, OIKOS, V35, P214, DOI 10.2307/3544429; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; MAY RM, 1988, SCIENCE, V241, P1441, DOI 10.1126/science.241.4872.1441; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Notman E, 1996, OECOLOGIA, V106, P221, DOI 10.1007/BF00328602; SCHUPP EW, 1992, AM NAT, V140, P526, DOI 10.1086/285426; VanderPutten WH, 1997, ECOLOGY, V78, P1785, DOI 10.1890/0012-9658(1997)078[1785:HSBPMA]2.0.CO;2; VANDERPUTTEN WH, 1993, NATURE, V362, P53; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; WOODS KD, 1979, OIKOS, V33, P31, DOI 10.2307/3544508	29	653	702	19	335	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 16	2000	404	6775					278	281		10.1038/35005072	http://dx.doi.org/10.1038/35005072			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	296JX	10749209				2022-12-24	WOS:000086022200047
J	Hirao, A; Kong, YY; Matsuoka, S; Wakeham, A; Ruland, J; Yoshida, H; Liu, D; Elledge, SJ; Mak, TW				Hirao, A; Kong, YY; Matsuoka, S; Wakeham, A; Ruland, J; Yoshida, H; Liu, D; Elledge, SJ; Mak, TW			DNA damage-induced activation of p53 by the checkpoint kinase Chk2	SCIENCE			English	Article							CELL-CYCLE REGULATION; INDUCED APOPTOSIS; RADIATION; ATM; PHOSPHORYLATION; TRANSCRIPTION; LINKAGE; GENE; P21	Chk2 is a protein kinase that is activated in response to DNA damage and may regulate cell cycle arrest. We generated Chk2-deficient mouse cells by gene targeting. Chk2(-/-) embryonic stem cells failed to maintain gamma-irradiation-induced arrest in the Ci phase of the cell cycle. Chk2(-/-) thymocytes were resistant to DNA damage-induced apoptosis. Chk2(-/-) cells were defective for p53 stabilization and for induction of p53-dependent transcripts such as p21 in response to gamma irradiation. Reintroduction of the Chk2 gene restored p53-dependent transcription in response to gamma irradiation. Chk2 directly phosphorylated p53 on serine 20, which is known to interfere with Mdm2 binding. This provides a mechanism for increased stability of p53 by prevention of ubiquitination in response to DNA damage.	Univ Toronto, Ontario Canc Inst, Amgen Inst, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2C1, Canada; Univ Toronto, Dept Immunol, Toronto, ON M5G 2C1, Canada; Baylor Coll Med, Howard Hughes Med Inst, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine	Mak, TW (corresponding author), Univ Toronto, Ontario Canc Inst, Amgen Inst, 620 Univ Ave,Suite 706, Toronto, ON M5G 2C1, Canada.		Ruland, Jürgen/Q-6680-2018	Ruland, Jürgen/0000-0002-8381-3597	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM044664, R01GM044664] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM44664] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bargonetti J, 1997, CELL MOL BIOL, V43, P935; Bell DW, 1999, SCIENCE, V286, P2528, DOI 10.1126/science.286.5449.2528; Blasina A, 1999, CURR BIOL, V9, P1, DOI 10.1016/S0960-9822(99)80041-4; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Chaturvedi P, 1999, ONCOGENE, V18, P4047, DOI 10.1038/sj.onc.1202925; Chehab NH, 1999, P NATL ACAD SCI USA, V96, P13777, DOI 10.1073/pnas.96.24.13777; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; HARPER JW, 1993, CELL, V75, P805; Hitoshi Y, 1998, IMMUNITY, V8, P461, DOI 10.1016/S1074-7613(00)80551-8; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Matsuoka S, 1998, SCIENCE, V282, P1893, DOI 10.1126/science.282.5395.1893; MIYASHITA T, 1995, CELL, V80, P293; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; SANCHEZ Y, UNPUB; Schmidt-Kastner PK, 1998, ONCOGENE, V16, P3003, DOI 10.1038/sj.onc.1201835; SELLINS KS, 1987, J IMMUNOL, V139, P3199; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yoshida H, 1998, IMMUNITY, V8, P115, DOI 10.1016/S1074-7613(00)80464-1	25	990	1026	2	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 10	2000	287	5459					1824	1827		10.1126/science.287.5459.1824	http://dx.doi.org/10.1126/science.287.5459.1824			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	292BY	10710310				2022-12-24	WOS:000085775300042
J	Dickson, D				Dickson, D			Affymetrix loses first round of patent battle	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					697	697		10.1038/35008240	http://dx.doi.org/10.1038/35008240			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783861	Bronze			2022-12-24	WOS:000086523600015
J	Dickson, D				Dickson, D			UK ethicists back use of stem cells	NATURE			English	News Item																			0	1	1	0	0	MACMILLAN MAGAZINES LTD	LONDON	PORTERS SOUTH, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 13	2000	404	6779					697	697		10.1038/35008240	http://dx.doi.org/10.1038/35008240			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	305DF	10783861	Bronze			2022-12-24	WOS:000086523600016
